PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	MacWilliams, B				MacWilliams, B			It's a dog's life for Siberian foxes	NATURE			English	News Item																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					845	845		10.1038/35091208	http://dx.doi.org/10.1038/35091208			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528439	Bronze			2022-12-24	WOS:000170689000009
J	Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M				Senftleben, U; Cao, YX; Xiao, GT; Greten, FR; Krahn, G; Bonizzi, G; Chen, Y; Hu, YL; Fong, A; Sun, SC; Karin, M			Activation by IKK alpha of a second, evolutionary conserved, NF-kappa B signaling pathway	SCIENCE			English	Article							MICE LACKING; BETA; PROTEINS; PHOSPHORYLATION; ALYMPHOPLASIA; DEFICIENT; INDUCTION; RESPONSES; SUBUNIT; CELLS	In mammals, the canonical nuclear factor kappaB (NF-kappaB) signaling pathway activated in response to infections is based on degradation Of I kappaB inhibitors. This pathway depends on the I kappaB kinase (IKK), which contains two catalytic subunits, IKK alpha and IKK beta. IKK beta is essential for inducible I kappaB phosphorylation and degradation, whereas IKK alpha is not. Here we show that IKK alpha is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-kappaB target genes, and processing of the NF-kappa B2 (p100) precursor. IKK alpha preferentially phosphorylates NF-kappa B2, and this activity requires its phosphorylation by upstream kinases, one of which may be NF-kappaB-inducing kinase (NIK). IKK alpha is therefore a pivotal component of a second NF-kappaB activation pathway based on regulated NF-kappa B2 processing rather than I kappaB degradation.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Ulm, Anesthesiol Clin, D-89075 Ulm, Germany; Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; Univ Ulm, Dept Dermatol, D-89081 Ulm, Germany	University of California System; University of California San Diego; Ulm University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Ulm University	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Bonizzi, Giuseppina/AAD-9042-2022; Greten, Florian R/AAF-5196-2020; Hu, Yinling/G-5682-2015	Greten, Florian R/0000-0002-3928-6080; Hu, Yinling/0000-0002-4795-8537	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151] Funding Source: NIH RePORTER; NIAID NIH HHS [AI434477, AI45045] Funding Source: Medline; NIEHS NIH HHS [ESO4151] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cao Y., UNPUB; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kaisho T, 2001, J EXP MED, V193, P417, DOI 10.1084/jem.193.4.417; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; RICE NR, 1992, CELL, V78, P773; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	29	1082	1140	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1495	1499		10.1126/science.1062677	http://dx.doi.org/10.1126/science.1062677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520989				2022-12-24	WOS:000170616000046
J	Barnes, DKA				Barnes, DKA			Resource availability Ancient homes for hard-up hermit crabs	NATURE			English	Article							SHELL UTILIZATION		Natl Univ Ireland Univ Coll Cork, Dept Zool & Anim Ecol, Cork, Ireland; Frontier, London EC2A 4QS, England	University College Cork	Barnes, DKA (corresponding author), British Antarctic Survey, High Cross,Maddingley Rd, Cambridge CB3 0ET, England.							Barnes DKA, 1998, J SHELLFISH RES, V17, P51; BARNES DKA, IN PRESS ECOLOGY BIO; BERTNESS MD, 1982, J EXP MAR BIOL ECOL, V64, P159, DOI 10.1016/0022-0981(82)90151-4; Burggren W.W., 1988, BIOL LAND CRABS; FOTHERINGHAM N, 1976, ECOLOGY, V57, P570, DOI 10.2307/1936441; HAZLETT BA, 1980, BEHAV ECOL SOCIOBIOL, V6, P177, DOI 10.1007/BF00569198; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; REESE ERNST S., 1962, ANIMAL BEHAVIOUR, V10, P347, DOI 10.1016/0003-3472(62)90058-1; RUTHERFORD JC, 1977, VELIGER, V19, P438	9	14	17	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	786		10.1038/35090632	http://dx.doi.org/10.1038/35090632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518955				2022-12-24	WOS:000170577200026
J	Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T				Fukui, Y; Hashimoto, O; Sanui, T; Oono, T; Koga, H; Abe, M; Inayoshi, A; Noda, M; Oike, M; Shirai, T; Sasazuki, T			Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration	NATURE			English	Article							CHEMOKINE RECEPTOR; MYOBLAST CITY; T-CELLS; ACTIVATION; ORGANS; CDC42; PHAGOCYTOSIS; POLARIZATION; CHEMOTAXIS; EXPRESSION	Cell migration is a fundamental biological process involving membrane polarization and cytoskeletal dynamics(1), both of which are regulated by Rho family GTPases(2-5). Among these molecules, Rac is crucial for generating the actin-rich lamellipodial protrusion, a principal part of the driving force for movement(3,6). The CDM family proteins, Caenorhabditis elegans CED-5, human DOCK180 and Drosophila melanogaster Myoblast City (MBC), are implicated to mediate membrane extension by functioning upstream of Rac(7-12). Although genetic analysis has shown that CED-5 and Myoblast City are crucial for migration of particular types of cells(8,9,12), physiological relevance of the CDM family proteins in mammals remains unknown. Here we show that DOCK2, a haematopoietic cell-specific CDM family protein(13), is indispensable for lymphocyte chemotaxis. DOCK2-dercient mice (DOCK2(-/-)) exhibited migration defects of T and B lymphocytes, but not of monocytes, in response to chemokines, resulting in several abnormalities including T lymphocytopenia, atrophy of lymphoid follicles and loss of marginal-zone B cells. In DOCK2(-/-) lymphocytes, chemokine-induced Rac activation and actin polymerization were almost totally abolished. Thus, in lymphocyte migration DOCK2 functions as a central regulator that mediates cytoskeletal reorganization through Rac activation.	Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128582, Japan; Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; Juntendo Univ, Sch Med, Dept Pathol 2, Bunkyo Ku, Tokyo 1130033, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Pharmacol, Higashi Ku, Fukuoka 8128582, Japan; Int Med Ctr Japan, Shinjuku Ku, Tokyo 1628655, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kurume University; Juntendo University; Kyushu University; National Center for Global Health & Medicine - Japan	Sasazuki, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Immunogenet,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.			Fukui, Yoshinori/0000-0003-2335-8745				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Onai N, 2000, BLOOD, V96, P2074; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	30	350	360	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					826	831		10.1038/35090591	http://dx.doi.org/10.1038/35090591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518968				2022-12-24	WOS:000170577200039
J	Shah, RR; Abbott, NL				Shah, RR; Abbott, NL			Principles for measurement of chemical exposure based on recognition-driven anchoring transitions in liquid crystals	SCIENCE			English	Article							SURFACE-CONFINED MONOLAYERS; PHASE PROBE MOLECULES; ACID; AMPLIFICATION; SENSORS; GOLD	The competitive binding of a molecule forming a liquid crystal and a targeted anatyte to a common molecular receptor presented at a solid surface possessing nanometer-scate topography is used to trigger an easily visualized surface-driven change in the orientation of a micrometer-thick film of liquid crystal. Diffusion of the targeted analyte from atmosphere to surface-immobilized receptor across the micrometer-thick film of liquid crystal is fast (on the order of seconds), and the competitive interaction of the targeted analyte and liquid crystal with the receptor provides a high level of tolerance to nontargeted species (water, ethanol, acetone, and hexanes). Systems that provide parts-per-billion (by volume) sensitivity to either organoamine or organophosphorus compounds are demonstrated, and their use for imaging of spatial gradients in concentration is reported. This approach does not require complex instrumentation and could provide the basis of wearable personalized sensors for measurement of real-time and cumulative exposure to environmental agents.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.							Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Cisper ME, 1997, RAPID COMMUN MASS SP, V11, P1449; Coetzee JF, 1972, J SOLUTION CHEM, V1, P77, DOI 10.1007/BF00648418; Crooks RM, 1997, FARADAY DISCUSS, V107, P285, DOI 10.1039/a704586g; DAWOOD MR, 1992, J CLIN MICROBIOL, V30, P2279, DOI 10.1128/JCM.30.9.2279-2283.1992; DICKERT FL, 1992, SENSOR ACTUAT B-CHEM, V6, P25, DOI 10.1016/0925-4005(92)80025-S; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GUILBAUL.GG, 1969, J PHYS CHEM-US, V73, P2243, DOI 10.1021/j100727a024; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; Israelachvili J, 2000, INTERMOLECULAR SURFA; JEROME B, 1993, PHYS REV E, V48, P4556, DOI 10.1103/PhysRevE.48.4556; Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b; KEPLEY LJ, 1992, ANAL CHEM, V64, P3191, DOI 10.1021/ac00048a018; MARCUS Y, 1991, J CHEM SOC DALTON, P2265, DOI 10.1039/dt9910002265; MARTELL AE, 1952, CHEM METAL CHELATE C; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Niculescu M, 2000, ANAL CHEM, V72, P1591, DOI 10.1021/ac990848+; NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012; PIERANSKI P, 1990, MOL CRYST LIQ CRYST, V179, P285, DOI 10.1080/00268949008055377; POZIOMEK EJ, 1974, MOL CRYST LIQ CRYST, V27, P175, DOI 10.1080/15421407408083128; Rittmann B., 2000, ENV BIOTECHNOLOGY PR; Shah RR, 2001, J PHYS CHEM B, V105, P4936, DOI 10.1021/jp004073g; Shah RR, 1999, J AM CHEM SOC, V121, P11300, DOI 10.1021/ja9844837; Skaife JJ, 1999, CHEM MATER, V11, P612, DOI 10.1021/cm9804822; THOMAS RC, 1995, J AM CHEM SOC, V117, P3830, DOI 10.1021/ja00118a019; Vo-Dinh T, 1999, FIELD ANAL CHEM TECH, V3, P346, DOI 10.1002/(SICI)1520-6521(1999)3:6<346::AID-FACT4>3.0.CO;2-Q; Wells M, 1996, LANGMUIR, V12, P1989, DOI 10.1021/la9507951; Yang HC, 1996, LANGMUIR, V12, P726, DOI 10.1021/la9505226	28	246	270	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1296	1299		10.1126/science.1062293	http://dx.doi.org/10.1126/science.1062293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509724				2022-12-24	WOS:000170492600033
J	Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C				Wilke, CO; Wang, JL; Ofria, C; Lenski, RE; Adami, C			Evolution of digital organisms at high mutation rates leads to survival of the flattest	NATURE			English	Article							SELECTION BALANCE; POPULATION	Darwinian evolution favours genotypes with high replication rates, a process called 'survival of the fittest'. However, knowing the replication rate of each individual genotype may not suffice to predict the eventual survivor, even in an asexual population. According to quasi-species theory, selection favours the cloud of genotypes, interconnected by mutation, whose average replication rate is highest(1-5). Here we confirm this prediction using digital organisms that self-replicate, mutate and evolve(6-9). Forty pairs of populations were derived from 40 different ancestors in identical selective environments, except that one of each pair experienced a 4-fold higher mutation rate. In 12 cases, the dominant genotype that evolved at the lower mutation rate achieved a replication rate >1.5-fold faster than its counterpart. We allowed each of these disparate pairs to compete across a range of mutation rates. In each case, as mutation rate was increased, the outcome of competition switched to favour the genotype with the lower replication rate. These genotypes, although they occupied lower fitness peaks, were located in flatter regions of the fitness surface and were therefore more robust with respect to mutations.	CALTECH, Digital Life Lab, Pasadena, CA 91125 USA; Michigan State Univ, Ctr Biol Modeling, E Lansing, MI 48824 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; Michigan State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Wilke, CO (corresponding author), CALTECH, Digital Life Lab, Mail Code 136-93, Pasadena, CA 91125 USA.	wilke@caltech.edu	Wilke, Claus O./B-4643-2008; Adami, Chris/A-9675-2011; Adami, Christoph/A-5181-2009	Adami, Chris/0000-0002-2915-9504; Wilke, Claus/0000-0002-7470-9261; Ofria, Charles/0000-0003-2924-1732; Lenski, Richard/0000-0002-1064-8375				Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Adami C., 1998, INTRO ARTIFICIAL LIF; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Eigen M, 1979, THE HYPERCYCLE, P60; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Freeland SJ, 1998, P ROY SOC B-BIOL SCI, V265, P2111, DOI 10.1098/rspb.1998.0547; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; Johnson T, 1999, P ROY SOC B-BIOL SCI, V266, P2389, DOI 10.1098/rspb.1999.0936; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; RAY TS, 1991, ARTIF LIFE, V2, P372; SCHUSTER P, 1988, B MATH BIOL, V50, P635, DOI 10.1016/S0092-8240(88)80059-4; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; WIKE CO, IN PRESS B MATH BIOL	28	420	428	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					331	333		10.1038/35085569	http://dx.doi.org/10.1038/35085569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460163				2022-12-24	WOS:000169918200046
J	DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A				DEPATER, I; HEILES, C; WONG, M; MADDALENA, RJ; BIRD, MK; FUNKE, O; NEIDHOEFER, J; PRICE, RM; KESTEVEN, M; CALABRETTA, M; KLEIN, MJ; GULKIS, S; BOLTON, SJ; FOSTER, RS; SUKUMAR, S; STROM, RG; LEPOOLE, RS; SPOELSTRA, T; ROBISON, M; HUNSTEAD, RW; CAMPBELLWILSON, D; YE, T; DULK, G; LEBLANC, Y; GALOPEAU, P; GERARD, E; LECACHEUX, A			OUTBURST OF JUPITER SYNCHROTRON-RADIATION AFTER THE IMPACT OF COMET SHOEMAKER-LEVY-9	SCIENCE			English	Article							RADIO IMAGES	Jupiter's nonthermal microwave emission, as measured by a global network of 11 radio telescopes, increased dramatically during the Shoemaker-Levy 9 impacts. The increase was wavelength-dependent, varying from similar to 10 percent at 70 to 90 centimeters to similar to 45 percent at 6 and 36 centimeters. The radio spectrum hardened (flattened toward shorter wavelengths) considerably during the week of impacts and continued to harden afterward. After the week of cometary impacts, the flux density began to subside at all wavelengths and was still declining 3 months later. Very Large Array and Australia Telescope images of the brightness distribution showed the enhancement to be localized in longitude and concentrated near the magnetic equator. The evidence therefore suggests that the increase in flux density was caused by a change in the resident particle population, for example, through an energization or spatial redistribution of the emitting particles.	NATL RADIO ASTRON OBSERV,GREEN BANK,WV 24944; UNIV BONN,D-53121 BONN,GERMANY; MAX PLANCK INST RADIOASTRON,D-53121 BONN,GERMANY; CSIRO,EPPING,NSW 2121,AUSTRALIA; CALTECH,JET PROP LAB,PASADENA,CA 91109; USN,RES LAB,WASHINGTON,DC 20375; NATL RES COUNCIL CANADA,DOMIN RADIO ASTROPHYS OBSERV,PENTICTON,BC V2A 6K3,CANADA; NETHERLANDS FDN RES ASTRON,7990 AA DWINGELOO,NETHERLANDS; LEIDEN UNIV,2300 RA LEIDEN,NETHERLANDS; NEW MEXICO INST MIN & TECHNOL,SOCORRO,NM 87801; UNIV SYDNEY,SCH PHYS,SYDNEY,NSW 2006,AUSTRALIA; DEPT ASTROPHYS PLANETARY & ATMOSPHER SCI,BOULDER,CO 80309; OBSERV PARIS,F-92195 MEUDON,FRANCE	National Radio Astronomy Observatory (NRAO); University of Bonn; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory; National Research Council Canada; Leiden University; Leiden University - Excl LUMC; New Mexico Institute of Mining Technology; University of Sydney; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	DEPATER, I (corresponding author), UNIV CALIF BERKELEY,DEPT ASTRON,BERKELEY,CA 94720, USA.		Bolton, Scott/M-4392-2019	bolton, scott/0000-0002-9115-0789				BAARS JWM, 1977, ASTRON ASTROPHYS, V61, P99; BIRD MK, 1994, 6069 INT ASTR UN CIR; BOLTON SJ, 1991, THESIS U CALIFORNIA; BOLTON SJ, 1994, EOS                S, V75, P405; BRECHT SH, IN PRESS GEOPHYS RES; BRICE N, 1973, ICARUS, V18, P206, DOI 10.1016/0019-1035(73)90204-2; CLARKE JT, 1995, SCIENCE, V267, P1302, DOI 10.1126/science.7871427; DEPATER I, 1991, ASTRON J, V102, P795, DOI 10.1086/115911; DEPATER I, 1990, J GEOPHYS RES-SPACE, V95, P39, DOI 10.1029/JA095iA01p00039; DEPATER I, 1990, ANNU REV ASTRON ASTR, V28, P347, DOI 10.1146/annurev.astro.28.1.347; DEPATER I, 1994, J GEOPHYS RES-SPACE, V99, P2271, DOI 10.1029/93JA02097; DEPATER I, 1994, GEOPHYS RES LETT, V21, P1071, DOI 10.1029/94GL01058; DEPATER I, UNPUB; DEPATER I, 1994, 6074 INT ASTR UN CIR; DEPATER I, NASA P, V494, P139; DESSLER AJ, 1994, GEOPHYS RES LETT, V21, P1043, DOI 10.1029/94GL01294; DESSLER AJ, 1994, B AM ASTRON SOC, V26, P1593; DULK GA, IN PRESS GEOPHYS RES; GROSSMAN AW, 1994, B AM ASTRON SOC, V26, P1587; HILL T, 1994, EOS                S, V75, P402; HORANYI M, 1994, GEOPHYS RES LETT, V21, P1039, DOI 10.1029/94GL01326; IP WH, 1994, PLANET SPACE SCI, V42, P527, DOI 10.1016/0032-0633(94)90073-6; IP WH, 1994, EOS                S, V75, P404; IP WH, IN PRESS PLANET SPAC; KLEIN MJ, NASA P, V494, P151; LEBLANC Y, IN PRESS GEOPHYS RES; OTT M, 1994, ASTRON ASTROPHYS, V284, P331; ULICH BL, 1976, ASTROPHYS J SUPPL S, V30, P247, DOI 10.1086/190361; WAITE JH, IN PRESS SCIENCE; Willis A. G., 1977, IAU S, V74, P39; Wong M, UNPUB	31	40	40	0	2	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 30	1995	268	5219					1879	1883		10.1126/science.11536723	http://dx.doi.org/10.1126/science.11536723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF990	11536723				2022-12-24	WOS:A1995RF99000032
J	DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW				DAMSTE, JSS; WAKEHAM, SG; KOHNEN, MEL; HAYES, JM; DELEEUW, JW			A 6,000-YEAR SEDIMENTARY MOLECULAR RECORD OF CHEMOCLINE EXCURSIONS IN THE BLACK-SEA	NATURE			English	Article							PHOTOSYNTHESIS; DIAGENESIS	THE Black Sea is the world's largest anoxic basin; it is also a contemporary analogue of the environment in which carbonaceous shales and petroleum source beds formed1. Recently, Repeta et al.2,3 reported that anoxygenic photosynthesis may be an important component of carbon cycling in the present Black Sea, owing to a shoaling of the chemocline and consequent penetration of the photic zone by anaerobic waters in the past few decades4,5. It has been suggested4 that this was due to an anthropogenic decrease in freshwater input to the Black Sea, although natural causes were not ruled out. Here we report the distributions of sequestered photosynthetic pigments in eight core samples of sediments from the Black Sea ranging in age from zero to 6,200 years before the present. Our results show that photosynthetic green sulphur bacteria (Clorobiaceae) have been active in the Black Sea for substantial periods of time in the past. This finding indicates that the penetration of the photic zone by anaerobic waters is not a recent phenomenon, and suggests that natural causes for shoaling of the chemocline are more likely than anthropogenic ones4.	DELFT UNIV TECHNOL,ORGAN GEOCHEM UNIT,2628 RZ DELFT,NETHERLANDS; SKIDAWAY INST OCEANOG,SAVANNAH,GA 31416; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Delft University of Technology; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	DAMSTE, JSS (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		Damste, Jaap S Sinninghe/F-6128-2011; de Leeuw, Jan W/F-6471-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; 				BRASSELL SC, 1986, NATURE, V320, P160, DOI 10.1038/320160a0; BRYANTSEV VA, 1988, OCEANOLOGY, V28, P180; BUKRY D, 1974, MEM AM ASS PETROL GE, V20, P253; DEMAISON GJ, 1980, AAPG BULL, V64, P1179; DEUSER WG, 1974, AAPG BULL, V20, P133; HAY BJ, 1991, DEEP-SEA RES, V38, pS1211; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; KEMPE S, 1990, NATURE, V346, P419, DOI 10.1038/346419a0; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1991, DEEP-SEA RES, V38, pS969, DOI 10.1016/S0198-0149(10)80019-6; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; Ross D., 1974, BLACK SEA GEOLOGY CH, P183; ROSS DA, 1970, SCIENCE, V170, P163, DOI 10.1126/science.170.3954.163; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; TUGRUL S, 1992, NATURE, V359, P137, DOI 10.1038/359137a0	21	199	203	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 29	1993	362	6423					827	829		10.1038/362827a0	http://dx.doi.org/10.1038/362827a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ563	11536532				2022-12-24	WOS:A1993KZ56300051
J	ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM				ALLAMANDOLA, LJ; SANDFORD, SA; TIELENS, AGGM; HERBST, TM			DIAMONDS IN DENSE MOLECULAR CLOUDS - A CHALLENGE TO THE STANDARD INTERSTELLAR-MEDIUM PARADIGM	SCIENCE			English	Article							METEORITES; EVOLUTION; ORIGIN; DUST	Observations of a newly discovered infrared C-H stretching band indicate that interstellar diamond-like material appears to be characteristic of dense clouds. In sharp contrast. the spectral signature of dust in the diffuse interstellar medium is dominated by -CH2- and -CH3 groups. This dichotomy in the aliphatic organic component between the dense and diffuse media challenges standard assumptions about the processes occurring in, and interactions between, these two media. The ubiquity of this interstellar diamond-like material rules out models for meteoritic diamond formation in unusual circumstellar environments and implies that the formation of the diamond-like material is associated with common interstellar processes or stellar types.	UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822	University of Hawaii System	ALLAMANDOLA, LJ (corresponding author), NASA,AMES RES CTR,MAIL STOP 245-6,MT VIEW,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROPHYS J, V399, P134, DOI 10.1086/171909; Bellamy L.J, 1958, INFRA RED SPECTRA CO; BERNATOWICZ TJ, 1990, ASTROPHYS J, V359, P246, DOI 10.1086/169056; BLAKE DF, 1988, NATURE, V332, P611, DOI 10.1038/332611a0; Clayton D. D., 1981, P LUNAR PLANET SCI, V12B, P1781; DULEY WW, 1989, MON NOT R ASTRON SOC, V236, P709, DOI 10.1093/mnras/236.4.709; EHRENFREUND P, 1992, ASTRON ASTROPHYS, V252, P612; Greenberg J. M., 1982, Submillimetre Wave Astronomy, P261; JONES AP, 1990, Q J ROY ASTRON SOC, V31, P567; JORGENSON UG, 1989, NATURE, V322, P702; KOBASHI K, 1988, SPIE, V969, P159; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1989, NATURE, V339, P117, DOI 10.1038/339117a0; MCKEE CF, 1989, INTERSTELLAR DUST, P431; MING T, 1988, GEOCHIM COSMOCHIM AC, V52, P1235, DOI 10.1016/0016-7037(88)90277-3; MORRISON RT, 1966, ORGANIC CHEM; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; NUTH JA, 1985, NATURE, V318, P166, DOI 10.1038/318166a0; PENDLETON Y, UNPUB; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SANDHU GS, 1988, SPIE DIAMOND OPTICS, V969, P37; SILVERSTEIN RM, 1967, SPECTROMETRIC IDENTI, pCH3; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333; TIELENS AGG, 1989, INTERSTELLAR DUST, P239; TIELENS AGG, 1990, NASA CP3061, P59; TIELENS AGGM, 1987, ASTROPHYS J, V319, pL109, DOI 10.1086/184964; Wexler AS, 1967, APPL SPECTROSC REV, V1, P29, DOI DOI 10.1080/05704926708547581; WILLNER SP, 1982, ASTROPHYS J, V253, P174, DOI 10.1086/159622	29	89	89	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 2	1993	260	5104					64	66		10.1126/science.11538059	http://dx.doi.org/10.1126/science.11538059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV423	11538059				2022-12-24	WOS:A1993KV42300025
J	BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE				BARON, R; JOSEPH, RD; OWEN, T; TENNYSON, J; MILLER, S; BALLESTER, GE			IMAGING JUPITER AURORAE FROM H-3+ EMISSIONS IN THE 3-4 MU-M BAND	NATURE			English	Article							SOUTH POLAR AURORAE; FUNDAMENTAL-BAND; IUE DATA; NORTH; SPECTROMETRY; VOYAGER	SINCE H-3+ was first spectroscopically detected on Jupiter 1,2, there has been considerable interest in using this simple molecular ion to probe conditions existing in the planet's auroral regions. Here we present a series of images of Jupiter recorded at wavelengths sensitive to emission by H-3+, which reveal the spatial distribution of excited H-3+ molecular ions in the jovian ionosphere, as seen from Earth. We believe that they provide high-spatial-resolution images of polar aurorae on Jupiter. They suggest that the intensity of the auroral emission can vary on a timescale of an hour, a shorter period than had previously been noted. We also find that the spatial distribution of H-3+ emissions correlates only partially with the loci of auroral activity inferred from ultraviolet and longer-wavelength infrared observations. The H-3+ emission may therefore be controlled by auroral processes that are different from those responsible for the ultraviolet and infrared emissions.	UNIV LONDON UNIV COLL,DEPT PHYS & ASTRON,LONDON WC1E 6BT,ENGLAND; UNIV OXFORD,DEPT EARTH SCI,OXFORD OX1 3PR,ENGLAND	University of London; University College London; University of Oxford	BARON, R (corresponding author), UNIV HAWAII,INST ASTRON,2680 WOODLAWN DR,HONOLULU,HI 96822, USA.		Tennyson, Jonathan/I-2222-2012	Tennyson, Jonathan/0000-0002-4994-5238; Miller, Steven/0000-0002-7159-6871				BARON R, 1991, IAU5132 CIRC; BARON R, 1991, IAU5211 CIRC; BROADFOOT AL, 1981, J GEOPHYS RES-SPACE, V86, P8259, DOI 10.1029/JA086iA10p08259; CALDWELL J, 1980, ICARUS, V44, P667, DOI 10.1016/0019-1035(80)90135-9; CALDWELL J, 1988, ICARUS, V74, P331, DOI 10.1016/0019-1035(88)90045-0; CONNERNEY JEP, 1981, J GEOPHYS RES-SPACE, V86, P8370, DOI 10.1029/JA086iA10p08370; DROSSART P, 1986, ICARUS, V66, P610, DOI 10.1016/0019-1035(86)90094-1; DROSSART P, 1989, NATURE, V340, P539, DOI 10.1038/340539a0; HERBERT F, 1987, J GEOPHYS RES, V92, P3141, DOI 10.1029/JA092iA04p03141; KIM SJ, 1985, ICARUS, V64, P233, DOI 10.1016/0019-1035(85)90088-0; KOSTIUK T, 1987, ICARUS, V72, P394, DOI 10.1016/0019-1035(87)90182-5; LIVENGOOD TA, 1990, GEOPHYS RES LETT, V17, P2265, DOI 10.1029/GL017i012p02265; LIVENGOOD TA, 1991, EOS, V72, P186; LIVENGOOD TA, 1990, J GEOPHYS RES, V95, P10365; MAILLARD JP, 1990, ASTROPHYS J, V363, pL37, DOI 10.1086/185859; MAJEWSKI WA, 1989, ASTROPHYS J, V347, pL51, DOI 10.1086/185605; MILLER S, 1990, ASTROPHYS J, V360, pL55, DOI 10.1086/185811; OKA T, 1990, ASTROPHYS J, V351, pL53, DOI 10.1086/185678; PRANGE R, IN PRESS ADV SPACE R; SKINNER TE, 1984, THESIS J HOPKINS U; Strobel D.F., 1983, INT REV PHYS CHEM, V3, P145, DOI [10.1080/01442358309353342, DOI 10.1080/01442358309353342]; TRAFTON L, 1989, ASTROPHYS J, V343, pL73, DOI 10.1086/185514	22	92	92	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 10	1991	353	6344					539	542		10.1038/353539a0	http://dx.doi.org/10.1038/353539a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ643	11538254				2022-12-24	WOS:A1991GJ64300059
J	FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P				FREEMAN, KH; HAYES, JM; TRENDEL, JM; ALBRECHT, P			EVIDENCE FROM CARBON ISOTOPE MEASUREMENTS FOR DIVERSE ORIGINS OF SEDIMENTARY HYDROCARBONS	NATURE			English	Article									INDIANA UNIV,DEPT GEOL,BLOOMINGTON,IN 47405; UNIV STRASBOURG 1,DEPT CHIM,CHIM ORGAN SUBST NAT LAB,F-67008 STRASBOURG,FRANCE	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	FREEMAN, KH (corresponding author), INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,GEOL BLDG,BLOOMINGTON,IN 47405, USA.		Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				COLEMAN DD, 1981, GEOCHIM COSMOCHIM AC, V45, P1033, DOI 10.1016/0016-7037(81)90129-0; COLLISTER JW, IN PRESS B US GEOL S; CORBET B, 1980, J AM CHEM SOC, V192, P1171; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DIDYK BM, 1978, NATURE, V272, P216, DOI 10.1038/272216a0; Ensminger A., 1973, ADV ORG GEOCHEM, P245; FRY B, 1986, LIMNOL OCEANOGR, V31, P79, DOI 10.4319/lo.1986.31.1.0079; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KEPKAY PE, 1979, SCIENCE, V204, P68, DOI 10.1126/science.204.4388.68; KIMBLE BJ, 1974, GEOCHIM COSMOCHIM AC, V38, P1165, DOI 10.1016/0016-7037(74)90011-8; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; MICHAELIS W, 1989, SCI TOTAL ENVIRON, V81-2, P41, DOI 10.1016/0048-9697(89)90109-5; NEUNLIST S, 1985, BIOCHEM J, V231, P635, DOI 10.1042/bj2310635; OSMOND CB, 1981, OECOLOGIA, V50, P117, DOI 10.1007/BF00378804; OURISSON G, 1987, ANNU REV MICROBIOL, V41, P301, DOI 10.1146/annurev.mi.41.100187.001505; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUIRK MM, 1984, CHEM GEOL, V42, P25, DOI 10.1016/0009-2541(84)90003-2; RIESKAUTT M, 1989, CHEM GEOL, V76, P143, DOI 10.1016/0009-2541(89)90133-2; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROBINSON N, 1989, CHEM GEOL, V76, P153, DOI 10.1016/0009-2541(89)90134-4; SEIFERT WK, 1980, ADV ORG GEOCHEM, P229; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; TENHAVEN HL, 1987, NATURE, V330, P641, DOI 10.1038/330641a0; TRENDEL JM, 1989, TETRAHEDRON, V45, P4457, DOI 10.1016/S0040-4020(01)89081-5; VANDORSSELAER A, 1977, B SOC CHIM FR II-CH, P165; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; ZUNDEL M, 1985, FEMS MICROBIOL LETT, V28, P61, DOI 10.1111/j.1574-6968.1985.tb00764.x	31	448	489	1	78	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					254	256		10.1038/343254a0	http://dx.doi.org/10.1038/343254a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536462				2022-12-24	WOS:A1990CJ68200068
J	MAHER, KA; STEVENSON, DJ				MAHER, KA; STEVENSON, DJ			IMPACT FRUSTRATION OF THE ORIGIN OF LIFE	NATURE			English	Article											MAHER, KA (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.							ABBOTT DH, 1984, TECTONICS, V3, P429, DOI 10.1029/TC003i004p00429; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; AWRAMIK SM, 1982, MINERAL DEPOSITS EVO, P309; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; CAIRNSMITH AG, 1985, SCI AM, V256, P90; CARR MH, 1984, NASA SP469; CHANG S, 1982, PHYS EARTH PLANET IN, V29, P261, DOI 10.1016/0031-9201(82)90017-6; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; Gault D.E., 1982, GEOL SOC AM SPEC PAP, V190, P69; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1979, ICARUS, V38, P230, DOI 10.1016/0019-1035(79)90180-5; GRIEVE RAF, 1984, 27TH INT GEOL C MOSC, V19, P99; HARTMAN WK, 1977, COMETS ASTEROIDS MET, P277; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; KASTING JF, 1984, ORIGINS LIFE EVOL B, V14, P75, DOI 10.1007/BF00933642; LAZCANO A, 1983, PRECAMBRIAN RES, V20, P259, DOI 10.1016/0301-9268(83)90076-1; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; MCGETCHIN TR, 1973, EARTH PLANET SC LETT, V20, P226, DOI [10.1016/0012-821X(73)90162-3, 10.1016/0012-821X(74)90115-0]; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MILLER SL, 1982, MINERAL DEPOSITS EVO, P155; MOORBATH S, 1984, ORIGINS LIFE, V15, P251; OKEEFE JD, 1982, NATURE, V298, P123, DOI 10.1038/298123a0; PRINN RG, 1985, EOS, V46, P813; SCHMIDT RM, 1982, GEOL SOC AM SPEC PAP, V190, P93, DOI DOI 10.1130/SPE190-P93; SEEBAUGH WR, 1977, IMPACT EXPLOSION CRA, P1043; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1970, ICARUS, V12, P188, DOI 10.1016/0019-1035(70)90072-2; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1982, NEW SOLAR SYSTEM, P33; Toon OB., 1982, GEOL SOC AM SPEC PAP, V190, P187	31	269	275	1	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	FEB 18	1988	331	6157					612	614		10.1038/331612a0	http://dx.doi.org/10.1038/331612a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M1180	11536595				2022-12-24	WOS:A1988M118000053
J	Smith, GCS; Pell, JP				Smith, GCS; Pell, JP			Teenage pregnancy and risk of adverse perinatal outcomes associated with first and second births: population based retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; INFANT-MORTALITY; PRETERM BIRTH; WEIGHT; DETERMINANTS; ADOLESCENTS; DELIVERY; SMOKING; MOTHERS; PARITY	Objective To determine whether first and second births among teenagers are associated With increased risk of adverse perinatal outcomes after confounding variables have been taken into account. Design Population based retrospective cohort study using routine discharge data for 1992-8. Setting Scotland. Main outcome measures Stillbirth, preterm. delivery, emergency caesarean section, and small for gestational age baby among non-smoking mothers aged 15-19 and 20-29. Results The 110 233 eligible deliveries Were stratified into first and second births. Among first births, the only significant difference in adverse outcomes by age group was for emergency caesarean section, which was less likely among younger mothers (odds ratio 0.5, 95% confidence interval 0.5 to 0.6). Second births in women aged 15-19 Were associated with an increased risk of moderate (1.6, 1.2 to 2.1) and extreme prematurity (2.5, 1.5 to 4.3) and stillbirth (2.6, 1.3 to 5.3) but a reduced risk of emergency caesarean section (0.7, 0.5 to 1.0). Conclusions First teenage births are not independently associated with ari increased risk of adverse pregnancy outcome and are at decreased risk of delivery by emergency caesarean section. However, second teenage births are associated with an almost threefold risk of preterm delivery and stillbirth.	Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Univ Glasgow, Queen Mothers Hosp, Dept Obstet & Gynaecol, Glasgow G3 8SH, Lanark, Scotland	University of Glasgow	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997				Astolfi P, 1999, HUM REPROD, V14, P2891, DOI 10.1093/humrep/14.11.2891; Berenson AB, 1997, J REPROD MED, V42, P559; BLANKSON ML, 1993, JAMA-J AM MED ASSOC, V269, P1401, DOI 10.1001/jama.269.11.1401; COLE SK, 1980, PERINATAL AUDIT SURV, P39; DIFRANZA JR, 1995, J FAM PRACTICE, V40, P385; ELSTER AB, 1984, AM J OBSTET GYNECOL, V149, P845, DOI 10.1016/0002-9378(84)90602-1; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; HELLERSTEDT WL, 1995, AM J PUBLIC HEALTH, V85, P1139, DOI 10.2105/AJPH.85.8_Pt_1.1139; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Lao TT, 1998, HUM REPROD, V13, P3228, DOI 10.1093/humrep/13.11.3228; Lao TT, 1997, HUM REPROD, V12, P2303, DOI 10.1093/humrep/12.10.2303; LEE KS, 1988, AM J OBSTET GYNECOL, V158, P84, DOI 10.1016/0002-9378(88)90783-1; LUMLEY J, 1993, BAILLIERE CLIN OB GY, V7, P477, DOI 10.1016/S0950-3552(05)80445-6; MCCORMICK MC, 1984, AM J PUBLIC HEALTH, V74, P18, DOI 10.2105/AJPH.74.1.18; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Olausson PMO, 1997, OBSTET GYNECOL, V89, P451, DOI 10.1097/00006250-199703000-00027; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; STROBINO DM, 1995, AM J EPIDEMIOL, V142, P504, DOI 10.1093/oxfordjournals.aje.a117668; SWEENEY PJ, 1989, AM J OBSTET GYNECOL, V160, P1361, DOI 10.1016/0002-9378(89)90856-9; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	24	139	142	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					476	479		10.1136/bmj.323.7311.476	http://dx.doi.org/10.1136/bmj.323.7311.476			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532837	Green Published, Bronze			2022-12-24	WOS:000170838500014
J	Charrier, I; Mathevon, N; Jouventin, P				Charrier, I; Mathevon, N; Jouventin, P			Mother's voice recognition by seal pups - Newborns need to learn their mother's call before she can take off on a fishing trip.	NATURE			English	Article							ARCTOCEPHALUS-TROPICALIS; VOCAL RECOGNITION; AMSTERDAM ISLAND; FUR SEALS; GROWTH		Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France; CNRS, CEFE, UPR 9056, F-34213 Montpellier, France; CNRS, NAMC, UMR 8620, F-91400 Orsay, France	Universite Jean Monnet; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Charrier, I (corresponding author), Univ St Etienne, Lab Biol Anim, F-42023 St Etienne 2, France.	mathevon@univ-st-etienne.fr		CHARRIER, Isabelle/0000-0003-4873-2342				Addae PC, 2000, APPL ANIM BEHAV SCI, V67, P77, DOI 10.1016/S0168-1591(99)00119-7; Gentry R.L., 1986, FUR SEALS MATERNAL S; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Georges JY, 2000, J ZOOL, V251, P277, DOI 10.1111/j.1469-7998.2000.tb01078.x; Hofer M.A., 1981, P77; Insley SJ, 2000, NATURE, V406, P404, DOI 10.1038/35019064; JONES IL, 1987, ANIM BEHAV, V35, P1405, DOI 10.1016/S0003-3472(87)80013-1; KERLEY GIH, 1985, J ZOOL, V205, P315; Riedman M., 1990, PINNIPEDS SEALS SEA; Roux J.-P., 1987, NOAA Technical Report NMFS, V51, P95; STIRLING I, 1975, J AUST MAMMAL SOC, V1, P389	11	93	97	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					873	873		10.1038/35091136	http://dx.doi.org/10.1038/35091136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528465	Bronze			2022-12-24	WOS:000170689000031
J	Bibby, TS; Nield, J; Barber, J				Bibby, TS; Nield, J; Barber, J			Iron deficiency induces the formation of an antenna ring around trimeric photosystem I in cyanobacteria	NATURE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; EQUATORIAL PACIFIC-OCEAN; ISIA GENE; COMPLEX; SYNECHOCYSTIS-6803; CRYSTALLOGRAPHY; LIMITATION; RESOLUTION; BACTERIA; SYSTEM	Although iron is the fourth most abundant element in the Earth's crust, its concentration in the aquatic ecosystems-particularly the open oceans-is sufficiently low to limit photosynthetic activity and phytoplankton growth(1,2). Cyanobacteria, a major class of phytoplankton, respond to iron deficiency by expressing the 'iron-stress-induced' gene, isiA(ref. 3). The protein encoded by this gene has an amino-acid sequence that shows significant homology with one of the chlorophyll a-binding proteins (CP43) of photosystem II (PSII)(4,5). The precise function of the CP43-like protein, here called CP43', has not been elucidated, although there have been many suggestions(3,6). Here we show that CP43' associates with photosystem I (PSI) to form a complex that consists of a ring of 18 CP43' molecules around a PSI trimer. This significantly increases the size of the light-harvesting system of PSI. The utilization of a PSII-like protein as an extra antenna for PSI emphasises the flexibility of cyanobacterial light-harvesting systems, and seems to be a strategy which compensates for the lowering of phycobilisome and PSI levels in response to iron deficiency.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England	Imperial College London	Barber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England.	j.barber@ic.ac.uk	Nield, Jon/C-5892-2013; Bibby, Thomas/C-9159-2014	Nield, Jon/0000-0001-9983-0239; Bibby, Thomas/0000-0003-1743-473X				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1994, J BIOENERG BIOMEMBR, V26, P17, DOI 10.1007/BF00763217; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; FALK S, 1995, PHOTOSYNTH RES, V45, P51, DOI 10.1007/BF00032235; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hankamer B, 1999, NAT STRUCT BIOL, V6, P560, DOI 10.1038/9341; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; ROGNER M, 1990, BIOCHIM BIOPHYS ACTA, V1015, P415, DOI 10.1016/0005-2728(90)90074-E; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; Sherman MB, 1998, ULTRAMICROSCOPY, V74, P179, DOI 10.1016/S0304-3991(98)00041-2; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	22	289	304	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					743	745		10.1038/35089098	http://dx.doi.org/10.1038/35089098			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507643				2022-12-24	WOS:000170450200047
J	Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB				Cagnin, A; Brooks, DJ; Kennedy, AM; Gunn, RN; Myers, R; Turkheimer, FE; Jones, T; Banati, RB			In-vivo measurement of activated microglia in dementia	LANCET			English	Article							H-3 PK11195 BINDING; ALZHEIMERS-DISEASE; PERIPHERAL BENZODIAZEPINE; EMISSION TOMOGRAPHY; FOCAL ISCHEMIA; BRAIN; PET; LESIONS; SITES; HIPPOCAMPUS	Background Activated microglia have a key role in the brain's immune response to neuronal degeneration. The transition of microglia from the normal resting state to the activated state is associated with an increased expression of receptors known as peripheral benzodiazepine binding sites, which are abundant on cells of mononuclear phagocyte lineage. We used brain imaging to study expression of these sites in healthy individuals and patients with Alzheimer's disease. Methods We studied 15 normal individuals (age 32-80 years), eight patients with Alzheimer's disease, and one patient with minimal cognitive impairment. Quantitative in-vivo measurements of glial activation were obtained with positron emission tomography (PET) and carbon-11-labelled (R)-PK11195, a specific ligand for the peripheral benzodiazepine binding site. Findings In normal individuals, regional [C-11](R)-PK11195 binding did not significantly change with age, except in the thalamus, where an age-dependent increase was found. By contrast, patients with Alzheimer's disease showed significantly increased regional [C-11](R)-PK11195 binding in the entorhinal, temporoparietal, and cingulate cortex. Interpretation In-vivo detection of increased [C-11](R)-PK11195 binding in Alzheimer-type dementia, including mild and early forms, suggests that microglial activation is an early event in the pathogenesis of the disease.	Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England; Max Planck Inst Neurobiol, Dept Neuromorphol, Martinsried, Germany; Fac Med, Imperial Coll, Dept Neuropathol, Div Neurosci & Psychol Med, London, England	Imperial College London; Max Planck Society; Imperial College London	Banati, RB (corresponding author), Hammersmith Hosp, Fac Med, Imperial Coll,Div Neurosci & Psychol Med, MRC Cyclotron Unit, London W12 0NN, England.	richard.banati@csc.mrc.ac.uk	Gunn, Roger/H-1666-2012; Turkheimer, Federico E/B-9485-2012	Gunn, Roger/0000-0003-1181-5769; Turkheimer, Federico E/0000-0002-3766-3815; Brooks, David/0000-0003-2602-2518				Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Conway EL, 1998, NEUROSCIENCE, V82, P805; CUNNINGHAM VJ, 1993, J CEREBR BLOOD F MET, V13, P15, DOI 10.1038/jcbfm.1993.5; Dumont F, 1999, EUR J NUCL MED, V26, P194, DOI 10.1007/s002590050376; Esiri M. M., 1997, GREENFIELDS NEUROPAT, P153; GROOM GN, 1995, J NUCL MED, V36, P2207; Gunn RN, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P401, DOI 10.1016/B978-012161340-2/50062-7; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P677, DOI 10.1097/00004728-199509000-00001; Hertz L., 1993, PERIPHERAL BENZODIAZ, P27; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Meguro K, 1999, BRAIN, V122, P1519, DOI 10.1093/brain/122.8.1519; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Niemann K, 2000, PSYCHIAT RES-NEUROIM, V99, P93, DOI 10.1016/S0925-4927(00)00059-7; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; SHAH F, 1994, NUCL MED BIOL, V21, P573, DOI 10.1016/0969-8051(94)90022-1; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7	30	805	827	0	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					461	467		10.1016/S0140-6736(01)05625-2	http://dx.doi.org/10.1016/S0140-6736(01)05625-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513911				2022-12-24	WOS:000170492400013
J	Matte, TD; Bresnahan, M; Begg, MD; Susser, E				Matte, TD; Bresnahan, M; Begg, MD; Susser, E			Influence of variation in birth weight within normal range and within sibships on IQ at age 7 years: cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; GROWTH	Objective To examine the relation between birth weight and measured intelligence at age 7 years in children within the normal range of birth weight and in siblings. Design Cohort study of siblings of the same sex. Setting 12 cities in the United States. Subjects 3484 children of 1683 mothers in a birth cohort study during the years 1959 through 1966. The sample was restricted to children born at greater than or equal to 37 weeks gestation and with birth weights of 1500-3999 g. Main outcome measure Full scale IQ at age 7 years. Results Mean IQ increased monotonically with birth weight in both sexes across the range of birth weight in a linear regression analysis of one randomly selected sibling per family (n = 1683) with adjustment for maternal age, race, education, socioeconomic status, and birth order. Within same sex sibling pairs, differences in birth weight were directly associated with differences in IQ in boys (812 pairs, predicted IQ difference per 100 g change in birth weight = 0.50, 95% confidence interval 0.28 to 0.71) but not girls (871 pairs, 0.10, - 0.09 to 0.30). The effect in boys remained after differences in birth order, maternal smoking, and head circumference were adjusted for and in an analysis restricted to children with birth weight greater than or equal to 2500 g. Conclusion The increase in childhood IQ with birth weight continues well into the normal birth weight range. For boys this relation holds within same sex sibships and therefore cannot be explained by confounding from family social environment.	New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY 10032 USA	New York Academy of Medicine; Columbia University; Columbia University	Matte, TD (corresponding author), New York Acad Med, Ctr Urban Epidemiol Studies, 1216 5th Ave, New York, NY 10029 USA.							[Anonymous], 1999, NATL VITAL STAT REPO; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; BRESLAU N, 1994, ARCH PEDIAT ADOL MED, V148, P377, DOI 10.1001/archpedi.1994.02170040043007; Broman SH, 1984, HDB LONGITUDINAL RES, V1; *COLL PER PROJ EL, 1958, REC NAT I NEUR DIS S; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; HARDY JB, 1977, EPIDEMIOLOGY PREMATU; Hutchison JB, 1997, CELL MOL NEUROBIOL, V17, P603, DOI 10.1023/A:1022581902880; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; MYRIANTHOPOULOS NC, 1968, SOC SCI MED, V2, P283, DOI 10.1016/0037-7856(68)90004-8; NISWANDER NR, 1972, WOMEN THEIR PREGNANC; RECORD RG, 1969, ANN HUM GENET, V33, P71, DOI 10.1111/j.1469-1809.1969.tb01631.x; Richter C.P., 1922, PSYCHOL MONOGR, V1, P1; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Stein Z., 1975, FAMINE HUM DEV DUTCH; Strauss RS, 1998, J PEDIATR-US, V133, P67, DOI 10.1016/S0022-3476(98)70180-5; Wechsler D., 2016, WECHSLER INTELLIGENC	18	218	221	1	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					310	314		10.1136/bmj.323.7308.310	http://dx.doi.org/10.1136/bmj.323.7308.310			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498487	Green Published, Bronze			2022-12-24	WOS:000170470900018
J	Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X				Gratacos, M; Nadal, M; Martin-Santos, R; Pujana, MA; Gago, J; Peral, B; Armengol, L; Ponsa, I; Miro, R; Bulbena, A; Estivill, X			A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders	CELL			English	Article							JOINT HYPERMOBILITY SYNDROME; ANXIETY DISORDERS; LOCUS-CERULEUS; TRK FAMILY; RECEPTOR; CELLS; NEUROTROPHIN-3; REARRANGEMENTS; ASSOCIATION; HYPOTHESIS	Anxiety disorders are complex and common psychiatric illnesses associated with considerable morbidity and social cost. We have studied the molecular basis of the cooccurrence of panic and phobic disorders with joint laxity. We have identified an interstitial duplication of human chromosome 15q24-26 (named DUP25), which is significantly associated with panic/agoraphobia/social phobia/joint laxity in families, and with panic disorder in nonfamilial cases. Mosaicism, different forms of DUP25 within the same family, and absence of segregation of 15q24-26 markers with DUP25 and the psychiatric phenotypes suggest a non-Mendelian mechanism of disease-causing mutation. We propose that DUP25, which is present in 7% control subjects, is a susceptibility factor for a clinical phenotype that includes panic and phobic disorders and joint laxity.	IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain; Hosp Mare Deu Esperanca, IMAS, Dept Psiquiatria, E-08083 Barcelona, Catalonia, Spain; IMIM, Unitat Recerca Psiquiatria, E-08083 Barcelona, Catalonia, Spain; Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, E-08193 Bellaterra, Catalonia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Estivill, X (corresponding author), IRO, Ctr Genet Med & Mol, E-08907 Barcelona, Catalonia, Spain.	estivill@iro.es	Estivill, Xavier/E-2957-2012; Bulbena, Antonio/AAG-5411-2019; Pujana, Miquel Angel/N-3127-2014; Estivill, Xavier/A-3125-2013; Peral, Belén/F-4562-2015	Bulbena, Antonio/0000-0003-2404-2478; Pujana, Miquel Angel/0000-0003-3222-4044; Estivill, Xavier/0000-0002-0723-2256; Peral, Belén/0000-0003-4984-4020; Nadal, Marga/0000-0002-5739-1693; miro, rosa/0000-0003-2508-5074; Ponsa, Immaculada/0000-0003-3436-1907				*AM PSYCH ASS, 1987, DSM3R DIAGN STAT MAN; ANASTASI J, 1990, AM J PATHOL, V136, P131; BARLOW DH, 1986, J NERV MENT DIS, V174, P63, DOI 10.1097/00005053-198602000-00001; Beighton PH, 1989, HYPERMOBILITY JOINTS; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; BULBENA A, 1993, PSYCHIAT RES, V46, P59, DOI 10.1016/0165-1781(93)90008-5; BULBENA A, 1988, LANCET, V2, P694; CELI FS, 1994, GENOMICS, V21, P304, DOI 10.1006/geno.1994.1270; COHEN ME, 1951, AM J HUM GENET, V3, P126; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROWE RR, 1983, ARCH GEN PSYCHIAT, V40, P1065; Crowe RR, 2001, AM J MED GENET, V105, P105, DOI 10.1002/1096-8628(20010108)105:1<105::AID-AJMG1072>3.0.CO;2-P; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; Deckert J, 1999, HUM MOL GENET, V8, P621, DOI 10.1093/hmg/8.4.621; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; ENG CM, 1991, GENOMICS, V9, P278, DOI 10.1016/0888-7543(91)90253-B; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FRITZE J, 1995, J PSYCHIATR NEUROSCI, V20, P39; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; HOPPER JL, 1987, GENET EPIDEMIOL, V4, P33, DOI 10.1002/gepi.1370040105; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KENDLER KS, 1993, PSYCHOL MED, V23, P397, DOI 10.1017/S003329170002849X; Kennedy JL, 1999, MOL PSYCHIATR, V4, P284, DOI 10.1038/sj.mp.4000507; KENYON K, 1993, J BIOL CHEM, V268, P18435; Knowles JA, 1998, AM J MED GENET, V81, P139, DOI 10.1002/(SICI)1096-8628(19980328)81:2<139::AID-AJMG4>3.0.CO;2-R; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MAIER W, 1993, J PSYCHIAT RES, V27, P79, DOI 10.1016/0022-3956(93)90019-X; Martin-Santos R, 1998, AM J PSYCHIAT, V155, P1578, DOI 10.1176/ajp.155.11.1578; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Nadal M, 1997, J MED GENET, V34, P50, DOI 10.1136/jmg.34.1.50; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P232; PAULS DL, 1980, AM J HUM GENET, V32, P639; Perna G, 1997, PSYCHIAT RES, V66, P69, DOI 10.1016/S0165-1781(97)85177-3; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; SAMBROOK J, 1989, MOL CLONING, V2, P9; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; SMITH MA, 1995, P NATL ACAD SCI USA, V92, P8788, DOI 10.1073/pnas.92.19.8788; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIELAND VJ, 1993, PSYCHIATR GENET, V3, P63, DOI 10.1097/00041444-199322000-00001; Wang ZW, 1998, AM J MED GENET, V81, P228, DOI 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S; Weiller E, 1998, BRIT J PSYCHIAT, V173, P18, DOI 10.1192/S0007125000293471; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P305; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E	50	155	156	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					367	379		10.1016/S0092-8674(01)00447-0	http://dx.doi.org/10.1016/S0092-8674(01)00447-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509185	Bronze			2022-12-24	WOS:000170433300014
J	Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL				Lo, WS; Duggan, L; Emre, NCT; Belotserkovskya, R; Lane, WS; Shiekhattar, R; Berger, SL			Snf1 - a histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription	SCIENCE			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; H3 PHOSPHORYLATION; PROTEIN-KINASE; ADA-COMPLEX; YEAST; ACETYLATION; PHOSPHATASE; REPRESSION; ACTIVATION	Modification of histories is an important element in the regulation of gene expression. Previous work suggested a link between acetylation and phosphorylation, but questioned its mechanistic basis. We have purified a histone H3 serine-10 kinase complex from Saccharomyces cerevisiae and have identified its catalytic subunit as Snf1. The Snf1/AMPK family of kinases function in conserved signal transduction pathways. Our results show that Snf1 and the acetyltransferase Gcn5 function in an obligate sequence to enhance INO1 transcription by modifying histone H3 serine-10 and lysine-14. Thus, phosphorylation and acetylation are targeted to the same histone by promoter-specific regulation by a kinase/acetyltransferase pair, supporting models of gene regulation wherein transcription is controlled by coordinated patterns of histone modification.	Wistar Inst Anat & Biol, Mol Genet Program, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	The Wistar Institute; Harvard University	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Mol Genet Program, 3601 Spruce St,Room 389, Philadelphia, PA 19104 USA.		Emre, Tolga/A-1787-2016	Emre, Tolga/0000-0001-8021-5228; Berger, Shelley/0000-0001-5398-4400				Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Berger SL, 2001, SCIENCE, V292, P64; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayes JJ, 2001, CURR OPIN GENET DEV, V11, P124, DOI 10.1016/S0959-437X(00)00168-4; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; John S, 2000, GENE DEV, V14, P1196; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roberts SM, 1997, GENETICS, V147, P451; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shirra MK, 1999, GENETICS, V152, P73; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; WOODS A, 1994, J BIOL CHEM, V269, P19509	29	287	298	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1142	1146		10.1126/science.1062322	http://dx.doi.org/10.1126/science.1062322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498592				2022-12-24	WOS:000170432600062
J	Ohman, MD; Hirche, HJ				Ohman, MD; Hirche, HJ			Density-dependent mortality in an oceanic copepod population	NATURE			English	Article							1997 SPRING BLOOM; PLANKTONIC MARINE COPEPOD; FREQUENCY TIME-SERIES; CALANUS-FINMARCHICUS; NORWEGIAN SEA; WEATHERSHIP M; DYNAMICS; PHYTOPLANKTON; PREDATION; BIOMASS	Planktonic copepods are primary consumers in the ocean and are perhaps the most numerous metazoans on earth. Secondary production by these zooplankton supports most food webs of the open sea, directly affecting pelagic fish populations and the biological pump of carbon into the deep ocean. Models of marine ecosystems are quite sensitive to the formulation of the term for zooplankton mortality(1-4), although there are few data available to constrain mortality rates in such models. Here we present the first evidence for nonlinear, density-dependent mortality rates of open-ocean zooplankton. A high-frequency time series reveals that per capita mortality rates of eggs of Calanus finmarchicus Gunnerus are a function of the abundance of adult females and juveniles. The temporal dynamics of zooplankton populations can be influenced as much by time-dependent mortality rates as by variations in 'bottom up' forcing. The functional form and rates chosen for zooplankton mortality in ecosystem models can alter the balance of pelagic ecosystems(1-3), modify elemental fluxes into the ocean's interior(5), and modulate interannual variability in pelagic ecosystems(6).	Stn Zool, F-06230 Villefranche Sur Mer, France; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Ohman, MD (corresponding author), Stn Zool, F-06230 Villefranche Sur Mer, France.	mohman@ucsd.edu	Ohman, Mark D/C-8763-2009	Ohman, Mark D/0000-0001-8136-3695				Aksnes DL, 1997, SARSIA, V82, P279, DOI 10.1080/00364827.1997.10413657; CAMPBELL RG, IN PRESS MAR ECOL PR; Carlotti F., 2000, P571, DOI 10.1016/B978-012327645-2/50013-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; DAAN R, 1988, MAR ECOL PROG SER, V47, P45, DOI 10.3354/meps047045; Edwards AM, 2000, J PLANKTON RES, V22, P1085, DOI 10.1093/plankt/22.6.1085; FASHAM MJR, 1995, DEEP-SEA RES PT I, V42, P1111, DOI 10.1016/0967-0637(95)00054-A; FASHAM MJR, 1993, GLOBAL CARBON CYCLE, P457; Gallego A, 1999, FISH OCEANOGR, V8, P77; Hainbucher Dagmar, 1999, Fisheries Oceanography, V8, P1, DOI 10.1046/j.1365-2419.1999.00009.x; HIRCHE HJ, IN PRESS MAR ECOL PR; Irigoien X, 1998, MAR ECOL PROG SER, V172, P127, DOI 10.3354/meps172127; LANDRY MR, 1978, INT REV GES HYDROBIO, V63, P77, DOI 10.1002/iroh.19780630106; LANDRY MR, 1981, MAR BIOL, V65, P77, DOI 10.1007/BF00397070; Li M, 2000, ESTUAR COAST SHELF S, V50, P467, DOI 10.1006/ecss.2000.0593; Lynch DR, 1998, MAR ECOL PROG SER, V169, P189, DOI 10.3354/meps169189; Meyer-Harms B, 1999, LIMNOL OCEANOGR, V44, P154, DOI 10.4319/lo.1999.44.1.0154; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Niehoff B, 1999, MAR ECOL PROG SER, V176, P81, DOI 10.3354/meps176081; OHMAN MD, 1994, LIMNOL OCEANOGR, V39, P21, DOI 10.4319/lo.1994.39.1.0021; OHMAN MD, 1998, EOS T AM GEOPHYS UN, V79, pOS155; PETERSON WT, 1994, LIMNOL OCEANOGR, V39, P1594, DOI 10.4319/lo.1994.39.7.1594; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Richardson Katherine, 1999, Fisheries Oceanography, V8, P153, DOI 10.1046/j.1365-2419.1999.00007.x; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; SOLOW AR, 1995, J PLANKTON RES, V17, P1669, DOI 10.1093/plankt/17.8.1669; STEELE JH, 1992, J PLANKTON RES, V14, P157, DOI 10.1093/plankt/14.1.157; Uye S, 1998, J MARINE SYST, V15, P495, DOI 10.1016/S0924-7963(97)00052-3; WOOD SN, 1994, ECOL MONOGR, V64, P23, DOI 10.2307/2937054	29	193	195	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					638	641		10.1038/35088068	http://dx.doi.org/10.1038/35088068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493921	Green Published			2022-12-24	WOS:000170318000041
J	Craven, RB; Roehrig, JT				Craven, RB; Roehrig, JT			West Nile Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW VOLUME APPLICATIONS; HALE COUNTY; NEW-YORK; ENCEPHALITIS; MALATHION; OUTBREAK; POPULATIONS; DIAGNOSIS; MOSQUITOS; EPIDEMIC		CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA	Craven, RB (corresponding author), CDCP, Arbovirus Dis Branch,Natl Ctr Infect Dis, Div Vector Borne Infect Dis, US Dept HHS,PHS, POB 2087,Foothills Campus, Ft Collins, CO 80522 USA.	rbc1@cdc.gov		Roehrig, John/0000-0001-7581-0479				Anderson JF, 1999, SCIENCE, V286, P2331, DOI 10.1126/science.286.5448.2331; ANDIS MD, 1987, J AM MOSQUITO CONTR, V3, P125; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P944; *CDCP, 1993, GUID ARB SURV US; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P820; CECCHINE G, 1996, REV SCI LIT IT PERTA, V8; Center for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P890; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P178; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P645; CRAVEN RB, 1991, TXB HUMAN VIROLOGY, P649; Hayes CG, 1989, ARBOVIRUSES EPIDEMIO, VV, P59; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; LEISER LB, 1982, MOSQ NEWS, V42, P617; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; MITCHELL CJ, 1969, J MED ENTOMOL, V6, P155, DOI 10.1093/jmedent/6.2.155; MITCHELL CJ, 1970, J MED ENTOMOL, V7, P85, DOI 10.1093/jmedent/7.1.85; MONATH TP, 1991, TROPICAL MED, P206; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; REISEN WK, 1985, J AM MOSQUITO CONTR, V1, P154; ROEHRIG JT, 2000, CLIN VIROLOGY MANUAL, P356; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; Tardei G, 2000, J CLIN MICROBIOL, V38, P2232; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7	32	28	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					651	653		10.1001/jama.286.6.651	http://dx.doi.org/10.1001/jama.286.6.651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495600				2022-12-24	WOS:000170271500002
J	Day, M; Morris, RGM				Day, M; Morris, RGM			Memory consolidation and NMDA receptors: Discrepancy between genetic and pharmacological approaches	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; SELECTIVE IMPAIRMENT; ANTAGONIST; BLOCKADE; AP5		Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Edinburgh	Day, M (corresponding author), Univ Edinburgh, Dept Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Morris, Richard G M/C-9982-2013					McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; 2001, SCIENCE, V291, P1902	10	24	27	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					U1	U1						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486056				2022-12-24	WOS:000170241000001
J	Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA				Salama, P; Assefa, F; Talley, L; Spiegel, P; van der Veen, A; Gotway, CA			Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ENERGY DEFICIENCY; REFUGEE POPULATIONS; HEALTH; SITUATIONS; COMMUNITY; THAILAND; SOMALIA; KOSOVO; STATE; SUDAN	Context The World Food Programme estimated that 10 million people were at risk of starvation in Ethiopia in 2000 but later reported that a famine had been averted. However, no population-based data on mortality or nutrition existed for Gode district, at the epicenter of the famine in the Somali region of Ethiopia. Objectives To estimate mortality rates, determine the major causes of death, and estimate the prevalence of malnutrition among children and adults for the population of Gode district. Design and Setting Two-stage cluster survey conducted from July 27 through August 1, 2000, which included anthropometric measures and 8-month retrospective mortality data collection. Participants A total of 595 households comprising 4032 people living in Gode district of Ethiopia. Main Outcome Measures Crude mortality rates and mortality rates for children younger than 5 years, causes of death, weight for height of less than -2 z scores among children aged 6 months to 5 years, and body mass index of less than 18.5 kg/m(2) among adults and older persons. Results Of the 595 households, 346 (58.2%) were displaced from their usual places of residence. From December 1999 through July 2000, total of 293 deaths occurred in the sample population; 159 (54.3%) deaths were among children younger than 5 years and 72 (24.6%) were among children aged 5 to 14 years. The crude mortality rate was 3.2/ 10000 per day (95% confidence interval [CI], 2.4-3.8/10000 per day), which is 3 times the cutoff used to define an emergency. The mortality rate for children younger than 5 years was 6.8/10000 per day (95% CI, 5.4-8.2/10000 per day). Approximately 77% of deaths occurred before major relief interventions began in April/May 2000. Wasting contributed to 72.3% of all deaths among children younger than 5 years. Measles alone or in combination with wasting accounted for 35 (22.0%) of 159 deaths among children younger than 5 years and for 12 (16.7%) of 72 deaths among children aged 5 to 14 years. The prevalence rate for wasting (weight for height of <-2 z score) among children aged 6 months to 5 years was 29.1% (95% CI, 24.7%-33.4%). Using a method to adjust body mass index for body shape, the prevalence of undernutrition (body mass index <18.5 kg/m(2)) among adults aged 18 to 59 years was 22.7% (95% CI, 17.9%-27.5%). Conclusions To prevent unnecessary deaths, the humanitarian response to famine needs to be rapid, well coordinated, and based on sound epidemiological evidence. Public health interventions, such as mass measles vaccination campaigns with coverage extended to children aged 12 to 15 years should be implemented as the first priority. The prevalence of wasting and undernutrition among children and adults, respectively, should be assessed in all prolonged, severe famines.	CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA USA; CDCP, Int Emergency & Refugee Hlth Branch, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA; Save Children USA, Washington, DC USA; Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; WHO, Off Reg Humanitarian Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Save the Children; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; World Health Organization	Salama, P (corresponding author), CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.	psalama@cdc.gov						AABY P, 1988, REV INFECT DIS, V10, P478; AABY P, 1983, J INFECT DIS, V147, P693, DOI 10.1093/infdis/147.4.693; *ACT AG HUNG, 2000, RAP ASS NUTR SIT 5 C, P1; BERTINI C, 2000, FINDINGS RECOMMENDAT; BORREL A, 2001, ADDRESSING NUTR NEED; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; COLLINS S, 1993, LANCET, V341, P1478; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; COLLINS S, 2000, ASSESSMENT NUTR STAT, P1; Davis AP, 1996, LANCET, V348, P868, DOI 10.1016/S0140-6736(96)02134-4; DEAN AG, 1990, EPI INFO VERSION 6 W; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; *GOV ETH, 1999, 1994 POP HOUS CENS E, P1; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; Kaartinen L, 1984, Lancet, V1, P39; KIDANE A, 1989, DEMOGRAPHY, V26, P515, DOI 10.2307/2061610; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; *MED SANS FRONT BE, 2000, NUTR SURV RETR MORT, P1; Morley D C, 1967, East Afr Med J, V44, P497; MURRAY MJ, 1976, LANCET, V1, P1283; NIEBURG P, 1988, DISASTERS, V12, P253, DOI 10.1111/j.1467-7717.1988.tb00674.x; NORGAN NG, 1994, AM J PHYS ANTHROPOL, V94, P229, DOI 10.1002/ajpa.1330940207; NORGAN NG, 1994, ANN HUM BIOL, V21, P79, DOI 10.1080/03014469400003092; Ronald C, 1999, BMJ, V318; Salama P, 2000, JAMA-J AM MED ASSOC, V284, P578, DOI 10.1001/jama.284.5.578; Salama P, 2001, LANCET, V357, P1430, DOI 10.1016/S0140-6736(00)04570-0; *SAVA CHILDR UK, 2000, ANTHR FOOD SEC ASS F, P1; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *STEER COMM HUM RE, 1998, SPHERE PROJ HUM CHAR; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; *UN CHILDR FUND, 2000, STAT WORLDS CHILDR; *UN CHILDR FUND, 2000, SIT REP; *UN CHILDR FUND U, 2000, SUMM RES NUTR SURV C, P1; *UN CHILDR FUND WH, 2000, REP FOOD NUTR SIT GO, P1; UN. High Commission for Refugees, 1999, HDB EM; *US AG INT DEV, 2000, ETH DROUGHT FACT SHE, P1; VESPA J, 1995, BRIT MED J, V311, P652, DOI 10.1136/bmj.311.7006.652; *WHO, 1994, WKLY EPIDEMIOL REC, V69, P245; *WORLD FOOD PROGR, 1999, SUMM CONS AG REP EM; World Health Organization, 1995, PHYS STAT US INT ANT	47	104	104	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					563	571		10.1001/jama.286.5.563	http://dx.doi.org/10.1001/jama.286.5.563			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	458HE	11476658	Bronze			2022-12-24	WOS:000170188300019
J	Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM				Cornelissen, JJLM; Donners, JJJM; de Gelder, R; Graswinckel, WS; Metselaar, GA; Rowan, AE; Sommerdijk, NAJM; Nolte, RJM			beta-helical polymers from isocyanopeptides	SCIENCE			English	Article							AQUEOUS-SOLUTION; SIDE-CHAINS; SHEET; POLYISOCYANIDES; PROTEIN; WATER; ACIDS	Polymerization of isocyanopeptides results in the formation of high molecular mass polymers that fold in a proteinlike fashion to give helical strands in which the peptide chains are arranged in beta -sheets. The beta -helical polymers retain their structure in water and unfold in a cooperative process at elevated temperatures. The peptide architecture in these polymers is a different form of the beta -helix motif found in proteins. Unlike their natural counterparts, which contain arrays of large beta -sheets stacked in a helical fashion, the isocyanopeptide polymers have a central helical core that acts as a director for the beta -sheet-like arrangement of the peptide side arms. The helical structure of these isocyanopeptide polymers has the potential to be controlled through tailoring of the side branches and the hydrogen-bonding network present in the beta -sheets.	Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen, Dept Inorgan Chem, NL-6525 ED Nijmegen, Netherlands; Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Eindhoven University of Technology	Nolte, RJM (corresponding author), Univ Nijmegen, Dept Organ Chem, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.		Rowan, Alan E/F-9702-2015; Nolte, Roeland/C-9930-2013; de Gelder, René/D-4587-2012; Sommerdijk, Nico A.J.M./B-7239-2013	Rowan, Alan E/0000-0003-0728-3851; Nolte, Roeland/0000-0002-5612-7815; de Gelder, René/0000-0001-6152-640X; Sommerdijk, Nico A.J.M./0000-0002-8956-195X				Baumeister B, 2000, CHEM COMMUN, P913, DOI 10.1039/b002113j; Branden C., 1999, INTRO PROTEIN STRUCT; Clericuzio M, 1997, J AM CHEM SOC, V119, P1059, DOI 10.1021/ja961692n; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GRANT DM, 1996, ENCY NUCL MAGNETIC R, V4; GREEN MM, 1988, MACROMOLECULES, V21, P1839, DOI 10.1021/ma00184a051; Griffiths-Jones SR, 2000, J AM CHEM SOC, V122, P8350, DOI 10.1021/ja000787t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huang JT, 1997, J POLYM SCI POL CHEM, V35, P439; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Nesloney CL, 1996, J AM CHEM SOC, V118, P5836, DOI 10.1021/ja952472x; NOLTE RJM, 1974, J AM CHEM SOC, V96, P5932, DOI 10.1021/ja00825a038; NOLTE RJM, 1994, CHEM SOC REV, V23, P11, DOI 10.1039/cs9942300011; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Pimentel G.C., 1960, HYDROGEN BOND; Prokhorova SA, 1998, MACROMOL RAPID COMM, V19, P359; Schenck HL, 1998, J AM CHEM SOC, V120, P4869, DOI 10.1021/ja973984+; Seebach D, 2000, HELV CHIM ACTA, V83, P2115, DOI 10.1002/1522-2675(20000906)83:9<2115::AID-HLCA2115>3.0.CO;2-E; SPEK AL, 1955, PLUTON PROGRAM PLOTT; TSANG KY, 1994, J AM CHEM SOC, V116, P3988, DOI 10.1021/ja00088a039; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	23	268	271	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					676	680		10.1126/science.1062224	http://dx.doi.org/10.1126/science.1062224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474106				2022-12-24	WOS:000170204600049
J	Robles-De-La-Torre, G; Hayward, V				Robles-De-La-Torre, G; Hayward, V			Force can overcome object geometry in the perception of shape through active touch	NATURE			English	Article							MOVEMENTS; FINGER; ELBOW	Haptic (touch) perception normally entails an active exploration of object surfaces over time. This is called active touch(1-3). When exploring the shape of an object, we experience both geometrical(4) and force cues. For example, when sliding a finger across a surface with a rigid bump on it, the finger moves over the bump while being opposed by a force whose direction and magnitude are related to the slope of the bump(5). The steeper the bump, the stronger the resistance. Geometrical and force cues are correlated, but it has been commonly assumed that shape perception relies on object geometry alone. Here we show that regardless of surface geometry, subjects identified and located shape features on the basis of force cues or their correlates. Using paradoxical stimuli, for example combining the force cues of a bump with the geometry of a hole, we found that subjects perceived a bump. Conversely, when combining the force cues of a hole with the geometry of a bump, subjects typically perceived a hole.	McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada	McGill University	Robles-De-La-Torre, G (corresponding author), McGill Univ, Ctr Intelligent Machines, Montreal, PQ H3A 2A7, Canada.		Hayward, Vincent/A-4646-2010	Hayward, Vincent/0000-0002-2102-1965				CLARK FJ, 1986, BRAIN, V109, P1195, DOI 10.1093/brain/109.6.1195; Coren S., 1992, LEFT HANDER SYNDROME; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GORDON IE, 1982, PERCEPT PSYCHOPHYS, V31, P446, DOI 10.3758/BF03204854; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Loomis JM, 1986, HDB PERCEPTION HUMAN, V2, p31/1; Minsky M. D. R, 1995, THESIS MIT; Pont SC, 1999, PERCEPT PSYCHOPHYS, V61, P874, DOI 10.3758/BF03206903; ROBLESDELATORRE G, 2000, P ASME DYN SYST CONT, V2, P1081; TAYLOR JL, 1992, J PHYSIOL-LONDON, V457, P503, DOI 10.1113/jphysiol.1992.sp019390	11	212	223	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					445	448		10.1038/35086588	http://dx.doi.org/10.1038/35086588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	456DQ	11473320				2022-12-24	WOS:000170068200050
J	Love, SG; Ahrens, TJ				Love, SG; Ahrens, TJ			Origin of asteroid rotation rates in catastrophic impacts	NATURE			English	Article							COLLISIONAL EVOLUTION; DESPINNING ASTEROIDS	The rotation rates of asteroids, which are deduced from periodic fluctuations in their brightnesses(1), are controlled by mutual collisions(2-8). The link between asteroid spin and collision history is usually made with reference to impact experiments on centimetre-scale targets, where material strength governs the impact response(2,3,9-11). Recent work, however, indicates that for objects of the size of most observed asteroids (greater than or equal to 1 km in diameter), gravity rather than intrinsic strength controls the dynamic response to collisions(12-14). Here we explore this idea by modelling the effect of impacts on large gravitating bodies. We find that the fraction of a projectile's angular momentum that is retained by a target asteroid is both lower and more variable than expected from laboratory experiments, with spin evolution being dominated by 'catastrophic' collisions that eject similar to 50 per cent of the target's mass. The remnant of an initially non-rotating silicate asteroid that suffers such a collision rotates at a rate of similar to 2.9 per day, which is close to the observed mean asteroid rotation rate of similar to 2.5 d(-1) Moreover, our calculations suggest that the observed trend in the mean spin frequency for different classes of asteroids(4) (2.2 d(-1) for C-type asteroids, 2.5 d(-1) for S-type, and 4.0 d(-1) for M-type) is due to increasing mean density, rather than increasing material strength.			Love, SG (corresponding author), CALTECH,SEISMOL LAB 25221,PASADENA,CA 91125, USA.							BELTON MJS, 1995, NATURE, V374, P785, DOI 10.1038/374785a0; Binzel R.P., 1989, ASTEROIDS, P416; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; Bottke WF, 1996, NATURE, V381, P51, DOI 10.1038/381051a0; BURNS JA, 1973, MON NOT R ASTRON SOC, V165, P403, DOI 10.1093/mnras/165.4.403; CELLINO A, 1990, ICARUS, V87, P391, DOI 10.1016/0019-1035(90)90142-V; DAVIS DR, 1989, ASTEROIDS, V2, P805; DOBROVOLSKIS AR, 1984, ICARUS, V57, P464, DOI 10.1016/0019-1035(84)90130-1; DONES L, 1993, SCIENCE, V259, P350, DOI 10.1126/science.259.5093.350; FARINELLA P, 1992, ASTRON ASTROPHYS, V253, P604; FUJIWARA A, 1981, ICARUS, V48, P329, DOI 10.1016/0019-1035(81)90113-5; Fujiwara A., 1989, ASTEROIDS, VII, P240; Harris A.W., 1989, ASTEROIDS, VII, P39; Harris A.W., 1996, LUNAR PLANET SCI, V27, P493; HARRIS AW, 1979, ICARUS, V40, P142; HOLSAPPLE KA, 1994, PLANET SPACE SCI, V42, P1067, DOI 10.1016/0032-0633(94)90007-8; Love SG, 1996, ICARUS, V124, P141, DOI 10.1006/icar.1996.0195; Melosh H.J, 1989, OXFORD MONOGRAPHS GE; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; RYAN EV, 1995, EOS, V76, pF336; TILLOTSON JH, 1962, GA3216 GEN DYN CORP; YANAGISAWA M, 1991, ICARUS, V94, P272, DOI 10.1016/0019-1035(91)90227-K	22	19	19	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAR 13	1997	386	6621					154	156		10.1038/386154a0	http://dx.doi.org/10.1038/386154a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WM973	11536797				2022-12-24	WOS:A1997WM97300055
J	Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV				Drab, M; Verkade, P; Elger, M; Kasper, M; Lohn, M; Lauterbach, B; Menne, J; Lindschau, C; Mende, F; Luft, FC; Schedl, A; Haller, H; Kurzchalia, TV			Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice	SCIENCE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; IN-VIVO; PROTEIN; TRANSPORT; CHOLESTEROL; CELLS; VIP21-CAVEOLIN; COMPONENT; MUSCLE	Caveolae are plasma membrane invaginations that may play an important role in numerous cellular processes including transport, signaling, and tumor suppression. By targeted disruption of caveolin-1, the main protein component of caveolae, we generated mice that lacked caveolae. The absence of this organelle impaired nitric oxide and calcium signaling in the cardiovascular system, causing aberrations in endothelium-dependent relaxation, contractility, and maintenance of myogenic tone. In addition, the lungs of knockout animals displayed thickening of alveolar septa caused by uncontrolled endothelial cell proliferation and fibrosis, resulting in severe physical limitations in caveolin-1-disrupted mice. Thus, caveolin-1 and caveolae play a fundamental role in organizing multiple signaling pathways in the cell.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Hannover Med Sch, D-30625 Hannover, Germany; Tech Univ Dresden, Inst Anat, D-01307 Dresden, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Hannover Medical School; Technische Universitat Dresden	Kurzchalia, TV (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany.		Schedl, Andreas/GOP-3427-2022; Lindschau, Carsten/AAE-6721-2020; Drab, Marek/J-5196-2013; Verkade, Paul/N-7240-2014; Eckhardt, Erik/G-1567-2010; Lindschau, Carsten/G-1798-2011; Schedl, Andreas/F-8823-2015; Drab, Marek/AAQ-1892-2020	Drab, Marek/0000-0002-2771-1692; Verkade, Paul/0000-0002-2497-1026; Lindschau, Carsten/0000-0003-1960-099X; Schedl, Andreas/0000-0001-9380-7396; Luft, Friedrich/0000-0002-8635-1199				Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; HALLER H, 1995, CIRC RES, V76, P21, DOI 10.1161/01.RES.76.1.21; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; PALADE GE, 1960, ANAT REC, V136, P254; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427	25	1248	1288	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2449	2452		10.1126/science.1062688	http://dx.doi.org/10.1126/science.1062688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498544				2022-12-24	WOS:000171237200046
J	Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D				Volkmann, N; Amann, KJ; Stoilova-McPhie, S; Egile, C; Winter, DC; Hazelwood, L; Heuser, JE; Li, R; Pollard, TD; Hanein, D			Structure of Arp2/3 complex in its activated state and in actin filament branch junctions	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP/SCAR PROTEINS; N-WASP; ACANTHAMOEBA; NUCLEATION; MOTILITY; CYTOSKELETON; DISSECTION; NETWORKS; PROFILIN	The seven-subunit Arp2/3 complex choreographs the formation of branched actin networks at the leading edge of migrating cells. When activated by Wiskott-Aldrich Syndrome protein (WASp), the Arp2/3 complex initiates actin filament branches from the sides of existing filaments. Electron cryomicroscopy and three-dimensional reconstruction of Acanthamoeba castellanil and Saccharomyces cerevisiae Arp2/3 complexes bound to the WASp carboxy-terminal domain reveal asymmetric, oblate ellipsoids. Image analysis of actin branches indicates that the complex binds the side of the mother filament, and Arp2 and Arp3 (for actin-related protein) are the first two subunits of the daughter filament. Comparison to the actin-free, WASp-activated complexes suggests that branch initiation involves large-scale structural rearrangements within Arp2/3.	Burnham Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Harvard University; Harvard Medical School; Washington University (WUSTL)	Hanein, D (corresponding author), Burnham Inst, La Jolla, CA 92037 USA.		Heuser, John/H-5940-2012					Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Winter D, 1997, CURR BIOL, V7, P519, DOI 10.1016/S0960-9822(06)00223-5; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	28	196	203	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2456	2459		10.1126/science.1063025	http://dx.doi.org/10.1126/science.1063025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11533442				2022-12-24	WOS:000171237200048
J	Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N				Freeman, C; Evans, CD; Monteith, DT; Reynolds, B; Fenner, N			Export of organic carbon from peat soils	NATURE			English	Article							MATTER; PEATLANDS; RIVERS		Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; Ctr Ecol & Hydrol, Wallingford OX10 3BB, Oxon, England; UCL, Environm Change Res Ctr, London WC1H 0AP, England; Ctr Ecol & Hydrol, Bangor LL57 2UP, Gwynedd, Wales	Bangor University; UK Centre for Ecology & Hydrology (UKCEH); University of London; University College London; UK Centre for Ecology & Hydrology (UKCEH)	Freeman, C (corresponding author), Univ Wales, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales.	c.freeman@bangor.ac.uk	Reynolds, Brian/G-6292-2011; Monteith, Donald/C-1534-2008; Evans, Christopher D/F-2087-2010	Monteith, Donald/0000-0003-3219-1772; Evans, Christopher D/0000-0002-7052-354X				FREEMAN C, 1990, FRESHWATER BIOL, V24, P159, DOI 10.1111/j.1365-2427.1990.tb00315.x; Freeman C, 2001, NATURE, V409, P149, DOI 10.1038/35051650; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hope D, 1997, HYDROL PROCESS, V11, P325, DOI 10.1002/(SICI)1099-1085(19970315)11:3&lt;325::AID-HYP476&gt;3.0.CO;2-I; KRUG EC, 1983, SCIENCE, V221, P520, DOI 10.1126/science.221.4610.520; LUGO AE, 1989, ECOSYSTEMS WORLD, V15, P53; MONTEITH DT, 2000, UK ACID WATERS MONIT; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; WETZEL RG, 1992, HYDROBIOLOGIA, V229, P181, DOI 10.1007/BF00007000	10	745	783	11	401	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					785	785		10.1038/35090628	http://dx.doi.org/10.1038/35090628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518954				2022-12-24	WOS:000170577200025
J	Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF				Rietze, RL; Valcanis, H; Brooker, GF; Thomas, T; Voss, AK; Bartlett, PF			Purification of a pluripotent neural stem cell from the adult mouse brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; IN-VIVO; NEURONS; EXPRESSION; ASTROCYTES; GENERATION; MARROW; BLOOD; MCD24	The adult mammalian central nervous system (CNS) contains a population of neural stem cells (NSCs)(1-4) with properties said to include the generation of non-neural progeny(5-7). However, the precise identity, location and potential of the NSC in situ remain unclear. We purified NSCs from the adult mouse brain by flow cytometry, and directly examined the cells' properties. Here we show that one type of NSC, which expresses the protein nestin but only low levels of PNA-binding and HSA proteins, is found in both ependymal and subventricular zones and accounts for about 63% of the total NSC activity. Furthermore, the selective depletion of the population of this stem cell in querkopf(8) mutant mice (which are deficient in production of olfactory neurons) suggests that it acts as a major functional stem cell in vivo. Most freshly isolated NSCs, when co-cultured with a muscle cell line, rapidly differentiated in vitro into myocytes that contain myosin heavy chain (MyHC). This demonstrates that a predominant, functional type of stem cell exists in the periventricular region of the adult brain with the intrinsic ability to generate neural and non-neural cells.	Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Bartlett, PF (corresponding author), Walter & Eliza Hall Inst Med Res, Royal Parade, Parkville, Vic 3050, Australia.	bartlett@wehi.edu.au	Bartlett, Perry/F-3813-2012; Voss, Anne K/F-5110-2013	Voss, Anne K/0000-0002-3853-9381; Thomas, Tim/0000-0002-7623-8344				BARTLETT PF, 1982, P NATL ACAD SCI-BIOL, V79, P2722, DOI 10.1073/pnas.79.8.2722; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Gritti A, 1999, J NEUROSCI, V19, P3287; Gritti A, 1996, J NEUROSCI, V16, P1091; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; SALNER AL, 1982, J NATL CANCER I, V68, P639; Shewan D, 1996, J NEUROSCI, V16, P2624; TAM PPL, 1992, DEVELOPMENT, V115, P703; Thomas T, 2000, DEVELOPMENT, V127, P2537	25	525	572	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					736	739		10.1038/35089085	http://dx.doi.org/10.1038/35089085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507641				2022-12-24	WOS:000170450200045
J	Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F				Bellaiche, Y; Radovic, A; Woods, DF; Hough, CD; Parmentier, ML; O'Kane, CJ; Bryant, PJ; Schweisguth, F			The partner of inscuteable/discs-large complex is required to establish planar polarity during asymmetric cell division in Drosophila	CELL			English	Article							TUMOR-SUPPRESSOR GENE; PROTEIN-KINASE-C; SIGNALING POLARIZES; ELEGANS; LOCALIZATION; BAZOOKA; NUMB; DETERMINANTS; COLOCALIZES; ORIENTATION	Frizzled (Fz) signaling regulates cell polarity in both vertebrates and invertebrates. In Drosophila, Fz orients the asymmetric division of the sensory organ precursor cell (pl) along the antero-posterior axis of the notum. Planar polarization involves a remodeling of the apical-basal polarity of the pi cell. The Discs-large (Dlg) and Partner of Inscuteable (Pins) proteins accumulate at the anterior cortex, while Bazooka (Baz) relocalizes to the posterior cortex. Dig interacts directly with Pins and regulates the localization of Pins and Baz. Pins acts with Fz to localize Baz posteriorly, but Baz is not required to localize Pins anteriorly. Finally, Baz and the Dig/Pins complex are required for the asymmetric localization of Numb. Thus, the Dig/Pins complex responds to Fz signaling to establish planar asymmetry in the pl cell.	Ecole Normale Super, UMR 8544, F-75230 Paris 05, France; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; CCIPE, UPR 9023, F-34094 Montpellier 05, France; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Irvine; University of Cambridge	Bellaiche, Y (corresponding author), Ecole Normale Super, UMR 8544, 46 Rue Ulm, F-75230 Paris 05, France.	bellaich@wotan.ens.fr	O'Kane, Cahir J/C-4413-2011; O'Kane, Cahir/Q-6681-2019; Parmentier, Marie-Laure/N-9915-2017	O'Kane, Cahir/0000-0002-3488-2078; Parmentier, Marie-Laure/0000-0001-6133-3413; bellaiche, yohanns/0000-0003-1686-2943	NCI NIH HHS [CA 23928] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boyd L, 1996, DEVELOPMENT, V122, P3075; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DRUBIN DG, 2000, CELL POLARITY; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jones KH, 1996, GENETICS, V142, P205; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Muller HAJ, 2000, DEV DYNAM, V218, P52; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; QUI RC, 2000, CURR BIOL, V10, P697; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tada M, 2000, DEVELOPMENT, V127, P2227; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	52	178	181	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					355	366		10.1016/S0092-8674(01)00444-5	http://dx.doi.org/10.1016/S0092-8674(01)00444-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509184	Bronze			2022-12-24	WOS:000170433300013
J	Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D				Munshi, N; Agalioti, T; Lomvardas, S; Merika, M; Chen, GY; Thanos, D			Coordination of a transcriptional switch by HMGI(Y) acetylation	SCIENCE			English	Article							IFN-BETA ENHANCEOSOME; GENE-EXPRESSION; RECRUITMENT; ACTIVATION; INDUCTION	Dynamic control of interferon-beta (IFN-beta) gene expression requires the regulated assembly and disassembly of the enhanceosome, a higher-order nucleoprotein complex formed in response to virus infection. The enhanceosome activates transcription by recruiting the histone acetyltransferase proteins CREB binding protein (CBP) and (p) under bar 300/(C) under bar BP-(a) under bar ssociated (f) under bar actors (PCAF)/GCN5, which, in addition to modifying histones, acetylate HMGI(Y), the architectural component required for enhanceosome assembly. We show that the accurate execution of the IFN-P transcriptional switch depends on the ordered acetylation of the high-mobility group I protein HMGI(Y) by PCAF/GCN5 and CBP, which acetylate HMGI(Y) at distinct lysine residues on endogenous promoters. Whereas acetylation of HMGI(Y) by CBP at lysine-65 destabilizes the enhanceosome, acetylation of HMGI(Y) by PCAF/GCN5 at lysine-71 potentiates transcription by stabilizing the enhanceosome and preventing acetylation by CBP.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Munshi, Nikhil/ABE-2338-2021; Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026; Agalioti, Theodora/0000-0002-5898-2751	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367, R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [1RO1GM54605, 5-T32-GM07367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074	10	182	188	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1133	1136		10.1126/science.293.5532.1133	http://dx.doi.org/10.1126/science.293.5532.1133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498590				2022-12-24	WOS:000170432600059
J	Kaptchuk, TJ; Eisenberg, DM				Kaptchuk, TJ; Eisenberg, DM			Varieties of healing. 2: A taxonomy of unconventional healing practices	ANNALS OF INTERNAL MEDICINE			English	Review							FOLK MEDICINE; ALTERNATIVE MEDICINE; HEALTH; RELIGION; CARE; TRANSFUSION; BELIEFS; THERAPY; CULTURE; FAITH	The first of two essays in this issue demonstrated that the United States has had a rich history of medical pluralism. This essay seeks to present an overview of contemporary unconventional medical practices in the United States. No clear definition of "alternative medicine" is offered because it is a residual category composed of heterogeneous healing methods. A descriptive taxonomy of contemporary unconventional healing could be more helpful. Two broad categories of unconventional medicine are described here: a more prominent, "mainstream" complementary and alternative medicine (CAM) and a more culture-bound, "parochial" unconventional medicine. The CAM component can be divided into professional groups, layperson-initiated popular health reform movements, New Age healing, alternative psychological therapies, and non-normative scientific enterprises. The parochial category can be divided into ethno-medicine, religious healing, and folk medicine. A topologic examination of U.S. health care can provide an important conceptual framework through which health care providers can understand the current situation in U.S. medical pluralism.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kaptchuk, TJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,W-K-400, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albanese Catherine L., 1990, NATURE RELIG AM ALGO; ALBRECHT GL, 1982, RES SOCIOLOGY HLTH C, V2; AMUNDSEN DW, 1982, B HIST MED, V56, P326; ANDERSON J, 1997, NEWSDAY         1105, pB10; [Anonymous], 2000, LANCET, V356, P2023; [Anonymous], 1982, CRUSADERS FITNESS HI; Baer H A, 1992, Med Anthropol, V13, P369; Barnes LL, 1998, CULT MED PSYCHIAT, V22, P413, DOI 10.1023/A:1005403825213; BARRETT S, 1985, JAMA-J AM MED ASSOC, V254, P1041, DOI 10.1001/jama.254.8.1041; Braden C.S., 1963, SPIRITS REBELLION RI; Brown Karen McCarthy, 2001, M LOLA VODOU PRIESTE; BURROUGHS H, 1993, ALTERNATIVE HEALING; Cassileth BR, 1996, CANCER INVEST, V14, P396, DOI 10.3109/07357909609012168; CAVENDER AP, 1992, SOUTH MED J, V85, P170, DOI 10.1097/00007611-199202000-00012; Chopra Deepak, 1989, QUANTUM HEALING EXPL; COHEN C, 1992, PRIMARY CARE, V19, P87; COOK C, 1986, SOUTH MED J, V79, P1098, DOI 10.1097/00007611-198609000-00014; COOTER R, 1987, MED FRINGE MED ORTHO; COULEHAN JL, 1985, SOC SCI MED, V21, P383, DOI 10.1016/0277-9536(85)90218-7; Csordas T., 1994, SACRED SELF CULTURAL; Cumberland W.H., 1986, CARING CURING HLTH M; CURRY P, 1987, ASTROLOGY SCI SOC HI; Deutsch RM, 1977, NEW NUTS BERRIES; DICK HG, 1946, J HIST MED, V13, P300; Dossey L., 1991, MEANING MED; DOWLING SJ, 1984, J ROY SOC MED, V77, P634, DOI 10.1177/014107688407700803; Easthope G, 1986, HEALERS ALTERNATIVE; EISENBERG DM, 1993, ANN INTERN MED, V118, P964, DOI 10.7326/0003-4819-118-12-199306150-00009; Eisenberg DM, 1997, ANN INTERN MED, V127, P61, DOI 10.7326/0003-4819-127-1-199707010-00010; Eisenberg DM, 2000, JAMA-J AM MED ASSOC, V283, P885; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ellwood Robert S, 1979, ALTERNATIVE ALTARS U; English-Lueck J., 1990, HLTH NEW AGE STUDY C; Ernst E, 1996, ARCH INTERN MED, V156, P2162, DOI 10.1001/archinte.156.19.2162; Ernst E, 1997, CIRCULATION, V96, P1031; Ernst E, 1999, FORSCH KOMPLEMENTMED, V6, P7, DOI 10.1159/000021201; Fadiman A., 1997, SPIRIT CATCHES YOU Y; FERNGREN GB, 1992, B HIST MED, V66, P1; FISCH S, 1968, MILBANK FUND Q, V46, P377, DOI 10.2307/3349335; Fox M, 1984, Med Anthropol, V8, P292; FUCHS M, 1975, MED CARE, V13, P915, DOI 10.1097/00005650-197511000-00004; Fuller R.C., 1982, MESMERISM AM CURE SO; Furnham A, 2000, COMPLEMENT THER MED, V8, P82, DOI 10.1054/ctim.2000.0355; FYE WB, 1986, CIRCULATION, V73, P21, DOI 10.1161/01.CIR.73.1.21; GEBHARD B, 1976, AM FOLK MED; GEVITZ N, 1995, MT SINAI J MED, V62, P127; Gevitz N., 1988, OTHER HEALERS UNORTH, P124; Gevitz N., 1982, DOS OSTEOPATHIC MED; GLIK DC, 1988, SOC SCI MED, V27, P1197, DOI 10.1016/0277-9536(88)90349-8; GOLDMAN B, 1991, CAN MED ASSOC J, V144, P218; GOLDSTEIN MS, 1987, J HEALTH SOC BEHAV, V28, P103, DOI 10.2307/2137125; GOOD BJ, 1981, 8 PUBL REG HLTH CAR; Gordon JS., 1996, MANIFESTO NEW MED; GORT EH, 1988, SOC SCI MED, V26, P1061, DOI 10.1016/0277-9536(88)90224-9; HAFNER AW, 1993, READERS GUIDE ALTERN; HAFNER AW, 1992, GUIDE AM MED ASS HIS; HAND W D, 1971, Journal of the History of Medicine and Allied Sciences, V26, P263; Harrell David E., 1978, ALL THINGS ARE POSSI; Harwood A, 1977, Cult Med Psychiatry, V1, P69; Harwood A, 1981, ETHNICITY MED CARE; HELMAN C G, 1978, Culture Medicine and Psychiatry, V2, P107, DOI 10.1007/BF00054580; HERINK R, 1980, PSYCHOTHERAPY HDB; HEXHAM I, 1992, PERSPECTIVES NEW AGE; Hufford DJ, 1997, PRIMARY CARE, V24, P723, DOI 10.1016/S0095-4543(05)70307-9; Jacobs C F, 1990, Med Anthropol, V12, P349; JOHNSON DM, 1986, SOCIOL ANAL, V47, P66, DOI 10.2307/3711279; JOHNSON KP, 1998, E CAYCE CONTEXT; Johnson Shirley M., 1997, Journal of the American Osteopathic Association, V97, P80; JONES RK, 1970, SOCIOLOGY, V4, P181, DOI 10.1177/003803857000400203; Judah J.S, 1967, HIST PHILOS METAPHYS; KANDEL RF, 1976, THESIS STATE U NEW Y; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Kaptchuk TJ, 1998, ARCH INTERN MED, V158, P2215, DOI 10.1001/archinte.158.20.2215; Kaptchuk TJ, 1998, NUTRITION, V14, P471; KAPTCHUK TJ, 2001, FUNDAMENTALS COMPLEM; KAPTCHUK TJ, 2000, WEB THAT HAS NO WEAV; KAPTCHUK TJ, 1986, HEALING ARTS JOURNEY; KARASU TB, 1986, AM J PSYCHIAT, V143, P687; Kaufman M., 1971, HOMEOPATHY AM RISE F; Kelsey Morton T., 1973, HEALING CHRISTIANITY; Kemper K J, 1996, Pediatr Rev, V17, P279, DOI 10.1542/pir.17-8-279; Kerr H., 1983, OCCULT AM NEW HIST P; KING DE, 1988, J FAM PRACTICE, V27, P505; Kirmayer L. J, 1988, BIOMEDICINE EXAMINED; KIRSCHNER HE, 1991, LIVE FOOD JUICES; KLEINMAN AM, 1973, INQUIRY, V16, P206, DOI 10.1080/00201747308601685; KNAPP JE, 1990, NATL STUDY PROFESSIO; Ko CY, 1997, ARCH SURG-CHICAGO, V132, P829; KOENIG HG, 1988, J AM GERIATR SOC, V36, P362, DOI 10.1111/j.1532-5415.1988.tb02365.x; Kohl L, 1989, TAOIST MEDITATION LO; KRIEGER D, 1979, AM J NURS, V79, P660, DOI 10.2307/3462338; LAETZ T, 1991, JAMA-J AM MED ASSOC, V266, P2996, DOI 10.1001/jama.266.21.2996; LEIBOWITZ J, 1990, ALEXANDER TECHNIQUE; LERNER M, 1994, CHOICES HEALING INTE; LEVIN JS, 1986, SOC SCI MED, V23, P889, DOI 10.1016/0277-9536(86)90217-0; Levine HD, 1941, NEW ENGL J MED, V224, P487, DOI 10.1056/NEJM194103202241201; Linden Wolfgang, 1994, Annals of Behavioral Medicine, V16, P35; MANN MC, 1992, ANN INTERN MED, V117, P1042, DOI 10.7326/0003-4819-117-12-1042; MARTINEZ C, 1966, J AMER MED ASSOC, V196, P161, DOI 10.1001/jama.196.2.161; MATHEWS HF, 1987, SOUTHERN MED J, V80, P885, DOI 10.1097/00007611-198707000-00019; MCGUIRE MB, 1983, CULT MED PSYCHIAT, V7, P221, DOI 10.1007/BF00049311; McGuire Meredith, 1988, RITUAL HEALING SUBUR; Melton J.G., 1990, NEW AGE ENCY; MITCHELL BB, 1997, ACUPUNCTURE ORIENTAL; *NAT CTR HLTH STAT, 1975, OFF VIS OST PHYS JAN; National Institutes of Health, 1994, ALT MED EXP MED HOR; OConnor BB, 1995, STUDIES HLTH ILLNESS, Vxxiv; OPENHEIM J, 1988, OTHER WORLD SPIRITUA; OSHERSON S, 1981, SOCIAL CONTEXTS HLTH; PACHTER LM, 1994, JAMA-J AM MED ASSOC, V271, P690, DOI 10.1001/jama.271.9.690; *PAN DEF DESCR, 1997, ALTERN THER HEALTH M, V3, P49; Parker G.T., 1973, MIND CURE NEW ENGLAN; PIETRONI PC, 1992, BRIT MED J, V305, P564, DOI 10.1136/bmj.305.6853.564; RINZLER CA, 1991, FEED COLD STARVE FEV; ROTHSTEIN W, 1972, AM PHYSICIANS 19 CEN; RYWERANT Y, 1983, FELDENKRAIS METHOD; SAKETKHOO K, 1978, CHEST, V74, P408, DOI 10.1378/chest.74.4.408; SAKS M, 1992, ALTERNATIVE MED BRIT; Schoepflin R., 1988, OTHER HEALERS UNORTH; SCOTT CS, 1974, PUBLIC HEALTH REP, V89, P524; Segen J. C., 1998, DICT ALTERNATIVE MED; SINGELENBERG R, 1990, SOC SCI MED, V31, P515, DOI 10.1016/0277-9536(90)90048-W; Snow L F, 1978, Cult Med Psychiatry, V2, P69, DOI 10.1007/BF00052450; TAPPEN FM, 1988, HEALING MASSAGE TECH; TROTTER R, 1981, CURANDERISMO MEXICAN; TURNER R, 1998, COMPLEMENTARY THERAP, V6, P141; *US C OFF TECHN AS, 1990, UNC CANC TREATM; Uva J L, 1991, JAMA, V266, P3065; VANPRAAG J, 1997, TALKING HEAVEN MEDIU; WARDWELL W, 1992, CHIROPRACTIC HIST EV; WARDWELL WI, 1994, PERSPECT BIOL MED, V37, P595; Weil A., 1995, SPONTANEOUS HEALING; YAHN G, 1979, JAMA-J AM MED ASSOC, V242, P2202, DOI 10.1001/jama.242.20.2202; YATES JW, 1981, MED PEDIATR ONCOL, V9, P121, DOI 10.1002/mpo.2950090204; Yuasa Yasuo., 1993, BODY SELF CULTIVATIO; Zefron L J, 1975, Nurs Forum, V14, P350, DOI 10.1111/j.1744-6198.1975.tb00596.x; [No title captured]	137	100	100	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					196	204		10.7326/0003-4819-135-3-200108070-00012	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00012			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487487				2022-12-24	WOS:000170298500006
J	Schoups, A; Vogels, R; Qian, N; Orban, G				Schoups, A; Vogels, R; Qian, N; Orban, G			Practising orientation identification improves orientation coding in V1 neurons	NATURE			English	Article							DISCRIMINATION TASK; FREQUENCY-DISCRIMINATION; DIRECTION DISCRIMINATION; SPATIAL-FREQUENCY; OWL MONKEYS; CORTEX; SPECIFICITY; REORGANIZATION; REPRESENTATION; PERFORMANCE	The adult brain shows remarkable plasticity, as demonstrated by the improvement in fine sensorial discriminations after intensive practice. The behavioural aspects of such perceptual learning are well documented, especially in the visual system(1-8). Specificity for stimulus attributes clearly implicates an early cortical site, where receptive fields retain fine selectivity for these attributes; however, the neuronal correlates of a simple visual discrimination task remained unidentified. Here we report electrophysiological correlates in the primary visual cortex (V1) of monkeys for learning orientation identification. We link the behavioural improvement in this type of learning to an improved neuronal performance of trained compared to naive neurons. Improved long-term neuronal performance resulted from changes in the characteristics of orientation tuning of individual neurons. More particularly, the slope of the orientation tuning curve that was measured at the trained orientation increased only for the subgroup of trained neurons most likely to code the orientation identified by the monkey. No modifications of the tuning curve were observed for orientations for which the monkey had not been trained. Thus training induces a specific and efficient increase in neuronal sensitivity in V1.	Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	KU Leuven; Columbia University; Columbia University	Schoups, A (corresponding author), Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, B-3000 Louvain, Belgium.			Orban, Guy/0000-0002-8179-9584				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gold J, 1999, NATURE, V402, P176, DOI 10.1038/46027; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Matthews N, 1999, VISION RES, V39, P3692, DOI 10.1016/S0042-6989(99)00069-3; Nudo RJ, 1996, J NEUROSCI, V16, P785; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qian N., 1999, Society for Neuroscience Abstracts, V25, P1316; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SOMERS DC, 1995, J NEUROSCI, V15, P5448; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; VOGELS R, 1990, J NEUROSCI, V10, P3543; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017; ZOHARY E, 1994, SCIENCE, V263, P1289, DOI 10.1126/science.8122114; ZOHARY E, 1994, INVEST OPHTH VIS SCI, V35, P1663	30	604	623	2	45	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					549	553		10.1038/35087601	http://dx.doi.org/10.1038/35087601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484056	Green Published			2022-12-24	WOS:000170202900048
J	Threlfall, AG; Woodman, CBJ				Threlfall, AG; Woodman, CBJ			Risk of breast cancer in women who attend the NHS breast screening programme: cohort study	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY		Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England	University of Manchester	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.							Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Moss S, 1998, J EPIDEMIOL COMMUN H, V52, P111, DOI 10.1136/jech.52.2.111; Prior P, 1996, J Med Screen, V3, P119; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Richardson A, 1997, J Med Screen, V4, P16	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					140	140		10.1136/bmj.323.7305.140	http://dx.doi.org/10.1136/bmj.323.7305.140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463682	Bronze, Green Published			2022-12-24	WOS:000170106200016
J	Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW				Longnecker, MP; Klebanoff, MA; Zhou, HB; Brock, JW			Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth	LANCET			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; HUMAN-MILK; ORGANOCHLORINE PESTICIDES; RESIDUE LEVELS; PREMATURE; P,P'-DDE; DELIVERY; MALARIA; BLOOD; WOMEN	Background DDT (1,1,1-trichloro-2.2-bis(p-chlorophenyl) ethane) is highly effective against most malaria-transmitting mosquitoes and is being widely used in malaria-endemic areas. The metabolite, DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene), has been linked to preterm birth in small studies, but these findings are inconclusive. Our aim was to investigate the association between DDE exposure and preterm birth. Methods Our study was based on the US Collaborative Perinatal Project (CPP). From this study we selected a subset of more than 44 000 eligible children born between 1959 and 1966 and measured the DDE concentration in their mothers' serum samples stored during pregnancy. Complete data were available for 2380 children, of whom 361 were born preterm and 221 were small-for-gestational age. Findings The median maternal DDE concentration was 25 mug/L (range 3-178)-several fold higher than current US concentrations. The adjusted odds ratios (OR) of preterm birth increased steadily with increasing concentrations of serum DDE (ORs=1, 1.5, 1.6, 2.5, 3.1; trend p<0.0001). Adjusted odds of small-for-gestational-age also increased, but less consistently (ORs=1, 1.9, 1.7, 1.6, 2.6; trend p=0.04). After excluding preterm births, the association of DDE with small-for-gestational-age remained. Interpretation The findings strongly suggest that DDT use increases preterm births, which is a major contributor to infant mortality. If this association is causal, it should be included in any assessment of the costs and benefits of vector control with DDT.	NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; NICHHD, Div Epidemiol Stat & Prevent Res, Rockville, MD USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA	Longnecker, MP (corresponding author), NIEHS, Epidemiol Branch, POB 12233 MD A3-05, Res Triangle Pk, NC 27709 USA.			Longnecker, Matthew/0000-0001-6073-5322	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049016, Z01ES101170, ZIAES049016, Z01ES100490] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; *ATSDR, 1994, TOX PROF DDT DDE DDD; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; Berkowitz GS, 1996, ARCH ENVIRON CON TOX, V30, P139, DOI 10.1007/BF00211340; BOUWMAN H, 1991, J TOXICOL ENV HEALTH, V33, P141, DOI 10.1080/15287399109531514; BRACKBILL Y, 1978, LANCET, V2, P520; Brock JW, 1996, J ANAL TOXICOL, V20, P528, DOI 10.1093/jat/20.7.528; DELONG RL, 1973, SCIENCE, V181, P1168, DOI 10.1126/science.181.4105.1168; HART MM, 1971, ARCH INT PHARMACOD T, V192, P286; Jeong SY, 2000, BIOCHEM BIOPH RES CO, V267, P262, DOI 10.1006/bbrc.1999.1916; JUBERG DR, 1992, TOXICOLOGY, V74, P161, DOI 10.1016/0300-483X(92)90136-3; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Klotz DM, 1997, MOL CELL ENDOCRINOL, V129, P63, DOI 10.1016/S0303-7207(96)04041-5; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110, DOI 10.1080/00039899909602244; Lunden A, 1998, ARCH ENVIRON CON TOX, V34, P414, DOI 10.1007/s002449900338; LUNDHOLM CE, 1992, ARCH TOXICOL, V66, P387, DOI 10.1007/BF02035127; LYON MF, 1980, PROC R SOC SER B-BIO, V208, P1, DOI 10.1098/rspb.1980.0040; NARAHASHI T, 1997, COMPREHENSIVE TOXICO, V11; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Noren K, 1999, ARCH ENVIRON CON TOX, V37, P408, DOI 10.1007/s002449900532; NOREN K, 1988, CHEMOSPHERE, V17, P39, DOI 10.1016/0045-6535(88)90042-2; OLEARY JA, 1970, AM J OBSTET GYNECOL, V106, P939, DOI 10.1016/0002-9378(70)90499-0; POLLIOTTI B, 1994, PLACENTA, V15, P477, DOI 10.1016/S0143-4004(05)80417-5; PROCIANOY RS, 1981, ACTA PAEDIATR SCAND, V70, P925, DOI 10.1111/j.1651-2227.1981.tb06252.x; Quensen JF, 1998, SCIENCE, V280, P722, DOI 10.1126/science.280.5364.722; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172; Sames WJ, 1996, J AM MOSQUITO CONTR, V12, P487; SAXENA MC, 1981, J ANAL TOXICOL, V5, P6, DOI 10.1093/jat/5.1.6; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Smith AG, 2000, LANCET, V356, P267, DOI 10.1016/S0140-6736(00)02497-1; STEHRGREEN PA, 1989, J TOXICOL ENV HEALTH, V27, P405, DOI 10.1080/15287398909531312; Ware G W, 1975, Residue Rev, V59, P119; WASSERMANN M, 1982, ENVIRON RES, V28, P106, DOI 10.1016/0013-9351(82)90158-X; *WHO, 1995, WHO TECHN REP SER, V857; WWF, 1999, HAZ EXP ASS DDT SYNT	38	331	339	1	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 14	2001	358	9276					110	114		10.1016/S0140-6736(01)05329-6	http://dx.doi.org/10.1016/S0140-6736(01)05329-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463412				2022-12-24	WOS:000169837700011
J	Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH				Dong, YH; Wang, LH; Xu, JL; Zhang, HB; Zhang, XF; Zhang, LH			Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase	NATURE			English	Article							AERUGINOSA VIRULENCE GENES; PSEUDOMONAS-AERUGINOSA; ERWINIA-CAROTOVORA; EXOENZYME PRODUCTION; AUTOINDUCER; SIGNAL; EXPRESSION; BINDING; DETERMINANTS; SPECIFICITY	Bacterial cells sense their population density through a sophisticated cell-cell communication system and trigger expression of particular genes when the density reaches a threshold. This type of gene regulation, which controls diverse biological functions including virulence, is known as quorum sensing(1,2). Quorum-sensing signals, such as acyl-homoserine lactones (AHLs), are the essential components of the communication system. AHLs regulate virulence gene expression in a range of plant and animal (including human) bacterial pathogens(3-9). AHL-producing tobacco restored the pathogenicity of an AHL-negative mutant of Erwinia carotovora(10). Different bacterial species may produce different AHLs, which vary in the length and substitution of the acyl chain but contain the same homoserine lactone moiety. Here we show that the acyl-homoserine lactonase (AHL-lactonase), a new enzyme from Bacillus sp.(11), inactivates AHL activity by hydrolysing the lactone bond of AHLs. Plants expressing AHL-lactonase quenched pathogen quorum-sensing signalling and showed significantly enhanced resistance to E. carotovora infection. Our results highlight a promising potential to use quorum-sensing signals as molecular targets for disease control, thereby broadening current approaches for prevention of bacterial infections.	Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, Singapore 117604, Singapore	National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol Agrobiol, Lab Biosignals & Bioengn, 1 Res Link, Singapore 117604, Singapore.		Wang, Lianhui/D-6826-2016					Beaujean A, 1998, J EXP BOT, V49, P1589, DOI 10.1093/jexbot/49.326.1589; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Costa JM, 1997, CAN J MICROBIOL, V43, P1164, DOI 10.1139/m97-165; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dunphy G, 1997, J BACTERIOL, V179, P5288, DOI 10.1128/jb.179.17.5288-5291.1997; Fray RG, 1999, NAT BIOTECHNOL, V17, P1017, DOI 10.1038/13717; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Gallois P., 1995, PLANT GENE TRANSFER, P39, DOI 10.1385/0-89603-321-X:39; Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Manefield M, 2000, APPL ENVIRON MICROB, V66, P2079, DOI 10.1128/AEM.66.5.2079-2084.2000; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Qin YP, 2000, EMBO J, V19, P5212, DOI 10.1093/emboj/19.19.5212; Robson ND, 1997, TRENDS BIOTECHNOL, V15, P458, DOI 10.1016/S0167-7799(97)01102-5; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Welch M, 2000, EMBO J, V19, P631, DOI 10.1093/emboj/19.4.631; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhu J, 1999, P NATL ACAD SCI USA, V96, P4832, DOI 10.1073/pnas.96.9.4832	28	718	828	24	274	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					813	817		10.1038/35081101	http://dx.doi.org/10.1038/35081101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459062				2022-12-24	WOS:000169246400053
J	BOWYER, S				BOWYER, S			ASTRONOMY AND THE EXTREME-ULTRAVIOLET EXPLORER SATELLITE	SCIENCE			English	Article							INTERSTELLAR	The extreme ultraviolet wave band (100 to 912 angstroms) was thought until recently to be useless to astronomy, primarily because the opacity of the interstellar medium would prevent observations at these wavelengths. However, the interstellar medium has been found to be markedly inhomogeneous in both density and ionization state and the sun is fortunately located in a region of low extreme ultraviolet opacity. The Extreme Ultraviolet Explorer, launched in June 1992, has surveyed the sky in this wave band and has detected a wide variety of astronomical sources at considerable distances, including some extragalactic objects. Studies in the extreme ultraviolet band have already begun to increase our understanding of the contents of the universe.			BOWYER, S (corresponding author), UNIV CALIF BERKELEY,CTR EUV ASTROPHYS,2150 KITTREDGE ST,BERKELEY,CA 94720, USA.							ALLER LH, 1959, PUBL ASTRON SOC PAC, V71, P324, DOI 10.1086/127390; BOWYER S, 1988, APPL OPTICS, V27, P1414, DOI 10.1364/AO.27.001414; Bowyer S., 1991, EXTREME ULTRAVIOLET, P397; BOWYER S, UNPUB; CASH W, 1978, ASTROPHYS J, V221, pL87, DOI 10.1086/182670; CASSINELLI JP, UNPUB; CULLY SL, 1993, ASTROPHYS J, V414, pL49, DOI 10.1086/186993; DUPREE AK, IN PRESS ASTROPHYS J; DUPUIS J, UNPUB; DUPUIS J, IN PRESS BR ASS ADV; FLEMING TA, 1986, ASTROPHYS J, V308, P176, DOI 10.1086/164488; FRUSCIONE A, IN PRESS ASTROPHYS J; GLADSTONE GR, UNPUB; GLADSTONE GR, IN PRESS GEOPHYS RES; GREEN J, 1990, ASTROPHYS J, V359, P499, DOI 10.1086/169081; GURSKY H, 1963, PHYS REV LETT, V11, P530, DOI 10.1103/PhysRevLett.11.530; HEILES C, 1991, EUV ASTRONOMY, P313; HENRY P, 1975, ASTROPHYS J, V195, P107, DOI 10.1086/153309; HETTRICK MC, 1983, APPL OPTICS, V22, P3921, DOI 10.1364/AO.22.003921; KIMBLE RA, 1993, ASTROPHYS J, V404, P663, DOI 10.1086/172319; KRASNOPOLSKY VA, UNPUB; LAMPTON M, 1976, ASTROPHYS J, V203, pL71, DOI 10.1086/182022; LIVINGSTON PM, 1968, J GEOPHYS RES, V73, P1107; MARTIN C, 1981, REV SCI INSTRUM, V52, P1967; PARESCE F, 1974, ASTROPHYS J, V187, P633, DOI 10.1086/152673; POUNDS K, 1993, MON NOT R ASTRON SOC, V206, P77; SIEGMUND OHW, 1986, J OPT SOC AM A, V3, P2139, DOI 10.1364/JOSAA.3.002139; SNOWDEN SL, 1993, ASTROPHYS J, V409, pL21, DOI 10.1086/186850; SPITZER L, 1990, ANNU REV ASTRON ASTR, V28, P71; VALLERGA JV, 1993, ASTROPHYS J, V414, pL65, DOI 10.1086/186997; VEDDER PW, 1993, IN PRESS ASTROPHYS J, V414, pL61; VENNES S, 1993, ASTROPHYS J, V410, pL119, DOI 10.1086/186894; [No title captured]	33	8	8	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 7	1994	263	5143					55	59		10.1126/science.11536659	http://dx.doi.org/10.1126/science.11536659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MQ301	11536659				2022-12-24	WOS:A1994MQ30100025
J	OWEN, T; BARNUN, A; KLEINFELD, I				OWEN, T; BARNUN, A; KLEINFELD, I			POSSIBLE COMETARY ORIGIN OF HEAVY NOBLE-GASES IN THE ATMOSPHERES OF VENUS, EARTH AND MARS	NATURE			English	Article							AMORPHOUS WATER ICE; TERRESTRIAL PLANETS; METEORITES; SHERGOTTITES; BASALTS; IMPACT; GLASS	MODELS that trace the origin of noble gases in the atmospheres of the terrestrial planets (Venus, Earth and Mars) to the 'planetary component' in chondritic meteorites confront several problems. The 'missing' xenon in the atmospheres of Mars and Earth (Fig. 1) is one of the most obvious; this gas is not hidden or trapped in surface materials 1. On Venus, the absolute abundances of neon and argon per gram of rock are higher even than those in carbonaceous chondrites, whereas the relative abundances of argon and krypton are closer to solar than to chondritic values (there is only an upper limit on xenon) 2 (Fig. 1). Pepin 3 has developed a model that emphasizes hydrodynamic escape of early, massive hydrogen atmospheres to explain the abundances and isotope ratios of noble gases on all three planets. We have previously suggested that the unusual abundances of heavy noble gases on Venus might be explained by the impact of a low-temperature comet 4-6. Further consideration of the probable history of the martian atmosphere 7, the noble-gas data from the (Mars-derived) SNC meteorites 8-10 and laboratory experiments on the trapping of noble gases in ice 6,11,12 lead us to propose here that the noble gases in the atmospheres of all of the terrestrial planets are dominated by a mixture of an internal component and a contribution from impacting icy planetesimals (comets). If true, this hypothesis illustrates the importance of impacts in determining the volatile inventories of these planets.	TEL AVIV UNIV, DEPT GEOPHYS & PLANETARY SCI, IL-69978 TEL AVIV, ISRAEL	Tel Aviv University	OWEN, T (corresponding author), UNIV HAWAII, INST ASTRON, 2680 WOODLAWN DR, HONOLULU, HI 96822 USA.							BARNUN A, 1989, ICARUS, V80, P243, DOI 10.1016/0019-1035(89)90136-X; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; BIEMANN K, 1976, SCIENCE, V194, P76, DOI 10.1126/science.194.4260.76; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOSS AP, 1989, ORIGIN EVOLUTION PLA, P35; BUS SJ, 1991, SCIENCE, V251, P774, DOI 10.1126/science.251.4995.774; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1976, EARTH PLANET SC LETT, V31, P369, DOI 10.1016/0012-821X(76)90118-7; HART R, 1983, NATURE, V305, P403, DOI 10.1038/305403a0; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7871, DOI 10.1029/JA085iA13p07871; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; HUNTEN DM, 1988, METEORITES EARLY SOL, P565; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KANEOKA I, 1983, EARTH PLANET SC LETT, V66, P427, DOI 10.1016/0012-821X(83)90156-5; LAUFER D, 1987, PHYS REV B, V36, P9219, DOI 10.1103/PhysRevB.36.9219; LUNINE JI, 1991, ICARUS, V94, P333, DOI 10.1016/0019-1035(91)90232-I; LUU JX, 1990, ASTRON J, V100, P913, DOI 10.1086/115571; MCELROY MB, 1972, SCIENCE, V175, P443, DOI 10.1126/science.175.4020.443; MEECH KJ, 1989, IAU4470 CIRC; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MUSSELWHITE DS, 1991, NATURE, V352, P697, DOI 10.1038/352697a0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; OTT U, 1988, GEOCHIM COSMOCHIM AC, V52, P1937, DOI 10.1016/0016-7037(88)90017-8; OTT U, 1988, METEORITICS, V23, P295; OTT U, 1985, NATURE, V317, P509, DOI 10.1038/317509a0; OWEN T, 1991, ASTROPHYS SPACE SC L, V167, P429; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; OWEN T, 1986, WORKSHOP EVOLUTION M, P31; OWEN T, IN PRESS MARS; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; SILL GT, 1978, ICARUS, V33, P13, DOI 10.1016/0019-1035(78)90020-9; STERN SA, 1992, ICARUS, V95, P157, DOI 10.1016/0019-1035(92)90198-G; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P1475, DOI 10.1016/0016-7037(79)90142-X; STOLPER EM, 1978, GEOCHIM COSMOCHIM AC, V42, P589; STUDACHER T, 1986, CHEM GEOL, V56, P193; WACKER JF, 1984, GEOCHIM COSMOCHIM AC, V48, P2373, DOI 10.1016/0016-7037(84)90232-1; WATSON LL, IN PRESS P LUNAR PLA; WETHERILL GW, 1990, ANNU REV EARTH PL SC, V18, P205, DOI 10.1146/annurev.ea.18.050190.001225; WETHERILL GW, 1981, ICARUS, V46, P70, DOI 10.1016/0019-1035(81)90076-2; WIENS RC, 1986, EARTH PLANET SC LETT, V77, P149, DOI 10.1016/0012-821X(86)90156-1; ZAHNLE K, 1990, ICARUS, V84, P502, DOI 10.1016/0019-1035(90)90050-J; [No title captured]	44	111	111	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					43	46		10.1038/358043a0	http://dx.doi.org/10.1038/358043a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536499				2022-12-24	WOS:A1992JB34100046
J	ENGEL, MH; MACKO, SA; SILFER, JA				ENGEL, MH; MACKO, SA; SILFER, JA			CARBON ISOTOPE COMPOSITION OF INDIVIDUAL AMINO-ACIDS IN THE MURCHISON METEORITE	NATURE			English	Article									UNIV VIRGINIA,DEPT ENVIRONM SCI,CHARLOTTESVILLE,VA 22903	University of Virginia	ENGEL, MH (corresponding author), UNIV OKLAHOMA,SCH GEOL & GEOPHYS,100 E BOYD ST,NORMAN,OK 73019, USA.		Macko, Stephen/K-4588-2015					CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; Cronin J. R., 1988, METEORITES EARLY SOL; CRONIN JR, 1971, SCIENCE, V172, P1327, DOI 10.1126/science.172.3990.1327; CRONIN JR, 1976, ORIGINS LIFE EVOL B, V7, P337, DOI 10.1007/BF00927928; Engel M.H., 1985, CHEM BIOCHEM AMINO, P462; ENGEL MH, 1982, NATURE, V296, P837, DOI 10.1038/296837a0; ENGEL MH, 1984, ANAL CHEM, V56, P2598, DOI 10.1021/ac00277a075; ENGEL MH, 1986, NATURE, V323, P531, DOI 10.1038/323531a0; ENGEL MH, 1983, NATURE, V301, P496, DOI 10.1038/301496a0; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FREEDMAN PA, 1988, J AM LAB, P114; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GRADY MM, 1988, GEOCHIM COSMOCHIM AC, V52, P2855, DOI 10.1016/0016-7037(88)90152-4; HARE PE, 1985, CHEM BIOCH AMINO ACI, P415; JULL AJT, 1989, GEOCHIM COSMOCHIM AC, V53, P2095, DOI 10.1016/0016-7037(89)90327-X; KENNICUTT MC, 1990, ORG GEOCHEM, V15, P193, DOI 10.1016/0146-6380(90)90083-C; KERRIDGE JF, 1985, GEOCHIM COSMOCHIM AC, V49, P1707, DOI 10.1016/0016-7037(85)90141-3; KHARE BN, 1986, ICARUS, V68, P176, DOI 10.1016/0019-1035(86)90080-1; MACKO SA, 1981, THESIS U TEXAS AUSTI; NOYES HP, 1977, ORIGINS LIFE EVOL B, V8, P21, DOI 10.1007/BF00930935; PILLINGER CT, 1982, NATURE, V296, P802, DOI 10.1038/296802a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SERBAN A, 1988, ORG GEOCHEM, V13, P1123, DOI 10.1016/0146-6380(88)90298-7; SHOCK EL, IN PRESS GEOCHIM COS; SILFER JA, UNPUB ANAL CHEM; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; 1990, SEARCH LIFES ORIGINS	28	219	222	1	40	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					47	49		10.1038/348047a0	http://dx.doi.org/10.1038/348047a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536470				2022-12-24	WOS:A1990EF99400056
J	ANDERS, E				ANDERS, E			PRE-BIOTIC ORGANIC-MATTER FROM COMETS AND ASTEROIDS	NATURE			English	Article									UNIV CHICAGO, DEPT CHEM, CHICAGO, IL 60637 USA	University of Chicago	ANDERS, E (corresponding author), UNIV CHICAGO, ENRICO FERMI INST, CHICAGO, IL 60637 USA.		Anders, Edward/B-7980-2009					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1968, ACCOUNTS CHEM RES, V1, P289, DOI 10.1021/ar50010a001; ANDERS E, 1973, SCIENCE, V182, P781, DOI 10.1126/science.182.4114.781; Anders E., 1973, Moon, V8, P3, DOI 10.1007/BF00562747; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARKER JL, 1968, GEOCHIM COSMOCHIM AC, V32, P627, DOI 10.1016/0016-7037(68)90053-7; BROWNLEE DE, 1985, REV EARTH PLANET SCI, V13, P189; CHAPMAN CR, 1975, SCIENCE, V190, P553, DOI 10.1126/science.190.4214.553; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; Cronin J.R., 1988, METEORITES EARLY SOL, P819; DEAMER DW, 1985, NATURE, V317, P792, DOI 10.1038/317792a0; DEAMER DW, IN PRESS ORIGINS LIF; DELSEMME AH, 1984, ORIGINS LIFE EVOL B, V14, P51, DOI 10.1007/BF00933639; DOHNANYI JS, 1971, SCIENCE, V173, P558, DOI 10.1126/science.173.3996.558; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; GROS J, 1976, P LUNAR PLANET SCI C, V7, P2403; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; Hertogen J., 1977, PROC LUNAR SCI C, P17; HUDSON B, 1981, SCIENCE, V211, P383, DOI 10.1126/science.211.4480.383; Hughes D. W., 1978, Cosmic dust, P123; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KIMURA K, 1974, GEOCHIM COSMOCHIM AC, V38, P683, DOI 10.1016/0016-7037(74)90144-6; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LEWIS RS, 1986, METEORITICS, V21, P434; Mason B., 1966, PRINCIPLES GEOCHEMIS, DOI DOI 10.1016/j.iswcr.2018.09.001; MATSUI T, 1986, NATURE, V322, P526, DOI 10.1038/322526a0; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; MULLIE F, 1987, TOP CURR CHEM, V139, P83; OPIK EJ, 1961, P GEOPHYS LAB LAWREN, P1; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PALME H, 1981, GEOCHIM COSMOCHIM AC, V45, P2417, DOI 10.1016/0016-7037(81)90095-8; REVELLE DO, 1979, J ATMOS TERR PHYS, V41, P453, DOI 10.1016/0021-9169(79)90071-0; SCHRAMM LS, 1989, METEORITICS, V24, P99, DOI 10.1111/j.1945-5100.1989.tb00950.x; Sears D. W., 1975, Modern Geology, V5, P155; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; THOMAS PJ, 1989, LUNAR PLANET SCI, V20, P1117; TURCO RP, 1982, ICARUS, V50, P1, DOI 10.1016/0019-1035(82)90096-3; TUREKIAN KK, 1969, EARTH PLANET SC LETT, V6, P346, DOI 10.1016/0012-821X(69)90183-6; Weissman P. R., 1982, GEOL SOC AM SPEC PAP, V190, P15; WETHERILL GW, 1981, ICARUS, V48, P308, DOI 10.1016/0019-1035(81)90112-3; WETHERILL GW, 1987, PHILOS T R SOC A, V323, P323, DOI 10.1098/rsta.1987.0089; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE KJ, 1988, ICARUS, V74, P62, DOI 10.1016/0019-1035(88)90031-0; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; [No title captured]	49	293	295	12	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	1989	342	6247					255	257		10.1038/342255a0	http://dx.doi.org/10.1038/342255a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ874	11536617				2022-12-24	WOS:A1989AZ87400046
J	Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M				Pizzarello, S; Huang, YS; Becker, L; Poreda, RJ; Nieman, RA; Cooper, G; Williams, M			The organic content of the Tagish Lake meteorite	SCIENCE			English	Article							MURCHISON METEORITE; CARBONACEOUS CHONDRITE; C-13 NMR; ACIDS; HYDROCARBONS; DERIVATIVES; MATTER	The Tagish Lake meteorite felt last year on a frozen take in Canada and may provide the most pristine material of its kind. Analyses have now shown this carbonaceous chondrite to contain a suite of soluble organic compounds (similar to 100 parts per million) that includes mono- and dicarboxylic acids, dicarboximides, pyridine carboxylic acids, a sulfonic acid, and both aliphatic and aromatic hydrocarbons. The insoluble carbon exhibits exclusive aromatic character, deuterium enrichment, and fullerenes containing "planetary" helium and argon. The findings provide insight into an outcome of early solar chemical evolution that differs from any seen so far in meteorites.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Calif Santa Barbara, Inst Crustal Studies, Santa Barbara, CA 93106 USA; Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Arizona State University; Arizona State University-Tempe; Brown University; University of California System; University of California Santa Barbara; University of Rochester; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Pizzarello, S (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.							ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Becker L, 2000, P NATL ACAD SCI USA, V97, P2979, DOI 10.1073/pnas.050519397; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI, V30; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; Cronin J.R., 1988, METEORITES EARLY SOL, P819; CRONIN JR, 1993, GEOCHIM COSMOCHIM AC, V57, P4745, DOI 10.1016/0016-7037(93)90197-5; CRONIN JR, 1987, GEOCHIM COSMOCHIM AC, V51, P299, DOI 10.1016/0016-7037(87)90242-0; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; CRONIN JR, 1990, GEOCHIM COSMOCHIM AC, V54, P2859, DOI 10.1016/0016-7037(90)90020-L; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Gilmour I., 2001, LUNAR PLANET SCI, V32; HAN J, 1969, NATURE, V222, P364, DOI 10.1038/222364a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LAWLESS JG, 1979, NATURE, V282, P396, DOI 10.1038/282396a0; PELTZER ET, 1978, NATURE, V272, P443, DOI 10.1038/272443a0; Pizzarello S, 2001, METEORIT PLANET SCI, V36, P897, DOI 10.1111/j.1945-5100.2001.tb01929.x; STUDIER MH, 1972, GEOCHIM COSMOCHIM AC, V36, P189	20	197	201	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2236	2239		10.1126/science.1062614	http://dx.doi.org/10.1126/science.1062614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520948				2022-12-24	WOS:000171139400038
J	Sherwood, T				Sherwood, T			100 years' observation of risks from radiation for British (male) radiologists	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Sherwood, T (corresponding author), Lancet, London WC1X 8RR, England.							Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; COURT BROWN W M, 1958, Br Med J, V2, P181; SMITH PG, 1981, BRIT J RADIOL, V54, P187, DOI 10.1259/0007-1285-54-639-187; SOUTHWOOD TRE, 1994, CLIN RADIOL, V49, P1, DOI 10.1016/S0009-9260(05)82905-8	4	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					604	604		10.1016/S0140-6736(01)05818-4	http://dx.doi.org/10.1016/S0140-6736(01)05818-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530145				2022-12-24	WOS:000170615500006
J	Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM				Gotz, J; Chen, F; van Dorpe, J; Nitsch, RM			Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A beta 42 fibrils	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; MICROTUBULE-BINDING; PROTEIN; PHOSPHORYLATION; NEUROTOXICITY; AMYOTROPHY; PATHOLOGY; ISOFORMS; BRAIN	beta -Amyloid plaques and neurofibrillary tangles (NFTs) are the defining neuropathological hallmarks of Alzheimer's disease, but their pathophysiological relation is unclear. Injection of beta -amyloid A beta (42) fibrils into the brains of P301L mutant tau transgenic mice caused fivefold increases in the numbers of NFTs in cell bodies within the amygdala from where neurons project to the injection sites. Gallyas silver impregnation identified NFTs that contained tau phosphorylated at serine 212/threonine 214 and serine 422. NFTs were composed of twisted filaments and occurred in 6-month-old mice as early as 18 days after A beta (42) injections. Our data support the hypothesis that A beta (42) fibrils can accelerate NFT formation in vivo.	Univ Zurich, Div Psychiat Res, CH-8008 Zurich, Switzerland; Katholieke Univ Leuven, Ctr Human Genet, Expt Genet Grp, Louvain, Belgium	University of Zurich; KU Leuven	Nitsch, RM (corresponding author), Univ Zurich, Div Psychiat Res, August Forel Str 1, CH-8008 Zurich, Switzerland.	goetz@bli.unizh.ch; nitsch@bli.unizh.ch	Götz, Jürgen/C-2448-2014	Götz, Jürgen/0000-0001-8501-7896				Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; GOTZ J, UNPUB; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; Paxinos K.B.J., 1997, MOUSE BRAIN STEREOTA; PRICE DL, 1994, ANNU REV MED, V45, P435; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8	32	1178	1238	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1491	1495		10.1126/science.1062097	http://dx.doi.org/10.1126/science.1062097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520988				2022-12-24	WOS:000170616000045
J	Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L				Herren, KR; Mackway-Jones, K; Richards, CR; Seneviratne, CJ; France, MW; Cotter, L			Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC TROPONIN-T; CHEST-PAIN; INFARCTION; AUDIT; ACCIDENT; TRIAL; ROOM	Objective To assess the clinical efficacy and accuracy of an emergency department based six hour rule-out protocol for myocardial damage. Design Diagnostic cohort study. Setting Emergency department of an inner city university hospital. Participants 383 consecutive patients aged over 25 years with chest pain of less than 12 hours' duration who were at low to moderate risk of acute myocardial infarction. Intervention Serial measurements of creatine kinase MB mass and continuous ST segment monitoring for six hours with 12 leads. Main outcome measure Performance of the diagnostic test against a gold standard consisting of either a 48 hour measurement of troponin T concentration or screening for myocardial infarction according to the World Health Organization's criteria. Results Outcome of the gold standard test was available for 292 patients. On the diagnostic test for the protocol, 53 patients had positive results and 239 patients had negative results. There were 18 false positive results and one false negative result. Sensitivity was 97.2% (95% confidence interval 95.0% to 99.0%), specificity 93.0% (90.0% to 96.0%), the negative predictive value 99.6%, and the positive predictive value 66.0%. The positive likelihood ratio was 13.9 and the negative likelihood ratio 0.03. Conclusions The six hour rule-out protocol for myocardial infarction is accurate mad efficacious. It can be used in patients presenting to emergency departments with chest pain indicating a low to moderate risk of myocardial infarction.	Manchester Royal Infirm, Dept Emergency Med, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Dept Clin Biochem, Manchester M13 9WL, Lancs, England; Manchester Royal Infirm, Manchester Heart Ctr, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Mackway-Jones, K (corresponding author), Manchester Royal Infirm, Dept Emergency Med, Oxford Rd, Manchester M13 9WL, Lancs, England.							CLEMENTS FM, 1988, CRIT CARE MED, V16, P710, DOI 10.1097/00003246-198807000-00013; Collinson PO, 2000, BRIT MED J, V320, P1702, DOI 10.1136/bmj.320.7251.1702; EMERSON PA, 1989, Q J MED, V70, P213; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; FOTHERGILL NJ, 1993, ARCH EMERG MED, V10, P155; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HUNT D, 1992, LANCET, V339, P753; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; KRUCOFF MW, 1986, AM J CARDIOL, V57, P916, DOI 10.1016/0002-9149(86)90730-7; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; LEE TH, 1987, ANN INTERN MED, V106, P181, DOI 10.7326/0003-4819-106-2-181; MAIR J, 1991, CLIN CHEM, V37, P845; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P532	14	28	28	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					372	374		10.1136/bmj.323.7309.372	http://dx.doi.org/10.1136/bmj.323.7309.372			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509427	Bronze, Green Published			2022-12-24	WOS:000170581400018
J	Henneman, ML; Memmott, J				Henneman, ML; Memmott, J			Infiltration of a Hawaiian community by introduced biological control agents	SCIENCE			English	Article								To examine the community-wide effects of introduced biocontrol agents on Kauai Island, Hawaii, we constructed quantitative food webs showing interactions among plants, moths, and moth parasitoids in a native forest. Eighty-three percent of parasitoids reared from native moths were biological control agents, 14% were accidental immigrants, and 3% were native species. Although parasitism by biological control agents reached 28% in some species of moth, all biocontrol agents reared had been released before 1945. This study highlights the importance of considering the potential damage caused by an introduced control agent, in addition to that caused by the target alien species.	Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol	Memmott, J (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	Jane.Memmott@bristol.ac.uk						BEARDSLEY JOHN W., 1961, PROC HAWAIIAN ENT SOC, V17, P333; BENNETT FD, 1993, FLA ENTOMOL, V76, P54, DOI 10.2307/3496013; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; CORNELL HV, 1993, AM NAT, V141, P847, DOI 10.1086/285512; COULSON J, 2001, RELEASES BENEFICIAL; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; FUNASAKI G Y, 1988, Proceedings of the Hawaiian Entomological Society, V28, P105; GAGNE WC, 1985, P 3 C EUR LEP CAMBR, P74; GLASSER JW, 1982, AM NAT, V119, P375, DOI 10.1086/283916; HADFIELD MG, 1993, AM ZOOL, V33, P610; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; HAWKINS BA, 1993, SCIENCE, V262, P1429, DOI 10.1126/science.262.5138.1429; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Howarth Francis G., 2000, P369; Johnson DM, 1998, FLA ENTOMOL, V81, P12, DOI 10.2307/3495992; LAI P Y, 1986, Proceedings of the Hawaiian Entomological Society, V26, P89; LAI PY, 1983, LIST BIOL CONTROL IN; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P147; Messing RH, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P45; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; SETTLE WH, 1990, ECOLOGY, V71, P1461, DOI 10.2307/1938283; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D., 1992, Selection criteria and ecological consequences of importing natural enemies., P103; Strong DR, 2000, SCIENCE, V288, P1969, DOI 10.1126/science.288.5473.1969; Strong DR, 2001, EVALUATING INDIRECT ECOLOGICAL EFFECTS OF BIOLOGICAL CONTROL, P57, DOI 10.1079/9780851994536.0057; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; VANDRIESCHE RG, 1994, FLA ENTOMOL, V77, P20, DOI 10.2307/3495870; Williams F. X., 1931, HDB INSECTS OTHER IN; Zimmerman EC, 1978, MICROLEPIDOPTERA 2, V9, P883	31	221	233	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1314	1316		10.1126/science.1060788	http://dx.doi.org/10.1126/science.1060788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509730				2022-12-24	WOS:000170492600039
J	Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV				Brewer, TF; Heymann, SJ; Krumplitsch, SM; Wilson, ME; Colditz, GA; Fineberg, HV			Strategies to decrease tuberculosis in US homeless populations - A computer simulation model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; DIRECTLY OBSERVED THERAPY; UNITED-STATES; ISONIAZID PROPHYLAXIS; HIV; SHELTER; TRANSMISSION; PREVENTION; RESISTANT	Context The rate of tuberculosis (TB) among US homeless persons maybe 20 times that of the general adult population. Studies suggest that the majority of urban homeless TB cases are attributable to ongoing transmission of TB. Optimal TB-control strategies in both chronically and transiently homeless populations are not known. Objective To examine the effects of TB-control strategies on projected TB cases and deaths in US homeless populations using a computer-based simulation model. Design, Setting, and Population The US general population and a theoretical population of 2 million homeless individuals in 1995 were divided into 18 clinical states based on the risk for or presence of TB and human immunodeficiency virus (HIV) infection in a semi-Markov model. Main Outcome Measures Prevalence of transiently and chronically homeless individuals with active TB and deaths from TB as a function of public health measures taken to control and eliminate TB, including improvement of treatment effectiveness, improvement in access to treatment, and vaccination with BCG. Results A 10% increase in access to treatment among homeless persons with active TB produced larger declines in predicted TB cases and deaths after 10 years (cases and deaths among chronically homeless persons decreased 12.5% and 19.8% and among transiently homeless persons dropped 35.9% and 32.4%, respectively) than improvements in the effectiveness of treatment programs (cases and deaths among chronically homeless per-sons declined 7.2% and 3.1% and among transiently homeless persons dropped 10.9% and 4.1%, respectively). A 10% increase in access to treatment among homeless persons with latent TB infection led to a 6.7% decline in TB among chronically homeless persons and a 5.7% decline among transiently homeless persons, while a 10% improvement in effectiveness of treatment for latent TB infection was associated with declines of 3.0% and 3.3%, respectively. When treatment for latent TB infection was modeled to be the same in vaccinated and nonvaccinated populations, BCG vaccination led to TB case declines of 15.4% and 21.5% in chronically and transiently homeless populations, respectively. Conclusions Overcoming barriers faced by homeless individuals in accessing TB treatment programs will be crucial to reducing the burden of TB in this high-risk group. Increased treatment access, improvement in the effectiveness of treatment programs, and BCG vaccination of HIV-negative homeless individuals have the best chance to markedly decrease TB morbidity and mortality.	Channing Labs, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Off Provost, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University	Brewer, TF (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.	timothy.brewer@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Heymann, Jody/0000-0003-0008-4198	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001444] Funding Source: NIH RePORTER; NIAID NIH HHS [1K08 AI01444-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P13; Barnes PF, 1996, JAMA-J AM MED ASSOC, V275, P305, DOI 10.1001/jama.275.4.305; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bock NN, 1998, INT J TUBERC LUNG D, V2, P124; Brewer TF, 1996, JAMA-J AM MED ASSOC, V276, P1898, DOI 10.1001/jama.276.23.1898; BRUDNEY K, 1991, AM REV RESPIR DIS, V144, P745, DOI 10.1164/ajrccm/144.4.745; Burman WJ, 1997, CHEST, V111, P1168, DOI 10.1378/chest.111.5.1168; BURT MR, 1999, HOMELESSNESS PROGRAM; CDC, 1999, REP TUB US 1998, P1; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2001, NAT IMM SURV Q3 1999; *CDCP, 1996, REP TUB US 1995, P26; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; COMSTOCK GW, 1976, PUBLIC HEALTH REP, V91, P276; COUNTS GW, 1984, REV INFECT DIS, V6, P640; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Diez E, 1996, TUBERCLE LUNG DIS, V77, P420, DOI 10.1016/S0962-8479(96)90114-8; ElSadr W, 1996, AM J PUBLIC HEALTH, V86, P1146, DOI 10.2105/AJPH.86.8_Pt_1.1146; Etkind S, 1991, Semin Respir Infect, V6, P273; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gallagher TC, 1997, MED CARE, V35, P814, DOI 10.1097/00005650-199708000-00007; GEITER L, 2000, ENDING NEGLECT ELIMI; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Gelberg L, 1996, J GEN INTERN MED, V11, P156, DOI 10.1007/BF02600268; Gelberg L, 1997, J GEN INTERN MED, V12, P25, DOI 10.1007/s11606-006-0004-4; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Gordin FM, 1996, AM J RESP CRIT CARE, V154, P1478, DOI 10.1164/ajrccm.154.5.8912768; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; HOBBY GL, 1974, AM REV RESPIR DIS, V110, P95; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P613; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; LeBaron CW, 1998, ARCH PEDIAT ADOL MED, V152, P327; LINK B, 1995, AM J ORTHOPSYCHIAT, V65, P347, DOI 10.1037/h0079653; LoBue PA, 1999, CHEST, V115, P218, DOI 10.1378/chest.115.1.218; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; NAZARSTEWART V, 1992, AM REV RESPIR DIS, V146, P57, DOI 10.1164/ajrccm/146.1.57; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Pilote L, 1996, ARCH INTERN MED, V156, P161, DOI 10.1001/archinte.156.2.161; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Rendleman NJ, 1999, AM J PREV MED, V17, P108, DOI 10.1016/S0749-3797(99)00052-5; ROSE DN, 1992, J GEN INTERN MED, V7, P589, DOI 10.1007/BF02599196; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; Shlay JC, 1996, SEX TRANSM DIS, V23, P304, DOI 10.1097/00007435-199607000-00011; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; STLAWRENCE JS, 1995, AIDS EDUC PREV, V7, P22; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; TORRES RA, 1990, ARCH INTERN MED, V150, P2030, DOI 10.1001/archinte.150.10.2030; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; *US C MAYORS, 2001, STAT REP HUNG HOM AM; *WHO, 2000, WHO VACC PREV DIS M; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	72	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					834	842		10.1001/jama.286.7.834	http://dx.doi.org/10.1001/jama.286.7.834			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	462PU	11497538	Bronze			2022-12-24	WOS:000170429600032
J	Zabihi, N; Teichman, JMH				Zabihi, N; Teichman, JMH			Dealing with the pain of renal colic	LANCET			English	Editorial Material							URETERAL PRESSURE; INDOMETHACIN		Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Teichman, JMH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Teichman, Joel/CAJ-0452-2022					Brater D. Craig, 1999, American Journal of Medicine, V107, p65S; CADNAPAPHORNCHAI P, 1978, PROSTAG OTH LIPID M, V16, P965, DOI 10.1016/0090-6980(78)90113-2; COLE RS, 1988, BRIT J UROL, V61, P19, DOI 10.1111/j.1464-410X.1988.tb09155.x; CORDELL WH, 1994, ANN EMERG MED, V23, P262, DOI 10.1016/S0196-0644(94)70038-9; ELSHERIF AE, 1995, J UROLOGY, V153, P1395, DOI 10.1016/S0022-5347(01)67411-1; HULAND H, 1981, INVEST UROL, V18, P274; KIMOTO Y, 1990, EUR J PHARMACOL, V175, P359, DOI 10.1016/0014-2999(90)90577-S; Lopes T, 2001, BJU INT, V87, P322, DOI 10.1046/j.1464-410x.2001.00068.x; MOODY TE, 1975, INVEST UROL, V13, P246; PERLMUTTER A, 1993, J UROLOGY, V149, P926, DOI 10.1016/S0022-5347(17)36261-4; SCHLONDORFF D, 1993, KIDNEY INT, V44, P643, DOI 10.1038/ki.1993.293; Segura JW, 1997, J UROLOGY, V158, P1915, DOI 10.1016/S0022-5347(01)64173-9; UDEN P, 1983, ACTA CHIR SCAND, V149, P497	13	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					437	438		10.1016/S0140-6736(01)05668-9	http://dx.doi.org/10.1016/S0140-6736(01)05668-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513904				2022-12-24	WOS:000170492400006
J	Vanclay, JK				Vanclay, JK			The effectiveness of parks	SCIENCE			English	Editorial Material									So Cross Univ, POB 157, Lismore, NSW 2480, Australia	Southern Cross University	Vanclay, JK (corresponding author), So Cross Univ, POB 157, Lismore, NSW 2480, Australia.	Jvanclay@scu.edu.au	Vanclay, Jerome/B-9266-2009	Vanclay, Jerome/0000-0002-5639-5481				Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125	1	36	38	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1007	1007		10.1126/science.293.5532.1007a	http://dx.doi.org/10.1126/science.293.5532.1007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498547				2022-12-24	WOS:000170432600001
J	Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E				Parmar, MKB; Griffiths, GO; Spiegelhalter, DJ; Souhami, RL; Altman, DG; van der Scheuren, E		CHART Steering Committee	Monitoring of large randomised clinical trials: a new approach with Bayesian methods	LANCET			English	Article							CELL LUNG-CANCER; CONVENTIONAL RADIOTHERAPY; MULTICENTER TRIAL; CHART; HEAD; NECK	Background In judging whether or not to continue enrolling patients into a randomised clinical trial, most data-monitoring and ethics committees (DMECs) rely on the p value for the difference in effect between the study groups. In the 1990s, two randomised controlled trials-one in patients with lung cancer and one in those with head and neck cancer-were instead monitored by Bayesian methods. We assessed the value of this approach in the monitoring of these clinical trials, Methods Before the trials opened, participating clinicians were asked their opinions on the expected difference between the study treatment (continuous hyperfractionated accelerated radiotherapy [CHART]) and conventional radiotherapy. These opinions were used to form an "enthusiastic" and a "sceptical" prior distribution. These prior distributions were combined with the trial data at each of the annual DMEC meetings. If, during monitoring, a result in favour of CHART was seen, the DMEC was to decide whether the results were sufficiently convincing to persuade a sceptic that CHART was worthwhile. Conversely, if there was apparently no or little difference, the DMEC was asked whether they thought the results sufficiently convincing to persuade an enthusiast that CHART was not worthwhile. Findings At each of the annual meetings, the DMEC concluded that there was insufficient evidence to convert either sceptics or enthusiasts, and that the trials should therefore remain open to recruitment. Neither trial was closed to recruitment earlier than planned. However if a conventional (p-value-based) stopping rule had been used, the lung-cancer trial would probably have been stopped. Interpretation This Bayesian approach to monitoring is simple to implement and straightforward for members of the DMEC to understand. In our opinion, it is more intuitively appealing than conventional approaches.	MRC, Clin Trials Unit, Canc Div, London NW1 2DA, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; UCL, Royal Free & Univ Coll Med Sch, London WC1E 6BT, England; Inst Hlth Sci, Ctr Stat Med, ICRF Med Stat Grp, Oxford, England; Univ Hosp Gasthuisberg, Louvain, Belgium	Medical Research Council Clinical Trials Unit; MRC Biostatistics Unit; University of Cambridge; University of London; University College London; University of Oxford; KU Leuven; University Hospital Leuven	Griffiths, GO (corresponding author), MRC, Clin Trials Unit, Canc Div, 222 Euston Rd, London NW1 2DA, England.	gg@ctu.mrc.ac.uk		Griffiths, Gareth/0000-0002-9579-8021				Armitage P, 1999, CONTROL CLIN TRIALS, V20, P207, DOI 10.1016/S0197-2456(99)00005-7; *CLIN TRIAL SERV U, 1989, ISIS3 PROT 3 INT STU; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Dische S, 1997, RADIOTHER ONCOL, V44, P123, DOI 10.1016/S0167-8140(97)00094-7; Fayers PM, 1997, STAT MED, V16, P1413, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1413::AID-SIM578>3.0.CO;2-U; Freidlin B, 1999, CONTROL CLIN TRIALS, V20, P395, DOI 10.1016/S0197-2456(99)00017-3; *MED RES COUNC, 1989, AXIS PROT ADJ XRAY 5; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PARMAR MKB, 1994, STAT MED, V13, P1297, DOI 10.1002/sim.4780131304; Saunders M, 1999, RADIOTHER ONCOL, V52, P137, DOI 10.1016/S0167-8140(99)00087-0; Saunders MI, 1996, BRIT J CANCER, V73, P1455, DOI 10.1038/bjc.1996.276; SPIEGELHALTER DJ, 1994, J R STAT SOC A STAT, V157, P357, DOI 10.2307/2983527; SPIEGELHALTER DJ, 1993, STAT MED, V12, P1501, DOI 10.1002/sim.4780121516; THORNTON JG, 1996, GROWTH RESTRICTION I; Whitehead J, 1997, DESIGN ANAL SEQUENTI	16	53	53	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					375	381		10.1016/S0140-6736(01)05558-1	http://dx.doi.org/10.1016/S0140-6736(01)05558-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502318				2022-12-24	WOS:000170235100013
J	Schwetz, BA				Schwetz, BA			New device for procedures on diseased bypass grafts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-24	WOS:000170188300004
J	McLeod, A				McLeod, A			Changing patterns of teenage pregnancy: population based study of small areas	BRITISH MEDICAL JOURNAL			English	Article								Objectives To measure the impact of socioeconomic deprivation on rates of teenage pregnancy and the extent of local variation in pregnancy rates in Scotland, and to examine how both have changed over time. Design Population study using routine data from hospital records, aggregated for small areas. Subjects Female teenagers resident in Scotland who were treated for pregnancy in an NHS hospital mi either 1981-5 (62 338 teenagers) or 1991-5 (48 514) and who were aged 13-19 at the time of conception. Main outcome measures Pregnancy rates per 1000 in age group and the proportions of pregnancies resulting in a maternity (live birth or stillbirth) in teenagers aged 13-15, 16-17, and 18-19. Results From the 1980s to the 1990s pregnancy rates increased differentially according to levels of local deprivation, as measured by the Carstairs index. Among teenagers aged less than 18 the annual pregnancy rate increased in the most deprived areas (from 7.0 to 12.5 pregnancies per 1000 13-15 year olds and from 67.6 to 84.6 per 1000 16-17 year olds), but there was no change, on average, among teenagers in the most affluent areas (3.8 per 1000 13-15 year olds and 28.9 per 1000 16-17 year olds). Among 18-19 year olds the pregnancy rate decreased in the most affluent areas (from 60.0 to 46.3 per 1000) and increased in the most deprived areas (from 112.4 to 116.0 per 1000). The amount of local variation explained by deprivation more than doubled from the 1980s to the 1990s. The proportion of pregnancies resulting in a maternity was positively associated with level of deprivation, but the effect remained similar over time. Conclusion From the 1980s to the 1990s the difference in rates of teenage pregnancy between more affluent and more deprived areas widened. This has implications for allocating resources to achieve government targets and points to important social processes behind the general increase in the number of teenage pregnancies in Scotland.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	McLeod, A (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.							Carstairs V., 1991, DEPRIVATION HLTH SCO; Churchill D, 2000, BRIT MED J, V321, P486, DOI 10.1136/bmj.321.7259.486; Coory M, 1998, STAT MED, V17, P2625, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2625::AID-SIM957>3.0.CO;2-4; *DEP HLTH, 1992, HLTH NAT; Diamond I, 1999, J ROY STAT SOC A STA, V162, P273, DOI 10.1111/1467-985X.00135; *INF STAT DIV, 1995, SCOTT HLTH STAT 1995; *INF STAT DIV, 1984, SCOTT HLTH STAT 1984; *ISD, 1998, TEEN PREGN SCOTL 15; Rigsby D C, 1998, J Pediatr Adolesc Gynecol, V11, P115; *SCOTT OFF, 1999, TOW HLTH SCOTL; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; *SOC EXCL UN, 1999, TEEN PREGN; StevensSimon C, 1996, J ADOLESCENT HEALTH, V19, P48, DOI 10.1016/1054-139X(95)00281-V	13	46	48	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					199	203		10.1136/bmj.323.7306.199	http://dx.doi.org/10.1136/bmj.323.7306.199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473910	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000170270200017
J	Brooks, CL; Onuchic, JN; Wales, DJ				Brooks, CL; Onuchic, JN; Wales, DJ			Statistical thermodynamics - Taking a walk on a landscape	SCIENCE			English	Editorial Material							TRANSITION-STATE; KINETICS; LIQUIDS; MECHANISMS; PROTEINS; GLASSES		Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of California System; University of California San Diego; University of Cambridge	Brooks, CL (corresponding author), Scripps Res Inst, Dept Mol Biol, Glebe, NSW 2037, Australia.	brooks@scripps.edu						ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Becker OM, 1997, J CHEM PHYS, V106, P1495, DOI 10.1063/1.473299; BERRY RS, 1987, NATO ASI SER B, V158, P185; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dugourd P, 1997, CHEM PHYS LETT, V267, P186, DOI 10.1016/S0009-2614(97)00062-6; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; Finke JM, 2000, BIOCHEMISTRY-US, V39, P15633, DOI 10.1021/bi001307d; Gruebele M, 1999, ANNU REV PHYS CHEM, V50, P485, DOI 10.1146/annurev.physchem.50.1.485; Hardin C, 2000, P NATL ACAD SCI USA, V97, P14235, DOI 10.1073/pnas.230432197; Hirst JD, 1999, PROTEIN ENG, V12, P721, DOI 10.1093/protein/12.9.721; Hummer G, 2001, PROTEINS, V42, P77, DOI 10.1002/1097-0134(20010101)42:1<77::AID-PROT80>3.3.CO;2-R; Klimov DK, 2000, P NATL ACAD SCI USA, V97, P2544, DOI 10.1073/pnas.97.6.2544; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; Sciortino F, 2000, J PHYS-CONDENS MAT, V12, P6525, DOI 10.1088/0953-8984/12/29/324; Shea JE, 2000, J CHEM PHYS, V113, P7663, DOI 10.1063/1.1313792; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shimada J, 2001, J MOL BIOL, V308, P79, DOI 10.1006/jmbi.2001.4586; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Skolnick J, 2000, NAT BIOTECHNOL, V18, P283, DOI 10.1038/73723; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; Wales DJ, 2000, ADV CHEM PHYS, V115, P1, DOI 10.1002/9780470141748.ch1; Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523; Xia XY, 2000, P NATL ACAD SCI USA, V97, P2990, DOI 10.1073/pnas.97.7.2990	27	154	156	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					612	613		10.1126/science.1062559	http://dx.doi.org/10.1126/science.1062559			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474087				2022-12-24	WOS:000170204600029
J	Dubrulle, J; McGrew, MJ; Pourquie, O				Dubrulle, J; McGrew, MJ; Pourquie, O			FGF signaling controls somite boundary position and regulates segmentation clock control of spatiotemporal Hox gene activation	CELL			English	Article							GROWTH-FACTOR RECEPTOR; VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; AVIAN EMBRYOS; MOUSE EMBRYO; CHICK-EMBRYO; EXPRESSION; SOMITOGENESIS; GASTRULATION; CELLS	Vertebrate segmentation requires a molecular oscillator, the segmentation clock, acting in presomitic mesoderm (PSM) cells to set the pace at which segmental boundaries are laid down. However, the signals that position each boundary remain unclear. Here, we report that FGF8 which is expressed in the posterior PSM, generates a moving wavefront at which level both segment boundary position and axial identity become determined. Furthermore, by manipulating boundary position in the chick embryo, we show that Hox gene expression is maintained in the appropriately numbered somite rather than at an absolute axial position. These results implicate FGF8 in ensuring tight coordination of the segmentation process and spatiotemporal Hox gene activation.	Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Univ Mediterranee AP Marseille, Dev Biol Inst Marseille, Lab Genet & Physiol Dev, CNRS,INSERM, Campus Luminy,Case 907, F-13288 Marseille 09, France.	pourquie@ibdm.univ-mrs.fr	Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				AOYAMA H, 1988, DEVELOPMENT, V104, P15; Araki I, 1999, DEVELOPMENT, V126, P5127; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1997, NATURE, V387, P97, DOI 10.1038/387097a0; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; DEUCHAR EM, 1967, J EMBRYOL EXP MORPH, V17, P349; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; GOULDING M, 1994, DEVELOPMENT, V120, P957; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirsinger E, 2000, INT REV CYTOL, V198, P1; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Jiang YJ, 1998, CURR BIOL, V8, pR868, DOI 10.1016/S0960-9822(07)00547-7; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kerszberg M, 2000, J THEOR BIOL, V205, P505, DOI 10.1006/jtbi.2000.2085; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KIENY M, 1972, DEV BIOL, V28, P142, DOI 10.1016/0012-1606(72)90133-9; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; MENKES B, 1977, VERTEBRATE LIMB SOMI, V3, P405; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nicolas JF, 1996, DEVELOPMENT, V122, P2933; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; PACKARD DS, 1978, J EXP ZOOL, V203, P295, DOI 10.1002/jez.1402030212; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; PATSTONE G, 1993, DEV BIOL, V155, P107, DOI 10.1006/dbio.1993.1011; Pourquie O, 2000, CURR OPIN CELL BIOL, V12, P747, DOI 10.1016/S0955-0674(00)00163-0; Pownall ME, 1996, DEVELOPMENT, V122, P3881; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Sosic D, 1997, DEV BIOL, V185, P229, DOI 10.1006/dbio.1997.8561; STERN CD, 1992, DEVELOPMENT, P151; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1988, DEVELOPMENT, V104, P231; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Vogel A, 1996, DEVELOPMENT, V122, P1737; YAMAGUCHI TP, 1992, DEV BIOL, V152, P75, DOI 10.1016/0012-1606(92)90157-C; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6	49	498	523	3	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					219	232		10.1016/S0092-8674(01)00437-8	http://dx.doi.org/10.1016/S0092-8674(01)00437-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511349	Bronze, Green Published			2022-12-24	WOS:000170193100011
J	Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT				Sanderson, SL; Cheer, AY; Goodrich, JS; Graziano, JD; Callan, WT			Crossflow filtration in suspension-feeding fishes	NATURE			English	Article							FLOW MICROFILTRATION; MEMBRANE FILTRATION; PARTICLE RETENTION; PERMEATE FLUX; MECHANISMS; FILTER; ULTRAFILTRATION; DEPOSITION; TRANSPORT; MIGRATION	Rows of comb-like or tufted gill rakers in the oral cavity of suspension-feeding fishes (for example, herring, anchovies and tilapia) have been thought to serve as (1) non-porous barriers that direct particle-laden water to the sticky oral roof, where particles are retained as water exits from the oral cavity, (2) conventional dead-end filters that sieve particles from water exiting between rakers, or (3) sticky filters that retain particles encountered by a hydrosol filtration mechanism(1-6). Here we present data from computational fluid dynamics and video endoscopy in suspension-feeding fish indicating that the rakers of three distantly related species function instead as a crossflow filter(7,8.) Particles are concentrated inside the oral cavity as filtrate exits between the rakers, but particles are not retained on the rakers. Instead, the high-velocity crossflow along the rakers carries particles away from the raker surfaces and transports the particles towards the oesophagus. This crossflow prevents particles from clogging the gaps between the rakers, and solves the mystery of particle transport from the rakers to the oesophagus.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Univ Calif Davis, Dept Math, Davis, CA 95616 USA; Univ Calif Davis, Inst Theoret Dynam, Davis, CA 95616 USA	William & Mary; University of California System; University of California Davis; University of California System; University of California Davis	Sanderson, SL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	slsand@wm.edu						BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; BOWEN WR, 1995, ADV COLLOID INTERFAC, V56, P141, DOI 10.1016/0001-8686(94)00232-2; CHEER AYL, 1987, J THEOR BIOL, V129, P17, DOI 10.1016/S0022-5193(87)80201-1; Chellam S, 1997, ENVIRON SCI TECHNOL, V31, P819, DOI 10.1021/es9605228; Cheryan M, 1998, ULTRAFILTRATION MICR; DREW DA, 1991, CHEM ENG SCI, V46, P3219, DOI 10.1016/0009-2509(91)85023-Q; Gerking SD, 1994, FEEDING ECOLOGY FISH; GIBSON RN, 1988, J FISH BIOL, V32, P949, DOI 10.1111/j.1095-8649.1988.tb05438.x; Goodrich JS, 2000, J FISH BIOL, V56, P858; GREEN G, 1980, DESALINATION, V35, P129, DOI 10.1016/S0011-9164(00)88607-5; HOOGENBOEZEM W, 1991, CAN J FISH AQUAT SCI, V48, P7, DOI 10.1139/f91-002; Kardong K.V., 2009, VERTEBRATES COMP ANA, V6th; Koehl M.A.R., 1995, Symposia of the Society for Experimental Biology, V49, P157; LABARBERA M, 1984, AM ZOOL, V24, P71; LANGELAND A, 1995, J FISH BIOL, V47, P719, DOI 10.1006/jfbi.1995.0174; LAUDER GV, 1980, J EXP BIOL, V88, P49; Li H, 1998, J MEMBRANE SCI, V149, P83, DOI 10.1016/S0376-7388(98)00181-1; MUMMERT JR, 1986, T AM FISH SOC, V115, P522, DOI 10.1577/1548-8659(1986)115<522:EOFSOT>2.0.CO;2; NORTON SF, 1993, J EXP BIOL, V176, P11; PORTER MC, 1972, IND ENG CHEM PROD RD, V11, P234, DOI 10.1021/i360043a002; SANDERSON SL, 1991, SCIENCE, V251, P1346, DOI 10.1126/science.251.4999.1346; SANDERSON SL, 1996, J EXP BIOL, V199, P1743; SANDERSON SL, 1993, FLUID DYNAMICS BIOL, P135; Sethi S, 1997, J MEMBRANE SCI, V136, P191, DOI 10.1016/S0376-7388(97)00168-3; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; Tardieu E, 1998, J MEMBRANE SCI, V147, P1, DOI 10.1016/S0376-7388(98)00091-X; Vogel S., 1994, LIFE MOVING FLUIDS P, V2nd ed.; Wiesner MR, 1999, J ENVIRON ENG-ASCE, V125, P1124, DOI 10.1061/(ASCE)0733-9372(1999)125:12(1124); Zeman L. J., 1996, MICROFILTRATION ULTR	29	104	106	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					439	441		10.1038/35086574	http://dx.doi.org/10.1038/35086574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473318				2022-12-24	WOS:000170068200048
J	Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS				Gachet, Y; Tournier, S; Millar, JBA; Hyams, JS			A MAP kinase-dependent actin checkpoint ensures proper spindle orientation in fission yeast	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; ATF1 TRANSCRIPTION FACTOR; ASYMMETRIC CELL-DIVISION; SCHIZOSACCHAROMYCES-POMBE; BIPOLAR SPINDLE; PROTEIN-KINASE; CYCLE; PROTEOLYSIS; PATHWAY; LOCALIZATION	The accurate segregation of chromosomes at mitosis depends on a correctly assembled bipolar spindle that exerts balanced forces on each sister chromatid(1,2). The integrity of mitotic chromosome segregation is ensured by the spindle assembly checkpoint (SAC) that delays mitosis in response to defective spindle organisation or failure of chromosome attachment(2,3). Here we describe a distinct mitotic checkpoint in the fission yeast, Schizosaccharomyces pombe, that monitors the integrity of the actin cytoskeleton and delays sister chromatid separation, spindle elongation and cytokinesis until spindle poles have been properly oriented. This mitotic delay is imposed by a stress-activated mitogen-activated protein (MAP) kinase pathway but is independent of the anaphase-promoting complex (APC)(4,5).	Natl Inst Med Res, Div Yeast Genet, London NW7 1AA, England; UCL, Dept Biol, London WC1E 6B, England	MRC National Institute for Medical Research; University of London; University College London	Millar, JBA (corresponding author), Natl Inst Med Res, Div Yeast Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	jmillar@nimr.mrc.ac.uk	Gachet, Yannick/AAK-5363-2021	Millar, Jonathan/0000-0002-9930-3989	MRC [MC_U117531948] Funding Source: UKRI; Medical Research Council [MC_U117531948] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALFA CE, 1990, NATURE, V347, P680, DOI 10.1038/347680a0; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BIRKENBIHL RP, 1995, J BIOL CHEM, V270, P7703, DOI 10.1074/jbc.270.13.7703; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hagan IM, 1996, CELL MOTIL CYTOSKEL, V34, P69; Hardwick KG, 1999, GENETICS, V152, P509; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Lu BW, 1998, CURR OPIN GENET DEV, V8, P392, DOI 10.1016/S0959-437X(98)80108-1; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; MARKS J, 1985, EUR J CELL BIOL, V39, P27; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; YAMASHITA M, 1991, DEV GROWTH DIFFER, V33, P617; Yanagida M, 1999, PHILOS T R SOC B, V354, P1559, DOI 10.1098/rstb.1999.0499; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	28	135	139	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					352	355		10.1038/35085604	http://dx.doi.org/10.1038/35085604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460168				2022-12-24	WOS:000169918200051
J	Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C				Thompson, JS; Bixler, SA; Qian, F; Vora, K; Scott, ML; Cachero, TG; Hession, C; Schneider, P; Sizing, ID; Mullen, C; Strauch, K; Zafari, M; Benjamin, CD; Tschopp, J; Browning, JL; Ambrose, C			BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; CELL MATURATION ANTIGEN; A/WYSNJ MICE; MEMBER; SUPERFAMILY; APRIL; TACI; GROWTH; TALL-1; BCMA	B cell homeostasis has been shown to critically depend on BAFF, the B cell activation factor from the tumor necrosis factor (TNF) family. Although BAFF is already known to bind two receptors, BCMA and TACI, we have identified a third receptor for BAFF that we have termed BAFF-R. BAFF-R binding appears to be highly specific for BAFF, suggesting a unique role for this ligand-receptor interaction. Consistent with this, the BAFF-R locus is disrupted in A/WySnJ mice, which display a B cell phenotype qualitatively similar to that of the BAFF-deficient mice. Thus, BAFF-R appears to be the principal receptor for BAFF-mediated mature B cell survival.	Biogen Inc, Cambridge, MA 02142 USA; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Biogen; University of Lausanne	Ambrose, C (corresponding author), Biogen Inc, 12 Cambridge Ctr, Cambridge, MA 02142 USA.	christine_ambrose@biogen.com		Browning, Jeffrey/0000-0001-9168-5233; Schneider, Pascal/0000-0003-0677-9409				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hoag KA, 2000, IMMUNOGENETICS, V51, P924, DOI 10.1007/s002510000223; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Lentz VM, 1998, J IMMUNOL, V160, P3743; Lentz VM, 1996, J IMMUNOL, V157, P598; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; QIAN F, UNPUB; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	30	736	882	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2108	2111		10.1126/science.1061965	http://dx.doi.org/10.1126/science.1061965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509692				2022-12-24	WOS:000171028700079
J	Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL				Tattersall, DB; Bak, S; Jones, PR; Olsen, CE; Nielsen, JK; Hansen, ML; Hoj, PB; Moller, BL			Resistance to an herbivore through engineered cyanogenic glucoside synthesis	SCIENCE			English	Article							BICOLOR L MOENCH; P-HYDROXYPHENYLACETALDEHYDE OXIME; SORGHUM-BICOLOR; CYTOCHROME P-450(TYR); ESCHERICHIA-COLI; L-TYROSINE; DHURRIN; BIOSYNTHESIS; EXPRESSION; PURIFICATION	The entire pathway for synthesis of the tyrosine-derived cyanogenic glucoside dhurrin has been transferred from Sorghum bicolor to Arabidopsis thaliana. Here, we document that genetically engineered plants are able to synthesize and store large amounts of new natural products. The presence of dhurrin in the transgenic A. thaliana plants confers resistance to the flea beetle Phyllotreta nemorum, which is a natural pest of other members of the crucifer group, demonstrating the potential utility of cyanogenic glucosides in plant defense.	Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Dept Chem, DK-1871 Frederiksberg C, Denmark; Univ Adelaide, Dept Hort Viticulture & Oenol, Glen Osmond, SA 5064, Australia; Australian Wine Res Inst, Glen Osmond, SA 5064, Australia	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Adelaide; Australian Wine Research Institute	Moller, BL (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, 40 Thorvaldsensvej, DK-1871 Frederiksberg C, Denmark.	blm@kvl.dk	Bak, Soren/H-4404-2014; Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022; Olsen, Carl E/H-3031-2014; Hoj, Peter B/E-8526-2011	Bak, Soren/0000-0003-4100-115X; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119; Olsen, Carl E/0000-0002-2275-0596; 				Bak S, 1999, PLANT J, V20, P663, DOI 10.1046/j.1365-313X.1999.00642.x; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; Bak S, 2000, PLANT PHYSIOL, V123, P1437, DOI 10.1104/pp.123.4.1437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; FRANZL S, 1985, TISSUE CELL, V17, P267, DOI 10.1016/0040-8166(85)90093-X; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; HALKIER BA, 1995, ARCH BIOCHEM BIOPHYS, V322, P369, DOI 10.1006/abbi.1995.1477; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; NAHRSTEDT A, 1986, PHYTOCHEMISTRY, V25, P2299, DOI 10.1016/S0031-9422(00)81683-0; Nielsen JK, 1997, ENTOMOL EXP APPL, V82, P25, DOI 10.1023/A:1002990929647; Nielsen JK, 2001, CHEMOECOLOGY, V11, P75, DOI 10.1007/PL00001835; Schappert PJ, 1999, ECOSCIENCE, V6, P511, DOI 10.1080/11956860.1999.11682560; Seigler D.S, 1991, HERBIVORES THEIR INT, V1; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; SIBBESEN O, 1994, P NATL ACAD SCI USA, V91, P9740, DOI 10.1073/pnas.91.21.9740; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; WANG P, 1992, ARCH BIOCHEM BIOPHYS, V298, P569, DOI 10.1016/0003-9861(92)90451-2	22	193	210	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1826	1828		10.1126/science.1062249	http://dx.doi.org/10.1126/science.1062249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474068				2022-12-24	WOS:000170894400046
J	Ezzati, M; Kammen, DM				Ezzati, M; Kammen, DM			Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study	LANCET			English	Article							DOMESTIC SMOKE POLLUTION; YOUNG GAMBIAN CHILDREN; DEVELOPING-COUNTRIES; RURAL-COMMUNITY; HILL REGION; EMISSIONS; HEALTH; WOMEN; NEPAL	Background Acute respiratory infections (ARI) are the leading cause of the global burden of disease and have been causally linked with exposure to pollutants from domestic biomass fuels in less-developed countries. We used longitudinal health data coupled with detailed monitoring of personal exposure from more than 2 years of field measurements in rural Kenya to estimate the exposure-response relation for particulates smaller than 10 mum in diameter (PM10) generated from biomass combustion. Methods 55 randomly-selected households (including 93 infants and children, 229 individuals between 5 and 49 years of age, and 23 aged 50 or older) in central Kenya were followed up for more than 2 years. Longitudinal data on ARI and acute lower respiratory infections (ALRI) were recorded at weekly clinical examinations. Exposure to PM10 was monitored by measurement of PM10 emission concentration and time-activity budgets. Findings With the best estimate of the exposure-response relation, we found that ARI and ALRI are increasing concave functions of average daily exposure to PM10, with the rate of increase declining for exposures above about 1000-2000 mug/m(3). After we had included high-intensity exposure episodes, sex was no longer a significant predictor of ARI and ALRI. Interpretation The benefits of reduced exposure to PM10 are larger for average exposure less than about 1000-2000 mug/m(3). Our findings have important consequences for international public-health policies, energy and combustion research, and technology transfer efforts that affect more than 2 billion people worldwide.	Resources Future Inc, Ctr Risk Management, Washington, DC 20036 USA; WHO, Global Programme Evidence Hlth Policy, Epidemiol & Burden Dis Unit, CH-1211 Geneva, Switzerland; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	Resources for the Future; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Resources Future Inc, Ctr Risk Management, 1616 P St NW, Washington, DC 20036 USA.							ARMSTRONG JRM, 1991, INT J EPIDEMIOL, V20, P424, DOI 10.1093/ije/20.2.424; Awasthi S, 1996, AM J TROP MED HYG, V55, P48, DOI 10.4269/ajtmh.1996.55.48; BallardTremeer G, 1996, BIOMASS BIOENERG, V11, P419, DOI 10.1016/S0961-9534(96)00040-2; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; BERMAN S, 1991, REV INFECT DIS, V13, pS454; BOLEIJ JSM, 1989, ATMOS ENVIRON, V23, P1677, DOI 10.1016/0004-6981(89)90052-8; Bruce N, 1998, INT J EPIDEMIOL, V27, P454, DOI 10.1093/ije/27.3.454; Campbell H, 1997, Health Bull (Edinb), V55, P20; CERQUEIRO MC, 1990, REV INFECT DIS, V12, pS1021; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; CRUZ JR, 1990, REV INFECT DIS, V12, pS1029; DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174; Ellegard A, 1996, ENVIRON HEALTH PERSP, V104, P980, DOI 10.2307/3433146; Ezzati M, 2000, ENVIRON HEALTH PERSP, V108, P833, DOI 10.2307/3434990; Ezzati M, 2000, ENVIRON SCI TECHNOL, V34, P578, DOI 10.1021/es9905795; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; OYEJIDE CO, 1990, REV INFECT DIS, V12, pS1042; PANDEY MR, 1984, THORAX, V39, P337, DOI 10.1136/thx.39.5.337; PANDEY MR, 1989, ENVIRON INT, V15, P337, DOI 10.1016/0160-4120(89)90046-9; SAKSENA S, 1992, ATMOS ENVIRON A-GEN, V26, P2125, DOI 10.1016/0960-1686(92)90096-4; Sharma S, 1998, ENVIRON HEALTH PERSP, V106, P291, DOI 10.2307/3434017; Smith K.R, 1988, ENVIRONMENT, V30, P16, DOI 10.1080/00139157.1988.9930921; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; SMITH KR, 1993, ANNU REV ENERG ENV, V18, P529, DOI 10.1146/annurev.eg.18.110193.002525; STANEK EJ, 1994, CLIN INFECT DIS, V18, P639, DOI 10.1093/clinids/18.4.639; *WHO, 1998, WORLD HLTH REP; Wilson R., 1996, PARTICLES OUR AIR CO; World Health Organization, 2000, HLTH SYST IMPR PERF; World Health Organization , 1999, WORLD HLTH REP 1999; World Health Organization, 1990, AC RESP INF CHILDR C	30	316	332	1	58	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					619	624		10.1016/S0140-6736(01)05777-4	http://dx.doi.org/10.1016/S0140-6736(01)05777-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530148				2022-12-24	WOS:000170615500009
J	Kourtzi, Z; Kanwisher, N				Kourtzi, Z; Kanwisher, N			Representation of perceived object shape by the human lateral occipital complex	SCIENCE			English	Article							RECOGNITION; AREAS; SELECTIVITY; ACTIVATION; CONTOURS; SURFACES	The human lateral occipital complex (LOC) has been implicated in object recognition, but it is unknown whether this region represents low-level image features or perceived object shape. We used an event-related functional magnetic resonance imaging adaptation paradigm in which the response to pairs of successively presented stimuli is tower when they are identical than when they are different. Adaptation across a change between the two stimuli in a pair provides evidence for a common neural representation invariant to that change. We found adaptation in the LOC when perceived shape was identical but contours differed, but not when contours were identical but perceived shape differed. These data indicate that the LOC represents not simple image features, but rather higher level shape information.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02128 USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	zoe.kourtzi@tuebingen.mpg.de		Kourtzi, Zoe/0000-0001-9441-7832	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bakin JS, 2000, J NEUROSCI, V20, P8188; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HE ZJ, 1992, NATURE, V359, P231, DOI 10.1038/359231a0; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; KOURTZI Z, UNPUB; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marr D., 1982, VISION; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Mendola JD, 1999, J NEUROSCI, V19, P8560; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Nakayama K, 1995, VISUAL COGNITION INV, P1; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Ullman S, 1998, COGNITION, V67, P21, DOI 10.1016/S0010-0277(98)00013-4; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	30	640	646	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1506	1509		10.1126/science.1061133	http://dx.doi.org/10.1126/science.1061133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520991				2022-12-24	WOS:000170616000049
J	Wand, AJ				Wand, AJ			On the dynamic origins of allosteric activation	SCIENCE			English	Editorial Material							CALMODULIN; NMR		Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA.	wand@mail.med.upenn.edu						AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Yang P, 1996, EUR J MINERAL, V8, P263	10	17	17	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520951				2022-12-24	WOS:000170616000001
J	Birch, JM; Dickinson, MH				Birch, JM; Dickinson, MH			Spanwise flow and the attachment of the leading-edge vortex on insect wings	NATURE			English	Article							UNSTEADY AERODYNAMIC PERFORMANCE; LOW REYNOLDS-NUMBERS; MANDUCA-SEXTA; FLIGHT; HAWKMOTH; MODEL; MECHANISM; ROTATION	The flow structure that is largely responsible for the good performance of insect wings has recently been identified as a leading-edge vortex(1,2). But because such vortices become detached from a wing in two-dimensional flow(1), an unknown mechanism must keep them attached to (three-dimensional) flapping wings. The current explanation, analogous to a mechanism operating on delta-wing aircraft, is that spanwise flow through a spiral vortex drains energy from the vortex core(3). We have tested this hypothesis by systematically mapping the flow generated by a dynamically scaled model insect while simultaneously measuring the resulting aerodynamic forces. Here we report that, at the Reynolds numbers matching the flows relevant for most insects, flapping wings do not generate a spiral vortex akin to that produced by delta-wing aircraft. We also rnd that limiting spanwise flow with fences and edge baffles does not cause detachment of the leading-edge vortex. The data support an alternative hypothesis-that downward flow induced by tip vortices limits the growth of the leading-edge vortex.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dickinson, MH (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	flymanmd@socrates.berkeley.edu						Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; DICKINSON MH, 1994, J EXP BIOL, V192, P179; DICKINSON MH, 1993, J EXP BIOL, V174, P45; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; KYIA M, 1977, J FLUID MECH, V82, P223; Liu H, 1998, J EXP BIOL, V201, P461; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; May RM, 1978, DIVERSITY INSECT FAU, P188; Milne-Thomson L. M., 2012, THEORETICAL AERODYNA; SARPKAYA T, 1975, J FLUID MECH, V68, P109, DOI 10.1017/S0022112075000717; Sunada S, 1997, J FLUID ENG-T ASME, V119, P129, DOI 10.1115/1.2819098; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Wang ZJ, 2000, PHYS REV LETT, V85, P2216, DOI 10.1103/PhysRevLett.85.2216; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Willmott AP, 1997, J EXP BIOL, V200, P2723	17	417	435	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					729	733		10.1038/35089071	http://dx.doi.org/10.1038/35089071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507639				2022-12-24	WOS:000170450200043
J	Hyman, DJ; Pavlik, VN				Hyman, DJ; Pavlik, VN			Characteristics of patients with uncontrolled hypertension in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTOLIC BLOOD-PRESSURE; CARE; AWARENESS	Background: Treatment of hypertension is one of the most common clinical responsibilities of U.S. physicians, yet only one fourth of patients with hypertension have their blood pressure adequately controlled. Methods: We analyzed data from the third National Health and Nutrition Examination Survey to assess the role of access to and use of health care in the control of hypertension. Hypertension was defined as a blood pressure of at least 140/90 mm Hg or the use of antihypertensive medication. Results: The study sample consisted of 16,095 adults who were at least 25 years old and for whom blood-pressure values were known. We estimated that 27 percent of the population had hypertension, but only 23 percent of those with hypertension were taking medications that controlled their condition. Among subjects with untreated or uncontrolled hypertension, the pattern was an elevation in the systolic blood pressure with a diastolic pressure of less than 90 mm Hg. The great majority had health insurance. Independent predictors of a lack of awareness of hypertension were an age of at least 65 years, male sex, non-Hispanic black race, and not having visited a physician within the preceding 12 months. The same variables, except for non-Hispanic black race, were independently associated with poor control of hypertension among those who were aware of their condition. An age of at least 65 years accounted for the greatest proportion of the attributable risk of the lack of awareness of hypertension and the lack of control of hypertension among those who were aware of their condition. Conclusions: Most cases of uncontrolled hypertension in the United States consist of isolated, mild systolic hypertension in older adults, most of whom have access to health care and relatively frequent contact with physicians. (N Engl J Med 2001;345:479-86.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Hyman, DJ (corresponding author), Ben Taub Gen Hosp, Dept Med, 1504 Taub Loop, Houston, TX 77030 USA.	dhyman@bcm.tmc.edu						Aday L A, 1974, Health Serv Res, V9, P208; Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Black HR, 1998, ARCH INTERN MED, V158, P573; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Coca A, 1998, J HYPERTENS, V16, pS45; Fagard RH, 1999, CLIN EXP HYPERTENS, V21, P491, DOI 10.3109/10641969909060982; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; HYMAN D, 2000, CLIN HYPERTENS, V2, P324; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Izzo JL, 2000, HYPERTENSION, V35, P1021, DOI 10.1161/01.HYP.35.5.1021; Joffres MR, 1997, AM J HYPERTENS, V10, P1097; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P160; Meissner I, 1999, HYPERTENSION, V34, P466, DOI 10.1161/01.HYP.34.3.466; MOY E, 1995, ARCH INTERN MED, V155, P1497, DOI 10.1001/archinte.155.14.1497; *NAT COMM QUAL ASS, 1999, HEDIS 2000, V2; *NAT CTR HLTH STAT, 1994, VIT HLTH STAT, V1; Nelson C, 1999, VITAL HLTH STAT, V13; Port S, 2000, LANCET, V355, P175, DOI 10.1016/S0140-6736(99)07051-8; SHAH BV, 1997, SUDAAN USERS MANUAL, V1	22	564	587	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2001	345	7					479	486		10.1056/NEJMoa010273	http://dx.doi.org/10.1056/NEJMoa010273			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462QM	11519501				2022-12-24	WOS:000170431300001
J	Villareal, DT; Binder, EF; Williams, DB; Schechtman, KB; Yarasheski, KE; Kohrt, WN				Villareal, DT; Binder, EF; Williams, DB; Schechtman, KB; Yarasheski, KE; Kohrt, WN			Bone mineral density response to estrogen replacement in frail elderly women - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; VITAMIN-D; THERAPY; CALCIUM; BODY; HIP; AGE; SUPPLEMENTATION; PERFORMANCE; PREVENTION	Context Although hormone replacement therapy (HRT) is an established approach for osteoporosis prevention, little is known about the osteoprotective effects of HRT in frail elderly women. Objective To determine whether HRT increases bone mineral density (BMD) in frail elderly women. Design and Setting Randomized, double-blind, placebo-controlled trial conducted in a US university-based research center from September 1995 to August 2000. Participants Sixty-seven women aged 75 years or older with mild-to-moderate physical frailty. Intervention Participants were randomly assigned to receive conjugated estrogens, 0.625 mg/d, plus trimonthly medroxyprogesterone acetate, 5 mg/d for 13 days (n=45), or matching placebo (n=22), for 9 months. Main Outcome Measures The primary outcome measure was 9-month change in BMD of the lumbar spine and hip, measured by dual-energy x-ray absorptiometry. Secondary outcomes were changes in markers of bone turnover. Results Based on intention-to-treat analyses, HRT resulted in significantly larger increases in BMD of the lumbar spine than placebo (mean change, 4.3% vs 0.4%; between-group difference, 3.9%; 95% confidence interval [CI], 3.5%-4.3%) and total hip (mean change, 1.7% vs -0.1%; between-group difference, 1.8%; 95% Cl, 1.5%-2.1%). Compared with placebo, HRT resulted in significant decreases in serum bone-specific alkaline phosphatase levels (mean change, -24% vs 6%; between-group difference, -30%; 95% Cl, -26% to -33%) and urine N-telopeptide levels (mean change, -48% vs 4%; between-group difference, -52%; 95% CI, -47% to -55%). Conclusions In physically frail elderly women, 9 months of HRT significantly increased BMD compared with placebo in clinically important skeletal regions. Further studies are needed to determine whether these osteogenic effects of HRT in elderly women are associated with a reduction in osteoporotic fractures.	Washington Univ, Sch Med, Div Geriatr & Gerontol,Dept Internal Med, Claude Pepper Older Amer Independence Ctr, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Geriatr Med, Denver, CO 80262 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Villareal, DT (corresponding author), Washington Univ, Sch Med, Div Geriatr & Gerontol,Dept Internal Med, Claude Pepper Older Amer Independence Ctr, 4488 Forest Pk Blvd, St Louis, MO 63108 USA.	dvillare@im.wustl.edu	Yarasheski, Kevin E/A-3025-2008; Yarasheski, Kevin/AAC-7450-2021	Yarasheski, Kevin/0000-0001-5436-2451	NCRR NIH HHS [K23 RR016191, K23 RR16191-01, RR00036] Funding Source: Medline; NIA NIH HHS [P60 AG013629, AG13629] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG013629] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allolio B, 1999, Osteoporos Int, V9 Suppl 2, pS9, DOI 10.1007/PL00004166; ARMAMENTOVILLAREAL R, 1995, J CLIN ENDOCR METAB, V80, P776, DOI 10.1210/jc.80.3.776; Binder EF, 2001, ANN INTERN MED, V134, P754, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00012; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; CHRISTIANSEN C, 1990, J CLIN ENDOCR METAB, V71, P836, DOI 10.1210/jcem-71-4-836; COSMAN F, 1994, J CLIN ENDOCR METAB, V78, P939, DOI 10.1210/jc.78.4.939; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; ELDERS PJM, 1988, BONE MINER, V5, P11, DOI 10.1016/0169-6009(88)90003-7; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Friedman L.M., 1980, FUNDAMENTALS CLIN TR; Garnero P, 1996, J BONE MINER RES, V11, P1531; GENNARI C, 1990, J CLIN ENDOCR METAB, V71, P1288, DOI 10.1210/jcem-71-5-1288; Handa VL, 1996, J AM GERIATR SOC, V44, P1; Holloszy John O., 1995, P633; HUI SL, 1987, BONE MINER, V2, P141; Kohrt WM, 1998, J APPL PHYSIOL, V84, P1506, DOI 10.1152/jappl.1998.84.5.1506; KOHRT WM, 1995, OSTEOPOROSIS INT, V5, P150, DOI 10.1007/BF02106093; LINDSAY R, 1976, LANCET, V1, P1038; Lindsay R, 1998, ENDOCRIN METAB CLIN, V27, P399, DOI 10.1016/S0889-8529(05)70012-8; LINDSAY R, 1990, OBSTET GYNECOL, V76, P290; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MARX CW, 1992, J BONE MINER RES, V7, P1275; MCKANE WR, 1995, J CLIN ENDOCR METAB, V80, P3458, DOI 10.1210/jc.80.12.3458; NILAS L, 1988, EUR J CLIN INVEST, V18, P529, DOI 10.1111/j.1365-2362.1988.tb01052.x; QUIGLEY MET, 1987, AM J OBSTET GYNECOL, V156, P1516; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; RESNICK NM, 1989, JAMA-J AM MED ASSOC, V261, P1025, DOI 10.1001/jama.261.7.1025; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rosen CJ, 1997, ENDOCRIN METAB CLIN, V26, P295, DOI 10.1016/S0889-8529(05)70248-6; Schneider DL, 1997, JAMA-J AM MED ASSOC, V277, P543, DOI 10.1001/jama.277.7.543; SEMAN E, 1997, AM J MED, V103, P745; Slemenda Charles, 1997, American Journal of Medicine, V103, p65S, DOI 10.1016/S0002-9343(97)90028-0; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x	40	68	69	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					815	820		10.1001/jama.286.7.815	http://dx.doi.org/10.1001/jama.286.7.815			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497535	Bronze			2022-12-24	WOS:000170429600029
J	Collins, S				Collins, S			Changing the way we address severe malnutrition during famine	LANCET			English	Editorial Material							CHILDREN	This year, yet again, saw widespread food Insecurity and famine across the horn of Africa. Again, humanitarian agencies set up operations to implement various relief programmes. Nutritional interventions included general ration distribution to the whole of an affected population; blanket supplementary feeding to all members of an identified risk group; and targeted dry supplementary feeding centres for moderately malnourished and therapeutic feeding centres for the severely malnourished. As is usual in emergencies, many of the therapeutic feeding centres were hard to set up and did not achieve an adequate coverage of all the severely malnourished. This combination of delays and low coverage meant that many therapeutic feeding centres achieved little overall impact on mortality. I believe that the present focus on therapeutic feeding centres as the sole mode of treating severely malnourished people during famine is inappropriate and often counter-productive. A new concept of community-based therapeutic care is necessary to complement therapeutic feeding centres' interventions if famine relief programmes are to address the plight of the severely malnourished in an efficient and effective manner. During an emergency, the community-based therapeutic care approach could quickly provide good coverage and appropriate treatment for large numbers of severely malnourished people. The principles behind community-based therapeutic care are, however, developmental, empowering communities to cope more effectively with crisis and with transition back to normality. This is very different to the therapeutic feeding centres' approach that disempowers communities, requires very large amounts of external staff and resources, and undermines the Infrastructure. Although emergency community-based therapeutic care programmes could be large-scale and implemented quickly, they could also evolve into developmental Hearth model nutritional programmes without changing their conceptual basis. Conversely, Hearth programmes, although largely sustainable, could in times of crisis quickly scale-up into rapid effective emergency interventions. Creating such a continuum between emergency and developmental approaches has long been a holy grall of humanitarianism.	Valld Int, Llanidloes SY18 6PJ, Powys, Wales; Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; de Waal A., 1989, FAMINE KILLS DARFUR; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; PHELPS L, 2001, UNPUB REPORT OXFAMS; *SPHER PROJ, 1999, PROJ TEAM SPHERE PRO; WOLLINKA O, 1997, HLTH NUTR MODEL APPL	9	78	79	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					498	501		10.1016/S0140-6736(01)05630-6	http://dx.doi.org/10.1016/S0140-6736(01)05630-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513936				2022-12-24	WOS:000170492400036
J	Weiss, NS; Rossing, MA				Weiss, NS; Rossing, MA			Oestrogen-replacement therapy and risk of ovarian cancer	LANCET			English	Editorial Material									Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Weiss, NS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.							AEDO AR, 1989, MATURITAS, V11, P147, DOI 10.1016/0378-5122(89)90007-8; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; COOK LS, 2000, WOMEN HLTH; Garg PP, 1998, OBSTET GYNECOL, V92, P472, DOI 10.1016/S0029-7844(98)00139-2; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; RODRIGUEZ G, 1999, H HARR OV CANC C STO; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; WEISS NS, 1996, CANC EPIDEMIOLOGY PR	9	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2001	358	9280					438	438		10.1016/S0140-6736(01)05669-0	http://dx.doi.org/10.1016/S0140-6736(01)05669-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513905				2022-12-24	WOS:000170492400007
J	Hackett, JA; Feldser, DM; Greider, CW				Hackett, JA; Feldser, DM; Greider, CW			Telomere dysfunction increases mutation rate and genomic instability	CELL			English	Article							SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; NONRECIPROCAL TRANSLOCATIONS; CHROMOSOMAL REARRANGEMENTS; FISSION YEAST; CAN1 LOCUS; REPLICATION; IDENTIFICATION; RECOMBINATION; MUTANTS	The increased tumor incidence in telomerase null mice suggests that telomere dysfunction induces genetic instability. To test this directly, we examined mutation rate in the absence of telomerase in S. cerevisiae. The mutation rate in the CAN1 gene increased 10- to 100-fold in est1 Delta strains as telomeres became dysfunctional. This increased mutation rate resulted from an increased frequency of terminal deletions. Chromosome fusions were recovered from est1 Delta strains, suggesting that the terminal deletions may occur by a breakage-fusion-bridge type mechanism. At one locus, chromosomes with terminal deletions gained a new telomere through a Rad52p-dependent, Rad51p-independent process consistent with break-induced replication. At a second locus, more complicated rearrangements involving multiple chromosomes were seen. These data suggest that telomerase can inhibit chromosomal instability.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	cgreider@jhmi.edu		Greider, Carol/0000-0002-5494-8126	NIGMS NIH HHS [GM43080] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043080] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bosco G, 1998, GENETICS, V150, P1037; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Brachmann CB, 1998, YEAST, V14, P115; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gasser SM, 2000, SCIENCE, V288, P1377, DOI 10.1126/science.288.5470.1377; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; GOCKE E, 1979, GENETICS, V91, P53; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HABER JE, 1984, GENETICS, V106, P185; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Le S, 1999, GENETICS, V152, P143; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lendvay TS, 1996, GENETICS, V144, P1399; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; LOEB LA, 1991, CANCER RES, V51, P3075; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; McClintock B, 1941, GENETICS, V26, P234; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; Morrow DM, 1997, GENETICS, V147, P371; Muller H.J., 1938, COLLECTING NET, V13, P181; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nadas A, 1996, ENVIRON MOL MUTAGEN, V28, P90; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shih IM, 2001, CANCER RES, V61, P818; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; WHELAN WL, 1979, GENETICS, V91, P35; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	48	290	299	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					275	286		10.1016/S0092-8674(01)00457-3	http://dx.doi.org/10.1016/S0092-8674(01)00457-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509177	Bronze			2022-12-24	WOS:000170433300006
J	Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K				Rubin, C; Turner, AS; Bain, S; Mallinckrodt, C; McLeod, K			Anabolism - Low mechanical signals strengthen long bones	NATURE			English	Article							STRAIN; MAGNITUDE		SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; Skeletech Inc, Bothell, WA 98021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University	Rubin, C (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Musculoskeletal Res Lab, Stony Brook, NY 11794 USA.	clinton.rubin@sunysb.edu						BAIN SD, 1990, J BONE MINER RES, V5, P1069; Blob RW, 1999, J EXP BIOL, V202, P1023; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; CARTER DR, 1981, MECHANICAL PROPERTIE, V45, P81; Fritton JC, 1997, ANN BIOMED ENG, V25, P831, DOI 10.1007/BF02684167; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; FROST HM, 1990, ANAT REC, V226, P403, DOI 10.1002/ar.1092260402; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; Hylander WL, 1998, AM J PHYS ANTHROPOL, V107, P257, DOI 10.1002/(SICI)1096-8644(199811)107:3<257::AID-AJPA3>3.3.CO;2-Y; RUBIN CT, 1995, J BONE MINER RES, V10, P488; RUBIN CT, 1982, J EXP BIOL, V101, P187; SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F; Wolff J., 1986, LAW BONE REMODELING	13	513	568	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					603	604		10.1038/35088122	http://dx.doi.org/10.1038/35088122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493908				2022-12-24	WOS:000170318000028
J	Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M				Bruce, MG; Rosenstein, NE; Capparella, JM; Shutt, KA; Perkins, BA; Collins, M			Risk factors for meningococcal disease in college students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAMPUS BAR PATRONAGE; UNITED-STATES; BACTERIAL-MENINGITIS; INFECTIONS; OUTBREAK; EPIDEMIOLOGY; ASSOCIATION; MYCOPLASMA; CHILDREN; VACCINE	Context Elevated rates of meningococcal disease were noted among 18- to 22-year-olds in the mid-1990's. However, national data on rates of meningococcal disease in US college students were not collected until 1998. Objectives To determine rates of meningococcal disease in US college students and to identify risk factors for meningococcal disease in this population. Design, Setting, and Patients Prospective surveillance study with nested case-control study of US college students with meningococcal infection from September 1, 1998, to August 31, 1999. Fifty state health departments and 231 college health centers participated. Main Outcome Measures incidence of and risk factors for meningococcal disease in US college students. Results Ninety-six cases of meningococcal disease were identified. The incidence rate for undergraduates was 0.7 per 100000 persons vs 1.4 per 100000 for the general population of 18- to 23-year-old nonstudents (P<.001). Freshmen living in dormitories had the highest incidence rate at 5.1 per 100000. Of the 79 case-patients for whom information was available, 54 (68%) had illness due to vaccine-preventable meningococcal serogroups. On multivariable analysis of case-control study data, freshmen who lived in dormitories had an elevated risk of meningococcal disease (matched odds ratio, 3.6; 95% confidence interval, 1.6-8.5; P=.003) compared with other college students. Conclusions Freshmen who live in dormitories have an independent, elevated risk of meningococcal disease compared with other college students. Use of the currently vat available quadrivalent polysaccharide vaccine among college students could substantially decrease their risk of meningococcal disease.	CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Amer Coll Hlth Assoc, Baltimore, MD USA; Univ Penn, Student Hlth Serv, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; University of Pennsylvania	Rosenstein, NE (corresponding author), CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-09, Atlanta, GA 30333 USA.			Shutt, Kathleen/0000-0003-3376-6152				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; *AM COLL HLTH ASS, 2001, REC MEN MEN VACC; AYCOCK WL, 1950, BACTERIOL REV, V14, P115, DOI 10.1128/MMBR.14.2.115-160.1950; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BRUNDAGE JF, 1987, EVOLUTION MENINGOCOC, P5; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Douglas KA, 1997, J AM COLL HEALTH, V46, P55, DOI 10.1080/07448489709595589; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FRANCKE EL, 1981, SURG CLIN N AM, V61, P135; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; Hall CB, 1996, PEDIATRICS, V97, P404; HANEBERG B, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P169; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; KRASINSKI K, 1987, AM J EPIDEMIOL, V125, P499, DOI 10.1093/oxfordjournals.aje.a114556; MARTONE WJ, 1999, CHANGING EPIDEMIOLOG, P1; Moodley JR, 1999, S AFR MED J, V89, P56; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Neal KR, 1999, EPIDEMIOL INFECT, V122, P351, DOI 10.1017/S0950268899002368; Nelson JD, 1996, NEW ENGL J MED, V335, P885, DOI 10.1056/NEJM199609193351210; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; SAX LJ, 1998, AM FRESHMAN NATL NOR; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STANWELLSMITH RE, 1994, EPIDEMIOL INFECT, V112, P315, DOI 10.1017/S0950268800057733; STUART JM, 1988, COMMUNITY MED, V10, P139; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; *UD DEP ED, 1999, NCES PUBL; *US CENS BUR, 1999, US CENS DAT 1998; WOODS CW, 1998, INF DIS SOC AM NOV 1; YOUNG LS, 1972, NEW ENGL J MED, V287, P5, DOI 10.1056/NEJM197207062870102; Yusuf HR, 1999, AM J PUBLIC HEALTH, V89, P712, DOI 10.2105/AJPH.89.5.712; 1997, MMWR MORB MORTAL WKL, V46, P13; 1999, COMMUN DIS REP, V9, P261	40	111	114	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					688	693		10.1001/jama.286.6.688	http://dx.doi.org/10.1001/jama.286.6.688			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495618				2022-12-24	WOS:000170271500024
J	Snyder, L; Sulmasy, DP				Snyder, L; Sulmasy, DP		Ethics Human Rights Comm Amer C	Physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT REQUESTS; EUTHANASIA; OREGON; DEATH; PAIN; LIFE; GUIDELINES; ATTITUDES; MANAGEMENT; END	Medical professional codes have long prohibited physician involvement in assisting a patient's suicide. However, despite ethical and legal prohibitions, calls for the liberalization of this ban have grown in recent years. The medical profession should articulate its views on the arguments for and against changes in public policy and decide whether changes are prudent. In addressing such a contentious issue, physicians, policymakers, and society must fully consider the needs of patients, the vulnerability of particular patient groups, issues of trust and professionalism, and the complexities of end-of-life health care. Physician-assisted suicide is prominent among the issues that define our professional norms and codes of ethics. The American College of Physicians-American Society of Internal Medicine (ACP-ASIM) does not support the legalization of physician-assisted suicide. The routine practice of physician-assisted suicide raises serious ethical and other concerns. Legalization would undermine the patient-physician relationship and the trust necessary to sustain it; after the medical profession's role in society; and endanger the value our society places on life, especially on the lives of disabled, incompetent, and vulnerable individuals. The ACP-ASIM remains thoroughly committed to improving care for patients at the end of life.	Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians	Snyder, L (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Abrahm JL, 1999, ANN INTERN MED, V131, P37, DOI 10.7326/0003-4819-131-1-199907060-00009; ALPERS A, 1995, JAMA-J AM MED ASSOC, V274, P483, DOI 10.1001/jama.274.6.483; Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; ANNAS GJ, 1994, NEW ENGL J MED, V331, P1240, DOI 10.1056/NEJM199411033311822; Annas GJ, 1996, NEW ENGL J MED, V335, P683, DOI 10.1056/NEJM199608293350924; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BAILE WF, 1993, CANCER, V72, P2786, DOI 10.1002/1097-0142(19931101)72:9<2786::AID-CNCR2820720942>3.0.CO;2-2; Baron CH, 1996, HARVARD J LEGIS, V33, P1; BATTIN MP, 1995, ACAD MED, V70, P583; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; BOSCHERT S, 1992, INTERNAL MED NE 1201, P3; BOSCHERT S, 1992, INTERNAL MED NE 1201, P20; BROCK DW, 1992, YALE J BIOL MED, V65, P121; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BUCHAN ML, 1995, J CLIN ETHIC, V6, P53; BYOCK I, 1997, DYING WELL PROSPECT, P245; Byock IR, 1997, MED ETHIC S, P107; CAIN C, 1998, DETROIT NEWS    1104, pA1; Callahan D, 1997, MED ETHIC S, P69; CALLAHAN D, 1992, HASTINGS CENT REP, V22, P52, DOI 10.2307/3562566; Caplan AL, 2000, ANN INTERN MED, V132, P476, DOI 10.7326/0003-4819-132-6-200003210-00009; CAPRON AM, 1992, HASTINGS CENT REP, V22, P30, DOI 10.2307/3562562; CASSEL CK, 1990, NEW ENGL J MED, V323, P750, DOI 10.1056/NEJM199009133231110; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Coleman CH, 1996, J LAW MED ETHICS, V24, P217, DOI 10.1111/j.1748-720X.1996.tb01855.x; CONWELL Y, 1991, NEW ENGL J MED, V325, P1100, DOI 10.1056/NEJM199110103251511; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel Ezekiel, 1997, Atl Mon, V279, P73; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Field MJ, 1997, APPROACHING DEATH IM; Fohr S A, 1998, J Palliat Med, V1, P315, DOI 10.1089/jpm.1998.1.315; Foley K, 1999, HASTINGS CENT REP, V29, P37, DOI 10.2307/3528194; FOLEY KM, 1991, J PAIN SYMPTOM MANAG, V6, P289, DOI 10.1016/0885-3924(91)90052-6; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; GAYLIN W, 1988, JAMA-J AM MED ASSOC, V259, P2139; GERT B, 1994, HASTINGS CENT REP, V24, P13, DOI 10.2307/3562837; GILLESPIE M, 1999, KEVORKIAN FACE MURDE; Glick SM, 1997, AM J MED, V102, P294, DOI 10.1016/S0002-9343(97)00016-8; GOAD M, 2000, PORTLAND PRESS  1108, pA1; GROSS J, 1991, NY TIMES        1107, pB16; Hardwig J, 1997, HASTINGS CENT REP, V27, P34, DOI 10.2307/3527626; Heilig S, 1997, WESTERN J MED, V166, P370; Hendin H, 1999, J CLIN PSYCHIAT, V60, P46; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; JONES WH, 1923, HIPPOCRATES, V1, P289; Jones WHS, 1923, HIPPOCRATES, P193; KAMISAR Y, 1993, HASTINGS CENT REP, V23, P32, DOI 10.2307/3563366; KAMISAR Y, 1958, MINN LAW REV, V42, P969; KASS LR, 1989, PUBLIC INTEREST, P25; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Lee MA, 1996, NEW ENGL J MED, V334, P310, DOI 10.1056/NEJM199602013340507; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lynn J, 1997, J AM GERIATR SOC, V45, P489, DOI 10.1111/j.1532-5415.1997.tb05176.x; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; Miller FG, 2000, ANN INTERN MED, V132, P470, DOI 10.7326/0003-4819-132-6-200003210-00008; MILLER FG, 1994, NEW ENGL J MED, V331, P119, DOI 10.1056/NEJM199407143310211; Nuland SB, 2000, NEW ENGL J MED, V342, P583, DOI 10.1056/NEJM200002243420811; *NY STAT TASK FORC, 1994, DEATH IS SOUGHT ASSI; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PELLEGRINO ED, 1995, ANN INTERN MED, V122, P377, DOI 10.7326/0003-4819-122-5-199503010-00010; Phillips RS, 2000, J AM GERIATR SOC, V48, pS1, DOI 10.1111/j.1532-5415.2000.tb03118.x; PIJNENBORG L, 1993, LANCET, V341, P1196, DOI 10.1016/0140-6736(93)91014-D; PRATT DA, 1999, ALBANY LAW J SCI TEC, V9, P161; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; SHAPIRO RS, 1994, ARCH INTERN MED, V154, P575, DOI 10.1001/archinte.154.5.575; Simons M, 2000, N Y Times Web, pA3; SIMONS M, 1995, NY TIMES        0909; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; SNYDER L, 1990, ANN INTERN MED, V112, P802, DOI 10.7326/0003-4819-112-11-802; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sulmasy DP, 1999, ARCH INTERN MED, V159, P545, DOI 10.1001/archinte.159.6.545; Sulmasy DP, 1998, J LAW MED ETHICS, V26, P55, DOI 10.1111/j.1748-720X.1998.tb01906.x; *TASK FORC IMPR CA, 1998, OR DEATH DIGN ACT GU; TOLLE SW, 1996, ETHICAL CHOICES CASE; TROLLOPE A, 1990, FIXED PERIOD NOVEL; van Delden JJM, 1999, J MED ETHICS, V25, P22, DOI 10.1136/jme.25.1.22; VANDELDEN JJM, 1993, HASTINGS CENT REP, V23, P24, DOI 10.2307/3562919; VANDERMAAS PJ, 1992, EUTHANASIA OTHER MED, P43; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wolf S M, 1996, Duquesne Law Rev, V35, P455; Young EWD, 1997, WESTERN J MED, V166, P381; [No title captured]	98	37	37	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					209	216		10.7326/0003-4819-135-3-200108070-00015	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	460FX	11487490				2022-12-24	WOS:000170298500009
J	Eichhorst, ST; Krammer, PH				Eichhorst, ST; Krammer, PH			Derangement of apoptosis in cancer	LANCET			English	Editorial Material							GENE; LYMPHOMA; CELLS		Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; German Canc Res Ctr, Div Immunogenet, Tumorimmunol Program, D-69120 Heidelberg, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Eichhorst, ST (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Catlett IM, 2001, J IMMUNOL, V166, P6019, DOI 10.4049/jimmunol.166.10.6019; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eichhorst ST, 2000, MOL CELL BIOL, V20, P7826, DOI 10.1128/MCB.20.20.7826-7837.2000; Kogan SC, 2001, J EXP MED, V193, P531, DOI 10.1084/jem.193.4.531; Krammer P H, 1999, Adv Immunol, V71, P163; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Peter ME, 1998, CURR OPIN IMMUNOL, V10, P545, DOI 10.1016/S0952-7915(98)80222-7; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489	14	11	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					345	346		10.1016/S0140-6736(01)05584-2	http://dx.doi.org/10.1016/S0140-6736(01)05584-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502308				2022-12-24	WOS:000170235100003
J	Gahan, LJ; Gould, F; Heckel, DG				Gahan, LJ; Gould, F; Heckel, DG			Identification of a gene associated with bit resistance in Heliothis virescens	SCIENCE			English	Article							BACILLUS-THURINGIENSIS TOXINS; CADHERIN SUPERFAMILY; QUANTITATIVE TRAITS; MENDELIAN FACTORS; RECEPTOR; MEMBERS; LEPIDOPTERA; NOCTUIDAE; ENDOTOXIN; CLONING	Transgenic crops producing insecticidal toxins from Bacillus thuringiensis (Bt) are widely used for pest control. Bt-resistant insect strains have been studied, but the molecular basis of resistance has remained elusive. Here, we show that disruption of a cadherin-superfamily gene by retrotransposon-mediated insertion was linked to high levels of resistance to the Et toxin Cry1Ac in the cotton pest Heliothis virescens. Monitoring the early phases of Bt resistance evolution in the field has been viewed as crucial but extremely difficult, especially when resistance is recessive. Our findings enable efficient DNA-based screening for resistant heterozygotes by directly detecting the recessive allele.	Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Melbourne; University of North Carolina; North Carolina State University; Clemson University	Heckel, DG (corresponding author), Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Parkville, Vic 3052, Australia.		Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Arkhipova IR, 1995, DROSOPHILA RETROTRAN; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; *GENB, AF367363 GENB; *GENB, AF367362 GENB; GILL SS, 1995, J BIOL CHEM, V270, P27277, DOI 10.1074/jbc.270.45.27277; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 1997, J ECON ENTOMOL, V90, P75, DOI 10.1093/jee/90.1.75; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Marillonnet S, 1998, GENETICS, V150, P1245; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Suzuki ST, 1996, J CELL BIOCHEM, V61, P531, DOI 10.1002/(SICI)1097-4644(19960616)61:4<531::AID-JCB6>3.0.CO;2-P; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; US EPA, 1998, EPA PUBL; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593	19	451	530	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					857	860		10.1126/science.1060949	http://dx.doi.org/10.1126/science.1060949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486086				2022-12-24	WOS:000170241000043
J	Kozloski, J; Hamzei-Sichani, F; Yuste, R				Kozloski, J; Hamzei-Sichani, F; Yuste, R			Stereotyped position of local synaptic targets in neocortex	SCIENCE			English	Article							RAT VISUAL-CORTEX; CEREBRAL-CORTEX; PROJECTION NEURONS; MORPHOLOGY; MONKEY; CAT; ORGANIZATION; CONNECTIONS; POTENTIALS; LAYER-5	The microcircuitry of the mammalian neocortex remains largely unknown. Although the neocortex could be composed of scores of precise circuits, an alternative possibility is that local connectivity is probabilistic or even random. To examine the precision and degree of determinism in the neocortical microcircuitry, we used optical probing to reconstruct microcircuits in layer 5 from mouse primary visual cortex. We stimulated "trigger" cells, isolated from a homogenous population of corticotectal pyramidal neurons, white optically detecting "follower" neurons directly driven by the triggers. Followers belonged to a few selective anatomical classes with stereotyped physiological and synaptic responses. Moreover, even the position of the followers appeared determined across animals. Our data reveal precisely organized cortical microcircuits.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kozloski, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.							Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; [Anonymous], 1995, INTRO GEOLOGICAL DAT; Braitenberg V, 1998, CORTEX STAT GEOMETRY; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; CAJAL SRY, 1923, RECUERDOS VIDA HIST; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; DOUGLAS RJ, 1998, SYNAPTIC ORG BRAIN, pCH12; Fairen A., 1984, CEREB CORTEX, V1, P201; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P274; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Marcoulides G.A., 1997, MULTIVARIATE STAT ME; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; MOUNTCASTLE VB, 1978, MINDFUL BRAIN, pCH1; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Peters A., 1984, CEREB CORTEX; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rumberger A, 1998, EXP BRAIN RES, V119, P375, DOI 10.1007/s002210050353; SCHOFIELD BR, 1987, J COMP NEUROL, V261, P85, DOI 10.1002/cne.902610107; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; SOLNICK B, 1984, P NATL ACAD SCI-BIOL, V81, P3898, DOI 10.1073/pnas.81.12.3898; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; White E.L., 1989, CORTICAL CIRCUITS SY	32	141	143	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					868	872		10.1126/science.293.5531.868	http://dx.doi.org/10.1126/science.293.5531.868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486089				2022-12-24	WOS:000170241000046
J	Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T				Komura, Y; Tamura, R; Uwano, T; Nishijo, H; Kaga, K; Ono, T			Retrospective and prospective coding for predicted reward in the sensory thalamus	NATURE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; AUDITORY THALAMUS; RECEPTIVE-FIELDS; BASAL GANGLIA; SINGLE UNITS; AMYGDALA; NEURONS; BRAIN; RAT	Reward is important for shaping goal-directed behaviour(1-4). After stimulus-reward associative learning, an organism can assess the motivational value of the incoming stimuli on the basis of past experience (retrospective processing), and predict forthcoming rewarding events (prospective processing)(1-5). The traditional role of the sensory thalamus is to relay current sensory information to cortex. Here we rnd that non-primary thalamic neurons respond to reward-related events in two ways. The early, phasic responses occurred shortly after the onset of the stimuli and depended on the sensory modality. Their magnitudes resisted extinction and correlated with the learning experience. The late responses gradually increased during the cue and delay periods, and peaked just before delivery of the reward. These responses were independent of sensory modality and were modulated by the value and timing of the reward. These observations provide new evidence that single thalamic neurons can code for the acquired significance of sensory stimuli in the early responses (retrospective coding) and predict upcoming reward value in the late responses (prospective coding).	Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan; Univ Tokyo, Sch Med, Dept Otorhinolaryngol, Tokyo 1130033, Japan	University of Toyama; University of Tokyo	Ono, T (corresponding author), Toyama Med & Pharmaceut Univ, Dept Physiol, Fac Med, Toyama 9300194, Japan.							[Anonymous], [No title captured]; Bechara A, 1998, J NEUROSCI, V18, P428; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BOUTON ME, 1994, CURR DIR PSYCHOL SCI, V3, P49, DOI 10.1111/1467-8721.ep10769943; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dolan R.J., 2000, NEW COGNITIVE NEUROS; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P901, DOI 10.1037/0735-7044.105.6.901; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Linke R, 1999, J COMP NEUROL, V403, P158; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; NAKAMURA K, 1987, J NEUROPHYSIOL, V58, P1123, DOI 10.1152/jn.1987.58.5.1123; ONO T, 1995, PROG NEUROBIOL, V46, P401, DOI 10.1016/0301-0082(95)00008-J; Rainer G, 1999, J NEUROSCI, V19, P5493; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROLLS ET, 1999, BRAIN EMOTION; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sefton Ann Jervie, 1995, P833; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; WINER JA, 1983, J NEUROSCI, V3, P2629; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; [No title captured]	30	183	186	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					546	549		10.1038/35087595	http://dx.doi.org/10.1038/35087595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484055				2022-12-24	WOS:000170202900047
J	Rogers, KC; Forster, CA				Rogers, KC; Forster, CA			The last of the dinosaur titans: a new sauropod from Madagascar	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS	The Titanosauria, the last surviving group of the giant sauropod dinosaurs, attained a near-global distribution by the close of the Cretaceous period (65 Myr ago). With the exception of a few new discoveries in Argentina(1-3), most titanosaurs are known only from fragmentary postcranial skeletons and rare, isolated skull elements(4-9). Here we describe the most complete titanosaur yet discovered. Rapetosaurus krausei gen. et sp. nov., from the Maevarano Formation of Madagascar, provides a view of titanosaur anatomy from head to tail. A total-evidence phylogenetic analysis supports a close relationship between brachiosaurids and titanosaurs (Titanosauriformes(10-13)). The inclusion of cranial data from Rapetosaurus also lays to rest questions concerning the phylogeny of the enigmatic Mongolian genera Nemegtosaurus and Quaesitosaurus(14,15). In spite of their elongated, diplodocoid-like skulls, all three taxa are now firmly nested within Titanosauria.	SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rogers, KC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.							BERMAN DS, 1982, CARNEGIE MUSEUM ANN, V51, P405; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Calvo J.O., 1997, AMEGHINIANA, V34, P534; CALVO JO, 1998, ACTA GEOL LILLOANA, V13, P156; Chatterjee Sankar, 1996, Memoirs of the Queensland Museum, V39, P489; Coria RA, 1999, AMEGHINIANA, V36, P98; Coria Rodolfo A., 1999, National Science Museum Monographs, V15, P47; Curry Rogers K., 1999, 7 INT S MES TERR EC, P20; Deperet C, 1896, B SOC GEOLOGIQUE FRA, V21, P176; Gauthier JA., 1986, ORIGIN BIRDS EVOLUTI, P1; Gomani Elizabeth M., 1998, Journal of Vertebrate Paleontology, V18, p46A; HUENE F, 1929, CENTRALBLATT MINER B, P493; Krause D.W., 1999, GSA TODAY, V9, P1; KURZANOV SM, 1983, PALEONTOL J, V2, P90; Martinez Ruben, 1998, Journal of Vertebrate Paleontology, V18, p61A; McIntosh J.S., 1990, P345; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; POWELL JE, 1986, THESIS U NACIONALE T; Ravoavy F, 1991, U ANTANANARIVO MEMOI, VII, P55; ROGERS KC, 1999, J VERT PALEONTOL, V19, pA41; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Romer A, 1956, OSTEOLOGY REPTILES; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 1997, Ameghiniana, V34, P3; SWOFFORD DL, 1999, PAUP STAR PHYLOGENET; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; WILSON JA, 1999, EVOLUTIONARY HIST SA	31	164	173	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					530	534		10.1038/35087566	http://dx.doi.org/10.1038/35087566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484051				2022-12-24	WOS:000170202900043
J	Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P				Gustafson, P; Gomes, VF; Vieira, CS; Jensen, H; Seng, R; Norberg, R; Samb, B; Naucler, A; Aaby, P			Tuberculosis mortality during a civil war in Guinea-Bissau	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMPACT; INFECTIONS; DIAGNOSIS; DISTRICT; ABIDJAN; AFRICA; MALAWI	Context Tuberculosis (TB) is an increasing global problem, despite effective drug therapies. Access to TB therapy during conflict situations has not been studied. Objective To determine the effect of irregular TB treatment due to an armed conflict in Guinea-Bissau, West Africa. Design, Setting, and Patients Ongoing retrospective cohort study conducted in the capital city of Bissau among 101 patients with TB who received irregular or no treatment during the civil war (war cohort; June 7-December 6, 1998) and 108 patients with TB who received treatment 12 months earlier (peace cohort; June 7-December 6,1997) and comparison of an additional 42 patients who had completed treatment before June 6, 1998, and 69 patients who had completed treatment before June 6, 1997. Main Outcome Measure Mortality rates, compared by irregular (war cohort) vs regular (peace cohort) access to treatment, by intensive vs continuation phase of treatment, and by those who had previously completed treatment for TB. Results Irregular treatment was associated with an increased mortality rate among patients with TB. The mortality rate ratio (MR) was 3.12 (95% confidence interval [CI], 1.20-8.12) in the war cohort, adjusting for age, sex, human immunodeficiency virus (HIV) infection, residence, and length of treatment. Each additional week of treatment before the war started increased probability of survival by 5% (95% CI, 0%-10%). In the intensive phase of treatment, the adjusted MR was 3.30 (95% CI, 1.04-10.50) and in the continuation phase it was 2.26 (95% CI, 0.33-15.34). Increased mortality among the war cohort was most marked in HIV-positive patients, who had an adjusted MR of 8.19 (95% CI, 1.62-41.25). Mortality was not increased in HIV-positive or HIV-negative patients who had completed TB treatment when the war started. Conclusions Interruption of treatment had a profound impact on mortality among patients with TB during the war in Guinea-Bissau. Regular treatment for TB was associated with significantly improved survival for HIV-infected individuals. In emergencies, it is crucial to ensure availability of TB drugs.	Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden; Hosp Raoul Follereau, Bissau, Guinea Bissau; State Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark; IMEA, INSERM, U88, Paris, France; Karolinska Inst, Swedish Inst Infect Dis Control, Stockholm, Sweden	Lund University; Skane University Hospital; Aarhus University; Statens Serum Institut; Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Swedish Institute for Infectious Disease Control	Gustafson, P (corresponding author), Malmo Univ Hosp, Dept Infect Dis, S-20502 Malmo, Sweden.	Per.Gustafson@inf.mas.lu.se		Aaby, Peter/0000-0001-8331-1389				Aaby P, 1999, BRIT MED J, V319, P878, DOI 10.1136/bmj.319.7214.878; AABY P, 1997, PROSPECTIVE COMMUNIT, P276; ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Andersson S, 1997, AIDS, V11, P1815, DOI 10.1097/00002030-199715000-00005; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; DATTA M, 1993, TUBERCLE LUNG DIS, V74, P180, DOI 10.1016/0962-8479(93)90008-L; DECOCK KM, 1991, BMJ-BRIT MED J, V302, P496, DOI 10.1136/bmj.302.6775.496; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; KREBS W, 1930, BEITR KLIN TUBERK, P345; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P95; LINCOLN EM, 1947, AM REV TUBERC PULM, V56, P75; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; NAUCLER A, 1991, AIDS, V5, P301, DOI 10.1097/00002030-199103000-00009; OBrien JK, 1997, CHEST, V112, P387, DOI 10.1378/chest.112.2.387; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Thompson BC, 1943, BRIT MED J, V1943, P721, DOI 10.1136/bmj.2.4326.721; THOMPSON BC, 1940, TUBERCLE, P217; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Walther-Jallow L, 1999, AIDS RES HUM RETROV, V15, P957, DOI 10.1089/088922299310467; WHO, 1997, MID IMP US ANT FOOD; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	27	44	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					599	603		10.1001/jama.286.5.599	http://dx.doi.org/10.1001/jama.286.5.599			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476664				2022-12-24	WOS:000170188300025
J	Schwetz, BA				Schwetz, BA			New oral contraceptive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-24	WOS:000170188300003
J	de Gennes, PG				de Gennes, PG			Ultradivided matter	NATURE			English	Editorial Material									Ecole Super Phys & Chim Ind, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	de Gennes, PG (corresponding author), Ecole Super Phys & Chim Ind, 10 Rue Vauquelin, F-75231 Paris 05, France.							CABANE B, 2001, COLLECTION ECOLE PHY; ISRAELASHVILI J, 1985, INTERMOLECULAR SURFA; Morawetz H., 1985, POLYM ORIGIN GROWTH; 2001, P 1 LAV SEM COLL EC	4	24	24	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					385	385		10.1038/35086662	http://dx.doi.org/10.1038/35086662			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473291				2022-12-24	WOS:000170068200023
J	Erickson, GM; Rogers, KC; Yerby, SA				Erickson, GM; Rogers, KC; Yerby, SA			Dinosaurian growth patterns and rapid avian growth rates	NATURE			English	Article							HISTOLOGY; BIRDS	Did dinosaurs grow in a manner similar to extant reptiles, mammals or birds, or were they unique(1)? Are rapid avian growth rates an innovation unique to birds, or were they inherited from dinosaurian precursors(2)? We quantified growth rates for a group of dinosaurs spanning the phylogenetic and size diversity for the clade and used regression analysis to characterize the results. Here we show that dinosaurs exhibited sigmoidal growth curves similar to those of other vertebrates, but had unique growth rates with respect to body mass. All dinosaurs grew at accelerated rates relative to the primitive condition seen in extant reptiles. Small dinosaurs grew at moderately rapid rates, similar to those of marsupials, but large species attained rates comparable to those of eutherian mammals and precocial birds. Growth in giant sauropods was similar to that of whales of comparable size. Non-avian dinosaurs did not attain rates like those of altricial birds. Avian growth rates were attained in a stepwise fashion after birds diverged from theropod ancestors in the Jurassic period.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; Sci Museum Minnesota, St Paul, MN 55102 USA; Macalester Coll, St Paul, MN 55102 USA; Stanford Univ, Dept Biomech Engn, Stanford, CA 94305 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; Macalester College; Stanford University	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.							ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; APPENZELLER T, 1994, SCIENCE, V266, P1805, DOI 10.1126/science.266.5192.1805; Bakker RT., 1986, DINOSAUR HERESIES; Calder WA., 1984, SIZE FUNCTION LIFE H; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CASTANET J, 1990, ANN SCI NAT ZOOL, V11, P191; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; DERICQLES A, 1983, COLD LOOK WARM BLOOD, P103; DERICQLES A, 1990, MOD GEOL, V15, P19; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; NORELL MA, IN PRESS SPECIAL PUB; Reid R.E.H., 1997, P449; RICQLES A, 1991, BONE MATRIX BONE SPE, V3, P1; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sussman M., 1964, GROWTH DEV; Thompson D.W., 1943, GROWTH FORM; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056	29	194	200	0	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					429	433		10.1038/35086558	http://dx.doi.org/10.1038/35086558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473315				2022-12-24	WOS:000170068200045
J	Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ				Gill, JA; Norris, K; Potts, PM; Gunnarsson, TG; Atkinson, PW; Sutherland, WJ			The buffer effect and large-scale population regulation in migratory birds	NATURE			English	Article							CONSEQUENCES; NUMBERS; COMPETITION; FECUNDITY; ARRIVAL	Buffer effects occur when sites vary in quality and fluctuations in population size are mirrored by large changes in animal numbers in poor-quality sites but only small changes in good-quality sites. Hence, the poor sites `buffer' the good sites(1,2,) a mechanism that can potentially drive population regulation if there are demographic costs of inhabiting poor sites. Here we show that for a migratory bird this process can apply on a country-wide scale with consequences for both survival and timing of arrival on the breeding grounds (an indicator of reproductive success(3,4)). The Icelandic population of the black-tailed godwit, Limosa limosa islandica, wintering in Britain has increased fourfold since the 1970s (ref. 5) but rates of change within individual estuaries have varied from zero to sixfold increases. In accordance with the buffer effect, rates of increase are greater on estuaries with low initial numbers, and godwits on these sites have lower prey-intake rates, lower survival rates and arrive later in Iceland than godwits on sites with stable populations. The buffer effect can therefore be a major process influencing large-scale population regulation of migratory species.	Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England; Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Iceland, Inst Biol, IS-108 Reykjavik, Iceland; Univ E Anglia, Sch Biol Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England; British Trust Ornithol, Thetford IP24 2PU, England	University of East Anglia; University of Reading; University of Iceland; University of East Anglia; British Trust for Ornithology	Gill, JA (corresponding author), Univ E Anglia, Sch Biol Sci, Tyndall Ctr, Norwich NR4 7TJ, Norfolk, England.	j.gill@uea.ac.uk	Gunnarsson, Tomas G/L-9783-2015; Gill, Jennifer A/A-7759-2008; Sutherland, William/B-1291-2013; Atkinson, Philip/B-8975-2009	Sutherland, William/0000-0002-6498-0437; Gunnarsson, Tomas Gretar/0000-0001-7692-0637; Atkinson, Philip/0000-0002-0838-557X				BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; Currie D, 2000, IBIS, V142, P389, DOI 10.1111/j.1474-919X.2000.tb04435.x; Ferrer M, 1996, ECOLOGY, V77, P69, DOI 10.2307/2265655; FRASER DF, 1980, ECOLOGY, V61, P790, DOI 10.2307/1936749; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gill JA, 2001, P ROY SOC B-BIOL SCI, V268, P369, DOI 10.1098/rspb.2000.1386; GOSSCUSTARD JD, 1980, ARDEA, V68, P31; HALAMA KJ, 1994, OIKOS, V69, P107, DOI 10.2307/3545289; KAY DG, 1975, J MAR BIOL ASSOC UK, V55, P811, DOI 10.1017/S0025315400017732; KLUYVER H. N., 1953, ARCH NEERLAND ZOOL, V10, P265; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; KREBS JR, 1970, J ZOOL, V162, P317; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; MOSER ME, 1988, J APPL ECOL, V25, P473, DOI 10.2307/2403838; POLLITT MS, 2000, WETLAND BIRD SURVEY; Sandercock BK, 1999, J AVIAN BIOL, V30, P460, DOI 10.2307/3677018; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; UNDERHILL LG, 1994, J APPL ECOL, V31, P463, DOI 10.2307/2404443; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	20	237	248	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					436	438		10.1038/35086568	http://dx.doi.org/10.1038/35086568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473317				2022-12-24	WOS:000170068200047
J	Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA				Hale, P; Makgoba, MW; Merson, MH; Quinn, TC; Richman, DD; Vella, S; Wabwire-Mangen, F; Wain-Hobson, S; Weiss, RA			Success hinges on support for treatment	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/ABI-3368-2020; Vella, Stefano/GZM-0519-2022; VELLA, STEFANO/V-8440-2019	VELLA, STEFANO/0000-0003-2347-5984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, Z01AI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					272	272		10.1038/35085656	http://dx.doi.org/10.1038/35085656			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460135	Bronze			2022-12-24	WOS:000169918200020
J	Rajagopal, MR; Joranson, DE; Gilson, AM				Rajagopal, MR; Joranson, DE; Gilson, AM			Medical use, misuse, and diversion of opioids in India	LANCET			English	Article							TRENDS; CANCER; CARE	In less-developed countries, opioids such as morphine are often not available for pain relief because of excessive regulations imposed to prevent their misuse and diversion. We describe the effect that these draconian measures have had on the availability of drugs for medical use in Kerala, India, and present results of a study, which we did to ascertain whether or not the misuse and diversion of opioids is as prevalent as the government reaction would suggest. We followed 1723 patients in Calicut, India, who were being treated for pain with oral morphine on an -outpatient home-care basis. Over 2 years, we did not identify any instances of misuse or diversion. These results suggest that, in the context of India as a less-developed country, oral morphine can be dispensed safely to patients for use at home. We recommend that palliative care programmes talk to concerned governmental authorities, to make them aware of the medical need for opioids, and communicate with local news media to increase awareness of palliative care and the use of these analgesics. Our project has overcome regulatory barriers that had interrupted availability of morphine and Its use in pain relief in India.	Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India; Pain & Policy Studies Grp, Madison, WI USA; Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Rajagopal, MR (corresponding author), Coll Med, Pain & Palliative Care Clin, Calicut, Kerala, India.	pain@vsnl.com						Ajithakumari K, 1997, PALLIATIVE MED, V11, P451, DOI 10.1177/026921639701100604; [Anonymous], [No title captured]; [Anonymous], 2000, ACH BAL NAT OP CONTR; *I MED, 1997, APPR DEATH IMPR CAR; *INT NARC CONTR BO, 2000, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 1999, NARC DRUGS EST WORLD; *INT NARC CONTR BO, 2000, REP INT NARC CONTR B; *INT NARC CONTR BO, 1989, NARC DRUGS EST WORLD; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 1999, REP INT NARC CONTR B; *JAP MIN HLTH WELF, 1999, REP ADM MEAS NARC ST; JORANSON DE, 1993, J PAIN SYMPTOM MANAG, V8, P353, DOI 10.1016/0885-3924(93)90052-W; Joranson DE, 2000, JAMA-J AM MED ASSOC, V283, P1710, DOI 10.1001/jama.283.13.1710; Kumar KS, 2000, PALLIATIVE MED, V14, P183, DOI 10.1191/026921600670697351; SIKORA K, 1998, WHO PROGRAMME CANC C; Sureshkumar K, 1996, PALLIATIVE MED, V10, P293, DOI 10.1177/026921639601000404; TEOH N, 1991, Palliative Medicine, V5, P185, DOI 10.1177/026921639100500302; *WHO, 1990, TECHN REP SER WHO, V804; *WHO, 1998, TECHN REP SER WHO, V882; *WHO COLL CTR POL, 2000, IMPR CANC PAIN REL W; World Health Organization, 1996, CANC PAIN REL GUID O	21	57	59	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					139	143		10.1016/S0140-6736(01)05322-3	http://dx.doi.org/10.1016/S0140-6736(01)05322-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463435				2022-12-24	WOS:000169837700033
J	LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE				LOGAN, GA; HAYES, JM; HIESHIMA, GB; SUMMONS, RE			TERMINAL PROTEROZOIC REORGANIZATION OF BIOGEOCHEMICAL CYCLES	NATURE			English	Article							CARBON ISOTOPE RATIOS; FOSSIL RECORD; ORGANIC-COMPOUNDS; WATER COLUMN	THE Proterozoic aeon (2,500-540 million years ago) saw episodic increases in atmospheric oxygen content(1), the evolution of multicellular life(2,3) and, at its close, an enormous radiation of animal diversity(3). These profound biological and environmental changes must have been linked, but the underlying mechanisms have been obscure, Here we show that hydrocarbons extracted from Proterozoic sediments in several locations worldwide are derived mainly from bacteria or other heterotrophs rather than from photosynthetic organisms, Biodegradation of algal products in sedimenting matter was therefore unusually complete, indicating that organic material was extensively reworked as it sank slowly through the water column, We propose that a significant proportion of this reworking will have been mediated by sulphate-reducing bacteria, forming sulphide, The production of sulphide and consumption of oxygen near the ocean surface will have inhibited transport of O-2 to the deep ocean, We find that preservation of algal-lipid skeletons improves at the beginning of the Cambrian, reflecting the increase in transport by rapidly sinking faecal pellets, We suggest that this rapid removal of organic matter will have increased oxygenation of surface waters, leading to a descent of the O-2-sulphide interface to the sea Boor and to marked changes in the marine environment, ultimately contributing to the Cambrian radiation.	INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA; GEOL SURVEY AUSTRALIA ORG, CANBERRA, ACT 2601, AUSTRALIA	Indiana University System; Indiana University Bloomington	LOGAN, GA (corresponding author), INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA.		Summons, Roger Everett/AAL-3789-2020					ALT JC, 1993, EARTH PLANET SC LETT, V119, P477, DOI 10.1016/0012-821X(93)90057-G; [Anonymous], [No title captured]; BENDER ML, 1990, J GEOPHYS RES-OCEANS, V95, P22243, DOI 10.1029/JC095iC12p22243; Beukes N.J., 1992, PROTEROZOIC BIOSPHER, P147; BJOROY M, 1992, ORG GEOCHEM, V19, P89, DOI 10.1016/0146-6380(92)90029-W; BRASIER MD, 1992, J GEOL SOC LONDON, V149, P621, DOI 10.1144/gsjgs.149.4.0621; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COLLISTER JW, 1992, THESIS INDIANA U; CRIMES TP, 1992, ANNU REV ECOL SYST, V23, P339, DOI 10.1146/annurev.es.23.110192.002011; De Leeuw J.W., 1993, ORG GEOCHEM, V11, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; GUTHRIE JM, 1994, THESIS INDIANA U; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; HIESHIMA GB, 1992, THESIS INDIANA U; HOERING TC, 1965, YB CARNEGIE I WASH, V64, P215; HOERING TC, 1966, YB CARNEGIE I WASH, V65, P365; HOLLANDER DJ, 1993, ORG GEOCHEM, V20, P1253, DOI 10.1016/0146-6380(93)90013-2; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; LAMBERT IB, 1990, STABLE ISOTOPE COMPO, P260; LIEN AY, 1983, GLOBAL BIOGEOCHEMICA, P95; LIPPS TH, 1992, ORIGIN EARLY EVOLUTI; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MOORE TB, 1992, PROTEROZOIC BIOSPHER, P605; MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0; NOTHOLT AJG, 1990, SPEC PUBL GEOL SOC L, V52; RAFF RA, 1970, NATURE, V228, P1003, DOI 10.1038/2281003a0; ROSS GM, IN PRESS PRECAMBR RE; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; SCHOELL M, 1994, ORG GEOCHEM, V21, P713, DOI 10.1016/0146-6380(94)90014-0; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9	38	347	370	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	1995	376	6535					53	56		10.1038/376053a0	http://dx.doi.org/10.1038/376053a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH111	11536694				2022-12-24	WOS:A1995RH11100059
J	UGARTE, D				UGARTE, D			CURLING AND CLOSURE OF GRAPHITIC NETWORKS UNDER ELECTRON-BEAM IRRADIATION	NATURE			English	Article							CARBON; C-60; FULLERENES	THE discovery1 of buckminsterfullerene (C60) and its production in macroscopic quantities2 has stimulated a great deal of research. More recently, attention has turned towards other curved graphitic networks, such as the giant fullerenes (C(n), n > 100)3,4 and carbon nanotubes5-8. A general mechanism has been proposed9 in which the graphitic sheets bend in an attempt to eliminate the highly energetic dangling bonds present at the edge of the growing structure. Here, I report the response of carbon soot particles and tubular graphitic structures to intense electron-beam irradiation in a high-resolution electron microscope; such conditions resemble a high-temperature regime, permitting a degree of structural fluidity. With increased irradiation, there is a gradual reorganization of the initial material into quasi-spherical particles composed of concentric graphitic shells. This lends weight to the nucleation scheme proposed9 for fullerenes, and moreover, suggests that planar graphite may not be the most stable allotrope of carbon in systems of limited size.			UGARTE, D (corresponding author), ECOLE POLYTECH FED LAUSANNE,INST PHYS EXPTL,CH-1015 LAUSANNE,SWITZERLAND.		Ugarte, Daniel/C-2326-2012	Ugarte, Daniel Mario/0000-0003-3332-9139				ADAMS GB, 1992, SCIENCE, V256, P1792, DOI 10.1126/science.256.5065.1792; BUNDY FP, 1989, PHYSICA A, V156, P169, DOI 10.1016/0378-4371(89)90115-5; CHAI Y, 1991, J PHYS CHEM-US, V95, P7564, DOI 10.1021/j100173a002; Curl R. F., 1991, Scientific American (International Edition), V265, P32, DOI 10.1038/scientificamerican1091-54; EBBESEN TW, 1992, NATURE, V358, P2200; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; IIJIMA S, 1987, J PHYS CHEM-US, V91, P3466, DOI 10.1021/j100297a002; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IIJIMA S, 1980, J CRYST GROWTH, V50, P657; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1987, NATURE, V329, P529, DOI 10.1038/329529a0; KROTO HW, 1988, NATURE, V331, P328, DOI 10.1038/331328a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; LAMB LD, 1992, SCIENCE, V255, P1413, DOI 10.1126/science.255.5050.1413; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; ROBERTSON DH, 1992, J PHYS CHEM-US, V96, P6133, DOI 10.1021/j100194a011; SCUSERIA GE, IN PRESS BUCKMINSTER; TANAKA K, 1992, CHEM PHYS LETT, V191, P469, DOI 10.1016/0009-2614(92)85410-C; ZHANG QL, 1986, J PHYS CHEM-US, V90, P525, DOI 10.1021/j100276a001	19	1718	1772	13	319	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 22	1992	359	6397					707	709		10.1038/359707a0	http://dx.doi.org/10.1038/359707a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU650	11536508				2022-12-24	WOS:A1992JU65000048
J	Hiroi, T; Zolensky, ME; Pieters, CM				Hiroi, T; Zolensky, ME; Pieters, CM			The Tagish Lake meteorite: A possible sample from a D-type asteroid	SCIENCE			English	Article							MAIN-BELT; BODIES; VESTA	A new type of carbonaceous chondrite, the Tagish Lake meteorite, exhibits a reflectance spectrum similar to spectra observed from the D-type asteroids, which are relatively abundant in the outer solar system beyond the main asteroid belt and have been inferred to be more primitive than any known meteorite. Until the Tagish Lake fait, these asteroids had no analog in the meteorite collections. The Tagish Lake meteorite is a carbon-rich (4 to 5 weight %), aqueously altered carbonaceous chondrite and contains high concentrations of presolar grains and carbonate minerals, which is consistent with the expectation that the D-type asteroids were originally made of primitive materials and did not experience any extensive heating.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; NASA, Earth Sci & Solar Syst Explorat Div, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Hiroi, T (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.			Zolensky, Michael/0000-0002-3181-1303				Bell J.F., 1989, ASTEROIDS, P921; BELL JF, 1988, LUNAR PLANET SCI, V19, P57; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; CASSIDY W, 1975, ICARUS, V25, P371, DOI 10.1016/0019-1035(75)90002-0; GAFFEY MJ, 1993, METEORITICS, V28, P161, DOI 10.1111/j.1945-5100.1993.tb00755.x; GOUNELLE M, 2001, LUNAR PLANET SCI, V32; LEBOFSKY LA, 1990, ICARUS, V83, P16, DOI 10.1016/0019-1035(90)90003-R; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; MILANI A, 1994, ICARUS, V107, P219, DOI 10.1006/icar.1994.1020; NOBILI AM, 1989, ASTEROIDS, V2, P862; Opik E.J., 1951, P R IRISH ACAD A, V54, P165; TEDESCO EF, 1989, ASTEROIDS, V2, P1090; Tholen D., 1984, THESIS U ARIZONA TUS; VILAS F, 1985, ICARUS, V64, P503, DOI 10.1016/0019-1035(85)90071-5; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; XU S, 1995, ICARUS, V115, P1, DOI 10.1006/icar.1995.1075; Yamada M, 1999, EARTH PLANETS SPACE, V51, P1255, DOI 10.1186/BF03351599; ZELLNER B, 1985, ICARUS, V61, P335	19	172	172	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2234	2236		10.1126/science.1063734	http://dx.doi.org/10.1126/science.1063734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11520950				2022-12-24	WOS:000171139400037
J	Bar-Nahum, G; Nudler, E				Bar-Nahum, G; Nudler, E			Isolation and characterization of sigma(70)-retaining transcription elongation complexes from Escherichia coli	CELL			English	Article							CORE RNA-POLYMERASE; SIGMA-SUBUNIT; PROMOTER STRENGTH; TERNARY COMPLEXES; PROTEIN; INITIATION; TERMINATION; RELEASE; INVITRO; ENZYME	sigma (70) subunit is thought to be released from the core RNA polymerase (RNAP) upon the transition from initiation to elongation or shortly afterward. Here, we identify a population of RNAP from E. coli that retains sigma (70) throughout elongation. The relative amount of this population appears to depend on cellular growth and reaches its maximum during the stationary phase. The proportion of sigma (70)-retaining elongation complexes (EC-sigma (70)) is invariant with various promoters or distances from the transcription start site. EC-sigma (70) responds to pauses, intrinsic terminators, and the elongation factor NusA similarly to EC without sigma (70). However, EC-sigma (70) has a substantially higher ability to support multiple rounds of transcription at certain promoters, suggesting its profound role in gene expression and regulation in bacteria.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.			Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUNNER M, 1987, EMBO J, V6, P3139, DOI 10.1002/j.1460-2075.1987.tb02624.x; BURGESS RR, 1971, ANNU REV BIOCHEM, V40, P711, DOI 10.1146/annurev.bi.40.070171.003431; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GNATT AL, 2001, STRUCTURAL BASIS TRA, P3; Gourse RL, 1998, COLD SPRING HARB SYM, V63, P131, DOI 10.1101/sqb.1998.63.131; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kusano S, 1997, GENES CELLS, V2, P433, DOI 10.1046/j.1365-2443.1997.13203301320330.x; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Liu KB, 1996, EMBO J, V15, P150, DOI 10.1002/j.1460-2075.1996.tb00343.x; LIU KB, 1995, P NATL ACAD SCI USA, V92, P5012, DOI 10.1073/pnas.92.11.5012; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; RAO L, 1994, J MOL BIOL, V235, P1421, DOI 10.1006/jmbi.1994.1098; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STACKHOUSE TM, 1989, BIOCHEMISTRY-US, V28, P7781, DOI 10.1021/bi00445a038; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; WU FYH, 1976, BIOCHEMISTRY-US, V15, P3254, DOI 10.1021/bi00660a014	35	96	99	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					443	451		10.1016/S0092-8674(01)00461-5	http://dx.doi.org/10.1016/S0092-8674(01)00461-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525730	Bronze			2022-12-24	WOS:000170665200008
J	Zhang, Z; Carmichael, GG				Zhang, Z; Carmichael, GG			The fate of dsRNA in the nucleus: A p54(nrb)-containing complex retention of promiscuously mediates the nuclear A-to-I edited RNAs	CELL			English	Article							DOUBLE-STRANDED-RNA; SPLICING FACTOR PSF; CONSTITUTIVE TRANSPORT ELEMENT; DNA-BINDING PROTEIN; UNWINDING ACTIVITY; SCAFFOLD PROTEINS; TOPOISOMERASE-I; ANTISENSE RNA; ADENOSINE; EXPORT	How do cells discriminate between selectively edited mRNAs that encode new protein isoforms, and dsRNA-induced, promiscuously edited RNAs that encode nonfunctional, mutant proteins? We have developed a Xenopus oocyte model system which shows that a variety of hyperedited, inosine-containing RNAs are specifically retained in the nucleus. To uncover the mechanism of inosine-induced retention, HeLa cell nuclear extracts were used to isolate a multiprotein complex that binds specifically and cooperatively to inosine-containing RNAs. This complex contains the inosine-specific RNA binding protein p54(nrb), the splicing factor PSF, and the inner nuclear matrix structural protein matrin 3. We provide evidence that one function of the complex identified here is to anchor hyperedited RNAs to the nuclear matrix, while allowing selectively edited mRNAs to be exported.	Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA	University of Connecticut	Carmichael, GG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Microbiol, Farmington, CT 06030 USA.	carmichael@nso2.uchc.edu			NCI NIH HHS [R01 CA045382, CA32325] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045382] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhmedov AT, 2000, NUCLEIC ACIDS RES, V28, P3022, DOI 10.1093/nar/28.16.3022; Ausubel F, 1989, MOL REPROD DEV, V1, P146; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; BRAUN IC, 2001, J BIOL CHEM, V19, P19; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Carmichael GG, 2000, BLOOD CELL MOL DIS, V26, P57; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; EGEBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270, DOI 10.1073/pnas.91.22.10270; Fischer U, 1999, NUCLEIC ACIDS RES, V27, P4128, DOI 10.1093/nar/27.21.4128; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; HIBINO Y, 1993, BIOCHIM BIOPHYS ACTA, V1174, P162, DOI 10.1016/0167-4781(93)90110-Y; HIBINO Y, 1993, BIOCHEM BIOPH RES CO, V197, P336, DOI 10.1006/bbrc.1993.2480; Hibino Y, 2000, BIOCHEM BIOPH RES CO, V279, P282, DOI 10.1006/bbrc.2000.3938; Hibino Y, 1998, BBA-GENE STRUCT EXPR, V1396, P88, DOI 10.1016/S0167-4781(97)00176-0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; JONES KR, 1990, NEURON, V4, P711, DOI 10.1016/0896-6273(90)90197-N; Karhumaa P, 2000, J BIOL CHEM, V275, P16044, DOI 10.1074/jbc.275.21.16044; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; LINDSEY LA, 1995, J BIOL CHEM, V270, P13415, DOI 10.1074/jbc.270.22.13415; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Meissner M, 2000, J CELL BIOCHEM, V76, P559, DOI 10.1002/(SICI)1097-4644(20000315)76:4<559::AID-JCB4>3.0.CO;2-U; Miralles F, 2000, J CELL BIOL, V148, P271, DOI 10.1083/jcb.148.2.271; NISHIKURA K, 1992, ANN NY ACAD SCI, V660, P240, DOI 10.1111/j.1749-6632.1992.tb21076.x; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Otto H, 2001, EUR J BIOCHEM, V268, P420, DOI 10.1046/j.1432-1033.2001.01901.x; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11507, DOI 10.1021/bi00113a004; Reim I, 1999, CHROMOSOMA, V108, P162, DOI 10.1007/s004120050365; Reim I, 1999, EXP CELL RES, V253, P573, DOI 10.1006/excr.1999.4647; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; SACCOMANNO L, 1994, MOL CELL BIOL, V14, P5425, DOI 10.1128/MCB.14.8.5425; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Straub T, 2000, BIOCHEMISTRY-US, V39, P7552, DOI 10.1021/bi992898e; Tiscornia G, 2000, MOL CELL, V5, P959, DOI 10.1016/S1097-2765(00)80261-0; Traish AM, 1997, DIAGN MOL PATHOL, V6, P209, DOI 10.1097/00019606-199708000-00005; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; ZHANG WW, 1993, BIOCHEM J, V290, P267, DOI 10.1042/bj2900267; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	61	373	393	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					465	475		10.1016/S0092-8674(01)00466-4	http://dx.doi.org/10.1016/S0092-8674(01)00466-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525732	Bronze			2022-12-24	WOS:000170665200010
J	Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM				Kessler, RC; Davis, RB; Foster, DF; Van Rompay, MI; Walters, EE; Wilkey, SA; Kaptchuk, TJ; Eisenberg, DM			Long-term trends in the use of complementary and alternative medical therapies in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES; CARE	Background: Although recent research has shown that many people in the United States use complementary and alternative medical (CAM) therapies, little is known about time trends in use. Objective: To present data on time trends in CAM therapy use in the United States over the past half-century. Design: Nationally representative telephone survey of 2055 respondents that obtained information on current use, lifetime use, and age at first use for 20 CAM therapies. Setting: The 48 contiguous U.S. states. Participants: Household residents 18 years of age and older. Measurement: Retrospective self-reports of age at first use for each of 20 CAM therapies. Results: Previously reported analyses of these data showed that more than one third of the U.S. population was currently using CAM therapy in the year of the interview (1997). Subsequent analyses of lifetime use and age at onset showed that 67.6% of respondents had used at least one CAM therapy in their lifetime. Lifetime use steadily increased with age across three age cohorts: Approximately 3 of every 10 respondents in the pre-baby boom cohort, 5 of 10 in the baby boom cohort, and 7 of 10 in the post-baby boom cohort reported using some type of CAM therapy by age 33 years. Of respondents who ever used a CAM therapy, nearly half continued to use many years later. A wide range of individual CAM therapies increased in use over time, and the growth was similar across all major sociodemographic sectors of the study sample. Conclusions: Use of CAM therapies by a large proportion of the study sample is the result of a secular trend that began at least a half century ago. This trend suggests a continuing demand for CAM therapies that will affect health care delivery for the foreseeable future.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Kessler, RC (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Van Rompay, Maria/G-9452-2012		NIAMS NIH HHS [U24 AR43441] Funding Source: Medline; NIMH NIH HHS [K05 MH00507] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K05MH000507] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; BERLINER HS, 1980, INT J HEALTH SERV, V10, P133, DOI 10.2190/XWR6-5QPX-GEGE-5GWR; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P31; Delbanco T, 1998, JAMA-J AM MED ASSOC, V280, P1560, DOI 10.1001/jama.280.18.1560; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Goldstein M. S., 1992, HLTH MOVEMENT PROMOT; HOLT D, 1979, J ROY STAT SOC A STA, V142, P33, DOI 10.2307/2344652; LEE ES, 1989, ANAL COMPLEXX SURVEY; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Pelletier KR, 1997, AM J HEALTH PROMOT, V12, P112, DOI 10.4278/0890-1171-12.2.112; ROTHSTEIN WG, 1985, AM PHYSICIANS 19 CEN; SAS, 1996, SAS US GUID REL 6 12; Shekelle PG, 1996, MED CARE, V34, P863, DOI 10.1097/00005650-199609000-00001; SHYROCK HS, 1971, METHODS MAT DEMOGRAP, V1; *US BUR CENS, 2001, US POP EST AG SEX RA; Wetzel MS, 1998, JAMA-J AM MED ASSOC, V280, P784, DOI 10.1001/jama.280.9.784; Whorton J C, 1986, Pharm Hist, V28, P14; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; [No title captured]	21	487	495	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					262	268		10.7326/0003-4819-135-4-200108210-00011	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00011			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	465KE	11511141				2022-12-24	WOS:000170587500005
J	Smaglik, P				Smaglik, P			Biologists officially welcome plan	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					665	665		10.1038/35089190	http://dx.doi.org/10.1038/35089190			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507594	Bronze			2022-12-24	WOS:000170450200003
J	King, SL				King, SL			The most primitive sense	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					766	766		10.1001/jama.286.7.766	http://dx.doi.org/10.1001/jama.286.7.766			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497512				2022-12-24	WOS:000170429600001
J	Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC				Harrison, LH; Pass, MA; Mendelsohn, AB; Egri, M; Rosenstein, NE; Bustamante, A; Razeq, J; Roche, JC			Invasive meningococcal disease in adolescents and young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEISSERIA-MENINGITIDIS; BACTERIAL-MENINGITIS; UNITED-STATES; VACCINE; PREVENTION; INFECTION; RISK	Context Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years. Objective To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s. Design and Setting Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland. Patients Maryland residents diagnosed as having invasive meningococcal disease. Main Outcome Measure Invasive meningococcal infection. Results Of 295 total cases, 71 (24.1%) occurred among persons aged 15 through 24 years. Sixteen (22.5%) of these cases were fatal. The annual incidence rate increased from 0.9 to 2.1 cases per 100000 among 15 through 24 year olds (P=.01). The proportion of all disease increased from 16.0% to 28.9% (P=.03). The incidence and proportion of cases subsequently decreased to 1.0 and 16.4% in 1998 through 1999, respectively. Infection in 15 through 24 year olds was more likely to be fatal than infection in those younger than age 15 years (22.5% vs 4.6%; P=.001). Infection in 15 through 24 year olds, compared with those aged 25 years or older, was more likely to be associated with male sex (66.2% vs 34.8%; P<.001) and serogroup C infection (46.9% vs 20.2%; P<.001), respectively. Infections were potentially preventable with the licensed meningococcal vaccine in 82.8% of 15 through 24 year olds, 68.1% of those younger than 15 years, and 76.8% of adults aged 25 years or older. Conclusions Incidence of meningococcal infection in 15 through 24 year olds in Maryland increased and then declined during the 1990s. Infection in this age group was associated with an unusually high case-fatality ratio, and the vast majority of cases were potentially vaccine preventable.	Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Meningitis & Special Pathogens Branch, Natl Ctr Infect Dis, Atlanta, GA USA; Maryland Dept Hlth & Mental Hyg, Labs Adm, Baltimore, MD USA; Maryland Dept Hlth & Mental Hyg, Epidemiol & Dis Control Program, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Maryland Department of Health & Mental Hygiene	Harrison, LH (corresponding author), Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, 521 Parran Hall,130 DeSoto St, Pittsburgh, PA 15261 USA.	lharriso@edc.gsph.pitt.edu		Mendelsohn, Aaron/0000-0002-0560-1177				Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; *ADV COMM IMM PRAC, 2000, MMWR-MORBID MORTAL W, V49, P13; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P229; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Barquet N, 1999, ARCH INTERN MED, V159, P2329, DOI 10.1001/archinte.159.19.2329; Carrol ED, 2000, ARCH DIS CHILD, V83, P271, DOI 10.1136/adc.83.3.271; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; FINN R, IN PRESS SO MED J; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; FISCHER M, 1998, 36 ANN M INF DIS SOC; Froeschle JE, 1999, CLIN INFECT DIS, V29, P215, DOI 10.1086/520166; GOLD R, 1971, B WORLD HEALTH ORGAN, V45, P279; HARRISON LH, 1995, JAMA-J AM MED ASSOC, V273, P419, DOI 10.1001/jama.273.5.419; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HARRISON LH, 1987, EVOLUTION MENINGOCOC, V1, P27; HUDSON PJ, 1986, PEDIATR INFECT DIS J, V5, P213, DOI 10.1097/00006454-198603000-00011; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; IMREY PB, 1995, J CLIN MICROBIOL, V33, P3133, DOI 10.1128/JCM.33.12.3133-3137.1995; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Knapp JS, 1999, MANUAL CLIN MICROBIO, P586; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; PELTOLA H, 1982, LANCET, V2, P595; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001/jama.279.6.435; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; SAEZNIETO JA, 1982, J HYG-CAMBRIDGE, V89, P139, DOI 10.1017/S0022172400070637; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Tappero JW, 1996, NEW ENGL J MED, V335, P833, DOI 10.1056/NEJM199609193351201; WOODS CW, 1998, 36 ANN M INF DIS SOC; 2001, FACT SHEET YOUTH RIS; 2000, MOR MORTAL WKLY REP, V49, P1	36	99	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					694	699		10.1001/jama.286.6.694	http://dx.doi.org/10.1001/jama.286.6.694			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495619				2022-12-24	WOS:000170271500025
J	Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD				Schatz, IJ; Masaki, K; Yano, K; Chen, R; Rodriguez, BL; Curb, JD			Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study	LANCET			English	Article							LOW SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; MEN; DISEASE; CANCER; RISK; DEATH	Background A generally held belief is that cholesterol concentrations should be kept low to lessen the risk of cardiovascular disease. However, studies of the relation between serum cholesterol and all-cause mortality in elderly people have shown contrasting results. To investigate these discrepancies, we did a longitudinal assessment of changes in both lipid and serum cholesterol concentrations over 20 years, and compared them with mortality. Methods Lipid and serum cholesterol concentrations were measured in 3572 Japanese/American men (aged 71-93 years) as part of the Honolulu Heart Program. We compared changes in these concentrations over 20 years with all-case mortality using three different Cox proportional hazards models. Findings Mean cholesterol fell significantly with increasing age. Age-adjusted mortality rates were 68.3, 48.9, 41.1, and 43.3 for the first to fourth quartiles of cholesterol concentrations, respectively. Relative risks for mortality were 0.72 (95% CI 0.60-0.87), 0.60 (0.49-0.74), and 0.65 (0.53-0.80), in the second, third, and fourth quartiles, respectively, with quartile 1 as reference. A Cox proportional hazard model assessed changes in cholesterol concentrations between examinations three and four. Only the group with low cholesterol concentration at both examinations had a significant association with mortality (risk ratio 1.64, 95% CI 1.13-2.36). Interpretation We have been unable to explain our results. These data cast doubt on the scientific justification for lowering cholesterol to very low concentrations (<4.65 mmol/L) in elderly people.	Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, Honolulu, HI 96813 USA; Kuakini Med Ctr, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Schatz, IJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Clin Epidemiol & Geriatr Div, 1356 Lusitana St,7th Floor, Honolulu, HI 96813 USA.	schatzi@hawaii.edu			NATIONAL INSTITUTE ON AGING [N01AG042149] Funding Source: NIH RePORTER; NIA NIH HHS [N0I-AG-4-2149] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbott RD, 1997, ANN EPIDEMIOL, V7, P417, DOI 10.1016/S1047-2797(97)00043-4; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; EPSTEIN FH, 1992, ATHEROSCLEROSIS, V94, P1, DOI 10.1016/0021-9150(92)90182-G; ETTINGER WH, 1995, J GERONTOL A-BIOL, V50, pM137, DOI 10.1093/gerona/50A.3.M137; Grundy S, 1996, CIRCULATION, V93, P1067; IRIBARREN C, 1995, CIRCULATION, V92, P2396, DOI 10.1161/01.CIR.92.9.2396; JACOBS DR, 1993, ANNU REV PUBL HEALTH, V14, P95; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; LAW MR, 1992, BRIT J CANCER, V65, P307, DOI 10.1038/bjc.1992.63; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; PEDERSEN TR, 1994, LANCET, V344, P1383; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Sharp DS, 1996, AM J RESP CRIT CARE, V153, P805, DOI 10.1164/ajrccm.153.2.8564136; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	21	307	316	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					351	355		10.1016/S0140-6736(01)05553-2	http://dx.doi.org/10.1016/S0140-6736(01)05553-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502313				2022-12-24	WOS:000170235100008
J	Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG				Temple, LKF; McLeod, RS; Gallinger, S; Wright, JG			Defining disease in the genomics era	SCIENCE			English	Editorial Material									Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada; Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Publ Hlth Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Temple, LKF (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON M5G 1X5, Canada.		Gallinger, Steven/E-4575-2013; McLeod, Robin/K-1476-2013						0	50	51	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					807	808		10.1126/science.1062938	http://dx.doi.org/10.1126/science.1062938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486074				2022-12-24	WOS:000170241000026
J	Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM				Rexrode, KM; Buring, JE; Glynn, RJ; Stampfer, MJ; Youngman, LD; Gaziano, JM			Analgesic use and renal function in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NONNARCOTIC ANALGESICS; COLORECTAL-CANCER; FAILURE; DISEASE; RISK; ASPIRIN; ACETAMINOPHEN; ABUSE	Context Several case-control studies suggest an association between analgesic use and increased risk of chronic renal disease, but few cohort studies have examined this association. Objective To determine whether analgesic use is associated with risk of renal dysfunction. Design and Setting Cohort study of analgesic use data from the Physicians' Health Study, which lasted 14 years from September 1982 to December 1995 with annual follow-up. Participants A total of 11 032 initially healthy men who provided blood samples and self-report of analgesic use. Main Outcome Measures Elevated creatinine level defined as 1.5 mg/dL (133 mu mol/L) or higher and a reduced creatinine clearance defined as 55 mL/min (0.9 mL/s) or less, and self-reported use of acetaminophen, aspirin, and other nonsteroidal antiinflammatory drugs (never [<12 pills]; 12-1499 pills; 1500-2499 pills; and <greater than or equal to>2500 pills). Results PI total of 460 men had elevated creatinine levels (4.2%) and 1258 had reduced creatinine clearance (11.4%). Mean creatinine levels and creatinine clearances were similar among men who did not use analgesics and those who did, even at total intakes of 2500 or more pills. In multivariable analyses adjusted for age; body mass index; history of hypertension, elevated cholesterol, and diabetes; occurrence of cardiovascular disease; physical activity; and use of other analgesics, the relative risks of elevated creatinine level associated with intake of 2500 or more pills were 0.83 (95% confidence interval [CI], 0.50-1.39, P for trend =.05) for acetaminophen, 0.98 (95% CI, 0.53-1.81; P for trend =.96) for aspirin, and 1.07 (95% CI, 0.71-1.64; P for trend =.86) for other nonsteroidal anti-inflammatory drugs. Ho association was observed be tween analgesic use and reduced creatinine clearance. Conclusions Moderate analgesic use in this cohort study of initially healthy men was not associated with increased risk of renal dysfunction.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; US FDA, Res Off, Laurel, MD USA; Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Gaziano, JM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, Channing Lab, 900 Commonwealth Ave, Boston, MA 02215 USA.		Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NCI NIH HHS [CA-40360, CA-34944] Funding Source: Medline; NHLBI NIH HHS [HL-34595, HL-26490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAKELY P, 1995, J AM SOC NEPHROL, V6, P48; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DAgati V, 1996, AM J KIDNEY DIS, V28, pS24, DOI 10.1016/S0272-6386(96)90565-X; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; DUBACH UC, 1991, NEW ENGL J MED, V324, P155, DOI 10.1056/NEJM199101173240304; ELSEVIERS MM, 1995, KIDNEY INT, V48, P1912, DOI 10.1038/ki.1995.491; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Gutthann SP, 1996, ARCH INTERN MED, V156, P2433, DOI 10.1001/archinte.1996.00440200041005; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; MCCREDIE M, 1988, NEPHRON, V49, P26; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; POMMER W, 1989, AM J NEPHROL, V9, P403, DOI 10.1159/000168002; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SANDLER DP, 1991, ANN INTERN MED, V115, P165, DOI 10.7326/0003-4819-115-3-165; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; SPUHLER O, 1953, Z KLIN MED, V151, P1; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; YOUNGMAN LD, 1993, FASEB J, V1, P377; 1988, N ENGL J MED, V318, P262; 1983, FED REG         1005, V48, P45466	27	78	80	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2001	286	3					315	321		10.1001/jama.286.3.315	http://dx.doi.org/10.1001/jama.286.3.315			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452QA	11466097	Bronze			2022-12-24	WOS:000169869200022
J	Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA				Chan, SY; Empig, CJ; Welte, FJ; Speck, RF; Schmaljohn, A; Kreisberg, JF; Goldsmith, MA			Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses	CELL			English	Article							BINDING-PROTEIN; GLYCOPROTEIN; MEMBRANE; IDENTIFICATION; SEQUESTRATION; INFECTIONS	Human infections by Marburg (MBG) and Ebola (EBO) viruses result in lethal hemorrhagic fever. To identify cellular entry factors employed by MBG virus, noninfectible cells transduced with an expression library were challenged with a selectable pseudotype virus packaged by MBG glycoproteins (GP). A cDNA encoding the folate receptor-alpha (FR-alpha) was recovered from cells exhibiting reconstitution of viral entry. A FR-alpha cDNA was recovered in a similar strategy employing EBO pseudotypes. FR-alpha expression in Jurkat cells facilitated MBG or EBO entry, and FR-blocking reagents inhibited infection by MBG or EBO. Finally, FR-alpha bound cells expressing MBG or EBO GP and mediated syncytia formation triggered by MBG GP. Thus, FR-alpha is a significant cofactor for cellular entry for MBG and EBO viruses.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94141 USA; USA, Med Res Inst Infect Dis, Div Virol, Frederick, MD 21702 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Goldsmith, MA (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	mgoldsmith@gladstone.ucsf.edu	Speck, Roberto F/O-2433-2016	Kreisberg, Jason/0000-0002-3616-079X; Speck, Roberto/0000-0002-8453-1137				Allan VJ, 2000, PRACT APPROACH SER, V218, P1; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Chan SY, 2000, J VIROL, V74, P4933, DOI 10.1128/JVI.74.10.4933-4937.2000; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Da Costa M, 2000, AM J PHYSIOL-CELL PH, V278, pC812, DOI 10.1152/ajpcell.2000.278.4.C812; FRA AM, 1994, J BIOL CHEM, V269, P30745; FRANKLIN WA, 1994, INT J CANCER, P89; Geisbert TW, 2000, LAB INVEST, V80, P171, DOI 10.1038/labinvest.3780021; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Hevey M, 1997, VIROLOGY, V239, P206, DOI 10.1006/viro.1997.8883; JOHNSON E, 1995, INT J EXP PATHOL, V76, P227; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; Lee RJ, 1996, BBA-MOL CELL RES, V1312, P237, DOI 10.1016/0167-4889(96)00041-9; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Maziarz KM, 1999, J BIOL CHEM, V274, P11086, DOI 10.1074/jbc.274.16.11086; Peters C.J., 1996, FIELDS VIROLOGY, P1161; Rijnboutt S, 1996, J CELL BIOL, V132, P35, DOI 10.1083/jcb.132.1.35; Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; SCHMALJOHN AL, 1995, VIROLOGY, V206, P963, DOI 10.1006/viro.1995.1019; SVENDSEN IB, 1982, CARLSBERG RES COMMUN, V47, P371, DOI 10.1007/BF02907775; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; VEY M, 1992, VIROLOGY, V188, P408, DOI 10.1016/0042-6822(92)90775-K; Villanueva J, 1998, AM J PHYSIOL-REG I, V275, pR1503, DOI 10.1152/ajpregu.1998.275.5.R1503; Volchkov VE, 2000, VIROLOGY, V268, P1, DOI 10.1006/viro.1999.0110; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; WEITMAN SD, 1992, CANCER RES, V52, P3396; WEITMAN SD, 1992, CANCER RES, V52, P6708; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	40	165	178	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					117	126		10.1016/S0092-8674(01)00418-4	http://dx.doi.org/10.1016/S0092-8674(01)00418-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461707	Bronze			2022-12-24	WOS:000169870300014
J	PRICE, LC; SCHOELL, M				PRICE, LC; SCHOELL, M			CONSTRAINTS ON THE ORIGINS OF HYDROCARBON-GAS FROM COMPOSITIONS OF GASES AT THEIR SITE OF ORIGIN	NATURE			English	Article							NATURAL GASES; KEROGEN	It is widely accepted that natural gas is formed from thermal decomposition of both oil in reservoirs and, to a lesser extent, the organic matter in shales from which the oil was derived(1-6). But laboratory pyrolysis experiments on shales do not reproduce the methane-rich composition typical of most gas reservoirs(7), leading to suggestions(7) that other mechanisms, such as transition-metal catalysis, may be important. The discrepancy might, however, instead arise because gas (and oil) deposits have migrated from their source rocks, so that the reservoir composition might not be representative of the composition in the source rocks where the hydrocarbons were generated. To address this question, we have analysed gas samples coproduced with oils directly from a source rock (the Bakken shales, North Dakota, USA) where the local geology has prevented significant hydrocarbon migration. The methane contents of these Bakken-shale gases are much lower than that of conventional gas reservoirs, but are consistent with that from pyrolysis experiments(8,9) on these shales. Thus, because these Bakken gases form with (rather than from) oils, we argue that compositional differences between gases from source rocks and conventional gas deposits result from fractionation processes occurring after hydrocarbon expulsion from the source rock.	CHEVRON PETR TECHNOL CO,LA HABRA,CA 90633	Chevron	PRICE, LC (corresponding author), US GEOL SURVEY,DENVER FED CTR,MS-940,DENVER,CO 80225, USA.							CHUNG HM, 1988, CHEM GEOL, V71, P97, DOI 10.1016/0009-2541(88)90108-8; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; FUEX AN, 1977, J GEOCHEM EXPLOR, V7, P155, DOI 10.1016/0375-6742(77)90080-2; GALIMOV EM, 1988, CHEM GEOL, V71, P77, DOI 10.1016/0009-2541(88)90107-6; GUSSOW WC, 1954, AAPG BULL, V38, P816; JAMES AT, 1983, AAPG BULL, V67, P1176; JENDEN PD, 1988, CHEM GEOL, V71, P117, DOI 10.1016/0009-2541(88)90110-6; MANGO FD, 1994, NATURE, V368, P536, DOI 10.1038/368536a0; MCNEIL RI, IN PRESS ENERGY FUEL; NAMAK JE, 1991, 9301 US DEP INT BUR; PRICE LC, 1994, B CAN PETROL GEOL, V42, P187; PRICE LC, 1985, J PETROL GEOL, V8, P59, DOI 10.1111/j.1747-5457.1985.tb00191.x; PRICE LC, 1992, GEOLOGICAL STUDIES R, P199; PRICE LC, SOURCES NATURAL GAS; RICE DD, 1988, 88391 US GEOL SURV O; SALISBURY GP, 1968, MEM AM ASS PETROL 9, V2, P1433; SCHOELL M, 1983, AAPG BULL, V67, P2225; SCHOELL M, 1988, CHEM GEOL, V71, P1, DOI 10.1016/0009-2541(88)90101-5; Tissot B.P., 1984, PETROLEUM FORMATION, DOI 10.1007/978-3-642-96446-6; WENGER LM, 1991, ORGANIC GEOCHEMISTRY, P335	20	79	91	3	48	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 23	1995	378	6555					368	371		10.1038/378368a0	http://dx.doi.org/10.1038/378368a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TF893	11536709				2022-12-24	WOS:A1995TF89300052
J	RAUP, DM; JABLONSKI, D				RAUP, DM; JABLONSKI, D			GEOGRAPHY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							MASS EXTINCTIONS; BOUNDARY	Analysis of the end-Cretaceous mass extinction, based on 3514 occurrences of 340 genera of marine bivalves (Mollusca), suggests that extinction intensities were uniformly global; no latitudinal gradients or other geographic patterns are detected. Elevated extinction intensities in some tropical areas are entirely a result of the distribution of one extinct group of highly specialized bivalves, the rudists. When rudists are omitted, intensities at those localities are statistically indistinguishable from those of both the rudist-free tropics and extratropical localities.			RAUP, DM (corresponding author), UNIV CHICAGO,DEPT GEOPHYS SCI,5734 ELLIS AVE,CHICAGO,IL 60637, USA.							ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1989, PHILOS T ROY SOC B, V325, P357, DOI 10.1098/rstb.1989.0093; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; KAUFFMAN E G, 1988, Palaios, V3, P194, DOI 10.2307/3514530; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1989, GEOL SOC AM BULL, V101, P1408, DOI 10.1130/0016-7606(1989)101<1408:EPOEAT>2.3.CO;2; Lipps J.H., 1986, P87; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1985, GEOLOGY, V13, P770, DOI 10.1130/0091-7613(1985)13<770:ETMFFN>2.0.CO;2; Masse J.-P., 1986, Bulletin du Centre de Recherches Exploration-Production Elf-Aquitaine, V10, P437; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; PERCHNIELSEN K, 1982, GEOL SOC AM SPEC PAP, V190, P353; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; SEPKOSKI JJ, 1989, J GEOL SOC LONDON, V146, P7, DOI 10.1144/gsjgs.146.1.0007; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; SOHL NF, 1987, J PALEONTOL, V61, P1085, DOI 10.1017/S0022336000029486; Stanley S.M., 1984, P69; STANLEY SM, 1988, AM J SCI, V288, P334, DOI 10.2475/ajs.288.4.334; WALLER TR, 1992, J PALEONTOL, V66, P215, DOI 10.1017/S0022336000033746; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; Zachos JC, 1986, PALEOCEANOGRAPHY, V1, P5, DOI 10.1029/PA001i001p00005; ZINSMEISTER WJ, 1989, J PALEONTOL, V63, P731, DOI 10.1017/S0022336000036453; [No title captured]; [No title captured]	27	87	90	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 14	1993	260	5110					971	973		10.1126/science.11537491	http://dx.doi.org/10.1126/science.11537491			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB791	11537491				2022-12-24	WOS:A1993LB79100039
J	SALAMA, F; ALLAMANDOLA, LJ				SALAMA, F; ALLAMANDOLA, LJ			IS A PYRENE-LIKE MOLECULAR ION THE CAUSE OF THE 4,430-ANGSTROM DIFFUSE INTERSTELLAR ABSORPTION-BAND	NATURE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EMISSION; SPECTRA; NAPHTHALENE; FEATURES; RADICALS	THE diffuse interstellar bands (DIBs), ubiquitous absorption features in astronomical spectra, have been known since early this century 1 and now number more than a hundred. Ranging from 4,400 angstrom to the near infrared 2, they differ markedly in depth, width and shape, making the concept of a single carrier unlikely. Whether they are due to gas or grains is not settled, but recent results 3 suggest that the DIB carriers are quite separate from the grains that cause visual extinction. Among molecular candidates the polycyclic aromatic hydrocarbons (PAHs) have been proposed as the possible carriers of some of the DIBs 4-7, and we present here laboratory measurements of the optical spectrum of the pyrene cation C16H10+ in neon and argon. matrices. The strongest absorption feature falls at 4,435 +/- 5 angstrom in the argon matrix and 4,395 +/- 5 angstrom in the neon matrix, both close to the strong 4,430-angstrom DIB. If this or a related pyrene-like species is responsible for this particular band, it must account for 0.2% of all cosmic carbon. The ion also shows an intense but puzzling broad continuum, extending from the ultraviolet to the visible, similar to what is seen in the naphthalene cation 8 and perhaps therefore a common feature of all PAH cations. This may provide an explanation of how PAHs convert a large fraction of interstellar radiation from ultraviolet and visible wavelengths down to the infrared.			SALAMA, F (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MS 245-6,MOFFETT FIELD,CA 94035, USA.		Salama, Farid/A-8787-2009	Salama, Farid/0000-0002-6064-4401				AITKEN DK, 1983, MON NOT R ASTRON SOC, V202, P1233, DOI 10.1093/mnras/202.4.1233; ALLAMANDOLA LJ, 1985, ASTROPHYS J, V290, pL25, DOI 10.1086/184435; ANDREWS L, 1982, J PHYS CHEM-US, V86, P2916, DOI 10.1021/j100212a023; Bondybey V. E., 1983, Molecular ions: Spectroscopy, structure and chemistry, P125; CLAR E, 1976, TETRAHEDRON, V32, P2563, DOI 10.1016/0040-4020(76)88027-1; CRAWFORD MK, 1985, ASTROPHYS J, V293, pL45, DOI 10.1086/184488; Hayes D. S., 1973, International Astronomical Union Symposium No.52, Interstellar Dust and Related Topics, P83; HERBIG GH, 1991, ASTROPHYS J, V382, P193, DOI 10.1086/170708; HERBIG GH, 1975, ASTROPHYS J, V196, P129, DOI 10.1086/153400; KARCHER W, 1983, SPECTRAL ATLAS POLYC, P92; KIRA A, 1976, J PHYS CHEM-US, V80, P1445, DOI 10.1021/j100554a011; KRELOWSKI J, 1989, INTERSTELLAR DUST, P67; LEGER A, 1985, ASTRON ASTROPHYS, V146, P81; LEGER A, 1984, ASTRON ASTROPHYS, V137, pL5; PANKASEM S, 1991, J PHYS CHEM-US, V95, P7385, DOI 10.1021/j100172a051; SALAMA F, 1991, J CHEM PHYS, V94, P6964, DOI 10.1063/1.460230; SALAMA F, 1991, J CHEM PHYS, V95, P6190, DOI 10.1063/1.461827; SALAMA F, IN PRESS ASTROPHYS J; SELLGREN K, 1990, ASTROPHYS J, V359, P384, DOI 10.1086/169072; SELLGREN K, 1984, ASTROPHYS J, V277, P623, DOI 10.1086/161733; SHIDA T, 1973, J AM CHEM SOC, V95, P3473, DOI 10.1021/ja00792a005; SNOW TP, 1991, ASTROPHYS J, V382, P189, DOI 10.1086/170707; VANBREDA IG, 1981, MON NOT R ASTRON SOC, V195, P79, DOI 10.1093/mnras/195.1.79; VANDERZWET GP, 1985, ASTRON ASTROPHYS, V146, P76	24	94	94	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUL 2	1992	358	6381					42	43		10.1038/358042a0	http://dx.doi.org/10.1038/358042a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB341	11536498				2022-12-24	WOS:A1992JB34100045
J	JASPER, JP; HAYES, JM				JASPER, JP; HAYES, JM			A CARBON ISOTOPE RECORD OF CO2 LEVELS DURING THE LATE QUATERNARY	NATURE			English	Article									INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	JASPER, JP (corresponding author), INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405, USA.							BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; BERGER WH, 1978, OCEANOL ACTA, V1, P203; BOUMA AH, 1983, AM ASS PET GEOL MEM, V34, P567; BOUMA AH, 1986, INITIAL REPORTS DSDP, V96, P777; BOYLE EA, 1988, J GEOPHYS RES-OCEANS, V93, P15701, DOI 10.1029/JC093iC12p15701; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; CONSTANS RE, 1986, INITIAL REP DEEP SEA, V96, P601; de Leeuw J., 1980, PHYS CHEM EARTH, V12, P211, DOI 10.1016/0079-1946(79)90105-8; EWING M., 1958, HABITAT OIL, P995; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; FARRIMOND P, 1985, ADV ORG GEOCHEM, P897; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1989, GEOCHIM COSMOCHIM AC, V53, P2961, DOI 10.1016/0016-7037(89)90172-5; Jasper JP, 1989, PALEOCEANOGRAPHY, V4, P603, DOI 10.1029/PA004i006p00603; JASPER JP, 1989, NATURE, V342, P60, DOI 10.1038/342060a0; JASPER JP, 1990, GEOCHIM COSMOCHIM AC, V54, P1117, DOI 10.1016/0016-7037(90)90443-O; KOHL B, 1986, INITIAL REP DEEP SEA, V96, P657; LEDBETTER MT, 1986, INITIAL REP DEEP SEA, V96, P685; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; MARLOWE IT, 1984, BRIT PHYCOL J, V19, P203, DOI 10.1080/00071618400650221; MCCABE B, 1985, THESIS U WAIKATO; NEWMAN JW, 1973, GEOCHIM COSMOCHIM AC, V37, P225, DOI 10.1016/0016-7037(73)90130-0; OKADA H, 1977, Micropaleontology (New York), V23, P1, DOI 10.2307/1485309; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; RECHKA JA, 1988, TETRAHEDRON LETT, V29, P2599, DOI 10.1016/S0040-4039(00)86122-5; SHACKLETON NJ, 1983, NATURE, V306, P319, DOI 10.1038/306319a0; Steeman Nielsen E., 1975, MARINE PHOTOSYNTHESI; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; WILLIAMS DF, 1986, INITIAL REP DEEP SEA, V96, P671	32	248	266	3	44	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 4	1990	347	6292					462	464		10.1038/347462a0	http://dx.doi.org/10.1038/347462a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB446	11536468				2022-12-24	WOS:A1990EB44600066
J	SANDER, SP; FRIEDL, RR; YUNG, YL				SANDER, SP; FRIEDL, RR; YUNG, YL			RATE OF FORMATION OF THE CLO DIMER IN THE POLAR STRATOSPHERE - IMPLICATIONS FOR OZONE LOSS	SCIENCE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	SANDER, SP (corresponding author), CALTECH,JET PROP LAB,PASADENA,CA 91109, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ALLEN M, 1981, J GEOPHYS RES-SPACE, V86, P3617, DOI 10.1029/JA086iA05p03617; ANDERSON JG, 1988, MAY NAT AER SPAC ADM; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; Benson S.W, 1976, THERMOCHEMICAL KINET; BURKHOLDER JV, IN PRESS J PHYS CHEM; CRUTZEN PJ, 1986, NATURE, V324, P651, DOI 10.1038/324651a0; DEMORE WB, 1987, JPL PUBL, V8741; DEZAFRA RL, 1987, NATURE, V328, P408, DOI 10.1038/328408a0; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; FRIEDL RR, 1989, J PHYS CHEM-US, V93, P4756, DOI 10.1021/j100349a016; FROIDEVAUX L, 1985, J GEOPHYS RES-ATMOS, V90, P2999, DOI 10.1029/JD090iD07p12999; HARTMANN DL, IN PRESS J GEOPHYS R; HAYMAN GD, 1989, CHEM PHYS LETT, V155, P1, DOI 10.1016/S0009-2614(89)87350-6; HAYMAN GD, 1986, GEOPHYS RES LETT, V13, P1347, DOI 10.1029/GL013i012p01347; HILLS AJ, 1987, NATURE, V328, P405, DOI 10.1038/328405a0; HOFMANN DJ, 1988, NASA10014 C PUBL; LUTHER K, 1979, S INT COMBUST P, V17, P535; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCELROY MB, 1989, SCIENCE, V243, P763, DOI 10.1126/science.243.4892.763; MCELROY MB, 1988, PLANET SPACE SCI, V36, P73, DOI 10.1016/0032-0633(88)90148-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; PATRICK R, 1983, INT J CHEM KINET, V15, P1189, DOI 10.1002/kin.550151107; PERMIEN T, 1988, SEP COOP SCI TECHN 6; RODRIGUEZ JM, 1986, GEOPHYS RES LETT, V13, P1292, DOI 10.1029/GL013i012p01292; SALAWITCH RJ, 1988, PLANET SPACE SCI, V36, P213, DOI 10.1016/0032-0633(88)90058-X; SANDER S, UNPUB; SANDER SP, 1988, GEOPHYS RES LETT, V15, P887, DOI 10.1029/GL015i008p00887; SANDER SP, 1989, J PHYS CHEM-US, V93, P4764, DOI 10.1021/j100349a017; SIMON FG, IN PRESS J PHYS CHEM; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1987, J GEOPHYS RES-ATMOS, V92, P8329, DOI 10.1029/JD092iD07p08329; SOLOMON SC, IN PRESS J GEOPHYS R; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; Toon GC, COMMUNICATION; TROE J, 1979, J PHYS CHEM-US, V83, P114, DOI 10.1021/j100464a019; WATSON RT, 1979, J PHYS CHEM-US, V83, P2936, DOI 10.1021/j100486a002; YUNG YL, IN PRESS	38	150	150	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1095	1098		10.1126/science.245.4922.1095	http://dx.doi.org/10.1126/science.245.4922.1095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538343				2022-12-24	WOS:A1989AN70200031
J	Blanck, HM; Khan, LK; Serdula, MK				Blanck, HM; Khan, LK; Serdula, MK			Use of nonprescription weight loss products - Results from a multistate survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIETARY-SUPPLEMENTS; UNITED-STATES; DOUBLE-BLIND; PHENYLPROPANOLAMINE; PLACEBO; OBESITY	Context Lifestyle changes to lose weight can be difficult; hence, both prescription and nonprescription diet products are appealing. Usage patterns of the nonprescription products phenylpropanolamine (PPA) and ephedra are of particular interest because of recent safety concerns. Objective To estimate the prevalence of overall and specific nonprescription weight loss product use by demographic characteristics, prescription diet pill use, diabetic status, and lifestyle choices. Design and Setting The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in 1998 in 5 states. Florida, Iowa, Michigan, West Virginia, and Wisconsin. Participants Population-based sample of 14679 non institutionalized adults IS years or older. Main Outcome Measures Prevalence of nonprescription weight loss product use in 1996-1998. Results Seven percent reported overall nonprescription weight loss product use, 2% reported PPA use, and 1% reported ephedra product use. Overall use was especially common among young obese women (28.4%). Moreover, 7.9% of normal-weight women reported use. There was no difference in nonprescription weight loss product use by daily consumption of fruits and vegetables; however, more users than nonusers reported being physically active (for those who exercised greater than or equal to 30 minutes 5 times per week, odds ratio, 1.5, 95% confidence interval, 1.2-2.0). Among prescription weight loss product users, 33.8% also took nonprescription product. Conclusions With increasing rates of obesity, nonprescription product use is likely to increase. Clinicians should know about their patients' use of both prescription and nonprescription weight loss products.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Blanck, HM (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,MS K-26, Atlanta, GA 30341 USA.							Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661; ASTRUP A, 1991, METABOLISM, V40, P323, DOI 10.1016/0026-0495(91)90117-F; ASTRUP A, 1992, INT J OBESITY, V16, P269; BRADLEY JG, 1991, POSTGRAD MED, V90, P43; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; *FDA, 2000, PUBL HLTH ADV SUBJ S; *FDA, 2000, DIET SUPPL CONT SPH; Greenway F, 1999, OBES RES, V7, P370, DOI 10.1002/j.1550-8528.1999.tb00420.x; Gurley BJ, 2000, AM J HEALTH-SYST PH, V57, P963, DOI 10.1093/ajhp/57.10.963; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Hankin J, 2000, J AM DIET ASSOC, V100, P419, DOI 10.1016/S0002-8223(00)00129-2; INSEL PA, 1991, BETA ADRENERGIC RECE, P295; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; LAKE CR, 1990, AM J MED, V89, P195, DOI 10.1016/0002-9343(90)90299-S; LEAVY AS, 1993, ANN INTERN MED 2, V119, P661; Lewis CJ, 2001, CRIT REV FOOD SCI, V41, P43, DOI 10.1080/20014091091724; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; NELSON DE, 1998, P SECT SURV METH AM; PENTEL P, 1984, JAMA-J AM MED ASSOC, V252, P1898, DOI 10.1001/jama.252.14.1898; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Shah BV, 1997, SUDAAN USERS MANUAL; U.S. Department of Health and Human Services, 1996, 76200 US DEP HLTH HU; WILLARD HF, 1990, CHROMOSOMES TODAY, V10, P47; 2000, FED REG, V65, P17477; 1997, FED REG, V62, P30677; [No title captured]	26	97	103	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					930	935		10.1001/jama.286.8.930	http://dx.doi.org/10.1001/jama.286.8.930			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509057	Bronze			2022-12-24	WOS:000170577300027
J	Cliffe, S; Tookey, PA; Nicoll, A				Cliffe, S; Tookey, PA; Nicoll, A			Antenatal detection of HIV: national surveillance and unlinked anonymous survey	BRITISH MEDICAL JOURNAL			English	Article							TRANSMISSION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, HIV & STI Div, London NW9 5EQ, England	University of London; University College London; Public Health England	Cliffe, S (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Tookey, Pat A/G-2732-2010	Tookey, Pat A/0000-0001-6258-0387				*COMM DIS SURV CTR, 2001, COMMUNICAB DIS REP, P11; Duong T, 1999, BRIT MED J, V319, P1227, DOI 10.1136/bmj.319.7219.1227; *INT WORK PART, 1998, RED MOTH CHILD TRANS; Ratcliffe J, 1998, AIDS, V12, P1381, DOI 10.1097/00002030-199811000-00021; *UK HLTH DEP, 1999, TARG AIM RED NUMB CH	5	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					376	377		10.1136/bmj.323.7309.376	http://dx.doi.org/10.1136/bmj.323.7309.376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509430	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000170581400021
J	Snaith, ML				Snaith, ML			Gout: diet and uric acid revisited	LANCET			English	Editorial Material							WEIGHT-LOSS; PLASMA; URATE		Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Snaith, ML (corresponding author), Univ Sheffield, Sch Med, Dept Rheumatol, Sheffield S10 2RX, S Yorkshire, England.							Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; GERTLER MN, ANN INTERN MED, V34, P1421; GUTMAN AB, 1957, AM J MED, P23600; HAVELOCK E, 1904, STUDY BRIT GENIUS; MYERS AR, 1968, AM J MED, V45, P520, DOI 10.1016/0002-9343(68)90168-X; NICHOLLS A, 1972, LANCET, V2, P1223; Phillips M, 2000, ARTHRITIS RHEUM, V43, pS401; Porter Roy, 1998, GOUT PATRICIAN MALAD; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; SIMKIN PA, 1977, ANN INTERN MED, V86, P230, DOI 10.7326/0003-4819-86-2-230; TALBOTT JH, 1981, SEMIN ARTHRITIS RHEU, V11, P288, DOI 10.1016/0049-0172(81)90094-9; WROTMANN RL, 1997, ARTHRITIS ALLIED CON, P2078; WYNGAARDEN JB, 1974, AM J MED, V56, P651, DOI 10.1016/0002-9343(74)90632-9; YAMASHITA S, 1986, INT J OBESITY, V10, P255; YU TF, 1974, AM J MED, V56, P676, DOI 10.1016/0002-9343(74)90634-2	16	22	23	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					525	525		10.1016/S0140-6736(01)05745-2	http://dx.doi.org/10.1016/S0140-6736(01)05745-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520519				2022-12-24	WOS:000170537700006
J	Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ				Graham, DJ; Drinkard, CR; Shatin, D; Tsong, Y; Burgess, MJ			Liver enzyme monitoring in patients treated with troglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATIC-FAILURE	Context Soon after initial marketing in March 1997, troglitazone, the first thiazolidinedione antidiabetic agent, was found to cause life-threatening acute liver failure. The drug was removed from the market in March 2000. Objective To evaluate the effect of US Food and Drug Administration (FDA) risk management efforts, including repeated labeling changes and "Dear Healthcare Professional" letters, on periodic liver enzyme monitoring of patients taking troglitazone. Design, Setting, and Participants Claims data from a large, multistate managed care organization were used to establish 4 cohorts of patients (N = 7603) with at least 90 days of health plan enrollment before first troglitazone prescription during 4 consecutive periods spanning April 1997 to September 1999 and representing 4 progressively stringent liver monitoring recommendations. Main Outcome Measures Percentage of eligible troglitazone users in each cohort with baseline, monthly (for up to 6 months of continuous use), and complete (baseline and monthly) enzyme monitoring, based on computerized records of laboratory claims. Results Baseline testing increased from 15% before any FDA monitoring recommendations (cohort 1) to 44.6% following 4 separate FDA interventions (cohort 4; P<.001). In cohort 4, 33.4% of users had follow-up testing after 1 month of therapy, falling to 13% after 5 months of continuous use. in all cohorts, less than 5% received all recommended liver enzyme tests by the third month of continuous use. Conclusions The FDA risk management efforts did not achieve meaningful or sustained improvement in liver enzyme testing. Evaluation of the impact of regulatory actions is needed before such actions can be regarded as effective or sufficient.	US FDA, Off Postmarketing Drug Risk Assessment, Rockville, MD 20857 USA; US FDA, Off Biostat, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; United Hlth Grp, Ctr Hlth Care Policy & Evaluat, Minneapolis, MN USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); UnitedHealth Group Incorporated	Graham, DJ (corresponding author), US FDA, Off Postmarketing Drug Risk Assessment, 5600 Fishers Ln,HFD-400,Room 15B-32, Rockville, MD 20857 USA.				FDA HHS [FD-U-000149, FD-U-0001643-01/02] Funding Source: Medline	FDA HHS		ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; GRAHAM DJ, 1999, FDA MET END DRUGS AD; Herrine SK, 1999, ANN INTERN MED, V130, P163, DOI 10.7326/0003-4819-130-2-199901190-00021; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jagannath S, 2000, ANN INTERN MED, V132, P677, DOI 10.7326/0003-4819-132-8-200004180-00021; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; REZULIN, 1998, PHYSICIANS DESK REFE, P2218; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; SIGMUND WR, 1998, IMPORTANT DRUG WARNI; SIGMUND WR, 1997, IMPORTANT DRUG WARNI; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Stolberg Sheryl Gay, 1999, N Y Times Web, pA9; Walker A M, 1995, Arch Fam Med, V4, P24, DOI 10.1001/archfami.4.1.24	16	104	106	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					831	833		10.1001/jama.286.7.831	http://dx.doi.org/10.1001/jama.286.7.831			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497537	Bronze			2022-12-24	WOS:000170429600031
J	Rescigno, M; Borrow, P				Rescigno, M; Borrow, P			The host-pathogen interaction: New themes from dendritic cell biology	CELL			English	Review							MATURATION; VIRUS; INFECTION		Univ Milano Bicocca, Dept Biosci & Biotechnol U3, I-20126 Milan, Italy; Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England	University of Milano-Bicocca	Rescigno, M (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol U3, Piazza Sci 2, I-20126 Milan, Italy.		Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X; Borrow, Persephone/0000-0002-3877-9780				Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Neutra MR, 1999, CURR TOP MICROBIOL, V236, P17; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900	15	114	120	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					267	270		10.1016/S0092-8674(01)00454-8	http://dx.doi.org/10.1016/S0092-8674(01)00454-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509175	Bronze			2022-12-24	WOS:000170433300004
J	Leman, P; Strachan, D				Leman, P; Strachan, D			A case-control study of food poisoning seen at an accident and emergency department	LANCET			English	Article							CONSUMER	We investigated the hypothesis that sporadic food poisoning is a result of the consumption of food cooked or prepared outside the home. We did a case-control study, set in an urban emergency department, to find out the odds ratios for the risk of food poisoning associated with various patterns of consumption. We found that recent eating out (exposure on the day of or day before presentation) was associated with an odds ratio of 2.41 (95% Cl 1.29-4.50) for presenting with food poisoning.	St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London, England	Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Leman, P (corresponding author), St Thomas Hosp, Dept Accid & Emergency, London SE1 7EH, England.							Bruhn CM, 1997, EMERG INFECT DIS, V3, P511, DOI 10.3201/eid0304.970415; Collins JE, 1997, EMERG INFECT DIS, V3, P471, DOI 10.3201/eid0304.970409; *DEP HLTH, 1992, PLCMO9214 DEP HLTH; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	4	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					387	388		10.1016/S0140-6736(01)05582-9	http://dx.doi.org/10.1016/S0140-6736(01)05582-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502323				2022-12-24	WOS:000170235100018
J	Wahlqvist, ML; Wattanapenpaiboon, N				Wahlqvist, ML; Wattanapenpaiboon, N			Hot foods - unexpected help with energy balance?	LANCET			English	Editorial Material									Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia	Monash University	Wahlqvist, ML (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Int Hlth & Dev Unit, Melbourne, Vic 3800, Australia.		Wahlqvist, Mark Lawrence/E-8800-2010					Cannon ME, 2001, MED J AUSTRALIA, V174, P520, DOI 10.5694/j.1326-5377.2001.tb143404.x; COLQUHOUN EQ, 1995, LIFE SCI, V57, P91, DOI 10.1016/0024-3205(95)00250-A; HENRY CJK, 1986, HUM NUTR-CLIN NUTR, V40C, P165; Kannar D, 2001, J AM COLL NUTR, V20, P225, DOI 10.1080/07315724.2001.10719036; McCrory MA, 1999, AM J CLIN NUTR, V69, P440; Organization WH, 1998, WELLB MEAS PRIM HLTH; Wahlqvist M.L., 1994, FUNCTIONAL FOODS DES, P71; Yoshioka M, 2001, BRIT J NUTR, V85, P203, DOI 10.1079/BJN2000224	8	32	32	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					348	349		10.1016/S0140-6736(01)05586-6	http://dx.doi.org/10.1016/S0140-6736(01)05586-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502310				2022-12-24	WOS:000170235100005
J	Hofbauer, LC; Schoppet, M				Hofbauer, LC; Schoppet, M			Osteoprotegerin: a link between osteoporosis and arterial calcification?	LANCET			English	Editorial Material							BONE LOSS; LIGAND; OSTEOCLASTOGENESIS; DESTRUCTION; CELLS		Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany; Univ Marburg, Dept Med, Div Cardiol, D-35033 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Hofbauer, LC (corresponding author), Univ Marburg, Dept Med, Div Gastroenterol & Endocrinol, D-35033 Marburg, Germany.		Hofbauer, Lorenz C/G-2490-2010	Hofbauer, Lorenz C/0000-0002-8691-8423				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Hak AE, 2000, ARTERIOSCL THROM VAS, V20, P1926, DOI 10.1161/01.ATV.20.8.1926; Hofbauer LC, 2001, BIOCHEM BIOPH RES CO, V280, P334, DOI 10.1006/bbrc.2000.4130; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Malyankar UM, 2000, J BIOL CHEM, V275, P20959, DOI 10.1074/jbc.C000290200; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Yano K, 1999, J BONE MINER RES, V14, P518, DOI 10.1359/jbmr.1999.14.4.518	16	100	111	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					257	259		10.1016/S0140-6736(01)05494-0	http://dx.doi.org/10.1016/S0140-6736(01)05494-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498208				2022-12-24	WOS:000170114400005
J	Minor, PD				Minor, PD			Biosafety consequences of eradication of wild-type polioviruses	LANCET			English	Editorial Material									Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	National Institute for Biological Standards & Control	Minor, PD (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.							Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; DOWDLE WR, 1997, J INFECT DIS S1, V109, P1; *HOUS COMM, 1980, REP INV CAUS 1978 BI; Kelly H, 2000, Commun Dis Intell, V24, P207; Mulders MN, 1997, J INFECT DIS, V176, P617, DOI 10.1086/514081; *WHO, 1999, WER, V74, P165; *WHO VACC ASS MON, 1999, WHOVB9932 VAC ASS MO; Wood D. J., 2000, Biologicals, V28, P199, DOI 10.1006/biol.2000.0257; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					166	168		10.1016/S0140-6736(01)05399-5	http://dx.doi.org/10.1016/S0140-6736(01)05399-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476828				2022-12-24	WOS:000169967100004
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			THE LIFE-SPAN OF THE BIOSPHERE REVISITED	NATURE			English	Article							EARTHS EARLY ATMOSPHERE; DISSOLUTION; EVOLUTION; CO2; TEMPERATURES; FEEDBACK; GROWTH; CLOUD; VENUS	A DECADE ago, Lovelock and Whitfield1 raised the question of how much longer the biosphere can survive on Earth. They pointed out that, despite the current fossil-fuel induced increase in the atmospheric CO2 concentration, the long-term trend should be in the opposite direction: as increased solar luminosity warms the Earth, silicate rocks should weather more readily, causing atmospheric CO2 to decrease. In their model1, atmospheric CO2 falls below the critical level for C3 photosynthesis, 150 parts per million (p.p.m.), in only 100 Myr, and this is assumed to mark the demise of the biosphere as a whole. Here, we re-examine this problem using a more elaborate model that includes a more accurate treatment of the greenhouse effect of CO2 (refs 2-4), a biologically mediated weathering parameterization, and the realization that C4 photosynthesis can persist to much lower concentrations of atmospheric CO2(<10 p.p.m.)5,6. We find that a C4-plant-based biosphere could survive for at least another 0.9 Gyr to 1.5 Gyr after the present time, depending respectively on whether CO2 or temperature is the limiting factor. Within an additional 1 Gyr, Earth may lose its water to space, thereby following the path of its sister planet, Venus.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Caldeira, Ken/E-7914-2011; Kasting, James/AAF-6851-2020	Caldeira, Ken/0000-0002-4591-643X; 				BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BLUM A, 1988, NATURE, V331, P431, DOI 10.1038/331431a0; BROCK TD, 1985, SCIENCE, V230, P132, DOI 10.1126/science.230.4722.132; CALDEIRA K, 1991, GEOLOGY, V19, P204, DOI 10.1130/0091-7613(1991)019<0204:CPCPAT>2.3.CO;2; CHAMEIDES WL, 1984, J GEOPHYS RES-ATMOS, V89, P4739, DOI 10.1029/JD089iD03p04739; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Heath O. V. S., 1969, PHYSL ASPECTS PHOTOS; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; LAGACHE M, 1976, GEOCHIM COSMOCHIM AC, V40, P157, DOI 10.1016/0016-7037(76)90173-3; LAGACHE M, 1965, B SOC FR MINERAL CR, V88, P223, DOI 10.3406/bulmi.1965.5840; LOVELOCK JE, 1982, NATURE, V296, P561, DOI 10.1038/296561a0; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MILLER AG, 1984, PLANT PHYSIOL, V75, P1064, DOI 10.1104/pp.75.4.1064; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SACKMANN IJ, 1990, ASTROPHYS J, V360, P727, DOI 10.1086/169158; SILLEN LG, 1961, OCEANOGRAPHY, P549; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; STETTER KO, 1986, THERMOPHILES GENERAL, P39; Stumm W., 1981, AQUATIC CHEM; VOLK T, 1987, AM J SCI, V287, P763, DOI 10.2475/ajs.287.8.763; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; WOGELIUS RA, 1991, GEOCHIM COSMOCHIM AC, V55, P943, DOI 10.1016/0016-7037(91)90153-V	28	165	168	1	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 24	1992	360	6406					721	723		10.1038/360721a0	http://dx.doi.org/10.1038/360721a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KE472	11536510				2022-12-24	WOS:A1992KE47200027
J	STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE				STUART, JJ; BROWN, SJ; BEEMAN, RW; DENELL, RE			A DEFICIENCY OF THE HOMEOTIC COMPLEX OF THE BEETLE TRIBOLIUM	NATURE			English	Article							GENE FUSHI-TARAZU; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; MOLECULAR ANALYSIS; ANTENNAPEDIA GENE; SEGMENTATION; EMBRYO; ACTIVATION; HEAD	IN Drosophila, the establishment of regional commitments along most of the anterior/posterior axis of the developing embryo depends on two clusters of homeotic genes: the Antennapedia complex (ANT-C) and the bithorax complex (BX-C). The red flour beetle has a single complex (HOM-C) representing the homologues of the ANT-C and BX-C in juxtaposition 1. Beetles trans-heterozygous for two particular HOM-C mutations spontaneously generate a large deficiency, presumably by an exchange within the common region of two overlapping inversions. Genetic and molecular results indicate that this deficiency spans at least the interval between the Deformed and abdominal-A homologues. In deficiency homozygous embryos, all gnathal, thoracic and abdominal segments develop antennal appendages, suggesting that a gene(s) has been deleted that acts to distinguish trunk from head. There is no evidence that beetles have a homologue of the segmentation gene fushi tarazu of similar genomic location and function. On the basis of the genetic tractability 2, convenient genome size and organization of Tribolium 3, and its relatively long phylogenetic divergence from Drosophila (> 300 million years), we have integrated developmental genetic and molecular analyses of the HOM-C. We isolated about 70 mutations in the complex representing at least six complementation groups. The homeotic phenotypes of adults 2 and lethal embryos lead us to believe that these beetle genes are homologous with the Drosophila genes indicated in Fig. 1.	KANSAS STATE UNIV AGR & APPL SCI,DIV BIOL,ACKERT HALL,MANHATTAN,KS 66506; USDA ARS,N CENT REG,US GRAIN MKT RES LAB,MANHATTAN,KS 66502	Kansas State University; United States Department of Agriculture (USDA)				Brown, Susan/0000-0002-7984-0445				AKAM M, 1988, DEVELOPMENT, V104, P123; BEEMAN RW, 1987, NATURE, V327, P247, DOI 10.1038/327247a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; BROWN SJ, 1990, INSECT BIOCHEM, V20, P185, DOI 10.1016/0020-1790(90)90011-I; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; DUNCAN I, 1986, CELL, V47, P297, DOI 10.1016/0092-8674(86)90452-6; INGHAM PW, 1986, NATURE, V324, P592, DOI 10.1038/324592a0; LEWIS E, 1978, NATURE, V276, P141; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MAHAFFEY JW, 1989, DEV GENETICS HIGHER, P329; MARTINEZARIAS A, 1986, EMBO J, V5, P135, DOI 10.1002/j.1460-2075.1986.tb04187.x; MERRILL VKL, 1987, DEV BIOL, V122, P379, DOI 10.1016/0012-1606(87)90303-4; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; Sturtevant AH, 1936, GENETICS, V21, P554; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	24	146	148	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 7	1991	350	6313					72	74		10.1038/350072a0	http://dx.doi.org/10.1038/350072a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA693	11536480				2022-12-24	WOS:A1991FA69300068
J	Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW				Benson, DE; Conrad, DW; de Lorimer, RM; Trammell, SA; Hellinga, HW			Design of bioelectronic interfaces by exploiting hinge-bending motions in proteins	SCIENCE			English	Article							BIOSENSOR; NANOBIOTECHNOLOGY; CONSTRUCTION	We report a flexible strategy for transducing ligand-binding events into electrochemical responses for a wide variety of proteins. The method exploits ligand-mediated hinge-bending motions, intrinsic to the bacterial periplasmic binding protein superfamily, to establish allosterically controlled interactions between electrode surfaces and redox-active, Ru(II)labeled proteins. This approach allows the development of protein-based bioelectronic interfaces that respond to a diverse set of analytes. Families of these interfaces can be generated either by exploiting natural binding diversity within the superfamily or by reengineering the specificity of individual proteins. These proteins may have numerous medical, environmental, and defense applications.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	Duke University; United States Department of Defense; United States Navy; Naval Research Laboratory	Hellinga, HW (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hwh@biochem.duke.edu	Trammell, Scott A./ABB-7140-2020; Wood, David W/B-2992-2012	Trammell, Scott A./0000-0002-7996-590X; 				Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Bard A. J., 1980, ELECTROCHEMICAL METH; Boon EM, 2000, NAT BIOTECHNOL, V18, P1096, DOI 10.1038/80301; BURTIS CA, 1994, CLIN CHEM; Cass AEG, 1990, BIOSENSORS PRACTICAL; Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268; Cheng Q, 1997, ADV MATER, V9, P481, DOI 10.1002/adma.19970090605; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Creager SE, 1998, ANAL CHEM, V70, P4257, DOI 10.1021/ac980482l; Edelstein RL, 2000, BIOSENS BIOELECTRON, V14, P805, DOI 10.1016/S0956-5663(99)00054-8; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gu LQ, 2001, SCIENCE, V291, P636, DOI 10.1126/science.291.5504.636; Hellinga HW, 1998, TRENDS BIOTECHNOL, V16, P183, DOI 10.1016/S0167-7799(98)01174-3; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laval JM, 2000, ANALYST, V125, P29, DOI 10.1039/a907827d; Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Marvin JS, 1998, J AM CHEM SOC, V120, P7, DOI 10.1021/ja972993f; Marvin JS, 2001, P NATL ACAD SCI USA, V98, P4955, DOI 10.1073/pnas.091083898; Perutz M. F., 1990, MECH COOPERATIVITY A; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Schutz S, 2000, SENSOR ACTUAT B-CHEM, V65, P291, DOI 10.1016/S0925-4005(99)00325-1; SHEN Y, 1993, NATURE, V366, P48, DOI 10.1038/366048a0; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang Y, 1998, ADV MATER, V10, P1536, DOI 10.1002/(SICI)1521-4095(199812)10:18<1536::AID-ADMA1536>3.3.CO;2-W; Thomson NH, 1999, BIOPHYS J, V76, P1024, DOI 10.1016/S0006-3495(99)77267-X; Trammell SA, 2001, BIOCONJUGATE CHEM, V12, P643, DOI 10.1021/bc010022q; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E	32	127	136	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1641	1644		10.1126/science.1062461	http://dx.doi.org/10.1126/science.1062461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533486				2022-12-24	WOS:000170802900058
J	Hawthorne, DJ; Via, S				Hawthorne, DJ; Via, S			Genetic linkage of ecological specialization and reproductive isolation in pea aphids	NATURE			English	Article							SYMPATRIC SPECIATION; NATURAL-SELECTION; EVOLUTION; ANIMALS; RACES	The evolution of ecological specialization generates biological diversity and may lead to speciation(1-3). Genetic architecture can either speed or retard this process. If resource use and mate choice have a common genetic basis through pleiotropy or close linkage, the resulting genetic correlations can promote the joint evolution of specialization and reproductive isolation, facilitating speciation(4-6). Here we present a model of the role of genetic correlations in specialization and speciation, and test it by analysing the genetic architecture of key traits in two highly specialized host races of the pea aphid (Acyrthosiphon pisum pisum; Hemiptera : Aphididae). We found several complexes of pleiotropic or closely linked quantitative trait loci (QTL) that affect key traits in ways that would promote speciation: QTL with antagonistic effects on performance on the two hosts are linked to QTL that produce asortative mating (through habitat choice). This type of genetic architecture may be common in taxa that have speciated under divergent natural selection.	Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Via, S (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	sv47@umail.umd.edu						BASTEN CJ, 1996, QTL CARTOGRAPHER VER; BUSH GL, 1994, TRENDS ECOL EVOL, V9, P285, DOI 10.1016/0169-5347(94)90031-0; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Cho YG, 1996, GENOME, V39, P373, DOI 10.1139/g96-048; CHURCHILL GA, 1994, GENETICS, V138, P963; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Filchak KE, 2000, NATURE, V407, P739, DOI 10.1038/35037578; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; KONDRASHOV AS, 1986, BIOL J LINN SOC, V27, P201, DOI 10.1111/j.1095-8312.1986.tb01734.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Littel RC, 1996, SAS SYSTEM MIXED MOD; Lynch Michael, 1998; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 1998, GENETICS, V149, P2099; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; RICE WR, 1993, EVOLUTION, V47, P1637, DOI 10.1111/j.1558-5646.1993.tb01257.x; Schemske D.W., 2000, EVOLUTION, V54, P1069, DOI [DOI 10.1111/J.0014-3820.2000.TB00111.X, DOI 10.1554/0014-3820(2000)054[1069:UTOOS]2.3.CO;2]; Schluter D, 1998, ENDLESS FORMS, P114; SUN RY, 1966, CAN J ZOOLOG, V44, P649, DOI 10.1139/z66-063; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VIA S, 1985, EVOLUTION, V39, P505, DOI 10.1111/j.1558-5646.1985.tb00391.x; Via S, 1999, EVOLUTION, V53, P1446, DOI [10.1111/j.1558-5646.1999.tb05409.x, 10.2307/2640891]; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; [No title captured]	30	426	437	2	156	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					904	907		10.1038/35091062	http://dx.doi.org/10.1038/35091062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528477				2022-12-24	WOS:000170689000043
J	Neth, O; Hann, I; Turner, MW; Klein, NJ				Neth, O; Hann, I; Turner, MW; Klein, NJ			Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study	LANCET			English	Article							SERINE-PROTEASE; GENE; ASSOCIATION; MUTATIONS; COMPLEMENT; POPULATIONS; INDUCTION; PROMOTER; LEUKEMIA; MBL	Background Infection is a major cause of morbidity and mortality in children with malignancy. Individuals with serum deficient in mannose-binding lectin (MBL)-an important component of the innate immune system-are more susceptible to infection than those with adequate concentrations. In this study, we investigated the capacity of this protein to influence infectious complications in children undergoing treatment for malignancy. Methods We enrolled 100 children receiving chemotherapy for malignancy at a children's hospital in London, UK. The frequency, duration, and causes of febrile neutropenic episodes were recorded, and MBL genotype and phenotype were determined by heteroduplex analysis and ELISAs, respectively. Serial MBL concentrations were also measured in patients during febrile episodes, and the results correlated with the MBL genotype (A/A indicating wild type, O/O indicating homozygous for MBL structural-gene mutations, and A/O indicating heterozygous for such mutations). Findings In the A/A patients, MBL concentrations almost doubled by day 7 of the febrile neutropenic episode before declining by day 14 (p=0.004). By contrast, fn patients with MBL mutations, concentrations did not alter significantly during the neutropenic episode. In the 6 months after initial diagnosis, most patients had at least one febrile neutropenic episode, but the median duration in patients with MBL mutations was twice as long as that in children with the wildtype genotype (20.5 days vs 10.0 days; p=0.014). Individuals with the lowest serum MBL concentrations at the time of diagnosis (<1000 <mu>g/L) had a higher median number of days of febrile neutropenia than did individuals with higher concentrations of MBL (p=0.012). Interpretation MBL deficiency seems to have an important influence on the duration of febrile neutropenic episodes in children with malignancy. This finding suggests that MBL infusions could represent a new therapeutic approach which would aid the management of chemotherapy-induced complications in this population of children.	Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Inst Child Hlth, Mol Haematol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London	Klein, NJ (corresponding author), Inst Child Hlth, Immunobiol Unit, 30 Guilford St, London WC1N 1EH, England.		Neth, Olaf/F-1167-2015; IBIS, INMUNODEFICIEN/C-1245-2016	Neth, Olaf/0000-0001-5018-0466; Klein, Nigel/0000-0003-3925-9258				Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Graudal NA, 1998, J RHEUMATOL, V25, P629; Hann I, 1997, BRIT J HAEMATOL, V99, P580, DOI 10.1046/j.1365-2141.1997.4453255.x; Hargrave DR, 2001, BRIT J HAEMATOL, V112, P293, DOI 10.1046/j.1365-2141.2001.02543.x; Jack D, 1997, HUM MUTAT, V9, P41, DOI 10.1002/(SICI)1098-1004(1997)9:1<41::AID-HUMU7>3.0.CO;2-S; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; Madsen HO, 1998, J IMMUNOL, V161, P3169; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Pui CH, 1997, NEW ENGL J MED, V336, P1781, DOI 10.1056/NEJM199706193362503; Riley LC, 1999, BRIT J HAEMATOL, V106, P436, DOI 10.1046/j.1365-2141.1999.01550.x; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; STILLER CA, 1997, PAEDIAT ONCOLOGY CLI, P3; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; Turner MW, 2000, HUM MOL GENET, V9, P1481, DOI 10.1093/hmg/9.10.1481; Valdimarsson H, 1998, SCAND J IMMUNOL, V48, P116; vanPelt LJ, 1997, PEDIATR HEMAT ONCOL, V14, P539, DOI 10.3109/08880019709030910	25	238	251	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					614	618		10.1016/S0140-6736(01)05776-2	http://dx.doi.org/10.1016/S0140-6736(01)05776-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530147				2022-12-24	WOS:000170615500008
J	Doyle, Y				Doyle, Y			Equity in the new NHS: hard lessons from implementing a local healthcare policy on donepezil	BRITISH MEDICAL JOURNAL			English	Article									Merton Sutton & Wandsworth Hlth Author, London, England		Doyle, Y (corresponding author), The Wilson, Surrey CR4 4TP, England.							BIRKS J, 2000, COCHRANE DATABASE SY; *DEP HLTH, 2000, NHS PLAN; Melzer D, 1998, BMJ-BRIT MED J, V316, P762, DOI 10.1136/bmj.316.7133.762; *NAT I CLIN EXC, 2001, DON RIV GAL TREATM; Rosen R, 1998, HEALTH POLICY, V43, P103, DOI 10.1016/S0168-8510(97)00091-2; *STAND MED ADV COM, 1998, US DON ALZH DIS; 1998, DRUG THER B, V36, P60	7	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					222	224		10.1136/bmj.323.7306.222	http://dx.doi.org/10.1136/bmj.323.7306.222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459UQ	11473920	Green Published			2022-12-24	WOS:000170270200024
J	Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B				Edlin, BR; Seal, KH; Lorvick, J; Kral, AH; Ciccarone, DH; Moore, LD; Lo, B			Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIRECTLY OBSERVED THERAPY; INTERFERON-ALPHA; ADHERENCE; TUBERCULOSIS; PROPHYLAXIS; COMBINATION; INFECTION; EQUIPMENT; EXCHANGE; SYRINGE		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Edlin, BR (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, 3180 18th St,Suite 302, San Francisco, CA 94110 USA.	bredlin@itsa.ucsf.edu	Edlin, Brian R/F-2966-2018; Ciccarone, Daniel/I-5404-2013	Edlin, Brian R/0000-0001-8172-8797; Lorvick, Jennifer/0000-0002-2836-3028; Kral, Alex/0000-0002-9092-3671; Ciccarone, Daniel/0000-0002-2355-5477	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013245] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1998, MMWR Recomm Rep, V47, P43; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Bamberger JD, 2000, AM J PUBLIC HEALTH, V90, P699, DOI 10.2105/AJPH.90.5.699; Bangsberg DR, 1999, J GEN INTERN MED, V14, P446, DOI 10.1046/j.1525-1497.1999.05109.x; Beauchamp TL., 1994, PRINCIPLES BIOMEDICA; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; BROERS B, 1994, ARCH INTERN MED, V154, P1121, DOI 10.1001/archinte.154.10.1121; Burris S, 2000, ANN INTERN MED, V133, P218, DOI 10.7326/0003-4819-133-3-200008010-00015; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; *EASL, 1999, J HEPATOL S1, V31, P3; Gerstein D., 1990, TREATING DRUG PROBLE; Gostin Lawrence O., 1999, HLTH HUMAN RIGHTS RE, P54; Gourevitch MN, 1996, J ADDICT DIS, V15, P93, DOI 10.1300/J069v15n01_07; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; HARRISON K, 1995, J ACQ IMMUN DEF SYND, V10, P386; Haynes R. B., 1979, COMPLIANCE HLTH CARE; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; King VL, 1999, METHADONE TREATMENT FOR OPIOID DEPENDENCE, P141; Lerner BH, 1998, ANN INTERN MED, V129, P573, DOI 10.7326/0003-4819-129-7-199810010-00012; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lorvick J, 1999, J URBAN HEALTH, V76, P461, DOI 10.1007/BF02351503; Lorvick J, 2001, AM J PUBLIC HEALTH, V91, P46, DOI 10.2105/AJPH.91.1.46; Maddrey WC, 1999, SEMIN LIVER DIS, V19, P67; Marco A, 1998, EUR RESPIR J, V12, P967, DOI 10.1183/09031936.98.12040967; Marlatt G. A, 2012, HARM REDUCTION PRAGM; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Moatti JP, 2000, AIDS, V14, P151, DOI 10.1097/00002030-200001280-00010; *NIH, 1997, MAN HAP C, V15; *NIH, 1997, INT PREV HIV RISK BE, V15; NORMAND J, 1995, PREVENTING HIV TRANS; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; *PAN CLIN PRACT TR, 2001, GUID US ANT AG HIV I; Pariante CM, 1999, LANCET, V354, P131, DOI 10.1016/S0140-6736(98)04793-X; *PUBL HLTH SERV, 1997, HIV PREV B MED ADV P; Quin JW, 1997, AUST NZ J MED, V27, P611, DOI 10.1111/j.1445-5994.1997.tb00985.x; RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577; ROBERTSON R, 1998, MANAGEMENT DRUG USER; Salomon N, 1997, INT J TUBERC LUNG D, V1, P397; Smirnoff M, 1998, INT J TUBERC LUNG D, V2, P134; Sorensen JL, 1998, AIDS CARE, V10, P297, DOI 10.1080/713612419; SYLVESTRE DL, 2000, ELIMINATING HLTH DIS, P422; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P591; Van Thiel DH, 1998, HEPATO-GASTROENTEROL, V45, P328; WARTENBERG AA, 1991, J GEN INTERN MED, V6, pS35, DOI 10.1007/BF02599256; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	50	172	172	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					211	214		10.1056/NEJM200107193450311	http://dx.doi.org/10.1056/NEJM200107193450311			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463019	Green Accepted			2022-12-24	WOS:000169912800011
J	Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S				Giese, B; Amaudrut, J; Kohler, AK; Spormann, M; Wessely, S			Direct observation of hole transfer through DNA by hopping between adenine bases and by tunnelling	NATURE			English	Article							RANGE ELECTRON-TRANSFER; DISTANCE DEPENDENCE; CHARGE-TRANSPORT; AQUEOUS-SOLUTION; MECHANISM; MOLECULES; MIGRATION; TRAP	The function of DNA during oxidative stress(1) and its suitability as a potential building block for molecular devices(2-4) depend on long-distance transfer of electrons and holes through the molecule, yet many conflicting measurements of the efficiency of this process have been reported(5,6). It is accepted that charges are transported over long distances through a multistep hopping reaction(7-11); this 'G-hopping'(8) involves positive charges moving between guanines (Gs), the DNA bases with the lowest ionization potential. But the mechanism fails to explain the persistence of efficient charge transfer when the guanine sites are distant(7,12), where transfer rates do not, as expected, decrease rapidly with transfer distance. Here we show experimentally that the rate of charge transfer between two guanine bases decreases with increasing separation only if the guanines are separated by no more than three base pairs; if more bridging base pairs are present, the transfer rates exhibit only a weak distance dependence. We attribute this distinct change in the distance dependence of the rate of charge transfer through DNA to a shift from coherent superexchange charge transfer (tunnelling) at short distances to a process mediated by thermally induced hopping of charges between adenine bases (A-hopping) at long distances. Our results confirm theoretical predictions of this behaviour(13-17), emphasizing that seemingly contradictory observations of a strong(8,9) as well as a weak(7,12) influence of distance on DNA charge transfer are readily explained by a change in the transfer mechanism.	Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Giese, B (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.			Amaudrut, Jerome/0000-0003-0498-4089				Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; FELTS AK, 1995, J PHYS CHEM-US, V99, P2929, DOI 10.1021/j100009a057; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Giese B, 2000, CHEMPHYSCHEM, V1, P195, DOI 10.1002/1439-7641(20001215)1:4<195::AID-CPHC195>3.0.CO;2-B; Giese B, 1999, ANGEW CHEM INT EDIT, V38, P996, DOI 10.1002/(SICI)1521-3773(19990401)38:7<996::AID-ANIE996>3.0.CO;2-4; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; MURPHY CJ, 1993, SCIENCE, V262, P1025, DOI 10.1126/science.7802858; Okada A, 1998, J PHYS CHEM A, V102, P1241, DOI 10.1021/jp972918r; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Saito I, 1998, J AM CHEM SOC, V120, P12686, DOI 10.1021/ja981888i; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Segal D, 2000, J PHYS CHEM B, V104, P3817, DOI 10.1021/jp993260f; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Williams TT, 2000, J AM CHEM SOC, V122, P9048, DOI 10.1021/ja001552k	21	712	725	8	149	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					318	320		10.1038/35085542	http://dx.doi.org/10.1038/35085542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460159				2022-12-24	WOS:000169918200042
J	Hale, P				Hale, P			Mission now possible for AIDS fund - Adequate support by the G8 countries is needed to defeat this global killer.	NATURE			English	Editorial Material									Fac Med Necker Enfants Malad, Inst Necker, F-75015 Paris, France; MRC S Africa, Congella, South Africa; Yale Univ, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA; Ist Super Sanita, Int AIDS Soc, I-00161 Rome, Italy; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Inst Pasteur, Paris, France; UCL, London WC1E 6BT, England	UDICE-French Research Universities; Universite Paris Cite; Yale University; Johns Hopkins University; University of California System; University of California San Diego; Istituto Superiore di Sanita (ISS); Makerere University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; University College London	Hale, P (corresponding author), Fac Med Necker Enfants Malad, Inst Necker, 156 Rue Vaugirard, F-75015 Paris, France.		VELLA, STEFANO/V-8440-2019	VELLA, STEFANO/0000-0003-2347-5984	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, ZIAAI000361] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Sachs JD, 2001, NAT MED, V7, P521, DOI 10.1038/87830; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876	2	6	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					271	272		10.1038/35085650	http://dx.doi.org/10.1038/35085650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460133				2022-12-24	WOS:000169918200019
J	Rausher, MD				Rausher, MD			Co-evolution and plant resistance to natural enemies	NATURE			English	Review							HESSIAN FLY DIPTERA; BACILLUS-THURINGIENSIS; ARABIDOPSIS-THALIANA; EVOLUTIONARY ECOLOGY; PLUTELLA-XYLOSTELLA; FIELD POPULATIONS; IPOMOEA-PURPUREA; TRANSGENIC CROPS; MORNING GLORY; RNA EVOLUTION	Co-evolution between plants and their natural enemies is generally believed to have generated much of the Earth's biological diversity. A process analogous to co-evolution occurs in agricultural systems, in which natural enemies adapt to crop resistance introduced by breeding or genetic engineering. Because of this similarity, the investigation of resistance mechanisms in crops is helping to elucidate the workings of co-evolution in nature, while evolutionary principles, including those derived from investigation of co-evolution in nature, are being applied in the management of resistance in genetically engineered crops.	Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA	Duke University	Rausher, MD (corresponding author), Duke Univ, Dept Biol, Evolut Ecol & Organismal Biol Grp, Durham, NC 27708 USA.	mrausher@duke.edu						Agrawal AA, 2000, TRENDS PLANT SCI, V5, P309, DOI 10.1016/S1360-1385(00)01679-4; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI 10.1111/j.1558-5646.1983.tb05524.x; Berenbaum M.R., 1988, P113; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BERENBAUM MR, 1986, EVOLUTION, V40, P1215, DOI 10.1111/j.1558-5646.1986.tb05746.x; BERGELSON J, 1994, AM NAT, V143, P349, DOI 10.1086/285607; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bergelson J, 1996, P ROY SOC B-BIOL SCI, V263, P1659, DOI 10.1098/rspb.1996.0242; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.1111/j.1558-5646.1996.tb02350.x, 10.2307/2410650]; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; CARROLL SP, 1992, EVOLUTION, V46, P1052, DOI 10.1111/j.1558-5646.1992.tb00619.x; CARROLL SP, 1987, ANN ENTOMOL SOC AM, V80, P373, DOI 10.1093/aesa/80.3.373; CASTILLOCHAVEZ C, 1988, EVOLUTION, V42, P986, DOI [10.2307/2408914, 10.1111/j.1558-5646.1988.tb02517.x]; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; COX TS, 1986, ENVIRON ENTOMOL, V15, P24, DOI 10.1093/ee/15.1.24; DeWit PJGM, 1997, TRENDS PLANT SCI, V2, P452, DOI 10.1016/S1360-1385(97)01139-4; DUSSOURD DE, 1987, SCIENCE, V237, P898, DOI 10.1126/science.3616620; EGGERSSCHUMACHER HA, 1983, ENTOMOL EXP APPL, V34, P301, DOI 10.1007/BF00186930; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eubanks MD, 1997, OECOLOGIA, V109, P454, DOI 10.1007/s004420050105; Ewald PW, 1994, EVOLUTION INFECT DIS; Fagerstrom T, 1987, FUNCT ECOL, V1, P73, DOI 10.2307/2389708; Feeny Paul, 1992, P1; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; FISCHHOFF DA, 1992, P 1992 BELTW COTT PR, P751; Fischhoff David A., 1996, V15, P214; FOSTER JE, 1991, ENVIRON ENTOMOL, V20, P964, DOI 10.1093/ee/20.4.964; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; FRY JD, 1990, AM NAT, V136, P569, DOI 10.1086/285116; FUTUYMA DJ, 1979, ECOL MONOGR, V49, P33, DOI 10.2307/1942571; GALLUN RL, 1977, ANN NY ACAD SCI, V287, P223, DOI 10.1111/j.1749-6632.1977.tb34241.x; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, AM SCI, V79, P496; Gould F., 1988, P13; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; HAMMA H, 1992, APPL ENTOMOL ZOOL, V27, P355; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hartl D. L., 1989, PRINCIPLES POPULATIO; HATCHETT JH, 1968, ANN ENTOMOL SOC AM, V61, P1446, DOI 10.1093/aesa/61.6.1446; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Heino M, 1998, CAN J FISH AQUAT SCI, V55, P1971, DOI 10.1139/cjfas-55-8-1971; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; International Conference on Harmonization, 1997, FED REG, V62, P27463; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; JERMY T, 1984, AM NAT, V124, P609, DOI 10.1086/284302; Jermy T., 1976, Symposia Biologica Hungarica, V16, P109; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Landweber LF, 1999, TRENDS ECOL EVOL, V14, P353, DOI 10.1016/S0169-5347(99)01680-8; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Li W-H, 1997, MOL EVOLUTION; Liu YB, 1997, P ROY SOC B-BIOL SCI, V264, P605, DOI 10.1098/rspb.1997.0086; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI 10.2307/2411196; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; MEFFE G. K., 1997, PRINCIPLES CONSERVAT; Meyers BC, 1998, PLANT CELL, V10, P1833, DOI 10.1105/tpc.10.11.1833; MULLER CH, 1969, SCIENCE, V164, P197, DOI 10.1126/science.164.3876.197; Murphy EJ, 1999, EVOL ECOL, V13, P517, DOI 10.1023/A:1006783902331; PAIGE KN, 1994, AM NAT, V143, P739, DOI 10.1086/285630; Painter RH, 1951, INSECT RESISTANCE CR; Parker JE, 1997, TRENDS BIOCHEM SCI, V22, P291, DOI 10.1016/S0968-0004(97)01089-X; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Perez CJ, 1997, J ECON ENTOMOL, V90, P1462, DOI 10.1093/jee/90.6.1462; PRYOR T, 1987, TRENDS GENET, V3, P157, DOI 10.1016/0168-9525(87)90217-4; Purrington CB, 1999, AM NAT, V154, pS82, DOI 10.1086/303285; RATHCKE BJ, 1975, SCIENCE, V187, P175, DOI 10.1126/science.187.4172.175; Rausher Mark D., 1993, P259; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; ROBINSON T, 1974, SCIENCE, V184, P430, DOI 10.1126/science.184.4135.430; ROSENTHAL GA, 1976, SCIENCE, V192, P256, DOI 10.1126/science.1257764; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Roush R. T., 1997, ADV INSECT CONTROL R, P271; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1982, J ECON ENTOMOL, V75, P708, DOI 10.1093/jee/75.4.708; SCHAFER JF, 1971, ANNU REV PHYTOPATHOL, V9, P235, DOI 10.1146/annurev.py.09.090171.001315; SEIGLER D, 1976, AM NAT, V110, P101, DOI 10.1086/283050; SEIGLER DS, BIOCH SYSTEM ECOL, V5, P195; Shelton AM, 2000, NAT BIOTECHNOL, V18, P339, DOI 10.1038/73804; Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/S1360-1385(96)80312-8; Shonle I, 2000, EVOLUTION, V54, P778, DOI 10.1111/j.0014-3820.2000.tb00079.x; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; SIMMS EL, 1989, EVOLUTION, V43, P573, DOI 10.1111/j.1558-5646.1989.tb04253.x; SIMMS EL, 1987, AM NAT, V130, P70; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Strong D.R., 1984, INSECTS PLANTS; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; Thompson J., 1982, INTERACTION COEVOLUT; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Tiffin P, 2000, AM NAT, V155, P128, DOI 10.1086/303301; Van EMDEN H. F., 1966, WORLD REV PEST CONTR, V5, P115; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Wood R. J., 1981, GENETIC CONSEQUENCES, P53; 1999, BIOSYSTEMS, V52; [No title captured]	103	311	350	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					857	864		10.1038/35081193	http://dx.doi.org/10.1038/35081193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459070				2022-12-24	WOS:000169246400064
J	KNOLL, AH; WALTER, MR				KNOLL, AH; WALTER, MR			LATEST PROTEROZOIC STRATIGRAPHY AND EARTH HISTORY	NATURE			English	Review							SEQUENCE STRATIGRAPHY; CENTRAL AUSTRALIA; EAST GREENLAND; TRACE FOSSILS; CARBONATES; BIOSTRATIGRAPHY; SUCCESSIONS; SVALBARD; METAZOA; AMADEUS	The end of the Proterozoic Eon was a time of pronounced biological, biogeochemical, climatic and tectonic change. New bio- and chemostratigraphic data provide an improved framework for stratigraphic correlation, making possible a deeper understanding of latest Proterozoic Earth history and providing tools for a chronostratigraphic division of late Proterozoic time.	MACQUARIE UNIV,SCH EARTH SCI,MACQUARIE,NSW 2109,AUSTRALIA	Macquarie University	KNOLL, AH (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.							AHARON P, 1987, NATURE, V327, P699, DOI 10.1038/327699a0; [Anonymous], 1978, BUREAU MINERAL RESOU; ASMEROM Y, 1991, GEOCHIM COSMOCHIM AC, V55, P2883, DOI 10.1016/0016-7037(91)90453-C; BEANUS MA, 1985, GEOL SOC AM BULL, V96, P737; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; CHRISTIEBLICK N, 1991, MAR GEOL, V97, P35, DOI 10.1016/0025-3227(91)90018-Y; CHRISTIEBLICK N, 1990, AM J SCI, V290A, P295; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; CLAYPOOL GE, 1980, CHEM GEOL, V28, P199, DOI 10.1016/0009-2541(80)90047-9; CLOUD P, 1982, SCIENCE, V217, P783, DOI 10.1126/science.217.4562.783; COMPSTON W, 1990, RES SCH EARTH SCI AU, P26; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; CRIMES TP, 1987, GEOL MAG, V124, P97; Darwin C., 1859, ORIGIN SPECIES FACSI; DERRY LA, 1989, GEOCHIM COSMOCHIM AC, V53, P2331, DOI 10.1016/0016-7037(89)90355-4; DERRY LA, IN PRESS GEOCHIM COS; DONNELLY TH, 1990, GEOLOGICAL SOC SPECI, V52, P273; FAIRCHILD IJ, 1987, SEDIMENTOLOGY, V34, P973, DOI 10.1111/j.1365-3091.1987.tb00587.x; FAIRCHILD IJ, 1990, AM J SCI, V290A, P46; FEDONKIN MA, 1990, VENDIAN SYSTEM, V1, P112; GERMS GJB, 1972, AM J SCI, V272, P752, DOI 10.2475/ajs.272.8.752; Glaessner M.F., 1984, DAWN ANIMAL LIFE; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GRANT SWF, 1990, AM J SCI, V290A, P261; HAMBREY MJ, 1981, EARTHS PREPLEISTOCEN; Harland W.B., 1990, GEOLOGIC TIME SCALE; Harland W.B., 1964, INT J EARTH SCI, V54, P45, DOI [10.1007/BF01821169, DOI 10.1007/BF01821169]; HARLAND WB, 1975, ICE AGES ANCIENT MOD, P189; HOFMANN HJ, 1990, GEOLOGY, V18, P1199, DOI 10.1130/0091-7613(1990)018<1199:ERFIBI>2.3.CO;2; HOFMANN HJ, 1987, GEOSCI CAN, V14, P135; Holser W.T., 1984, PATTERNS CHANGE EART, P123, DOI DOI 10.1007/978-3-642-69317-5_8; JENKINS RJF, 1984, GEOL MAG, V121, P635, DOI 10.1017/S0016756800030788; JENKINS RJF, 1984, T R SOC S AUST, V105, P179; KAUFMAN AJ, 1991, PRECAMBRIAN RES, V49, P301, DOI 10.1016/0301-9268(91)90039-D; KAUFMAN AJ, IN PRESS EARTH PLANE; KHOMENTOVSKY AA, 1990, VENDIAN SYSTEM, V2, P102; Kirschvink J.L., 1991, GSA TODAY, V1, P69; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KNOLL AH, 1989, NATURE, V337, P602, DOI 10.1038/337602a0; KNOLL AH, IN PRESS PALAEONTOLO; KNOLL AH, 1991, SCI AM, V265, P65; KROGH TE, 1988, CAN J EARTH SCI, V25, P442, DOI 10.1139/e88-045; LAMBERT IB, 1987, NATURE, V325, P140, DOI 10.1038/325140a0; Lindsay J. F., 1989, BASIN RES, V2, P3; LINDSAY JF, 1987, AAPG BULL, V71, P1387; Moczydlowska M., 1991, FOSSILS STRATA, V29, P1; MORRIS SC, 1990, AM J SCI, V290A, P245; MORRIS SC, 1989, PRECAMBRIAN CAMBRIAN, P7; NARBONNE GM, 1988, B NEW YORK STATE MUS, V463, P72; PLUMB KA, 1991, EPISODES, V14, P139, DOI 10.18814/epiiugs/1991/v14i2/005; ROSS GM, 1988, GEOLOGY, V16, P139, DOI 10.1130/0091-7613(1988)016<0139:TSAARC>2.3.CO;2; ROSS GM, 1991, GEOLOGICAL ASS CANAD, V16, P108; Schopf JW, 1983, EARTHS EARLIEST BIOS; Sokolov B. S., 1952, IZV AN SSSR GEOL, V5, P21; SOKOLOV BS, 1990, VENDIAN SYSTEM, V1; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1990, PALAEONTOLOGY, V33, P287; VONDERBORCH CC, 1988, AUST J EARTH SCI, V35, P59, DOI 10.1080/08120098808729439; Walter M. R., 1976, STROMATOLITES; WALTER MR, 1985, PRECAMBRIAN RES, V29, P149, DOI 10.1016/0301-9268(85)90066-X; WALTER MR, 1989, ALCHERINGA, V13, P209, DOI 10.1080/03115518908527821; WHITTAKER A, 1991, J GEOL SOC LONDON, V148, P813, DOI 10.1144/gsjgs.148.5.0813; Willis BJ, 1907, RES CHINA; Yin L., 1985, PALAEONTOLOGIA CATHA, V2, P229; ZANG W, 1989, NATURE, V337, P632	65	238	260	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 23	1992	356	6371					673	678		10.1038/356673a0	http://dx.doi.org/10.1038/356673a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ146	11537861				2022-12-24	WOS:A1992HQ14600048
J	SCHWARTZ, AW; BAKKER, CG				SCHWARTZ, AW; BAKKER, CG			WAS ADENINE THE 1ST PURINE	SCIENCE			English	Article											SCHWARTZ, AW (corresponding author), CATHOLIC UNIV NIJMEGEN,FAC SCI,EXOBIOL LAB,6525 ED NIJMEGEN,NETHERLANDS.							Cronin J.R., 1988, METEORITES EARLY SOL, P819; FERRIS JP, 1978, J MOL EVOL, V11, P293, DOI 10.1007/BF01733839; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; Miller S. L., 1974, ORIGINS LIFE EARTH; ORO J, 1960, BIOCHEM BIOPH RES CO, V2, P407, DOI 10.1016/0006-291X(60)90138-8; SANCHEZ RA, 1967, J MOL BIOL, V30, P223; SCHWARTZ AW, 1983, NATURWISSENSCHAFTEN, V70, P373, DOI 10.1007/BF01047172; SCHWARTZ AW, 1984, ORIGINS LIFE EVOL B, V14, P91, DOI 10.1007/BF00933644; SCHWARTZ AW, 1982, J MOL EVOL, V18, P351, DOI 10.1007/BF01733902; SCHWARTZ AW, 1985, SCIENCE, V228, P585, DOI 10.1126/science.228.4699.585; SMITH CVZ, 1973, CHEM SOC PERKIN T 1, P1855; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; VISSCHER J, 1989, SCIENCE, V244, P329, DOI 10.1126/science.2540527; VISSCHER J, 1988, J MOL EVOL, V28, P3, DOI 10.1007/BF02143492; VOET AB, 1983, BIOORG CHEM, V12, P8, DOI 10.1016/0045-2068(83)90003-2	15	31	33	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 8	1989	245	4922					1102	1104		10.1126/science.11538344	http://dx.doi.org/10.1126/science.11538344			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN702	11538344				2022-12-24	WOS:A1989AN70200034
J	Knight, SW; Bass, BL				Knight, SW; Bass, BL			A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; POLYMERASE; ARABIDOPSIS; NEUROSPORA; EXPRESSION; HELICASE; SEQUENCE; VIRUS	An early event in RNA interference (RNAi) is the cleavage of the initiating double-stranded RNA (dsRNA) to short pieces, 21 to 23 nucleotides in length. Here we describe a null mutation in dicer-1 (dcr-1), a gene proposed to encode the enzyme that generates these short RNAs. We find that dcr-1(-/-) animals have defects in RNAi under some, but not all, conditions. Mutant animals have germ line defects that lead to sterility, suggesting that cleavage of dsRNA to short pieces is a requisite event in normal development.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 50 N Med Dr,Room 211, Salt Lake City, UT 84132 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044073] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BRENNER S, 1974, GENETICS, V77, P71; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DAVIDSON EH, 1979, SCIENCE, V204, P1052, DOI 10.1126/science.451548; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mello C, 1995, CAENORHABDITIS ELEGA, P451; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHEDL T, 1997, C ELEGANS, V2, P241; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Yochem J, 1998, GENETICS, V149, P1323; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	32	639	719	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2269	2271		10.1126/science.1062039	http://dx.doi.org/10.1126/science.1062039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11486053	Green Accepted			2022-12-24	WOS:000171139400048
J	Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH				Simon, A; Cuisset, L; Vincent, MF; van der Velde-Visser, SD; Delpech, M; van der Meer, JWM; Drenth, JPH		HIDS Study Grp	Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-IgD and periodic fever syndrome: Its application as a diagnostic tool	ANNALS OF INTERNAL MEDICINE			English	Article							HYPERIMMUNOGLOBULINEMIA-D; UNKNOWN ORIGIN; MUTATIONS; ATTACKS; MVK	Background: The hyper-IgD and periodic fever syndrome (HIDS) is characterized by recurrent attacks of fever, abdominal distress, and arthralgia and is caused by mevalonate kinase mutations. Objective: To ascertain the role of mevalonate kinase and the usefulness of molecular diagnosis in HIDS. Design: Cross-sectional study. Setting: The international Nijmegen HIDS registry. Patients: 54 patients from 41 families who met the clinical criteria for HIDS. Measurements: Clinical symptoms and signs, immunoglobulin concentration, leukocyte count, erythrocyte sedimentation rate, mutation analysis, and mevalonate kinase enzyme activity assay. Results: There were two groups of patients: 41 patients with mevalonate kinase mutations (classic-type HIDS) and 13 patients without mutations (variant-type HIDS). Patients with classic-type HIDS had a lower mevalonate kinase enzyme activity, a higher IgD level, and more additional symptoms with attacks. The IgD level did not correlate with disease severity, mevalonate kinase enzyme activity, or genotype. Conclusion: Genetic heterogeneity exists among patients with a clinical diagnosis of HIDS.	Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Genet & Physiopathol Malad Inflammatoires Heredit, Paris, France; Hop Cochin, F-75674 Paris, France; Catholic Univ Louvain, B-1200 Brussels, Belgium	Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain	Simon, A (corresponding author), Radboud Univ Nijmegen Med Ctr, Div Gen Internal Med, Box 9101, NL-6500 HB Nijmegen, Netherlands.	a.simon@worldonline.nl	Drenth, Joost/V-7436-2019; van der Meer, Jos W.M./C-8521-2013; Drenth, J.P.H./H-8025-2014; Simon, Anna/D-3757-2009	van der Meer, Jos W.M./0000-0001-5120-3690; Simon, Anna/0000-0002-6141-7921				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; de Kleijn EMH, 1997, MEDICINE, V76, P392, DOI 10.1097/00005792-199711000-00002; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 2000, BRIT MED J, V320, P1091, DOI 10.1136/bmj.320.7242.1091; DRENTH JPH, 1995, BLOOD, V85, P3586, DOI 10.1182/blood.V85.12.3586.bloodjournal85123586; DRENTH JPH, 1995, EUR J CLIN INVEST, V25, P683, DOI 10.1111/j.1365-2362.1995.tb01986.x; Eisenberg S, 1998, ANN INTERN MED, V129, P539, DOI 10.7326/0003-4819-129-7-199810010-00005; GIBSON KM, 1989, ENZYME, V41, P47, DOI 10.1159/000469050; Grose C, 1996, PEDIATR INFECT DIS J, V15, P72, DOI 10.1097/00006454-199601000-00016; HARALDSSON A, 1992, J CLIN IMMUNOL, V12, P424, DOI 10.1007/BF00918854; HOFFMANN GF, 1992, J INHERIT METAB DIS, V15, P738, DOI 10.1007/BF01800016; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; KNOCKAERT DC, 1993, MEDICINE, V72, P184; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Palinski W, 2000, NAT MED, V6, P1311, DOI 10.1038/82107; VANDERMEER JWM, 1984, LANCET, V1, P1087	19	63	67	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					338	343		10.7326/0003-4819-135-5-200109040-00010	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529697				2022-12-24	WOS:000170780600004
J	Ford, EB; Seager, S; Turner, EL				Ford, EB; Seager, S; Turner, EL			Characterization of extrasolar terrestrial planets from diurnal photometric variability	NATURE			English	Article							EARTH	The detection of massive planets orbiting nearby stars has become almost routine(1,2), but current techniques are as yet unable to detect terrestrial planets with masses comparable to the Earth's. Future space-based observatories to detect Earth-like planets are being planned. Terrestrial planets orbiting in the habitable zones of stars-where planetary surface conditions are compatible with the presence of liquid water-are of enormous interest because they might have global environments similar to Earth's and even harbour life. The light scattered by such a planet will vary in intensity and colour as the planet rotates; the resulting light curve will contain information about the planet's surface and atmospheric properties. Here we report a model that predicts features that should be discernible in the light curve obtained by low-precision photometry. For extrasolar planets similar to Earth, we expect daily flux variations of up to hundreds of per cent, depending sensitively on ice and cloud cover as well as seasonal variations. This suggests that the meteorological variability, composition of the surface (for example, ocean versus land fraction) and rotation period of an Earth-like planet could be derived from photometric observations. Even signatures of Earth-like plant life could be constrained or possibly, with further study, even uniquely determined.	Princeton Univ Observ, Princeton, NJ 08540 USA; Inst Adv Study, Princeton, NJ 08540 USA	Princeton University; Institute for Advanced Study - USA	Ford, EB (corresponding author), Princeton Univ Observ, Peyton Hall, Princeton, NJ 08540 USA.	eford@astro.princeton.edu	Ford, Eric B./AAB-5479-2019; Turner, Edwin L/A-4295-2011	Ford, Eric B./0000-0001-6545-639X; 				BEICHMAN CA, 1999, NASA JPL PUBL, V993, P1; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; BUKATA RP, 1995, OPTICAL PROPERTIES R, P37; Butler RP, 1996, PUBL ASTRON SOC PAC, V108, P500, DOI 10.1086/133755; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Goode PR, 2001, GEOPHYS RES LETT, V28, P1671, DOI 10.1029/2000GL012580; Hapke B., 1993, THEORY REFLECTANCE E; HOVENIER JW, 1989, ASTRON ASTROPHYS, V214, P391; JACQUEMOUD S, 1992, REMOTE SENS ENVIRON, V41, P123, DOI 10.1016/0034-4257(92)90072-R; JEROME JH, 1988, APPL OPTICS, V27, P4012, DOI 10.1364/AO.27.004012; KIRK JTO, 1991, LIMNOL OCEANOGR, V36, P455, DOI 10.4319/lo.1991.36.3.0455; Kondratyev K.Y., 1969, RAD ATMOSPHERE; Marcy G. W., 2000, Protostars and planets 4, P1285; MYNENI RB, 1995, REMOTE SENS ENVIRON, V51, P169, DOI 10.1016/0034-4257(94)00073-V; Nisenson P, 2001, ASTROPHYS J, V548, pL201, DOI 10.1086/319110; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Schindler TL, 2000, ICARUS, V145, P262, DOI 10.1006/icar.2000.6340; SPERGEL DN, UNPUB APPL OPTICS; SPERGEL DN, 2001, ASTROPH0101142; VERBISCER AJ, 1990, ICARUS, V88, P418, DOI 10.1016/0019-1035(90)90092-N; VOKROUHLICKY D, 1995, ASTRON ASTROPHYS, V298, P307; WOESSNER P, 1987, REMOTE SENS ENVIRON, V21, P243, DOI 10.1016/0034-4257(87)90011-3; 2000, ESASCI200012, P1	25	158	159	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					885	887		10.1038/35091009	http://dx.doi.org/10.1038/35091009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528471	Green Submitted			2022-12-24	WOS:000170689000037
J	Pastores, GM; Thadhani, R				Pastores, GM; Thadhani, R			Enzyme-replacement therapy for Anderson-Fabry disease	LANCET			English	Editorial Material									NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02114 USA	New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pastores, GM (corresponding author), NYU, Sch Med, Dept Neurol & Pediat, Neurogenet Program, New York, NY 10003 USA.		Pastores, Gregory M./AAE-8647-2020					Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; DESNIEK RJ, 2000, METABOLIC MOL BASES, V3, P3733; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Frustaci A, 2001, NEW ENGL J MED, V345, P25, DOI 10.1056/NEJM200107053450104; Jung SC, 2001, P NATL ACAD SCI USA, V98, P2676, DOI 10.1073/pnas.051634498; KUHN H, 1982, CIRCULATION, V66, P117; MACDERMOT KD, IN PRESS J MED GENET; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; PASTORES GM, 1999, ENFERMEDAD GAUCHER E, P13; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743	12	50	55	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					601	603		10.1016/S0140-6736(01)05816-0	http://dx.doi.org/10.1016/S0140-6736(01)05816-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530143				2022-12-24	WOS:000170615500004
J	Jeruzalmi, D; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; O'Donnell, M; Kuriyan, J			Crystal structure of the processivity clamp loader gamma (gamma) complex of E-coli DNA polymerase III	CELL			English	Article							CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; SLIDING CLAMPS; ACCESSORY PROTEINS; DELTA-SUBUNIT; BETA-CLAMP; MECHANISM; BINDING; ASSOCIATION; HYDROLYSIS	The gamma complex, an AAA+ ATPase, is the bacterial homolog of eukaryotic replication factor C (RFC) that loads the sliding clamp (beta, homologous to PCNA) onto DNA. The 2.7/3.0 Angstrom crystal structure of gamma complex reveals a pentameric arrangement of subunits, with stoichiometry delta':gamma (3):delta. The C-terminal domains of the subunits form a circular collar that supports an asymmetric arrangement of the N-terminal ATP binding domains of the gamma motor and the structurally related domains of the delta' stator and the delta wrench. The structure suggests a mechanism by which the gamma complex switches between a closed state, in which the beta -interacting element of delta is hidden by delta', and an open form similar to the crystal structure, in which delta is free to bind to beta.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [R01 GM-45547, R01 GM-38839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM045547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertram JG, 2000, J BIOL CHEM, V275, P28413, DOI 10.1074/jbc.M910441199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; OYAMA T, 2001, IN PRESS MOL CELL, V8; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Shiomi Y, 2000, P NATL ACAD SCI USA, V97, P14127, DOI 10.1073/pnas.97.26.14127; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	50	244	249	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					429	441		10.1016/S0092-8674(01)00463-9	http://dx.doi.org/10.1016/S0092-8674(01)00463-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525729	Bronze			2022-12-24	WOS:000170665200007
J	Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD				Fairhall, AL; Lewen, GD; Bialek, W; van Steveninck, RRD			Efficiency and ambiguity in an adaptive neural code	NATURE			English	Article							INFORMATION-TRANSMISSION; SPIKE TRAINS; ADAPTATION; TIME; DYNAMICS; SYSTEM	We examine the dynamics of a neural code in the context of stimuli whose statistical properties are themselves evolving dynamically. Adaptation to these statistics occurs over a wide range of timescales-from tens of milliseconds to minutes. Rapid components of adaptation serve to optimize the information that action potentials carry about rapid stimulus variations within the local statistical ensemble, while changes in the rate and statistics of action-potential firing encode information about the ensemble itself, thus resolving potential ambiguities. The speed with which information is optimized and ambiguities are resolved approaches the physical limit imposed by statistical sampling and noise.	NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Fairhall, AL (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow HB, 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BORST A, 1987, BIOL CYBERN, V56, P209, DOI 10.1007/BF00365215; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Carandini M, 1997, J NEUROSCI, V17, P8621; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Fairhall AL, 2001, ADV NEUR IN, V13, P124; Feynman R.P., 1965, PATH INTEGRALS QUANT; Franceschini N., 1989, P360; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; GREEN DM, 1966, SIGNAL DETECTION THE; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; Hopfield JJ, 1996, P NATL ACAD SCI USA, V93, P15440, DOI 10.1073/pnas.93.26.15440; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Markram H, 1998, NEUROBIOL LEARN MEM, V70, P101, DOI 10.1006/nlme.1998.3841; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Perkel D, 1968, NEUROSCI RES PROG B, V6, P3; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Schilstra C, 1999, J EXP BIOL, V202, P1481; Schneidman E, 2001, ADV NEUR IN, V13, P159; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; SHAPLEY R, 1979, VISION RES, V19, P431, DOI 10.1016/0042-6989(79)90109-3; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11, P166; SMIRNAKIS S, 1997, NATURE, V386, P67; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Toib A, 1998, J NEUROSCI, V18, P1893; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; vanSteveninck RRD, 1996, NATURAL & ARTIFICIAL PARALLEL COMPUTATION, P21; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang YQ, 2000, PHYS REV E, V62, P1063, DOI 10.1103/PhysRevE.62.1063; Warland DK, 1991, READING SPIKES REAL; Wiener N., 1949, EXTRAPOLATION INTERP	45	546	554	1	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					787	792		10.1038/35090500	http://dx.doi.org/10.1038/35090500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518957				2022-12-24	WOS:000170577200028
J	Brabin, L				Brabin, L			Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?	BRITISH MEDICAL JOURNAL			English	Article							HERPES-SIMPLEX VIRUS; CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL HERPES; TYPE-2; WOMEN; RISK; TRANSMISSION		St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England	University of Manchester	Brabin, L (corresponding author), St Marys Hosp, Acad Unit Obstet & Gynaecol & Reprod Hlth Care, Manchester M13 0JH, Lancs, England.			Brabin, Loretta/0000-0003-4478-6503				Apter D, 1997, ANN NY ACAD SCI, V816, P9, DOI 10.1111/j.1749-6632.1997.tb52125.x; Brabin L, 2000, ACTA TROP, V75, P53, DOI 10.1016/S0001-706X(99)00093-5; BRABIN L, 1996, PREVENTION PELVIC IN, P160; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; BURNSTEIN GR, 2001, SEX TRANSM INFECT, V77, P26; COTTINGHAM J, 1992, GENITOURIN MED, V68, P209; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Greenblatt RM, 2000, J INFECT DIS, V181, P82, DOI 10.1086/315207; Hewitt R G, 2001, AIDS Read, V11, P29; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; MERTZ GJ, 1992, ANN INTERN MED, V116, P197, DOI 10.7326/0003-4819-116-3-197; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Moscicki AB, 2001, J INFECT DIS, V183, P865, DOI 10.1086/319261; Mosure DJ, 1996, AM J EPIDEMIOL, V144, P997, DOI 10.1093/oxfordjournals.aje.a008870; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Robbins AS, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(00)00280-4; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V268, P1702, DOI 10.1001/jama.268.13.1702; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Sonnex C, 1998, SEX TRANSM INFECT, V74, P11, DOI 10.1136/sti.74.1.11; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1913, DOI 10.1001/jama.284.15.1913; *UNDP UNFPA WHO WO, 2000, REPR HLTH RES WHO NE; Wang CC, 1999, J ACQ IMMUN DEF SYND, V21, P51, DOI 10.1097/00126334-199905010-00007; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246	25	13	13	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					394	395		10.1136/bmj.323.7309.394	http://dx.doi.org/10.1136/bmj.323.7309.394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509437	Green Published			2022-12-24	WOS:000170581400032
J	Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA				Cunliffe, NA; Gondwe, JS; Kirkwood, CD; Graham, SM; Nhlane, NM; Thindwa, BDM; Dove, W; Broadhead, RL; Molyneux, ME; Hart, CA			Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children	LANCET			English	Article							YOUNG-CHILDREN; ACUTE DIARRHEA; EPIDEMIOLOGY; SEVERITY; DISEASE; VACCINE; BLANTYRE; HEALTHY	Background Rotaviruses represent important causes of severe diarrhoea in early childhood. We examined the effect of HIV infection on the presentation and outcome of rotavirus gastroenteritis in Malawian children. Methods Children younger than 5 years who were treated for acute gastroenteritis at the Queen Elizabeth Central Hospital in Blantyre from July, 1997, to June, 1999, were enrolled. Children with rotavirus diarrhoea, with and without HIV infection, were followed up for up to 4 weeks after hospital discharge. Rotavirus disease severity (assessed with a 20-point score), duration of rotavirus shedding, and seroresponse to rotavirus were compared between HIV-infected and HIV-uninfected children. Findings 786 inpatients (median age 8 months, 271 [34%] of whom were HIV-1-infected) and 400 outpatients (median age 9 months, 65 [16%] of whom were HIV-infected) were enrolled. Rotavirus was detected less frequently among HIV-infected children (102 of 336 [30%]) than among HIV-uninfected children (348 of 850 [41%], (relative risk 0.71 [95% CI 0.53-0.87], p=0.0007). There were no differences in rotavirus disease severity for hospitalised children with and without HIV infection, but HIV-infected children were more likely to die during follow-up (11/50 [22%]) than HIV-uninfected children (0/61, p<0.0001). Of 29 HIV-infected and 45 HIV-uninfected children who completed follow-up, six (21%) HIV-infected children shed rotavirus, compared with two (4%) HIV-uninfected children (4.66 [1.01-21.51], p=0.05), but shedding was not associated with diarrhoea. Three-quarters of children exhibited a four-fold rise of serum IgG or lgA to rotavirus, which did not vary by HIV status. Interpretation. Malawian children with concomitant HIV infection resolved acute rotavirus infections. Rotavirus vaccine safety and immunogenicity in HIV-infected infants should now be determined.	Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England; Univ Malawi, Wellcome Trust Res Labs, Coll Med, Blantyre, Malawi; Univ Liverpool, Coll Med, Blantyre, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre, Malawi; Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Malawi; University of Malawi; University of Malawi; Royal Children's Hospital Melbourne; Liverpool School of Tropical Medicine; University of Liverpool	Cunliffe, NA (corresponding author), Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.	N.A.Cunllffe@liverpool.ac.uk		Graham, Stephen/0000-0003-3525-2294; Cunliffe, Nigel/0000-0002-5449-4988				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; BERN C, 1992, J CLIN MICROBIOL, V30, P3234, DOI 10.1128/JCM.30.12.3234-3238.1992; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 1999, J MED VIROL, V57, P308, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;308::AID-JMV15&gt;3.0.CO;2-B; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; DAGAN R, 1990, PEDIATR INFECT DIS J, V9, P314, DOI 10.1097/00006454-199005000-00003; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Fontana M, 1996, J PEDIATR GASTR NUTR, V23, P492, DOI 10.1097/00005176-199611000-00026; FRANCO MA, 1995, J VIROL, V69, P7800, DOI 10.1128/JVI.69.12.7800-7806.1995; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Kapikian A.Z., 1996, FIELDS VIROLOGY, P1657; KOTLOFF KL, 1994, JAMA-J AM MED ASSOC, V271, P448, DOI 10.1001/jama.271.6.448; Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000; McNeal MM, 1997, J VIROL, V71, P8735, DOI 10.1128/JVI.71.11.8735-8742.1997; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; MIOTTI PG, 1992, J INFECT DIS, V165, P1116, DOI 10.1093/infdis/165.6.1116; Molbak K, 2000, VACCINE, V19, P393, DOI 10.1016/S0264-410X(00)00199-7; MONROE SS, 1993, J CLIN MICROBIOL, V31, P2866, DOI 10.1128/JCM.31.11.2866-2872.1993; OSHITANI H, 1994, J INFECT DIS, V169, P897, DOI 10.1093/infdis/169.4.897; PAVIA AT, 1992, PEDIATR INFECT DIS J, V11, P996, DOI 10.1097/00006454-199211120-00002; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Taha T E, 2000, Pediatrics, V106, pE77, DOI 10.1542/peds.106.6.e77; THEA DM, 1993, NEW ENGL J MED, V329, P1696, DOI 10.1056/NEJM199312023292304	33	56	58	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2001	358	9281					550	555		10.1016/S0140-6736(01)05706-3	http://dx.doi.org/10.1016/S0140-6736(01)05706-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520526				2022-12-24	WOS:000170537700013
J	Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S				Amador, V; Monte, E; Garcia-Martinez, JL; Prat, S			Gibberellins signal nuclear import of PHOR1, a photoperiod-responsive protein with homology to Drosophila armadillo	CELL			English	Article							BETA-CATENIN; GENETIC-ANALYSIS; SOLANUM-TUBEROSUM; REPEAT PROTEIN; PHYTOCHROME-B; TRANSDUCTION; ARABIDOPSIS; EXPRESSION; POTATO; PLANTS	S. tuberosum ssp. andigena potato plants require short days (SD) for tuberization. We have isolated PHOR1 (photoperiod-responsive 1), which shows upregulated expression in induced leaves (SD). PHOR1 encodes an arm repeat protein with homology to the Drosophila segment polarity protein armadillo. Antisense inhibition of PHOR1 produces a semidwarf phenotype similar to that of GA-deficient plants, and the antisense lines show reduced GA responsiveness combined with a higher endogenous GA content than wild-type plants. Feedback regulation of GA biosynthetic genes is also altered in these lines. Conversely, transgenic lines overexpressing PHOR1 show an enhanced response to GA. GA application induces rapid migration of PHOR1-GFP protein to the nucleus. Thus, PHOR1 appears to be a general component of GA signaling pathways that relocalizes to the nucleus in the presence of GA.	CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, ES-08034 Barcelona, Spain; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Prat, S (corresponding author), CSIC, Inst Biol Mol Barcelona, Dept Mol Genet, Jordi Girona 18-26, ES-08034 Barcelona, Spain.		Elena, Monte/I-7221-2015; Prat, Salome/L-9240-2014	Prat, Salome/0000-0003-2684-5485; Monte, Elena/0000-0002-7340-9355				AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; Dale TC, 1998, BIOCHEM J, V329, P209; Ewing E. E., 1992, Horticultural Reviews, V14, P89; Ewing Elmer E., 1995, P698; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Hedden P, 2000, CURR OPIN BIOTECH, V11, P130, DOI 10.1016/S0958-1669(00)00071-9; Hedden P, 1999, PLANT PHYSIOL, V119, P365, DOI 10.1104/pp.119.2.365; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jackson SD, 1996, PHYSIOL PLANTARUM, V98, P407, DOI 10.1034/j.1399-3054.1996.980224.x; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lange T, 1998, PLANTA, V204, P409, DOI 10.1007/s004250050274; Lovegrove A, 2000, TRENDS PLANT SCI, V5, P102, DOI 10.1016/S1360-1385(00)01571-5; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Monte E, 1999, PLANT J, V19, P399, DOI 10.1046/j.1365-313X.1999.00537.x; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pukatzki S, 1998, J BIOL CHEM, V273, P24131, DOI 10.1074/jbc.273.37.24131; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Shi LF, 1998, PLANT MOL BIOL, V38, P1053, DOI 10.1023/A:1006007315718; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Smith HMS, 1999, PLANT PHYSIOL, V119, P1157, DOI 10.1104/pp.119.4.1157; Sun TP, 2000, CURR OPIN PLANT BIOL, V3, P374, DOI 10.1016/S1369-5266(00)00099-6; Swain SM, 1996, PLANT PHYSIOL, V112, P11, DOI 10.1104/pp.112.1.11; TALON M, 1990, PLANTA, V182, P501, DOI 10.1007/BF02341024; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; VANDENBERG JH, 1995, J PLANT PHYSIOL, V146, P467, DOI 10.1016/S0176-1617(11)82010-9; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	44	137	161	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					343	354		10.1016/S0092-8674(01)00445-7	http://dx.doi.org/10.1016/S0092-8674(01)00445-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509183	Bronze			2022-12-24	WOS:000170433300012
J	Corma, A; Nemeth, LT; Renz, M; Valencia, S				Corma, A; Nemeth, LT; Renz, M; Valencia, S			Sn-zeolite beta as a heterogeneous chemoselective catalyst for Baeyer-Villiger oxidations	NATURE			English	Article							HYDROGEN-PEROXIDE; PLATINUM COMPLEXES; CYCLIC-KETONES	The Baeyer-Villiger oxidation, first reported more than 100 years ago(1), has evolved into a versatile reaction widely used(2) to convert ketones-readily available building blocks in organic chemistry-into more complex and valuable esters and lactones. Catalytic versions of the Baeyer-Villiger oxidation are particularly attractive for practical applications, because catalytic transformations simplify processing conditions while minimizing reactant use as well as waste production. Further benefits are expected from replacing peracids, the traditionally used oxidant, by cheaper and less polluting hydrogen peroxide(3). Dissolved platinum complexes(4) and solid acids, such as zeolites(5,6) or sulphonated resins(7), efficiently activate ketone oxidation by hydrogen peroxide. But these catalysts lack sufficient selectivity for the desired product if the starting material contains functional groups other than the ketone group; they perform especially poorly in the presence of carbon-carbon double bonds. Here we show that upon incorporation of 1.6 weight per cent tin into its framework, zeolite beta acts as an efficient and stable heterogeneous catalyst for the Baeyer-Villiger oxidation of saturated as well as unsaturated ketones by hydrogen peroxide, with the desired lactones forming more than 98% of the reaction products. We ascribe this high selectivity to direct activation of the ketone group, whereas other catalysts first activate hydrogen peroxide, which can then interact with the ketone group as well as other functional groups.	Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain; Universal Oil Prod, UOP LLC, Des Plaines, IL 60017 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Avda Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	Renz, Michael/B-9361-2011; CANOS, AVELINO CORMA/A-3040-2013; Valencia, Susana/I-4644-2015	Renz, Michael/0000-0002-1101-9562; CANOS, AVELINO CORMA/0000-0002-2232-3527; Valencia, Susana/0000-0001-7160-2795				Arends IWCE, 1997, ANGEW CHEM INT EDIT, V36, P1144, DOI 10.1002/anie.199711441; Baeyer A., 1899, CHEM BER, V32, P3625; Bhaumik A, 1996, CATAL LETT, V40, P47, DOI 10.1007/BF00807456; CAMBLOR MA, 1992, J CHEM SOC CHEM COMM, P589, DOI 10.1039/c39920000589; CHANG CD, 1996, Patent No. 4870192; Corma A., 1999, US Patent, Patent No. [5968473A, 5968473]; Fischer J, 1999, APPL CATAL A-GEN, V180, P435, DOI 10.1016/S0926-860X(98)00378-0; FRISONE MD, 1993, ORGANOMETALLICS, V12, P148; Gavagnin R, 1998, ORGANOMETALLICS, V17, P661, DOI 10.1021/om970756f; HERRMANN WA, 1994, J MOL CATAL, V94, P213, DOI 10.1016/S0304-5102(94)87043-8; HERRMANN WA, 1995, J ORGANOMET CHEM, V500, P149, DOI 10.1016/0022-328X(95)00518-U; HOELDERICH W, 1999, Patent No. 19745442; Huang HH, 2001, WATER RES, V35, P2291, DOI 10.1016/S0043-1354(00)00496-6; JACOBSON SE, 1978, J CHEM SOC CHEM COMM, P888, DOI 10.1039/c39780000888; Kelly D. R., 1998, BIOTRANSFORMATIONS A, V8a, P535; Palazzi C, 2000, J MOL CATAL A-CHEM, V151, P245, DOI 10.1016/S1381-1169(99)00249-6; Renz M, 1999, EUR J ORG CHEM, V1999, P737; SEN T, 1995, J CHEM SOC CHEM COMM, P207, DOI 10.1039/c39950000207; Shambayati S., 1991, COMPREHENSIVE ORGANI, V1, P283; Strukul G, 1998, ANGEW CHEM INT EDIT, V37, P1199, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1198::AID-ANIE1198>3.0.CO;2-Y	20	788	825	19	537	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					423	425		10.1038/35086546	http://dx.doi.org/10.1038/35086546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473313				2022-12-24	WOS:000170068200043
J	Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL				Volkman, SK; Barry, AE; Lyons, EJ; Nielsen, KM; Thomas, SM; Choi, M; Thakore, SS; Day, KP; Wirth, DF; Hartl, DL			Recent origin of Plasmodium falciparum from a single progenitor	SCIENCE			English	Article							CHLOROQUINE RESISTANCE; POPULATION-STRUCTURE; ANTIGENIC VARIATION; MALARIA; GENE; ERYTHROCYTES; MUTATIONS; SEQUENCE; SURFACE; PROTEIN	Genetic variability of Plasmodium falciparum underlies its transmission success and thwarts efforts to control disease caused by this parasite. Genetic variation in antigenic, drug resistance, and pathogenesis determinants is abundant, consistent with an ancient origin of P. falciparum, whereas DNA variation at silent (synonymous) sites in coding sequences appears virtually absent, consistent with a recent origin of the parasite. To resolve this paradox, we analyzed introns and demonstrated that these are deficient in single-nucleotide polymorphisms, as are synonymous sites in coding regions. These data establish the recent origin of P. falciparum and further provide an explanation for the abundant diversity observed in antigen and other selected genes.	Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Norwegian Univ Sci & Technol, Dept Bot, N-7491 Trondheim, Norway	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Norwegian University of Science & Technology (NTNU)	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Oxford Genome Divers Project, 665 Huntington Ave, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu	Nielsen, Kaare Magne/G-8107-2018; Day, Karen/F-3697-2015	Nielsen, Kaare Magne/0000-0002-7217-2114; Day, Karen/0000-0002-6115-6135; Barry, Alyssa/0000-0002-1189-2310				Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BIGGS BA, 1991, P NATL ACAD SCI USA, V88, P9171, DOI 10.1073/pnas.88.20.9171; Biswas S, 2000, TROP MED INT HEALTH, V5, P737, DOI 10.1046/j.1365-3156.2000.00632.x; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; BRUCECHWATT LJ, 1965, B WORLD HEALTH ORGAN, V32, P363; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hughes AL, 1998, GENETICS, V150, P511; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; JARCHO S, 1964, B HIST MED, V37, P1; KEMP DJ, 1990, ADV PARASIT, V29, P75; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li W-H, 1997, MOL EVOLUTION; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; MCCUTCHAN TF, 1990, IMMUNOL LETT, V25, P23, DOI 10.1016/0165-2478(90)90085-5; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 1998, GENETICS, V150, P515; Rich SM, 1997, P NATL ACAD SCI USA, V94, P13040, DOI 10.1073/pnas.94.24.13040; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; 2000, WHO TECH REP SER, V892, P1	33	128	134	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					482	484		10.1126/science.1059878	http://dx.doi.org/10.1126/science.1059878			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463913				2022-12-24	WOS:000169966700044
J	Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC				Abrieu, A; Magnaghi-Jaulin, L; Kahana, JA; Peter, M; Castro, A; Vigneron, S; Lorca, T; Cleveland, DW; Labbe, JC			Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint	CELL			English	Article							SPINDLE ASSEMBLY CHECKPOINT; POLE BODY DUPLICATION; XENOPUS EGG EXTRACTS; DEPENDENT PROTEIN-KINASE; CENP-E; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; UNATTACHED KINETOCHORES; CHROMOSOME ALIGNMENT; ANAPHASE INITIATION	The mitotic checkpoint acts to inhibit entry into anaphase until all chromosomes have successfully attached to spindle microtubules. Unattached kinetochores are believed to release an activated form of Mad2 that inhibits APC/C-dependent ubiquitination and subsequent proteolysis of components needed for anaphase onset. Using Xenopus egg extracts, a vertebrate homolog of yeast Mps1p is shown here to be a kinetochore-associated kinase, whose activity is necessary to establish and maintain the checkpoint. Since high levels of Mad2 overcome checkpoint loss in Mps1-depleted extracts, Mps1 acts upstream of Mad2-mediated inhibition of APC/C. Mps1 is essential for the checkpoint because it is required for recruitment and retention of active CENP-E at kinetochores, which in turn is necessary for kinetochore association of Mad1 and Mad2.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; CNRS, UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Abrieu, Ariane/P-3307-2019; CASTRO, ANNA/F-4350-2010; Abrieu, Ariane/G-6336-2013; labbe, jean-claude/B-2277-2009; Cleveland, Don/AAN-9783-2021; Peter, Marion/Y-5024-2019	CASTRO, ANNA/0000-0002-3655-1352; Abrieu, Ariane/0000-0002-0942-8877; Peter, Marion/0000-0002-5720-4798; Peter, Matthias/0000-0002-2160-6824; Lorca, Thierry/0000-0003-2007-8924; Cleveland, Don/0000-0002-1934-3682				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Brady DM, 2000, CURR BIOL, V10, P675, DOI 10.1016/S0960-9822(00)00515-7; Brown KD, 1996, J CELL SCI, V109, P961; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 1997, METHOD ENZYMOL, V283, P572; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HOGG D, 1994, ONCOGENE, V9, P89; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1994, BBA-MOL CELL RES, V1223, P325, DOI 10.1016/0167-4889(94)90091-4; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MILLS GB, 1992, J BIOL CHEM, V267, P16000; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MORIN N, 1994, EMBO J, V13, P4343, DOI 10.1002/j.1460-2075.1994.tb06754.x; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Shapiro PS, 1998, J CELL BIOL, V142, P1533, DOI 10.1083/jcb.142.6.1533; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	55	264	283	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					83	93		10.1016/S0092-8674(01)00410-X	http://dx.doi.org/10.1016/S0092-8674(01)00410-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461704	Bronze			2022-12-24	WOS:000169870300011
J	Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC				Grishok, A; Pasquinelli, AE; Conte, D; Li, N; Parrish, S; Ha, I; Baillie, DL; Fire, A; Ruvkun, G; Mello, CC			Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C-elegans developmental timing	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; CELL-DIFFERENTIATION; MESSENGER-RNA; LIN-4 RNA; PROTEINS; TRANSCRIPTION; TRANSLATION; HELICASE; SEQUENCE	RNAi is a gene-silencing phenomenon triggered by double-stranded (ds) RNA and involves the generation of 21 to 26 nt RNA segments that guide mRNA destruction. In Caenorhabditis elegans, lin-4 and let-7 encode small temporal RNAs (stRNAs) of 22 nt that regulate stage-specific development. Here we show that inactivation of genes related to RNAi pathway genes, a homolog of Drosophila Dicer (dcr-1), and two homologs of rde-1 (alg-1 and alg-2), cause heterochronic phenotypes similar to lin-4 and let-7 mutations. Further we show that dcr-1, alg-1, and alg-2 are necessary for the maturation and activity of the lin-4 and let-7 stRNAs. Our findings suggest that a common processing machinery generates guide RNAs that mediate both RNAi and endogenous gene regulation.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Johns Hopkins Univ, Biol Grad Program, Baltimore, MD 21218 USA; Simon Fraser Univ, Inst Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Carnegie Inst Sci, Baltimore, MD 21210 USA; Hanwha Chem R&D Inst, Daejun 305345, South Korea	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Simon Fraser University; Carnegie Institution for Science	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Pillay, Nischalan/F-9536-2012	Fire, Andrew/0000-0001-6217-8312; Grishok, Alla/0000-0001-8922-7575	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07321, R01 GM037706, GM58800, GM37706] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Antebi A, 1998, DEVELOPMENT, V125, P1191; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Baulcombe D, 1999, ARCH VIROL, P189; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lynn K, 1999, DEVELOPMENT, V126, P469; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schmidt A, 1999, GENETICS, V151, P749; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Stewart HI, 1998, MOL GEN GENET, V260, P280, DOI 10.1007/PL00013816; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wilson JE, 1996, DEVELOPMENT, V122, P1631; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	42	1437	1634	3	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					23	34		10.1016/S0092-8674(01)00431-7	http://dx.doi.org/10.1016/S0092-8674(01)00431-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461699	Bronze			2022-12-24	WOS:000169870300006
J	SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL				SHEEHAN, PM; FASTOVSKY, DE; HOFFMANN, RG; BERGHAUS, CB; GABRIEL, DL			SUDDEN EXTINCTION OF THE DINOSAURS - LATEST CRETACEOUS, UPPER GREAT-PLAINS, USA	SCIENCE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTIONS	Results of a three-year field study of family-level patterns of ecological diversity of dinosaurs in the Hell Creek Formation of Montana and North Dakota show no evidence (probability P < 0.05) of a gradual decline of dinosaurs at the end of the Cretaceous. Stratigraphic reliability was maintained through a tripartite division of the Hell Creek, and preservational biases were corrected for by comparison of results only from similar facies as well as through the use of large-scale, statistically rigorous survey and collection procedures. The findings are in agreement with an abrupt extinction event such as one caused by an asteroid impact.	UNIV RHODE ISL, DEPT GEOL, KINGSTON, RI 02881 USA; MED COLL WISCONSIN, DIV BIOSTAT, MILWAUKEE, WI 53226 USA	University of Rhode Island; Medical College of Wisconsin	SHEEHAN, PM (corresponding author), MILWAUKEE PUBL MUSEUM, DEPT GEOL, MILWAUKEE, WI 53233 USA.							ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1987, PHYS TODAY, V40, P24, DOI 10.1063/1.881078; ALVAREZ LW, 1983, P NATL ACAD SCI USA, V80, P627, DOI 10.1073/pnas.80.2.627; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ARCHIBALD JD, 1982, AM SCI, V70, P377; ARCHIBALD JD, 1987, MEM SOC GEOL FR, V150, P45; Behrensmeyer A.K., 1980, P72; BOHOR BF, 1984, SCIENCE, V224, P867, DOI 10.1126/science.224.4651.867; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; CARPENTER K, 1983, NATURWISSENSCHAFTEN, V70, P611, DOI 10.1007/BF00377404; Clemens W.A., 1986, P63; CLEMENS WA, 1981, PALEOBIOLOGY, V7, P293, DOI 10.1017/S0094837300004589; CLEMENS WA, 1980, MEM SOC GEOL FR, V139, P67; CLEMENS WA, 1982, GEOL SOC AM SPEC PAP, V190, P407; Cody M. L., 1975, ECOLOGY EVOLUTION CO; FASTOVSKY D E, 1987, Palaios, V2, P282, DOI 10.2307/3514678; FASTOVSKY DE, 1986, GEOLOGY, V14, P279, DOI 10.1130/0091-7613(1986)14<279:SSAEDT>2.0.CO;2; Fastovsky DE, 1990, GEOLOGICAL SOC AM SP, V247, P541, DOI [10.1130/SPE247-p541, DOI 10.1130/SPE247-P541]; GABRIEL DL, 1980, LORE, V30, P24; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; Hutchinson G.E., 1978, INTRO POPULATION ECO; JOHNSON KR, 1987, GEOL SOC AM ABSTR, V19, P718; JOHNSON KR, 1990, GEOL SOC AM ABSTR, V22, pA323; Kraus M.J., 1986, PALEOSOLS THEIR RECO, P180; MacArthur R.H., 1972, pvii; May R.M., 1975, P81; MORRIS PJ, 1990, GEOL SOC AM SPEC PAP, V247, P433; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; OFFICER CB, 1990, J GEOL EDUC, V38, P402; Padian K., 1985, P41; PADIAN K, 1989, AGE DINOSAURS SHORT, V2; PIELOU E C, 1969, P286; RAUP D M, 1975, Paleobiology, V1, P333; RAUP DM, 1979, SCIENCE, V206, P217, DOI 10.1126/science.206.4415.217; RETALLACK G, 1986, SCIENCE, V234, P1170, DOI 10.1126/science.234.4781.1170; RUSSELL DA, 1984, NATURE, V307, P360, DOI 10.1038/307360a0; RUSSELL DA, 1982, SCI AM, V246, P58, DOI 10.1038/scientificamerican0182-58; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; RUSSELL LS, 1973, CAN J EARTH SCI, V10, P140, DOI 10.1139/e73-016; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; SCHOPF TJM, 1982, GEOL SOC AM SPEC PAP, V190, P415; SERENO PC, 1986, NATL GEOGR RES, V2, P234; SHEEHAN PM, 1986, SCIENCE, V234, P1171, DOI 10.1126/science.234.4781.1171; Simberloff D., 1978, BIOL DATA WATER POLL, P150; SLOAN RE, 1986, SCIENCE, V232, P629, DOI 10.1126/science.232.4750.629; SLOAN RE, 1976, ATHLON ESSAYS PALAEO, P134; SLOAN RE, 1987, GEOL SOC AM ABSTR, V19, P848; SMIT J, 1984, SCIENCE, V223, P1177, DOI 10.1126/science.223.4641.1177; Smit J., 1987, MEM SOC GEOL FR, V150, P53; SMITH AB, 1988, EVOL BIOL, V23, P127; Strong D.R., 1984, ECOLOGICAL COMMUNITI; TAMM V, 1991, GEOL ASS CAN ABSTR, V16, pA122; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; van Valen L, 1977, Evolutionary Theory, V2, P37; VANVALEN L, 1977, NATURE, V270, P193, DOI 10.1038/270193a0; WARD PD, 1990, GEOL SOC AM ABSTR, V22, pA356; Weishampel D.B., 1990, DINOSAURIA; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; ZACHOS JC, 1989, NATURE, V337, P61, DOI 10.1038/337061a0; ZALEHA MJ, 1987, SEPM ANN MIDYEAR M, V4, P94	62	93	98	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	1991	254	5033					835	839		10.1126/science.11536489	http://dx.doi.org/10.1126/science.11536489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	11536489				2022-12-24	WOS:A1991GN83300038
J	ZAHNLE, K; GRINSPOON, D				ZAHNLE, K; GRINSPOON, D			COMET DUST AS A SOURCE OF AMINO-ACIDS AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article											ZAHNLE, K (corresponding author), NASA,AMES RES CTR,MS 245-3,MOFFETT FIELD,CA 94035, USA.							ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BROMLEY R, 1979, CRETACEOUS TERTIARY, P16; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; CLUBE SVM, 1986, GALAXY SOLAR SYSTEM, P260; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; CRONIN JR, 1989, NATURE, V339, P423, DOI 10.1038/339423a0; DONNISON JR, 1986, ASTRON ASTROPHYS, V167, P359; GILMOUR I, 1989, GEOCHIM COSMOCHIM AC, V53, P503, DOI 10.1016/0016-7037(89)90401-8; HEISLER J, 1987, ICARUS, V70, P269, DOI 10.1016/0019-1035(87)90135-7; Hills J. G., 1986, GALAXY SOLAR SYSTEM, P397; HUGHES DW, 1987, ASTRON ASTROPHYS, V187, P879; HUT P, 1987, NATURE, V329, P118, DOI 10.1038/329118a0; Jessberger E. K., 1989, ORIGIN EVOLUTION PLA, P167; KASTNER M, 1984, SCIENCE, V226, P137, DOI 10.1126/science.226.4671.137; OBERBECK V, 1988, ORIG LIFE, V19, P39; OLSSONSTEEL D, 1987, MON NOT R ASTRON SOC, V227, P501, DOI 10.1093/mnras/227.2.501; OLSSONSTEEL D, 1988, ICARUS, V75, P64, DOI 10.1016/0019-1035(88)90127-3; PREISINGER A, 1986, NATURE, V322, P794, DOI 10.1038/322794a0; SEKANINA Z, 1984, ICARUS, V58, P81, DOI 10.1016/0019-1035(84)90099-X; STOHL J, 1987, ASTRON ASTROPHYS, V187, P933; SURLYK F, 1979, CRETACEOUS TERTIARY, P164; VICKERY A, IN PRESS GLOBAL CATA; WHIPPLE F, 1976, MEM SOC R LIEGE 6, V55, P101; WHIPPLE FL, 1951, ASTROPHYS J, V113, P464, DOI 10.1086/145416; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; ZAHNLE K, 1989, B AM ASTRON SOC, V21, P923; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0	28	60	61	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 8	1990	348	6297					157	160		10.1038/348157a0	http://dx.doi.org/10.1038/348157a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG776	11536472				2022-12-24	WOS:A1990EG77600054
J	Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW				Wang, HY; Ma, LG; Li, JM; Zhao, HY; Deng, XW			Direct interaction of Arabidopsis cryptochromes with COP1 in light control development	SCIENCE			English	Article							BZIP PROTEIN; GENE; ENCODES; HY5	Arabidopsis seedling photomorphogenesis involves two antagonistically acting components, COP1 and HY5. COP1 specifically targets HY5 for degradation via the 26S proteasome in the dark through their direct physical interaction. Little is known regarding how light signals perceived by photoreceptors are transduced to regulate COP1. Arabidopsis has two related cryptochromes (cry1 and cry2) mediating various blue/ultraviolet-A light responses. Here we show that both photoactivated cryptochromes repress COP1 activity through a direct protein-protein contact and that this direct regulation is primarily responsible for the cryptochrome-mediated blue light regulation of seedling photomorphogenic development and genome expression profile.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Beijing Univ, Coll Life Sci, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, Beijing 100871, Peoples R China; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Peking University; Yale University	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Deng, Xing Wang/ABF-4107-2020		NIGMS NIH HHS [GM59507, GM-47850] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047850, R01GM047850, R37GM047850, R01GM059507] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Holm M, 1999, PLANT MOL BIOL, V41, P151, DOI 10.1023/A:1006324115086; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; MA L, IN PRESS PLANT CELL; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; MCNELLIS TW, 1994, PLANT CELL, V6, P1391, DOI 10.1105/tpc.6.10.1391; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7	23	371	410	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					154	158		10.1126/science.1063630	http://dx.doi.org/10.1126/science.1063630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11509693				2022-12-24	WOS:000171448800050
J	Johnson, JP; Zagotta, WN				Johnson, JP; Zagotta, WN			Rotational movement during cyclic nucleotide-gated channel opening	NATURE			English	Article							LIGAND-BINDING DOMAIN; ACTIVATED CHANNELS; GATING MACHINERY; REARRANGEMENTS; STOICHIOMETRY; TRANSITION; MECHANISM; RESIDUE; NICKEL; CELLS	Cyclic nucleotide-gated (CNG) channels are crucial components of visual, olfactory and gustatory signalling pathways. They open in response to direct binding of intracellular cyclic nucleotides and thus contribute to cellular control of both the membrane potential and intracellular Ca2+ levels(1). Cytosolic Ni2+ potentiates the rod channel (CNG1) response to cyclic nucleotides(2-4) and inhibits the olfactory channel (CNG2) response(5). Modulation is due to coordination of Ni2+ by channel-specific histidines in the Clinker, between the S6 transmembrane segment and the cyclic nucleotide-binding domain. Here we report, using a histidine scan of the initial C-linker of the CNG1 channel, stripes of sites producing Ni2+ potentiation or Ni2+ inhibition, separated by 50 degrees on an a-helix. These results suggest a model for channel gating where rotation of the post-S6 region around the channel's central axis realigns the Ni2+-coordinating residues of multiple subunits. This rotation probably initiates movement of the S6 and pore opening.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357290, Seattle, WA 98195 USA.			Johnson Jr., J.P./0000-0002-5762-5138	NEI NIH HHS [R01 EY010329, R01 EY010329-08] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cowan J.A., 1997, INORGANIC BIOCH INTR; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Maroney MJ, 1999, CURR OPIN CHEM BIOL, V3, P188, DOI 10.1016/S1367-5931(99)80032-5; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Shammat IM, 1999, NEURON, V23, P809, DOI 10.1016/S0896-6273(01)80038-6; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	26	88	90	1	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					917	921		10.1038/35091089	http://dx.doi.org/10.1038/35091089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528481				2022-12-24	WOS:000170689000047
J	Raj, K; Ogston, P; Beard, P				Raj, K; Ogston, P; Beard, P			Virus-mediated killing of cells that lack p53 activity	NATURE			English	Article							ADENOASSOCIATED VIRUS; DNA-DAMAGE; E2 PROTEIN; PHOSPHORYLATION; REQUIREMENT; INHIBITION; MITOSIS; KINASE; CDC25C; PHASE	A major goal of molecular oncology is to identify means to kill cells lacking p53 function. Most current cancer therapy is based on damaging cellular DNA by irradiation or chemicals. Recent reports(1,2) support the notion that, in the event of DNA damage, the p53 tumour-suppressor protein is able to prevent cell death by sustaining an arrest of the cell cycle at the G2 phase. We report here that adeno-associated virus (AAV) selectively induces apoptosis in cells that lack active p53. Cells with intact p53 activity are not killed but undergo arrest in the G2 phase of the cell cycle. This arrest is characterized by an increase in p53 activity and p21 levels and by the targeted destruction of CDC25C. Neither cell killing nor arrest depends upon AAV-encoded proteins. Rather, AAV DNA, which is single-stranded with hairpin structures at both ends(3,4), elicits in cells a DNA damage response that, in the absence of active p53, leads to cell death. AAV inhibits tumour growth in mice. Thus viruses can be used to deliver DNA of unusual structure into cells to trigger a DNA damage response without damaging cellular DNA and to selectively eliminate those cells lacking p53 activity.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Beard, P (corresponding author), Swiss Inst Expt Canc Res, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.							BEAMISH H, 1994, INT J RADIAT BIOL, V65, P175, DOI 10.1080/09553009414550211; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; DELAMAZA LM, 1981, JNCI-J NATL CANCER I, V67, P1323; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fournier N, 1999, ONCOGENE, V18, P4015, DOI 10.1038/sj.onc.1202775; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ogston P, 2000, J VIROL, V74, P3494, DOI 10.1128/JVI.74.8.3494-3504.2000; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; RUFFING M, 1992, J VIROL, V66, P6922, DOI 10.1128/JVI.66.12.6922-6930.1992; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; WOZNIAK AJ, 1983, CANCER RES, V43, P120; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG DZ, 1995, NAT STRUCT BIOL, V2, P577, DOI 10.1038/nsb0795-577	22	161	173	1	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					914	917		10.1038/35091082	http://dx.doi.org/10.1038/35091082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528480				2022-12-24	WOS:000170689000046
J	Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G				Aizenberg, J; Tkachenko, A; Weiner, S; Addadi, L; Hendler, G			Calcitic microlenses as part of the photoreceptor system in brittlestars	NATURE			English	Article							OPHIUROIDEA; ECHINODERMATA; BIOMINERALIZATION; LOCALIZATION	Photosensitivity in most echinoderms has been attributed to 'diffuse' dermal receptors(1-3). Here we report that certain single calcite crystals used by brittlestars for skeletal construction(4,5) are also a component of specialized photosensory organs, conceivably with the function of a compound eye. The analysis of arm ossicles in Ophiocoma(6) showed that in light-sensitive species, the periphery of the labyrinthic calcitic skeleton extends into a regular array of spherical microstructures that have a characteristic double-lens design. These structures are absent in light-indifferent species. Photolithographic experiments in which a photoresist film was illuminated through the lens array showed selective exposure of the photoresist under the lens centres. These results provide experimental evidence that the microlenses are optical elements that guide and focus the light inside the tissue. The estimated focal distance (4-7 mum below the lenses) coincides with the location of nerve bundles-the presumed primary photoreceptors. The lens array is designed to minimize spherical aberration and birefringence and to detect light from a particular direction. The optical performance is further optimized by phototropic chromatophores that regulate the dose of illumination reaching the receptors. These structures represent an example of a multifunctional biomaterial that fulfills both mechanical and optical functions.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; Natl Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Weizmann Institute of Science	Aizenberg, J (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Tkachenko, Alexei V/I-9040-2012	Tkachenko, Alexei V/0000-0003-1291-243X				Aizenberg J, 1997, APPL PHYS LETT, V71, P3773, DOI 10.1063/1.120502; Ameye L, 1999, J HISTOCHEM CYTOCHEM, V47, P1189, DOI 10.1177/002215549904700911; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; CLARKSON ENK, 1975, NATURE, V254, P663, DOI 10.1038/254663a0; COBB JLS, 1990, COMP BIOCHEM PHYS A, V97, P329, DOI 10.1016/0300-9629(90)90619-4; COBB JLS, 1986, J NEUROCYTOL, V15, P97, DOI 10.1007/BF02057908; Cowles RP, 1910, J EXP ZOOL, V9, P387, DOI 10.1002/jez.1400090209; Doderlein L, 1898, DENKSCHR MED NAT GES, V8, P491; DONNAY G, 1969, SCIENCE, V166, P1147, DOI 10.1126/science.166.3909.1147; FLINT HT, 1936, GEOMETRICAL OPTICS; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; HENDLER G, 1984, PSZNI MAR ECOL, V5, P379, DOI 10.1111/j.1439-0485.1984.tb00131.x; HENDLER G, 1987, ZOOMORPHOLOGY, V107, P261, DOI 10.1007/BF00312172; Hyman L.H., 1955, INVERTEBRATES, V4; Johnsen S, 1997, BIOL BULL, V193, P97, DOI 10.2307/1542739; Land M. F., 1981, COMP PHYSL EVOLUTI B, P471; Lowenstam H. A., 1989, BIOMINERALISATION, P123; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; Smith AB., 1980, SPEC PAP PALAEONTOL, V25, P1; Stubbs T.R., 1982, Echinoderms, P403; TOWE KM, 1973, SCIENCE, V179, P1007, DOI 10.1126/science.179.4077.1007; Wainwright S.A., 1976, MECH DESIGN ORGANISM; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yoshida M., 1984, PHOTORECEPTION ECHIN, P743	25	468	494	9	232	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					819	822		10.1038/35090573	http://dx.doi.org/10.1038/35090573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518966				2022-12-24	WOS:000170577200037
J	Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S				Lewis, S; Sherratt, TN; Hamer, KC; Wanless, S			Evidence of intra-specific competition for food in a pelagic seabird	NATURE			English	Article							COLONY DISTRIBUTIONS; BRITISH-ISLES; POPULATION; SIZE; SEA	The factors affecting the population dynamics of seabirds have long intrigued biologists(1-5). Current data suggest that density-dependent depletion of prey during the breeding season may regulate population size(6-9). However, much of the evidence for this has been circumstantial, and the underlying mechanisms are unclear(5,10). Here, we show that the per capita population growth rates of northern gannet Morus bassanus at colonies in Britain and Ireland have declined with increasing population size. Furthermore, direct observations reveal that the mean foraging trip duration of breeding gannets is positively correlated with colony size, both among colonies of different sizes in the same year, and within colonies as they change in size. To understand this phenomenon, we have developed a model which demonstrates that disturbance of fish alone can readily generate conditions under which gannets at larger colonies have to travel further to obtain food.	Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; Ctr Ecol & Hydrol, Banchory Res Stn, Hill Of Brathens AB31 4BW, Aberdeen, Scotland	Durham University; UK Centre for Ecology & Hydrology (UKCEH)	Sherratt, TN (corresponding author), Univ Durham, Dept Biol Sci, South Rd, Durham DH1 3LE, England.		Wanless, Sarah/K-2338-2012; Lewis, Sue/D-3380-2012	Wanless, Sarah/0000-0002-2788-4606; 				ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Birkhead T.R., 1985, P145; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; CAIRNS DK, 1989, AM NAT, V134, P141, DOI 10.1086/284970; COULSON JC, 1983, BIRD STUDY, V30, P9, DOI 10.1080/00063658309476769; CRAMP S, 1974, SEABIRDS BRITAIN IRE, P238; Croxall JP., 1987, SEABIRDS FEEDING ECO; CROXALL JP, 1991, BIRD POPULATION STUD, P272; Fisher J, 1943, J ANIM ECOL, V12, P173, DOI 10.2307/1376; Forbes LS, 2000, ECOGRAPHY, V23, P575, DOI 10.1034/j.1600-0587.2000.230508.x; Furness R. W., 1997, P INT S ROL FOR FISH, P147; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; FURNESS RW, 1992, ARDEA, V80, P105; Garthe S, 1999, MAR ECOL PROG SER, V185, P93, DOI 10.3354/meps185093; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; Hamer KC, 2000, MAR ECOL PROG SER, V200, P257, DOI 10.3354/meps200257; HAMER KC, IN PRESS MAR ECOL PR; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; LACK D, 1966, POPULATION STUDIES B, P252; LLOYD C, 1991, STATUS SEABIRDS BRIT, P13; LOGERWELL EA, 1997, P INT S ROL FOR FISH, P191; MONAGHAN P, 1989, J FISH BIOL, V35, P339; Murray S., 1997, Scottish Birds, V19, P10; MURRAY S, 1986, Scottish Birds, V14, P74; NELSON J.B., 1978, SULIDAE GANNETS BOOB; NUR N, 2000, BIRD STUDY, V46, P575; POLLARD E, 1987, ECOLOGY, V68, P2046, DOI 10.2307/1939895; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; UPTON AJ, 2000, 24 JNCC UK NAT CONS; WOOLLER RD, 1992, TRENDS ECOL EVOL, V7, P111, DOI 10.1016/0169-5347(92)90143-Y	30	315	326	1	102	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					816	819		10.1038/35090566	http://dx.doi.org/10.1038/35090566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518965				2022-12-24	WOS:000170577200036
J	Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA				Sawka, AM; Young, WF; Thompson, GB; Grant, CS; Farley, DR; Leibson, C; van Heerden, JA			Primary aldosteronism: Factors associated with normalization of blood pressure after surgery	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY HYPERALDOSTERONISM; UNILATERAL ADRENALECTOMY; PERSISTENT HYPERTENSION; DIAGNOSIS; PREVALENCE; ADENOMA	Background: Hypertension often persists after adrenalectomy for primary aldosteronism. Objective: To determine factors associated with resolution of hypertension after adrenalectomy for primary aldosteronism. Design: Retrospective cohort study. Setting: Tertiary care referral center in Rochester, Minnesota. Patients: All patients who underwent adrenalectomy for primary aldosteronism between I January 1993 and 31 December 1999. Measurements: Preoperative plasma renin activity, plasma and urinary aldosterone concentrations, and adrenal imaging. Followup blood pressure, measured at a clinic visit or at home, was reviewed. Results: 97 adrenalectomies were performed, and follow-up was available in 93 patients. Hypertension was resolved at follow-up (blood pressure < 140/90 mm Hg) without use of antihypertensive agents in 31 of 93 patients (33%). According to a stepwise multivariable logistic regression analysis adjusted for duration of follow-up, resolution of hypertension was independently associated with family history of hypertension in no more than 1 first-degree relative (odds ratio [OR], 10.9; P < 0.001) and preoperative use of two or fewer antihypertensive agents (OR, 4.7; P = 0.005). Additional factors associated with resolution of hypertension based on univariate analysis included younger age, shorter duration of hypertension, higher preoperative ratio of plasma aldosterone concentration to plasma renin activity, and higher urine aldosterone level (P < 0.05). Conclusions: Resolution of hypertension after adrenalectomy for primary aldosteronism is independently associated with a lack of family history of hypertension and preoperative use of two or fewer anti hypertensive agents.	Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, Rochester, MN 55905 USA	Mayo Clinic	Young, WF (corresponding author), Mayo Clin & Mayo Fdn, Div Metab Endocrinol & Nutr, 200 1st St SW, Rochester, MN 55905 USA.		Sawka, Anna/AAA-4336-2020					BLUMENFELD JD, 1994, ANN INTERN MED, V121, P877, DOI 10.7326/0003-4819-121-11-199412010-00010; Celen O, 1996, ARCH SURG-CHICAGO, V131, P646; CONN JW, 1990, J LAB CLIN MED, V116, P253; FAVIA G, 1992, WORLD J SURG, V16, P680, DOI 10.1007/BF02067355; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; IRONY I, 1990, AM J HYPERTENS, V3, P576, DOI 10.1093/ajh/3.7.576; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Lo CY, 1996, ANN SURG, V224, P125, DOI 10.1097/00000658-199608000-00003; Loh KC, 2000, J CLIN ENDOCR METAB, V85, P2854, DOI 10.1210/jc.85.8.2854; LUND JO, 1981, ACTA MED SCAND, P54; *NAT HIGH BLOOD PR, 1997, REP JOINT NAT COMM P; OBARA T, 1992, SURGERY, V112, P987; Proye CAG, 1998, SURGERY, V124, P1128, DOI 10.1067/msy.1998.93108; Shen WT, 1999, ARCH SURG-CHICAGO, V134, P628, DOI 10.1001/archsurg.134.6.628; STOWASSER M, 1994, CLIN EXP PHARMACOL P, V21, P319, DOI 10.1111/j.1440-1681.1994.tb02520.x; STREETEN DHP, 1979, AM J MED, V67, P403, DOI 10.1016/0002-9343(79)90786-1; Torpy DJ, 1999, VITAM HORM, V57, P177; Young W F Jr, 1999, Cardiol Rev, V7, P207, DOI 10.1097/00045415-199907000-00012; Young WF, 1997, ENDOCRINOLOGIST, V7, P213, DOI 10.1097/00019616-199707040-00003	19	232	242	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					258	261		10.7326/0003-4819-135-4-200108210-00010	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511140				2022-12-24	WOS:000170587500004
J	Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP				Ylikorkala, A; Rossi, DJ; Korsisaari, N; Luukko, K; Alitalo, K; Henkemeyer, M; Makela, TP			Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC LETHALITY; FACTOR EXPRESSION; GENE; KINASE; ACTIVATION; CARCINOMA; HYPOXIA; PROTEIN; FLK-1	The LKB1 tumor suppressor gene, mutated in Peutz-Jeghers syndrome, encodes a serine/threonine kinase of unknown function. Here we show that mice with a targeted disruption of Lkb1 die at midgestation, with the embryos showing neural tube defects, mesenchymal cell death, and vascular abnormalities. Extraembryonic development was also severely affected; the mutant placentas exhibited defective labyrinth layer development and the fetal vessels failed to invade the placenta. These phenotypes were associated,with tissue-specific deregulation of vascular endothelial growth factor (VEGF) expression, including a marked increase in the amount of VEGF messenger RNA. Moreover, VEGF production in cultured Lkb1(-/-) fibroblasts was elevated in both normoxic and hypoxic conditions. These findings place Lkb1 in the VEGF signaling pathway and suggest that the vascular defects accompanying Lkb1 loss are mediated at least in part by VEGF.	Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Univ Bergen, Dept Anat & Cell Biol, N-5009 Bergen, Norway; Univ Helsinki, Cent Hosp, Diagnost Lab, Helsinki 00029, Finland; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75235 USA	University of Helsinki; University of Helsinki; University of Bergen; University of Helsinki; Helsinki University Central Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Makela, TP (corresponding author), Univ Helsinki, Haartman Inst, Mol & Canc Biol Program, POB 63, FIN-00014 Helsinki, Finland.		makela, tomi/B-3734-2009; Alitalo, Kari K/J-5013-2014	makela, tomi/0000-0002-4869-8044; Alitalo, Kari K/0000-0002-7331-0902; Henkemeyer, Mark/0000-0002-7525-1061				Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gleadle JM, 1997, BLOOD, V89, P503, DOI 10.1182/blood.V89.2.503; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Luukko K, 1999, MECH DEVELOP, V83, P187, DOI 10.1016/S0925-4773(99)00050-7; Pal S, 1997, J BIOL CHEM, V272, P27509, DOI 10.1074/jbc.272.44.27509; Siemeister G, 1996, CANCER RES, V56, P2299; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YLIKORKALA A, UNPUB	17	237	256	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1323	1326		10.1126/science.1062074	http://dx.doi.org/10.1126/science.1062074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509733				2022-12-24	WOS:000170492600042
J	Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A				Hammes, A; Guo, JK; Lutsch, G; Leheste, JR; Landrock, D; Ziegler, U; Gubler, MC; Schedl, A			Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation	CELL			English	Article							TUMOR-SUPPRESSOR GENE; SRY-RELATED GENE; FRASIER-SYNDROME; SUBNUCLEAR LOCALIZATION; CAMPOMELIC DYSPLASIA; GLOMERULAR PROTEIN; WT1; EXPRESSION; MOUSE; MUTATIONS	Alternative splicing of Wt1 results in the insertion or omission of the three amino acids KTS between zinc fingers 3 and 4. In vitro experiments suggest distinct molecular functions for + and -KTS isoforms. We have generated mouse strains in which specific isoforms have been removed. Heterozygous mice with a reduction of +KTS levels develop glomerulosclerosis and represent a model for Frasier syndrome. Homozygous mutants of both strains die after birth due to kidney defects. Strikingly, mice lacking +KTS isoforms show a complete XY sex reversal due to a dramatic reduction of Sry expression levels. Our data demonstrate distinct functions for the two splice variants and place the +KTS variants as important regulators for Sty in the sex determination pathway.	MDC Mol Med, D-13092 Berlin, Germany; Hop Necker Enfants Malad, Dept Pediat Nephrol, F-75743 Paris 15, France	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Schedl, A (corresponding author), Newcastle Univ, Sch Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andreas.schedl@ncl.ac.uk	Schedl, Andreas/GOP-3427-2022; Schedl, Andreas/F-8823-2015	Schedl, Andreas/0000-0001-9380-7396; Hammes-Lewin, Annette/0000-0003-1663-8378; Gubler, Marie-Claire/0000-0002-3526-5661				Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Davies RC, 2000, HUM MOL GENET, V9, P1177, DOI 10.1093/hmg/9.8.1177; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gubler M C, 1999, Adv Nephrol Necker Hosp, V29, P299; HACKER A, 1995, DEVELOPMENT, V121, P1603; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Hogan B, 1994, MANIPULATING MOUSE E; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Ito S, 1999, PEDIATR NEPHROL, V13, P790, DOI 10.1007/s004670050702; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; KENT J, 1995, ONCOGENE, V11, P1781; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; Kim J, 1999, MOL CELL BIOL, V19, P2289; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Ladomery MR, 1999, J BIOL CHEM, V274, P36520, DOI 10.1074/jbc.274.51.36520; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Menke AL, 1998, INT REV CYTOL, V181, P151, DOI 10.1016/S0074-7696(08)60418-0; Miles C, 1998, P NATL ACAD SCI USA, V95, P13068, DOI 10.1073/pnas.95.22.13068; Moore AW, 1999, DEVELOPMENT, V126, P1845; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Nagamine CM, 1999, DEV BIOL, V216, P182, DOI 10.1006/dbio.1999.9436; Patek CE, 1999, P NATL ACAD SCI USA, V96, P2931, DOI 10.1073/pnas.96.6.2931; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Toyooka Y, 1998, INT J DEV BIOL, V42, P1143; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WILLNOW TE, 1994, METHOD CELL BIOL, V43, P305	45	382	396	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					319	329		10.1016/S0092-8674(01)00453-6	http://dx.doi.org/10.1016/S0092-8674(01)00453-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509181	Bronze			2022-12-24	WOS:000170433300010
J	Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T				Amidzic, O; Riehle, HJ; Fehr, T; Wienbruch, C; Elbert, T			Pattern of focal gamma-bursts in chess players - Grandmasters call on regions of the brain not used so much by less skilled amateurs.	NATURE			English	Article							MEMORY		Univ Konstanz, D-78457 Constance, Germany	University of Konstanz	Amidzic, O (corresponding author), Univ Konstanz, Univ Str 10,Fac D30, D-78457 Constance, Germany.		Fehr, Thorsten/P-5058-2018; Elbert, Thomas/C-8556-2009	Fehr, Thorsten/0000-0002-2224-1740; Elbert, Thomas/0000-0003-1332-4939				Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Elo Arpad E, 1978, RATING CHESSPLAYERS; Gobet F, 1998, COGNITION, V66, P115, DOI 10.1016/S0010-0277(98)00020-1; Pulvermuller F, 1999, TRENDS COGN SCI, V3, P250, DOI 10.1016/S1364-6613(99)01344-3; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195	6	55	57	3	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					603	603		10.1038/35088119	http://dx.doi.org/10.1038/35088119			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	460PP	11493907	Green Published, Bronze			2022-12-24	WOS:000170318000027
J	Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH				Ridker, PM; Danesh, J; Youngman, L; Collins, R; Stampfer, MJ; Peto, R; Hennekens, CH			A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CHLAMYDIA-PNEUMONIAE; CARDIOVASCULAR RISK; INFECTION; INFLAMMATION; MORTALITY	Background: The role of Helicobacter pylori as a determinant of cardiovascular disease is controversial. Objective: To determine whether previous exposure to H. pylori is associated with an increased risk for myocardial infarction. Design: Prospective case-control study. Setting: Physicians' Health Study. Participants: Initially healthy U.S. men. Measurements: Titers of IgG antibody against H. pylori and several inflammatory markers were measured in baseline blood samples obtained from 445 men who subsequently had a myocardial infarction (case-patients) and 445 men matched for age and smoking status who remained free of vascular disease (controls) during a mean follow-up of 8.9 years. Results: Baseline seropositivity was similar among case-patients and controls (43.4% vs. 44.3%; rate ratio, 0.96 [95% Cl, 0.7 to 1.3]). Minimal evidence of association was found between magnitude of seropositivity and subsequent risk and between seropositivity and levels of the inflammatory biomarkers. Conclusion: in a socioeconomically homogeneous population, we found limited evidence of association between H. pylori exposure and risk for future myocardial infarction.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Leducq Ctr Mol & Genet Epidemiol Cardiovasc Dis, Ctr Cardiovasc Dis Prevent, Boston, MA USA; Univ Miami, Miami, FL 33152 USA; Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Miami; Radcliffe Infirmary; University of Oxford	Ridker, PM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58755] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aromaa A., 1996, Gut, V39, pA91; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Folsom AR, 1998, CIRCULATION, V98, P845, DOI 10.1161/01.CIR.98.9.845; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Ma J, 1999, J AM COLL CARDIOL, V33, P1347, DOI 10.1016/S0735-1097(99)00007-8; MURRAY LJ, 1995, BRIT HEART J, V74, P497; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1998, CIRCULATION, V97, P1671, DOI 10.1161/01.CIR.97.17.1671; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 1999, AM J MED, V106, P376; Strachan DP, 1998, CIRCULATION, V98, P1286, DOI 10.1161/01.CIR.98.13.1286; Strandberg TE, 1997, BRIT MED J, V314, P1317, DOI 10.1136/bmj.314.7090.1317; Wald NJ, 1997, BMJ-BRIT MED J, V315, P1199, DOI 10.1136/bmj.315.7117.1199; Whincup P, 2000, CIRCULATION, V101, P1647; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568; Witherell H, 1999, GASTROENTEROLOGY, V116, pA355	20	60	62	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					184	188		10.7326/0003-4819-135-3-200108070-00010	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487485				2022-12-24	WOS:000170298500004
J	Coker, R				Coker, R			Detention and mandatory treatment for tuberculosis patients in Russia	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, R (corresponding author), Univ London London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, Keppel St, London WC1E 7HT, England.							Coker R. J., 2000, CHAOS COERCION DETEN; COKER RJ, 1994, IN PRESS THORAX; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; FARMER P, 1999, GLOBAL IMPACT DRUG R; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V269, P255, DOI 10.1001/jama.269.2.255; KRAUT AM, 1994, SILENT TRAVELLERS GE; MACLEOD RM, 1967, PUBLIC LAW, V107, P189; RISSE GB, 1988, AIDS BURDENS HIST, P33; RISSE GB, 1988, AIDS BURDENS HIST; SHILOVA MV, 2000, TUBERCULOSIS RUSSIA; Stern V., 1999, SENTENCED DIE PROBLE; *U CAL FJ CURR NAT, 1996, P C OCT 24 26 1996; Wares DF, 1997, LANCET, V350, P957, DOI 10.1016/S0140-6736(05)63295-3	14	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					349	350		10.1016/S0140-6736(01)05587-8	http://dx.doi.org/10.1016/S0140-6736(01)05587-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502311				2022-12-24	WOS:000170235100006
J	Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O				Evans, J; Heron, J; Francomb, H; Oke, S; Golding, O		Avon Longitudinal Study Parents	Cohort study of depressed mood during pregnancy and after childbirth	BRITISH MEDICAL JOURNAL			English	Article							POSTNATAL DEPRESSION; PSYCHIATRIC-DISORDER; ASSOCIATION; PREVALENCE; WOMEN	Objective To follow mothers' mood through pregnancy and after childbirth and compare reported symptoms of depression at each stage. Design Longitudinal cohort study. Setting Avon. Participants Pregnant women resident within Avon with an expected date of delivery between 1 April 1991 and 31 December 1992. Main outcome measures Symptom scores from the Edinburgh postnatal depression scale at 18 and 32 weeks of pregnancy and 8 weeks and 8 months postpartum. Proportion of women above a threshold indicating probable depressive disorder. Results Depression scores were higher at 32 weeks of pregnancy than 8 weeks postpartum (difference in means 0.88, 95% confidence interval 0.79 to 0.97). There was no difference in the distribution of total scores or scores for individual items at the four time points. 1222 (13.5%) women scored above threshold for probable depression at 32 weeks of pregnancy, 821 (9.1%) at 8 weeks postpartum, and 147 (1.6%) throughout. More mothers moved above the threshold for depression between 18 weeks and 32 weeks of pregnancy than between 32 weeks of pregnancy and 8 weeks postpartum. Conclusions Symptoms of depression are not more common or severe after childbirth than during pregnancy. Research and clinical efforts need to be moved towards understanding, recognising, and treating antenatal depression.	Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Div Child Hlth, Bristol BS8 1TQ, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Dept Womens Hlth & Care Newborn, Bristol BS10 5NB, Avon, England; Barrow Hosp, Mother & Baby Unit, Bristol BS48 3SG, Avon, England	University of Bristol; University of Bristol; North Bristol NHS Trust; Southmead Hospital	Evans, J (corresponding author), Univ Bristol, Div Psychiat, Bristol BS2 8DZ, Avon, England.		Heron, Jon/D-5884-2011	Heron, Jon/0000-0001-6199-5644; Evans, Jonathan/0000-0003-3171-640X; Golding, Jean/0000-0003-2826-3307	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; COOPER PJ, 1988, BRIT J PSYCHIAT, V152, P799, DOI 10.1192/bjp.152.6.799; COX JL, 1982, BRIT J PSYCHIAT, V140, P111, DOI 10.1192/bjp.140.2.111; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crown S, 1979, MANUAL CROWN CRISP E; Fergusson DM, 1996, PAEDIATR PERINAT EP, V10, P279, DOI 10.1111/j.1365-3016.1996.tb00051.x; GREEN JM, 1991, BRIT J PSYCHIAT, V158, P865, DOI 10.1192/bjp.158.6.865a; GREEN JM, 1990, J REPROD INFANT PSYC, V0008; HARRIS B, 1992, BMJ-BRIT MED J, V305, P152, DOI 10.1136/bmj.305.6846.152; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; KENDELL RE, 1976, PSYCHOL MED, V6, P297, DOI 10.1017/S0033291700013854; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; OHARA MW, 1984, J ABNORM PSYCHOL, V93, P158, DOI 10.1037/0021-843X.93.2.158; OHARA MW, 1990, J ABNORM PSYCHOL, V99, P3, DOI 10.1037/0021-843X.99.1.3; PAGEL MD, 1990, SOC SCI MED, V30, P597, DOI 10.1016/0277-9536(90)90158-O; PITT B, 1968, BRIT J PSYCHIAT, V114, P1325, DOI 10.1192/bjp.114.516.1325; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; Spinelli MG, 1997, AM J PSYCHIAT, V154, P1028; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; Thorpe K., 1993, J REPROD INFANT PSYC, V11, P119, DOI [10.1080/02646839308403204, DOI 10.1080/02646839308403204]; WATSON JP, 1984, BRIT J PSYCHIAT, V144, P453, DOI 10.1192/bjp.144.5.453	24	870	889	1	71	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					257	260		10.1136/bmj.323.7307.257	http://dx.doi.org/10.1136/bmj.323.7307.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	461ZT	11485953	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000170394300017
J	Mustard, JF; Cooper, CD; Rifkin, MK				Mustard, JF; Cooper, CD; Rifkin, MK			Evidence for recent climate change on Mars from the identification of youthful near-surface ground ice	NATURE			English	Article							GLOBAL SURVEYOR; ORBITER CAMERA; WATER; BEHAVIOR; MODEL; VIEWS	Ground ice in the crust and soil may be one of the largest reservoirs of water on Mars(1-3). Near-surface ground ice is predicted to be stable at latitudes higher than 40 degrees (ref. 4), where a number of geomorphologic features indicative of viscous creep and hence ground ice have been observed(5). Mid-latitude soils have also been implicated as a water-ice reservoir(6), the capacity of which is predicted to vary on a 100,000-year timescale owing to orbitally driven variations in climate(7). It is uncertain, however, whether near-surface ground ice currently exists at these latitudes, and how it is changing with time. Here we report observational evidence for a mid-latitude reservoir of near-surface water ice occupying the pore space of soils. The thickness of the ice-occupied soil reservoir (1-10 m) and its distribution in the 30 degrees to 60 degrees latitude bands indicate a reservoir of (1.5-6.0) x 10(4) km(3), equivalent to a global layer of water 10-40 cm thick. We infer that the reservoir was created during the last phase of high orbital obliquity less than 100,000 years ago, and is now being diminished.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Mustard, JF (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.							Carr M.H, 1996, WATER MARS; Christensen, 1992, MARS, P686; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; COOPER CD, 2000, LUNAR PLANET SCI, V31, P1747; Edgett KS, 2000, J GEOPHYS RES-PLANET, V105, P1623, DOI 10.1029/1999JE001152; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Haberle RM, 1997, J GEOPHYS RES-PLANET, V102, P9051, DOI 10.1029/97JE00383; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; Houben H, 1997, J GEOPHYS RES-PLANET, V102, P9069, DOI 10.1029/97JE00046; Johnson JB, 2000, GEOPHYS RES LETT, V27, P2769, DOI 10.1029/1999GL011077; Kreslavsky MA, 2000, J GEOPHYS RES-PLANET, V105, P26695, DOI 10.1029/2000JE001259; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Metzger SM, 1999, GEOPHYS RES LETT, V26, P2781, DOI 10.1029/1999GL008341; MUSTARD JF, 2001, LUNAR PLANET SCI, V32, P1988; Renno NO, 2000, J GEOPHYS RES-PLANET, V105, P1859, DOI 10.1029/1999JE001037; Seibert NM, 2001, GEOPHYS RES LETT, V28, P899, DOI 10.1029/2000GL012093; SQURYES SW, 1986, SCIENCE, V231, P249; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; STORRS AD, 1988, ICARUS, V76, P493, DOI 10.1016/0019-1035(88)90017-6	20	425	429	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					411	414		10.1038/35086515	http://dx.doi.org/10.1038/35086515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473309				2022-12-24	WOS:000170068200039
J	Folkers, GK; Fauci, AS				Folkers, GK; Fauci, AS			The AIDS research model - Implications for other infectious diseases of global health importance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHALLENGES; PREVENTION; HIV/AIDS		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Bldg 31,Room 7A03,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	afauci@nih.gov						[Anonymous], WHO REP INF DIS REM; [Anonymous], 2001, NIAID GLOB HLTH RES; Auerbach JD, 2000, AM J PUBLIC HEALTH, V90, P1029, DOI 10.2105/AJPH.90.7.1029; Binswanger HP, 2001, SCIENCE, V292, P221, DOI 10.1126/science.1057504; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P250; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; Fauci AS, 1998, EMERG INFECT DIS, V4, P374, DOI 10.3201/eid0403.980308; GALLO RC, 1987, NATURE, V326, P435; Gellman Barton, 2000, WASH POST, pA01; GREENE WC, 1991, NEW ENGL J MED, V324, P308, DOI 10.1056/NEJM199101313240506; *I GLOB HLTH, 2000, GLOB HLTH FOR, V1; Institute of Medicine, 1997, AM VIT INT GLOB HLTH; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWRENCE C, 2001, HLTH FUNDING UPDATE; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; National Intelligence Council, 2000, GLOB INF DIS THREAT; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; SELIK RM, 1993, TRANSFUSION, V33, P890, DOI 10.1046/j.1537-2995.1993.331194082377.x; Shorter E, 1987, HLTH CENTURY; *UN GEN ASS SPEC S, 2001, GLOB CRIS GLOB ACT; *UNAIDS, 2000, REP GLOB HIV AIDS EP; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209; World Health Organization, 2000, WORLD HLTH REP 2000; 1998, MMWR MORB MORTAL WKL, V47, P43; 2000, HIV AIDS SURVEILLANC, V12, P1	28	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					458	461		10.1001/jama.286.4.458	http://dx.doi.org/10.1001/jama.286.4.458			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466126				2022-12-24	WOS:000170069000019
J	Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y				Saitoe, M; Schwarz, TL; Umbach, JA; Gundersen, CB; Kidokoro, Y			Absence of junctional glutamate receptor clusters in Drosophila mutants lacking spontaneous transmitter release	SCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; NEURONAL-SYNAPTOBREVIN; EMBRYOS; SYNAPSE; NEUROTRANSMITTER; MELANOGASTER; MUTATIONS; SYNTAXIN; LARVAE; CSP	Little is known about the functional significance of spontaneous miniature synaptic potentials, which are the result of vesicular exocytosis at nerve terminals. Here, by using Drosophila mutants with specific defects in presynaptic function, we found that glutamate receptors clustered normally at neuromuscular junctions of mutants that retained spontaneous transmitter secretion but had Lost the ability to release transmitter in response to action potential. In contrast, receptor clustering was defective in mutants in which both spontaneous and evoked vesicle exocytosis were absent. Thus, spontaneous vesicle exocytosis appears to be tightly Linked to the clustering of glutamate receptors during development.	Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan; Tokyo Metropolitan Inst Neurosci, Tokyo 1838526, Japan; Stanford Univ, Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Gunma University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saitoe, M (corresponding author), Gunma Univ, Sch Med, Inst Behav Sci, Gunma 3718511, Japan.			Gundersen, Cameron/0000-0002-1552-6086; Saitoe, Minoru/0000-0001-9731-4214				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; BROADIE KS, 1993, J NEUROSCI, V13, P144; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MORR J, COMMUNICATION; Nishikawa K, 1995, J NEUROSCI, V15, P7905; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; PESTRONK A, 1976, NATURE, V264, P787, DOI 10.1038/264787a0; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schulze KL, 1996, GENETICS, V144, P1713; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Yoshihara M, 1999, J NEUROSCI, V19, P2432	25	94	96	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					514	517		10.1126/science.1061270	http://dx.doi.org/10.1126/science.1061270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463917				2022-12-24	WOS:000169966700052
J	Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR				Turk, D; McPhaden, MJ; Busalacchi, AJ; Lewis, MR			Remotely sensed biological production in the equatorial Pacific	SCIENCE			English	Article							1997-98 EL-NINO; ATMOSPHERIC CO2; OCEAN; CARBON; EXPORT; MODEL; CYCLE	A combination of ship, buoy, and satellite observations in the tropical Pacific during the period from 1992 to 2000 provides a basin-scale perspective on the net effects of El Nino and La Nina on biogeochemical cycles. New biological production during the 1997-99 El Nino/La Nina period varied by more than a factor of 2, The resulting interannual changes in global carbon sequestration associated with the El Nino/La Nina cycle contributed to the Largest known natural perturbation of the global carbon cycle over these time scales.	Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA	Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park	Turk, D (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada.		McPhaden, Michael J/D-9799-2016	McPhaden, Michael J/0000-0002-8423-5805				BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BARBER RT, 1989, GLOBAL ECOLOGICAL CO, P21; BATTISTI DS, 1988, J ATMOS SCI, V45, P2889, DOI 10.1175/1520-0469(1988)045<2889:DATOAW>2.0.CO;2; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Cullen JJ, 1995, LIMNOL OCEANOGR, V40, P1336, DOI 10.4319/lo.1995.40.7.1336; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; Hackert EC, 2001, J GEOPHYS RES-OCEANS, V106, P2345, DOI 10.1029/1999JC000055; Leonard CL, 1996, INT J REMOTE SENS, V17, P721, DOI 10.1080/01431169608949040; McCarthy JJ, 1996, DEEP-SEA RES PT II, V43, P1065, DOI 10.1016/0967-0645(96)00022-7; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Meinen CS, 2001, J PHYS OCEANOGR, V31, P1324, DOI 10.1175/1520-0485(2001)031<1324:IVIWWV>2.0.CO;2; MURRAY JW, 1989, DEEP-SEA RES, V36, P1471, DOI 10.1016/0198-0149(89)90052-6; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; Murtugudde RG, 1999, J GEOPHYS RES-OCEANS, V104, P18351, DOI 10.1029/1999JC900135; PENA MA, 1992, MAR ECOL PROG SER, V80, P265, DOI 10.3354/meps080265; PICAUT J, IN PRESS RADAR ALTIM; Raimbault P, 1999, J GEOPHYS RES-OCEANS, V104, P3341, DOI 10.1029/1998JC900004; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Rodier M, 1997, DEEP-SEA RES PT II, V44, P2085, DOI 10.1016/S0967-0645(97)00092-1; SCHOPF PS, 1988, J ATMOS SCI, V45, P549, DOI 10.1175/1520-0469(1988)045<0549:VIACOM>2.0.CO;2; Siegel DA, 1999, J GEOPHYS RES-OCEANS, V104, P13359, DOI 10.1029/1999JC900051; Turk D, 2001, J GEOPHYS RES-OCEANS, V106, P4501, DOI 10.1029/1999JC000058; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; WHEELER P, UNPUB JOINT GLOBAL O; WILKERSON FP, 1992, J GEOPHYS RES-OCEANS, V97, P669, DOI 10.1029/91JC01534	31	58	73	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					471	474		10.1126/science.1056449	http://dx.doi.org/10.1126/science.1056449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463910				2022-12-24	WOS:000169966700041
J	ALVAREZ, W; ASARO, F; MONTANARI, A				ALVAREZ, W; ASARO, F; MONTANARI, A			IRIDIUM PROFILE FOR 10-MILLION YEARS ACROSS THE CRETACEOUS-TERTIARY BOUNDARY AT GUBBIO (ITALY)	SCIENCE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	ALVAREZ, W (corresponding author), UNIV CALIF BERKELEY, DEPT GEOL & GEOPHYS, BERKELEY, CA 94720 USA.				NIDCR NIH HHS [DE-AC03-76SF00098] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ LW, 1988, 196TH AM CHEM SOC NA; ALVAREZ W, 1985, J SEDIMENT PETROL, V55, P720; ALVAREZ W, 1977, GEOL SOC AM BULL, V88, P383, DOI 10.1130/0016-7606(1977)88<383:UCMSAG>2.0.CO;2; ALVAREZ W, 1990, SCI AM, V263, P78, DOI 10.1038/scientificamerican1090-78; Alvarez W., 1986, EOS, V67, P649, DOI [10.1029/EO067I035P00649, DOI 10.1029/EO067I035P00649]; ALVAREZ W, 1979, EOS, V60, P734; [Anonymous], [No title captured]; ARTHUR MA, 1977, GEOL SOC AM BULL, V88, P367, DOI 10.1130/0016-7606(1977)88<367:UCMSAG>2.0.CO;2; BERGGREN WA, 1985, GEOL SOC AM BULL, V96, P1407, DOI 10.1130/0016-7606(1985)96<1407:CG>2.0.CO;2; CROCKET JH, 1988, GEOLOGY, V16, P77, DOI 10.1130/0091-7613(1988)016<0077:DONMAT>2.3.CO;2; FISCHER AG, 1986, SOC GEOL ITAL MEM, V31, P45; HERBERT TD, 1990, EARTH PLANET SC LETT, V99, P263, DOI 10.1016/0012-821X(90)90115-E; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Herbert TD, 1986, PALEOCEANOGRAPHY, V1, P495, DOI 10.1029/PA001i004p00495; JOHNSSON MJ, 1986, J SEDIMENT PETROL, V56, P501; KENT DV, 1985, GEOL SOC AM BULL, V96, P1419, DOI 10.1130/0016-7606(1985)96<1419:ACAJG>2.0.CO;2; KOTAKE N, 1989, LETHAIA, V22, P327, DOI 10.1111/j.1502-3931.1989.tb01349.x; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; LOWRIE W, 1990, EARTH PLANET SC LETT, V98, P303, DOI 10.1016/0012-821X(90)90032-S; LOWRIE W, 1981, GEOLOGY, V9, P392, DOI 10.1130/0091-7613(1981)9<392:OHMYOG>2.0.CO;2; LUTERBACHER H. P., 1962, RIV ITAL PALEONTOL E STRATIGR, V68, P253; MICHEL HV, 1985, INITIAL REP DEEP SEA, V86, P533; MICHEL HV, 1990, P OC DRILL PROGR SCI, V0113; ORTH CJ, 1984, SCIENCE, V223, P163, DOI 10.1126/science.223.4632.163; ROCCHIA R, 1990, EARTH PLANET SC LETT, V99, P206, DOI 10.1016/0012-821X(90)90111-A; Schwarzacher W, 1987, PALEOCEANOGRAPHY, V2, P79, DOI 10.1029/PA002i001p00079; SCHWARZACHER W, 1982, CYCLIC EVENT STRATIF, P72; SHARPTON VL, IN PRESS GEOL SOC AM, V247; SMIT J, COMMUNICATION; SMIT J, 1989, TERR ABS, V1, P421; TORNAGHI M E, 1989, Rivista Italiana di Paleontologia e Stratigrafia, V95, P223; VANNUCCI R, 1982, RENDICONTI SOC ITALI, V38, P413; WEZEL FC, 1981, CR ACAD SCI II, V293, P837	34	50	52	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	1990	250	4988					1700	1702		10.1126/science.11538083	http://dx.doi.org/10.1126/science.11538083			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN920	11538083				2022-12-24	WOS:A1990EN92000037
J	MELOSH, HJ				MELOSH, HJ			THE ROCKY ROAD TO PANSPERMIA	NATURE			English	Letter											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Curran D. R., 1977, IMPACT EXPLOSION CRA, P1057; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Melosh H.J., 1981, P 17 LUN PLAN SCI, V12A, P29; MELOSH HJ, 1984, ICARUS, V59, P234, DOI 10.1016/0019-1035(84)90026-5; MELOSH HJ, 1985, GEOLOGY, V13, P144, DOI 10.1130/0091-7613(1985)13<144:EORFFP>2.0.CO;2; Mitchell F.J., 1972, ANAL SURVEYOR 3 MAT, P239; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; RODDY DJ, 1987, INT J IMPACT ENG, V5, P525; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; VICKERY AM, 1987, SCIENCE, V237, P738, DOI 10.1126/science.237.4816.738; WETHERILL GW, 1984, METEORITICS, V19, P1	12	147	149	3	80	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					687	688		10.1038/332687a0	http://dx.doi.org/10.1038/332687a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11536601				2022-12-24	WOS:A1988N029300038
J	Walsh, EC; Stainier, DYR				Walsh, EC; Stainier, DYR			UDP-glucose dehydrogenase required for cardiac valve formation in zebrafish	SCIENCE			English	Article							ENDOCARDIAL CUSHION FORMATION; TGF-BETA RECEPTOR; CELL-TRANSFORMATION; NEUREGULIN RECEPTOR; HEART; GENE; BIOSYNTHESIS; DROSOPHILA; MORPHOGENESIS; PROTEOGLYCANS	Cardiac valve formation is a complex process that involves cell signaling events between the myocardial and endocardial layers of the heart across an elaborate extracellular matrix. These signals lead to marked morphogenetic movements and transdifferentiation of the endocardial cells at chamber boundaries. Here we identify the genetic defect in zebrafish jekyll mutants, which are deficient in the initiation of heart valve formation. The jekyll mutation disrupts a homolog of Drosophila Sugarless, a uridine 5'-diphosphate (UDP)-glucose dehydrogenase required for heparan sulfate, chondroitin sulfate, and hyaluronic acid production, The atrioventricular border cells do not differentiate from their neighbors in jekyll mutants, suggesting that Jekyll is required in a cell signaling event that establishes a boundary between the atrium and ventricle.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026	NHLBI NIH HHS [HL54737] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Binari RC, 1997, DEVELOPMENT, V124, P2623; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Kim C., UNPUB; Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 1999, DEVELOPMENT, V126, P3715; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Postlethwait JH, 1997, TRENDS GENET, V13, P183, DOI 10.1016/S0168-9525(97)01129-3; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; SAQI MAS, 1994, COMPUT APPL BIOSCI, V10, P545; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C, 1999, DEVELOPMENT, V126, P229; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; WALSH EC, UNPUB; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406	34	230	233	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1670	1673		10.1126/science.293.5535.1670	http://dx.doi.org/10.1126/science.293.5535.1670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533493				2022-12-24	WOS:000170802900066
J	Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A				Ballard, C; Fosssey, J; Chithramohan, R; Howard, R; Burns, A; Thompson, P; Tadros, G; Fairbairn, A			Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Royal Coll Psychiatrists, London SW1X 8PG, England		Fairbairn, A (corresponding author), Royal Coll Psychiatrists, London SW1X 8PG, England.		Howard, Robert/E-4890-2010	Burns, Alistair/0000-0002-9837-0645; Ballard, Clive/0000-0003-0022-5632; Howard, Robert/0000-0002-3071-2338				Brooker D., 1995, J MENTAL HLTH, V4, P145, DOI DOI 10.1080/09638239550037686; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; *DEP HLTH, 1999, FIT FUT NAT REQ STAN; Kitwood T., 1997, EVALUATING DEMENTIA; LEAPER R, 1998, TRAINING QUALIFICATI	5	74	75	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					426	427		10.1136/bmj.323.7310.426	http://dx.doi.org/10.1136/bmj.323.7310.426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520838	Bronze, Green Published			2022-12-24	WOS:000170793600019
J	Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E				Lewis, J; Dickson, DW; Lin, WL; Chisholm, L; Corral, A; Jones, G; Yen, SH; Sahara, N; Skipper, L; Yager, D; Eckman, C; Hardy, J; Hutton, M; McGowan, E			Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP	SCIENCE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; BETA-PROTEIN; IN-VIVO; A-BETA; PRESENILIN-1; GENE; MUTATIONS; A-BETA-42(43)	JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressing mutant beta -amyloid precursor protein (APP), thus modulating the APP-A beta (beta -amyloid peptide) environment. The resulting double mutant (tau/APP) progeny and the Tg2576 parental strain developed A beta deposits at the same age; however, relative to JNPL3 mice, the double mutants exhibited neurofibrillary tangle pathology that was substantially enhanced in the limbic system and olfactory cortex. These results indicate that either APP or A beta influences the formation of neurofibrillary tangles. The interaction between A beta and tau pathologies in these mice supports the hypothesis that a similar interaction occurs in Alzheimer's disease.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA	Mayo Clinic	Hutton, M (corresponding author), Mayo Clin Jacksonville, Birdsall Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	hutton.michael@mayo.edu	Hardy, John/C-2451-2009	Hardy, John/0000-0002-3122-0423; Dickson, Dennis W/0000-0001-7189-7917; Skipper, Lisa/0000-0002-1524-9787	NATIONAL INSTITUTE ON AGING [Z01AG000951, ZIAAG000951] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; DeTure M, 2001, ALZHEIMER'S DISEASE, P651, DOI 10.1002/0470846453.ch60; DICKSON DW, 1993, ACTA NEUROPATHOL, V85, P463; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P131; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Haugabook SJ, 2001, FASEB J, V15, P16; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kawas C, 1999, ALZHEIMER DIS, P95; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LEWIS J, 2000, NEUROSCI NEWS, V3, P63; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; MIKOL J, 1980, ACTA NEUROPATHOL, V49, P57, DOI 10.1007/BF00692220; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	37	1150	1225	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1487	1491		10.1126/science.1058189	http://dx.doi.org/10.1126/science.1058189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520987				2022-12-24	WOS:000170616000044
J	Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS				Michaud, DS; Giovannucci, E; Willett, WC; Colditz, GA; Stampfer, MJ; Fuchs, CS			Physical activity, obesity, height, and the risk of pancreatic cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-FAT DISTRIBUTION; NATIONAL DEATH INDEX; GROWTH-FACTOR-I; DIABETES-MELLITUS; ACTIVITY QUESTIONNAIRE; NUTRITIONAL FACTORS; INSULIN; MORTALITY; MEN; GLUCOSE	Context Diabetes mellitus and elevated postload plasma glucose levels have been associated with an increased risk of pancreatic cancer in previous studies. By virtue of their influence on insulin resistance, obesity and physical inactivity may increase risk of pancreatic cancer. Objective To examine obesity, height, and physical activity in relation to pancreatic cancer risk. Design and Setting Two US cohort studies conducted by mailed questionnaire, the Health Professionals Follow-Up Study (initiated in 1986) and the Nurses' Health Study (initiated in 1976), with 10 to 20 years of follow-up. Participants A total of 46648 men aged 40 to 75 years and 117041 women aged 30 to 55 years who were free of prior cancer at baseline and had complete data on height and weight. Main Outcome Measures Relative risk of pancreatic cancer, analyzed by self-reported body mass index (BMI), height, and level of physical activity. Results During follow-up, we documented 350 incident pancreatic cancer cases. Individuals with a BMI of at least 30 kg/m(2) had an elevated risk of pancreatic cancer compared with those with a BMI of less than 23 kg/m(2) (multivariable relative risk [RR], 1.72; 95% confidence interval [CI], 1.19-2.48), Height was associated with an increased pancreatic cancer risk (multivariable RR, 1.81; 95% CI, 1.31-2.52 for the highest vs lowest categories). An inverse relation was observed for moderate activity (multivariable RR, 0.45; 95% CI, 0.29-0.70 for the highest vs lowest categories; P for trend <.001). Total physical activity was not associated with risk among individuals with a BMI of less than 25 kg/m(2) but was inversely associated with risk among individuals with a BMI of at least 25 kg/m(2) (pooled multivariable RR, 0.59; 95% CI, 0.37-0.94 for the top vs bottom tertiles of total physical activity; P for trend=.04). Conclusion In 2 prospective cohort studies, obesity significantly increased the risk of pancreatic cancer. Physical activity appears to decrease the risk of pancreatic cancer, especially among those who are overweight.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Michaud, DS (corresponding author), NCI, 6120 Execut Blvd,EPS Room 7026, Rockville, MD 20852 USA.	michaudd@mail.nih.gov	Colditz, Graham/A-3963-2009; Michaud, Dominique S/I-5231-2014	Colditz, Graham/0000-0002-7307-0291; 	NATIONAL CANCER INSTITUTE [P01CA087969, R01CA086102] Funding Source: NIH RePORTER; NCI NIH HHS [CA 87969, CA 86102, CA 55075] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlgren JD, 1996, SEMIN ONCOL, V23, P241; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBANES D, 1988, CANCER RES, V48, P1658; *AM CANC SOC INC, 2000, CANC FACTS FIG 2000; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; BERGMANN U, 1995, CANCER RES, V55, P2007; BOYLE P, 1989, INT J PANCREATOL, V5, P327, DOI 10.1007/BF02924298; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CHAPMAN DG, 1968, BIOMETRICS, V24, P315, DOI 10.2307/2528037; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chow WH, 1999, BRIT J CANCER, V79, P640, DOI 10.1038/sj.bjc.6690101; Coughlin SS, 2000, CANCER CAUSE CONTROL, V11, P915, DOI 10.1023/A:1026580131793; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEMESQUITA HBB, 1992, INT J CANCER, V52, P24, DOI 10.1002/ijc.2910520106; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DiPietro L, 1998, J AM GERIATR SOC, V46, P875, DOI 10.1111/j.1532-5415.1998.tb02722.x; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; GHADIRIAN P, 1991, INT J CANCER, V47, P1, DOI 10.1002/ijc.2910470102; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; HENDERSON JR, 1981, GUT, V22, P158, DOI 10.1136/gut.22.2.158; HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306; Ji BT, 1996, INT J CANCER, V66, P432; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P375, DOI 10.1007/BF00051341; Kelley DE, 1999, MED SCI SPORT EXER, V31, pS619, DOI 10.1097/00005768-199911001-00021; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; LEVINE W, 1990, AM J EPIDEMIOL, V131, P254, DOI 10.1093/oxfordjournals.aje.a115495; LYON JL, 1993, CANCER EPIDEM BIOMAR, V2, P513; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; OHMURA E, 1990, CANCER RES, V50, P103; OSHIDA Y, 1989, J APPL PHYSIOL, V66, P2206, DOI 10.1152/jappl.1989.66.5.2206; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; SHIBATA A, 1994, INT J CANCER, V58, P46, DOI 10.1002/ijc.2910580109; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Silverman DT, 2001, TERATOGEN CARCIN MUT, V21, P7, DOI 10.1002/1520-6866(2001)21:1<7::AID-TCM3>3.0.CO;2-A; Smith GD, 1998, BMJ-BRIT MED J, V317, P1351, DOI 10.1136/bmj.317.7169.1351; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TAKEDA Y, 1991, J CANCER RES CLIN, V117, P416, DOI 10.1007/BF01612760; Wang MY, 1998, CANCER RES, V58, P38; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	50	435	446	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					921	929		10.1001/jama.286.8.921	http://dx.doi.org/10.1001/jama.286.8.921			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509056	Bronze			2022-12-24	WOS:000170577300026
J	Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M				Lopes, M; Cotta-Ramusino, C; Pellicioli, A; Liberi, G; Plevani, P; Muzi-Falconi, M; Newlon, CS; Foiani, M			The DNA replication checkpoint response stabilizes stalled replication forks	NATURE			English	Article							S-PHASE; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINTS; ORIGINS; PROGRESSION; PROTEIN; PHOSPHORYLATION; RECOMBINATION; ACTIVATION; PLASMIDS	In response to DNA damage and blocks to replication, eukaryotes activate the checkpoint pathways that prevent genomic instability and cancer by coordinating cell cycle progression with DNA repair(1-5). In budding yeast, the checkpoint response requires the Mec1-dependent activation of the Rad53 protein kinase(3,4,6). Active Rad53 slows DNA synthesis when DNA is damaged(7) and prevents firing of late origins of replication(8,9). Further, rad53 mutants are unable to recover from a replication block 10. Mec1 and Rad53 also modulate the phosphorylation state of different DNA replication and repair enzymes(6,11-13). Little is known of the mechanisms by which checkpoint pathways interact with the replication apparatus when DNA is damaged or replication blocked. We used the two-dimensional gel technique(14) to examine replication intermediates in response to hydroxyurea-induced replication blocks. Here we show that hydroxyurea-treated rad53 mutants accumulate unusual DNA structures at replication forks. The persistence of these abnormal molecules during recovery from the hydroxyurea block correlates with the inability to dephosphorylate Rad53. Further, Rad53 is required to properly maintain stable replication forks during the block. We propose that Rad53 prevents collapse of the fork when replication pauses.	Ist FIRC Oncol Mol, I-20141 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microorganismi, I-20133 Milan, Italy; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	IFOM - FIRC Institute of Molecular Oncology; University of Milan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Foiani, M (corresponding author), Ist FIRC Oncol Mol, Via Serio 21, I-20141 Milan, Italy.		Muzi-Falconi, Marco/A-6035-2012; Pellicioli, Achille/B-8765-2017; LIBERI, GIORDANO/AAY-7273-2020; Lopes, Massimo/G-4300-2013; Foiani, Marco/M-8234-2014	Muzi-Falconi, Marco/0000-0001-7046-6090; Pellicioli, Achille/0000-0002-1528-9009; LIBERI, GIORDANO/0000-0003-3160-2242; Foiani, Marco/0000-0003-4795-834X; Lopes, Massimo/0000-0003-3847-8133; PLEVANI, PAOLO/0000-0003-1869-2626	Telethon [E.1108] Funding Source: Medline	Telethon(Fondazione Telethon)		Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FOIANI M, 2000, MUTAT RES, V21, P286; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; MARTINPARRAS L, 1992, J BIOL CHEM, V267, P22496; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rothstein R, 2000, GENE DEV, V14, P1; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Weinert T, 1997, CANCER SURV, V29, P109; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	29	607	620	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					557	561		10.1038/35087613	http://dx.doi.org/10.1038/35087613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484058				2022-12-24	WOS:000170202900050
J	Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T				Nielsen, SJ; Schneider, R; Bauer, UM; Bannister, AJ; Morrison, A; O'Carroll, D; Firestein, R; Cleary, M; Jenuwein, T; Herrera, RE; Kouzarides, T			Rb targets histone H3 methylation and HP1 to promoters	NATURE			English	Article							RETINOBLASTOMA PROTEIN; CHROMATIN-STRUCTURE; IN-VIVO; DEACETYLASE; EXPRESSION; DOMAIN	In eukaryotic cells the histone methylase SUV39H1 and the methyl-lysine binding protein HP1 functionally interact to repress transcription at heterochromatic sites(1). Lysine 9 of histone H3 is methylated by SUV39H1 (ref. 2), creating a binding site for the chromo domain of HP1 (refs 3, 4). Here we show that SUV39H1 and HP1 are both involved in the repressive functions of the retinoblastoma (Rb) protein. Rb associates with SUV39H1 and HP1 in vivo by means of its pocket domain. SUV39H1 cooperates with Rb to repress the cyclin E promoter, and in fibroblasts that are disrupted for SUV39, the activity of the cyclin E and cyclin A2 genes are specifically elevated. Chromatin immunoprecipitations show that Rb is necessary to direct methylation of histone H3, and is necessary for binding of HP1 to the cyclin E promoter. These results indicate that the SUV39H1-HP1 complex is not only involved in heterochromatic silencing but also has a role in repression of euchromatic genes by Rb and perhaps other co-repressor proteins.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Dept Pathol, Cambridge CB2 1QR, England; Baylor Coll Med, Dept Mol & Cellular Biol, Breast Ctr, Houston, TX 77030 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA	Baylor College of Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University	Kouzarides, T (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk		O'Carroll, Donal/0000-0002-8626-2217; Bannister, Andrew/0000-0002-6312-4436; Morrison, Ashby/0000-0003-1228-5093; Kouzarides, Tony/0000-0002-8918-4162	NIGMS NIH HHS [R25 GM056929] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Korner K, 2000, J BIOL CHEM, V275, P18676, DOI 10.1074/jbc.M001110200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8	19	704	741	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					561	565		10.1038/35087620	http://dx.doi.org/10.1038/35087620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484059				2022-12-24	WOS:000170202900051
J	Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D				Clark, JS; Carpenter, SR; Barber, M; Collins, S; Dobson, A; Foley, JA; Lodge, DM; Pascual, M; Pielke, R; Pizer, W; Pringle, C; Reid, WV; Rose, KA; Sala, O; Schlesinger, WH; Wall, DH; Wear, D			Ecological forecasts: An emerging imperative	SCIENCE			English	Editorial Material							SPREAD; AGRICULTURE; INVASION; MALARIA; MODELS; CARBON; CO2	Planning and decision-making can be improved by access to reliable forecasts of ecosystem state, ecosystem services, and natural capital. Availability of new data sets, together with progress in computation and statistics, will increase our ability to forecast ecosystem change. An agenda that would lead toward a capacity to produce, evaluate, and communicate forecasts of critical ecosystem services requires a process that engages scientists and decision-makers. interdisciplinary linkages are necessary because of the climate and societal controls on ecosystems, the feedbacks involving social change, and the decision-making relevance of forecasts.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Ecol Soc Amer, Washington, DC 20006 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI 53706 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Natl Ctr Atmospher Res, Environm & Societal Impacts Grp, Boulder, CO 80301 USA; Resources Future Inc, Washington, DC 20036 USA; Univ Georgia, Dept Ecol, Athens, GA 30602 USA; Millennium Ecosyst Assessment, Seattle, WA 98103 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Univ Buenos Aires, CONICET, Fac Agron, IFEVA,Dept Ecol, RA-1417 Buenos Aires, DF, Argentina; Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Forest Serv, USDA, Res Triangle Pk, NC 27709 USA	Duke University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Princeton University; University of Wisconsin System; University of Wisconsin Madison; University of Notre Dame; University of Michigan System; University of Michigan; National Center Atmospheric Research (NCAR) - USA; Resources for the Future; University System of Georgia; University of Georgia; Louisiana State University System; Louisiana State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Duke University; Colorado State University; United States Department of Agriculture (USDA); United States Forest Service	Clark, JS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	jimclark@duke.edu	Collins, Scott L/P-7742-2014; Clark, James S./G-6331-2011; Wall, Diana H/F-5491-2011; Foley, Jonathan A/GRS-5522-2022; Lodge, David Michael/AAX-1781-2021; Rose, Kenneth/AAA-3534-2022; Carpenter, Stephen/AAQ-6404-2020; Pringle, Catherine M/I-1841-2012	Collins, Scott L/0000-0002-0193-2892; Rose, Kenneth/0000-0002-9310-8410; Sala, Osvaldo/0000-0003-0142-9450				[Anonymous], 2000, SPECIAL REPORT EMISS; Benstead JP, 1999, ECOL APPL, V9, P656, DOI 10.1890/1051-0761(1999)009[0656:EOALHD]2.0.CO;2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V2; *BIO SERV, 1981, PRES IMPL FOR ORG SH, V1; Brabets T. P, 1996, 964001 US GEOL SURV; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Carlin B. P., 2000, C&H TEXT STAT SCI; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Carpenter SR, 2000, ECOSYSTEMS, V3, P495, DOI 10.1007/s100210000043; Clark J., UNPUB; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Dye C, 2000, SCIENCE, V289, P1697; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; HARRISON S, 1993, CONSERV BIOL, V7, P950, DOI 10.1046/j.1523-1739.1993.740950.x; JUDGE GG, 1982, THEORY PRACTICE ECON; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.1890/0012-9658(1999)080[0298:IIMTEA]2.0.CO;2; Nalepa TF, 1995, J GREAT LAKES RES, V21, P411, DOI 10.1016/S0380-1330(95)71055-3; *NAT AC SCI, 2001, UND WEATH CLIM EC IN; *NAT AC SCI, 2000, GRAND CHALL ENV SCI; National Research Council, 1999, MAK CLIM FOR MATT; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; RASKIN P, 2000, 8 STOCKH ENV I POL S; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Richards J.F., 1990, EARTH TRANSFORMED HU, P163; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SAREWITZ D, 2000, PREDICTION SCI POLIC; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shugart H.H., 1984, THEORY FOREST DYNAMI; Stokstad E, 1999, SCIENCE, V285, P1199, DOI 10.1126/science.285.5431.1199; Strayer DL, 1999, J N AM BENTHOL SOC, V18, P74, DOI 10.2307/1468010; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Wear DN, 1998, ECOSYSTEMS, V1, P575, DOI 10.1007/s100219900052; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Wikle CK, 2001, J AM STAT ASSOC, V96, P382, DOI 10.1198/016214501753168109	45	622	658	7	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					657	660		10.1126/science.293.5530.657	http://dx.doi.org/10.1126/science.293.5530.657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474103				2022-12-24	WOS:000170204600045
J	Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR				Fernandez-Lopez, S; Kim, HS; Choi, EC; Delgado, M; Granja, JR; Khasanov, A; Kraehenbuehl, K; Long, G; Weinberger, DA; Wilcoxen, KM; Ghadiri, MR			Antibacterial agents based on the cyclic D,L-alpha-peptide architecture	NATURE			English	Article							TRANSMEMBRANE ION CHANNELS; ANTIMICROBIAL PEPTIDES; NANOTUBES; MEMBRANES; CELLS; DYES	The rapid emergence of bacterial infections that are resistant to many drugs underscores the need for new therapeutic agents(1-3). Here we report that six- and eight-residue cyclic D,L-alpha -peptides act preferentially on Gram-positive and/or Gram-negative bacterial membranes compared to mammalian cells, increase membrane permeability, collapse transmembrane ion potentials, and cause rapid cell death. The effectiveness of this class of materials as selective antibacterial agents is highlighted by the high efficacy observed against lethal methicillin-resistant Staphylococcus aureus infections in mice. Cyclic D,L-alpha -peptides are proteolytically stable, easy to synthesize, and can be derived from a potentially vast membrane-active sequence space. The unique abiotic structure of the cyclic peptides and their quick bactericidal action may also contribute to limit temporal acquirement of drug resistant bacteria. The low molecular weight D,L-alpha -peptides offer an attractive complement to the current arsenal of naturally derived antibiotics, and hold considerable potential in combating a variety of existing and emerging infectious diseases.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ghadiri, MR (corresponding author), Scripps Res Inst, Dept Chem, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ghadiri@scripps.edu	Abrams, William R/A-5782-2008; Long, Georgina V/C-1771-2013; Granja, Juan R/P-7646-2014	Long, Georgina V/0000-0001-8894-3545; Granja, Juan R/0000-0002-5842-7504				AMSTERDAM D, 1991, ANTIBIOTICS LAB MED, P53; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Clark TD, 1998, J AM CHEM SOC, V120, P651, DOI 10.1021/ja972786f; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; GRANJA JR, 1994, J AM CHEM SOC, V116, P10785, DOI 10.1021/ja00102a054; Khurshid MA, 1999, MMWR-MORBID MORTAL W, V48, P1165; Kim HS, 1998, J AM CHEM SOC, V120, P4417, DOI 10.1021/ja9735315; KIM HS, 1999, SELF ASSEMBLING CYCL, pCH3; Koplan J. P, 1998, PREVENTING EMERGING; LOEW LM, 1994, ADV CHEM SER, V235, P151; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Oren Z, 1998, BIOPOLYMERS, V47, P451; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Seebach D, 1997, HELV CHIM ACTA, V80, P173, DOI 10.1002/hlca.19970800116; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403	22	788	822	4	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					452	455		10.1038/35086601	http://dx.doi.org/10.1038/35086601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473322				2022-12-24	WOS:000170068200052
J	Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD				Crespo-Facorro, B; Paradiso, S; Andreasen, NC; O'Leary, DS; Watkins, GL; Ponto, LLB; Hichwa, RD			Neural mechanisms of anhedonia in schizophrenia - A PET study of response to unpleasant and pleasant odors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; NUCLEUS-ACCUMBENS; BRAIN ACTIVITY; COGNITIVE DYSMETRIA; FUNCTIONAL-ANATOMY; FACIAL EXPRESSIONS; OLFACTORY FUNCTION; <O-15>WATER PET; CEREBELLAR	Context Loss of the capacity to experience pleasure (anhedonia) is a core clinical feature of schizophrenia. Although functional imaging techniques have been successful in identifying the neural basis of cognitive impairments in schizophrenia, no attempts to date have been made to investigate neural systems underlying emotional disturbances. Objective To study the neural basis of emotional processing in schizophrenia by exploring the pattern of brain responses to olfactory stimuli in patients and healthy volunteers. Design Positron emission tomographic study of patients with schizophrenia and healthy volunteers, Positron emission tomographic data were collected between July 21, 1995, and September 11, 1997, and data analyses were conducted in 1999-2001. Setting The Mental Health Clinical Research Center at the University of Iowa, Iowa City. Participants Sixteen healthy volunteers with a mean age of 29.5; years and 18 patients with schizophrenia and a mean age of 30.0 years. Main Outcome Measure Areas of relative increase or decrease in regional cerebral blood flow, measured using positron emission tomography and the [O-15]water method while participants performed an emotion-induction olfactory task to determine response to pleasant (vanillin) and unpleasant (4-methylvaleric acid) odors, compared between patients and healthy volunteers. Results Patients with schizophrenia subjectively experienced unpleasant odors in a manner similar to healthy volunteers but showed impairment in the experience of pleasant odors. The analysis of the regional cerebral blood flow revealed that patients failed to activate limbic/paralimbic regions (eg, insular cortex, nucleus accumbens, and parahippocampal gyrus) during the experience of unpleasant odors, recruiting a compensatory set of frontal cortical regions instead. Conclusion Abnormalities in the complex functional interactions between mesolimbic and frontal regions may underlie emotional disturbances in schizophrenia.	Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Hosp Univ Marques de Valdecilla, Santander, Spain; Univ Iowa Hosp & Clin, Dept Radiol, Positron Emiss Tomog Imaging Ctr, Iowa City, IA 52242 USA	University of Iowa; Hospital Universitario Marques de Valdecilla (HUMV); University of Iowa	Andreasen, NC (corresponding author), Univ Iowa Hosp & Clin, Mental Hlth Clin Res Ctr, Coll Med, Dept Psychiat, Room 2911 JPP,200 Hawkins Dr, Iowa City, IA 52242 USA.		Crespo-Facorro, BENEDICTO/AAY-2238-2021; Paradiso, Sergio/H-9052-2012; Crespo-Facorro, BENEDICTO/GXZ-9830-2022	Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Andreasen, Nancy/0000-0001-5730-9744; O'Leary, Daniel/0000-0003-1959-6521; Ponto, Laura/0000-0003-1197-6714	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043271, P50MH043271, T32MH019113, R01MH060990] Funding Source: NIH RePORTER; NIMH NIH HHS [MH19113, MH60990, MHCRC43271] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andreasen NC, 1999, ARCH GEN PSYCHIAT, V56, P781, DOI 10.1001/archpsyc.56.9.781; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1996, J CEREBR BLOOD F MET, V16, P804, DOI 10.1097/00004647-199609000-00005; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; ANDREASEN NC, 1995, P NATL ACAD SCI USA, V92, P5111, DOI 10.1073/pnas.92.11.5111; Andreasen NC, 1995, NEUROIMAGE, V2, P296, DOI 10.1006/nimg.1995.1037; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P754; Arndt S, 1996, J CEREBR BLOOD F MET, V16, P1271, DOI 10.1097/00004647-199611000-00023; Arnold SE, 1996, ACTA NEUROPATHOL, V92, P217, DOI 10.1007/s004010050512; BERENBAUM H, 1990, PSYCHOL MED, V20, P367, DOI 10.1017/S0033291700017682; BERTOLUCCIDANGIO M, 1990, J NEUROCHEM, V55, P1208, DOI 10.1111/j.1471-4159.1990.tb03126.x; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BROWN SL, 1979, J NERV MENT DIS, V167, P410, DOI 10.1097/00005053-197907000-00003; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; CIZADLO T, 1994, SPIE INT SOC OPTICAL, V2168, P423; CLARK DC, 1987, ANHEDONIA AFFECT DEF; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; CROW TJ, 1977, PSYCHOL MED, V7, P213, DOI 10.1017/S0033291700029287; Curtis VA, 1998, AM J PSYCHIAT, V155, P1056, DOI 10.1176/ajp.155.8.1056; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Epstein J, 1999, ANN NY ACAD SCI, V877, P562, DOI 10.1111/j.1749-6632.1999.tb09289.x; Fulbright RK, 1998, AM J NEURORADIOL, V19, P1721; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; GRAY JA, 1995, NEUROPSYCHOLOGIA, V33, P1143, DOI 10.1016/0028-3932(95)00054-7; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; HURTIG RR, 1994, J CEREBR BLOOD F MET, V14, P423, DOI 10.1038/jcbfm.1994.53; ITO M, 1993, TRENDS NEUROSCI, V16, P448, DOI 10.1016/0166-2236(93)90073-U; KIM SG, 1994, SCIENCE, V265, P949, DOI 10.1126/science.8052851; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kopala LC, 1998, AM J PSYCHIAT, V155, P134, DOI 10.1176/ajp.155.1.134; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; Kraepelin E., 1919, CUTTING SHEPHERD; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LEINER HC, 1989, BEHAV NEUROSCI, V103, P998, DOI 10.1037/0735-7044.103.5.998; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Moberg PJ, 1997, AM J PSYCHIAT, V154, P1016; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; Paradiso S, 1999, AM J PSYCHIAT, V156, P1618, DOI 10.1176/ajp.156.10.1618; Paradiso S, 1997, AM J PSYCHIAT, V154, P384; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Qureshy A, 2000, J NEUROPHYSIOL, V84, P1656, DOI 10.1152/jn.2000.84.3.1656; RAICHLE ME, 1983, J NUCL MED, V24, P790; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; SERBY MJ, 1992, SCI OLFACTION, P410; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Talairach J., 1988, COPLANAR STEREOTAXIC; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wollenweber SD, 1997, IEEE T NUCL SCI, V44, P1613, DOI 10.1109/23.632741; Wright IC, 1999, SCHIZOPHR RES, V35, P1, DOI 10.1016/S0920-9964(98)00094-2; YAKOVLEV PI, 1948, J NERV MENT DIS, V107, P313, DOI 10.1097/00005053-194810740-00001; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021	80	184	185	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					427	435		10.1001/jama.286.4.427	http://dx.doi.org/10.1001/jama.286.4.427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	456DZ	11466121	Bronze			2022-12-24	WOS:000170069000014
J	Hoehler, TM; Bebout, BM; Des Marais, DJ				Hoehler, TM; Bebout, BM; Des Marais, DJ			The role of microbial mats in the production of reduced gases on the early Earth	NATURE			English	Article							OXYGEN; CYANOBACTERIA; FERMENTATION	The advent of oxygenic photosynthesis on Earth may have increased global biological productivity by a factor of 100-1,000 (ref. 1), profoundly affecting both geochemical and biological evolution. Much of this new productivity probably occurred in microbial mats, which incorporate a range of photosynthetic and anaerobic microorganisms in extremely close physical proximity(2,3). The potential contribution of these systems to global biogeochemical change would have depended on the nature of the interactions among these mat microorganisms. Here we report that in modern, cyanobacteria-dominated mats from hypersaline environments in Guerrero Negro, Mexico, photosynthetic microorganisms generate H-2 and CO-gases that provide a basis for direct chemical interactions with neighbouring chemotrophic and heterotrophic microbes(4). We also observe an unexpected flux of CH4, which is probably related to H-2-based alteration of the redox potential within the mats. These fluxes would have been most important during the nearly 2-billion-year period during which photosynthetic mats contributed substantially to biological productivity(5) -and hence, to biogeochemistry-on Earth. In particular, the large fluxes of H-2 that we observe could, with subsequent escape to space, represent a potentially important mechanism for oxidation of the primitive oceans and atmosphere.	NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Hoehler, TM (corresponding author), NASA, Ames Res Ctr, Exobiol Branch, MS 239-4, Moffett Field, CA 94035 USA.	thoehler@mail.arc.nasa.gov						Bebout B.M., 1994, MICROBIAL MATS STRUC, P265; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; COHEN Y, 1984, ANCIENT STROMATOLITE; CONRAD R, 1988, ADV MICROB ECOL, V10, P231; Des Marais D.J., 1995, ADV MICROBIAL ECOL P, P251; DesMarais DJ, 1997, REV MINERAL, V35, P429; Dolfing J., 1988, BIOL ANAEROBIC MICRO, P417; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Holland H.D., 1984, CHEM EVOLUTION ATMOS; IANNOTTI EL, 1973, J BACTERIOL, V114, P1231, DOI 10.1128/JB.114.3.1231-1240.1973; LOVLEY DR, 1983, APPL ENVIRON MICROB, V45, P187, DOI 10.1128/AEM.45.1.187-192.1983; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; NEWTON W, 1977, RECENT DEV NITROGEN; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; Schink B., 1988, BIOL ANAEROBIC MICRO, P771; Skyring G. W., 1989, MICROBIAL MATS PHYSL, P170; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1111/j.1574-6976.1997.tb00350.x; Stal LJ, 1994, MICROBIAL MATS STRUC; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; Walter M. R., 1976, STROMATOLITES; Wolin M.J., 1982, ASM NEWS, V48, P561; [No title captured]	27	175	186	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					324	327		10.1038/35085554	http://dx.doi.org/10.1038/35085554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460161				2022-12-24	WOS:000169918200044
J	Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK				Kamada, K; Shu, F; Chen, H; Malik, S; Stelzer, G; Roeder, RG; Meisterernst, M; Burley, SK			Crystal structure of Negative Cofactor 2 recognizing the TBP-DNA transcription complex	CELL			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; YEAST TFIIA/TBP/DNA COMPLEX; HISTONE FOLD; IN-VIVO; PREINITIATION COMPLEX; GENE-TRANSCRIPTION; REPRESSOR COMPLEX; MINOR-GROOVE; BOX	The X-ray structure of a ternary complex of Negative Cofactor 2 (NC2), the TATA box binding protein (TBP), and DNA has been determined at 2.6 Angstrom resolution. The N termini of NC2 alpha and beta resemble histones H2A and H2B, respectively, and form a heterodimer that binds to the bent DNA double helix on the underside of the preformed TBP-DNA complex via electrostatic interactions. NC2 beta contributes to inhibition of TATA-dependent transcription through interactions of its C-terminal or helix with a conserved hydrophobic feature on the upper surface of TBP, which in turn positions the penultimate a helix of NC2 beta to block recognition of the TBP-DNA complex by transcription factor IIB. Further regulatory implications of the NC2 heterodimer structure are discussed.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Natl Res Ctr Environm & Hlth, Inst Immunol, Dept Gene Express, D-81377 Munich, Germany; Univ Munich, Mol Biol Lab, D-81377 Munich, Germany	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Munich; University of Munich	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.		Kamada, Katsuhiko/M-3666-2017	Kamada, Katsuhiko/0000-0001-8523-3417; Burley, Stephen K./0000-0002-2487-9713				ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; Castano E, 2000, P NATL ACAD SCI USA, V97, P7184, DOI 10.1073/pnas.140202297; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; DeDecker BS, 1996, J MOL BIOL, V264, P1072, DOI 10.1006/jmbi.1996.0697; Gadbois EL, 1997, P NATL ACAD SCI USA, V94, P3145, DOI 10.1073/pnas.94.7.3145; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; INOSTROZA JA, 1992, CELL, V70, P477; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kaiser K, 1996, TRENDS BIOCHEM SCI, V21, P342, DOI 10.1016/S0968-0004(96)10043-8; Kim J, 1996, J BIOL CHEM, V271, P18405, DOI 10.1074/jbc.271.31.18405; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Lemaire M, 2000, MOL MICROBIOL, V36, P163, DOI 10.1046/j.1365-2958.2000.01839.x; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; NIKOLOV DB, 1996, P NATL ACAD SCI USA, V93, P4956; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36	55	118	124	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					71	81		10.1016/S0092-8674(01)00417-2	http://dx.doi.org/10.1016/S0092-8674(01)00417-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461703	Bronze			2022-12-24	WOS:000169870300010
J	SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C				SAGAN, C; THOMPSON, WR; CARLSON, R; GURNETT, D; HORD, C			A SEARCH FOR LIFE ON EARTH FROM THE GALILEO SPACECRAFT	NATURE			English	Article							SPECTROMETER EXPERIMENT	In its December 1990 fly-by of Earth, the Galileo spacecraft found evidence of abundant gaseous oxygen, a widely distributed surface pigment with a sharp absorption edge in the red part of the visible spectrum, and atmospheric methane in extreme thermodynamic disequilibrium; together, these are strongly suggestive of life on Earth. Moreover, the presence of narrow-band, pulsed, amplitude-modulated radio transmission seems uniquely attributable to intelligence. These observations constitute a control experiment for the search for extraterrestrial life by modern interplanetary spacecraft.	JET PROP LAB,ATMOSPHER & COMETARY SCI SECT,PASADENA,CA 91109; UNIV IOWA,DEPT PHYS & ASTRON,IOWA CITY,IA 52242; UNIV COLORADO,ATMOSPHER & SPACE PHYS LAB,BOULDER,CO 80309	National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Iowa; University of Colorado System; University of Colorado Boulder	SAGAN, C (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							BELTON MJS, 1992, SPACE SCI REV, V60, P413, DOI 10.1007/BF00216864; BOWKER DE, 1985, REF PUBL NASA, V1139; CARLSON RW, 1992, SPACE SCI REV, V60, P457, DOI 10.1007/BF00216865; CARLSON RW, IN PRESS ANTARCT J U; CHAMEIDES WL, 1992, CHEM ENG NEWS, V60, P38; Chapman S, 1931, P PHYS SOC, V43, P483, DOI 10.1088/0959-5309/43/5/302; DROSSART PJ, UNPUB PLANET SPACE S; FAINBERG J, 1974, SPACE SCI REV, V16, P145, DOI 10.1007/BF00240885; GOLD T, 1992, P NATL ACAD SCI USA, V89, P6045, DOI 10.1073/pnas.89.13.6045; GURNETT DA, 1992, SPACE SCI REV, V60, P341, DOI 10.1007/BF00216861; GURNETT DA, 1974, J GEOPHYS RES, V79, P4227, DOI 10.1029/JA079i028p04227; Henderson L.J., 1913, FITNESS ENV INQUIRY; HINES CO, 1965, PHYSICS EARTHS UPPER; HOGAN KB, 1991, NATURE, V354, P181, DOI 10.1038/354181a0; HORD CW, 1992, SPACE SCI REV, V60, P503, DOI 10.1007/BF00216866; KELLER A, 1990, THESIS U IOWA; KILSTON SD, 1966, ICARUS, V5, P79, DOI 10.1016/0019-1035(66)90010-8; LABELLE J, 1989, RADIO SCI, V24, P725, DOI 10.1029/RS024i006p00725; LEDERBERG J, 1965, NATURE, V207, P9, DOI 10.1038/207009a0; LEDERBERG J, 1962, P NATL ACAD SCI USA, V48, P1473, DOI 10.1073/pnas.48.9.1473; LEGER A, IN PRESS ASTR ASTROP; Lewis JS., 1984, PLANETS THEIR ATMOSP; LIPPINCOTT ER, 1967, ASTROPHYS J, V147, P753, DOI 10.1086/149051; LOVELOCK JE, 1975, PROC R SOC SER B-BIO, V189, P167, DOI 10.1098/rspb.1975.0051; LOVELOCK JE, 1965, NATURE, V207, P568, DOI 10.1038/207568a0; Owen T., 1980, STRATEGIES SEARCH LI, V83, P177, DOI DOI 10.1007/978-94-009-9115-6_17; SAGAN C, 1975, PROC R SOC SER B-BIO, V189, P143, DOI 10.1098/rspb.1975.0048; SAGAN C, 1971, ICARUS, V15, P515, DOI 10.1016/0019-1035(71)90132-1; SAGAN C, 1966, BIOL EXPLORATION MAR, pCH9; Shklovskii IS, 1966, INTELLIGENT LIFE UNI, V399, P639; SULLIVAN WT, 1978, SCIENCE, V199, P377, DOI 10.1126/science.199.4327.377; VONZAHN U, 1983, VENUS, pCH13; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; [No title captured]	34	248	248	1	56	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 21	1993	365	6448					715	721		10.1038/365715a0	http://dx.doi.org/10.1038/365715a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC812	11536539				2022-12-24	WOS:A1993MC81200051
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			A BANGIOPHYTE RED ALGA FROM THE PROTEROZOIC OF ARCTIC CANADA	SCIENCE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.		Butterfield, Nicholas/AAV-8215-2021	Butterfield, Nicholas/0000-0002-3046-7520				[Anonymous], 1985, PALEOALGOLOGY; BEEUNAS MA, 1985, GEOL SOC AM BULL, V96, P737, DOI 10.1130/0016-7606(1985)96<737:PSISOS>2.0.CO;2; BHATTACHARYA D, 1987, J PHYCOL, V26, P181; BOLD HC, 1986, INTRO ALGAE; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI 10.1515/9781400858712; BUTTERFIELD NJ, 1988, NATURE, V334, P424, DOI 10.1038/334424a0; BUTTERFIELD NJ, 1989, GEOL SOC AM ABSTR, V21, pA146; BUTTERFIELD NJ, UNPUB; CAMPBELL SE, 1980, PHYCOLOGIA, V19, P25, DOI 10.2216/i0031-8884-19-1-25.1; COLE K, 1975, Phycologia, V14, P239, DOI 10.2216/i0031-8884-14-4-239.1; COLE KM, 1985, J PHYCOL, V21, P585; DU RL, 1986, ACTA GEOL SINICA, P115; FRITSCH FE, 1965, STRUCTURE REPRODUCTI; FRY WL, 1983, REV PALAEOBOT PALYNO, V39, P313, DOI 10.1016/0034-6667(83)90018-0; GARBARY DJ, 1980, SYESIS, V13, P137; GERMAN TN, 1981, PALEONTOLOG J, P100; Gnilovskaya M.B., 1988, VENDOTAENIDS E EUROP; GOLUBIC S, COMMUNICATION; GRANT SWF, 1987, GEOL SOC AM ABSTR, V19, P681; GREY K, 1990, PRECAMBRIAN RES, V46, P307, DOI 10.1016/0301-9268(90)90018-L; Heaman L.M., 1990, GEOLOGICAL ASS CANAD, V15, pA55; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LECHEMINANT AN, 1989, EARTH PLANET SC LETT, V96, P38, DOI 10.1016/0012-821X(89)90122-2; MARTIN TC, 1974, J PHYCOL, V10, P57, DOI 10.1111/j.1529-8817.1974.tb02678.x; PERASSO R, 1989, NATURE, V339, P142, DOI 10.1038/339142a0; SHEATH RG, 1985, J PHYCOL, V21, P297; SHEATH RG, 1980, J PHYCOL, V16, P412; SHEATH RG, 1984, PHYCOLOGIA, V23, P383, DOI 10.2216/i0031-8884-23-3-383.1; STEWART WD, 1987, 8326 GEOL SURV CAN P; TAPPAN H, 1976, GEOL SOC AM BULL, V87, P633, DOI 10.1130/0016-7606(1976)87<633:PEABAE>2.0.CO;2; VIDAL G, 1989, LETHAIA, V22, P375, DOI 10.1111/j.1502-3931.1989.tb01437.x; Walcott C.D., 1919, SMITHSONIAN MISCELLA, V67, P217; WALTER MR, 1976, J PALEONTOL, V50, P872; WHELAN JF, 1990, AM J SCI, V290, P396, DOI 10.2475/ajs.290.4.396; Zhang Y., 1989, LETHAIA, V22, P113	35	135	147	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 5	1990	250	4977					104	107		10.1126/science.11538072	http://dx.doi.org/10.1126/science.11538072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB467	11538072				2022-12-24	WOS:A1990EB46700030
J	ROTHSCHILD, LJ; MANCINELLI, RL				ROTHSCHILD, LJ; MANCINELLI, RL			MODEL OF CARBON FIXATION IN MICROBIAL MATS FROM 3,500 MYR AGO TO THE PRESENT	NATURE			English	Article											ROTHSCHILD, LJ (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MAIL STOP 239-12,MOFFETT FIELD,CA 94035, USA.		Mancinelli, Rocco/L-8971-2016					AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Awramik SM, 1984, MICROBIAL MATS STROM, P1; BADGER MR, 1982, PLANT PHYSIOL, V70, P517, DOI 10.1104/pp.70.2.517; Brasier M. D., 1980, MICROFOSSILS; DAMELIO ED, 1987, ARCH MICROBIOL, V147, P528; Des Marais D.J., 1989, MICROBIAL MATPHYSL, P191; GARRETT P, 1970, SCIENCE, V169, P171, DOI 10.1126/science.169.3941.171; Glaessner M.F., 1984, DAWN ANIMAL LIFE; JAVOR BJ, 1981, GEOMICROBIOL J, V2, P237, DOI 10.1080/01490458109377766; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187	16	26	26	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					710	712		10.1038/345710a0	http://dx.doi.org/10.1038/345710a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	11536465				2022-12-24	WOS:A1990DK39900063
J	SHOCK, EL; SCHULTE, MD				SHOCK, EL; SCHULTE, MD			AMINO-ACID SYNTHESIS IN CARBONACEOUS METEORITES BY AQUEOUS ALTERATION OF POLYCYCLIC AROMATIC-HYDROCARBONS	NATURE			English	Article											SHOCK, EL (corresponding author), WASHINGTON UNIV,DEPT EARTH & PLANETARY SCI,ST LOUIS,MO 63130, USA.			Shock, Everett/0000-0002-4283-0163; Schulte, Mitchell/0000-0001-8141-2020				ALLAMANDOLA LJ, 1987, SCIENCE, V237, P56, DOI 10.1126/science.237.4810.56; Basile B. P., 1984, ORG GEOCHEM, V5, P211, DOI 10.1016/0146-6380(84)90008-1; BECKER RH, 1982, GEOCHIM COSMOCHIM AC, V46, P97, DOI 10.1016/0016-7037(82)90294-0; BERNATOWICZ T, 1987, NATURE, V330, P728, DOI 10.1038/330728a0; Bradley J. P., 1988, METEORITES EARLY SOL, P861; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHANG S, 1986, P116; CHANG S, 1978, LUNAR PLANET SCI, V9, P157; CLAYTON RN, 1963, SCIENCE, V140, P192, DOI 10.1126/science.140.3563.192; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; Cronin J.R., 1988, METEORITES EARLY SOL, P819; DAYHOFF MO, 1967, NASA SP3040; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1085, DOI 10.1016/0016-7037(62)90047-9; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FRENKLACH M, 1989, NATURE, V339, P196, DOI 10.1038/339196a0; GRIMM RE, 1989, ICARUS, V82, P244, DOI 10.1016/0019-1035(89)90038-9; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; HERBERT F, 1989, ICARUS, V78, P402, DOI 10.1016/0019-1035(89)90187-5; HERBST E, 1985, ORIGINS LIFE EVOL B, V16, P3, DOI 10.1007/BF01808046; HUSS GR, 1987, EARTH MOON PLANETS, V40, P165; Kerridge J.F., 1979, ASTEROIDS, P745; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LANGE MA, 1985, GEOCHIM COSMOCHIM AC, V49, P1715, DOI 10.1016/0016-7037(85)90142-5; LARIMER JW, 1967, GEOCHIM COSMOCHIM AC, V31, P1239, DOI 10.1016/S0016-7037(67)80014-0; MCSWEEN HY, 1987, GEOCHIM COSMOCHIM AC, V51, P2469, DOI 10.1016/0016-7037(87)90298-5; MCSWEEN HY, 1979, GEOCHIM COSMOCHIM AC, V43, P1761, DOI 10.1016/0016-7037(79)90024-3; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; PRINN RG, 1987, ANNU REV EARTH PL SC, V15, P171; SHOCK E L, 1989, Origins of Life and Evolution of the Biosphere, V19, P538, DOI 10.1007/BF02388991; SHOCK EL, 1988, GEOLOGY, V16, P886, DOI 10.1130/0091-7613(1988)016<0886:OAMISB>2.3.CO;2; SHOCK EL, 1989, GEOLOGY, V17, P572, DOI 10.1130/0091-7613(1989)017<0572:CTOAMI>2.3.CO;2; SHOCK EL, IN PRES GEOCHIM COSM; Stull D.R., 1969, CHEM THERMODYN; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; WONG WK, 1971, J CHEM THERMODYN, V3, P105, DOI 10.1016/S0021-9614(71)80071-X; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; ZENOBI R, 1989, SCIENCE, V1246, P1026; Zinner E., 1988, METEORITES EARLY SOL; Zolensky M., 1988, METEORITES EARLY SOL, P114; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7	40	74	74	1	26	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 22	1990	343	6260					728	731		10.1038/343728a0	http://dx.doi.org/10.1038/343728a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	11536464				2022-12-24	WOS:A1990CP80700051
J	Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB				Eisenberg, DM; Kessler, RC; Van Rompay, MI; Kaptchuk, TJ; Wilkey, SA; Appel, S; Davis, RB			Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey	ANNALS OF INTERNAL MEDICINE			English	Article							ALTERNATIVE MEDICINE; HEALTH-CARE; UNCONVENTIONAL MEDICINE; UNITED-STATES; RHEUMATOLOGISTS; PREVALENCE; PHYSICIANS; CHOICE	Background: Little is known about perceptions of complementary and alternative medical (CAM) therapy relative to conventional therapy among patients who use both. Objective: To document perceptions about CAM therapies among persons who use CAM and conventional therapies. Design: Nationally representative, random-household telephone survey. Setting: The 48 contiguous U.S. states. Participants: 831 adults who saw a medical doctor and used CAM therapies in 1997. Measurements: Perceptions about helpfulness and patterns of CAM therapy use relative to conventional therapy use and reasons for nondisclosure of CAM therapies. Results: Of 831 respondents who saw a medical doctor and used CAM therapies in the previous 12 months, 79% perceived the combination to be superior to either one alone. Of 411 respondents who reported seeing both a medical doctor and a CAM provider, 70% typically saw a medical doctor before or concurrent with their visits to a CAM provider; 15% typically saw a CAM provider before seeing a medical doctor. Perceived confidence in CAM providers was not substantially different from confidence in medical doctors. Among the 831 respondents who in the past year had used a CAM therapy and seen a medical doctor, 63% to 72% did not disclose at least one type of CAM therapy to the medical doctor. Among 507 respondents who reported their reasons for nondisclosure of use of 726 alternative therapies, common reasons for nondisclosure were "It wasn't important for the doctor to know" (61%), "The doctor never asked" (60%), "It was none of the doctor's business" (31%), and "The doctor would not understand" (20%). Fewer respondents (14%) thought their doctor would disapprove of or discourage CAM use, and 2% thought their doctor might not continue as their provider. Respondents judged CAM therapies to be more helpful than conventional care for the treatment of headache and neck and back conditions but considered conventional care to be more helpful than CAM therapy for treatment of hypertension. Conclusions: National survey data do not support the view that use of CAM therapy in the United States primarily reflects dissatisfaction with conventional care. Adults who use both appear to value both and tend to be less concerned about their medical doctor's disapproval than about their doctor's inability to understand or incorporate CAM therapy use within the context of their medical management.	Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Eisenberg, DM (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Alternat Med Res & Educ, 330 Brookline Ave, Boston, MA 02215 USA.	deisenbe@caregroup.harvard.edu	Van Rompay, Maria/G-9452-2012		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR043441] Funding Source: NIH RePORTER; NIAMS NIH HHS [U24 AR43441-02S1A1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Beyerstein B, 1997, CAN J PUBLIC HEALTH, V88, P149, DOI 10.1007/BF03403878; CAMPION EW, 1993, NEW ENGL J MED, V328, P282, DOI 10.1056/NEJM199301283280413; CHERKIN DC, 1989, WESTERN J MED, V150, P351; Davidoff F, 1998, ANN INTERN MED, V129, P1068, DOI 10.7326/0003-4819-129-12-199812150-00014; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; GoldbeckWood S, 1996, BRIT MED J, V313, P131, DOI 10.1136/bmj.313.7050.131a; HENTSCHEL C, 1996, EUR J PHYS MED REHAB, V6, P144; Hilsden RJ, 1998, AM J GASTROENTEROL, V93, P697; Kelner M, 1997, SOC SCI MED, V45, P203, DOI 10.1016/S0277-9536(96)00334-6; Lazar JS, 1997, PRIMARY CARE, V24, P699, DOI 10.1016/S0095-4543(05)70305-5; MacLennan AH, 1996, LANCET, V347, P569, DOI 10.1016/S0140-6736(96)91271-4; McGregor KJ, 1996, SOC SCI MED, V43, P1317, DOI 10.1016/0277-9536(95)00405-X; MOORE J, 1985, BRIT MED J, V290, P28, DOI 10.1136/bmj.290.6461.28; MURRAY J, 1993, SOC SCI MED, V37, P983, DOI 10.1016/0277-9536(93)90432-4; MURRAY RH, 1992, NEW ENGL J MED, V326, P61, DOI 10.1056/NEJM199201023260113; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; RASMUSSEN NK, 1990, COMPLEMENT MED RES, V4, P16; *RES TRIANGL I, 1997, SUDAAN PROF SOFTW SU; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; VASKILAMPI T, 1993, CLIN RES METHODOLOGY; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; VISSER GJ, 1992, BRIT J RHEUMATOL, V31, P485	27	428	436	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					344	351		10.7326/0003-4819-135-5-200109040-00011	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529698				2022-12-24	WOS:000170780600005
J	Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ				Hammond, SM; Boettcher, S; Caudy, AA; Kobayashi, R; Hannon, GJ			Argonaute2, a link between genetic and biochemical analyses of RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; MESSENGER-RNA; INTERFERENCE; ARABIDOPSIS; POLYMERASE; HELICASE; NEUROSPORA; TRANSGENE; PROTEINS	Double-stranded RNA induces potent and specific gene silencing through a process referred to as RNA interference (RNAi) or posttranscriptional gene silencing (PTGS). RNAi is mediated by RNA-induced silencing complex (RISC), a sequence-specific, multicomponent nuclease that destroys messenger RNAs homologous to the silencing trigger. RISC is known to contain short RNAs (similar to 22 nucleotides) derived from the double-stranded RNA trigger, but the protein components of this activity are unknown. Here, we report the biochemical purification of the RNAi effector nuclease from cultured Drosophila cells. The active fraction contains a ribonucleoprotein complex of similar to 500 kilodaltons. Protein microsequencing reveals that one constituent of this complex is a member of the Argonaute family of proteins, which are essential for gene silencing in Caenorhabditis elegans, Neurospora, and Arabidopsis. This observation begins the process of forging links between genetic analysis of RNAi from diverse organisms and the biochemical model of RNAi that is emerging from Drosophila in vitro systems.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Genet Inc, Cambridge, MA 02138 USA	Cold Spring Harbor Laboratory	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Caudy, Amy/0000-0001-6307-8137	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM62534] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; KETTING R, UNPUB; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	1098	1238	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1146	1150		10.1126/science.1064023	http://dx.doi.org/10.1126/science.1064023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498593				2022-12-24	WOS:000170432600063
J	Robert, F				Robert, F			Isotope geochemistry - The origin of water on Earth	SCIENCE			English	Editorial Material							DEUTERIUM; METEORITE; HYDROGEN		CNRS, Museum Minerol, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Robert, F (corresponding author), CNRS, Museum Minerol, 61 Rue Buffon, F-75005 Paris, France.	robert@mnhn.fr						Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; BROWN PD, 1989, MON NOT R ASTRON SOC, V237, P661, DOI 10.1093/mnras/237.3.661; DELOULE E, 1995, GEOCHIM COSMOCHIM AC, V59, P4695, DOI 10.1016/0016-7037(95)00313-4; Deloule E, 1998, GEOCHIM COSMOCHIM AC, V62, P3367, DOI 10.1016/S0016-7037(98)00232-4; DHENDECOURT L, 2001, C DEUT U OBS MEUD FR; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Geiss J, 1998, SPACE SCI REV, V84, P239, DOI 10.1023/A:1005039822524; Glassgold A. E., 2000, Protostars and planets 4, P429; HALBOUT J, 1990, GEOCHIM COSMOCHIM AC, V54, P1453, DOI 10.1016/0016-7037(90)90168-K; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Malfait K, 1999, ASTRON ASTROPHYS, V345, P181; Morbidelli A, 2000, METEORIT PLANET SCI, V35, P1309, DOI 10.1111/j.1945-5100.2000.tb01518.x; Robert F, 2000, SPACE SCI REV, V92, P201, DOI 10.1023/A:1005291127595; Teixeira TC, 1999, ASTRON ASTROPHYS, V347, pL19	16	88	90	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1056	1058		10.1126/science.1064051	http://dx.doi.org/10.1126/science.1064051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498566				2022-12-24	WOS:000170432600034
J	Pockley, P				Pockley, P			Commission plots transgenic future	NATURE			English	News Item																		Pockley P, 2000, NATURE, V404, P914, DOI 10.1038/35010234	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					573	573		10.1038/35088195	http://dx.doi.org/10.1038/35088195			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493883	Bronze			2022-12-24	WOS:000170318000007
J	Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA				Lavery, JV; Boyle, J; Dickens, BM; Maclean, H; Singer, PA			Origins of the desire for euthanasia and assisted suicide in people with HIV-1 or AIDS: a qualitative study	LANCET			English	Article							TERMINALLY ILL; NETHERLANDS; ATTITUDES; DEATH; CARE; CAREGIVERS	Background Euthanasia and assisted suicide, and policies to address them are the subjects of contentious debate in many countries. However, the question of why people desire euthanasia or assisted suicide has not been coherently answered. We aimed to answer this question in a specific group of patients. Methods We did a qualitative study of 32 people with HIV-1 or AIDS, who were enrolled in the HIV-1 Ontario Observational Database at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada. We elicited participants' experiences of deliberation about euthanasia or assisted suicide, and the meaning of these experiences with in-depth, face-to-face interviews. We analysed our data with grounded theory methods. Findings Participants' desire for euthanasia and assisted suicide were affected by two main factors: disintegration, which resulted from symptoms and loss of function; and loss of community, which we defined as progressive diminishment of opportunities to initiate and maintain close personal relationships. These factors resulted in perceived loss of self. Euthanasia and assisted suicide were seen by participants as means of limiting loss of self. Interpretation These determinants of desire for euthanasia or assisted suicide in people with HIV-1 or AIDS have implications for the debate on these practices, and development of policies to regulate them.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada; Queens Univ, Queens Hlth Policy Res Unit, Kingston, ON, Canada; Univ Toronto, Fac Law, Dept Philosophy, Toronto, ON M5S 1A1, Canada; Univ Toronto, Fac Publ Hlth Sci, Toronto, ON M5S 1A1, Canada; Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5S 1A1, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lavery, JV (corresponding author), NIH, Fogarty Int Ctr, Div Adv Studies & Policy Anal, Bldg 16, Bethesda, MD 20892 USA.		Lavery, James/E-5254-2012					Angell M, 1996, NEW ENGL J MED, V335, P1676, DOI 10.1056/NEJM199611283352209; Antonovsky A, 1987, UNRAVELING MYSTERY H, P15; ATKINSON JH, 1988, ARCH GEN PSYCHIAT, V45, P859; BARRETT RK, 1995, AIDS PATIENT CARE, V9, P240, DOI 10.1089/apc.1995.9.240; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; CALLAHAN D, 1993, HASTINGS CENT REP, V23, P33, DOI 10.2307/3562588; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; DWORKIN R, 1993, LIFES DOMINION ARGUM, P210; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser Barney., 1992, BASICS GROUNDED THEO; GREEN G, 1995, AIDS CARE, V7, P169; Haverkate I, 2000, BRIT MED J, V321, P865, DOI 10.1136/bmj.321.7265.865; JECKER NS, 1993, J CLIN ETHIC, V4, P16; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; LAANE HM, 1995, AIDS CARE, V7, P163; Roscoe LA, 2000, NEW ENGL J MED, V343, P1735, DOI 10.1056/NEJM200012073432315; SCHNEIDER SG, 1991, J PERS SOC PSYCHOL, V61, P776, DOI 10.1037/0022-3514.61.5.776; Shortt S, 1999, J Health Serv Res Policy, V4, P230; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Strauss A., 1990, BASICS QUALITATIVE R; VANDENBOOM F, 1995, AIDS CARE, V7, P175; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Walker RJ, 1996, HEALTH SOC WORK, V21, P49, DOI 10.1093/hsw/21.1.49; Yalom ID., 1980, EXISTENTIAL PSYCHOTH	30	72	72	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					362	367		10.1016/S0140-6736(01)05555-6	http://dx.doi.org/10.1016/S0140-6736(01)05555-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459DE	11502315				2022-12-24	WOS:000170235100010
J	Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR				Marin, O; Yaron, A; Bagri, A; Tessier-Lavigne, M; Rubenstein, JLR			Sorting of striatal and cortical interneurons regulated by semaphorin-neuropilin interactions	SCIENCE			English	Article							NEURONS; MIGRATION; RECEPTORS; GUIDANCE; ORIGIN; GENES	Most striatal and cortical interneurons arise from the basal telencephalon, later segregating to their respective targets. Here, we show that migrating cortical interneurons avoid entering the striatum because of a chemorepulsive signal composed at least in part of semaphorin 3A and semaphorin 3F. Migrating interneurons expressing neuropilins, receptors for semaphorins, are directed to the cortex; those lacking them go to the striatum. Loss of neuropilin function increases the number of interneurons that migrate into the striatum. These observations reveal a mechanism by which neuropilins mediate sorting of distinct neuronal populations into different brain structures, and provide evidence that, in addition to guiding axons, these receptors also control neuronal migration in the central nervous system.	Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Langley Porter Psychiat Inst, Nina Ireland Lab Dev Neurobiol, Dept Psychiat, San Francisco, CA 94143 USA.	jlrr@cgl.ucsf.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [K02MH01046-01, R01MH51561-01A1, R01MH49428-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046, R01MH049428, R01MH051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Marin O, 2000, J NEUROSCI, V20, P6063; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	13	323	329	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					872	875		10.1126/science.1061891	http://dx.doi.org/10.1126/science.1061891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486090				2022-12-24	WOS:000170241000047
J	Johnston, SD; Smye, M; Watson, RGP				Johnston, SD; Smye, M; Watson, RGP			Intestinal permeability and morphometric recovery in coeliac disease	LANCET			English	Editorial Material							CELIAC-DISEASE; PERSISTENT DEFECT; ABSORPTION TEST		Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland; Royal Victoria Hosp, Dept Clin Chem, Belfast BT12 6BA, Antrim, North Ireland; Queens Univ Belfast, Dept Med, Belfast BT7 1NN, Antrim, North Ireland	Belfast City Hospital; Queens University Belfast	Johnston, SD (corresponding author), Belfast City Hosp, Dept Gastroenterol, Belfast BT9 7AB, Antrim, North Ireland.							BJARNASON I, 1983, LANCET, V1, P323; BJARNASON I, 1994, SCAND J GASTROENTERO, V29, P630, DOI 10.3109/00365529409092484; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; CHADWICK VS, 1977, GASTROENTEROLOGY, V73, P247; Cummins AG, 2001, CLIN SCI, V100, P379, DOI 10.1042/CS20000193; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; HAMILTON I, 1982, GUT, V23, P202, DOI 10.1136/gut.23.3.202; JUBY LD, 1987, J CLIN PATHOL, V40, P714, DOI 10.1136/jcp.40.7.714; LIM SG, 1993, SCAND J GASTROENTERO, V28, P573, DOI 10.3109/00365529309096090; Uil JJ, 1996, EUR J GASTROEN HEPAT, V8, P219, DOI 10.1097/00042737-199603000-00006	10	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					259	260		10.1016/S0140-6736(01)05495-2	http://dx.doi.org/10.1016/S0140-6736(01)05495-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498209				2022-12-24	WOS:000170114400006
J	Katzmann, DJ; Babst, M; Emr, SD				Katzmann, DJ; Babst, M; Emr, SD			Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I	CELL			English	Article							GROWTH-FACTOR-RECEPTOR; DOA4 DEUBIQUITINATING ENZYME; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; MULTIUBIQUITIN CHAIN; SYNTAXIN HOMOLOG; YEAST VACUOLE; C-CBL; TRANSPORT; MEMBRANE	The multivesicular body (MVB) pathway is responsible for both the biosynthetic delivery of lysosomal hydrolases and the downregulation of numerous activated cell surface receptors which are degraded in the lysosome. We demonstrate that ubiquitination serves as a signal for sorting into the MVB pathway. In addition, we characterize a 350 kDa complex, ESCRT-I (composed of Vps23, Vps28, and Vps37), that recognizes ubiquitinated MVB cargo and whose function is required for sorting into MVB vesicles. This recognition event depends on a conserved UBC-like domain in Vps23. We propose that ESCRT-I represents a conserved component of the endosomal sorting machinery that functions in both yeast and mammalian cells to couple ubiquitin modification to protein sorting and receptor downregulation in the MVB pathway.	Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Emr, SD (corresponding author), Univ Calif San Diego, Sch Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA.				NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NCI NIH HHS [CA 58689] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hong SJ, 1998, MOL GEN GENET, V259, P404, DOI 10.1007/s004380050830; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kornilova E, 1996, J BIOL CHEM, V271, P30340, DOI 10.1074/jbc.271.48.30340; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li Y, 1999, MOL CELL BIOL, V19, P3588; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Sorkin Alexander, 1998, Frontiers in Bioscience, V3, pD729; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; TRAGLIA HM, 1989, MOL CELL BIOL, V9, P2989, DOI 10.1128/MCB.9.7.2989; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wurmser AE, 1998, EMBO J, V17, P4930, DOI 10.1093/emboj/17.17.4930; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	46	1054	1083	4	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					145	155		10.1016/S0092-8674(01)00434-2	http://dx.doi.org/10.1016/S0092-8674(01)00434-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511343	Bronze			2022-12-24	WOS:000170193100005
J	Ghigo, JM				Ghigo, JM			Natural conjugative plasmids induce bacterial biofilm development	NATURE			English	Article								Horizontal gene transfer is a principal source of evolution leading to change in the ecological character of bacterial species(1). Bacterial conjugation(2), which promotes the horizontal transfer of genetic material between donor and recipient cells by physical contact, is a phenomenon of fundamental evolutionary consequence(3). Although conjugation has been studied primarily in liquid, most natural bacterial populations are found associated with environmental surfaces in complex multispecies communities called biofilms(4). Biofilms are ideally suited to the exchange of genetic material of various origins, and it has been shown that bacterial conjugation occurs within biofilms(5,6). Here I investigate the direct contribution of conjugative plasmids themselves to the capacity of the bacterial host to form a biofilm. Natural conjugative plasmids expressed factors that induced planktonic bacteria to form or enter biofilm communities, which favour the infectious transfer of the plasmid. This general connection between conjugation and biofilms suggests that medically relevant plasmid-bearing strains are more likely to form a biofilm. This may influence both the chances of biofilm-related infection risks and of conjugational spread of virulence factors.	Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghigo, JM (corresponding author), Inst Pasteur, Unite Membranes Bacteriennes, CNRS, URA 2172, 25 Rue Dr Roux, F-75724 Paris 15, France.	jmghigo@pasteur.fr	GHIGO, Jean-Marc/AAP-4011-2021	GHIGO, Jean-Marc/0000-0001-6528-118X				Bergstrom CT, 2000, GENETICS, V155, P1505; BRADLEY DE, 1980, J BACTERIOL, V143, P1466, DOI 10.1128/JB.143.3.1466-1470.1980; BUKHARI AI, 1977, DNA INSERTION ELEMEN, P601; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Frost LS., 1993, BACTERIAL CONJUGATIO, P189; Hausner M, 1999, APPL ENVIRON MICROB, V65, P3710; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; LUNDQUIST PD, 1986, GENETICS, V113, P483; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pratt LA, 1999, CURR OPIN MICROBIOL, V2, P598, DOI 10.1016/S1369-5274(99)00028-4; RIED G, 1987, FEBS LETT, V223, P387, DOI 10.1016/0014-5793(87)80324-1; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	19	475	505	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					442	445		10.1038/35086581	http://dx.doi.org/10.1038/35086581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473319				2022-12-24	WOS:000170068200049
J	Tiwari, RK; Rao, KNN				Tiwari, RK; Rao, KNN			Periodicity in marine phosphorus burial rate	NATURE			English	Letter							CYCLE		Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Geophysical Research Institute (NGRI)	Tiwari, RK (corresponding author), Natl Geophys Res Inst, Theoret Geophys Grp, Hyderabad 500007, Andhra Pradesh, India.		Rajesh, Rekapalli/AAP-8508-2021					FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FISCHER AG, 1977, DEEP WATER CARBONATE, P19, DOI DOI 10.2110/PEC.77.25; Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; HARLAND WB, 1989, GEOLOGICAL TIME SCAL; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Negi JG, 1996, MAR GEOL, V133, P113, DOI 10.1016/0025-3227(96)00003-5; RAMPINO MR, 1993, EARTH PLANET SC LETT, V114, P215, DOI 10.1016/0012-821X(93)90026-6; RAUP DM, 1988, SCIENCE, V241, P94, DOI 10.1126/science.241.4861.94; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; STIGLER SM, 1987, SCIENCE, V238, P940, DOI 10.1126/science.238.4829.940; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455	12	11	12	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	1999	400	6739					31	32		10.1038/21807	http://dx.doi.org/10.1038/21807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	213DA	11536905				2022-12-24	WOS:000081255700035
J	BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F				BLAKE, D; ALLAMANDOLA, L; SANDFORD, S; HUDGINS, D; FREUND, F			CLATHRATE HYDRATE FORMATION IN AMORPHOUS COMETARY ICE ANALOGS INVACUO	SCIENCE			English	Article							PHYSICO-CHEMICAL PHENOMENA; INFRARED-SPECTRA; SOLAR-SYSTEM; WATER; EROSION; OXIRANE; GRAINS; SNOWS	The presence of clathrate hydrates in cometary ice has been suggested to account for anomalous gas release at large radial distances from the sun as well as the retention of volatiles in comets to elevated temperatures. However, how clathrate hydrates can form in low-pressure environments, such as in cold interstellar molecular clouds, in the outer reaches of the early solar nebula, or in cometary ices, has been poorly understood. Experiments performed with the use of a modified electron microscope demonstrate that during the warming of vapor-deposited amorphous ices in vacuo, clathrate hydrates can form by rearrangements in the solid state. Phase separations and microporous textures that are the result of these rearrangements may account for a variety of anomalous cometary phenomena.	NASA,AMES RES CTR,ASTROPHYS BRANCH,MOFFETT FIELD,CA 94035; SAN JOSE STATE UNIV,DEPT PHYS,SAN JOSE,CA 95192	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; San Jose State University	BLAKE, D (corresponding author), NASA,AMES RES CTR,PLANETARY BIOL BRANCH,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1988, DUST UNIVERSE, P229; BARNUN A, 1987, PHYS REV B, V35, P2427, DOI 10.1103/PhysRevB.35.2427; BERTIE JE, 1978, J CHEM PHYS, V69, P4105, DOI 10.1063/1.437089; BERTIE JE, 1983, J CHEM PHYS, V78, P6340, DOI 10.1063/1.444563; BLAKE DF, 1990, 12 P INT C EL MICR S, V1, P594; BOCKELEEMORVAN D, 1991, NATURE, V350, P318, DOI 10.1038/350318a0; BOUTRON P, 1978, J CHEM PHYS, V68, P5032, DOI 10.1063/1.435619; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; Delsemme A., 1952, ANN ASTROPHYS, V15, P1; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P717, DOI 10.1016/0032-0633(70)90053-X; DELSEMME AH, 1970, PLANET SPACE SCI, V18, P709, DOI 10.1016/0032-0633(70)90052-8; DHENDECOURT LB, 1986, ASTRON ASTROPHYS, V158, P119; ENGLE S, 1990, ICARUS, V85, P380; FLEYFEL F, 1991, J PHYS CHEM-US, V95, P3811, DOI 10.1021/j100162a068; Greenberg J., 1982, COMETS, P131; GUTZOW I, 1980, CONTEMP PHYS, V21, P121, DOI 10.1080/00107518008210949; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HSUING P, 1990, LUNAR PLANET SCI, V21, P538; JOHNSON RE, 1983, ASTRON ASTROPHYS, V123, P343; JOHNSON RE, 1987, ASTRON ASTROPHYS, V187, P889; KOCHAN H, 1989, LUNAR PLANET SCI, V20, P524; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MAK TCW, 1965, J CHEM PHYS, V42, P2732, DOI 10.1063/1.1703229; MILLER SL, 1973, PHYSICS CHEM ICE, P42; MOORE MH, 1983, ICARUS, V54, P388, DOI 10.1016/0019-1035(83)90236-1; RICHARDSON HH, 1985, J CHEM PHYS, V83, P4387, DOI 10.1063/1.449055; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; SANDFORD SA, 1990, ASTROPHYS J, V355, P357, DOI 10.1086/168770; STRAZZULLA G, 1983, ASTRON ASTROPHYS, V123, P93; Tielens A., 1989, IAU S, P239; Tielens A. G., 1987, PHYSICAL PROCESSES I, V333	35	151	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					548	551		10.1126/science.11538372	http://dx.doi.org/10.1126/science.11538372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	11538372				2022-12-24	WOS:A1991GL79900042
J	Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M				Zhu, H; Bilgin, M; Bangham, R; Hall, D; Casamayor, A; Bertone, P; Lan, N; Jansen, R; Bidlingmaier, S; Houfek, T; Mitchell, T; Miller, P; Dean, RA; Gerstein, M; Snyder, M			Global analysis of protein activities using proteome chips	SCIENCE			English	Article							ASH1 MESSENGER-RNA; ARP2/3 COMPLEX; BUDDING YEAST; KINASES; CALMODULIN; SUBUNIT; GENOME; MOTOR	To facilitate studies of the yeast proteome, we cloned 5800 open reading frames and overexpressed and purified their corresponding proteins. The proteins were printed onto slides at high spatial density to form a yeast proteome microarray and screened for their ability to interact with proteins and phospholipids. We identified many new calmodulin- and phospholipid-interacting proteins; a common potential binding motif was identified for many of the calmodulin-binding proteins. Thus, microarrays of an entire eukaryotic proteome can be prepared and screened for diverse biochemical activities. The microarrays can also be used to screen protein-drug interactions and to detect posttranslational modifications.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; N Carolina State Univ, Fungal Genom Lab, Raleigh, NC 27695 USA; Yale Univ, Dept Anesthesiol, New Haven, CT 06520 USA	Yale University; Yale University; University of North Carolina; North Carolina State University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Casamayor, Antonio/C-2509-2017; Casamayor, Antonio/A-3190-2012	Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Casamayor, Antonio/0000-0003-2788-7329; Snyder, Michael/0000-0003-0784-7987				Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CAVEMAN A, 2000, J CELL SCI, V113, P3543; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fields S, 1999, P NATL ACAD SCI USA, V96, P8825, DOI 10.1073/pnas.96.16.8825; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gerstein M, 1998, PROTEINS, V33, P518, DOI 10.1002/(SICI)1097-0134(19981201)33:4<518::AID-PROT5>3.0.CO;2-J; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Guerra R, 2000, BIOSCIENCE REP, V20, P41, DOI 10.1023/A:1005583117296; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Li Y, 1999, MOL CELL BIOL, V19, P3588; MacBeath G, 2000, SCIENCE, V289, P1760; MARTIN TF, 2000, ANNU REV CELL DEV BI, V14, P231; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Menendez J, 1998, YEAST, V14, P647; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Pardo M, 1999, YEAST, V15, P459, DOI 10.1002/(SICI)1097-0061(199904)15:6<459::AID-YEA387>3.0.CO;2-L; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; STIRLING DA, 1994, EMBO J, V13, P4329, DOI 10.1002/j.1460-2075.1994.tb06753.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wera S, 2001, FEMS YEAST RES, V1, P9, DOI 10.1111/j.1567-1364.2001.tb00008.x; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8	37	1710	1864	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2101	2105		10.1126/science.1062191	http://dx.doi.org/10.1126/science.1062191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11474067	Green Submitted			2022-12-24	WOS:000171028700077
J	Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR				Middeldorp, S; Meinardi, JR; Koopman, MMW; van Pampus, ECM; Hamulyak, K; van der Meer, J; Prins, MH; Buller, HR			A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVATED PROTEIN-C; DEEP-VEIN THROMBOSIS; COAGULATION-FACTOR-V; RISK-FACTORS; RESISTANCE; THROMBOPHILIA; POPULATION	Background: The factor V Leiden mutation is a common genetic defect associated with an increased risk for venous thromboembolism. The clinical implications for asymptomatic carriers of this mutation and, consequently, the usefulness of screening families in which a proband has both the mutation and venous thrombo embolism are unclear. Objective: To determine the incidence of venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation. Design: Prospective cohort study. Setting: University hospitals in the Netherlands. Participants: 470 asymptomatic carriers of the factor V Leiden mutation (234 men, 236 women; mean age, 43 years [range, 15 to 88 years]), 12 of whom were homozygous. Carriers were identified by screening the first-degree relatives (>15 years of age) of 247 symptomatic probands. Measurements: Objectively diagnosed episodes of venous thromboembolism and the relationship between incidence and exposure to high-risk situations. Results: Nine venous thromboembolic events were observed in 1564 observation-years, resulting in an annual incidence of 0.58% (95% CI, 0.26% to 1.10%). The incidence of spontaneous venous thromboembolism was 0.26% (CI, 0.07% to 0.65%) per year; 3.5% (CI, 0.1% to 17.8%) per episode of surgery, trauma, or immobilization; 0.0% (CI, 0.0% to 19.5%) per pregnancy; 1.8% (CI, 0.4% to 5.2%) per year of oral contraceptive use; and 2.9% (CI, 0.8% to 15.3%) per year of use of hormone replacement therapy. Conclusions: The absolute annual incidence of spontaneous venous thromboembolism in asymptomatic carriers of the factor V Leiden mutation is low and does not justify routine screening of the families of symptomatic patients.	Acad Med Ctr, Dept Vasc Med, NL-1100 DE Amsterdam, Netherlands; Univ Groningen Hosp, Groningen, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC)	Middeldorp, S (corresponding author), Acad Med Ctr, Dept Vasc Med, F4-277,Box 22700, NL-1100 DE Amsterdam, Netherlands.		Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Dahlback B, 1996, LANCET, V347, P1346, DOI 10.1016/S0140-6736(96)91004-1; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Middeldorp S, 1998, ANN INTERN MED, V128, P15, DOI 10.7326/0003-4819-128-1-199801010-00003; Middeldorp S, 1998, SEMIN THROMB HEMOST, V24, P363, DOI 10.1055/s-2007-996024; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Simioni P, 1999, ANN INTERN MED, V130, P538, DOI 10.7326/0003-4819-130-6-199903160-00012; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VOORBERG J, 1994, LANCET, V343, P1535, DOI 10.1016/S0140-6736(94)92939-4	20	138	140	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					322	327		10.7326/0003-4819-135-5-200109040-00008	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468WF	11529695				2022-12-24	WOS:000170780600002
J	Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ				Fevre, EM; Coleman, PG; Odiit, M; Magona, JW; Welburn, SC; Woolhouse, MEJ			The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda	LANCET			English	Article								Background Sleeping sickness, caused by two trypanosome subspecies, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, is a parasitic disease transmitted by the tsetse fly in sub-Saharan Africa. We report on a recent outbreak of T b rhodesiense sleeping sickness outside the established south-east Ugandan focus, in Soroti District where the disease had previously been absent. Soroti District has been the subject of large-scale livestock restocking activities and, because domestic cattle are important reservoirs of T b rhodesiense, we investigated the role of cattle in the origins of the outbreak. Methods We identified the origins of cattle entering the outbreak area in the 4 years preceding the outbreak. A matched case-control study was conducted to assess whether the distance of villages from the main market involved with restocking was a risk factor for sleeping sickness. We investigated the spatial clustering of sleeping sickness cases at the start of the outbreak. Findings Over 50% (1510 of 2796) of cattle traded at the market were reported to have originated from endemic sleeping sickness areas. The case-control study revealed that distance to the cattle market was a highly significant risk factor for sleeping sickness (p<0.001) and that there was a significant clustering of cases (27 of 28) close to the market at the start of the outbreak (p<0.001). As the outbreak progressed, the average distance of cases moved away from the cattle market (0.014 km per day, 95% CI 0.008-0.020 km per day, p<0.001). Interpretations The results are consistent with the disease being introduced by cattle infected with T b rhodesiense imported to the market from the endemic sleeping sickness focus. The subsequent spread of the disease away from the market suggests that sleeping sickness is becoming established in this new focus. Public health measures directed at controlling the infection in the animal reservoir should be considered to prevent the spread of sleeping sickness.	Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Livestock Hlth Res Inst, Tororo, Uganda	University of Edinburgh	Fevre, EM (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.			Welburn, Susan/0000-0002-9903-7086; Fevre, Eric/0000-0001-8931-4986				ABARU DE, 1985, TROP MED PARASITOL, V36, P72; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; Hide G, 1996, PARASITOL TODAY, V12, P50, DOI 10.1016/0169-4758(96)80654-5; HIDE G, 1991, EXP PARASITOL, V72, P430, DOI 10.1016/0014-4894(91)90089-F; KOERNER T, 1995, PARASITOL TODAY, V11, P303, DOI 10.1016/0169-4758(95)80046-8; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LANCIEN J, 1991, ANN SOC BELG MED TR, V71, P35; MEHLITZ D, 1981, TROPENMED PARASITOL, V32, P129; Odiit M, 1997, E AFR MED J, V74, P792; ONYANGO RJ, 1966, T ROY SOC TROP MED H, V60, P175, DOI 10.1016/0035-9203(66)90024-1; ONYANGO RJ, 1967, HUMAN TRYPANOSOMIASI, P43; Welburn SC, 2001, TRENDS PARASITOL, V17, P19, DOI 10.1016/S1471-4922(00)01839-0	13	146	149	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					625	628		10.1016/S0140-6736(01)05778-6	http://dx.doi.org/10.1016/S0140-6736(01)05778-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530149				2022-12-24	WOS:000170615500010
J	Blinkhorn, S				Blinkhorn, S			Yes, but what's it for?	NATURE			English	Article									Psychometr Res & Dev Ltd, St Albans AL1 3HT, England		Blinkhorn, S (corresponding author), Psychometr Res & Dev Ltd, Brewmaster House, St Albans AL1 3HT, England.								0	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					771	771		10.1038/35090659	http://dx.doi.org/10.1038/35090659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518944				2022-12-24	WOS:000170577200018
J	Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D				Navin, TR; Beard, CB; Huang, L; del Rio, C; Lee, S; Pieniazek, NJ; Carter, JL; Le, T; Hightower, A; Rimland, D			Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study	LANCET			English	Article							SULFONE PROPHYLAXIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; AIDS PATIENTS; RESISTANCE; SEQUENCE	Background Investigators have reported that patients infected with Pneumocystis carinii containing mutations in the DHPS (dihydropteroate synthase) gene have a worse outcome than those infected with P carinii containing wildtype DHPS. We investigated patients with HIV-1 infection and P carinii pneumonia to determine if DHPS mutations were associated with poor outcomes in these patients. Methods We compared presence of mutations at the DHPS locus with survival and response of patients to cotrimoxazole or other drugs. Findings For patients initially given co-trimoxazole, nine (14%) of 66 with DHPS mutant died, compared with nine (25%) of 36 with wild type (risk ratio=0.55 [95% CI=0.24-1.25]; p=0.15). Ten (15%) of 66 patients with a DHPS mutant did not respond to treatment, compared with 13 (36%) of 36 patients with the wild type (0.42 [0.20-0.86]; p=0.02). For patients aged 40 years or older, four (14%) of 29 with the mutant and nine (56%) of 16 with the wild type died (0.25 [0.09-0.67]; p=0.005). Interpretation These results, by contrast with those of previous studies, suggest that patients with wild-type P carinii do not have a better outcome than patients with the mutant when given co-trimoxazole. Our results suggest that presence of a DHPS mutation should be only one of several criteria guiding the choice of initial drug treatment of P carinii pneumonia in patients with HIV-1 infection.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, US PHS,US Dept HHS, Atlanta, GA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, US PHS,US Dept HHS, Atlanta, GA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Ctr AIDS Res, San Francisco, CA USA; Emory Univ, Sch Med, Dept Med, Atlanta, GA USA; Emory Univ, Sch Med, Ctr AIDS Res, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Res Ctr AIDS & HIV Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; United States Public Health Service; Centers for Disease Control & Prevention - USA; United States Public Health Service; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Navin, TR (corresponding author), Mailstop E-10,1600 Clifton Rd, Atlanta, GA 30333 USA.		Huang, Laurence/AAZ-7120-2021; del Rio, Carlos/B-3763-2012	Huang, Laurence/0000-0003-3888-2195; del Rio, Carlos/0000-0002-0153-3517				Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Beard CB, 2000, EMERG INFECT DIS, V6, P265, DOI 10.3201/eid0603.000306; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; FERMER C, 1995, J BACTERIOL, V177, P4669, DOI 10.1128/jb.177.16.4669-4675.1995; Helweg-Larsen J, 1999, LANCET, V354, P1347, DOI 10.1016/S0140-6736(99)03320-6; Huang L, 2000, J INFECT DIS, V182, P1192, DOI 10.1086/315824; Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1; Kazanjian P, 1998, AIDS, V12, P873, DOI 10.1097/00002030-199808000-00009; Kazanjian P, 2000, J INFECT DIS, V182, P551, DOI 10.1086/315719; Lane BR, 1997, J INFECT DIS, V175, P482, DOI 10.1093/infdis/175.2.482; LOPEZ P, 1987, J BACTERIOL, V169, P4320, DOI 10.1128/jb.169.9.4320-4326.1987; Ma L, 1999, J INFECT DIS, V180, P1969, DOI 10.1086/315148; Martin JN, 1999, J INFECT DIS, V180, P1809, DOI 10.1086/315132; Mei Q, 1998, LANCET, V351, P1631, DOI 10.1016/S0140-6736(05)77687-X; 1999, AIDS REPORTING UPDAT	15	92	94	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					545	549		10.1016/S0140-6736(01)05705-1	http://dx.doi.org/10.1016/S0140-6736(01)05705-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520525	Green Submitted			2022-12-24	WOS:000170537700012
J	Bertrand, CA				Bertrand, CA			Color by number: Imaging large data	SCIENCE			English	Article									Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bertrand, CA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA.							Lawler A, 2001, SCIENCE, V292, P1044, DOI 10.1126/science.292.5519.1044; Paddock S, 2001, BIOTECHNIQUES, V30, P283, DOI 10.2144/01302bt01; RUSS C, 1999, IMAGE PROCESSING HDB; Smallcombe A, 2001, BIOTECHNIQUES, V30, P1240, DOI 10.2144/01306bt01	4	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1335	1336		10.1126/science.293.5533.1335	http://dx.doi.org/10.1126/science.293.5533.1335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509735				2022-12-24	WOS:000170492600045
J	Hauf, S; Waizenegger, IC; Peters, JM				Hauf, S; Waizenegger, IC; Peters, JM			Cohesin cleavage by separase required for anaphase and cytokinesis in human cells	SCIENCE			English	Article							SISTER-CHROMATID SEPARATION; FISSION YEAST; DEGRADATION; PROTEOLYSIS; CHROMOSOME; INHIBITOR; IDENTIFICATION; COMPLEXES; PROPHASE; MITOSIS	Cell division depends on the separation of sister chromatids in anaphase. In yeast, sister separation is initiated by cleavage of cohesin by the protease separase. In vertebrates, most cohesin is removed from chromosome arms by a cleavage-independent mechanism. Only residual amounts of cohesin are cleaved at the onset of anaphase, coinciding with its disappearance from centromeres. We have identified two separase cleavage sites in the human cohesin subunit SCC1 and have conditionally expressed noncleavable SCC1 mutants in human cells. our results indicate that cohesin cleavage by separase is essential for sister chromatid separation and for the completion of cytokinesis.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Hauf, Silke/H-7321-2012	Hauf, Silke/0000-0001-5938-721X				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; HAUF S, UNPUB; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McClintock B., 1941, COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, V9, P72; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	22	372	383	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1320	1323		10.1126/science.1061376	http://dx.doi.org/10.1126/science.1061376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509732				2022-12-24	WOS:000170492600041
J	Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR				Wheeler, DA; Arathoon, EG; Pitts, M; Cedillos, RA; Bu, TE; Porras, GD; Herrera, G; Sosa, NR			Availability of HIV care in Central America	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-1	Central America is an area with a growing human immunodeficiency virus (HIV) epidemic, but with marked limitations in its health care infrastructure. Estimated adult HIV infection rates range from 0.20% in Nicaragua to 2.01% in Belize. Hospitals and clinicians with experience in HIV care exist mainly, if not only, in capital cities and principal economic centers. Nationally sponsored social security systems in each country consistently offer a wider range of services than do ministry of health systems. Estimated access to the social security system ranges from 0% in Belize and 10% of the population in Honduras to 95% in Costa Rica. Combination antiretroviral therapy is not available through the ministries of health and zidovudine is only sporadically available for prevention of perinatal transmission. Combination therapy is available through the social security system in the countries of Guatemala, Panama, and Costa Rica only. A wide variety of antiretroviral agents are available through private pharmacies in all countries except Belize. With the exception of Costa Ricans, most people with HIV infection in Central America have limited access to HIV-specific health services and limited or no access to antiretroviral agents.	Infect Dis Physicians, Annandale, VA 22003 USA; Hosp San Juan Dios, Guatemala City, Guatemala; Natl AIDS Program, Belize City, Belize; Hosp Rosales, San Salvador, El Salvador; Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; Hosp Bautista, Managua, Nicaragua; Hosp Calderon Guardia, San Jose, Costa Rica; Complejo Hosp Metropolitano Arnulfo Arias Madrid, Panama City, Panama		Wheeler, DA (corresponding author), Infect Dis Physicians, 3289 Woodburn Rd,Suite 200, Annandale, VA 22003 USA.		Arathoon, Eduardo G./J-8751-2019	Arathoon, Eduardo G./0000-0002-6225-7413				AGUAIS J, 2000, 13 INT AIDS C JUL 13; Candal DH, 1997, AIDS RES HUM RETROV, V13, P1349, DOI 10.1089/aid.1997.13.1349; GONZALEZDIAZ E, 1999, INF DIS SOC AM ANN M; HASELTINE WA, 1998, ESTABLISHING PRIORIT; HERRERA G, 1999, 1 CENTR AM C SEX TRA; *J HOPK U AIDS SER, 1998, HOPK HIV REP S; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Lara C, 1997, J CLIN MICROBIOL, V35, P783, DOI 10.1128/JCM.35.3.783-784.1997; *PAN AM HLTH ORG, 2000, AIDS SURV AM BIANN R; *PAN AM HLTH ORG W, 2000, BUILD BLOCKS GUID PR; QUATTRINI E, 2000, 13 INT AIDS C JUL 11; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; *U NAC AUT HOND, 1999, AN AC SIT NAC, P56; WEBER AE, 2000, 13 INT AIDS C JUL 10	14	12	13	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					853	860		10.1001/jama.286.7.853	http://dx.doi.org/10.1001/jama.286.7.853			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497545				2022-12-24	WOS:000170429600035
J	Ferguson-Smith, AC; Surani, MA				Ferguson-Smith, AC; Surani, MA			Imprinting and the epigenetic asymmetry between parental genomes	SCIENCE			English	Editorial Material							DNA METHYLATION; ANTISENSE RNA; IGF2R GENE; CPG ISLAND; HISTONE H3; GERM-LINE; LYSINE 9; EXPRESSION; CTCF; UPSTREAM	Genomic imprinting confers a developmental asymmetry on the parental genomes, through epigenetic modifications in the germ line and embryo. These heritable modifications regulate the monoallelic activity of parental alleles resulting in their functional differences during development. Specific cis-acting regulatory elements associated with imprinted genes carry modifications involving chromatin structural changes and DNA methylation. Some of these modifications are initiated in the germ tine. Comparative genomic analysis at imprinted domains is emerging as a powerful toot for the identification of conserved elements amenable to more detailed functional analysis, and for providing insight into the emergence of imprinting during the evolution of mammalian species. Genomic imprinting therefore provides a model system for the analysis of the epigenetic control of genome function.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Physiol Lab, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge; University of Cambridge	Ferguson-Smith, AC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	afsmith@mole.bio.cam.ac.uk; as10021@mole.bio.cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894; Surani, Azim/0000-0002-8640-4318				ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Arney KL, 2001, INT J DEV BIOL, V45, P533; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BAYLIN S, IN PRESS SCIENCE; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Cranston MJ, 2001, GENOMICS, V73, P98, DOI 10.1006/geno.2001.6514; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Dean W, 2001, CURR BIOL, V11, pR527, DOI 10.1016/S0960-9822(01)00311-6; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Ferguson-Smith AC, 2000, CURR BIOL, V10, pR872, DOI 10.1016/S0960-9822(00)00817-4; Grandjean V, 2001, FEBS LETT, V488, P165, DOI 10.1016/S0014-5793(00)02349-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; JAENISCH R, IN PRESS SCIENCE; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BK, 2001, HUM MOL GENET, V10, P807, DOI 10.1093/hmg/10.8.807; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kato Y, 1999, DEVELOPMENT, V126, P1823; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Loebel DAF, 1996, GENOME RES, V6, P114, DOI 10.1101/gr.6.2.114; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NEUMANN B, 1995, NAT GENET, V9, P451, DOI 10.1038/ng0495-451b; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; PAULSEN M, IN PRESS J PATHOL; PAULSEN M, UNPUB; Pickard B, 2001, MECH DEVELOP, V103, P35, DOI 10.1016/S0925-4773(01)00329-X; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Riesewijk AM, 1996, GENOMICS, V31, P158, DOI 10.1006/geno.1996.0027; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; Schmidt JV, 2000, GENE DEV, V14, P1997; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; SURANI MA, 1993, PHILOS T R SOC B, V339, P165, DOI 10.1098/rstb.1993.0013; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; TAKADA S, UNPUB; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Werren JH, 2000, GENETICS, V155, P1469; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	63	307	335	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1086	1089		10.1126/science.1064020	http://dx.doi.org/10.1126/science.1064020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498578				2022-12-24	WOS:000170432600046
J	Noma, K; Allis, CD; Grewal, SIS				Noma, K; Allis, CD; Grewal, SIS			Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries	SCIENCE			English	Article							FISSION YEAST; PROTEIN; DIRECTIONALITY; EXPRESSION; CENTROMERE; REGION; LOCI	Eukaryotic genomes are organized into discrete structural and functional chromatin domains. Here, we show that distinct site-specific histone H3 methylation patterns define euchromatic and heterochromatic chromosomal domains within a 47-kilobase region of the mating-type locus in fission yeast. H3 methylated at lysine 9 (H3 Lys(9)), and its interacting Swi6 protein, are strictly localized to a 20-kilobase silent heterochromatic interval. In contrast, H3 methylated at lysine 4 (H3 LyS(4)) is specific to the surrounding euchromatic regions. Two inverted repeats flanking the silent interval serve as boundary elements to mark the borders between heterochromatin and euchromatin. Deletions of these boundary elements lead to spreading of H3 Lys(9) methylation and Swi6 into neighboring sequences. Furthermore, the H3 Lys(9) methylation and corresponding heterochromatin-associated complexes prevent H3 LyS(4) methylation in the silent domain.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Cold Spring Harbor Laboratory; University of Virginia	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM059772, R01GM053512] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53512, GM59772] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayoub N, 1999, GENETICS, V152, P495; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grewal SIS, 1997, GENETICS, V146, P1221; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NAKAYAMA J, UNPUB; Partridge JF, 2000, GENE DEV, V14, P783; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	25	577	600	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1150	1155		10.1126/science.1064150	http://dx.doi.org/10.1126/science.1064150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498594				2022-12-24	WOS:000170432600064
J	Pouille, F; Scanziani, M				Pouille, F; Scanziani, M			Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition	SCIENCE			English	Article							COINCIDENCE DETECTOR; CORTICAL NEURON; BRAIN-SLICES; INTERNEURONS; CA1; HIPPOCAMPUS; POTENTIALS; NOREPINEPHRINE; INTEGRATOR	The temporal resolution of neuronal integration depends on the time window within which excitatory inputs summate to reach the threshold for spike generation. Here, we show that in rat hippocampal pyramidal cells this window is very narrow (less than 2 milliseconds). This narrowness results from the short delay with which disynaptic feed-forward inhibition follows monosynaptic excitation. Simultaneous somatic and dendritic recordings indicate that feedforward inhibition is much stronger in the soma than in the dendrites, resulting in a broader integration window in the latter compartment. Thus, the subcellular partitioning of feed-forward inhibition enforces precise coincidence detection in the soma, while allowing dendrites to sum incoming activity over broader time windows.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Zurich	Scanziani, M (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Bergles DE, 1996, J NEUROSCI, V16, P572; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; KNOWLES WD, 1981, J NEUROSCI, V1, P318; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MAJOR G, 1994, J NEUROSCI, V14, P4613; McQuiston AR, 1999, J NEUROSCI, V19, P5693, DOI 10.1523/JNEUROSCI.19-14-05693.1999; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Seutin V, 1997, NEUROPHARMACOLOGY, V36, P1653, DOI 10.1016/S0028-3908(97)00147-0; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sturm AK, 2001, BIOL CYBERN, V84, P153, DOI 10.1007/s004220000209; TEITELBAUM H, 1975, Science (Washington D C), V188, P1114, DOI 10.1126/science.175440; ZHANG S, 1994, J NEUROPHYSIOL, V72, P705, DOI 10.1152/jn.1994.72.2.705	23	801	811	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1159	1163		10.1126/science.1060342	http://dx.doi.org/10.1126/science.1060342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498596				2022-12-24	WOS:000170432600066
J	Smallman, HS; MacLeod, DIA; Doyle, P				Smallman, HS; MacLeod, DIA; Doyle, P			Vision: Realignment of cones after cataract removal	NATURE			English	Article									Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Pacific Sci & Engn Grp, San Diego, CA 92122 USA; Dartmouth Coll, Dept Math, Hanover, NH 03755 USA	University of California System; University of California San Diego; Dartmouth College	Smallman, HS (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.							APPLEGATE RA, 1993, J OPT SOC AM A, V10, P1611, DOI 10.1364/JOSAA.10.001611; APPLEGATE RA, 1981, INVEST OPHTH VIS SCI, V21, P869; BONDS AB, 1978, INVEST OPHTH VIS SCI, V17, P754; Dennison D., 1979, Encyclopedia of Plant Physiology, New Series, Volume 7. Physiology of movements [Haupt, W.; Feinleib, M.E. (Editors)]., P506; ENOCH J M, 1961, Optom Wkly, V8, P329; ENOCH JM, 1981, PHILOS T R SOC B, V291, P323, DOI 10.1098/rstb.1981.0002; ENOCH JM, 1991, VISUAL OPTICS INSTRU, P280; FINE I, IN PRESS VISION RES; Kono M, 2001, VISION RES, V41, P103, DOI 10.1016/S0042-6989(00)00228-5; LATIES AM, 1968, NATURE, V218, P172, DOI 10.1038/218172a0; Laties AM, 1979, MOTILITY CELL FUNCTI, P285; MACLEOD DIA, 1974, VISION RES, V14, P369, DOI 10.1016/0042-6989(74)90235-1; Stiles WS, 1933, P R SOC LOND B-CONTA, V112, P428, DOI 10.1098/rspb.1933.0020	13	21	21	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					604	605		10.1038/35088126	http://dx.doi.org/10.1038/35088126			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493909				2022-12-24	WOS:000170318000029
J	Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L				Trembath, RC; Thomson, JR; Machado, RD; Morgan, NV; Atkinson, C; Winship, I; Simonneau, G; Galie, N; Loyd, JE; Humbert, M; Nichols, WC; Morrell, NW; Berg, J; Manes, A; McGaughran, J; Pauciulo, M; Wheeler, L			Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIOVENOUS-MALFORMATIONS; GERMLINE MUTATIONS; PENDRED SYNDROME; KINASE-1 GENE; RECEPTOR; BETA; ENDOGLIN; TYPE-2; GROWTH; PPH1	Background: Most patients with familial primary pulmonary hypertension have defects in the gene for bone morphogenetic protein receptor II (BMPR2), a member of the transforming growth factor beta (TGF-beta) superfamily of receptors. Because patients with hereditary hemorrhagic telangiectasia may have lung disease that is indistinguishable from primary pulmonary hypertension, we investigated the genetic basis of lung disease in these patients. Methods: We evaluated members of five kindreds plus one individual patient with hereditary hemorrhagic telangiectasia and identified 10 cases of pulmonary hypertension. In the two largest families, we used microsatellite markers to test for linkage to genes encoding TGF-beta -receptor proteins, including endoglin and activin-receptor-like kinase 1 (ALK1), and BMPR2. In subjects with hereditary hemorrhagic telangiectasia and pulmonary hypertension, we also scanned ALK1 and BMPR2 for mutations. Results: We identified suggestive linkage of pulmonary hypertension with hereditary hemorrhagic telangiectasia on chromosome 12q13, a region that includes ALK1. We identified amino acid changes in activin-receptor-like kinase 1 that were inherited in subjects who had a disorder with clinical and histologic features indistinguishable from those of primary pulmonary hypertension. Immunohistochemical analysis in four subjects and one control showed pulmonary vascular endothelial expression of activin-receptor-like kinase 1 in normal and diseased pulmonary arteries. Conclusions: Pulmonary hypertension in association with hereditary hemorrhagic telangiectasia can involve mutations in ALK1. These mutations are associated with diverse effects, including the vascular dilatation characteristic of hereditary hemorrhagic telangiectasia and the occlusion of small pulmonary arteries that is typical of primary pulmonary hypertension.	Univ Leicester, Dept Med, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Genet, Div Med Genet, Leicester LE1 7RH, Leics, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Papworth Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; Univ Auckland, Sch Med, Dept Mol Med, Auckland, New Zealand; Univ Paris Sud, Assistance Publ Hop Paris, Hop Antoine Beclere, Serv Pneumol, Clamart, France; Univ Bologna, Inst Cardiol, Bologna, Italy; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	University of Leicester; University of Leicester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; University of Cambridge; University of Auckland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; University of Bologna; Vanderbilt University; Cincinnati Children's Hospital Medical Center	Trembath, RC (corresponding author), Univ Leicester, Dept Med, Div Med Genet, Adrian Bldg, Leicester LE1 7RH, Leics, England.		Morgan, Neil V/A-5475-2009; Galie, Nazzareno/F-7004-2014; Winship, Ingrid M/D-7204-2016; wei, wei/HHR-8613-2022; Simonneau, Gerald/ABE-6614-2020; Machado, Rajiv D./AAD-7813-2019; McGaughran, Julie/A-2563-2012	Morgan, Neil V/0000-0001-6433-5692; Galie, Nazzareno/0000-0003-4271-8670; Machado, Rajiv D./0000-0001-9247-0744; Morrell, Nicholas/0000-0001-5700-9792; McGaughran, Julie/0000-0002-0926-7858; Trembath, Richard/0000-0003-0550-3400; Loyd, James/0000-0002-5042-7390; Winship, Ingrid/0000-0001-8535-6003; Humbert, Marc/0000-0003-0703-2892	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048164, R01HL061997] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48164, HL61997] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cool CD, 1999, AM J PATHOL, V155, P411, DOI 10.1016/S0002-9440(10)65137-1; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Coyle B, 1996, NAT GENET, V12, P421, DOI 10.1038/ng0496-421; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Gausden E, 1997, J MED GENET, V34, P126, DOI 10.1136/jmg.34.2.126; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Klaus Daniel J., 1998, Human Mutation, V12, P137, DOI 10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.0.CO;2-M; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Makowski GS, 1998, ANN CLIN LAB SCI, V28, P254; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Morse JH, 1997, CIRCULATION, V95, P2603, DOI 10.1161/01.CIR.95.12.2603; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SAPRU RP, 1969, BRIT HEART J, V31, P559; Schulick AH, 1998, P NATL ACAD SCI USA, V95, P6983, DOI 10.1073/pnas.95.12.6983; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1999, THORAX, V54, P714, DOI 10.1136/thx.54.8.714; Thomson JR, 2000, J CLIN PATHOL, V53, P899, DOI 10.1136/jcp.53.12.899; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; TRELL E, 1972, AM J MED, V53, P50, DOI 10.1016/0002-9343(72)90115-5; WHYTE MKB, 1993, J APPL PHYSIOL, V75, P321, DOI 10.1152/jappl.1993.75.1.321	33	506	539	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					325	334		10.1056/NEJM200108023450503	http://dx.doi.org/10.1056/NEJM200108023450503			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484689	Green Published, Green Accepted			2022-12-24	WOS:000170193600003
J	Schwetz, BA				Schwetz, BA			New weight-reduction system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2001	286	5					527	527		10.1001/jama.286.5.527	http://dx.doi.org/10.1001/jama.286.5.527			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458HE	11476645				2022-12-24	WOS:000170188300005
J	Inchausti, P; Halley, J				Inchausti, P; Halley, J			Investigating long-term ecological variability using the global population dynamics database	SCIENCE			English	Editorial Material								The Global Population Dynamics Database (GPDD) is an important new source of information for ecologists, resource managers, and environmental scientists interested in the dynamics of natural populations. It comprises more than 4500 time series of population abundance for over 1800 animal species across many taxonomic groups and geographical locations. The GPDD offers great potential for asking comparative questions about the nature of population variability. We illustrate this by characterizing some critical features of ecological variability, variance growth, and spectral reddening.	Ecole Normale Super, Ecol Lab, F-75005 Paris, France; Aristotle Univ Thessaloniki, Sch Biol, Dept Ecol, GR-54006 Thessaloniki, Greece	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Aristotle University of Thessaloniki	Inchausti, P (corresponding author), Ecole Normale Super, Ecol Lab, 46 Rue Ulm, F-75005 Paris, France.	inchauss@biologie.ens.fr; jmax@bio.auth.gr	Halley, John M/AAP-3004-2020					Adler R., 1997, PRACTICAL GUIDE HEAV; ARINO A, 1995, EVOL ECOL, V9, P423; CYR H, 1996, OIKOS, V79, P54; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; HALLEY JW, UNPUB; Kendall BE, 1998, ECOL LETT, V1, P160; LAWTON JH, 1988, NATURE, V334, P563, DOI 10.1038/334563a0; MACARDLE B, 1990, J ANIM ECOL, V59, P439; May R.M., 1975, P81; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Pimm S. L., 1991, BALANCE NATURE ECOLO; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; Royama T., 1992, ANAL POPULATION ECOL; STEELE J, 1986, NATURE, V313, P355; White A, 1996, NATURE, V381, P198, DOI 10.1038/381198a0	16	101	104	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					655	657		10.1126/science.293.5530.655	http://dx.doi.org/10.1126/science.293.5530.655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474102				2022-12-24	WOS:000170204600044
J	Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF				Yusupova, GZ; Yusupov, MM; Cate, JHD; Noller, HF			The path of messenger RNA through the ribosome	CELL			English	Article							DIRECTED CROSS-LINKING; BINDING; SITE; INITIATION; SUBUNIT; REGION; NUCLEOTIDES; TRANSLATION; COMPLEXES; SEQUENCE	Using X-ray crystallography, we have directly observed the path of mRNA in the 70S ribosome in Fourier difference maps at 7 Angstrom resolution. About 30 nucleotides of the mRNA are wrapped in a groove that encircles the neck of the 30S subunit. The Shine-Dalgarno helix is bound in a large cleft between the head and the back of the platform. At the interface, only about eight nucleotides (-1 to +7), centered on the junction between the A and P codons, are exposed, and bond almost exclusively to 16S rRNA. The mRNA enters the ribosome around position + 13 to + 15, the location of downstream pseudoknots that stimulate -1 translational frame shifting.	Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Whitehead Inst, Cambridge, MA 01242 USA	University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); Whitehead Institute	Noller, HF (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	harry@nuvolari.ucsc.edu	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014	Yusupov, Marat/0000-0001-5544-0597; 				Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alam SL, 1999, P NATL ACAD SCI USA, V96, P14177, DOI 10.1073/pnas.96.25.14177; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALAKIN A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P119, DOI 10.1016/0167-4781(90)90151-Q; BELITSINA NV, 1981, FEBS LETT, V131, P289, DOI 10.1016/0014-5793(81)80387-0; BHANGU R, 1992, BIOCHEMISTRY-US, V31, P5937, DOI 10.1021/bi00140a033; BHANGU R, 1994, BIOCHEMISTRY-US, V33, P3063, DOI 10.1021/bi00176a040; BRETSCHER MS, 1968, NATURE, V220, P1088, DOI 10.1038/2201088a0; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIMACOMBE R, 1995, EUR J BIOCHEM, V230, P365; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; DOKUDOVSKAYA SS, 1993, BIOTECHNOL APPL BIOC, V18, P149; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Greuer B, 1999, RNA, V5, P1521, DOI 10.1017/S1355838299991550; GUALERZI C, 1977, BIOCHEMISTRY-US, V16, P1684, DOI 10.1021/bi00627a025; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JUZUMIENE DI, 1995, J BIOL CHEM, V270, P12794, DOI 10.1074/jbc.270.21.12794; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; PESTKA S, 1967, J BIOL CHEM, V242, P4939; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; RINKEAPPEL J, 1993, NUCLEIC ACIDS RES, V21, P2853, DOI 10.1093/nar/21.12.2853; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sergiev PV, 1997, RNA, V3, P464; SHATSKY IN, 1991, BIOCHIMIE, V73, P937, DOI 10.1016/0300-9084(91)90135-N; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; VONAHSEN U, 1995, SCIENCE, V267, P234, DOI 10.1126/science.7528943; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	39	472	534	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					233	241		10.1016/S0092-8674(01)00435-4	http://dx.doi.org/10.1016/S0092-8674(01)00435-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511350	Bronze			2022-12-24	WOS:000170193100012
J	Padian, K; de Ricqles, AJ; Horner, JR				Padian, K; de Ricqles, AJ; Horner, JR			Dinosaurian growth rates and bird origins	NATURE			English	Article							BONE MICROSTRUCTURE; PERIOSTEAL BONE; SKELETOCHRONOLOGY; HISTOLOGY; ONTOGENY	Dinosaurs, like other tetrapods, grew more quickly just after hatching than later in life. However, they did not grow like most other non-avian reptiles, which grow slowly and gradually through life. Rather, microscopic analyses of the long-bone tissues show that dinosaurs grew to their adult size relatively quickly, much as large birds and mammals do today. The first birds reduced their adult body size by shortening the phase of rapid growth common to their larger theropod dinosaur relatives. These changes in timing were primarily related not to physiological differences but to differences in growth strategy.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; Univ Paris 07, CNRS, UMR 8570, Equipe Format Squelett, F-75251 Paris 05, France; Coll France, F-75231 Paris, France; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Montana State University System; Montana State University Bozeman	Padian, K (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kpadian@socrates.berkeley.edu						ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1993, BONE; [Anonymous], 1980, COLD LOOK WARM BLOOD; Apanius V., 1998, AVIAN GROWTH DEV EVO; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; Chinsamy A, 1998, CRETACEOUS RES, V19, P225, DOI 10.1006/cres.1997.0102; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; de Ricqles Armand, 2000, Annee Biologique, V39, P69; DERICQLES A, 2001, IN PRESS PERSPECTIVE; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL G A, 1972, Zoologicheskii Zhurnal, V51, P1726; Padian K, 1997, ENCY DINOSAURS, P288; Reid R.E.H., 1997, P449; Reid R.E.H., 1997, P403; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Spotila J. R., 1980, COLD LOOK WARM BLOOD, P233; van Soest R. W. M, 1971, Bijdragen tot de Dierkunde, V41, P61; Varricchio D. J., 1997, ENCY DINOSAURS, P282, DOI DOI 10.1016/J.CUB.2016.10.043; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhang Fucheng, 1998, Vertebrata Palasiatica, V36, P126	41	207	216	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					405	408		10.1038/35086500	http://dx.doi.org/10.1038/35086500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473307				2022-12-24	WOS:000170068200037
J	Knee, LBG; Brunt, CM				Knee, LBG; Brunt, CM			A massive cloud of cold atomic hydrogen in the outer Galaxy	NATURE			English	Article							H-I; MOLECULAR CLOUDS; MILKY-WAY; TEMPERATURES; SUPERSHELLS; SHELLS	A large fraction of the mass of the interstellar medium in our Galaxy is in the form of warm (10(3)-10(4) K) and cool (50-100 K) atomic hydrogen (H I) gas(1). Cold (10-30 K) regions are thought to be dominated by dense clouds of molecular hydrogen(2). Cold H I is difficult to observe, and therefore our knowledge of its abundance and distribution in the interstellar medium is poor. The few known clouds of cold H I are much smaller in size and mass than typical molecular clouds 3-5. Here we report the discovery that the H I supershell GSH139-03-69 is very cold (10 K). It is about 2 kiloparsecs in size and as massive as the largest molecular complexes(6). The existence of such an immense structure composed of cold atomic hydrogen in the interstellar medium runs counter to the prevailing view that cold gas resides almost exclusively in clouds dominated by molecular hydrogen.	Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, Penticton, BC V2A 6K3, Canada; Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada	National Research Council Canada; University of Calgary	Knee, LBG (corresponding author), Natl Res Council Canada, Herzberg Inst Astrophys, Dominion Radio Astrophys Observ, POB 248, Penticton, BC V2A 6K3, Canada.	lewis.knee@nrc.ca		Knee, Lewis/0000-0002-9342-9003				BLITZ L, 1991, NATO ADV SCI I C-MAT, V342, P3; Burton W. B., 1988, GALACTIC EXTRAGALACT, V2nd, P295; CRUTCHER RM, 1974, ASTROPHYS J, V188, P481, DOI 10.1086/152738; Dame TM, 2001, ASTROPHYS J, V547, P792, DOI 10.1086/318388; DICKEY JM, 1990, ANNU REV ASTRON ASTR, V28, P215, DOI 10.1146/annurev.aa.28.090190.001243; Ehlerova S, 1997, ASTRON ASTROPHYS, V328, P121; ELMEGREEN BG, 1987, ASTROPHYS J, V320, P182, DOI 10.1086/165534; Gibson SJ, 2000, ASTROPHYS J, V540, P851, DOI 10.1086/309364; Hartmann D., 1997, ATLAS GALACTIC NEUTR; HEILES C, 1979, ASTROPHYS J, V229, P533, DOI 10.1086/156986; HEILES C, 1982, ASTROPHYS J, V262, P135, DOI 10.1086/160403; Heyer MH, 1998, ASTROPHYS J SUPPL S, V115, P241, DOI 10.1086/313086; Higgs LA, 2000, ASTRON J, V120, P2471, DOI 10.1086/316833; Higgs LA, 1999, ASTR SOC P, V168, P15; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023, DOI 10.1093/mnras/221.4.1023; Kulkarni S. R., INTERSTELLAR PROCESS, V134, P87, DOI [10.1007/978-94-009-3861-8_5, DOI 10.1007/978-94-009-3861-8_5]; KULKARNI SR, 1985, ASTROPHYS J, V291, P716, DOI 10.1086/163110; Landecker TL, 2000, ASTRON ASTROPHYS SUP, V145, P509, DOI 10.1051/aas:2000257; Perna R, 2000, ASTROPHYS J, V539, P706, DOI 10.1086/309282; SOLOMON PM, 1987, ASTROPHYS J, V319, P730, DOI 10.1086/165493; Spitzer L, 2008, JRASC; TAYLOR AR, UNPUB ASTRON J; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; TRAPERO J, 1995, ASTROPHYS J, V445, P231, DOI 10.1086/175690; VANDISHOECK EF, 1986, ASTROPHYS J SUPPL S, V62, P109, DOI 10.1086/191135; WANNIER PG, 1983, ASTROPHYS J, V268, P727, DOI 10.1086/160995	26	40	41	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					308	310		10.1038/35085519	http://dx.doi.org/10.1038/35085519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460155				2022-12-24	WOS:000169918200038
J	Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM				Meijers-Heijboer, H; van Geel, B; van Putten, WLJ; Henzen-Logmans, SC; Seynaeve, C; Menke-Pluymers, MBE; Bartels, CCM; Verhoog, LC; van den Ouweland, AMW; Niermeijer, MF; Brekelmans, CTM; Klijn, JGM			Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OVARIAN-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; HIGH-RISK; SURGERY; CARRIERS; SATISFACTION; TAMOXIFEN; SURVIVAL; FAMILIES	Background: Women with a BRCA1 or BRCA2 mutation have a high risk of breast cancer and may choose to undergo prophylactic bilateral total mastectomy. We investigated the efficacy of this procedure in such women. Methods: We conducted a prospective study of 139 women with a pathogenic BRCA1 or BRCA2 mutation who were enrolled in a breast-cancer surveillance program at the Rotterdam Family Cancer Clinic. At the time of enrollment, none of the women had a history of breast cancer. Seventy-six of these women eventually underwent prophylactic mastectomy, and the other 63 remained under regular surveillance. The effect of mastectomy on the incidence of breast cancer was analyzed by the Cox proportional-hazards method in which mastectomy was modeled as a time-dependent covariate. Results: No cases of breast cancer were observed after prophylactic mastectomy after a mean (+/-SE) follow-up of 2.9+/-1.4 years, whereas eight breast cancers developed in women under regular surveillance after a mean follow-up of 3.0+/-1.5 years (P=0.003; hazard ratio, 0; 95 percent confidence interval, 0 to 0.36). The actuarial mean five-year incidence of breast cancer among all women in the surveillance group was 17+/-7 percent. On the basis of an exponential model, the yearly incidence of breast cancer in this group was 2.5 percent. The observed number of breast cancers in the surveillance group was consistent with the expected number (ratio of observed to expected cases, 1.2; 95 percent confidence interval, 0.4 to 3.7; P=0.80). Conclusions: In women with a BRCA1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up. (N Engl J Med 2001;345:159-64.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Surg, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Stat, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Pathol, NL-3075 EA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Klijn, JGM (corresponding author), Erasmus Univ, Med Ctr, Dr Daniel den Hoed Klin, Dept Med Oncol,Rotterdam Family Canc Clin, Groene Hilledijk 301, NL-3075 EA Rotterdam, Netherlands.	bos@onch.azrl.nl						BERMAN L, 2000, LANCET, V356, P881; BILIMORIA MM, 1995, CA-CANCER J CLIN, V45, P263, DOI 10.3322/canjclin.45.5.263; Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HARTMANN LC, 2000, P AM ASSOC CANC RES, V41, P222; Hatcher MB, 2001, BRIT MED J, V322, P76, DOI 10.1136/bmj.322.7278.76; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; Khurana KK, 2000, ARCH PATHOL LAB MED, V124, P378; Klijn JGM, 1997, EUR J CANCER, V33, P2149, DOI 10.1016/S0959-8049(97)00360-2; Kriege M., 2000, European Journal of Cancer, V36, pS137; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Peelen T, 2000, BRIT J CANCER, V82, P151, DOI 10.1054/bjoc.1999.0892; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; PetrijBosch A, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503a; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; SKOLNICK MH, 1990, SCIENCE, V250, P1715, DOI 10.1126/science.2270486; STEFANEK ME, 1995, PREV MED, V24, P412, DOI 10.1006/pmed.1995.1066; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; Whittemore AS, 1997, AM J HUM GENET, V60, P496; Wooster R, 1996, NATURE, V379, P749, DOI 10.1038/379749a0; ZION SM, 2000, PROG P AM SOC CLIN O, V19, pA441	34	669	688	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					159	164		10.1056/NEJM200107193450301	http://dx.doi.org/10.1056/NEJM200107193450301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463009	Green Published			2022-12-24	WOS:000169912800001
J	Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH				Reimold, AM; Iwakoshi, NN; Manis, J; Vallabhajosyula, P; Szomolanyi-Tsuda, E; Gravallese, EM; Friend, D; Grusby, MJ; Alt, F; Glimcher, LH			Plasma cell differentiation requires the transcription factor XBP-1	NATURE			English	Article							B-CELL; GERMINAL CENTER; T-CELL; TERMINAL DIFFERENTIATION; BLIMP-1 EXPRESSION; DEFICIENT MICE; IGM SECRETION; PROTEIN; LYMPHOCYTES; MEMORY	Considerable progress has been made in identifying the transcription factors involved in the early specification of the B-lymphocyte lineage. However, little is known about factors that control the transition of mature activated B cells to antibody-secreting plasma cells. Here we report that the transcription factor XBP-1 is required for the generation of plasma cells. XBP-1 transcripts were rapidly upregulated in vitro by stimuli that induce plasma-cell differentiation, and were found at high levels in plasma cells from rheumatoid synovium. When introduced into B-lineage cells, XBP-1 initiated plasma-cell differentiation. Mouse lymphoid chimaeras deficient in XBP-1 possessed normal numbers of activated B lymphocytes that proliferated, secreted cytokines and formed normal germinal centres. However, they secreted very little immunoglobulin of any isotype and failed to control infection with the B-cell-dependent polyoma virus, because plasma cells were markedly absent. XBP-1 is the only transcription factor known to be selectively and specifically required for the terminal differentiation of B lymphocytes to plasma cells.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.		Longo, Kenneth A/A-5631-2010					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Altmeyer A, 1997, IMMUNITY, V7, P667, DOI 10.1016/S1074-7613(00)80387-8; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; Bachmann MF, 1999, CURR OPIN IMMUNOL, V11, P332, DOI 10.1016/S0952-7915(99)80053-3; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BROOKS K, 1983, NATURE, V302, P825, DOI 10.1038/302825a0; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Choe J, 1998, EUR J IMMUNOL, V28, P508, DOI 10.1002/(SICI)1521-4141(199802)28:02<508::AID-IMMU508>3.0.CO;2-I; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gartner F, 2000, J EXP MED, V192, P1745, DOI 10.1084/jem.192.12.1745; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; GRAVALLESE EM, 1991, ARTHRITIS RHEUM-US, V34, P1076, DOI 10.1002/art.1780340903; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; ILLERA VA, 1993, J IMMUNOL, V151, P2965; Kim HJ, 1999, J IMMUNOL, V162, P3053; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lin KI, 2000, MOL CELL BIOL, V20, P8684, DOI 10.1128/MCB.20.23.8684-8695.2000; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu Y J, 1997, Semin Immunol, V9, P235, DOI 10.1006/smim.1997.0080; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Melchers F, 1997, CURR TOP MICROBIOL, V224, P19; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Oliver AM, 1997, J IMMUNOL, V158, P1108; RANDALL TD, 1993, MOL CELL BIOL, V13, P3929, DOI 10.1128/MCB.13.7.3929; Reimold AM, 1996, J EXP MED, V183, P393, DOI 10.1084/jem.183.2.393; Reimold AM, 2000, GENE DEV, V14, P152; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Schwoon DR, 1997, EUR ADDICT RES, V3, P11, DOI 10.1159/000259142; Soro PG, 1999, J IMMUNOL, V163, P611; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SzomolanyiTsuda E, 1996, J EXP MED, V183, P403, DOI 10.1084/jem.183.2.403; SZOMOLANYITSUDA.E, J IMMUNOL, V164, P5877; Takatsu K, 1997, P SOC EXP BIOL MED, V215, P121; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Wen XY, 1999, INT J ONCOL, V15, P173; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	49	960	1007	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					300	307		10.1038/35085509	http://dx.doi.org/10.1038/35085509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460154				2022-12-24	WOS:000169918200037
J	MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM				MARAIS, DJD; STRAUSS, H; SUMMONS, RE; HAYES, JM			CARBON ISOTOPE EVIDENCE FOR THE STEPWISE OXIDATION OF THE PROTEROZOIC ENVIRONMENT	NATURE			English	Article							CENTRAL AUSTRALIA; AMADEUS BASIN; RECORD; OCEANS; EVAPORITE; PALEOSOL; DEPOSITS; DIOXIDE; SULFATE; OXYGEN	The oxidation of the Earth's crust and the increase in atmospheric oxygen early in Earth history have been linked to the accumulation of reduced carbon in sedimentary rocks. Trends in the carbon isotope composition of sedimentary organic carbon and carbonate show that during the Proterozoic aeon (2.5-0.54 Gyr ago) the organic carbon reservoir grew in size, relative to the carbonate reservoir. This increase, and the concomitant release of oxidizing power in the environment, occurred mostly during episodes of global rifting and orogeny.	RUHR UNIV BOCHUM, INST GEOL, W-4630 BOCHUM 1, GERMANY; BUR MINERAL RESOURCES, CANBERRA, ACT 2605, AUSTRALIA; INDIANA UNIV, DEPT GEOL SCI, BIOGEOCHEM LABS, BLOOMINGTON, IN 47405 USA; INDIANA UNIV, DEPT CHEM, BLOOMINGTON, IN 47405 USA	Ruhr University Bochum; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	MARAIS, DJD (corresponding author), NASA, AMES RES CTR, MOFFETT FIELD, CA 94035 USA.		Summons, Roger Everett/AAL-3789-2020					[Anonymous], 1992, PROTEROZOIC BIOSPHER; Badger M.R., 1987, PROGR PHOTOSYNTHESIS; BAKER AJ, 1989, NATURE, V337, P352, DOI 10.1038/337352a0; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BEUKES NJ, 1989, SEDIMENTOLOGY, V36, P383, DOI 10.1111/j.1365-3091.1989.tb00615.x; BROECKER WS, 1983, SCI AM, V249, P146, DOI 10.1038/scientificamerican0983-146; BROWN JS, 1965, GEOL SOC AM BULL, V67, P1590; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CANFIELD DE, IN PRESS NATO ARW IN; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; Des Marais D.J, 1991, PALAEOGEOGRAPHY PALA, V97, P93, DOI DOI 10.1016/0031-0182(91)90185-T; EASTOE CJ, 1990, PRECAMBRIAN RES, V46, P353, DOI 10.1016/0301-9268(90)90021-H; ERIKSSON PG, 1992, PRECAMBRIAN RES, V54, P257, DOI 10.1016/0301-9268(92)90073-W; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; GARRELS RM, 1974, SEA, V5, P303; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; HARLAND WB, 1983, GEOL SOC AM MEM, V161, P279; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; Holland H. D., 1978, CHEM ATMOSPHERE OCEA, P1; Holland H.D., 1984, CHEM EVOLUTION ATMOS, P1; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; HOLLAND HD, 1973, HYDROGEOCHEMISTRY BI, P68; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; JAHNKE L, 1983, J BACTERIOL, V155, P488, DOI 10.1128/JB.155.2.488-492.1983; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; LINDSAY JF, 1987, GEOL SOC AM BULL, V99, P852, DOI 10.1130/0016-7606(1987)99<852:UPEITA>2.0.CO;2; McKirdy D.M., 1974, GEOLOGY, V2, P591, DOI [591, DOI 10.1130/0091-7613(1974)2<591:MAOCIC>2.0.CO;2]; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; PIPER JDA, 1983, GEOL SOC AM MEM, V161, P11; PIPER JDA, 1982, EARTH PLANET SC LETT, V59, P61, DOI 10.1016/0012-821X(82)90118-2; REDDING CE, 1980, ADV ORG GEOCHEM, P711; Schidlowski, 1982, MINERAL DEPOSITS EVO, P103; SCHIDLOWSKI M, 1976, GEOCHIM COSMOCHIM AC, V40, P449, DOI 10.1016/0016-7037(76)90010-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; STEWART AJ, 1979, SEDIMENTOLOGY, V26, P33, DOI 10.1111/j.1365-3091.1979.tb00337.x; Strauss H., 1992, PROTEROZOIC BIOSPHER, P117; SUMMONS RE, 1990, AM J SCI, V290A, P212; VEIZER J, 1982, NATURWISSENSCHAFTEN, V69, P173, DOI 10.1007/BF00364890; VEIZER J, 1992, GEOCHIM COSMOCHIM AC, V56, P875, DOI 10.1016/0016-7037(92)90033-F; VEIZER J, 1988, ORIGINS LIFE EVOL B, V18, P13, DOI 10.1007/BF01808778; VEIZER J, 1976, GEOCHIM COSMOCHIM AC, V40, P905, DOI 10.1016/0016-7037(76)90139-3; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WALKER RN, 1977, NATURE, V265, P526, DOI 10.1038/265526a0; Windley B. F., 1984, EVOLVING CONTINENTS, P1; Worsley TR, 1986, PALEOCEANOGRAPHY, V1, P233, DOI 10.1029/PA001i003p00233; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; [No title captured]; [No title captured]	59	319	328	14	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	1992	359	6396					605	609		10.1038/359605a0	http://dx.doi.org/10.1038/359605a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JT824	11536507				2022-12-24	WOS:A1992JT82400046
J	FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA				FOMENKOVA, MN; KERRIDGE, JF; MARTI, K; MCFADDEN, LA			COMPOSITIONAL TRENDS IN ROCK-FORMING ELEMENTS OF COMET HALLEY DUST	SCIENCE			English	Article							AQUEOUS ACTIVITY; PARENT BODY; PARTICLES; SPECTRA; CHONDRITES; SURFACE; IMPACT; GRAINS	The VEGA 1 and 2 spacecraft flew by comet P/Halley in 1986 carrying, among other instruments, two mass spectrometers to measure the elemental composition of dust particles emitted from the comet. Most particles seem to be a mixture of silicates of variable magnesium-iron composition and organic matter. Comprehensive study of data and consideration of the mass of dust particles reveal cometary grains of "unusual" composition: magnesium-rich and iron-rich particles. Magnesium-rich particles are most likely magnesium carbonates, which could not have formed under conditions of equilibrium condensation but rather require formation by aqueous alteration. The composition of the iron-rich particles can also be related to secondary processes in the comet.	UNIV CALIF SAN DIEGO,CALIF SPACE INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego	FOMENKOVA, MN (corresponding author), ACAD SCI USSR,SPACE RES INST,MOSCOW,USSR.		McFadden, Lucy-Ann/I-4902-2013	McFadden, Lucy-Ann/0000-0002-0537-9975				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARPIGNY C, 1979, ELEMENTS ISOTOPES UN, P189; BALEBANOV VM, 1984, VENUS HALLEY MISSION, P88; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P617; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CLARK BC, 1987, ASTRON ASTROPHYS, V187, P779; DELSEMME AH, 1991, COMETS POSTHALLEY ER, P377; DIKOV YP, 1989, ADV SPACE RES, V9, P253; DYCHNE A, 1991, 260891 SPAC RES I TE; EVLANOV EN, 1991, CHEM SPACE, P383; FOMENKOVA M, 1991, LPSC, V22, P397; FREDRIKSSON K, 1988, METEORITICS, V23, P35, DOI 10.1111/j.1945-5100.1988.tb00894.x; HALLIDAY I, 1987, ASTRON ASTROPHYS, V187, P921; INOGAMOV NA, 1986, DOKL AKAD NAUK SSSR, V277, P1377; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KERRIDGE JF, 1979, SCIENCE, V205, P395, DOI 10.1126/science.205.4404.395; KERRIDGE JF, 1979, P LUNAR PLANET SCI C, V10, P989; KISSEL J, 1986, NATURE, V321, P280, DOI 10.1038/321280a0; KISSEL J, 1987, APPL PHYS A-MATER, V42, P69, DOI 10.1007/BF00618161; KORTH A, 1989, NATURE, V337, P53, DOI 10.1038/337053a0; Kracher A., 1984, J GEOPHYS RES S, V89, pB559; LANGEVIN Y, 1987, ASTRON ASTROPHYS, V187, P761; LAWLER ME, 1989, ICARUS, V80, P225, DOI 10.1016/0019-1035(89)90135-8; MUKHIN L, 1991, NATURE, V350, P480, DOI 10.1038/350480a0; MUMMA MJ, 1990, BAAS, V22, P1088; PRINN RG, 1988, ORIGIN EVOLUTION PLA, P78; RIETMEIJER FJM, 1991, EARTH PLANET SC LETT, V102, P148, DOI 10.1016/0012-821X(91)90004-2; RIETMEIJER FJM, 1989, LUNAR PLANET SCI, V20, P904; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Sears D.W.G., 1988, METEORITES EARLY SOL, P3; SHRAMM LS, 1989, METEORITICS, V24, P99; ZINNER EK, 1989, LUNAR PLANET SCI, V20, P1245; ZOLENSKY ME, 1992, P LUNAR PLANET SCI, V22, P161	33	83	83	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 9	1992	258	5080					266	269		10.1126/science.11538058	http://dx.doi.org/10.1126/science.11538058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR860	11538058				2022-12-24	WOS:A1992JR86000024
J	SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ				SLEEP, NH; ZAHNLE, KJ; KASTING, JF; MOROWITZ, HJ			ANNIHILATION OF ECOSYSTEMS BY LARGE ASTEROID IMPACTS ON THE EARLY EARTH	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; PENN STATE UNIV,DEPT GEOSCI,UNIVERSITY PK,PA 16802; GEORGE MASON UNIV,DEPT BIOL,FAIRFAX,VA 22030	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Mason University	SLEEP, NH (corresponding author), STANFORD UNIV,DEPT BIOPHYS,STANFORD,CA 94305, USA.		Kasting, James/AAF-6851-2020					BALDWIN RB, 1987, ICARUS, V71, P1, DOI 10.1016/0019-1035(87)90158-8; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; BALDWIN RB, 1981, P LUNAR PLANET SCI A, V12, P19; BRATERMAN PS, 1983, NATURE, V303, P163, DOI 10.1038/303163a0; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P2415, DOI 10.1029/JB090iB14p12415; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; CARLSON RW, 1979, EARTH PLANET SC LETT, V45, P123, DOI 10.1016/0012-821X(79)90114-6; CLOUD P, 1983, SCI AM, V249, P176, DOI 10.1038/scientificamerican0983-176; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; DAVIS PA, 1987, J GEOPHYS RES-SOLID, V92, pE387, DOI 10.1029/JB092iB04p0E387; DONNISON JR, 1984, MON NOT R ASTRON SOC, V210, P673, DOI 10.1093/mnras/210.3.673; Hartmann W.K., 1980, LUNAR HIGHLANDS CRUS, P155; HARTMANN WK, 1987, ICARUS, V69, P33, DOI 10.1016/0019-1035(87)90005-4; HUGHES DW, 1982, MON NOT R ASTRON SOC, V199, P1149, DOI 10.1093/mnras/199.4.1149; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; JANNASCH HW, 1983, HYDROTHERMAL PROCESS, P677; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; KOROTEV RL, 1987, J GEOPHYS RES-SOLID, V92, pE447, DOI 10.1029/JB092iB04p0E447; LINDSTROM MM, 1986, J GEOPHYS RES-SOLID, V91, pD263, DOI 10.1029/JB091iB04p0D263; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MARVIN UB, 1989, SCIENCE, V243, P925, DOI 10.1126/science.243.4893.925; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; NEWSOM HE, 1988, NATURE, V338, P29; PIETERS CM, 1986, REV GEOPHYS, V24, P557, DOI 10.1029/RG024i003p00557; RINGWOOD AE, 1986, ORIGIN MOON, P331; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P214; Spudis P.D., 1988, P LUN PLAN SCI C, P155; SPUDIS PD, 1986, J GEOPHYS RES-SOLID, V91, pE84, DOI 10.1029/JB091iB13p00E84; Swindle T.D., 1986, P C KON HI LUN PLAN, P331; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1987, NATURE, V329, P710, DOI 10.1038/329710a0; WARREN PH, 1989, EARTH PLANET SC LETT, V91, P245, DOI 10.1016/0012-821X(89)90001-0; WETHERILL GW, 1988, ICARUS, V75, P552	35	325	334	1	53	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 9	1989	342	6246					139	142		10.1038/342139a0	http://dx.doi.org/10.1038/342139a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY739	11536616				2022-12-24	WOS:A1989AY73900055
J	Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D				Eggert, US; Ruiz, N; Falcone, BV; Branstrom, AA; Goldman, RC; Silhavy, TJ; Kahne, D			Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin	SCIENCE			English	Article							ESCHERICHIA-COLI; GLYCOPEPTIDE ANTIBIOTICS; LYTIC TRANSGLYCOSYLASE; MEMBRANE LOCALIZATION; RESISTANCE; IDENTIFICATION; CHROMOSOME; STRAINS; SYSTEM; GROWTH	Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Adv Med Inc, San Francisco, CA 94080 USA	Princeton University; Princeton University	Kahne, D (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	dkahne@princeton.edu		Ruiz, Natividad/0000-0002-6369-2206; Falcone, Brian/0000-0001-8506-0915; Silhavy, Thomas/0000-0001-7672-5153; Eggert, Ulrike/0000-0003-0932-5525				Alaimo PJ, 2001, CURR OPIN CHEM BIOL, V5, P360, DOI 10.1016/S1367-5931(00)00215-5; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; Branstrom AA, 2000, FEMS MICROBIOL LETT, V191, P187, DOI 10.1111/j.1574-6968.2000.tb09338.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kerns R, 2000, J AM CHEM SOC, V122, P12608, DOI 10.1021/ja0027665; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; NAGARAJAN R, 1989, J ANTIBIOT, V42, P63, DOI 10.7164/antibiotics.42.63; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; SAMPSON BA, 1989, GENETICS, V122, P491; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Silhavy T.J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; UMEDA M, 1991, GENE, V98, P1, DOI 10.1016/0378-1119(91)90096-T; VANHEIJENOORT Y, 1987, J GEN MICROBIOL, V133, P667; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zelenitsky SA, 1997, ANTIMICROB AGENTS CH, V41, P1407, DOI 10.1128/AAC.41.6.1407	25	112	116	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					361	364		10.1126/science.1063611	http://dx.doi.org/10.1126/science.1063611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11520949				2022-12-24	WOS:000171601400040
J	Norell, MA; Makovicky, PJ; Currie, PJ				Norell, MA; Makovicky, PJ; Currie, PJ			Palaeontology - The beaks of ostrich dinosaurs	NATURE			English	Article									Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Royal Tyrell Museum Palaeontol, Drumheller, AB T0J 0Y0, Canada	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Norell, MA (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; Eberth D.A., 1997, ENCY DINOSAURS, P379; GOODMAN DC, 1962, FUNCTIONAL ANATOMY F, P1; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Makovicky Peter J., 1998, American Museum Novitates, V3247, P1; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Padian K., 1997, ENCY DINOSAURS, P499; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Zweers G.A, 1977, Contributions vert. Evol., V3, P1	11	59	60	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					873	874		10.1038/35091139	http://dx.doi.org/10.1038/35091139			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528466				2022-12-24	WOS:000170689000032
J	Cui, Y; Wei, QQ; Park, HK; Lieber, CM				Cui, Y; Wei, QQ; Park, HK; Lieber, CM			Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species	SCIENCE			English	Article								Boron-doped silicon nanowires (SiNWs) were used to create highly sensitive, real-time electrically based sensors for biological and chemical species. Amine- and oxide-functionalized SiNWs exhibit pH-dependent conductance that was linear over a large dynamic range and could be understood in terms of the change in surface charge during protonation and deprotonation. Biotin-modified SiNWs were used to detect streptavidin down to at least a picomolar concentration range. In addition, antigen-functionalized SiNWs show reversible antibody binding and concentration-dependent detection in real time. Lastly, detection of the reversible binding of the metabolic indicator Ca2+ was demonstrated, The small size and capability of these semiconductor nanowires for sensitive, label-free, real-time detection of a wide range of chemical and biological species could be exploited in array-based screening and in vivo diagnostics.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	cmt@cmliris.harvard.edu	Park, Hongkun/R-9842-2019; Cui, Yi/L-5804-2013; Chu, Yung-Ming/C-6318-2009; Dee, Chang Fu/G-4842-2010	Park, Hongkun/0000-0001-9576-8829; Cui, Yi/0000-0002-6103-6352; Dee, Chang Fu/0000-0003-1015-9181				BAGCI H, 1993, FEBS LETT, V322, P47, DOI 10.1016/0014-5793(93)81108-C; Bartlett P. N., 1996, HDB CHEM BIOL SENSOR, P139; BAYER EA, 1990, METHOD ENZYMOL, V184, P49; BERGVELD P, 1972, IEEE T BIO-MED ENG, VBM19, P342, DOI 10.1109/TBME.1972.324137; Blackburn G. F., 1987, BIOSENSORS FUNDAMENT, P481; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; BOLT GH, 1957, J PHYS CHEM-US, V61, P1166, DOI 10.1021/j150555a007; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Cui Y, 2001, APPL PHYS LETT, V78, P2214, DOI 10.1063/1.1363692; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Iler R. K, 1979, CHEM SILICA; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Seker F, 2000, CHEM REV, V100, P2505, DOI 10.1021/cr980093r; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Vezenov DV, 1997, J AM CHEM SOC, V119, P2006, DOI 10.1021/ja963375m	22	5149	5451	56	2434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1289	1292		10.1126/science.1062711	http://dx.doi.org/10.1126/science.1062711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509722				2022-12-24	WOS:000170492600031
J	Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V				Karcher, RL; Roland, JT; Zappacosta, F; Huddleston, MJ; Annan, RS; Carr, SA; Gelfand, V			Cell cycle regulation of myosin-V by calcium/calmodulin-dependent protein kinase II	SCIENCE			English	Article							MASS-SPECTROMETRY; ORGANELLE TRANSPORT; SELECTIVE DETECTION; MOTOR PROTEIN; MELANOPHORES; PHOSPHOPEPTIDES; PHOSPHORYLATION; MUTAGENESIS; DEGRADATION; ASSOCIATION	Organelle transport by myosin-V is down-regulated during mitosis, presumably by myosin-V phosphorylation. We used mass spectrometry phosphopeptide mapping to show that the tall of myosin-V was phosphorylated in mitotic Xenopus egg extract on a single serine residue localized in the carboxyl-terminal organelle-binding domain. Phosphorylation resulted in the release of the motor from the organelle. The phosphorylation site matched the consensus sequence of calcium/calmodulin-dependent protein kinase II (CaMKII), and inhibitors of CaMKII prevented myosin-V release. The modulation of cargo binding by phosphorylation is likely to represent a general mechanism regulating organelle transport by myosin-V.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; GlaxoSmithKline, Dept Phys & Struct Chem, King Of Prussia, PA 19406 USA	University of Illinois System; University of Illinois Urbana-Champaign; GlaxoSmithKline	Gelfand, V (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		Roland, Joseph/C-9592-2013; Gelfand, Vladimir I/D-2545-2013; Gelfand, Vladimir/M-1974-2019; Carr, Steven A./AAH-8366-2019	Gelfand, Vladimir I/0000-0002-6361-2798; Gelfand, Vladimir/0000-0002-6361-2798; Roland, Jr., J. Thomas/0000-0003-1181-4651	NIGMS NIH HHS [GM-52111] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052111, R55GM052111] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g; Annan RS, 2001, ANAL CHEM, V73, P393, DOI 10.1021/ac001130t; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Carr SA, 1996, ANAL BIOCHEM, V239, P180, DOI 10.1006/abio.1996.0313; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUDDLESTON MJ, 1993, J AM SOC MASS SPECTR, V4, P710, DOI 10.1016/1044-0305(93)80049-5; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LINDSAY HD, 1995, J CELL SCI, V108, P3557; Niclas J, 1996, J CELL BIOL, V133, P585, DOI 10.1083/jcb.133.3.585; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Nilsson H, 1997, CELL MOTIL CYTOSKEL, V38, P397, DOI 10.1002/(SICI)1097-0169(1997)38:4<397::AID-CM9>3.3.CO;2-5; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; Rogers SL, 1997, P NATL ACAD SCI USA, V94, P3720, DOI 10.1073/pnas.94.8.3720; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; STARODUBOV S M, 1988, Ontogenez, V19, P279; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	118	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1317	1320		10.1126/science.1061086	http://dx.doi.org/10.1126/science.1061086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509731				2022-12-24	WOS:000170492600040
J	Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA				Strom, BL; Schinnar, R; Ziegler, EE; Barnhart, KT; Sammel, MD; Macones, GA; Stallings, VA; Drulis, JM; Nelson, SE; Hanson, SA			Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYTO-ESTROGENS; PHYTOESTROGENS; ISOFLAVONES; PROTEIN; BINDING; RELEVANCE; RECEPTORS; AFFINITY; DISEASE; CANCER	Context A large body of evidence documents the role of phytoestrogens in influencing hormone-dependent states. Infants fed soy formula receive high levels of phytoestrogens, in the form of soy isoflavones, during a stage of development at which permanent effects are theoretically possible. However, a paucity of data exists on the long-term effects of infant soy formulas. Objective To examine the association between infant exposure to soy formula and health in young adulthood, with an emphasis on reproductive health. Design, Setting, and Participants Retrospective cohort study conducted from March to August 1999 among adults aged 20 to 34 years who, as infants, participated during 1965-1978 in controlled feeding studies conducted at the University of Iowa, Iowa City (248 were fed soy formula and 563 were fed cow milk formula during infancy). Main Outcome Measures Self-reported pubertal maturation, menstrual and reproductive history, height and usual weight, and current health, compared based on type of formula exposure during infancy. Results No statistically significant differences were observed between groups in either women or men for more than 30 outcomes. However, women who had been fed soy formula reported slightly longer duration of menstrual bleeding (adjusted mean difference, 0.37 days; 95% confidence interval [CI], 0.06-0.68), with no difference in severity of menstrual flow. They also reported greater discomfort with menstruation (unadjusted relative risk for extreme discomfort vs no or mild pain, 1.77; 95% CI, 1.04-3.00). Conclusions Exposure to soy formula does not appear to lead to different general health or reproductive outcomes than exposure to cow milk formula. Although the few positive findings should be explored in future studies, our findings are reassuring about the safety of infant soy formula.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Iowa, Dept Pediat, Fomon Infant Nutr Unit, Iowa City, IA 52242 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Iowa	Strom, BL (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 824 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	bstrom@cceb.med.upenn.edu		Sammel, Mary/0000-0003-1248-4199	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083279] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acacio BD, 2000, FERTIL STERIL, V73, P595, DOI 10.1016/S0015-0282(99)00591-9; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.2307/3432518; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; CARTER MW, 1953, P SOC EXP BIOL MED, V84, P506, DOI 10.3181/00379727-84-20693; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; CHENG E, 1953, SCIENCE, V118, P164, DOI 10.1126/science.118.3058.164; DRANE H, 1975, FOOD COSMET TOXICOL, V13, P491, DOI 10.1016/S0015-6264(75)80216-1; DRANE HM, 1980, FOOD COSMET TOXICOL, V18, P425, DOI 10.1016/0015-6264(80)90201-1; FOLMAN Y, 1966, J ENDOCRINOL, V34, P215, DOI 10.1677/joe.0.0340215; FOMON SJ, 1984, PEDIATR RES, V18, P1233, DOI 10.1203/00006450-198412000-00001; FOMON SJ, 1986, J NUTR, V116, P1405, DOI 10.1093/jn/116.8.1405; FOMON SJ, 1971, ACTA PAEDIATR SCAND, P1; GAVALER JS, 1995, P SOC EXP BIOL MED, V208, P98; GREENLAND S, 1988, J CLIN EPIDEMIOL, V41, P1167, DOI 10.1016/0895-4356(88)90020-0; Huggett AC, 1997, LANCET, V350, P815, DOI 10.1016/S0140-6736(05)62613-X; Humfrey Charles D. N., 1998, Natural Toxins, V6, P51, DOI [10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.3.CO;2-0, 10.1002/(SICI)1522-7189(199804)6:2<51::AID-NT11>3.0.CO;2-9]; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Irvine CHG, 1998, P SOC EXP BIOL MED, V217, P247; IRVING C, 1995, NEW ZEAL MED J, V108, P208; KATZENELLENBOGEN BS, 1977, ENDOCRINOLOGY, V100, P1252, DOI 10.1210/endo-100-5-1252; Klein KO, 1998, NUTR REV, V56, P193, DOI 10.1111/j.1753-4887.1998.tb01748.x; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Knight DC, 1996, OBSTET GYNECOL, V87, P897; MCCULLAGH P., 1991, GEN LINEAR MODELS; MEHTA CR, 1992, AM STAT, V46, P146, DOI 10.2307/2684185; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; MOULE G. R., 1963, Anim. Breed. Abstr., V31, P139; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; North K, 2000, BJU INT, V85, P107, DOI 10.1046/j.1464-410x.2000.00436.x; ROSENBLUM ER, 1992, ALCOHOL CLIN EXP RES, V16, P843, DOI 10.1111/j.1530-0277.1992.tb01879.x; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; SETCHELL KDR, 1987, GASTROENTEROLOGY, V93, P225, DOI 10.1016/0016-5085(87)91006-7; SETCHELL KDR, 1984, AM J CLIN NUTR, V40, P569, DOI 10.1093/ajcn/40.3.569; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Sheehan DM, 1998, P SOC EXP BIOL MED, V217, P379, DOI 10.3181/00379727-217-44248; SHEMESH M, 1972, J REPROD FERTIL, V29, P1; SHUTT DA, 1972, J ENDOCRINOL, V52, P299, DOI 10.1677/joe.0.0520299; SHUTT DA, 1976, ENDEAVOUR, V35, P110, DOI 10.1016/0160-9327(76)90004-1; Siegel S., 1988, NONPARAMETRIC STAT B; SUTHERLAND RL, 1980, NATURE, V288, P273, DOI 10.1038/288273a0; TANG BY, 1980, J ENDOCRINOL, V85, P291, DOI 10.1677/joe.0.0850291; WHITTEN PL, 1995, P SOC EXP BIOL MED, V208, P82; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	49	224	234	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2001	286	7					807	814		10.1001/jama.286.7.807	http://dx.doi.org/10.1001/jama.286.7.807			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	462PU	11497534	Bronze			2022-12-24	WOS:000170429600028
J	Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB				Heckman, DS; Geiser, DM; Eidell, BR; Stauffer, RL; Kardos, NL; Hedges, SB			Molecular evidence for the early colonization of land by fungi and plants	SCIENCE			English	Article							DETERMINING DIVERGENCE TIMES; EARLY EVOLUTION; ORIGIN; DIVERSIFICATION; CLOCK; LIFE	The colonization of land by eukaryotes probably was facilitated by a partnership (symbiosis) between a photosynthesizing organism (phototroph) and a fungus. However, the time when colonization occurred remains speculative. The first fossil land plants and fungi appeared 480 to 460 million years ago (Ma), whereas molecular clock estimates suggest an earlier colonization of land, about 600 Ma. Our protein sequence analyses indicate that green algae and major lineages of fungi were present 1000 Ma and that land plants appeared by 700 Ma, possibly affecting Earth's atmosphere, climate, and evolution of animals in the Precambrian.	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedges, SB (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sbh1@psu.edu	Geiser, David/J-9950-2013					Alexopoulos C. J., 1996; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; Berbee ML, 2001, MYCOTA, V7, P229; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; Goremykin VV, 1997, PLANT SYST EVOL, V206, P337, DOI 10.1007/BF00987956; GRAY J, 1992, AM SCI, V80, P444; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Kroken SB, 1996, AM J BOT, V83, P1241, DOI 10.2307/2446108; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumar S., 1996, PHYLTEST PROGRAM TES; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Schwartzman D., 1999, LIFE TEMPERATURE EAR; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; TAYLOR TN, 1995, NATURE, V378, P244, DOI 10.1038/378244a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Watanabe Y, 2000, NATURE, V408, P574, DOI 10.1038/35046052; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	37	672	713	7	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1129	1133		10.1126/science.1061457	http://dx.doi.org/10.1126/science.1061457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498589				2022-12-24	WOS:000170432600058
J	Matzke, M; Matzke, AJM; Kooter, JM				Matzke, M; Matzke, AJM; Kooter, JM			RNA: Guiding gene silencing	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; DNA METHYLTRANSFERASES; MESSENGER-RNA; EVOLUTION; PLANTS; ARABIDOPSIS; METHYLATION; MECHANISMS; DISRUPTION; TRANSGENE	In diverse organisms, small RNAs derived from cleavage of double-stranded RNA can trigger epigenetic gene silencing in the cytoplasm and at the genome level. Small RNAs can guide posttranscriptional degradation of complementary messenger RNAs and, in plants, transcriptional gene silencing by methylation of homologous DNA sequences. RNA silencing is a potent means to counteract foreign sequences and could play an important role in plant and animal development.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Vrije Univ Amsterdam, Dept Dev Genet, Amsterdam, Netherlands	Austrian Academy of Sciences; Vrije Universiteit Amsterdam	Matzke, M (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.		Matzke, Antonius/H-8698-2015					Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Barstead R, 2001, CURR OPIN CHEM BIOL, V5, P63, DOI 10.1016/S1367-5931(00)00173-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; DAVIDSON EH, 1979, SCIENCE, V204, P1051; Doudna JA, 2000, NAT STRUCT BIOL, V7, P954, DOI 10.1038/80729; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HAMMOND SM, IN PRESS SCIENCE; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; TSUCHI T, 2001, CHEMBIOCHEM, V2, P239; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	53	259	358	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1080	1083		10.1126/science.1063051	http://dx.doi.org/10.1126/science.1063051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498576				2022-12-24	WOS:000170432600044
J	Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP				Wilson, FH; Disse-Nicodeme, S; Choate, KA; Ishikawa, K; Nelson-Willams, C; Desitter, I; Gunel, M; Milford, DV; Lipkin, GW; Achard, JM; Feely, MP; Dussol, B; Berland, Y; Unwin, RJ; Mayan, H; Simon, DB; Farfel, Z; Jeunemaitre, X; Lifton, RP			Human hypertension caused by mutations in WNK kinases	SCIENCE			English	Article							PSEUDOHYPOALDOSTERONISM TYPE-II; FAMILIAL HYPERKALEMIA; CHLORIDE REABSORPTION; MULTILOCUS LINKAGE; BLOOD-PRESSURE; DEFECT; LOCUS	Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of anti hypertensive drugs.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Coll France, INSERM, U36, F-75005 Paris, France; Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England; Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TT, W Midlands, England; Hop Amiens Sud, Serv Nephrol, Amiens, France; Gen Infirm, Unit Mol Vasc Med, Leeds LS1 3EX, W Yorkshire, England; Hop St Marguerite, Serv Nephrol & Hemodialyse, Marseille, France; UCL, Dept Nephrol, London W1W 7EY, England; UCL, Dept Physiol, London W1W 7EY, England; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Dept Med E, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sheba Med Ctr, Fac Med, Biochem Pharmacol Lab, IL-52621 Tel Hashomer, Israel	Howard Hughes Medical Institute; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; University of Birmingham; University of Birmingham; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Leeds General Infirmary; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of London; University College London; University of London; University College London; Chaim Sheba Medical Center; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.	richard.ltifton@yale.edu	JEUNEMAITRE, Xavier/AAQ-4853-2021; achard, jean-michel/A-3392-2017	JEUNEMAITRE, Xavier/0000-0001-5925-381X; Wilson, Frederick/0000-0002-5019-0186				Baima J, 1999, HYPERTENSION, V34, P4, DOI 10.1161/01.HYP.34.1.4; BAZ M, 1990, PRESSE MED, V19, P1981; Disse-Nicodeme S, 2000, AM J HUM GENET, V67, P302, DOI 10.1086/303020; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; Gordon Richard D., 1995, P2111; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE MR, 1980, LANCET, V1, P879; LEE MR, 1979, Q J MED, V48, P245; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; PAVER W K, 1964, Med J Aust, V2, P305; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; TAKE C, 1991, NEW ENGL J MED, V324, P472, DOI 10.1056/NEJM199102143240707; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795	21	1084	1134	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1107	1112		10.1126/science.1062844	http://dx.doi.org/10.1126/science.1062844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498583				2022-12-24	WOS:000170432600051
J	Drake, MJ; Mills, IW; Gillespie, JI				Drake, MJ; Mills, IW; Gillespie, JI			Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function	LANCET			English	Article							HUMAN URINARY-BLADDER; OBSTRUCTION; TISSUE; CELLS; PIG	Normal bladder function is controlled by the central nervous system (CNS) and any peripheral contribution to bladder control is believed to be small. Nevertheless, anatomically and functionally, such a contribution might exist. Taking account of this evidence, we propose that the detrusor muscle is arranged into modules, which are circumscribed areas of muscle active during the filling phase of the micturition cycle. These modules might be controlled by a peripheral myovesical plexus, consisting of intramural ganglia and interstitial cells. Detrusor overactivity is the occurrence of abnormal increases in pressure during bladder filling, which the patient cannot inhibit. This disorder is thought to be a consequence of abnormal expression of the micturition reflex or changes in the properties of the smooth muscle. We propose that detrusor overactivity results from exaggerated symptomatic expression of peripheral autonomous activity, resulting from a shift in the balance of excitation and inhibition in smooth muscle modules. These structures responsible for origin and spread of peripheral autonomous activity could be targeted to help develop new therapeutic strategies.	Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; St Marys Hosp, Dept Urol, London, England	Newcastle University - UK; Imperial College London	Drake, MJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Tyne Micturit Res Grp, Sch Surg Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Drake, Marcus/C-4542-2014	Drake, Marcus/0000-0002-6230-2552				BRADING AF, 1994, BRIT J UROL, V73, P3, DOI 10.1111/j.1464-410X.1994.tb07447.x; Brading AF, 1997, UROLOGY, V50, P57, DOI 10.1016/S0090-4295(97)00591-8; Bristow SE, 1996, BRIT J UROL, V77, P333, DOI 10.1046/j.1464-410X.1996.08981.x; Charlton RG, 1999, BJU INT, V84, P953; COOLSAET BLRA, 1993, NEUROUROL URODYNAM, V12, P463, DOI 10.1002/nau.1930120504; DEGROAT WC, 1997, UROLOGY S6A, V50, pS36; Furness JB., 1987, ENTERIC NERVOUS SYST; Greenland JE, 2000, BJU INT, V85, P1109, DOI 10.1046/j.1464-410x.2000.00611.x; LENNON GM, 1993, BRIT J UROL, V72, P702, DOI 10.1111/j.1464-410X.1993.tb16251.x; Mills I. W., 1998, Neurourology and Urodynamics, V17, P352; Sanders KM, 1996, GASTROENTEROLOGY, V111, P492, DOI 10.1053/gast.1996.v111.pm8690216; Sergeant GP, 2000, J PHYSIOL-LONDON, V526, P359, DOI 10.1111/j.1469-7793.2000.t01-2-00359.x; SETHIA KK, 1990, J UROLOGY, V143, P1243, DOI 10.1016/S0022-5347(17)40246-1; SKEHAN AM, 1993, J UROLOGY, V149, P1156, DOI 10.1016/S0022-5347(17)36339-5; Smet PJ, 1996, NEUROSCIENCE, V71, P337, DOI 10.1016/0306-4522(95)00453-X; Smet PJ, 1996, J NEUROCYTOL, V25, P112, DOI 10.1007/BF02284790	16	115	125	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					401	403		10.1016/S0140-6736(01)05549-0	http://dx.doi.org/10.1016/S0140-6736(01)05549-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502339				2022-12-24	WOS:000170235100034
J	Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW				Liquori, CL; Ricker, K; Moseley, ML; Jacobsen, JF; Kress, W; Naylor, SL; Day, JW; Ranum, LPW			Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9	SCIENCE			English	Article							TRINUCLEOTIDE REPEAT EXPANSION; BINDING-PROTEIN BINDS; FRAGILE-X-SYNDROME; REDUCES EXPRESSION; MESSENGER-RNA; CHROMOSOME 3Q; CTG REPEAT; MYOPATHY; LINKAGE; GENE	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, can be caused by a mutation on either chromosome 19q13 (DM1) or 3q21 (DM2/PROMM). DM1 is caused by a CTG expansion in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK). Several mechanisms have been invoked to explain how this mutation, which does not alter the protein-coding portion of a gene, causes the specific constellation of clinical features characteristic of DM. We now report that DM2 is caused by a CCTG expansion (mean similar to 5000 repeats) located in intron 1 of the zinc finger protein 9 (ZNF9) gene. Parallels between these mutations indicate that microsatellite expansions in RNA can be pathogenic and cause the multisystemic features of DM1 and DM2.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol MMC 206, Minneapolis, MN 55455 USA; Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; Univ Wurzburg, Inst Human Genet, D-97070 Wurzburg, Germany; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wurzburg; University of Wurzburg; University of Texas System; University of Texas Health San Antonio	Ranum, LPW (corresponding author), Univ Minnesota, Inst Human Genet, 420 Delaware St SE, Minneapolis, MN 55455 USA.			Day, John/0000-0002-0086-9529	NCI NIH HHS [CA56266] Funding Source: Medline; NHGRI NIH HHS [HG002051] Funding Source: Medline; NINDS NIH HHS [NS35870] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035870] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alwazzan M, 1999, HUM MOL GENET, V8, P1491, DOI 10.1093/hmg/8.8.1491; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; DEMUNAIN AL, 1994, ANN NEUROL, V35, P374, DOI 10.1002/ana.410350323; FLINK IL, 1995, GENE, V163, P279, DOI 10.1016/0378-1119(95)00421-2; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; *GENB, AC022944 GENB; *GENB, M28372 GENB; *GENB, AC023598 GENB; *GENB, AF388525 GENB; *GENB, AF388526 GENB; *GENB, AF389886 GENB; *GENB, AC022993 GENB; *GENB, AF389887 GENB; Groenen P, 1998, BIOESSAYS, V20, P901, DOI 10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0; Harper P.S., 1989, MYOTONIC DYSTROPHY; Helderman-van den Enden ATJM, 1999, J MED GENET, V36, P253; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moutou C, 1997, HUM MOL GENET, V6, P971, DOI 10.1093/hmg/6.7.971; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; RANUM LPW, UNPUB; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; Schneider C, 2000, NEUROLOGY, V55, P383, DOI 10.1212/WNL.55.3.383; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Steinert H., 1909, DTSCH Z NERVENHEILKU, V37, P58, DOI [10.1007/BF01671719, DOI 10.1007/BF01671719]; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WONG LJC, 1995, AM J HUM GENET, V56, P114	49	849	898	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					864	867		10.1126/science.1062125	http://dx.doi.org/10.1126/science.1062125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486088				2022-12-24	WOS:000170241000045
J	Budd, G				Budd, G			Climbing life's tree	NATURE			English	Editorial Material									Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden	Uppsala University	Budd, G (corresponding author), Uppsala Univ, Dept Earth Sci, Norbyvagen 22, SE-75236 Uppsala, Sweden.			Budd, Graham/0000-0001-9007-4369				Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Smith A.B., 1994, SYSTEMATICS FOSSIL R	2	18	19	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					487	487		10.1038/35087679	http://dx.doi.org/10.1038/35087679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484029				2022-12-24	WOS:000170202900023
J	Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B				Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B		Natl Israel Ovarian Canc Study Grp	Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; DETERMINANTS; POPULATION; OVULATION; ISRAEL; WOMEN	Background Multiparity and the use of oral contraceptives reduce the risk of ovarian cancer, but their effects on this risk in women with a BRCA1 or BRCA2 mutation are unclear. Methods We conducted a population-based case control study of ovarian cancer among Jewish women in Israel. Women were tested for the two founder mutations in BRCA1 and the one founder mutation in BRCA2 that are known to be common among Jews. We estimated the effects of parity and oral-contraceptive use on the risk of ovarian cancer in carriers and noncarriers in separate analyses that included all control women, who did not have ovarian cancer. Results Of 751 controls who underwent mutation analysis, 13 (1.7 percent) had a BRCA1 or BRCA2 mutation, whereas 244 of 840 women with ovarian cancer (29.0 percent) had a BRCA1 or BRCA2 mutation. Overall, each additional birth and each additional year of use of oral contraceptives were found to lower the risk of ovarian cancer, as expected. Additional births were protective in separate analyses of carriers and non-carriers, but oral-contraceptive use appeared to reduce the risk only in noncarriers; among carriers, the reduction in the odds of ovarian cancer was 12 percent per birth (95 percent confidence interval, 2.3 to 21 percent) and 0..2 percent per year of oral-contraceptive use (-4.9 to 5.0 percent). Conclusions The risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation decreases with each birth but not with increased duration of use of oral contraceptives. These data suggest that it is premature to use oral contraceptives for the chemoprevention of ovarian cancer in carriers of such mutations. (N Engl J Med 2001;345:235-40.) Copyright (C) 2001 Massachusetts Medical Society.	Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Shaare Zedek Med Ctr, Jerusalem, Israel; Sapir Med Ctr, Kefar Sava, Israel; Edith Wolfson Med Ctr, Holon, Israel	Chaim Sheba Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Modan, B (corresponding author), Chaim Sheba Med Ctr, Dept Clin Epidemiol, IL-52621 Tel Hashomer, Israel.	BModan@gcrtner.hcalth.gov.il	Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; 	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP010171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER; NCI NIH HHS [MS N02-CP-81005, N02-CP-60534, N02-CP-91026, R01 CA61126-01-03] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; ALBERT P, IN PRESS AM J EPIDEM; BOOTH M, 1989, BRIT J CANCER, V60, P592, DOI 10.1038/bjc.1989.320; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Eeles RA, 2000, BRIT J CANCER, V83, P25; FATHALLA MF, 1971, LANCET, V2, P163; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; Godard B, 1998, AM J OBSTET GYNECOL, V179, P403, DOI 10.1016/S0002-9378(98)70372-2; GWINN ML, 1990, J CLIN EPIDEMIOL, V43, P559, DOI 10.1016/0895-4356(90)90160-Q; HARTGE P, 1989, AM J OBSTET GYNECOL, V161, P10, DOI 10.1016/0002-9378(89)90221-4; HARTGE P, 1995, BRIT J CANCER, V71, P642, DOI 10.1038/bjc.1995.126; MCGOWAN L, 1988, European Journal of Gynaecological Oncology, V9, P195; Modan B, 1996, JAMA-J AM MED ASSOC, V276, P1823, DOI 10.1001/jama.276.22.1823; Modan B, 1998, AM J EPIDEMIOL, V147, P1038; MORI M, 1988, AM J EPIDEMIOL, V128, P771, DOI 10.1093/oxfordjournals.aje.a115030; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; PARAZZINI F, 1991, EUR J CANCER, V27, P594, DOI 10.1016/0277-5379(91)90226-4; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Salazar-Martinez E, 1999, CANCER RES, V59, P3658; Schildkraut Joellen M., 2001, Gynecologic Oncology, V80, P275; Struewing JP, 1999, AM J HUM GENET, V65, P1800, DOI 10.1086/302678; Ursin G, 1997, CANCER RES, V57, P3678; WEISS NS, 1981, INT J CANCER, V28, P669, DOI 10.1002/ijc.2910280602; WEISS NS, 1988, AM J EPIDEMIOL, V128, P451, DOI 10.1093/oxfordjournals.aje.a114993; WU ML, 1988, AM J EPIDEMIOL, V128, P1216, DOI 10.1093/oxfordjournals.aje.a115076	29	261	264	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2001	345	4					235	240		10.1056/NEJM200107263450401	http://dx.doi.org/10.1056/NEJM200107263450401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	455XZ	11474660	Bronze			2022-12-24	WOS:000170054200001
J	Shelton, JD; Johnston, B				Shelton, JD; Johnston, B			Condom gap in Africa: evidence from donor agencies and key informants	BRITISH MEDICAL JOURNAL			English	Article									US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA; Futures Grp Int, Populat Hlth & Nutr Informat Project, Washington, DC 20005 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Ctr Populat Hlth & Nutr, Washington, DC 20523 USA.							Gardner R, 1999, POPULATION REPORTS H, V9; HANENBERG RS, 1994, LANCET, V344, P243, DOI 10.1016/S0140-6736(94)93004-X; Sidley P, 2001, BRIT MED J, V322, P635, DOI 10.1136/bmj.322.7287.635	3	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					139	139		10.1136/bmj.323.7305.139	http://dx.doi.org/10.1136/bmj.323.7305.139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463681	Bronze, Green Published			2022-12-24	WOS:000170106200015
J	Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG				Ellis, DA; Mabury, SA; Martin, JW; Muir, DCG			Thermolysis of fluoropolymers as a potential source of halogenated organic acids in the environment	NATURE			English	Article							TRIFLUOROACETIC-ACID; SURFACE WATERS; PRECIPITATION; RADICALS; DEGRADATION; MECHANISM; PYROLYSIS; KINETICS; OZONE; RAIN	Following the introduction of hydrochlorofluorocarbon (HCFCs) and hydrofluorocarbon (HFCs) gases as replacements for the ozone-destroying chlorofluorocarbons (CFCs), it has been discovered that HCFCs/HFCs can degrade in the atmosphere to produce trifluoroacetic acid(1), a compound with no known loss mechanisms in the environment(2,3), and higher concentrations in natural waters(4) have been shown to be mildly phytotoxic(5). Present environmental levels of trifluooracetic acid are not accounted by HCFC/HFC degradation alone(8-10). Here we report that thermolysis of fluorinated polymers, such as the commercial polymers Teflon and Kel-F, can also produce trifluoroacetate and the similar compound chlorodifluoroacetate. This can occur either directly, or indirectly via products that are known to degrade to these haloacetates in the atmosphere(11). The environmental significance of these findings is confirmed by modelling, which indicates that the thermolysis of fluoropolymers in industrial and consumer high-temperature applications (ovens, nonstick cooking utensils and combustion engines) is likely to be a significant source of trifluoroacetate in urban rain water (similar to 25 ng l(-1), as estimated for Toronto). Thermolysis also leads to longer chain polyfluoro- and/or polychlorofluoro- (C3-C14) carboxylic acids which may be equally persistent. Some of these products have recently been linked with possible adverse health(6) and environmental impacts and are being phased out of the US market(7). Furthermore, we detected CFCs and fluorocarbons- groups that can destroy ozone and act as greenhouse gases, respectively-among the other thermal degradation products, suggesting that continued use of fluoropolymers may also exacerbate stratospheric ozone-depletion and global warming.	Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Guelph, Dept Environm Biol, Guelph, ON N1G 2W1, Canada; Environm Canada, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada	University of Toronto; University of Guelph; Environment & Climate Change Canada; National Water Research Institute	Mabury, SA (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.		Martin, Jonathan W/J-3824-2013; Muir, Derek/AAD-7526-2021	Martin, Jonathan W/0000-0001-6265-4294; Muir, Derek/0000-0001-6631-9776				Acerboni G, 1999, CHEM PHYS LETT, V309, P364, DOI 10.1016/S0009-2614(99)00698-3; ARITO H, 1977, Annals of Occupational Hygiene, V20, P247, DOI 10.1093/annhyg/20.3.247; ATKINSON B, 1957, J CHEM SOC, P2086, DOI 10.1039/jr9570002086; Berends AG, 1999, ENVIRON TOXICOL CHEM, V18, P1053, DOI [10.1002/etc.5620180533, 10.1897/1551-5028(1999)018&lt;1053:TOTTAO&gt;2.3.CO;2]; Berg M, 2000, ENVIRON SCI TECHNOL, V34, P2675, DOI 10.1021/es990855f; Boutonnet JC, 1999, HUM ECOL RISK ASSESS, V5, P59, DOI 10.1080/10807039991289644; BROWN D, 2000, WASH POST       0517; Buravtsev NN, 1999, J FLUORINE CHEM, V96, P35, DOI 10.1016/S0022-1139(98)00325-X; Cahill TM, 2000, ENVIRON SCI TECHNOL, V34, P2909, DOI 10.1021/es991435t; Cahill TM, 2001, ENVIRON SCI TECHNOL, V35, P820, DOI 10.1021/es0013982; Ellis DA, 2000, ENVIRON SCI TECHNOL, V34, P632, DOI 10.1021/es990422c; FEIRING AE, 1994, ORGANOFLUORINE CHEM, P348; FRANKLIN J, 1993, CHEMOSPHERE, V27, P1565, DOI 10.1016/0045-6535(93)90251-Y; Holloway JH, 2000, J FLUORINE CHEM, V104, P3, DOI 10.1016/S0022-1139(00)00222-0; Hynes RG, 1999, J PHYS CHEM A, V103, P5967, DOI 10.1021/jp991065v; Imbalzano J.F, 1991, CHEM ENG PROG, V30, P69; Johns K, 2000, J FLUORINE CHEM, V104, P5, DOI 10.1016/S0022-1139(00)00251-7; Jordan A, 1999, ENVIRON SCI TECHNOL, V33, P522, DOI 10.1021/es980674y; Lemieux PM, 2000, ENVIRON SCI TECHNOL, V34, P377, DOI 10.1021/es990465t; Martin JW, 2000, ENVIRON SCI TECHNOL, V34, P274, DOI 10.1021/es990935j; Mashino M, 2000, J PHYS CHEM A, V104, P7255, DOI 10.1021/jp000498r; Paleta O, 1997, J FLUORINE CHEM, V86, P155, DOI 10.1016/S0022-1139(97)00083-3; RAVISHANKARA AR, 1993, SCIENCE, V259, P194, DOI 10.1126/science.259.5092.194; Rizvi M, 1995, J THERM ANAL, V45, P1597, DOI 10.1007/BF02547453; Schneider WF, 1996, J PHYS CHEM-US, V100, P6097, DOI 10.1021/jp952703m; Scott BF, 2000, ENVIRON SCI TECHNOL, V34, P4266, DOI 10.1021/es9908523; Simon CM, 1998, POLYM DEGRAD STABIL, V62, P1, DOI 10.1016/S0141-3910(97)00097-9; Teruel MA, 1999, INT J CHEM KINET, V31, P867, DOI 10.1002/(SICI)1097-4601(1999)31:12<867::AID-KIN5>3.0.CO;2-R; Upham BL, 1998, INT J CANCER, V78, P491, DOI 10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9; Von Sydow LM, 2000, ENVIRON SCI TECHNOL, V34, P3115, DOI 10.1021/es9913683; Wujcik CE, 1999, ENVIRON SCI TECHNOL, V33, P1747, DOI 10.1021/es980697c	31	223	232	7	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					321	324		10.1038/35085548	http://dx.doi.org/10.1038/35085548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460160				2022-12-24	WOS:000169918200043
J	Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ				Wang, C; Deng, L; Hong, M; Akkaraju, GR; Inoue, J; Chen, ZJJ			TAK1 is a ubiquitin-dependent kinase of MKK and IKK	NATURE			English	Article							I-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; DEFECTIVE INTERLEUKIN-1; ACTIVATION; PROTEIN; TRAF6; INDUCTION; ALPHA; IL-1; JNK	TRAF6 is a signal transducer that activates I kappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS)(1-4). IKK activation by TRAF6 requires two intermediary factors, TRAF6-regulated IKK activator 1 (TRIKA1) and TRIKA2 (ref. 5). TRIKA1 is a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A (or the functionally equivalent Mms2). This Ubc complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism(5). Here we report the purification and identification of TRIKA2, which is composed of TAK1, TAB1 and TAB2, a protein kinase complex previously implicated in IKK activation through an unknown mechanism(6,7). We find that the TAK1 kinase complex phosphorylates and activates IKK in a manner that depends on TRAF6 and Ubc13-Uev1A. Moreover, the activity of TAK1 to phosphorylate MKK6, which activates the JNK-p38 kinase pathway, is directly regulated by K63-linked polyubiquitination. We also provide evidence that TRAF6 is conjugated by the K63 polyubiquitin chains. These results indicate that ubiquitination has an important regulatory role in stress response pathways, including those of IKK and JNK.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Keio Univ, Dept Appl Chem, Kouhoku Ku, Kanagawa 2238522, Japan	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Keio University	Chen, ZJJ (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Akkaraju, Giridhar/0000-0003-2977-2744				Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	24	1565	1648	4	129	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					346	351		10.1038/35085597	http://dx.doi.org/10.1038/35085597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460167				2022-12-24	WOS:000169918200050
J	Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ				Humphries, SE; Talmud, PJ; Hawe, E; Bolla, M; Day, INM; Miller, GJ			Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study	LANCET			English	Article							DIAGONAL GEL-ELECTROPHORESIS; APOE-DEFICIENT MICE; ALZHEIMERS-DISEASE; E POLYMORPHISM; MYOCARDIAL-INFARCTION; RISK; LIPOPROTEIN; ATHEROSCLEROSIS; AUTOANTIBODIES; ACTIVATION	Background The common isoforms of apolipoprotein E (apoE), E2, E3, and E4, are important determinants of plasma lipid concentrations, and the epsilon4 allele is associated with raised risk of coronary heart disease. We investigated whether the effect of smoking on coronary heart disease risk is affected by APOE genotype. Methods We enrolled 3052 middle-aged men who were free of coronary heart disease for prospective cardiovascular surveillance in the second Northwick Park Heart Study (NPHSII). Smoking habit was ascertained at baseline and yearly by questionnaire. APOE genotype was identified by PCR and restriction enzyme digestion. Endpoints were fatal coronary heart disease, non-fatal myocardial infarction, and coronary artery surgery and silent myocardial infarction at follow-up. Findings During 18 836 person years of surveillance, 96 men had an acute myocardial infarction, 26 needed coronary artery surgery, and 14 had silent myocardial infarctions. Compared with never-smokers, risk of coronary heart disease in ex-smokers was 1.34 (95% CI 0.86-2.08) and in smokers it was 1.94 (1.25-3.01). This risk was independent of other classic risk factors. In never-smokers, risk was closely similar in men with different genotypes. Risk in men homozygous for the epsilon3 allele was 1.74 (1.10-2.77) in ex-smokers and 1.68 (1.01-2.83) in smokers, whereas in men carrying the epsilon4 allele risk was 0.84 (0.40-1.75) and 3.17 (1.82-5.50), respectively, with no significant differences in risk in the epsilon2 carriers. For the epsilon3 group, the genotype effect on risk was no longer significant after adjustment for classic risk factors (including plasma lipids). However. even after adjustment. smokers who were carriers of the epsilon4 allele, showed significantly raised risk of coronary heart disease compared with the non-smoking group (2.79, 1.59-4.91, epsilon4-smoking interaction p=0.007). Interpretation Smoking increases the risk of coronary heart disease in men of all genotypes but particularly in men carrying the epsilon4 allele.	Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England; St Bartholomews Hosp, Coll Med, Wolfson Inst Prevent Med, MRC Epidemiol & Med Care Unit, London, England; Southampton Univ Hosp NHS Trust & Sch Med, Human Genet Res Div, Southampton, Hants, England	University of London; King's College London; University College London; UCL Medical School; University of London; Queen Mary University London; University of Southampton	Humphries, SE (corresponding author), Royal Free & UCL, Sch Med, Rayne Inst, Dept Med,Ctr Cardiovasc Genet, London WC1E 6JJ, England.	rmhaseh@ucl.ac.uk	Talmud, Philippa J/C-4402-2008; Humphries, Stephen E/C-5075-2008	Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	NHLBI NIH HHS [HL 33014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN DR, 1988, J VASC SURG, V7, P139, DOI 10.1067/mva.1988.avs0070139; BLANN AD, 1992, ATHEROSCLEROSIS, V96, P249, DOI 10.1016/0021-9150(92)90072-O; BOLLA MK, 1995, CLIN CHEM, V41, P1599; CHAIT A, 1993, AM J MED, V94, P350, DOI 10.1016/0002-9343(93)90144-E; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DALMON J, 1993, MOL CELL BIOL, V13, P1183, DOI 10.1128/MCB.13.2.1183; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAY INM, 1994, ANAL BIOCHEM, V222, P389, DOI 10.1006/abio.1994.1507; Desurmont C, 2000, ARTERIOSCL THROM VAS, V20, P435, DOI 10.1161/01.ATV.20.2.435; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; DOLL RICHARD, 1966, NAT CANCER INST MONOGR, V19, P205; Eliasson B, 1997, ATHEROSCLEROSIS, V129, P79, DOI 10.1016/S0021-9150(96)06028-5; Fickl H, 1996, ATHEROSCLEROSIS, V124, P75, DOI 10.1016/0021-9150(96)05820-0; Gerdes LU, 2000, CIRCULATION, V101, P1366, DOI 10.1161/01.CIR.101.12.1366; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Haffer S., 1996, ARTERIOSCLER THROMB, V58, P585; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Kessler C, 1997, ARTERIOSCL THROM VAS, V17, P2880, DOI 10.1161/01.ATV.17.11.2880; Lowe Gordon D. O., 1993, Current Opinion in Lipidology, V4, P283, DOI 10.1097/00041433-199308000-00004; MILLER GJ, 1995, THROMB HAEMOSTASIS, V73, P82; Miller GJ, 1996, THROMB HAEMOSTASIS, V75, P767; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; *MRC COMM RES CHRO, 1976, QUEST RESP SYMPT; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Prineas R., 1982, MINNESOTA CODE MANUA; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Smith JD, 1998, INT J CLIN LAB RES, V28, P116, DOI 10.1007/s005990050030; Stengard JH, 1999, CLIN GENET, V56, P367; Talmud PJ, 2000, ATHEROSCLEROSIS, V149, P75, DOI 10.1016/S0021-9150(99)00309-3; Terry JG, 1996, STROKE, V27, P1755, DOI 10.1161/01.STR.27.10.1755; *WHO REG OFF EUR, 1976, MYOC INF COMM REG; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250	36	197	211	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2001	358	9276					115	119		10.1016/S0140-6736(01)05330-2	http://dx.doi.org/10.1016/S0140-6736(01)05330-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	452BR	11463413				2022-12-24	WOS:000169837700012
J	Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ				Hogberg, P; Nordgren, A; Buchmann, N; Taylor, AFS; Ekblad, A; Hogberg, MN; Nyberg, G; Ottosson-Lofvenius, M; Read, DJ			Large-scale forest girdling shows that current photosynthesis drives soil respiration	NATURE			English	Article							CARBON BALANCE; TEMPERATURE SENSITIVITY; ROOTS	The respiratory activities of plant roots, of their mycorrhizal fungi and of the free-living microbial heterotrophs (decomposers) in soils are significant components of the global carbon balance, but their relative contributions remain uncertain(1,2). To separate mycorrhizal root respiration from heterotrophic respiration in a boreal pine forest, we conducted a large-scale tree-girdling experiment, comprising 9 plots each containing about 120 trees. Tree-girdling involves stripping the stem bark to the depth of the current xylem at breast height terminating the supply of current photosynthates to roots and their mycorrhizal fungi without physically disturbing the delicate root-microbe-soil system. Here we report that girdling reduced soil respiration within 1-2 months by about 54% relative to respiration on ungirdled control plots, and that decreases of up to 37% were detected within 5 days. These values clearly show that the flux of current assimilates to roots is a key driver of soil respiration; they are conservative estimates of root respiration, however, because girdling increased the use of starch reserves in the roots. Our results indicate that models of soil respiration should incorporate measures of photosynthesis and of seasonal patterns of photosynthate allocation to roots.	SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden; Max Planck Inst Biogeochem, D-07701 Jena, Germany; SLU, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Swedish University of Agricultural Sciences; Max Planck Society; Swedish University of Agricultural Sciences; University of Sheffield	Hogberg, P (corresponding author), SLU, Depr Forest Ecol, Sect Soil Sci, SE-90183 Umea, Sweden.		Buchmann, Nina/E-6095-2011; Read, David/C-2454-2013; Ekblad, Alf/AAG-2632-2019; Högberg, Mona N./L-9635-2014; Högberg, Peter/B-2916-2012	Buchmann, Nina/0000-0003-0826-2980; Högberg, Mona N./0000-0003-1258-7630; Högberg, Peter/0000-0002-2849-2719; Nyberg, Gert/0000-0003-1979-8772				Agren G. I., 1980, Ecological Bulletins, V32, P307; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; EDWARDS NT, 1979, OECOLOGIA, V40, P247, DOI 10.1007/BF00345322; Ericsson A., 1980, Ecological Bulletins, V32, P239; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Hansen J., 1997, P97; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg P, 1996, SOIL BIOL BIOCHEM, V28, P1131, DOI 10.1016/0038-0717(96)00124-1; Lindroth A, 1998, GLOBAL CHANGE BIOL, V4, P443, DOI 10.1046/j.1365-2486.1998.00165.x; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Plamboeck AH, 1999, OECOLOGIA, V119, P452, DOI 10.1007/s004420050807; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; SODERSTROM B, 1987, SOIL BIOL BIOCHEM, V19, P231, DOI 10.1016/0038-0717(87)90002-2; STEEN E, 1986, NEW PHYTOL, V104, P339, DOI 10.1111/j.1469-8137.1986.tb02901.x; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	18	1393	1538	21	693	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					789	792		10.1038/35081058	http://dx.doi.org/10.1038/35081058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459055				2022-12-24	WOS:000169246400046
J	BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM				BECKER, L; BADA, JL; WINANS, RE; HUNT, JE; BUNCH, TE; FRENCH, BM			FULLERENES IN THE 1.85-BILLION-YEAR-OLD SUDBURY IMPACT STRUCTURE	SCIENCE			English	Article							EARTHS EARLY ATMOSPHERE; MASS-SPECTROMETRY; ALLENDE METEORITE; ION FORMATION; C-60; CARBON; C60	Fullerenes (C-60 and C-70) have been identified by laser desorption, laser desorption postionization, and high-resolution electron-impact mass spectrometry in shock-produced breccias (Onaping Formation) of the Sudbury impact structure in Ontario, Canada, The C-60 isotope is present at a level of a few parts per million. The fullerenes were likely synthesized within the impact plume from the carbon contained in the bolide. The oxidation of the fullerenes during the 1.85 billion years of exposure was apparently prevented by the presence of sulfur in the form of sulfide-silicate complexes associated with the fullerenes.	ARGONNE NATL LAB,DIV CHEM,ARGONNE,IL 60439; NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035; NASA HEADQUARTERS,WASHINGTON,DC 20546	United States Department of Energy (DOE); Argonne National Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA)	BECKER, L (corresponding author), UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,LA JOLLA,CA 92093, USA.			Winans, Randall/0000-0002-7080-7673				AVERMANN M, 1992, TECTONOPHYSICS, V216, P227, DOI 10.1016/0040-1951(92)90169-7; BECKER L, 1993, NATURE, V361, P595, DOI 10.1038/361595a0; BECKER L, UNPUB; BECKER L, 1993, THESIS U CALIFORNIA; BRINKMALM G, 1992, CHEM PHYS LETT, V191, P345, DOI 10.1016/0009-2614(92)85312-X; BURROWS AG, 1929, ONT DEP MINES B, V38, P1; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; CHANG TM, 1992, J AM CHEM SOC, V114, P7603, DOI 10.1021/ja00045a066; CHIBANTE LPF, 1993, GEOCHIM COSMOCHIM AC, V57, P1879, DOI 10.1016/0016-7037(93)90119-H; CREASY WR, 1988, CHEM PHYS, V126, P453, DOI 10.1016/0301-0104(88)85053-5; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; DALY TK, 1993, SCIENCE, V259, P1599, DOI 10.1126/science.259.5101.1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; DIBIOZALO FR, 1994, NATURE, V369, P37; Dietz R.S., 1968, SHOCK METAMORPHISM N, P267; DIETZ RS, 1964, J GEOL, V72, P412, DOI 10.1086/626999; FAGGART BE, 1985, SCIENCE, V230, P436, DOI 10.1126/science.230.4724.436; French B.M., 1968, SHOCK METAMORPHISM N, P383; FRENCH BM, 1972, GEOL ASSOC CAN SPEC, V10, P19; GREENWOOD PF, 1990, ORG MASS SPECTROM, V25, P353, DOI 10.1002/oms.1210250703; GRIEVE RAF, 1991, J GEOPHYS RES-PLANET, V96, P22753, DOI 10.1029/91JE02513; HAHN JH, 1988, SCIENCE, V239, P1523, DOI 10.1126/science.239.4847.1523; HEYMANN D, 1992, LUNAR PLANET SCI, V23, P1053; HEYMANN D, 1991, LUNAR PLANET SCI, V22, P569; HEYMANN D, 1993, LUNAR PLANET, V24, P437; HEYMANN D, 1994, LUNAR PLANET SCI, V25, P545; HOWARD JB, 1990, NATURE, V352, P141; HUNT JE, 1991, NATO ASI SER, P309; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1990, NASA CONF P, V3061, P275; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; KROUGH TE, 1984, ONT GEOL SURV SPEC, V1, P431; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MCKINNON JT, 1992, COMBUST FLAME, V88, P102, DOI 10.1016/0010-2180(92)90010-M; MUIR TL, 1984, ONT GEOL SURV REP, V1, P103; OBERBECK VR, 1989, LUNAR PLANET SCI, V20, P671; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; PILLINGER CT, 1993, PHILOS T R SOC A, V343, P73, DOI 10.1098/rsta.1993.0042; ROHLING EA, 1984, J CHEM PHYS, V81, P3332; SHARPTON VL, 1992, NATURE, V359, P819, DOI 10.1038/359819a0; TAYLOR R, 1993, NATURE, V366, P728, DOI 10.1038/366728a0; TAYLOR R, 1991, NATURE, V351, P277, DOI 10.1038/351277a0; UGARTE D, 1992, NATURE, V359, P707, DOI 10.1038/359707a0; WEBSTER A, 1991, NATURE, V352, P412, DOI 10.1038/352412a0; WEBSTER A, 1993, MONTHLY NOT R ASTRON, V255, P41; WURZ P, 1992, VACUUM, V43, P381, DOI 10.1016/0042-207X(92)90041-T; WURZ P, 1992, J PHYS CHEM-US, V96, P10129, DOI 10.1021/j100204a011; ZENOBI R, 1989, SCIENCE, V246, P1026, DOI 10.1126/science.246.4933.1026	51	115	119	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 29	1994	265	5172					642	645		10.1126/science.11536660	http://dx.doi.org/10.1126/science.11536660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NZ538	11536660				2022-12-24	WOS:A1994NZ53800027
J	TOWE, KM				TOWE, KM			AEROBIC RESPIRATION IN THE ARCHEAN	NATURE			English	Article											TOWE, KM (corresponding author), SMITHSONIAN INST,DEPT PALEOBIOL,WASHINGTON,DC 20560, USA.							BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; Chapman D.J., 1983, P302; Claypool G.E., 1974, NATURAL GASES MARINE, P99, DOI DOI 10.1007/978-1-4684-2757-8_8; CLOUD P, 1973, ECON GEOL, V68, P1135, DOI 10.2113/gsecongeo.68.7.1135; DREVER JI, 1974, GEOL SOC AM BULL, V85, P1099, DOI 10.1130/0016-7606(1974)85<1099:GMFTOO>2.0.CO;2; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; GARRELS RM, 1974, SEA, V5, P303; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HENRICHS SM, 1987, GEOMICROBIOL J, V5, P191, DOI 10.1080/01490458709385971; Holland H.D., 1984, CHEM EVOLUTION ATMOS; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1981, J GEOPHYS RES-OCEANS, V86, P1147, DOI 10.1029/JC086iC02p01147; KASTING JF, 1983, PRECAMBRIAN RES, V20, P121, DOI 10.1016/0301-9268(83)90069-4; KNOLL AH, 1979, ORIGINS LIFE EVOL B, V9, P313, DOI 10.1007/BF00926824; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MOFETT JW, 1990, NATURE, V345, P421; MULLER PJ, 1979, DEEP-SEA RES, V26, P1347, DOI 10.1016/0198-0149(79)90003-7; REIMER TO, 1979, PRECAMBRIAN RES, V9, P93, DOI 10.1016/0301-9268(79)90053-6; ROSENFELD WD, 1959, SCIENCE, V130, P1658, DOI 10.1126/science.130.3389.1658-a; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHOPF JW, 1988, MOL EVOLUTION FOSSIL, P89; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; TOWE KM, 1985, ORIGINS LIFE EVOL B, V15, P235, DOI 10.1007/BF01808171; Towe KM, 1988, MOL EVOLUTION FOSSIL, P114; VEIZER J, 1985, J GEOL, V93, P625, DOI 10.1086/628992; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1980, HDB ENV CHEM A, V1, P87; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; WINFREY MR, 1983, APPL ENVIRON MICROB, V45, P193, DOI 10.1128/AEM.45.1.193-199.1983; WOLIN MJ, 1987, GEOMICROBIOL J, V5, P239, DOI 10.1080/01490458709385972	32	56	58	2	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 1	1990	348	6296					54	56		10.1038/348054a0	http://dx.doi.org/10.1038/348054a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF994	11536471				2022-12-24	WOS:A1990EF99400059
J	Hugouvieux, V; Kwak, JM; Schroeder, JI				Hugouvieux, V; Kwak, JM; Schroeder, JI			An mRNA cap binding protein, ABH1, modulates early abscisic acid signal transduction in Arabidopsis	CELL			English	Article							CYTOPLASMIC CALCIUM; ANION CHANNELS; CYTOSOLIC CA-2+; GENE-EXPRESSION; ION CHANNELS; ETHYLENE; COMPLEX; MUTANT; ABA; GROWTH	The plant hormone abscisic acid (ABA) regulates important stress and developmental responses. We have isolated a recessive ABA hypersensitive mutant, abh1, that shows hormone specificity to ABA. ABH1 encodes the Arabidopsis homolog of a nuclear mRNA cap binding protein and functions in a heterodimeric complex to bind the mRNA cap structure. DNA chip analyses show that only a few transcripts are downregulated in abh1, several of which are implicated in ABA signaling. Consistent with these results, abh1 plants show ABA-hypersensitive stomatal closing and reduced wilting during drought. Interestingly, ABA-hypersensitive cytosolic calcium increases in abh1 guard cells demonstrate amplification of early ABA signaling. Thus, ABH1 represents a modulator of ABA signaling proposed to function by transcript alteration of early ABA signaling elements.	Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	julian@biomail.ucsd.edu	Kwak, June M/G-8332-2011	Kwak, June M/0000-0001-6948-5155; Schroeder, Julian/0000-0002-3283-5972	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060396] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM60396-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN AC, 1994, PLANT CELL, V6, P1319; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; ARMSTRONG F, 1995, P NATL ACAD SCI USA, V92, P9520, DOI 10.1073/pnas.92.21.9520; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Bethke PC, 1998, CURR OPIN PLANT BIOL, V1, P440, DOI 10.1016/S1369-5266(98)80270-7; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Bueno P, 1998, PLANT SCI, V138, P27, DOI 10.1016/S0168-9452(98)00154-X; CARY AJ, 1995, PLANT PHYSIOL, V107, P1075, DOI 10.1104/pp.107.4.1075; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Fortes P, 1999, MOL CELL BIOL, V19, P6543; Foster R, 1999, PLANT J, V17, P363, DOI 10.1046/j.1365-313X.1999.00384.x; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; Ghassemian M, 2000, PLANT CELL, V12, P1117, DOI 10.1105/tpc.12.7.1117; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; KARSSEN CM, 1989, ANN BOT-LONDON, V63, P71, DOI 10.1093/oxfordjournals.aob.a087730; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; KOOMNEEF M, 1998, PLANT PHYSIOL BIOCH, V36, P83, DOI DOI 10.1016/S0981-9428(98)80093-4; KOOMNEEF M, 1994, PHYSIOL PLANTARUM, P313; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; MacIntosh GC, 2001, P NATL ACAD SCI USA, V98, P1018, DOI 10.1073/pnas.98.3.1018; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MARCOTTE WR, 1992, BIOCHEM SOC T, V20, P93, DOI 10.1042/bst0200093; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pei ZM, 1998, SCIENCE, V282, P287, DOI 10.1126/science.282.5387.287; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Steber CM, 1998, GENETICS, V149, P509; Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010; UEMURA H, 1992, J BACTERIOL, V174, P5526, DOI 10.1128/JB.174.17.5526-5532.1992; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WILHELM KS, 1993, PLANT MOL BIOL, V23, P1073, DOI 10.1007/BF00021822; Wilson KF, 1999, J BIOL CHEM, V274, P4166, DOI 10.1074/jbc.274.7.4166; Yalovsky S, 2000, PLANT CELL, V12, P1257, DOI 10.1105/tpc.12.8.1257; Ziegelhoffer EC, 2000, P NATL ACAD SCI USA, V97, P7633, DOI 10.1073/pnas.130189397	67	322	333	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					477	487		10.1016/S0092-8674(01)00460-3	http://dx.doi.org/10.1016/S0092-8674(01)00460-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525733	Bronze			2022-12-24	WOS:000170665200011
J	Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG				Vocadlo, DJ; Davies, GJ; Laine, R; Withers, SG			Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate	NATURE			English	Article							CRYSTALLOGRAPHIC EVIDENCE; BETA-GLUCOSIDASE; HYDROLYSIS; DISTORTION; MECHANISM; INSIGHTS; ACID	Hen egg-white lysozyme (HEWL) was the first enzyme to have its three-dimensional structure determined by X-ray diffraction techniques(1). A catalytic mechanism, featuring a long-lived oxo-carbenium-ion intermediate, was proposed on the basis of model-building studies(2). The `Phillips' mechanism is widely held as the paradigm for the catalytic mechanism of beta -glycosidases that cleave glycosidic linkages with net retention of configuration of the anomeric centre. Studies with other retaining beta -glycosidases, however, provide strong evidence pointing to a common mechanism for these enzymes that involves a covalent glycosyl-enzyme intermediate, as previously postulated(3). Here we show, in three different cases using electrospray ionization mass spectrometry, a catalytically competent covalent glycosyl-enzyme intermediate during the catalytic cycle of HEWL. We also show the three-dimensional structure of this intermediate as determined by Xray diffraction. We formulate a general catalytic mechanism for all retaining beta -glycosidases that includes substrate distortion, formation of a covalent intermediate, and the electrophilic migration of C1 along the reaction coordinate.	Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; Louisiana State Univ, Dept Biol, Baton Rouge, LA 70808 USA; Louisiana State Univ, Dept Chem, Baton Rouge, LA 70808 USA	University of British Columbia; University of British Columbia; University of York - UK; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Withers, SG (corresponding author), Univ British Columbia, Prot Engn Network Ctr Excellence, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Davies, Gideon J/A-9042-2011; Laine, Roger A/B-9434-2014; Withers, Stephen G/I-7229-2019; Vocadlo, David J/E-5508-2014; Laine, Roger/ABE-2473-2020	Davies, Gideon J/0000-0002-7343-776X; Laine, Roger A/0000-0001-5984-4409; Withers, Stephen G/0000-0002-6722-5701; Vocadlo, David J/0000-0001-6897-5558; 				AMYES TL, 1989, J AM CHEM SOC, V111, P7888, DOI 10.1021/ja00202a033; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALLARDIE FW, 1977, BIOORG CHEM, V6, P483, DOI 10.1016/0045-2068(77)90047-5; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; CHIPMAN DM, 1968, J BIOL CHEM, V243, P487; DAHLQUIS.FW, 1969, BIOCHEMISTRY-US, V8, P4214, DOI 10.1021/bi00838a045; Davies G. J., 1998, INCOMPREHENSIVE BIOL, P119; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Fedorov A, 2001, BIOCHEMISTRY-US, V40, P853, DOI 10.1021/bi002499f; FINK AL, 1980, BIOCHEMISTRY-US, V19, P811, DOI 10.1021/bi00545a030; HOLLER E, 1975, BIOCHEMISTRY-US, V14, P2377, DOI 10.1021/bi00682a017; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILLIPS DC, 1967, P NATL ACAD SCI USA, V57, P484; RANDMEIR T, 1969, BIOCHEMISTRY-US, V8, P4206, DOI 10.1021/bi00838a044; ROSENBERG S, 1981, BIOCHEMISTRY-US, V20, P3196, DOI 10.1021/bi00514a032; SINNOTT ML, 1973, BIOCHEM J, V133, P89, DOI 10.1042/bj1330089; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034	29	509	524	1	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					835	838		10.1038/35090602	http://dx.doi.org/10.1038/35090602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518970	Green Accepted			2022-12-24	WOS:000170577200041
J	des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW				des Etangs, AL; Vidal-Madjar, A; Roberge, A; Feldman, PD; Deleuil, M; Andre, M; Blair, WP; Bouret, JC; Desert, JM; Ferlet, R; Friedman, S; Hebrard, G; Lemoine, M; Moos, HW			Deficiency of molecular hydrogen in the disk of beta Pictoris	NATURE			English	Article							HST-GHRS OBSERVATIONS; CIRCUMSTELLAR DISK; CO; GAS; BODIES; SPACE; CI	Molecular hydrogen (H-2) is by far the most abundant material from which stars, protoplanetary disks and giant planets form, but it is difficult to detect directly. Infrared emission lines from H-2 have recently been reported(1) towards beta Pictoris, a star harbouring a young planetary system(2). This star is surrounded by a dusty 'debris disk' that is continuously replenished either by collisions between asteroidal objects(3) or by evaporation of ices on Chiron-like objects(4). A gaseous disk has also been inferred from absorption lines in the stellar spectrum(5-8). Here we present the far-ultraviolet spectrum of beta Pictoris, in which H-2 absorption lines are not seen. This allows us to set a very low upper limit on the column density of H-2 : N(H-2) less than or equal to 10(18) cm(-2). This non-detection is puzzling when compared to the quantity of H-2 inferred from the infrared observations, but it does show that H-2 is not in the disk on the direct line of sight. Carbon monoxide (CO) has been seen in absorption against the star(8-10), yielding a ratio of CO/H-2 >6 x 10(-4). As CO would be destroyed under ambient conditions in about 200 years (refs 9, 11), our result demonstrates that the CO in the disk arises from evaporation of planetesimals.	CNRS, Inst Astrophys Paris, F-75014 Paris, France; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Lab Astrophys Marseille, F-13376 Marseille 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; UDICE-French Research Universities; Aix-Marseille Universite	des Etangs, AL (corresponding author), CNRS, Inst Astrophys Paris, 98 Bis Bld Arago, F-75014 Paris, France.	lecaveli@iap.fr	Lemoine, Martin/AAE-6416-2019; Lecavelier des Etangs, Alain/GLU-6503-2022; Roberge, Aki/D-2782-2012	Lemoine, Martin/0000-0002-2395-7812; Lecavelier des Etangs, Alain/0000-0002-5637-5253; Roberge, Aki/0000-0002-2989-3725; Deleuil, Magali/0000-0001-6036-0225				Backman D. E., 1993, PROTOSTARS PLANETS, P1253; BEUST H, 1990, ASTRON ASTROPHYS, V236, P202; CARRUTHERS GR, 1970, ASTROPHYS J, V161, pL81, DOI 10.1086/180575; DELEUIL M, IN PRESS ASTROPHYS J; desEtangs AL, 1996, ASTRON ASTROPHYS, V307, P542; DESETANGS AL, 1999, PLANETS OUTSIDE SOLA, P95; FERLET R, 1987, ASTRON ASTROPHYS, V185, P267; HOBBS LM, 1985, ASTROPHYS J, V293, pL29, DOI 10.1086/184485; Jolly A, 1998, ASTRON ASTROPHYS, V329, P1028; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Liseau R, 1998, ASTRON ASTROPHYS, V334, P935; Magnani L, 1998, ASTROPHYS J, V504, P290, DOI 10.1086/306062; Moos HW, 2000, ASTROPHYS J, V538, pL1, DOI 10.1086/312795; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; ROBERGE A, 1908, ASTROPHYS J, V551, pL97; SHULL JM, 1982, ANNU REV ASTRON ASTR, V20, P163, DOI 10.1146/annurev.aa.20.090182.001115; SPITZER L, 1973, ASTROPHYS J, V181, pL116, DOI 10.1086/181197; Thi WF, 2001, NATURE, V409, P60, DOI 10.1038/35051033; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245; VIDALMADJAR A, 1986, ASTRON ASTROPHYS, V167, P325	24	94	95	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					706	708		10.1038/35089006	http://dx.doi.org/10.1038/35089006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507632				2022-12-24	WOS:000170450200036
J	Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ				Geijsen, N; Uings, IJ; Pals, C; Armstrong, J; McKinnon, M; Raaijmakers, JAM; Lammers, JWJ; Koenderman, L; Coffer, PJ			Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein	SCIENCE			English	Article							INTERLEUKIN-5 RECEPTOR; IL-5 RECEPTOR; ALPHA-CHAIN; CELL; PDZ; MICE; DIFFERENTIATION; RECOGNITION; EXPRESSION; ACTIVATOR	Cytokine receptors consist of multiple subunits, which are often shared between different receptors, resulting in the functional redundancy sometimes observed between cytokines. The interleukin 5 (IL-5) receptor consists of an IL-5-specific alpha -subunit (IL-5R alpha) and a signal-transducing beta -subunit (betac) shared with the IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors. In this study, we sought to find a rote for the cytoplasmic domain of IL-5R alpha. We show that syntenin, a protein containing PSD-95/Discs large/zO-1 (PDZ) domains, associates with the cytoplasmic tail of the IL-5R alpha. Syntenin was found to directly associate with the transcription factor Sox4. Association of syntenin with IL-5R alpha was required for IL-5-mediated activation of Sox4. These studies identify a mechanism of transcriptional activation by cytokine-specific receptor subunits.	Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, NL-3584 CX Utrecht, Netherlands; Glaxo Wellcome Med Res Ctr, Cell Biol Unit, Stevenage SG1 2NY, Herts, England	Utrecht University; Utrecht University Medical Center; GlaxoSmithKline	Coffer, PJ (corresponding author), Univ Utrecht, Med Ctr, Heart Lung Ctr Utrecht, Dept Pulm Dis, G03-550,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Coffer, Paul/AAF-7970-2020; Koenderman, Leo/AAE-7870-2020; Coffer, Paul J/A-5769-2009	Koenderman, Leo/0000-0002-5636-6453; 				Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hiroi T, 1999, J IMMUNOL, V162, P821; HITOSHI Y, 1990, J IMMUNOL, V144, P4218; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; LOPEZ AF, 1988, J EXP MED, V167, P219, DOI 10.1084/jem.167.1.219; Moon BG, 2001, IMMUNOLOGY, V102, P289, DOI 10.1046/j.1365-2567.2001.01196.x; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WETZEL GD, 1989, EUR J IMMUNOL, V19, P1701, DOI 10.1002/eji.1830190926; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	18	100	109	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1136	1138		10.1126/science.1059157	http://dx.doi.org/10.1126/science.1059157			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498591				2022-12-24	WOS:000170432600060
J	deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J				deVeber, G; Andrew, M; Adams, C; Bjornson, B; Booth, F; Buckley, DJ; Camfield, CS; David, M; Humphreys, P; Langevin, P; MacDonald, EA; Gillett, J		Canadian Pediat Ischemic Stroke St	Cerebral sinovenous thrombosis in children.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAGITTAL SINUS THROMBOSIS; ARTERIAL ISCHEMIC STROKE; FACTOR-V LEIDEN; VENOUS THROMBOSIS; VEIN-THROMBOSIS; INFANTS; CHILDHOOD; ANGIOGRAPHY; DEFICIENCY; DISORDERS	Background: Cerebral sinovenous thrombosis in children is a serious disorder, and information is needed about its prevention and treatment. Methods: The Canadian Pediatric Ischemic Stroke Registry was initiated in 1992 at the 16 pediatric tertiary care centers in Canada. Children (newborn to 18 years of age) with symptoms and radiographic confirmation of sinovenous thrombosis were included. Results: During the first six years of the registry, 160 consecutive children with sinovenous thrombosis were enrolled, and the incidence of the disorder was 0.67 case per 100,000 children per year. Neonates were most commonly affected. Fifty-eight percent of the children had seizures, 76 percent had diffuse neurologic signs, and 42 percent had focal neurologic signs. Risk factors included head and neck disorders (in 29 percent), acute systemic illnesses (in 54 percent), chronic systemic diseases (in 36 percent), and prothrombotic states (in 41 percent). Venous infarcts occurred in 41 percent of the children. Fifty-three percent of the children received antithrombotic agents. Neurologic deficits were present in 38 percent of the children, and 8 percent died; half the deaths were due to sinovenous thrombosis. Predictors of adverse neurologic outcomes were seizures at presentation and venous infarcts. Conclusions: Sinovenous thrombosis in children affects primarily neonates and results in neurologic impairment or death in approximately half the cases. The occurrence of venous infarcts or seizures portends a poor outcome. (N Engl J Med 2001;345:417-23.) Copyright (C) 2001 Massachusetts Medical Society.	Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Populat Hlth Sci Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; Mem Univ Newfoundland, Dept Pediat, St Johns, NF A1C 5S7, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; Univ Montreal, Dept Hematol Oncol, Montreal, PQ, Canada; Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; CHU Laval, Dept Pediat Neurol, St Foy, PQ, Canada; Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; Univ Western Ontario, Dept Clin Neurosci, London, ON N6A 3K7, Canada; McMaster Univ, Dept Pediat, Hamilton, ON, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; Univ Alberta, Dept Pediat, Edmonton, AB, Canada; Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of British Columbia; University of Manitoba; Memorial University Newfoundland; Dalhousie University; Universite de Montreal; University of Ottawa; Laval University; Queens University - Canada; Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; McGill University; McGill University; McGill University; University of Alberta; University of Saskatchewan	deVeber, G (corresponding author), Hosp Sick Children, Div Neurol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Bjornson, Bruce Hal/A-8616-2010	Bjornson, Bruce Hal/0000-0002-1465-6196; /0000-0002-9584-0576				BARAM TZ, 1988, ANN NEUROL, V24, P792, DOI 10.1002/ana.410240617; BARRON TF, 1992, PEDIATR NEUROL, V8, P112, DOI 10.1016/0887-8994(92)90030-3; BEZINQUE SL, 1995, PEDIATR RADIOL, V25, P175, DOI 10.1007/BF02021526; Bonduel M, 1999, ARCH NEUROL-CHICAGO, V56, P967, DOI 10.1001/archneur.56.8.967; Bousser MG, 1997, MAJOR PROBLEMS NEURO, V33; BROWN MT, 1991, NEUROLOGY, V41, P455, DOI 10.1212/WNL.41.3.455; *CANSIM, STAT CAN; CANTU C, 1993, STROKE, V24, P1880, DOI 10.1161/01.STR.24.12.1880; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724; deVeber G, 1998, ARCH NEUROL-CHICAGO, V55, P1539, DOI 10.1001/archneur.55.12.1539; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; DINDAR F, 1974, CAN MED ASSOC J, V111, P545; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Einhaupl KM, 1990, CEREBRAL SINUS THROM, P149, DOI 10.1007/978- 1-4684-8199-0_14; HICKEY WF, 1982, AM J MED, V73, P740; JUSTICH E, 1984, EUR J RADIOL, V4, P294; LEE BCP, 1984, AM J NEURORADIOL, V5, P281; LUDWIG B, 1980, NEURORADIOLOGY, V20, P145, DOI 10.1007/BF00341779; Maiti B., 1997, Journal of the Neurological Sciences, V150, pS147, DOI 10.1016/S0022-510X(97)85563-3; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MEDLOCK MD, 1992, NEUROSURGERY, V31, P870, DOI 10.1227/00006123-199211000-00007; Nagaraja D, 1999, NEUROL INDIA, V47, P43; *PRACT MAN INF, 1997, INT CLASS DIS 9 REV; PRATS JM, 1992, NEUROLOGY, V42, P2303, DOI 10.1212/WNL.42.12.2303-a; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; RICH C, 1993, STROKE, V24, P603, DOI 10.1161/01.STR.24.4.603; *SAS I, 1998, STATV VERS 5 1; SCOTTI LN, 1974, RADIOLOGY, V112, P393, DOI 10.1148/112.2.393; SHEVELL MI, 1989, PEDIATR NEUROL, V5, P161, DOI 10.1016/0887-8994(89)90065-9; UZIEL Y, 1995, J PEDIATR-US, V126, P722, DOI 10.1016/S0022-3476(95)70399-3; VANKUIJCK MAP, 1994, NEUROPEDIATRICS, V25, P16, DOI 10.1055/s-2008-1071575; vonScheven E, 1996, J PEDIATR-US, V129, P339, DOI 10.1016/S0022-3476(96)70064-1; YUH WTC, 1994, AM J NEURORADIOL, V15, P309; Zuber M, 1996, STROKE, V27, P1721, DOI 10.1161/01.STR.27.10.1721	36	710	742	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					417	423		10.1056/NEJM200108093450604	http://dx.doi.org/10.1056/NEJM200108093450604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496852				2022-12-24	WOS:000170295000004
J	Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA				Feltbower, RG; Moorman, AV; Dovey, G; Kinsey, S; McKinney, PA			Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK	LANCET			English	Article							LEUKEMIA	Between 1980 and 1998, in the north-west of England, a significant rise in childhood acute lymphoblastic leukaemia was caused by an Increase in the precursor B-cell form of this disease. We analysed data on children who were diagnosed with leukaemia in Yorkshire, UK, between 1974 and 1997. The incidence of acute lymphoblastic leukaemia remained stable, although a non-significant yearly increase of 2.4% was noted for the precursor B-cell form of this disease from 1980 onwards. The precursor B-cell form accounted for 80% of all acute lymphoblastic leukaemia. Our data are not consistent with increasing Incidence for precursor B-cell acute lymphoblastic leukaemia, although numbers of children with acute myeloid leukaemia are rising.	Paediat Epidemiol Grp, Leeds LS2 9LN, W Yorkshire, England; Leukaemia Res Fund Ctr Clin Epidemiol, Leeds LS2 9LN, W Yorkshire, England; Unit Epidemiol & Hlth Serv Res, Leeds LS2 9LN, W Yorkshire, England; St James Univ Hosp, Childrens Day Hosp, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; Saint James's University Hospital	McKinney, PA (corresponding author), Paediat Epidemiol Grp, 30 Hyde Terrace, Leeds LS2 9LN, W Yorkshire, England.	p.a.mckinney@leeds.ac.uk	Moorman, Anthony/F-5518-2010; Moorman, Anthony/G-1468-2014	Moorman, Anthony/0000-0002-9781-6107				BLAIR V, 1994, EUR J CANCER, V30A, P1490, DOI 10.1016/0959-8049(94)00274-9; COEBERGH JWW, 1989, BRIT J CANCER, V59, P100, DOI 10.1038/bjc.1989.20; DRAPER GJ, 1994, CANCER SURV, V20, P493; McKinney PA, 1998, BRIT J CANCER, V78, P974, DOI 10.1038/bjc.1998.612; McNally RJQ, 2000, LANCET, V356, P485, DOI 10.1016/S0140-6736(00)02562-9	5	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					385	387		10.1016/S0140-6736(01)05581-7	http://dx.doi.org/10.1016/S0140-6736(01)05581-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502322				2022-12-24	WOS:000170235100017
J	Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW				Derkatch, IL; Bradley, ME; Hong, JY; Liebman, SW			Prions affect the appearance of other prions: The story of [PIN+]	CELL			English	Article							DE-NOVO APPEARANCE; YEAST SACCHAROMYCES-CEREVISIAE; RELEASE FACTOR; PSI+ PRION; IN-VITRO; PROTEIN HSP104; FORMING DOMAIN; SUP35 PROTEIN; PROPAGATION; PSI(+)	Prions are self-propagating protein conformations. Recent research brought insight into prion propagation, but how they first appear is unknown. We previously established that the yeast non-Mendelian trait [PIN+] is required for the de novo appearance of the [PSI+] prion. Here, we show that the presence of prions formed by Rnq1 or Ure2 is sufficient to make cells [PIN+]. Thus, [PIN+] can be caused by more than one prion. Furthermore, an unbiased functional screen for [PIN+] prions uncovered the known prion gene, URE2, the proposed prion gene, NEW1, and nine novel candidate prion genes all carrying prion domains. Importantly, the de novo appearance of Rnq1::GFP prion aggregates also requires the presence of other prions, suggesting the existence of a general mechanism by which the appearance of prions is enhanced by heterologous prion aggregates.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave, Chicago, IL 60607 USA.	suel@uic.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56350, R01 GM056350] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Bailleul PA, 1999, GENETICS, V153, P81; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX B, 1994, CURR BIOL, V4, P744, DOI 10.1016/S0960-9822(00)00167-6; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Fernandez-Bellot E, 2000, EMBO J, V19, P3215, DOI 10.1093/emboj/19.13.3215; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; INGEVECHTOMOV SG, 1988, GENETIKA+, V24, P2110; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kisilevsky R, 1999, AMYLOID, V6, P98, DOI 10.3109/13506129909007309; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rose MD., 1990, METHODS YEAST GENETI; Sambrook JFE, 1989, MOL CLONING LAB MANU; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sherman F., 1986, METHODS YEAST GENETI; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TUITE MF, 1981, GENETICS, V98, P691; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	57	469	487	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					171	182		10.1016/S0092-8674(01)00427-5	http://dx.doi.org/10.1016/S0092-8674(01)00427-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511345	Bronze			2022-12-24	WOS:000170193100007
J	Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A				Kuroda, A; Nomura, K; Ohtomo, R; Kato, J; Ikeda, T; Takiguchi, N; Ohtake, H; Kornberg, A			Role of inorganic polyphosphate in promoting ribosomal, protein degradation by the ion protease in E-coli	SCIENCE			English	Article							ESCHERICHIA-COLI; LON PROTEASE; SULA; PURIFICATION; SYSTEM	Inorganic polyphosphate (polyp), a polymer of hundreds of phosphate (P-i) residues, accumulates in Escherichia coli in response to stresses, including amino acid starvation. Here we show that the adenosine 5'-triphosphate-dependent protease Lon formed a complex with polyp and degraded most of the ribosomal proteins, including S2, L9, and L13. Purified S2 also bound to polyp and formed a complex with Lon in the presence of polyP. Thus, polyP may promote ribosomal. protein degradation by the Lon protease, thereby supplying the amino acids needed to respond to starvation.	Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima 7398527, Japan; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Hiroshima University; Stanford University	Kuroda, A (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.		Kato, Junichi/S-1469-2018; Takiguchi, Noboru/F-3419-2014	Kato, Junichi/0000-0003-0279-8813; Takiguchi, Noboru/0000-0001-7266-0276				Ault-Riche D, 1998, J BACTERIOL, V180, P1841; CACHIA C, 1991, J CHROMATOGR, V539, P343, DOI 10.1016/S0021-9673(01)83943-1; CHUNG CH, 1982, P NATL ACAD SCI-BIOL, V79, P795, DOI 10.1073/pnas.79.3.795; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Miller C. G., 1996, ESCHERICHIA COLI SAL, P938; MIZUSAWA S, 1983, P NATL ACAD SCI-BIOL, V80, P358, DOI 10.1073/pnas.80.2.358; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; NISHI K, 1988, MOL GEN GENET, V212, P177, DOI 10.1007/BF00322462; SONEZAKI S, 1994, APPL MICROBIOL BIOT, V42, P313; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	17	285	295	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					705	708		10.1126/science.1061315	http://dx.doi.org/10.1126/science.1061315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474114				2022-12-24	WOS:000170204600057
J	Ruiz, J				Ruiz, J			The stability against freezing of an internal liquid-water ocean in Callisto	NATURE			English	Article							GALILEAN SATELLITES; SUBSURFACE OCEANS; ICY SATELLITES; OUTER PLANETS; EVOLUTION; CONVECTION; GANYMEDE; EUROPA; MODELS; SHELL	The discovery of the induced magnetic field of Callisto-one of Jupiter's moons-has been interpreted(1,2) as evidence for a subsurface ocean, even though the presence of such an ocean is difficult to understand in the context of existing theoretical models(3-5). Tidal heating should not be significant for Callisto, and, in the absence of such heating, it is difficult to see how this internal ocean could have survived until today without freezing(1,6). Previous work(3,4) indicated that an outer ice layer on the ocean would be unstable against solid-state convection, which once begun would lead to total freezing of liquid water in about 10(8) years. Here I show that when a methodology(7) for more physically reasonable water ice viscosities (that is, stress-dependent non-newtonian viscosities, rather than the stress-independent newtonian viscosities considered previously) is adopted, the outer ice shell becomes stable against convection. This implies that a subsurface ocean could have survived up to the present, without the need for invoking antifreeze substances or other special conditions.	Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain; Univ Complutense Madrid, Seminar Planetary Sci, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Ruiz, J (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam, E-28040 Madrid, Spain.	jaruiz@eucmax.sim.ucm.es	Ruiz, Javier/P-3975-2015	Ruiz, Javier/0000-0002-3937-8380				Anderson JD, 1998, SCIENCE, V280, P1573, DOI 10.1126/science.280.5369.1573; CASSEN PM, 1982, SATELLITES JUPITER, P93; CONSOLMAGNO GJ, 1978, ICARUS, V34, P280, DOI 10.1016/0019-1035(78)90168-9; Davies ME, 1998, ICARUS, V135, P372, DOI 10.1006/icar.1998.5982; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; DURHAM WB, IN PRESS J GEOPHYS; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; GOLDSBY DL, IN PRESS J GEOPHYS; GOLDSBY DL, 1997, LUNAR PLANET SCI, V28, P429; Kamb B., 1972, FLOW FRACTURE ROCKS, P211, DOI [10.1029/GM016p0211, DOI 10.1029/GM016P0211]; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; KIRK RL, 1987, ICARUS, V69, P91, DOI 10.1016/0019-1035(87)90009-1; KLINGER J, 1980, SCIENCE, V209, P271, DOI 10.1126/science.209.4453.271; LEWIS JS, 1971, SCIENCE, V172, P1127, DOI 10.1126/science.172.3988.1127; LUPO MJ, 1979, ICARUS, V40, P157, DOI 10.1016/0019-1035(79)90061-7; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; McKinnon WB, 1998, ASTROPHYS SPACE SC L, V227, P525, DOI 10.1007/978-94-011-5252-5_22; MUELLER S, 1988, ICARUS, V76, P437, DOI 10.1016/0019-1035(88)90014-0; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; REYNOLDS RT, 1979, GEOPHYS RES LETT, V6, P121, DOI 10.1029/GL006i002p00121; Schubert G., 1986, SATELLITES, P224; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Showman AP, 1997, ICARUS, V127, P93, DOI 10.1006/icar.1996.5669; Solomatov VS, 1996, J GEOPHYS RES-PLANET, V101, P4737, DOI 10.1029/95JE03361; SOLOMATOV VS, 1995, PHYS FLUIDS, V7, P266, DOI 10.1063/1.868624; Sotin C, 1998, ASTROPHYS SPACE SC L, V227, P79, DOI 10.1007/978-94-011-5252-5_4; STEVENSON DJ, 1998, EOS T AGU S, V79, pF535; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	30	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					409	411		10.1038/35086506	http://dx.doi.org/10.1038/35086506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473308	Green Accepted			2022-12-24	WOS:000170068200038
J	Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J				Otsuka, R; Watanabe, H; Hirata, K; Tokai, K; Muro, T; Yoshiyama, M; Takeuchi, K; Yoshikawa, J			Acute effects of passive smoking on the coronary circulation in healthy young adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW VELOCITY; ENVIRONMENTAL TOBACCO-SMOKE; AMERICAN-HEART-ASSOCIATION; DOPPLER-ECHOCARDIOGRAPHY; CIGARETTE-SMOKING; ARTERY STENOSIS; DISEASE; RESERVE; RISK	Context Recent studies have shown that passive smoking is a risk factor for ischemic heart disease and may be associated with vascular endothelial dysfunction, The acute effects of passive smoking on coronary circulation in nonsmokers are not known. Objective To determine the acute effects of passive smoking on coronary circulation using coronary flow velocity reserve (CFVR), assessed by noninvasive transthoracic Doppler echocardiography. Design, Setting, and Participants Cross-sectional study conducted from-September 2000 to November 2000 among 30 Japanese men (mean age, 27 years; 15 healthy nonsmokers and 15 asymptomatic active smokers) without history of hypertension, diabetes mellitus, or hyperlipidemia. Main Outcome Measures Coronary flow velocity reserve, calculated as the ratio of hyperemic to basal coronary flow velocity induced by intravenous infusion of adenosine triphosphate and measured in each participant before and after a 30-min ute exposure to environmental tobacco smoke. Results Heart rate and blood pressure responses to adenosine triphosphate infusion were not affected by passive smoking exposure in either group. Passive smoking exposure had no effect on basal coronary flow velocity in either group. Mean (SD) CFVR in nonsmokers was significantly higher than that in active smokers before passive smoking exposure (4.4 [0.91] vs 3.6 [0.88], respectively; P=.02), while CFVR after passive smoking exposure did not differ between groups (P=.83). Passive smoking exposure significantly reduced mean (SD) CFVR in nonsmokers (4.4 [0.91] vs 3.4 [0.73], respectively; P<.001). Conclusions Passive smoking substantially reduced CFVR in healthy nonsmokers. This finding provides direct evidence that passive smoking may cause endothelial dysfunction of the coronary circulation in nonsmokers.	Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University	Watanabe, H (corresponding author), Osaka City Univ, Sch Med, Dept Internal Med & Cardiol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.							ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102; CAMICI P, 1989, AM J PHYSIOL, V257, pE309, DOI 10.1152/ajpendo.1989.257.3.E309; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; DAYANIKLI F, 1994, CIRCULATION, V90, P808, DOI 10.1161/01.CIR.90.2.808; DESILVA R, 1994, CARDIOVASC RES, V28, P1595; FOLKOW B, 1990, HYPERTENSION, V16, P89, DOI 10.1161/01.HYP.16.1.89; Frielingsdorf J, 1996, CIRCULATION, V93, P1380, DOI 10.1161/01.CIR.93.7.1380; FUSEJIMA K, 1987, J AM COLL CARDIOL, V10, P1024, DOI 10.1016/S0735-1097(87)80342-X; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; HOLBROOK JH, 1984, CIRCULATION, V70, P1114; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374; KENNY A, 1994, BRIT HEART J, V71, P57; KENNY A, 1992, AM J CARDIOL, V69, P1265, DOI 10.1016/0002-9149(92)91218-S; KENNY A, 1994, AM J CARDIOL, V73, P1021, DOI 10.1016/0002-9149(94)90164-3; KRITZ H, 1995, ARCH INTERN MED, V155, P1942, DOI 10.1001/archinte.155.18.1942; Miller DD, 1996, CIRCULATION, V94, P2447, DOI 10.1161/01.CIR.94.10.2447; Nagamachi S, 1996, J NUCL MED, V37, P1626; NITENBERG A, 1993, DIABETES, V42, P1017, DOI 10.2337/diabetes.42.7.1017; PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820; PENN A, 1994, CIRCULATION, V90, P1363, DOI 10.1161/01.CIR.90.3.1363; RAIJ L, 1994, CIRCULATION, V90, P575; ROSS JJ, 1990, J AM COLL CARDIOL, V15, P373, DOI 10.1016/S0735-1097(10)80065-8; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; SEILER C, 1993, CIRCULATION, V88, P2139, DOI 10.1161/01.CIR.88.5.2139; Sonoda S, 1998, AM HEART J, V135, P621, DOI 10.1016/S0002-8703(98)70277-7; Steenland K, 1996, CIRCULATION, V94, P622, DOI 10.1161/01.CIR.94.4.622; STEENLAND K, 1992, JAMA-J AM MED ASSOC, V267, P94, DOI 10.1001/jama.267.1.94; Sumida H, 1998, J AM COLL CARDIOL, V31, P811, DOI 10.1016/S0735-1097(98)00010-2; Tanaka T, 1998, AM J CARDIOL, V82, P1275, DOI 10.1016/S0002-9149(98)00614-6; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Valkonen M, 1998, CIRCULATION, V97, P2012, DOI 10.1161/01.CIR.97.20.2012; Verberne HJ, 1999, HEART, V82, P509, DOI 10.1136/hrt.82.4.509; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; WELLS AJ, 1988, ENVIRON INT, V14, P249; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094; ZHU BQ, 1993, J AM COLL CARDIOL, V21, P225, DOI 10.1016/0735-1097(93)90741-I	41	260	272	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					436	441		10.1001/jama.286.4.436	http://dx.doi.org/10.1001/jama.286.4.436			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466122	Bronze			2022-12-24	WOS:000170069000015
J	Cha, BJ; Koppetsch, BS; Theurkauf, WE				Cha, BJ; Koppetsch, BS; Theurkauf, WE			In vivo analysis of Drosophila bicoid mRNA localization reveals a novel microtubule-dependent axis specification pathway	CELL			English	Article							MESSENGER-RNA LOCALIZATION; ALPHA-LIKE PROTEIN; ANTEROPOSTERIOR POLARITY; SPATIAL-DISTRIBUTION; ANTERIOR POLE; OOGENESIS; OOCYTES; POSTERIOR; TRANSPORT; CYTOSKELETON	Drosophila bicoid mRNA is synthesized in the nurse cells and transported to the oocyte where microtubules and Exuperantia protein mediate localization to the anterior pole. Fluorescent bicoid mRNA injected into the oocyte displays nonpolar microtubule-dependent transport to the closest cortical surface, and the oocyte microtubule cytoskeleton lacks clear axial asymmetry. Nonetheless, bicoid mRNA injected into the nurse cell cytoplasm, withdrawn, and injected into a second oocyte shows microtubule-dependent transport to the anterior cortex. Nurse cells require microtubules and Exuperantia to support anterior transport of bicoid mRNA, and microtubules are required for bicoid mRNA-Exuperantia particle coassembly. We propose that microtubule-dependent Exuperantia-bicoid mRNA complex formation in the nurse cell cytoplasm allows anterior-specific transport on a grossly nonpolar oocyte microtubule network.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Theurkauf, WE (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.			Theurkauf, William/0000-0001-7342-1912				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHAO YC, 1991, DEV GENET, V12, P333, DOI 10.1002/dvg.1020120502; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; HAY B, 1990, DEVELOPMENT, V109, P425; Hays T, 2000, NAT CELL BIOL, V2, pE60, DOI 10.1038/35008687; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King R. C., 1970, OVARIAN DEV DROSOPHI; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; MARCEY D, 1991, EMBO J, V10, P4259, DOI 10.1002/j.1460-2075.1991.tb05004.x; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Pokrywka NJ, 1995, CURR TOP DEV BIOL, V31, P139; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Spradling Allan C., 1993, P1; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Waters JC, 1997, CURR OPIN CELL BIOL, V9, P37, DOI 10.1016/S0955-0674(97)80149-4; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	41	153	155	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					35	46		10.1016/S0092-8674(01)00419-6	http://dx.doi.org/10.1016/S0092-8674(01)00419-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461700	Bronze			2022-12-24	WOS:000169870300007
J	CANFIELD, DE; DESMARAIS, DJ				CANFIELD, DE; DESMARAIS, DJ			AEROBIC SULFATE REDUCTION IN MICROBIAL MATS	SCIENCE			English	Article							COASTAL MARINE-SEDIMENTS; CYANOBACTERIAL MATS; OXYGEN MICROPROFILE; REDUCING BACTERIA; ORGANIC-MATTER; SULFUR; PHOTOSYNTHESIS; SULFIDE	Measurements of bacterial sulfate reduction and dissolved oxygen (O2) in hypersaline bacterial mats from Baja California, Mexico, revealed that sulfate reduction occurred consistently within the well-oxygenated photosynthetic zone of the mats. This evidence that dissimilatory sulfate reduction can occur in the presence of O2 challenges the conventional view that sulfate reduction is a strictly anaerobic process. At constant temperature, the rates of sulfate reduction in oxygenated mats during daytime were similar to rates in anoxic mats at night: thus, during a 24-hour cycle, variations in light and O2 have little effect on rates of sulfate reduction in these mats.			CANFIELD, DE (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.		Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERNER RA, 1980, EARLY DIAGENESIS; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; CANFIELD DE, 1986, CHEM GEOL, V54, P149, DOI 10.1016/0009-2541(86)90078-1; CANFIELD DE, UNPUB; Cohen Y., 1984, EOS, V65, P905; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; Dijk C. v., 1983, FEBS LETT, V156, P340; DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; HARGRAVE B, COMMUNICATION; HASTINGS D, 1988, LIMNOL OCEANOGR, V33, P391, DOI 10.4319/lo.1988.33.3.0391; JORGENSEN BB, 1977, MAR BIOL, V41, P7, DOI 10.1007/BF00390576; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1987, APPL ENVIRON MICROB, V53, P879, DOI 10.1128/AEM.53.4.879-886.1987; JORGENSEN BB, 1986, FEMS MICROBIOL ECOL, V38, P179, DOI 10.1016/0378-1097(86)90049-2; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P11; JORGENSEN BB, 1989, OPHELIA, V31, P29, DOI 10.1080/00785326.1989.10430849; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P814; JORGENSEN BB, 1988, LIMNOL OCEANOGR, V33, P99, DOI 10.4319/lo.1988.33.1.0099; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Lovely D.R., 1987, APPL ENVIRON MICROB, V53, P2636; MARAIS DJD, 1990, TRENDS ECOL EVOL, V5, P140, DOI 10.1016/0169-5347(90)90219-4; MARAIS DJD, 1989, MICROBIAL MATS PHYSL, pCH17; OREMLAND RS, 1988, ADV MICROB ECOL, V10, P285; Peck H. D. Jr., 1988, The Nitrogen and Sulphur Cycles. Proceedings of the 42nd Symposium of the Society for General Microbiology. Southampton, UK, January 1988., P99; Postgate J.R, 1979, SULPHATE REDUCING BA; REVSBECH NP, 1981, LIMNOL OCEANOGR, V26, P717, DOI 10.4319/lo.1981.26.4.0717; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P749, DOI 10.4319/lo.1983.28.4.0749; REVSBECH NP, 1983, LIMNOL OCEANOGR, V28, P1062, DOI 10.4319/lo.1983.28.6.1062; REVSBECH NP, 1980, LIMNOL OCEANOGR, V25, P403, DOI 10.4319/lo.1980.25.3.0403; REVSBECH NP, 1989, MICROBIAL MATS PHYSL, pCH13; SKYRING GW, 1983, AUST J MAR FRESH RES, V34, P359; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; Zhabina N.N., 1978, ENV BIOGEOCHEMISTRY, P735	36	310	315	5	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 22	1991	251	5000					1471	1473		10.1126/science.11538266	http://dx.doi.org/10.1126/science.11538266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC853	11538266				2022-12-24	WOS:A1991FC85300043
J	MELOSH, HJ; VICKERY, AM				MELOSH, HJ; VICKERY, AM			IMPACT EROSION OF THE PRIMORDIAL ATMOSPHERE OF MARS	NATURE			English	Article											MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.							Ahrens T.J., 1987, INT J IMPACT ENG, V5, P13; BAKER VR, 1986, J GEOPHYS RES-SOLID, V91, P3561, DOI 10.1029/JB091iB03p03561; CAMERON AGW, 1983, ICARUS, V56, P195, DOI 10.1016/0019-1035(83)90032-5; CESS RD, 1980, ICARUS, V41, P159, DOI 10.1016/0019-1035(80)90169-4; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; HARTMANN WK, 1977, ICARUS, V31, P260, DOI 10.1016/0019-1035(77)90037-9; Melosh H.L, 1989, IMPACT CRATERING GEO; MELOSH HJ, 1988, EOS, V69, P388; NEUKUM G, 1976, SCIENCE, V194, P1381, DOI 10.1126/science.194.4272.1381; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; STROM RG, 1984, NASA SP469; WALKER JGC, 1987, ICARUS, V68, P87; WATKINS GH, 1983, THESIS MIT; 1981, BASALTIC VOLCANISM T	14	312	312	0	30	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 6	1989	338	6215					487	489		10.1038/338487a0	http://dx.doi.org/10.1038/338487a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U0084	11536608				2022-12-24	WOS:A1989U008400048
J	Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ				Koepp, DM; Schaefer, LK; Ye, X; Keyomarsi, K; Chu, C; Harper, JW; Elledge, SJ			Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase	SCIENCE			English	Article							F-BOX PROTEINS; CELL-CYCLE; FAMILY; PROTEOLYSIS; DEGRADATION; REGULATORS; SKP2; G(1)	Cyclin E binds and activates the cyclin-dependent kinase Cdk2 and catalyzes the transition from the G(1) phase to the S phase of the cell cycle. The amount of cyclin E protein present in the cell is tightly controlled by ubiquitin-mediated proteolysis. Here we identify the ubiquitin ligase responsible for cyclin E ubiquitination as SCFFbw7 and demonstrate that it is functionally conserved in yeast, flies, and mammals. Fbw7 associates specifically with phosphorylated cyclin E, and SCF Fbw7 catalyzes cyclin E ubiquitination in vitro. Depletion of Fbw7 leads to accumulation and stabilization of cyclin E in vivo in human and Drosophila melanogaster cells. Multiple F-box proteins contribute to cyclin E stability in yeast, suggesting an overlap in SCF E3 ligase specificity that allows combinatorial control of cyclin E degradation.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Elledge, SJ (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.		Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; KOEPP D, UNPUB; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu GY, 1998, P NATL ACAD SCI USA, V95, P15787, DOI 10.1073/pnas.95.26.15787	26	640	656	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					173	177		10.1126/science.1065203	http://dx.doi.org/10.1126/science.1065203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11533444				2022-12-24	WOS:000171448800055
J	Shin, JS; Abraham, SN				Shin, JS; Abraham, SN			Cell biology - Caveolae - Not just craters in the cellular landscape	SCIENCE			English	Editorial Material							TRANSCYTOSIS; CHOLESTEROL; TOXIN; ENTRY		Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Shin, JS (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	Abrah006@mc.duke.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Bomsel M, 2000, MOL BIOL CELL, V11, p497A; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Hansen GH, 1999, GASTROENTEROLOGY, V116, P610, DOI 10.1016/S0016-5085(99)70183-6; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408	14	59	63	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1447	1448		10.1126/science.1061079	http://dx.doi.org/10.1126/science.1061079			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520975				2022-12-24	WOS:000170616000032
J	Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L				Tice, JA; Ross, E; Coxson, PG; Rosenberg, I; Weinstein, MC; Hunink, MGM; Goldman, PA; Williams, L; Goldman, L			Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease - Effect of grain fortification and beyond	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID SUPPLEMENTATION; CARDIOVASCULAR RISK FACTOR; SERUM TOTAL HOMOCYSTEINE; VASCULAR-DISEASE; ARTERY DISEASE; MYOCARDIAL-INFARCTION; CONTROLLED TRIAL; CLINICAL-TRIALS; HOMOCYST(E)INE LEVELS; SECONDARY PREVENTION	Context A high homocysteine level has been identified as an independent modifiable risk factor for coronary heart disease (CHD) events and death. Since January 1998, the US Food and Drug Administration has required that all enriched grain products contain 140 mug of folic acid per 100 g, a level considered to decrease homocysteine levels. Objectives To examine the potential effect of grain fortification with folic acid on CHID events and to estimate the cost-effectiveness of additional vitamin supplementation (folic acid and cyanocobalamin) for CHID prevention. Design and Setting Cost-effectiveness analysis using the Coronary Heart Disease Policy Model, a validated, state-transition model of CHD events in adults aged 35 through 84 years. Data from the third National Health and Nutrition Examination Survey (NHANES III) were used to estimate age- and sex-specific differences in homocysteine levels. Intervention Hypothetical comparison between a diet that includes enriched grain products projected to increase folic acid intake by 100 mug/d with the same diet without folic acid fortification; and a comparison between vitamin therapy that consists of 1 mg of folic acid and 0.5 mg of cyanocobalamin and the diet that includes grains fortified with folic acid. Main Outcome Measures Incidence of myocardial infarction and death from CHID, quality-adjusted life-years (QALYs) saved, and medical costs. Results Grain fortification with folic acid was predicted to decrease CHID events by 8% in women and 13% in men, with comparable reductions in CHID mortality. The model projected that, compared with grain fortification alone, treating all patients with known CHID with folic acid and cyanocobalamin over a 10-year period would result in 310000 fewer deaths and lower costs. Over the same 10-year period, providing vitamin supplementation in addition to grain fortification to all men aged 45 years or older without known CHID was projected to save more than 300000 QALYs, to save more than US $2 billion, and to be the preferred strategy. For women without CHD, the preferred vitamin supplementation strategy would be to treat all women older than 55 years, a strategy projected to save more than 140000 QALYs over 10 years. Conclusions Folic acid and cyanocobalamin supplementation may be cost-effective among many population subgroups and could have a major epidemiologic benefit for primary and secondary prevention of CHID if ongoing clinical trials confirm that homocysteine-lowering therapy decreases CHID event rates.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA; Tufts Univ, Div Clin Nutr, Boston, MA 02111 USA; Tufts Univ, Div Gen Internal Med, Boston, MA 02111 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Erasmus Med Ctr, Dept Radiol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands	University of California System; University of California San Francisco; Tufts University; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tice, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA 94143 USA.			Tice, Jeffrey/0000-0002-9857-2028				ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; BERGMARK C, 1993, EUR J VASCULAR SURG, V7, P391, DOI 10.1016/S0950-821X(05)80255-5; Bostom AG, 1997, ARTERIOSCL THROM VAS, V17, P2554, DOI 10.1161/01.ATV.17.11.2554; Bostom AG, 1997, ANN INTERN MED, V127, P1089, DOI 10.7326/0003-4819-127-12-199712150-00006; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM L, 1990, ATHEROSCLEROSIS, V81, P51, DOI 10.1016/0021-9150(90)90058-Q; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Bronstrup A, 1998, AM J CLIN NUTR, V68, P1104; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Chauveau P, 1996, MINER ELECTROL METAB, V22, P106; Cheng SWK, 1997, ANN VASC SURG, V11, P217, DOI 10.1007/s100169900037; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Cuskelly G. J., 1995, IRISH J MED SCI, V164; DALERY K, 1995, AM J CARDIOL, V75, P1107, DOI 10.1016/S0002-9149(99)80739-5; den Heijer M, 1998, ARTERIOSCL THROM VAS, V18, P356, DOI 10.1161/01.ATV.18.3.356; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKINSON CJ, 1995, QJM-INT J MED, V88, P357; ELVEBACK LR, 1981, MAYO CLIN PROC, V56, P665; Evans RW, 1997, ARTERIOSCL THROM VAS, V17, P1947, DOI 10.1161/01.ATV.17.10.1947; Fenech M, 1998, CARCINOGENESIS, V19, P1163, DOI 10.1093/carcin/19.7.1163; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; FRANKEN DG, 1994, J INHERIT METAB DIS, V17, P159, DOI 10.1007/BF00735426; FRANKEN DG, 1994, ARTERIOSCLER THROMB, V14, P465, DOI 10.1161/01.ATV.14.3.465; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; GENEST JJ, 1990, J AM COLL CARDIOL, V16, P1114, DOI 10.1016/0735-1097(90)90542-W; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Guttormsen AB, 1996, J CLIN INVEST, V98, P2174, DOI 10.1172/JCI119024; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; ISRAELSSON B, 1988, ATHEROSCLEROSIS, V71, P227, DOI 10.1016/0021-9150(88)90147-5; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Janssen MJFM, 1996, MINER ELECTROL METAB, V22, P110; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Koehler KM, 1997, J AM DIET ASSOC, V97, P167, DOI 10.1016/S0002-8223(97)00044-8; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; LANDGREN F, 1995, J INTERN MED, V237, P381, DOI 10.1111/j.1365-2796.1995.tb01190.x; Malinow MR, 1998, NEW ENGL J MED, V338, P1009, DOI 10.1056/NEJM199804093381501; MALINOW MR, 1990, CIRCULATION, V81, P2004, DOI 10.1161/01.CIR.81.6.2004; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; MCCULLY KS, 1969, AM J PATHOL, V56, P111; *MED EC CO INC, 1997, DRUG TOP RED BOOK; MOLGAARD J, 1992, J INTERN MED, V231, P273; Morris S, 1997, HEALTH ECON, V6, P589, DOI 10.1002/(SICI)1099-1050(199711)6:6<589::AID-HEC286>3.0.CO;2-D; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NAT CTR HLTH STAT, 1989, VIT STAT US 1986, V2; *NAT CTR HLTH STAT, 1981, VIT STA US A, V2; *NAT HLTH NUTR EX, 1990, NAT HLTH NUTR EX SUR; National Health and Nutrition Examination Survey III, 1998, NAT HLTH NUTR EX SUR; NAURATH HJ, 1995, LANCET, V346, P85, DOI 10.1016/S0140-6736(95)92113-3; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; OKEEFE CA, 1995, J NUTR, V125, P2717; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825; Russell LB, 1998, NEW ENGL J MED, V339, P1158, DOI 10.1056/NEJM199810153391612; SALTZMAN E, 1994, CLIN RES, V42, pA172; SanthoshKumar CR, 1997, EUR J CLIN NUTR, V51, P188, DOI 10.1038/sj.ejcn.1600385; Schorah CJ, 1998, EUR J CLIN NUTR, V52, P407, DOI 10.1038/sj.ejcn.1600576; Schwartz SM, 1997, CIRCULATION, V96, P412; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; STINNETT A, 1996, COST EFFECTIVENESS H, P348; TAYLOR LM, 1991, J VASC SURG, V13, P128, DOI 10.1016/0741-5214(91)90020-U; Torrance GW, 1996, COST EFFECTIVENESS H, P276; Tsevat J, 2001, AM HEART J, V141, P727, DOI 10.1067/mhj.2001.114805; Tucker KL, 1996, JAMA-J AM MED ASSOC, V276, P1879, DOI 10.1001/jama.276.23.1879; U.S. Department of Health and Human Services, 1990, NIH PUBL; UBBINK JB, 1991, KLIN WOCHENSCHR, V69, P527, DOI 10.1007/BF01649290; UBBINK JB, 1994, J NUTR, V124, P1927, DOI 10.1093/jn/124.10.1927; UBBINK JB, 1995, CLIN CHEM, V41, P1033; UBBINK JB, 1993, CLIN INVESTIGATOR, V71, P993, DOI 10.1007/BF00180030; *US BUR CENS, 1990, US POP EST AG SE S P, V25; VANDENBERG M, 1994, J VASC SURG, V20, P933, DOI 10.1016/0741-5214(94)90230-5; VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924; Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P460, DOI 10.1161/01.ATV.14.3.460; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; WILCKEN DEL, 1988, METABOLISM, V37, P697, DOI 10.1016/0026-0495(88)90093-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodside JV, 1998, AM J CLIN NUTR, V67, P858, DOI 10.1093/ajcn/67.5.858; Woodside JV, 1997, P NUTR SOC, V56, P479, DOI 10.1079/PNS19970048; WU LL, 1994, CLIN CHEM, V40, P552; 1996, FED REG, V61, P59489; 1993, FED REG, V58, P53305	99	71	76	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2001	286	8					936	943		10.1001/jama.286.8.936	http://dx.doi.org/10.1001/jama.286.8.936			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465EU	11509058	Bronze			2022-12-24	WOS:000170577300028
J	Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O				Dobbek, H; Svetlitchnyi, V; Gremer, L; Huber, R; Meyer, O			Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster	SCIENCE			English	Article							IRON-SULFUR PROTEINS; RUBRUM CO-DEHYDROGENASE; RHODOSPIRILLUM-RUBRUM; ANGSTROM; NICKEL; FE; RESOLUTION; REDUCTION; OXIDATION	The homodimeric nickel-containing CO dehydrogenase from the anaerobic bacterium Carboxydothermus hydrogenoformans catalyzes the oxidation of CO to CO2. A crystal structure of the reduced enzyme has been solved at 1.6 angstrom resolution. This structure represents the prototype for Ni-containing CO dehydrogenases from anaerobic bacteria and archaea. It contains five metal clusters of which clusters B, B', and a subunit-bridging, surface-exposed cluster D are cubane-type [4Fe-4S] clusters. The active-site clusters C and C' are novel, asymmetric [Ni-4Fe-5S] clusters. Their integral Ni ion, which is the likely site of CO oxidation, is coordinated by four sulfur ligands with square planar geometry.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany; Univ Bayreuth, Lehrstuhl Mikrobiol, D-95440 Bayreuth, Germany	Max Planck Society; University of Bayreuth; University of Bayreuth	Dobbek, H (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.		Gremer, Lothar/H-9128-2013	Gremer, Lothar/0000-0001-7065-5027				Arendsen AF, 1998, J BIOL INORG CHEM, V3, P81, DOI 10.1007/s007750050210; Arendsen AF, 1999, ADV INORG CHEM, V47, P219, DOI 10.1016/S0898-8838(08)60079-3; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BONAM D, 1987, J BIOL CHEM, V262, P2980; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coyle C.L, 1988, BIOINORGANIC CHEM NI, P1; CRANE BR, 1995, SCIENCE, V270, P59, DOI 10.1126/science.270.5233.59; DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P1; DeRose VJ, 1998, J AM CHEM SOC, V120, P8767, DOI 10.1021/ja9731480; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Ermler U, 1998, CURR OPIN STRUC BIOL, V8, P749, DOI 10.1016/S0959-440X(98)80095-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERRY JG, 1995, ANNU REV MICROBIOL, V49, P305, DOI 10.1146/annurev.mi.49.100195.001513; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1111/j.1574-6968.2000.tb09346.x; Hanzelmann P, 2000, J MOL BIOL, V301, P1221, DOI 10.1006/jmbi.2000.4023; Heo J, 1999, J AM CHEM SOC, V121, P11045, DOI 10.1021/ja990397a; Heo JY, 2000, BIOCHEMISTRY-US, V39, P7956, DOI 10.1021/bi992958g; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu ZG, 1996, J AM CHEM SOC, V118, P830, DOI 10.1021/ja9528386; Johnson MK, 1998, CURR OPIN CHEM BIOL, V2, P173, DOI 10.1016/S1367-5931(98)80058-6; KUMAR M, 1993, J AM CHEM SOC, V115, P11646, DOI 10.1021/ja00077a093; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Ragsdale SW, 1996, CHEM REV, V96, P2515, DOI 10.1021/cr950058+; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Spangler NJ, 1998, J BIOL CHEM, V273, P4059, DOI 10.1074/jbc.273.7.4059; Staples CR, 1999, J AM CHEM SOC, V121, P11034, DOI 10.1021/ja990396i; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; SVETLITCHNYI V, IN PRESS J BACTERIOL; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TURK D, 1992, THESIS TU MUNCHEN MU	36	390	429	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1281	1285		10.1126/science.1061500	http://dx.doi.org/10.1126/science.1061500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509720				2022-12-24	WOS:000170492600029
J	Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J				Boekema, EJ; Hifney, A; Yakushevska, AE; Piotrowski, M; Keegstra, W; Berry, S; Michel, KP; Pistorius, EK; Kruip, J			A giant chlorophyll-protein complex induced by iron defciency in cyanobacteria	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II COMPLEX; SYNECHOCOCCUS SP; ISIA GENE; STRESS; PURIFICATION; ORGANIZATION; LIMITATION; SUBUNITS	Cyanobacteria are abundant throughout most of the world's water bodies and contribute significantly to global primary productivity through oxygenic photosynthesis. This reaction is catalysed by two membrane-bound protein complexes, photosystem I (PSI) and photosystem II (PSII), which both contain chlorophyll-binding subunits functioning as an internal antenna(1). In addition, phycobilisomes act as peripheral antenna systems, but no additional light-harvesting systems have been found under normal growth conditions. Iron deficiency, which is often the limiting factor for cyanobacterial growth in aquatic ecosystems(2), leads to the induction of additional proteins such as IsiA (ref. 3). Although IsiA has been implicated in chlorophyll storage, energy absorption and protection against excessive light, its precise molecular function and association to other proteins is unknown. Here we report the purification of a specific PSI-IsiA supercomplex, which is abundant under conditions of iron limitation. Electron microscopy shows that this supercomplex consists of trimeric PSI surrounded by a closed ring of 18 IsiA proteins binding around 180 chlorophyll molecules. We provide a structural characterization of an additional chlorophyll-containing, membrane-integral antenna in a cyanobacterial photosystem.	Univ Bielefeld, D-33501 Bielefeld, Germany; Univ Groningen, Groningen Biomol Sci, NL-9747 AG Groningen, Netherlands; Univ Groningen, Inst Biotechnol, NL-9747 AG Groningen, Netherlands; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Bielefeld; University of Groningen; University of Groningen; Ruhr University Bochum	Pistorius, EK (corresponding author), Univ Bielefeld, D-33501 Bielefeld, Germany.	e.pistorius@biologie.uni-bielefeld.de; jochen.kruip@ruhr-uni-bochum.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337; hifney, Awatief/0000-0002-1247-1876				Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Boekema EJ, 2001, BIOCHEMISTRY-US, V40, P1029, DOI 10.1021/bi0015358; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; DEKKER JP, 1988, BIOCHIM BIOPHYS ACTA, V936, P307, DOI 10.1016/0005-2728(88)90006-0; Exss-Sonne P, 2000, PHOTOSYNTH RES, V63, P145, DOI 10.1023/A:1006322925324; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; GUIKEMA JA, 1983, PLANT PHYSIOL, V73, P250, DOI 10.1104/pp.73.2.250; HARAUZ G, 1988, METHOD ENZYMOL, V164, P35; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LAUDENBACH DE, 1988, J BACTERIOL, V170, P5018, DOI 10.1128/jb.170.11.5018-5026.1988; Lelong C, 1996, EMBO J, V15, P2160, DOI 10.1002/j.1460-2075.1996.tb00569.x; LEONHARDT K, 1992, J GEN MICROBIOL, V138, P1613, DOI 10.1099/00221287-138-8-1613; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D; PAKRASI HB, 1985, P NATL ACAD SCI USA, V82, P6903, DOI 10.1073/pnas.82.20.6903; Park YI, 1999, MOL MICROBIOL, V32, P123, DOI 10.1046/j.1365-2958.1999.01332.x; STRAUS NA, 1994, ADV PHOTOSYNTHESIS, V1, P731; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0; Wenk SO, 2000, J CHROMATOGR B, V737, P131, DOI 10.1016/S0378-4347(99)00525-3; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	24	270	289	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					745	748		10.1038/35089104	http://dx.doi.org/10.1038/35089104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507644	Green Published			2022-12-24	WOS:000170450200048
J	Ohl, FW; Scheich, H; Freeman, WJ				Ohl, FW; Scheich, H; Freeman, WJ			Change in pattern of ongoing cortical activity with auditory category learning	NATURE			English	Article							FREQUENCY-MODULATED TONES; OLFACTORY EEG; CORTEX; DISCRIMINATION; REPRESENTATION; SYSTEMS	Humans are able to classify novel items correctly by category(1,2); some other animals have also been shown to do this(3-7). During category learning, humans group perceptual stimuli by abstracting qualities from similarity relationships of their physical properties(1,2,8). Forming categories is fundamental to cognition(9) and can be independent of a 'memory store' of information about the items or a prototype(10). The neurophysiological mechanisms underlying the formation of categories are unknown. Using an animal model of category learning(6), in which frequency-modulated tones are distinguished into the categories of 'rising' and 'falling' modulation, we demonstrate here that the sorting of stimuli into these categories emerges as a sudden change in an animal's learning strategy. Electro-corticographical recording from the auditory cortex(11) shows that the transition is accompanied by a change in the dynamics of cortical stimulus representation. We suggest that this dynamic change represents a mechanism underlying the recognition of the abstract quality (or qualities) that defines the categories.	Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Leibniz Institut fur Neurobiologie (LIN); University of California System; University of California Berkeley	Ohl, FW (corresponding author), Leibniz Inst Neurobiol, Brenneckstr 6, D-39118 Magdeburg, Germany.	frank.ohl@ifn-magdeburg.de						Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Barrie JM, 1996, J NEUROPHYSIOL, V76, P520, DOI 10.1152/jn.1996.76.1.520; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P451, DOI 10.1007/BF00249600; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Freeman W.J., 2000, NEURODYNAMICS EXPLOR, DOI 10.1007/978-1-4471-0371-4; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P766, DOI 10.1037/0735-7044.101.6.766; FREEMAN WJ, 1982, PSYCHOPHYSIOLOGY, V19, P44, DOI 10.1111/j.1469-8986.1982.tb02598.x; FREEMAN WJ, 1994, PHYSICA D, V75, P151, DOI 10.1016/0167-2789(94)90280-1; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HERRNSTEIN RJ, 1990, COGNITION, V37, P133, DOI 10.1016/0010-0277(90)90021-B; HUOTILAINEN M, 1995, NEUROREPORT, V6, P841, DOI 10.1097/00001756-199504190-00004; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; KOMATSU LK, 1992, PSYCHOL BULL, V112, P500, DOI 10.1037/0033-2909.112.3.500; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LEA SEG, 1984, ANIMAL COGNITION, P263; Marshuetz C, 2000, J COGNITIVE NEUROSCI, P146; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; Medin D.L., 1998, PERCEPTION COGNITION, P403, DOI DOI 10.1016/B978-012301160-2/50015-0; MOODY DB, 1995, METHODS COMP PSYCHOA, P293; Ohl FW, 1999, LEARN MEMORY, V6, P347; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Ohl FW, 2000, J NEUROPHYSIOL, V83, P3123, DOI 10.1152/jn.2000.83.5.3123; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PEARCE JM, 1991, CURRENT TOPICS IN ANIMAL LEARNING : BRAIN, EMOTION, AND COGNITION, P141; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; WOODRUFF G, 1981, NATURE, V293, P568, DOI 10.1038/293568a0	30	246	249	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					733	736		10.1038/35089076	http://dx.doi.org/10.1038/35089076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	462ZB	11507640				2022-12-24	WOS:000170450200044
J	Robert, KA; Thompson, MB				Robert, KA; Thompson, MB			Sex determination - Viviparous lizard selects sex of embryos	NATURE			English	Article							REPTILES; TEMPERATURES		Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Inst Wildlife Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Robert, KA (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	krobert@bio.usyd.edu.au	Thompson, Mike/ABA-8716-2020; Robert, Kylie/C-5181-2009	Robert, Kylie/0000-0002-8554-8440; Thompson, Michael/0000-0002-2496-992X				BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Ciofi C, 1997, APPL ANIM BEHAV SCI, V51, P251, DOI 10.1016/S0168-1591(96)01108-2; Cogger HG, 1986, REPTILES AMPHIBIANS; CREE A, 1995, NATURE, V375, P543, DOI 10.1038/375543a0; Harlow Peter S., 1996, Herpetological Review, V27, P71; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Olsson M, 2001, J EVOLUTION BIOL, V14, P120, DOI 10.1046/j.1420-9101.2001.00255.x; SCHWARZKOPF L, 1991, OECOLOGIA, V88, P562, DOI 10.1007/BF00317720; Whetton PH, 2001, CLIMATE RES, V16, P181, DOI 10.3354/cr016181; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; YNTEMA CL, 1981, J MORPHOL, V167, P297, DOI 10.1002/jmor.1051670304	12	79	87	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2001	412	6848					698	699		10.1038/35089135	http://dx.doi.org/10.1038/35089135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507628				2022-12-24	WOS:000170450200032
J	Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE				Fridkin, SK; Edwards, JR; Courval, JM; Hill, H; Tenover, FC; Lawton, R; Gaynes, RP; McGowan, JE		Intensive Care Antimicrobial Resis	The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units	ANNALS OF INTERNAL MEDICINE			English	Article							ANTIMICROBIAL RESISTANCE; NOSOCOMIAL INFECTIONS; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; HOSPITALS; SEVERITY; FAECIUM; IMPACT; RISK	Background: Patient-specific risk factors for acquisition of vancomycin-resistant enterococci (VRE) among hospitalized patients are becoming well defined. However, few studies have reported data on the institutional risk factors, including rates of antimicrobial use, that predict rates of VRE. Identifying modifiable institutional factors can advance quality-improvement efforts to minimize hospital-acquired infections with VRE. Objective: To determine the independent importance of any association between antimicrobial use and risk factors for nosocomial infection on rates of VRE in intensive care units (ICUs). Design: Prospective ecologic study. Setting: 126 adult ICUs from 60 U.S. hospitals from January 1996 through July 1999. Patients: All patients admitted to participating ICUs. Measurements: Monthly use of antimicrobial agents (defined daily doses per 1000 patient-days), nosocomial infection rates, and susceptibilities of all tested enterococci isolated from clinical cultures. Results: Prevalence of VRE (median, 10%; range, 0% to 59%) varied by type of ICU and by teaching status and size of the hospital. Prevalence of VRE was strongly associated with VRE prevalence among inpatient non-ICU areas and outpatient areas in the hospital, ventilator-days per 1000 patient-days, and rate of parenteral vancomycin use. In a weighted linear regression model controlling for type of ICU and rates of VRE among non-ICU inpatient areas rates of vancomycin use (P < 0.001) and third-generation cephalosporin use (P = 0.02) were independently associated with VRE prevalence. Conclusions: Higher rates of vancomycin or third-generation cephalosporin use were associated with increased prevalence of VRE, independent of other ICU characteristics and the endemic VRE prevalence elsewhere in the hospital. Decreasing the use rates of these antimicrobial agents could reduce rates of VRE in ICUs.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Fridkin, SK (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, MS A-35,1600 Clifton Rd, Atlanta, GA 30333 USA.	skf0@cdc.gov	mcgowan, john e/G-5404-2011					[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; BOYCE JM, 1994, J CLIN MICROBIOL, V32, P1148, DOI 10.1128/JCM.32.5.1148-1153.1994; CULLEN DJ, 1984, CRIT CARE MED, V12, P155, DOI 10.1097/00003246-198403000-00001; Duncan RA, 1997, INFECT CONT HOSP EP, V18, P260; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Evans ME, 1996, INFECT CONT HOSP EP, V17, P356; Fridkin SK, 1999, CLIN INFECT DIS, V28, P1119, DOI 10.1086/514752; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; FRIDKIN SK, IN PRESS CLIN INFECT; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hamilton C. Dukes, 1997, Clinical Infectious Diseases, V25, P425; HANDWERGER S, 1993, CLIN INFECT DIS, V16, P750, DOI 10.1093/clind/16.6.750; JOHNSON SV, 1995, PHARMACOTHERAPY, V15, P579, DOI 10.1002/j.1875-9114.1995.tb02866.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Montecalvo MA, 1996, ARCH INTERN MED, V156, P1458, DOI 10.1001/archinte.156.13.1458; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; PETROFSKY MV, 1997, INFECT CONT HOSP EP, V18, pP33; Quale J, 1996, CLIN INFECT DIS, V23, P1020, DOI 10.1093/clinids/23.5.1020; Salemi C, 1998, Clin Perform Qual Health Care, V6, P12; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Singer MV, 1998, INFECT CONT HOSP EP, V19, P248; Steward CD, 2000, DIAGN MICR INFEC DIS, V38, P59, DOI 10.1016/S0732-8893(00)00161-9; Stroud L, 1996, INFECT CONT HOSP EP, V17, P576; Watanakunakorn C, 1997, INFECT CONT HOSP EP, V18, P767; Wenzel RP, 1999, CLIN INFECT DIS, V28, P1126, DOI 10.1086/514753	29	201	216	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2001	135	3					175	183		10.7326/0003-4819-135-3-200108070-00009	http://dx.doi.org/10.7326/0003-4819-135-3-200108070-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460FX	11487484				2022-12-24	WOS:000170298500003
J	Goodman, S				Goodman, S			Pressure grows over US blood ban	NATURE			English	News Item																		2001, NATURE, V412, P7	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					467	467		10.1038/35087718	http://dx.doi.org/10.1038/35087718			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484010	Bronze			2022-12-24	WOS:000170202900007
J	Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN				Fox, NC; Crum, WR; Scahill, RI; Stevens, JM; Janssen, JC; Rossor, MN			Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images	LANCET			English	Article							PRECLINICAL PHASE; APOLIPOPROTEIN-E; ATROPHY; RISK; MRI; REGISTRATION; MICROSCOPY; PATTERNS; ALLELE	Background Early diagnosis and monitoring of the progression of Alzheimer's disease is important for the development of therapeutic strategies. To detect the earliest structural brain changes, individuals need to be studied before symptom onset. We used an imaging technique known as voxel-compression mapping to localise progressive atrophy in patients with preclinical Alzheimer's disease. Methods Four symptom-free individuals from families with early-onset Alzheimer's disease with known autosomal dominant mutations underwent serial magnetic resonance imaging (MRI) over 5-8 years. All four became symptomatic during follow-up. 20 individuals with a clinical diagnosis of probable Alzheimer's disease and 20 control participants also underwent serial MR imaging. A non-linear fluid matching algorithm was applied to register repeat scans onto baseline imaging. Jacobian determinants were used to create the voxel-compression maps. Findings Progressive atrophy was revealed in presymptomatic individuals, with posterior cingulate and neocortical temporoparietal cortical losses, and medial temporal-lobe atrophy. In patients with known Alzheimer's disease, atrophy was widespread apart from in the primary motor and sensory cortices and cerebellum, reflecting the clinical phenomenology. Interpretation Voxel-compression maps confirmed early involvement of the medial temporal lobes, but also showed posterior cingulate and temporoparietal cortical losses at presymptomatic stage. This technique could be applied diagnostically and used to monitor the effects of therapeutic intervention.	UCL, Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London, England; Imperial Coll Sch Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Fox, NC (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, 8-11 Queen Sq, London WC1N 3BG, England.	nfox@dementia.ionl.ucl.ac.uk	Rossor, Martin/C-1598-2008; Fox, Nick C/B-1319-2009; Crum, William R/C-4891-2008; Fox, Nick C/AAE-1849-2021	Fox, Nick C/0000-0002-6660-657X; Crum, William R/0000-0001-9369-2197; Fox, Nick C/0000-0002-6660-657X; Scahill, Rachael/0000-0002-1832-106X; Rossor, Martin/0000-0001-8215-3120				Benveniste H, 1999, P NATL ACAD SCI USA, V96, P14079, DOI 10.1073/pnas.96.24.14079; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Fabrigoule C, 1998, BRAIN, V121, P135, DOI 10.1093/brain/121.1.135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox NC, 1999, LANCET, V353, P2125, DOI 10.1016/S0140-6736(99)00496-1; Fox NC, 1997, J MAGN RESON IMAGING, V7, P1069, DOI 10.1002/jmri.1880070620; Fox NC, 1998, BRAIN, V121, P1631, DOI 10.1093/brain/121.9.1631; Fox NC, 2000, NAT MED, V6, P20, DOI 10.1038/71481; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NEWMAN SK, 1994, J NEUROL NEUROSUR PS, V57, P967, DOI 10.1136/jnnp.57.8.967; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Warrington EK., 1984, RECOGNITION MEMORY T; WHITWELL JL, IN PRESS AM J NEUROR	24	341	349	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					201	205		10.1016/S0140-6736(01)05408-3	http://dx.doi.org/10.1016/S0140-6736(01)05408-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476837				2022-12-24	WOS:000169967100013
J	Dalton, R				Dalton, R			Action urged to combat killer algae	NATURE			English	News Item																			0	4	4	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					260	260		10.1038/35085712	http://dx.doi.org/10.1038/35085712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460123	Bronze			2022-12-24	WOS:000169918200010
J	Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R				Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RSK; Kuppers, R; Dalla-Favera, R			Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas	NATURE			English	Article							DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; HODGKINS-LYMPHOMA; BURKITT-LYMPHOMA; BCL-6 MUTATIONS; BINDING PROTEIN; IG GENES; TRANSLOCATIONS	Genomic instability promotes tumorigenesis and can occur through various mechanisms, including defective segregation of chromosomes or inactivation of DNA mismatch repair(1). Although B-cell lymphomas are associated with chromosomal translocations that deregulate oncogene expression(2), a mechanism for genome-wide instability during lymphomagenesis has not been described. During B-cell development, the immunoglobulin variable (V) region genes are subject to somatic hypermutation in germinal-centre B cells(3). Here we report that an aberrant hypermutation activity targets multiple loci, including the proto-oncogenes PIM1, MYC, RhoH/TTF (ARHH) and PAX5, in more than 50% of diffuse large-cell lymphomas (DLCLs), which are tumours derived from germinal centres. Mutations are distributed in the 5' untranslated or coding sequences, are independent of chromosomal translocations, and share features typical of V-region-associated somatic hypermutation. In contrast to mutations in V regions, however, these mutations are not detectable in normal germinal-centre B cells or in other germinal-centre-derived lymphomas, suggesting a DLCL-associated malfunction of somatic hypermutation. Intriguingly, the four hypermutable genes are susceptible to chromosomal translocations in the same region, consistent with a role for hypermutation in generating translocations by DNA double-strand breaks(4-6). By mutating multiple genes, and possibly by favouring chromosomal translocations, aberrant hypermutation may represent the major contributor to lymphomagenesis.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Mem Sloan Kettering Canc Ctr, Canc Genet Lab, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Columbia University; Columbia University; University of Cologne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Kuppers, Ralf/0000-0002-6691-7191				Akasaka H, 2000, CANCER RES, V60, P2335; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; CUYPERS HT, 1984, CELL, V37, P141; DALLAFAVERA R, 2001, CANC PRINCIPLES PRAC, P2215; Dang CV, 1999, MOL CELL BIOL, V19, P1; Gamberi B, 1997, BLOOD, V89, P975; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Klein U, 1998, IMMUNOL REV, V162, P261; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pasqualucci L, 2000, CANCER RES, V60, P5644; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Raffeld M, 1995, Curr Top Microbiol Immunol, V194, P265; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2000, INT IMMUNOL, V12, P1085, DOI 10.1093/intimm/12.7.1085; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Storb U, 1998, IMMUNOL REV, V162, P153; Zan H, 1999, J IMMUNOL, V162, P3437	30	740	770	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					341	346		10.1038/35085588	http://dx.doi.org/10.1038/35085588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460166				2022-12-24	WOS:000169918200049
J	Richmond, JE; Weimer, RM; Jorgensen, EM				Richmond, JE; Weimer, RM; Jorgensen, EM			An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming	NATURE			English	Article							MUNC13-1; EXPRESSION; FUSION; FAMILY; GENE	The priming step of synaptic vesicle exocytosis is thought to require the formation of the SNARE complex, which comprises the proteins synaptobrevin, SNAP-25 and syntaxin(1-3). In solution syntaxin adopts a default, closed configuration that is incompatible with formation of the SNARE complex(4). Specifically, the amino terminus of syntaxin binds the SNARE motif and occludes interactions with the other SNARE proteins. The N terminus of syntaxin also binds the presynaptic protein UNC-13 (ref. 5). Studies in mouse, Drosophila and Caenorhabditis elegans suggest that UNC-13 functions at a post-docking step of exocytosis, most likely during synaptic vesicle priming(6-8). Therefore, UNC-13 binding to the N terminus of syntaxin may promote the open configuration of syntaxin(9). To test this model, we engineered mutations into C. elegans syntaxin that cause the protein to adopt the open configuration constitutively(4). Here we demonstrate that the open form of syntaxin can bypass the requirement for UNC-13 in synaptic vesicle priming. Thus, it is likely that UNC-13 primes synaptic vesicles for fusion by promoting the open configuration of syntaxin.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NIMH NIH HHS [R03 MH059820-02, R03 MH059820-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1997, J BIOL CHEM, V272, P2520; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; Nonet ML, 1998, J NEUROSCI, V18, P70; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; THOMAS JH, 1990, GENETICS, V124, P855; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4	21	306	316	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 19	2001	412	6844					338	341		10.1038/35085583	http://dx.doi.org/10.1038/35085583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460165	Green Accepted			2022-12-24	WOS:000169918200048
J	Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N				Tahaoglu, K; Torun, T; Sevim, T; Atac, G; Kir, A; Karasulu, L; Ozmen, I; Kapakli, N			The treatment of multidrug-resistant tuberculosis in Turkey	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MDR-TB; CHEMOTHERAPY; RIFAMPIN	Background: We evaluated the results of treatment in 158 consecutive patients with multidrug-resistant tuberculosis who were treated at our center in Istanbul, Turkey. Methods: A total of 21 female patients and 137 male patients (age range, 15 to 68 years) received treatment for multidrug-resistant tuberculosis between March 1992 and October 1999. The patients had previously received a mean of 5.7 antituberculosis drugs and were infected with organisms that were resistant to a mean of 4.4 drugs. All patients received at least three drugs thought to be active; the treatment was continued for at least 18 months after the conversion to a negative culture and for at least 24 months in the absence of first-line drugs. Results: The mean number of drugs given during the study was 5.5 (range, 3 to 9). Surgical resection was performed in 36 patients. Adverse effects led to discontinuation of one or more drugs in 62 patients (39 percent). Cultures became negative in 150 patients (95 percent) after a mean of 1.9 months (range, 1 to 9). The overall success rate of treatment was 77 percent, with cures in 78 patients (49 percent) and probable cures in 43 (27 percent). Treatment failed in 13 patients (8 percent). Seven patients died (4 percent). Seventeen patients (11 percent) did not complete the treatment regimen. Thirty-eight percent of the patients with unsuccessful outcomes were infected with organisms that were resistant to more than five drugs. In a step-down logistic-regression analysis, a successful outcome was independently associated with a younger age (P=0.013) and the absence of previous treatment with ofloxacin (P=0.005). Conclusions: Most patients with multidrug-resistant tuberculosis can be cured with the use of appropriate, intensive treatment regimens. (N Engl J Med 2001;345:170-4.) Copyright (C) 2001 Massachusetts Medical Society.	Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Pulm Dis, Istanbul, Turkey; Sureyyapasa Ctr Chest Dis & Thorac Surg, Dept Thorac Surg, Istanbul, Turkey; Univ Istanbul, Istanbul Fac Med, Dept Chest Dis, Istanbul, Turkey	Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital; Istanbul University	Tahaoglu, K (corresponding author), Ekin Tibbi Yayincilik, Osmanaga Mah Nuzhet Efendi Sok 49-3, TR-81320 Istanbul, Turkey.		Ozmen, Ipek/I-3449-2018	Ozmen, Ipek/0000-0002-3448-3675				Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1999, INT J TUBERC LUNG D, V3, P643; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1999, MULTIDRUG RESISTAN 5; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; ISEMAN MD, 1991, AM REV RESPIR DIS, V143, P697, DOI 10.1164/ajrccm/143.4_Pt_1.697; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; RIEDER HL, 1994, TUBERCLE LUNG DIS, V75, P321, DOI 10.1016/0962-8479(94)90075-2; TAHAOGLU K, 1994, TUBERCLE LUNG DIS, V75, P324, DOI 10.1016/0962-8479(94)90076-0; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404	12	205	216	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					170	174		10.1056/NEJM200107193450303	http://dx.doi.org/10.1056/NEJM200107193450303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463011				2022-12-24	WOS:000169912800003
J	Yung, YL; Lee, T; Wang, CH; Shieh, YT				Yung, YL; Lee, T; Wang, CH; Shieh, YT			Dust: A diagnostic of the hydrologic cycle during the last glacial maximum	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; DESERT DUST; ICE; ATMOSPHERE; AEROSOLS; CLIMATE; SIMULATIONS; TRANSPORT; IMPACT	Dust concentrations in ice of the last glacial maximum (LGM) are high in ice cores from Greenland and Antarctica. The magnitude of the enhancements can be explained if the strength of the hydrologic cycle during the LGM was about half of that at present. This notion is consistent with a large decrease (5 degrees C) in ocean temperature during the LGM, as recently deduced from measurements of strontium and calcium in corals.	ACAD SINICA, INST EARTH SCI, TAIPEI 115, TAIWAN	Academia Sinica - Taiwan	Yung, YL (corresponding author), CALTECH, DIV GEOL & PLANETARY SCI, PASADENA, CA 91125 USA.		Yung, Yuk/AAM-4850-2021; Lee, Typhoon/N-8347-2013	Yung, Yuk/0000-0002-4263-2562; Wang, Chung-Ho/0000-0003-2014-6747	NINDS NIH HHS [NSC 84-2111-M-001-027GP] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALKANSKI YJ, 1993, J GEOPHYS RES-ATMOS, V98, P20573, DOI 10.1029/93JD02456; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; CHAPPELLAZ JA, 1993, TELLUS B, V45, P228, DOI 10.1034/j.1600-0889.1993.t01-2-00002.x; Crowley T. J., 1991, PALEOCLIMATOLOGY; Fairbridge R.W., 1961, PHYS CHEM EARTH, V4, P99, DOI [10.1016/0079-1946(61)90004-0, DOI 10.1016/0079-1946(61)90004-0]; FRIEDLINGSTEIN P, 1995, J GEOPHYS RES-ATMOS, V100, P7203, DOI 10.1029/94JD02948; GENTHON C, 1992, TELLUS B, V44, P371, DOI 10.1034/j.1600-0889.1992.00014.x; GROUSSET FE, 1992, EARTH PLANET SC LETT, V111, P175, DOI 10.1016/0012-821X(92)90177-W; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hammer C. U., 1985, GEOPHYS MONOGR SER, V33, P90, DOI DOI 10.1029/GM033P0090/SUMMARY); Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; HARVEY LDD, 1988, NATURE, V334, P333, DOI 10.1038/334333a0; Holloway R.G., 1985, POLLEN RECORDS LATE, P39; JOUSSAUME S, 1993, J GEOPHYS RES-ATMOS, V98, P2767, DOI 10.1029/92JD01921; JOUZEL J, 1989, QUATERNARY RES, V31, P135, DOI 10.1016/0033-5894(89)90003-3; KUKLA G, 1988, GEOLOGY, V16, P811, DOI 10.1130/0091-7613(1988)016<0811:PCICDB>2.3.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P288, DOI 10.1175/1520-0477(1990)071<0288:SCCGW>2.0.CO;2; LINDZEN RS, 1990, B AM METEOROL SOC, V71, P1465; MURPHY JR, 1993, J GEOPHYS RES-PLANET, V98, P3197, DOI 10.1029/92JE02945; PETIT JR, 1981, NATURE, V293, P391, DOI 10.1038/293391a0; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; SANTEE M, 1993, J GEOPHYS RES-PLANET, V98, P3261, DOI 10.1029/92JE01896; SENIOR CA, 1993, J CLIMATE, V6, P393, DOI 10.1175/1520-0442(1993)006<0393:CDACTI>2.0.CO;2; SHIA RL, 1989, J GEOPHYS RES-ATMOS, V94, P18467, DOI 10.1029/JD094iD15p18467; STUTE M, 1992, SCIENCE, V256, P1000, DOI 10.1126/science.256.5059.1000; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; WEARE BC, 1994, J CLIMATE, V7, P248, DOI 10.1175/1520-0442(1994)007<0248:IBCPAS>2.0.CO;2; YANG H, 1991, J ATMOS SCI, V48, P442, DOI 10.1175/1520-0469(1991)048<0442:SOTPDA>2.0.CO;2; 1992, CLIMATE CHANGE 199 S; 1990, CLIMATE CHANGE IPCC	33	103	114	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	1996	271	5251					962	963		10.1126/science.271.5251.962	http://dx.doi.org/10.1126/science.271.5251.962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TV704	11536732				2022-12-24	WOS:A1996TV70400040
J	HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ				HEATH, JR; SHEEKS, RA; COOKSY, AL; SAYKALLY, RJ			THE C7 CLUSTER - STRUCTURE AND INFRARED FREQUENCIES	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			SAYKALLY, RICHARD/0000-0001-8942-3656; Cooksy, Andrew/0000-0002-2794-4269				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BUSAROW KL, 1988, J CHEM PHYS, V89, P1968; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; FREED KF, 1982, ASTROPHYS J, V263, P718, DOI 10.1086/160543; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; GEUSIC ME, 1986, J CHEM PHYS, V84, P2421, DOI 10.1063/1.450354; HEATH JR, 1989, SCIENCE, V244, P564, DOI 10.1126/science.11539817; Herzberg G., 1945, INFRARED RAMAN SPECT, V2; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; KARU D, 1990, APPL OPTICS, V29, P119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MOAZZENAHMADI N, 1989, CHEM PHYS LETT, V157, P1, DOI 10.1016/0009-2614(89)87196-9; MOAZZENAHMADI N, 1989, J CHEM PHYS, V91, P2140, DOI 10.1063/1.457073; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; SCHMUTTENMAER CA, 1990, SCIENCE, V249, P897, DOI 10.1126/science.11538082; SUZUKI H, 1981, 13TH OK C TRANS IONS; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; YANG SH, 1987, CHEM PHYS LETT, V139, P233, DOI 10.1016/0009-2614(87)80548-1	22	67	67	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					895	897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538081	Green Accepted			2022-12-24	WOS:A1990DV75100037
J	Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K				Chamoun, Z; Mann, RK; Nellen, D; von Kessler, DP; Bellotto, M; Beachy, PA; Basler, K			Skinny Hedgehog, an acyltransferase required for palmitoylation and activity of the Hedgehog signal	SCIENCE			English	Article							DROSOPHILA; POLARITY; PROTEIN; IDENTIFICATION; MUTATIONS; GENES; CHROMOSOME; WINGLESS; PATTERN; RNA	One of the most dominant influences in the patterning of multicellular embryos is exerted by the Hedgehog (Hh) family of secreted signaling proteins. Here, we identify a segment polarity gene in Drosophila, melanogaster, Skinny hedgehog (ski), and show that its product is required in Hh-expressing cells for production of appropriate signaling activity in embryos and in the imaginal precursors of adult tissues. The ski gene encodes an apparent acyltransferase, and we provide genetic and biochemical evidence that Hh proteins from ski mutant cells retain carboxyl-terminal cholesterol modification but lack amino-terminal palmitate modification. Our results suggest that ski encodes an enzyme that acts within the secretory pathway to catalyze amino-terminal palmitoylation of Hh, and further demonstrate that this lipid modification is required for the embryonic and larval patterning activities of the Hh signal.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	Howard Hughes Medical Institute; Johns Hopkins University; University of Zurich; University of Zurich	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	pbeachy@jhmi.edu; basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chou TB, 1996, GENETICS, V144, P1673; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Deak P, 1997, GENETICS, V147, P1697; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kawakami Y, 2001, J IMMUNOL, V166, P2871, DOI 10.4049/jimmunol.166.4.2871; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Li BL, 1999, J BIOL CHEM, V274, P11060, DOI 10.1074/jbc.274.16.11060; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; WAHI M, 1995, GENETICS, V140, P79; WOHLWILL AD, 1991, GENETICS, V128, P763	28	326	340	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2080	2084		10.1126/science.1064437	http://dx.doi.org/10.1126/science.1064437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11486055				2022-12-24	WOS:000171028700072
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKC zeta	CELL			English	Article							SACCHAROMYCES-CEREVISIAE GENE; PROTEIN-KINASE-C; RHO GTPASES; T-CELLS; BINDING; RAC; ADHESION; PHOSPHORYLATION; MEMBRANE; DYNACTIN	We describe here a signal transduction pathway controlling the establishment of mammalian cell polarity. Scratching a confluent monolayer of primary rat astrocytes leads to polarization of cells at the leading edge. The microtubule organizing center, the microtubule cytoskeleton, and the Golgi reorganize to face the new free space, and directed cell protrusion and migration specifically occur perpendicularly to the scratch. We show here that the interaction of integrins with extracellular matrix at the newly formed cell front leads to the activation and polarized recruitment of Cdc42, which in turn recruits and activates a cytoplasmic mPar6/PKC zeta complex. Localized PKC zeta activity, acting through the microtubule motor protein dynein, is required for all aspects of induced polarity in these cells.	UCL, MRC, Lab Mol Cell Biol, London WC1E 6BT, England; UCL, CRC, Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; Doe CQ, 2001, NAT CELL BIOL, V3, pE7, DOI 10.1038/35050684; Etienne-Manneville S, 1999, J IMMUNOL, V163, P668; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Koonce MP, 1999, EMBO J, V18, P6786, DOI 10.1093/emboj/18.23.6786; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leng LJ, 1998, BLOOD, V91, P4206, DOI 10.1182/blood.V91.11.4206.411k30_4206_4215; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lowin-Kropf B, 1998, J CELL BIOL, V140, P861, DOI 10.1083/jcb.140.4.861; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	41	811	832	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					489	498		10.1016/S0092-8674(01)00471-8	http://dx.doi.org/10.1016/S0092-8674(01)00471-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525734	Bronze			2022-12-24	WOS:000170665200012
J	Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP				Kim, T; Tao-Cheng, JH; Eiden, LE; Loh, YP			Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis	CELL			English	Article							TERMINAL DOMAINS; CELLS; EXPRESSION; AGGREGATION; PROTEIN; GENE; PH; VESICLES; PEPTIDES; PATHWAY	We present evidence that regulation of dense-core secretory granule biogenesis and hormone secretion in endocrine cells is dependent on chromogranin A (CGA). Downregulation of CGA expression in a neuroendocrine cell line, PC12, by antisense RNAs led to profound loss of dense-core secretory granules, impairment of regulated secretion of a transfected prohormone, and reduction of secretory granule proteins. Transfection of bovine CGA into a CGA-deficient PC12 clone rescued the regulated secretory phenotype. Stable transfection of CGA into a CGA-deficient pituitary cell line, 6T3, lacking a regulated secretory pathway, restored regulated secretion. Overexpression of CGA induced dense-core granules, immunoreactive for CGA, in nonendocrine fibroblast CV-1 cells. We conclude that CGA is an "on/off" switch that alone is sufficient to drive dense-core secretory granule biogenesis and hormone sequestration in endocrine cells.	NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; NINDS, EM Facil, Bethesda, MD 20892 USA; NIMH, Lab Cellular & Mol Regulat, Mol Neurosci Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Loh, YP (corresponding author), NICHHD, Dev Neurobiol Lab, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	ypl@codon.nih.gov		Eiden, Lee/0000-0001-7524-944X	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002386, ZIAMH002386] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENEDUM UM, 1987, EMBO J, V6, P1203, DOI 10.1002/j.1460-2075.1987.tb02355.x; CASTRO MG, 1989, MOL CELL ENDOCRINOL, V65, P165, DOI 10.1016/0303-7207(89)90177-9; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Corradi N, 1996, J BIOL CHEM, V271, P27116, DOI 10.1074/jbc.271.43.27116; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; ERICKSON JD, 1993, J NEUROCHEM, V61, P2314, DOI 10.1111/j.1471-4159.1993.tb07476.x; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; FISCHERCOLBRIE R, 1987, J NEUROCHEM, V48, P262, DOI 10.1111/j.1471-4159.1987.tb13157.x; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; GORR SU, 1989, AM J PHYSIOL, V257, pE247, DOI 10.1152/ajpendo.1989.257.2.E247; HEISLER S, 1984, J NEUROCHEM, V42, P1659, DOI 10.1111/j.1471-4159.1984.tb12757.x; HENDY GN, 1995, CLIN INVEST MED, V18, P47; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO AL, 1991, MOL ENDOCRINOL, V5, P1651, DOI 10.1210/mend-5-11-1651; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Jain RK, 2000, J BIOL CHEM, V275, P27032; LOH YP, 1985, J BIOL CHEM, V260, P7194; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pance A, 1999, J NEUROCHEM, V73, P21, DOI 10.1046/j.1471-4159.1999.0730021.x; SCHAFER MKH, 1994, PEPTIDES, V15, P263, DOI 10.1016/0196-9781(94)90012-4; Tanner VA, 1996, J HISTOCHEM CYTOCHEM, V44, P1481, DOI 10.1177/44.12.8985140; Watanabe T, 1998, ENDOCRINOLOGY, V139, P2765, DOI 10.1210/en.139.6.2765; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; WU HJ, 1991, J BIOL CHEM, V266, P13130; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; YOO SH, 1995, J BIOL CHEM, V270, P12578, DOI 10.1074/jbc.270.21.12578	30	337	352	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					499	509		10.1016/S0092-8674(01)00459-7	http://dx.doi.org/10.1016/S0092-8674(01)00459-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525735	Bronze			2022-12-24	WOS:000170665200013
J	Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS				Lawrance, RA; Dorsch, MF; Sapsford, R; Mackintosh, AF; Greenwood, DC; Jackson, BM; Morrell, C; Robinson, MB; Hall, AS		EMMACE Study Grp	Use of cumulative mortality data in patients with acute myocardial infarction for early detection of variation in clinical practice: observational study	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC-SURGERY; HEART-SURGERY; TRIAL	Objectives Use of cumulative mortality adjusted for case mix in patients with acute myocardial infarction for early detection of variation in clinical practice. Design Observational study. Setting 20 hospitals across the former Yorkshire region. Participants All 2153 consecutive patients with confirmed acute myocardial infarction identified during three months. Main outcome measures Variable life-adjusted displays showing cumulative differences between observed and expected mortality of patients; expected mortality calculated from risk model based on admission characteristics of age. heart rate, and systolic blood pressure. Results The performance of two individual hospitals over three months was examined as an example. One, the smallest district hospital in the region, had a series of 30 consecutive patients but had five more deaths than predicted. The variable life-adjusted display showed minimal variation from that predicted for the first 15 patients followed by a run of unexpectedly high mortality. The second example was the main tertiary referral centre for the region, which admitted 188 consecutive patients. The display showed a period of apparently poor performance followed by substantial improvement, where the plot rose steadily from a cumulative net lives saved of - 4 to 7. These variations in patient outcome are unlikely to have been revealed during conventional audit practice. Conclusions Variable life-adjusted display has been integrated. into surgical care as a graphical display of risk-adjusted survival for individual surgeons or centres. In combination with a simple risk model, it may have a role in monitoring performance and outcome in patients with acute myocardial infarction.	Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England; St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9PL, W Yorkshire, England	Leeds General Infirmary; University of Leeds; Saint James's University Hospital; University of Leeds	Hall, AS (corresponding author), Leeds Gen Infirm, BHF Heart Res Ctr, Leeds LS2 9JT, W Yorkshire, England.		Greenwood, Darren C/C-3220-2008; Hall, Alistair/K-1953-2019	Greenwood, Darren C/0000-0001-7035-3096; Hall, Alistair/0000-0003-0306-7887				ANDERSON RG, 1996, FEDERAL RESERVE BANK, V0078; BIRKHEAD J, 2000, EHEART, V84; de Mol BA, 1998, LANCET, V351, P144, DOI 10.1016/S0140-6736(05)78110-1; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; *DEP HLTH, 2000, NAT SERV FRAM COR HE; DORSCH MF, IN PRESS HEART; Ecochard E, 2000, HEART, V84, P5, DOI 10.1136/heart.84.1.5; IEZZONI LI, 1992, MED CARE, V30, P347, DOI 10.1097/00005650-199204000-00005; LAWRANCE RA, 2000, EHEART, V84; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lovegrove J, 1997, LANCET, V350, P1128, DOI 10.1016/S0140-6736(97)06507-0; NASHEF SAM, 1992, BRIT MED J, V305, P1066, DOI 10.1136/bmj.305.6861.1066; Nashef SAM, 1998, LANCET, V351, P143, DOI 10.1016/S0140-6736(05)78111-3; PARSONNET V, 1989, CIRCULATION 2, V76, P3; Poloniecki J, 1998, BRIT MED J, V316, P1697, DOI 10.1136/bmj.316.7146.1697; Sergeant P, 1997, LANCET, V350, P1114, DOI 10.1016/S0140-6736(97)22042-8; Sherlaw-Johnson C, 2000, HEART, V84, P79, DOI 10.1136/heart.84.1.79; WILLIAMS SM, 1992, BRIT MED J, V304, P1359, DOI 10.1136/bmj.304.6838.1359	18	39	39	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2001	323	7308					324	327		10.1136/bmj.323.7308.324	http://dx.doi.org/10.1136/bmj.323.7308.324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498491	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000170470900022
J	Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS				Nelson, G; Hoon, MA; Chandrashekar, J; Zhang, YF; Ryba, NJP; Zuker, CS			Mammalian sweet taste receptors	CELL			English	Article							PUTATIVE PHEROMONE RECEPTORS; PROTEIN-COUPLED RECEPTORS; GLUTAMATE RECEPTORS; MULTIGENE FAMILY; MICE; EXPRESSION; RESPONSES; G-ALPHA(16); PREFERENCE; HAMSTER	The sense of taste provides animals with valuable information about the quality and nutritional value of food. Previously, we identified a large family of mammalian taste receptors involved in bitter taste perception (the T2Rs). We now report the characterization of mammalian sweet taste receptors. First, transgenic rescue experiments prove that the Sac locus encodes T1R3, a member of the T1R family of candidate taste receptors. Second, using a heterologous expression system, we demonstrate that T1R2 and T1R3 combine to function as a sweet receptor, recognizing sweet-tasting molecules as diverse as sucrose, saccharin, dulcin, and acesulfame-K. Finally, we present a detailed analysis of the patterns of expression of T1Rs and T2Rs, thus providing a view of the representation of sweet and bitter taste at the periphery.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	czuker@flyeye.ucsd.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Boughter JD, 1997, J NEUROSCI, V17, P2852; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Danilova V, 1998, J NEUROPHYSIOL, V80, P2102, DOI 10.1152/jn.1998.80.4.2102; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCBURNEY DH, 1979, PSYCHOL BULL, V86, P151, DOI 10.1037/0033-2909.86.1.151; MISTRETTA CM, 1995, NEUROL DIS, V32, P635; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nagarajan S, 1996, J MED CHEM, V39, P4167, DOI 10.1021/jm960349q; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NINOMIYA Y, 1984, BRAIN RES, V302, P305, DOI 10.1016/0006-8993(84)90244-0; Ninomiya Y, 1997, AM J PHYSIOL-REG I, V272, pR1002, DOI 10.1152/ajpregu.1997.272.3.R1002; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SMITH DV, 1993, MECH TASTE TRANSDUCT, P295; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7	38	1257	1343	7	253	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					381	390		10.1016/S0092-8674(01)00451-2	http://dx.doi.org/10.1016/S0092-8674(01)00451-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509186	Bronze			2022-12-24	WOS:000170433300015
J	Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A				Wakioka, T; Sasaki, A; Kato, R; Shouda, T; Matsumoto, A; Miyoshi, K; Tsuneoka, M; Komiya, S; Baron, R; Yoshimura, A			Spred is a Sprouty-related suppressor of Ras signalling	NATURE			English	Article							DROSOPHILA SPROUTY; KINASE-ACTIVITY; RAF-1; EXPRESSION; ACTIVATION; DIFFERENTIATION; PHOSPHORYLATION; INHIBITOR; CLONING; HOMOLOG	Cellular proliferation, and differentiation of cells in response to extracellular signals, are controlled by the signal transduction pathway of Ras, Raf and MAP (mitogen-activated protein) kinase. The mechanisms that regulate this pathway are not well known. Here we describe two structurally similar tyrosine kinase substrates, Spred-1 and Spred-2. These two proteins contain a cysteine-rich domain related to Sprouty (the SPR domain) at the carboxy terminus. In Drosophila, Sprouty inhibits the signalling by receptors of fibroblast growth factor (FGF) and epidermal growth factor (EGF) by suppressing the MAP kinase pathway(2-7). Like Sprouty, Spred inhibited growth-factor-mediated activation of MAP kinase. The Ras-MAP kinase pathway is essential in the differentiation of neuronal cells and myocytes. Expression of a dominant negative form of Spred and Spred-antibody microinjection revealed that endogenous Spred regulates differentiation in these types of cells. Spred constitutively associated with Ras but did not prevent activation of Ras or membrane translocation of Raf. Instead, Spred inhibited the activation of MAP kinase by suppressing phosphorylation and activation of Raf. Spred may represent a class of proteins that modulate Ras-Raf interaction and MAP kinase signalling.	Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; Kagoshima Univ, Fac Med, Dept Orthopaed, Kagoshima 899, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Kyushu University; Kagoshima University; Kurume University; Yale University	Yoshimura, A (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan.		Yoshimura, Akihiko/K-5515-2013	Sasaki, Atsuo/0000-0003-2963-4501				Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; DeMille MMC, 1996, GENE, V183, P103, DOI 10.1016/S0378-1119(96)00506-9; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reich A, 1999, DEVELOPMENT, V126, P4139; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROSE DW, 1992, J CELL BIOL, V119, P1405, DOI 10.1083/jcb.119.6.1405; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163	23	344	361	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					647	651		10.1038/35088082	http://dx.doi.org/10.1038/35088082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493923				2022-12-24	WOS:000170318000043
J	Klemperer, W				Klemperer, W			Astronomy - The complex story of H-2	SCIENCE			English	Editorial Material							MOLECULAR-HYDROGEN; CHEMISTRY; LINES		Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Klemperer, W (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Biham O, 2001, ASTROPHYS J, V553, P595, DOI 10.1086/320975; de Lange A, 2001, PHYS REV LETT, V86, P2988, DOI 10.1103/PhysRevLett.86.2988; GEBALLE TR, 1993, ASTR SOC P, V41, P147; HERBST E, 1995, ANNU REV PHYS CHEM, V46, P27, DOI 10.1146/annurev.pc.46.100195.000331; MAHAN BH, 1970, ACCOUNTS CHEM RES, V8, P55; McCall BJ, 1999, ASTROPHYS J, V522, P338, DOI 10.1086/307637; MORTON DC, 1975, ASTROPHYS J, V197, P85, DOI 10.1086/153490; Rychlewski J, 1999, ADV QUANTUM CHEM, V31, P173; SPITZER L, 1974, ASTROPHYS J SUPPL S, V28, P373, DOI 10.1086/190323; STARK J, 1927, WIEN HARMS HDB EXPT, V21, P442	10	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					815	816		10.1126/science.1062991	http://dx.doi.org/10.1126/science.1062991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486077				2022-12-24	WOS:000170241000031
J	de Leon, MSP; Zollikofer, CPE				de Leon, MSP; Zollikofer, CPE			Neanderthal cranial ontogeny and its implications for late hominid diversity	NATURE			English	Article							PALEOANTHROPOLOGY; MORPHOLOGY; MANDIBLES; GROWTH; SHAPE; BASE; FACE	Homo neanderthalensis has a unique combination of craniofacial features that are distinct from fossil and extant anatomically modern' Homo sapiens (modern humans). Morphological evidence, direct isotopic dates(1) and fossil mitochondrial DNA from three Neanderthals(2,3) indicate that the Neanderthals were a separate evolutionary lineage for at least 500,000 yr. However, it is unknown when and how Neanderthal craniofacial autapomorphies (unique, derived characters) emerged during ontogeny. Here we use computerized fossil reconstruction(4) and geometric morphometrics (5,6) to show that characteristic differences in cranial and mandibular shape between Neanderthals and modern humans arose very early during development, possibly prenatally, and were maintained throughout postnatal ontogeny. Postnatal differences in cranial ontogeny between the two taxa are characterized primarily by heterochronic modifications of a common spatial pattern of development. Evidence for early ontogenetic divergence together with evolutionary stasis of taxon-specific patterns of ontogeny is consistent with separation of Neanderthals and modern humans at the species level.	Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, Inst Informat MultiMedia Lab, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Zollikofer, CPE (corresponding author), Univ Zurich Irchel, Inst Anthropol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	zolli@ir.unizh.ch						Bookstein FL, 1991, MORPHOMETRIC TOOLS L; De Leon MSP, 1999, ANAT REC, V254, P474; DEAN MC, 1986, AM J PHYS ANTHROPOL, V70, P301, DOI 10.1002/ajpa.1330700305; DELEON MSP, 2000, THESIS U ZURICH; Enlow D. H., 1990, FACIAL GROWTH; FRANCISCUS RG, 1995, J HUM EVOL, V28, P577, DOI 10.1006/jhev.1995.1043; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lieberman Daniel E., 2000, Linnean Society Symposium Series, V20, P85; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Maureille B, 1999, J HUM EVOL, V37, P137, DOI 10.1006/jhev.1999.0312; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; RAK Y, 1994, J HUM EVOL, V26, P313, DOI 10.1006/jhev.1994.1019; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Schwartz JH, 1996, P NATL ACAD SCI USA, V93, P10852, DOI 10.1073/pnas.93.20.10852; STRINGER CB, 1990, MG PRIMATOL, V14, P115; Stringer Christopher, 1993, SEARCH NEANDERTHALS; Tattersall I, 1998, ANAT RECORD, V253, P113; TILLIER AM, 1989, HUMAN REVOLUTION, P286; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; WILLIAMS FL, 2000, NEANDERTHALS EDGE, P257; Zollikofer CPE, 1998, EVOL ANTHROPOL, V6, P41, DOI 10.1002/(SICI)1520-6505(1998)6:2<41::AID-EVAN2>3.0.CO;2-Z; ZOLLIKOFER CPE, 1995, IEEE COMPUT GRAPH, V15, P48, DOI 10.1109/38.469515; ZOLLIKOFER CPE, 1995, NATURE, V375, P283, DOI 10.1038/375283b0	30	226	236	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					534	538		10.1038/35087573	http://dx.doi.org/10.1038/35087573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	458PC	11484052				2022-12-24	WOS:000170202900044
J	Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW				Ellner, SP; McCauley, E; Kendall, BE; Briggs, CJ; Hosseini, PR; Wood, SN; Janssen, A; Sabelis, MW; Turchin, P; Nisbet, RM; Murdoch, WW			Habitat structure and population persistence in an experimental community	NATURE			English	Article							PREDATOR-PREY SYSTEM; METAPOPULATION PERSISTENCE; LOCAL EXTINCTION; DYNAMICS; MODELS; STABILITY; DISPERSAL	Understanding spatial population dynamics is fundamental for many questions in ecology and conservation(1-4). Many theoretical mechanisms have been proposed whereby spatial structure can promote population persistence, in particular for exploiter-victim systems (host-parasite/pathogen, predator-prey) whose interactions are inherently oscillatory and therefore prone to extinction of local populations(5-11). Experiments have confirmed that spatial structure can extend persistence(11-16), but it has rarely been possible to identify the specific mechanisms involved. Here we use a model-based approach to identify the effects of spatial population processes in experimental systems of bean plants (Phaseolus lunatus), herbivorous mites (Tetranychus urticae) and predatory mites (Phytoseiulus persimilis). On isolated plants, and in a spatially undivided experimental system of 90 plants, prey and predator populations collapsed; however, introducing habitat structure allowed long-term persistence. Using mechanistic models, we determine that spatial population structure did not contribute to persistence, and spatially explicit models are not needed. Rather, habitat structure reduced the success of predators at locating prey outbreaks, allowing between-plant asynchrony of local population cycles due to random colonization events.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Univ Calgary, Dept Biol Sci, Div Ecol, Calgary, AB T2N 1N4, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ St Andrews, Sch Math & Comp Sci, St Andrews KY16 9SS, Fife, Scotland; Inst Biodivers & Ecosyst Dynam, NL-1090 GB Amsterdam, Netherlands; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	Cornell University; University of Calgary; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of St Andrews; University of Amsterdam; University of Connecticut	Ellner, SP (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	spe2@cornell.edu	Briggs, Cheryl/F-7456-2013; Wood, Simon N/B-3058-2010; Janssen, Arne/B-2657-2009; Kendall, Bruce/C-1871-2008; Nisbet, Roger M/B-6951-2014; Hosseini, Parviez/F-8439-2010	Wood, Simon N/0000-0002-2034-7453; Janssen, Arne/0000-0001-5075-5303; Kendall, Bruce/0000-0003-1782-8106; 				Caswell H., 2001, MATRIX POPULATION MO, V2nd; de Roos AM, 1998, THEOR POPUL BIOL, V53, P108, DOI 10.1006/tpbi.1997.1345; DEROOS AM, 1991, P ROY SOC B-BIOL SCI, V246, P117, DOI 10.1098/rspb.1991.0132; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Gilpin ME., 1997, METAPOPULATION BIOL; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1988, ANN ZOOL FENN, V25, P55; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; Helle W., 1985, SPIDER MITES THEIR B; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1963, HILGARDIA, V34, P305; Janssen A, 1997, EXP APPL ACAROL, V21, P415, DOI 10.1023/A:1018479828913; Levin SA, 1997, SCIENCE, V275, P334, DOI 10.1126/science.275.5298.334; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; McCauley E, 2000, ECOLOGY, V81, P3350, DOI 10.1890/0012-9658(2000)081[3350:ICPFPD]2.0.CO;2; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; NISBET RM, 1982, MODELLING FLUCTUATIN, pCH10; Pels B, 1999, OIKOS, V86, P573, DOI 10.2307/3546662; SABELIS MW, 1991, BIOL J LINN SOC, V42, P267, DOI 10.1111/j.1095-8312.1991.tb00563.x; SABELIS MW, 1990, OECOLOGIA, V82, P289, DOI 10.1007/BF00317473; SABELIS MW, 1988, THEOR POPUL BIOL, V34, P169, DOI 10.1016/0040-5809(88)90040-8; SABELIS MW, 1987, NETH J ZOOL, V37, P117; Tilman D., 1997, SPATIAL ECOLOGY ROLE; VANDEKLASHORST G, 1992, EXP APPL ACAROL, V14, P185, DOI 10.1007/BF01200563; Wright S, 1943, GENETICS, V28, P114; [No title captured]	29	163	181	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2001	412	6846					538	543		10.1038/35087580	http://dx.doi.org/10.1038/35087580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484053				2022-12-24	WOS:000170202900045
J	Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF				Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF		European Grp Blood & Marrow Transp	Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey	LANCET			English	Article							TOTAL-BODY IRRADIATION; CHRONIC MYELOID-LEUKEMIA; RADIATION WORKERS; LYMPHOMA; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; FERTILITY; CHILDREN; FAILURE; EMBRYOS	Background Some patients treated by transplantation of haemopoietic stem cells (peripheral blood or bone marrow) become permanently infertile, but others retain or recover fertility. We assessed the outcome of conception in women, and partners of men previously treated by autologous or allogeneic stem cell transplantation (SCT). Methods We sent questionnaires to 229 centres of the European Group for Blood and Marrow Transplantation. We sought details about the original disease, transplant procedure, and outcome of conception for both male and female patients. Findings 199 centres gave information relating to 19 412 allogeneic and 17 950 autologous transplant patients. 232 (0.6%) patients conceived after SCT. Crude annual birth rate for 4-month survivors of SCT was lower than the national average for England and Wales at 1.7 per 1000 patients. 312 conceptions were reported in 113 patients (74 allograft) and partners of 119 patients (93 allograft). Most pregnancies were uncomplicated and resulted in 271 livebirths. 28 (42%) of 67 allograft recipients had caesarean section compared with 16% in the normal population (difference=26% [95% CI 15-38]), 12 (20%) of 59 had preterm delivery compared with a normal rate of 6% (14% [4-24]), and 12 (23%) of 52 had low birthweight singleton offspring compared with a normal rate of 6% (17% [6-29]). Interpretation Pregnancy after SCT is likely to have a successful outcome. Pregnancies in allograft patients who have received total body irradiation should be treated as high risk for maternal and fetal complications.	Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, London W12 0NN, England; Hop St Louis, Dept Hematol BMT, Paris, France; Hop Hotel Dieu, Serv Hematol, Paris, France; UCL Hosp, Dept Haematol, London, England; Huddinge Univ Hosp, Dept Hematol, S-14186 Huddinge, Sweden; Osped San Martino Genova, Dept Hematol, Genoa, Italy; Royal Marsden Hosp, Leukaemia Myeloma Units, Surrey, England; Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Donauspital, L Boltzmann Inst, Dept Internal Med 2, Vienna, Austria; Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munich, Germany	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University College London Hospitals NHS Foundation Trust; University of London; University College London; Karolinska Institutet; University of Genoa; IRCCS AOU San Martino IST; Royal Marsden NHS Foundation Trust; Newcastle University - UK; Donauspital; University of Munich	Apperley, JF (corresponding author), Hammersmith Hosp, Imperial Coll Sci & Med, Dept Haematol, Du Cane Rd, London W12 0NN, England.	j.apperley@ic.ac.uk	Szydlo, Richard/C-6678-2012; Ljungman, Per/M-4946-2019	Szydlo, Richard/0000-0003-1102-8298; 				APPERLEY JF, 1995, BLOOD REV, V9, P93, DOI 10.1016/S0268-960X(95)90030-6; ATKINSON HG, 1994, LANCET, V344, P199, DOI 10.1016/S0140-6736(94)92804-5; Blondel B., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P770; BorgnaPignatti C, 1996, BONE MARROW TRANSPL, V18, P235; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P519; CHATTERJEE R, 1994, BONE MARROW TRANSPL, V13, P511; Deeg HJ, 1998, BLOOD, V91, P3637; *DEP HLTH, 1997, B DEP HLTH, V28; Draper GJ, 1997, BRIT MED J, V315, P1181, DOI 10.1136/bmj.315.7117.1181; *EUROCAT, 1997, 7 EUROCAT; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; GARDNER MJ, 1992, BRIT MED J, V305, P715, DOI 10.1136/bmj.305.6855.715; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; Gulati SC, 1998, J CLIN ONCOL, V16, P1978, DOI 10.1200/JCO.1998.16.5.1978; Jackson GH, 1997, LEUKEMIA LYMPHOMA, V28, P127, DOI 10.3109/10428199709058338; LEE S, 1995, J ASSIST REPROD GEN, V12, P294, DOI 10.1007/BF02212935; Letendre L, 1997, MED PEDIATR ONCOL, V28, P147; Lipton JH, 1997, J CLIN ONCOL, V15, P3347, DOI 10.1200/JCO.1997.15.11.3347; NEEL JV, 1990, AM J HUM GENET, V46, P1053; *NORD MED COMM, 1993, BRITHS INF MORT NORD; *OFF NAT STAT, 1998, SER MB3, V12; *OFF NAT STAT, 1997, SER FMI, V24; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; RIO B, 1994, BONE MARROW TRANSPL, V13, P487; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; Singhal S, 1996, BONE MARROW TRANSPL, V18, P1049; TANBO T, 1995, OBSTET GYNECOL, V86, P188, DOI 10.1016/0029-7844(95)00159-O	28	237	247	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					271	276		10.1016/S0140-6736(01)05482-4	http://dx.doi.org/10.1016/S0140-6736(01)05482-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498213				2022-12-24	WOS:000170114400010
J	Faergemann, J				Faergemann, J			Treatment of seborrhoeic dermatitis with oral terbinafine?	LANCET			English	Editorial Material							PITYROSPORUM-OVALE; MALASSEZIA-FURFUR		Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Faergemann, J (corresponding author), Sahlgrens Univ Hosp, Dept Dermatol, S-41345 Gothenburg, Sweden.							Bergbrant I M, 1991, Acta Derm Venereol Suppl (Stockh), V167, P1; Camera E, 1999, BRIT J DERMATOL, V140, P640, DOI 10.1046/j.1365-2133.1999.02762.x; Faergemann J, 1996, BRIT J DERMATOL, V134, P12, DOI 10.1111/j.1365-2133.1996.tb15652.x; FAERGEMANN J, 1986, BRIT J DERMATOL, V114, P695, DOI 10.1111/j.1365-2133.1986.tb04878.x; Faergemann J, 2000, Am J Clin Dermatol, V1, P75, DOI 10.2165/00128071-200001020-00001; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Faergemann J, 1999, ALLERGY, V54, P413, DOI 10.1034/j.1398-9995.1999.00089.x; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; KESEVAN S, 1997, J INVEST DERMATOL, V108, pA389; Leeming JP, 1997, BRIT J DERMATOL, V137, P764, DOI 10.1111/j.1365-2133.1997.tb01115.x; Neuber K, 1996, ARCH DERMATOL RES, V288, P532, DOI 10.1007/s004030050098; Rosen T, 1997, INT J DERMATOL, V36, P788, DOI 10.1046/j.1365-4362.1997.00309.x; Scaparro E, 2001, BRIT J DERMATOL, V144, P854, DOI 10.1046/j.1365-2133.2001.04144.x; SHUSTER S, 1984, BRIT J DERMATOL, V111, P235, DOI 10.1111/j.1365-2133.1984.tb04050.x; VILLARS V, 1989, CLIN EXP DERMATOL, V14, P124, DOI 10.1111/j.1365-2230.1989.tb00908.x	15	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					170	170		10.1016/S0140-6736(01)05401-0	http://dx.doi.org/10.1016/S0140-6736(01)05401-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476831				2022-12-24	WOS:000169967100006
J	Davis, GL; Rodrigue, JR				Davis, GL; Rodrigue, JR			Treatment of chronic hepatitis C in active drug users	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS-INFECTION; UNITED-STATES; INTERFERON; RISK; PREVALENCE; MORTALITY; RIBAVIRIN; THERAPY; ALCOHOL; DISEASE		Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Coll Hlth Profess, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Davis, GL (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32610 USA.							Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; [Anonymous], 1999, J Hepatol, V30, P956; BELL J, 1990, MED J AUSTRALIA, V153, P274, DOI 10.5694/j.1326-5377.1990.tb136900.x; Brown K, 1998, AUST NZ J PUBL HEAL, V22, P384, DOI 10.1111/j.1467-842X.1998.tb01396.x; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; Davis GL, 1998, HEPATOLOGY, V28, p390A; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Fontana RJ, 2000, DIGEST DIS, V18, P107, DOI 10.1159/000051384; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GONZALEZPERALTA RP, 1994, J HEPATOL, V21, P255, DOI 10.1016/S0168-8278(05)80405-2; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Ho SB, 2001, AM J GASTROENTEROL, V96, P157; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; JOE GW, 1982, AM J PUBLIC HEALTH, V72, P703, DOI 10.2105/AJPH.72.7.703; Johnson ME, 1998, AM J GASTROENTEROL, V93, P785; LAI ME, 1994, LANCET, V343, P388, DOI 10.1016/S0140-6736(94)91224-6; Leal P, 1999, J MED SCREEN, V6, P124, DOI 10.1136/jms.6.3.124; Manns MP, 2000, HEPATOLOGY, V32, p297A; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; MEYER RA, 1991, AM J GASTROENTEROL, V86, P1224; Muir AJ, 1999, HEPATOLOGY, V30, p190A; *NIH CONS DEV C, 1997, HEPATOLOGY S, V1, pS2; Ohnishi K, 1996, AM J GASTROENTEROL, V91, P1374; Ono K, 1996, ALCOHOL CLIN EXP RES, V20, P1560, DOI 10.1111/j.1530-0277.1996.tb01699.x; Rosenthal RN, 1999, ADDICTIONS COMPREHEN, P439; Schiff Eugene R., 1999, American Journal of Medicine, V107, p95S; Sherman M, 1997, CAN J GASTROENTEROL, V11, P407, DOI 10.1155/1997/454278; Stein MD, 2001, DRUG ALCOHOL DEPEN, V61, P211, DOI 10.1016/S0376-8716(00)00144-7; Stephenson J, 2001, JAMA-J AM MED ASSOC, V285, P1003, DOI 10.1001/jama.285.8.1003; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	36	95	96	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					215	217		10.1056/NEJM200107193450312	http://dx.doi.org/10.1056/NEJM200107193450312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	453JM	11463020				2022-12-24	WOS:000169912800012
J	Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H				Bayer, KU; De Koninck, P; Leonard, AS; Hell, JW; Schulman, H			Interaction with the NMDA receptor locks CaMKII in an active conformation	NATURE			English	Article							PROTEIN-KINASE-II; NR2B SUBUNIT; CALMODULIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; TRANSLOCATION; NEUROSCIENCE; SYNAPSES; ISOFORM; DENSITY	Calcium- and calmodulin-dependent protein kinase II (CaMKII) and glutamate receptors are integrally involved in forms of synaptic plasticity that may underlie learning and memory. In the simplest model for long-term potentiation(1), CaMKII is activated by Ca2+ influx through NMDA (N-methyl-D-aspartate) receptors and then potentiates synaptic efficacy by inducing synaptic insertion(2,3) and increased single-channel conductance(4) of AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors. Here we show that regulated CaMKII interaction with two sites on the NMDA receptor subunit NR2B provides a mechanism for the glutamate-induced translocation of the kinase to the synapse in hippocampal neurons. This interaction can lead to additional forms of potentiation by: facilitated CaMKII response to synaptoc Ca2+; suppression of inhibitory autophosphorylation of CaMKII; and, most notably, direct generation of sustained Ca2+/calmodulin (CaM)-independent (autonomous) kinase activity by a mechanism that is independent of the phosphorylation state. Furthermore, the interaction leads to trapping of CaM that may reduce down-regulation of NMDA receptor activity(5). CaMKII-NR2B interaction may be prototypical for direct activation of a kinase by its targeting protein.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison	Bayer, KU (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	ulli.bayer@stanford.edu; schulman@cmgm.stanford.edu	Hell, Johannes W./P-5085-2019					Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 1996, MOL CELL BIOL, V16, P29; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Gardoni F, 1998, J NEUROCHEM, V71, P1733; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Schulman H, 1999, CALCIUM AS A CELLULAR REGULATOR, P311; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	30	511	543	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					801	805		10.1038/35081080	http://dx.doi.org/10.1038/35081080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459059				2022-12-24	WOS:000169246400050
J	KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK				KARLSSON, KR; CLAYTON, RN; GIBSON, EK; MAYEDA, TK			WATER IN SNC METEORITES - EVIDENCE FOR A MARTIAN HYDROSPHERE	SCIENCE			English	Article							ANTARCTIC SHERGOTTITE; NOBLE-GASES; MARS; EETA-79001; AMPHIBOLE; OXYGEN	The Shergotty-Nakhla-Chassigny (SNC) meteorites, purportedly of martian origin, contain 0.04 to 0.4 percent water by weight. Oxygen isotopic analysis can bc used to determine whether this water is extraterrestrial or terrestrial. Such analysis reveals that a portion of the water is extraterrestrial and furthermore was not in oxygen isotopic equilibrium with the host rock. Lack of equilibrium between water and host rock implies that the lithosphere and hydrosphere of the SNC parent body formed two distinct oxygen isotopic reservoirs. If Mars was the parent body, the maintenance of two distinct reservoirs may result from the absence of plate tectonics on the planet.	NASA,LYNDON B JOHNSON SPACE CTR,PLANETARY SCI BRANCH,HOUSTON,TX 77058; UNIV CHICAGO,DEPT GEOPHYS SCI,CHICAGO,IL 60637; UNIV CHICAGO,ENRICO FERMI INST,DEPT CHEM,CHICAGO,IL 60637	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Chicago; University of Chicago								ASHWORTH JR, 1975, NATURE, V256, P714, DOI 10.1038/256714a0; BECKER RH, 1984, EARTH PLANET SC LETT, V69, P225, DOI 10.1016/0012-821X(84)90183-3; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; CARR MH, 1987, NATURE, V326, P30, DOI 10.1038/326030a0; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; FALLICK AE, 1983, LUNAR PLANET SCI, V14, P183; FIREMAN EL, 1982, EARTH PLANET SC LETT, V60, P339, DOI 10.1016/0012-821X(82)90072-3; FLORAN RJ, 1978, GEOCHIM COSMOCHIM AC, V42, P1213, DOI 10.1016/0016-7037(78)90115-1; GOODING JL, 1990, METEORITICS, V25, P281, DOI 10.1111/j.1945-5100.1990.tb00712.x; GOODING JL, 1991, GEOCHIM COSMOCHIM AC, V26, P135; HARVEY HP, 1991, METEORITICS, V26, P343; JAKOSKY BM, 1991, ICARUS, V94, P14, DOI 10.1016/0019-1035(91)90138-J; JULL AJT, 1988, GEOCHIM COSMOCHIM AC, V52, P1309, DOI 10.1016/0016-7037(88)90285-2; KERRIDGE JF, 1988, LUNAR PLANET SCI, V19, P599; MUEHLENBACHS K, 1976, J GEOPHYS RES, V81, P4365, DOI 10.1029/JB081i023p04365; NORMAN DI, 1982, NATURE, V296, P551, DOI 10.1038/296551a0; ONEIL JR, 1966, J GEOPHYS RES, V71, P4956; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; SARAFIN R, 1985, EARTH PLANET SC LETT, V75, P72, DOI 10.1016/0012-821X(85)90051-2; SCHUELER B, 1990, GEOPHYS RES LETT, V17, P1295, DOI 10.1029/GL017i009p01295; Smykatz-Kloss W., 1974, DIFFERENTIAL THERMAL, DOI DOI 10.1007/978-3-642-65951-5; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; TREIMAN AH, 1985, METEORITICS, V20, P229, DOI 10.1111/j.1945-5100.1985.tb00862.x; TREIMAN AH, 1991, METEORITICS, V26, P402; WATSON LL, 1991, LUNAR PLANET SCI, V22, P1473; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359; YANG J, 1985, LUNAR PLANET SCI, V16, P25	29	150	151	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 13	1992	255	5050					1409	1411		10.1126/science.11537889	http://dx.doi.org/10.1126/science.11537889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH744	11537889				2022-12-24	WOS:A1992HH74400046
J	MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D				MELOSH, HJ; SCHNEIDER, NM; ZAHNLE, KJ; LATHAM, D			IGNITION OF GLOBAL WILDFIRES AT THE CRETACEOUS TERTIARY BOUNDARY	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; US FOREST SERV,INTERMT FIRE SCI LAB,MISSOULA,MT 59807	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Agriculture (USDA); United States Forest Service	MELOSH, HJ (corresponding author), UNIV ARIZONA,LUNAR & PLANETARY LAB,TUCSON,AZ 85721, USA.		Baykaykom, supit/B-5173-2009					ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVAREZ W, 1986, EOS, V67, P653; ARGYLE E, 1986, SCIENCE, V234, P261, DOI 10.1126/science.234.4774.261-d; ARGYLE E, 1989, ICARUS, V77, P220, DOI 10.1016/0019-1035(89)90018-3; Bate R.R., 1971, FUNDAMENTALS ASTRODY; BOHOR BF, 1987, GEOLOGY, V15, P896, DOI 10.1130/0091-7613(1987)15<896:DSATML>2.0.CO;2; BOHOR BF, 1987, SCIENCE, V236, P705, DOI 10.1126/science.236.4802.705; BROWNLEE DE, 1985, ANNU REV EARTH PL SC, V13, P147, DOI 10.1146/annurev.ea.13.050185.001051; Chamberlain J. W., 1987, THEORY PLANETARY ATM, p[1, 89]; EMILIANI C, 1981, EARTH PLANET SC LETT, V55, P317, DOI 10.1016/0012-821X(81)90161-8; GLASSTONE S, 1977, EFFECTS NUCLEAR WEAP; HILDEBRAND AR, 1989, LUNAR PLANET SCI, V20, P414; HOLTON JR, 1979, INTRO DYNAMIC METEOR, P1; JONES EM, 1982, GEOL SOC AM SPEC PAP, V190, P175; KYTE FT, 1985, EARTH PLANET SC LETT, V73, P183, DOI 10.1016/0012-821X(85)90067-6; LAROCCA AJ, 1978, INFRARED HDB; Martin S., 1965, 10 S INT COMB, P877, DOI 10.1016/S0082-0784(65)80232-6; Melosh H.J, 1989, IMPACT CRATERING GEO, P1; Melosh H. J., 1982, GEOL SOC AM SPEC PAP, V190, P121; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; MONTANARI A, 1983, GEOLOGY, V11, P668, DOI 10.1130/0091-7613(1983)11<668:SATCBA>2.0.CO;2; OKEEFE JD, 1988, GLOBAL CATASTROPHES, P133; SIMMS DL, 1967, COMBUST FLAME, V11, P377, DOI 10.1016/0010-2180(67)90058-2; SIMMS DL, 1963, COMBUST FLAME, V7, P253; SMIT J, 1981, NATURE, V292, P47, DOI 10.1038/292047a0; VICKERY AM, IN PRESS GEOL SOC AM; WHIPPLE FL, 1950, P NATL ACAD SCI USA, V36, P687, DOI 10.1073/pnas.36.12.687; WOLBACH WS, 1985, SCIENCE, V230, P167, DOI 10.1126/science.230.4722.167; WOLBACH WS, 1988, NATURE, V334, P665, DOI 10.1038/334665a0; ZAHNLE KJ, IN PRESS GEOL SOC AM; [No title captured], DOI DOI 10.1130/SPE190-P103	31	139	143	1	20	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 18	1990	343	6255					251	254		10.1038/343251a0	http://dx.doi.org/10.1038/343251a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	11536461				2022-12-24	WOS:A1990CJ68200067
J	McMahon, SM; Miller, KH; Drake, J				McMahon, SM; Miller, KH; Drake, J			Social science and ecology - Networking tips for social scientists and ecologists	SCIENCE			English	Editorial Material									Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA; E Carolina Univ, Coastal Resources Management Program, Greenville, NC 27858 USA; E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	McMahon, SM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Complex Syst Grp, Knoxville, TN 37996 USA.							JOHNSON JC, 2001, J SOC STRUCT, V2; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; WASSERMAN S, 1994, ADV SOCIAL NETWORK A; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449; NETWORK ANAL MARKS W; NETWORKING INVISIBLE	6	19	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1604	1605		10.1126/science.1062026	http://dx.doi.org/10.1126/science.1062026			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533467				2022-12-24	WOS:000170802900037
J	Pledger, G; Stringer, MD				Pledger, G; Stringer, MD			Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study	BRITISH MEDICAL JOURNAL			English	Article									Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England; Leeds Teaching Hosp NHS Trust, Dept Paediat Surg, Leeds LS9 7TF, W Yorkshire, England	University of Leeds	Pledger, G (corresponding author), Oaktree Cottage Mitford, Morpeth NE61 3PN, Northd, England.							Barker DJP, 1998, MOTHERS BABIES HLTH; *DEP HLTH, 1963, HOSP IN PAT ENQ HOSP; PLEDGER HG, 1969, BMJ-BRIT MED J, V4, P466, DOI 10.1136/bmj.4.5681.466; PLEDGER HG, 1987, BMJ-BRIT MED J, V295, P1233, DOI 10.1136/bmj.295.6608.1233; WILLIAMS N, 1991, ARCH DIS CHILD, V66, P1270, DOI 10.1136/adc.66.11.1270	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2001	323	7310					430	431		10.1136/bmj.323.7310.430	http://dx.doi.org/10.1136/bmj.323.7310.430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520842	Green Published, Bronze			2022-12-24	WOS:000170793600023
J	Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS				Takamoto, DY; Aydil, E; Zasadzinski, JA; Ivanova, AT; Schwartz, DK; Yang, TL; Cremer, PS			Stable ordering in Langmuir-Blodgett films	SCIENCE			English	Article							X-RAY-DIFFRACTION; STEARIC-ACID; WATER; REFLECTIVITY; MONOLAYERS; GENERATION; MOLECULES; SURFACE; SALTS	Defects in the layering of Langmuir-Blodgett (LB) films can be eliminated by depositing from the appropriate monolayer phase at the air-water interface. LB films deposited from the hexagonal phase of cadmium arachidate (CdA(2)) at pH 7 spontaneously transform into the bulk soap structure, a centrosymmetric bilayer with an orthorhombic herringbone packing. A large wavelength folding mechanism accelerates the conversion between the two structures, leading to a disruption of the desired layering. At pH > 8.5, though it is more difficult to draw LB films, almost perfect layering is obtained due to the inability to convert from the as-deposited structure to the equilibrium one.	Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA; Tulane Univ, Dept Chem, New Orleans, LA 70118 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	University of California System; University of California Santa Barbara; Tulane University; Texas A&M University System; Texas A&M University College Station	Zasadzinski, JA (corresponding author), Univ Calif Santa Barbara, Dept Chem & Mat Engn, Santa Barbara, CA 93106 USA.		Aydil, Eray/M-5503-2019; Schwartz, Daniel K/H-5153-2012; Yang, Tinglu/N-3569-2013	Schwartz, Daniel K/0000-0001-5397-7200; Yang, Tinglu/0000-0003-0872-8218; Aydil, Eray/0000-0002-8377-9480	NHLBI NIH HHS [HL51177] Funding Source: Medline; NIGMS NIH HHS [GM47334] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashwell GJ, 1999, J MATER CHEM, V9, P1991, DOI 10.1039/a902604e; Corkery RW, 1997, LANGMUIR, V13, P3591, DOI 10.1021/la9701743; Ganguly P, 1997, LANGMUIR, V13, P6582, DOI 10.1021/la970626b; GARNAES J, 1992, NATURE, V357, P54, DOI 10.1038/357054a0; Gragson DE, 1998, J PHYS CHEM B, V102, P3847, DOI 10.1021/jp9806011; Harkins WD, 1938, J CHEM PHYS, V6, P298, DOI 10.1063/1.1750252; Kaganer VM, 1999, REV MOD PHYS, V71, P779, DOI 10.1103/RevModPhys.71.779; Kitaigorodskii A. I., 1962, ORGANIC CHEM CRYSTAL; Kuzmenko I, 1998, LANGMUIR, V14, P3882, DOI 10.1021/la970819z; LEVEILLER F, 1994, LANGMUIR, V10, P819, DOI 10.1021/la00015a037; LEVEILLER F, 1991, SCIENCE, V252, P1532, DOI 10.1126/science.252.5012.1532; Miranda PB, 1998, CHEM PHYS LETT, V286, P1, DOI 10.1016/S0009-2614(97)01476-0; PENNER TL, 1994, NATURE, V367, P49, DOI 10.1038/367049a0; ROBERTS GG, 1990, LANGMUIRBLODGETT FIL; Schwartz D. K., 1997, Surface Science Reports, V27, P241, DOI 10.1016/S0167-5729(97)00003-4; SCHWARTZ DK, 1992, J PHYS CHEM-US, V96, P10444, DOI 10.1021/j100204a059; SCHWARTZ DK, 1993, J AM CHEM SOC, V115, P7374, DOI 10.1021/ja00069a040; SCHWARTZ DK, 1993, PHYS REV E, V47, P452, DOI 10.1103/PhysRevE.47.452; SCHWARTZ DK, 1992, SCIENCE, V257, P508, DOI 10.1126/science.257.5069.508; SHEN YR, 1989, ANNU REV PHYS CHEM, V40, P327, DOI 10.1146/annurev.pc.40.100189.001551; TIPPMANNKRAYER P, 1992, THIN SOLID FILMS, V210, P577, DOI 10.1016/0040-6090(92)90346-D; WIESLER DG, 1995, THIN SOLID FILMS, V266, P69, DOI 10.1016/0040-6090(95)06603-9; YAZDANIAN M, 1992, LANGMUIR, V8, P630, DOI 10.1021/la00038a055; ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836	24	95	98	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2001	293	5533					1292	1295		10.1126/science.1060018	http://dx.doi.org/10.1126/science.1060018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509723				2022-12-24	WOS:000170492600032
J	Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS				Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS			Dysfunction of endothelial protein C activation in severe meningococcal sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; ADHESION MOLECULE EXPRESSION; COLI SEPTIC SHOCK; PURPURA FULMINANS; TISSUE FACTOR; NEISSERIA-MENINGITIDIS; PATHWAY INHIBITOR; ANTITHROMBIN-III; LIPOOLIGOSACCHARIDE STRUCTURE; SOLUBLE THROMBOMODULIN	Background: Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression of thrombomodulin and the endothelial protein C receptor in the dermal microvasculature of children with severe meningococcemia and purpuric or petechial lesions. Methods: We assessed the integrity of the endothelium and the expression of thrombomodulin and the endothelial protein C receptor in biopsy specimens of purpuric lesions from 21 children with meningococcal sepsis (median age, 41 months), as compared with control skin-biopsy specimens. Results: The expression of endothelial thrombomodulin and of the endothelial protein C receptor was lower in the patients with meningococcal sepsis than in the controls, both in vessels with thrombosis and in vessels without thrombosis. On electron microscopical examination, the endothelial cells were generally intact in both thrombosed and nonthrombosed vessels. Plasma thrombomodulin levels in the children with meningococcal sepsis (median, 6.4 ng per liter) were higher than those in the controls (median, 3.6 ng per liter; P=0.002). Plasma levels of protein C antigen, protein S antigen, and antithrombin antigen were lower than those in the controls. In two patients treated with unactivated protein C concentrate, activated protein C was undetectable at the time of admission, and plasma levels remained low. Conclusions: In severe meningococcal sepsis, protein C activation is impaired, a finding consistent with down-regulation of the endothelial thrombomodulin-endothelial protein C receptor pathway. (N Engl J Med 2001;345:408-16.) Copyright (C) 2001 Massachusetts Medical Society.	St Marys Hosp, Imperial Coll Sch med, Dept Paediat, London W2 1PG, England; St Marys Hosp, Imperial Coll Sch med, Dept Pathol, London W2 1PG, England; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK USA; Howard Hughes Med Inst, Oklahoma City, OK USA; Univ Bristol, Dept Pathol, Bristol, Avon, England; Univ Bristol, Dept Microbiol, Bristol, Avon, England	Imperial College London; Imperial College London; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute; University of Bristol; University of Bristol	Levin, M (corresponding author), St Marys Hosp, Imperial Coll Sch med, Dept Paediat, Norfolk Pl, London W2 1PG, England.		Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642; Levin, Michael/0000-0003-2767-6919; Goldin, Robert/0000-0001-5184-4519; Harrison, Odile/0000-0002-1623-0295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054804] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL54804] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Achtman M, 1995, MENINGOCOCCAL DIS, P159; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BRANDTZAEG P, 1990, THROMB RES, V57, P271, DOI 10.1016/0049-3848(90)90326-8; BRANDTZAEG P, 1989, THROMB RES, V55, P459, DOI 10.1016/0049-3848(89)90054-6; BRANDTZAEG P, 1995, MENINGOCOCCAL DIS, P71; CATTORETTI G, 1993, J PATHOL, V171, P83, DOI 10.1002/path.1711710205; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 1998, DRUGS, V55, P767, DOI 10.2165/00003495-199855060-00004; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; DEUTZTERLOUW PP, 1990, CLIN CHIM ACTA, V186, P321, DOI 10.1016/0009-8981(90)90318-M; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; DREYFUS M, 1991, NEW ENGL J MED, V325, P1565, DOI 10.1056/NEJM199111283252207; Duncan A, 1997, LANCET, V350, P1565, DOI 10.1016/S0140-6736(05)64007-X; EDGAR P, 1989, J CLIN PATHOL, V42, P985, DOI 10.1136/jcp.42.9.985; ELEY B, 2000, TXB PEDIAT DERMATOLO, V2, P1574; Esmon CT, 1999, THROMB HAEMOSTASIS, V82, P251; Esmon CT, 1997, THROMB HAEMOSTASIS, V78, P70; Faust SN, 2000, BEST PRACT RES CL HA, V13, P179, DOI 10.1053/beha.2000.0067; FOURRIER F, 1990, INTENS CARE MED, V16, P121, DOI 10.1007/BF01699858; FOURRIER F, 1993, CHEST, V104, P882, DOI 10.1378/chest.104.3.882; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Furuno T, 1997, INT ARCH ALLERGY IMM, V112, P262, DOI 10.1159/000237464; GRUBER A, 1992, BLOOD, V79, P2340; HARRIS OB, 2000, 12 INT PATH NEISS C, P18; Hazelzet JA, 1996, THROMB HAEMOSTASIS, V76, P932; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; HESSELVIK JF, 1991, THROMB HAEMOSTASIS, V65, P126; Heyderman RS, 1997, MICROB PATHOGENESIS, V22, P265, DOI 10.1006/mpat.1996.0112; HEYDERMAN RS, 1992, THROMB RES, V67, P677, DOI 10.1016/0049-3848(92)90071-H; HEYDERMAN RS, 2000, TXB PEDIAT DERMATOLO, V1, P384; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; IBA T, 1995, SURG TODAY, V25, P585, DOI 10.1007/BF00311430; Ikegami K, 1998, J TRAUMA, V44, P789, DOI 10.1097/00005373-199805000-00008; KLEIN NJ, 1992, J CELL SCI, V102, P821; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Krafte-Jacobs B, 1998, CRIT CARE MED, V26, P933, DOI 10.1097/00003246-199805000-00032; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Laszik Z, 1997, CIRCULATION, V96, P3633; Levi M, 1999, THROMB HAEMOSTASIS, V82, P695; LEVIN M, 1995, J PEDIATR-US, V127, P355, DOI 10.1016/S0022-3476(95)70063-3; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; NADEL S, 1995, MENINGOCOCCAL DIS, P207; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; PARAMO JA, 1990, THROMB HAEMOSTASIS, V64, P3; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; POWARS D, 1993, CLIN INFECT DIS, V17, P254, DOI 10.1093/clinids/17.2.254; Rintala E, 1998, CRIT CARE MED, V26, P965, DOI 10.1097/00003246-199805000-00038; Sadler JE, 1997, THROMB HAEMOSTASIS, V78, P392; SHETH SB, 1991, AM J HEMATOL, V36, P14, DOI 10.1002/ajh.2830360104; Shimura M, 1996, AM J HEMATOL, V52, P165; Smith OP, 1997, LANCET, V350, P1590, DOI 10.1016/S0140-6736(97)06356-3; SORIA J, 1985, THROMB HAEMOSTASIS, V53, P293; SOTTO MN, 1976, J INFECT DIS, V133, P506, DOI 10.1093/infdis/133.5.506; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; VANDEUREN M, 1993, BMJ-BRIT MED J, V306, P1229, DOI 10.1136/bmj.306.6887.1229; White B, 2000, BLOOD, V96, P3719, DOI 10.1182/blood.V96.12.3719.h8003719_3719_3724; ZENZ W, 1995, PEDIATRICS, V96, P44	66	480	508	0	14	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2001	345	6					408	416		10.1056/NEJM200108093450603	http://dx.doi.org/10.1056/NEJM200108093450603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	460EJ	11496851				2022-12-24	WOS:000170295000003
J	Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J				Harvey, R; Lane, A; Murray, L; Harvey, I; Nair, P; Donovan, J			Effect of Helicobacter pylori infection on blood pressure: a community based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ASSOCIATION		N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	North Bristol NHS Trust; University of Bristol	Harvey, R (corresponding author), N Bristol NHS Trust, Frenchay Hosp, Bristol BS16 1LE, Avon, England.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARNES RJ, 1991, BRIT J GEN PRACT, V41, P286; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Lip GYH, 1996, BRIT MED J, V312, P250; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568	5	19	20	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					264	265		10.1136/bmj.323.7307.264	http://dx.doi.org/10.1136/bmj.323.7307.264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485956	Bronze, Green Published			2022-12-24	WOS:000170394300020
J	Catling, DC; Zahnle, KJ; McKay, CP				Catling, DC; Zahnle, KJ; McKay, CP			Biogenic methane, hydrogen escape, and the irreversible oxidation of early Earth	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; REDOX STATES; EVOLUTION; DOLOMITE; MANTLE; GA; PHOTOSYNTHESIS; GREENHOUSE; PALEOSOLS; ISOTOPES	The low O-2 content of the Archean atmosphere implies that methane should have been present at levels similar to 10(2) to 10(3) parts per million volume (ppmv) (compared with 1.7 ppmv today) given a plausible biogenic source. CH4 is favored as the greenhouse gas that countered the lower luminosity of the early Sun. But abundant CH4 implies that hydrogen escapes to space (up arrow space) orders of magnitude faster than today. Such reductant loss oxidizes the Earth. Photosynthesis splits water into O-2 and H, and methanogenesis transfers the H into CH4. Hydrogen escape after CH4 photolysis, therefore, causes a net gain of oxygen [CO2 + 2H(2)O CH4 --> 2O(2) --> CO2 + O-2 + 4H(up arrow space)]. Expected irreversible oxidation (similar to 10(12) to 10(13) moles oxygen per year) may help explain how Earth's surface environment became irreversibly oxidized.	NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; SETI Inst, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Catling, DC (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Mail Stop 245-3, Moffett Field, CA 94035 USA.	catling@humbabe.arc.nasa.gov	Catling, David C/D-2082-2009	Catling, David/0000-0001-5646-120X				Anbar AD, 2001, J GEOPHYS RES-PLANET, V106, P3219, DOI 10.1029/2000JE001272; BAHCALL JN, 1988, REV MOD PHYS, V60, P297, DOI 10.1103/RevModPhys.60.297; Bau M, 1999, EARTH PLANET SC LETT, V174, P43, DOI 10.1016/S0012-821X(99)00261-7; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2000, SCIENCE, V287, P1630, DOI 10.1126/science.287.5458.1630; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUDYKO ML, 1985, HIST EARTHS ATMOSPHE; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; Canil D, 1999, GEOCHIM COSMOCHIM AC, V63, P557, DOI 10.1016/S0016-7037(98)00287-7; CHAMBERLAIN JW, 1987, THEORY PLANETARY ATM, P34; DELANO JW, IN PRESS ORIGIN LIFE; Des Marais DJ, 2000, SCIENCE, V289, P1703; DIX GR, 1995, PRECAMBRIAN RES, V70, P253, DOI 10.1016/0301-9268(94)00044-R; EUGSTER HP, 1972, P INT GEOL C, V24, P3; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Francois LM, 1986, PALEOCEANOGRAPHY, V1, P355, DOI 10.1029/PA001i004p00355; FYFE WS, 1978, FLUIDS EARTHS CRUST, pCH7; Green MG, 2000, TECTONOPHYSICS, V322, P69, DOI 10.1016/S0040-1951(00)00058-5; Hayes J.M., 1994, EARLY LIFE EARTH, V84, P220; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Holland HD., 1999, GEOCHEM NEWS, V100, P20; HUNTEN DM, 1973, J ATMOS SCI, V30, P1481, DOI 10.1175/1520-0469(1973)030<1481:TEOLGF>2.0.CO;2; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; Kump LR, 2001, GEOCHEM GEOPHY GEOSY, V2; Lecuyer C, 1999, EARTH PLANET SC LETT, V165, P197, DOI 10.1016/S0012-821X(98)00267-2; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Melezhik VA, 1999, EARTH-SCI REV, V48, P71, DOI 10.1016/S0012-8252(99)00044-6; MELNIK YP, 1982, PRECAMBRIAN BANDED I, P68; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; PAVLOV AA, IN PRESS J GEOPHYS R; Prasad N, 1996, CATENA, V27, P105, DOI 10.1016/0341-8162(96)00003-3; Rye R, 2000, GEOLOGY, V28, P483, DOI 10.1130/0091-7613(2000)28<483:LAWAGE>2.0.CO;2; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; SCHIDLOWSKI M, 1987, ANNU REV EARTH PL SC, V15, P47, DOI 10.1146/annurev.ea.15.050187.000403; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Sleep NH, 2001, J GEOPHYS RES-PLANET, V106, P1373, DOI 10.1029/2000JE001247; Taylor H.P., 1977, J GEOL SOC LONDON, V133, P509, DOI [10.1144/gsjgs.133.6.0509, DOI 10.1144/GSJGS.133.6.0509]; VISCONTI G, 1975, J ATMOS SCI, V32, P1631, DOI 10.1175/1520-0469(1975)032<1631:TETOAP>2.0.CO;2; WALTER FM, 1991, SUN TIME, P633; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	46	309	331	9	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					839	843		10.1126/science.1061976	http://dx.doi.org/10.1126/science.1061976			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486082				2022-12-24	WOS:000170241000038
J	Lange, RA; Hillis, LD				Lange, RA; Hillis, LD			Medical progress - Cardiovascular complications of cocaine use	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDUCED CORONARY VASOCONSTRICTION; MYOCARDIAL-INFARCTION; CHEST-PAIN; ARTERY-DISEASE; COCAETHYLENE DEGRADATION; PROCAINAMIDE INHIBITION; INTRANASAL COCAINE; AORTIC DISSECTION; CLINICAL SAFETY; HUMAN PLATELETS		Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Room CS7-102,5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Lange, Richard/AAM-9594-2021					AMIN M, 1990, AM J CARDIOL, V66, P1434, DOI 10.1016/0002-9149(90)90529-A; Bailey DN, 1999, THER DRUG MONIT, V21, P301, DOI 10.1097/00007691-199906000-00008; Bailey DN, 1999, J ANAL TOXICOL, V23, P99, DOI 10.1093/jat/23.2.99; Bailey DN, 1999, J ANAL TOXICOL, V23, P173, DOI 10.1093/jat/23.3.173; Baumann BM, 2000, ACAD EMERG MED, V7, P878, DOI 10.1111/j.1553-2712.2000.tb02065.x; Baumgartner FJ, 1997, ANN THORAC SURG, V64, P1518, DOI 10.1016/S0003-4975(97)00988-0; BERTOLET BD, 1990, CLIN CARDIOL, V13, P323, DOI 10.1002/clc.4960130505; Besse S, 1997, EUR J PHARMACOL, V338, P123, DOI 10.1016/S0014-2999(97)81939-5; BILLMAN GE, 1993, J CARDIOVASC PHARM, V22, P869, DOI 10.1097/00005344-199312000-00015; BOEHRER JD, 1993, AM J MED, V94, P608, DOI 10.1016/0002-9343(93)90212-8; BRICKNER ME, 1991, CIRCULATION, V84, P1130, DOI 10.1161/01.CIR.84.3.1130; BRODY SL, 1990, AM J MED, V88, P325, DOI 10.1016/0002-9343(90)90484-U; BROGAN WC, 1992, ANN INTERN MED, V116, P556, DOI 10.7326/0003-4819-116-7-556; BROGAN WC, 1991, J AM COLL CARDIOL, V18, P581, DOI 10.1016/0735-1097(91)90617-I; CHAMBERS HF, 1987, ANN INTERN MED, V106, P833, DOI 10.7326/0003-4819-106-6-833; CHOKSHI SK, 1989, ANN INTERN MED, V111, P1039, DOI 10.7326/0003-4819-111-12-1039; COLEMAN DL, 1982, WESTERN J MED, V136, P444; DANIEL WC, 1995, AM J CARDIOL, V76, P398, DOI 10.1016/S0002-9149(99)80109-X; DARAS M, 1994, ACTA NEUROL SCAND, V90, P124; ESCOBEDO LG, 1991, ARCH PATHOL LAB MED, V115, P900; Fendrich M, 1999, AM J EPIDEMIOL, V149, P955; FLORES ED, 1990, J AM COLL CARDIOL, V16, P74, DOI 10.1016/0735-1097(90)90459-3; Gan XH, 1999, CLIN IMMUNOL, V91, P68, DOI 10.1006/clim.1998.4683; GITTER MJ, 1991, ANN INTERN MED, V115, P277, DOI 10.7326/0003-4819-115-4-277; GRANT BF, 1990, DRUG ALCOHOL DEPEN, V25, P97, DOI 10.1016/0376-8716(90)90147-7; HEARN WL, 1991, J NEUROCHEM, V56, P698, DOI 10.1111/j.1471-4159.1991.tb08205.x; HEARN WL, 1991, PHARM BIOCH BEHAV, P531; HENDERSON CE, 1988, AM J PERINAT, V5, P142, DOI 10.1055/s-2007-999673; Hoffman RS, 1996, AM J EMERG MED, V14, P693, DOI 10.1016/S0735-6757(96)90091-1; Hollander J E, 1994, Acad Emerg Med, V1, P330; HOLLANDER J E, 1992, Journal of Emergency Medicine, V10, P169, DOI 10.1016/0736-4679(92)90212-C; HOLLANDER JE, 1995, ARCH INTERN MED, V155, P1081, DOI 10.1001/archinte.155.10.1081; HOLLANDER JE, 1995, ANN EMERG MED, V26, P671, DOI 10.1016/S0196-0644(95)70035-8; HOLLANDER JE, 1995, CHEST, V107, P1237, DOI 10.1378/chest.107.5.1237; HOLLANDER JE, 1995, ACAD EMERG MED, V2, P179, DOI 10.1111/j.1553-2712.1995.tb03191.x; Hollander JE, 1998, AM HEART J, V135, P245, DOI 10.1016/S0002-8703(98)70089-4; Hollander JE, 1997, VET HUM TOXICOL, V39, P276; HOLLANDER JE, 1992, NEW ENGL J MED, V327, P361; Huang L, 1997, AM J PHYSIOL-HEART C, V273, pH893, DOI 10.1152/ajpheart.1997.273.2.H893; INOUE H, 1988, J AM COLL CARDIOL, V11, P867, DOI 10.1016/0735-1097(88)90224-0; ISNER JM, 1986, NEW ENGL J MED, V315, P1438, DOI 10.1056/NEJM198612043152302; JEFFCOAT AR, 1989, DRUG METAB DISPOS, V17, P153; Kanani PM, 1998, J CARDIOVASC PHARM, V32, P42, DOI 10.1097/00005344-199807000-00007; Kerns William Ii, 1997, Journal of Emergency Medicine, V15, P321, DOI 10.1016/S0736-4679(97)00003-6; Kidwell DA, 1997, FORENSIC SCI INT, V84, P75, DOI 10.1016/S0379-0738(96)02051-8; Kolodgie FD, 1999, EXP MOL PATHOL, V66, P109, DOI 10.1006/exmp.1999.2253; KOLODGIE FD, 1991, J AM COLL CARDIOL, V17, P1553, DOI 10.1016/0735-1097(91)90646-Q; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LANGE RA, 1990, ANN INTERN MED, V112, P897, DOI 10.7326/0003-4819-112-12-897; Madu EC, 1999, ANGIOLOGY, V50, P163, DOI 10.1177/000331979905000212; Mao JT, 1997, CELL IMMUNOL, V181, P38, DOI 10.1006/cimm.1997.1185; MINOR RL, 1991, ANN INTERN MED, V115, P797, DOI 10.7326/0003-4819-115-10-797; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; Mo W, 1998, AM J HYPERTENS, V11, P708, DOI 10.1016/S0895-7061(98)00041-7; MOLITERNO DJ, 1994, AM J MED, V96, P492, DOI 10.1016/0002-9343(94)90087-6; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; NEGUS BH, 1994, AM J CARDIOL, V73, P510, DOI 10.1016/0002-9149(94)90684-X; Neiman J, 2000, EUR J NEUROL, V7, P595, DOI 10.1046/j.1468-1331.2000.00045.x; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; *OFF APPL STUD, 1999, DHHS PUBL; Parker RB, 1999, J CARDIOVASC PHARM, V34, P864, DOI 10.1097/00005344-199912000-00014; Perera R, 1997, J ELECTROCARDIOL, V30, P337, DOI 10.1016/S0022-0736(97)80047-7; Perreault C L, 1991, NIDA Res Monogr, V108, P139; PERREAULT CL, 1993, CARDIOVASC RES, V27, P262, DOI 10.1093/cvr/27.2.262; Perron AD, 1997, AM J EMERG MED, V15, P507, DOI 10.1016/S0735-6757(97)90196-0; PIRWITZ MJ, 1995, ARCH INTERN MED, V155, P1186, DOI 10.1001/archinte.155.11.1186; Pitts WR, 1997, PROG CARDIOVASC DIS, V40, P65, DOI 10.1016/S0033-0620(97)80023-0; Pitts WR, 1998, CIRCULATION, V97, P1270, DOI 10.1161/01.CIR.97.13.1270; RANDALL T, 1992, JAMA-J AM MED ASSOC, V267, P1043, DOI 10.1001/jama.267.8.1043; REZKALLA SH, 1993, AM J CARDIOL, V72, P243, DOI 10.1016/0002-9149(93)90173-A; RINDER HM, 1994, CIRCULATION, V90, P1162, DOI 10.1161/01.CIR.90.3.1162; SHIH RD, 1995, ANN EMERG MED, V26, P702, DOI 10.1016/S0196-0644(95)70041-2; Sofuoglu M, 2000, PHARMACOL BIOCHEM BE, V65, P255, DOI 10.1016/S0091-3057(99)00201-4; STENBERG RG, 1989, ARCH PATHOL LAB MED, V113, P521; *SUBST AB MENT HLT, 2000, DRUG AB WARN NETW AN; TAZELAAR HD, 1987, HUM PATHOL, V18, P195, DOI 10.1016/S0046-8177(87)80338-6; VIRMANI R, 1988, AM HEART J, V115, P1068, DOI 10.1016/0002-8703(88)90078-6; Wang RY, 1999, AM J EMERG MED, V17, P364, DOI 10.1016/S0735-6757(99)90088-8; WIENER RS, 1986, AM J MED, V81, P699, DOI 10.1016/0002-9343(86)90559-0; Wilbert-Lampen U, 1998, CIRCULATION, V98, P385, DOI 10.1161/01.CIR.98.5.385; WINNIFORD MD, 1986, CIRCULATION, V73, P662, DOI 10.1161/01.CIR.73.4.662; WIT AL, 1986, HEART CARDIOVASCULAR, V2, P1449; Xiao YJ, 2000, J PHARMACOL EXP THER, V292, P8; 2000, CIRCULATION S1, V102, P86; 2000, CIRCULATION S1, V102, P223	86	472	489	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					351	358		10.1056/NEJM200108023450507	http://dx.doi.org/10.1056/NEJM200108023450507			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484693				2022-12-24	WOS:000170193600008
J	Osherovich, LZ; Weissman, JS				Osherovich, LZ; Weissman, JS			Multiple GIn/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI+] prion	CELL			English	Article							TRANSLATION TERMINATION EFFICIENCY; AMYLOID-LIKE FIBRILS; SACCHAROMYCES-CEREVISIAE; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; GLUTAMINE REPEATS; CELL-DEATH; POLYGLUTAMINE; PROPAGATION; INHERITANCE	The yeast prion [PSI+] results from self-propagating aggregates of Sup35p. De novo formation of [PSI+] requires an additional non-Mendelian trait, thought to result from a prion form of one or more unknown proteins. We find that the Gln/Asn-rich prion domains of two proteins, New1p and Rnq1p, can control susceptibility to [PSI+] induction as well as enhance aggregation of a human glutamine expansion disease protein. [PSI+] inducibility results from gain-of-function properties of New1p and Rnq1p aggregates rather than from inactivation of the normal proteins. These studies suggest a molecular basis for the epigenetic control of [PSI+] inducibility and may reveal a broader role for this phenomenon in the physiology of protein aggregation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Osherovich, LZ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	lxoshe@itsa.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FESCHENKO MS, 1992, J BIOL CHEM, V267, P4097; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Lindquist S, 1995, COLD SPRING HARB SYM, V60, P451, DOI 10.1101/SQB.1995.060.01.050; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; TUITE MF, 1981, GENETICS, V98, P691; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wickner RB, 2000, CURR BIOL, V10, pR335, DOI 10.1016/S0960-9822(00)00460-7; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	42	257	269	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2001	106	2					183	194		10.1016/S0092-8674(01)00440-8	http://dx.doi.org/10.1016/S0092-8674(01)00440-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511346	Bronze			2022-12-24	WOS:000170193100008
J	Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D				Zakany, J; Kmita, M; Alarcon, P; de la Pompa, JL; Duboule, D			Localized and transient transcription of Hox genes suggests a link between patterning and the segmentation clock	CELL			English	Article							SOMITE BOUNDARY FORMATION; LUNATIC FRINGE; DELTA-HOMOLOG; REGULATORY CONTROLS; HOMEOBOX GENE; BODY PLAN; MOUSE; EXPRESSION; COMPLEX; MURINE	During development, Hox gene transcription is activated in presomitic mesoderm with a time sequence that follows the order of the genes along the chromosome. Here, we show that Hoxd1 and other Hox genes display dynamic stripes of expression within presomitic mesoderm. The underlying transcriptional bursts may reflect the mechanism that coordinates Hox gene activation with somitogenesis. This mechanism appears to depend upon Notch signaling, as mice deficient for RBPJk, the effector of the Notch pathway, showed severely reduced Hoxd gene expression in presomitic mesoderm. These results suggest a molecular link between Hox gene activation and the segmentation clock. Such a linkage would efficiently keep in phase the production of novel segments with their morphological specification.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Hosp Duran & Reynals, Inst Recerca Oncol, Dept Mol Oncol, Barcelona, Spain; EMBL, Mouse Biol Program, Rome, Italy	University of Geneva; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; European Molecular Biology Laboratory (EMBL)	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.		De La Pompa, José Luis/F-9719-2014	De La Pompa, José Luis/0000-0001-6761-7265; duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DUBOULE D, 1994, DEVELOPMENT, P135; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; Gerard M, 1997, DEV BIOL, V190, P32, DOI 10.1006/dbio.1997.8679; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2000, GENE DEV, V14, P198; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; OKA C, 1995, DEVELOPMENT, V121, P3291; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Stern CD, 2000, CURR TOP DEV BIOL, V47, P107; STUBBS L, 1990, GENOMICS, V7, P422, DOI 10.1016/0888-7543(90)90177-V; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; Tam PPL, 2000, CURR TOP DEV BIOL, V47, P1; Tan DP, 1996, P NATL ACAD SCI USA, V93, P8247, DOI 10.1073/pnas.93.16.8247; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zakany J, 1996, NATURE, V384, P69, DOI 10.1038/384069a0; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	48	150	154	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					207	217		10.1016/S0092-8674(01)00436-6	http://dx.doi.org/10.1016/S0092-8674(01)00436-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511348	Bronze			2022-12-24	WOS:000170193100010
J	Woodruff, PG; Fahy, JV				Woodruff, PG; Fahy, JV			Asthma: Prevalence, pathogenesis, and prospects for novel therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-IGE ANTIBODY; HOUSE-DUST MITE; CHILDHOOD ASTHMA; IMMUNOTHERAPY; PREGNANCY; MORTALITY; ALLERGENS; EXPOSURE; ATOPY; PHASE		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fahy, JV (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 505 Parnassus Ave,Box 0111, San Francisco, CA 94143 USA.	jfahy@itsa.ucsf.edu			NHLBI NIH HHS [HL-07185, R01 HL-61662, P01 HL-56385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056385, R01HL061662] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Boulet LP, 1997, AM J RESP CRIT CARE, V155, P1835, DOI 10.1164/ajrccm.155.6.9196083; Boushey HA, 2000, LANCET, V356, P2114, DOI 10.1016/S0140-6736(00)03486-3; BOUSHEY HA, 2000, TXB RESP MED, P1247; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Campbell D, 2000, CLIN IMMUNOL, V97, P193, DOI 10.1006/clim.2000.4926; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; Custovic A, 2000, J ALLERGY CLIN IMMUN, V105, P252, DOI 10.1016/S0091-6749(00)90073-3; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Grant EN, 1999, J ALLERGY CLIN IMMUN, V104, pS1, DOI 10.1016/S0091-6749(99)70268-X; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Kim TS, 1997, J IMMUNOL, V158, P4137; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Litonjua AA, 2001, J ALLERGY CLIN IMMUN, V107, P41, DOI 10.1067/mai.2001.111143; Los H, 1999, EUR RESPIR J, V14, P1210, DOI 10.1183/09031936.99.14512109; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Martinez FD, 2001, RESPIR RES, V2, P129, DOI 10.1186/rr48; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Ronmark E, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e37; Sly RM, 2000, ANN ALLERG ASTHMA IM, V85, P121, DOI 10.1016/S1081-1206(10)62451-9; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wills-Karp M, 2000, IMMUNOPHARMACOLOGY, V48, P263, DOI 10.1016/S0162-3109(00)00223-X	37	36	44	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2001	286	4					395	398		10.1001/jama.286.4.395	http://dx.doi.org/10.1001/jama.286.4.395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456DZ	11466111				2022-12-24	WOS:000170069000001
J	Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M				Schmitz, B; PeuckerEhrenbrink, E; Lindstrom, M; Tassinari, M			Accretion rates of meteorites and cosmic dust in the Early Ordovician	SCIENCE			English	Article							CHONDRITE PARENT BODY; ISOTOPE SYSTEMATICS; CONTINENTAL-CRUST; OSMIUM; RECORD; LIFE	Abundant fossil meteorites in marine, condensed Lower Ordovician limestones from Kinnekulle, Sweden, indicate that accretion rates of meteorites were one to two orders of magnitude higher during an interval of the Early Ordovician than at0 present, Osmium isotope and iridium analyses of whole-rock limestone indicate a coeval enhancement of one order of magnitude in the influx rate of cosmic dust. Enhanced accretion of cosmic matter may be related to the disruption of the L chondrite parent body around 500 million years ago.	WOODS HOLE OCEANOG INST,DEPT MARINE CHEM & GEOCHEM,WOODS HOLE,MA 02543; UNIV STOCKHOLM,DEPT GEOL & GEOCHEM,S-10691 STOCKHOLM,SWEDEN; PALEO GEOL CTR,S-53130 LINKOPING,SWEDEN	Woods Hole Oceanographic Institution; Stockholm University	Schmitz, B (corresponding author), GOTHENBURG UNIV,CTR EARTH SCI,DEPT MARINE GEOL,S-41381 GOTHENBURG,SWEDEN.			Peucker-Ehrenbrink, Bernhard/0000-0002-3819-992X				BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bland PA, 1996, GEOCHIM COSMOCHIM AC, V60, P2053, DOI 10.1016/0016-7037(96)00125-1; BOGARD DD, 1995, GEOCHIM COSMOCHIM AC, V59, P1383, DOI 10.1016/0016-7037(95)00051-Z; BURKE WH, 1982, GEOLOGY, V10, P516, DOI 10.1130/0091-7613(1982)10<516:VOSSTP>2.0.CO;2; ESSER BK, 1993, GEOCHIM COSMOCHIM AC, V57, P3093, DOI 10.1016/0016-7037(93)90296-9; ESSER BK, 1988, GEOCHIM COSMOCHIM AC, V52, P1383, DOI 10.1016/0016-7037(88)90209-8; GRIEVE RAF, 1987, ANNU REV EARTH PL SC, V15, P245, DOI 10.1146/annurev.ea.15.050187.001333; GRIEVE RAF, 1995, GSA TODAY, V5, P189; Haack H, 1996, ICARUS, V119, P182, DOI 10.1006/icar.1996.0010; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; JENNISKENS P, 1994, METEORITICS, V29, P246, DOI 10.1111/j.1945-5100.1994.tb00678.x; LINDNER M, 1989, GEOCHIM COSMOCHIM AC, V53, P1597, DOI 10.1016/0016-7037(89)90241-X; LINDSTROM M, 1971, GEOL RUNDSCH, V60, P419, DOI DOI 10.1007/BF02000464; NYSTROM JO, 1988, NATURE, V336, P572, DOI 10.1038/336572a0; PEDERSEN RB, 1992, TERRA NOVA, V4, P217, DOI 10.1111/j.1365-3121.1992.tb00475.x; PeuckerEhrenbrink B, 1996, GEOCHIM COSMOCHIM AC, V60, P3187, DOI 10.1016/0016-7037(96)00161-5; PEUCKEREHRENBRINK B, 1995, EARTH PLANET SC LETT, V130, P155, DOI 10.1016/0012-821X(95)00003-U; RAVIZZA G, 1993, GEOCHIM COSMOCHIM AC, V57, P4301, DOI 10.1016/0016-7037(93)90324-P; RAVIZZA G, 1989, GEOCHIM COSMOCHIM AC, V53, P3257, DOI 10.1016/0016-7037(89)90105-1; Schmitz B, 1996, EARTH PLANET SC LETT, V145, P31, DOI 10.1016/S0012-821X(96)00205-1; SCHMITZ B, IN PRESS CHEM GEOL I; THORSLUND P, 1984, LITHOS, V17, P87, DOI 10.1016/0024-4937(84)90008-2; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	23	62	62	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 3	1997	278	5335					88	90		10.1126/science.278.5335.88	http://dx.doi.org/10.1126/science.278.5335.88			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XZ124	11536823				2022-12-24	WOS:A1997XZ12400042
J	SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC				SLOAN, LC; WALKER, JCG; MOORE, TC; REA, DK; ZACHOS, JC			POSSIBLE METHANE-INDUCED POLAR WARMING IN THE EARLY EOCENE	NATURE			English	Article							STRATOSPHERIC CLOUDS; CLIMATE; RATES; CH4	RECONSTRUCTIONS of early Eocene climate depict a world in which the polar environments support mammals and reptiles, deciduous forests, warm oceans and rare frost conditions 1-5. At the same time, tropical sea surface temperatures are interpreted to have been the same as or slightly cooler than present values 6. The question of how to warm polar regions of Earth without noticeably warming the tropics remains unresolved; increased amounts of greenhouse gases would be expected to warm all latitudes equally 7. Oceanic heat transport has been postulated as a mechanism for heating high latitudes 8-10, but it is difficult to explain the dynamics that would achieve this 7,11. Here we consider estimates of Eocene wetland areas and suggest that the flux of methane, an important greenhouse gas, may have been substantially greater during the Eocene than at present. Elevated methane concentrations would have enhanced early Eocene global warming, and also might specifically have prevented severe winter cooling of polar regions because of the potential of atmospheric methane to promote the formation of optically thick, polar stratospheric ice clouds 12-14.			SLOAN, LC (corresponding author), UNIV MICHIGAN,DEPT GEOL SCI,ANN ARBOR,MI 48109, USA.		Zachos, James C/A-7674-2008; Moore, Theodore/N-8848-2014	Zachos, James C/0000-0001-8439-1886; Moore, Theodore/0000-0003-4121-1325				ARTHUR MA, 1992, GEOL SOC AM PROG, V23, P178; Askin R.A., 1988, Geological Society of America Memoir, V169, P131; BARRON EJ, 1982, PALAEOGEOGR PALAEOCL, V40, P103, DOI 10.1016/0031-0182(82)90086-4; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; CASE JA, 1988, GEOLOGY PALEONTOLOGY, P523; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; CROWLEY TJ, 1991, QUATERNARY SCI REV, V10, P275, DOI 10.1016/0277-3791(91)90025-P; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Houghton J.T., 1990, CLIMATE CHANGE IPCC; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KINNE S, 1990, GEOPHYS RES LETT, V17, P373, DOI 10.1029/GL017i004p00373; MCCORMICK MP, 1987, J GEOPHYS RES-ATMOS, V92, P4297, DOI 10.1029/JD092iD04p04297; MCCORMICK MP, 1989, J GEOPHYS RES-ATMOS, V94, P11241, DOI 10.1029/JD094iD09p11241; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P741, DOI 10.1029/PA002i006p00741; POLLACK JB, 1985, J ATMOS SCI, V42, P245, DOI 10.1175/1520-0469(1985)042<0245:TIOPSC>2.0.CO;2; RAMANATHAN V, 1989, SCIENCE, V243, P57, DOI 10.1126/science.243.4887.57; RAMANATHAN V, 1987, REV GEOPHYS, V25, P1441, DOI 10.1029/RG025i007p01441; RASMUSSEN RA, 1981, J GEOPHYS RES-OCEANS, V86, P9826, DOI 10.1029/JC086iC10p09826; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; RINSLAND CP, 1984, J GEOPHYS RES-ATMOS, V89, P7259, DOI 10.1029/JD089iD05p07259; Ronov A.B., 1979, INT GEOL REV, V21, P415, DOI 10.1080/00206818209467074; SCHWEITZER HJ, 1980, PALAEOGEOGR PALAEOCL, V30, P297, DOI 10.1016/0031-0182(80)90062-0; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; SHEPPARD JC, 1982, J GEOPHYS RES-OCEANS, V87, P1305, DOI 10.1029/JC087iC02p01305; SLOAN LC, 1990, THESIS PENNSYLVANIA; SLOAN LC, UNPUB GEOPHYS RES LE; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X	31	106	108	1	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 28	1992	357	6376					320	322		10.1038/357320a0	http://dx.doi.org/10.1038/357320a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW132	11536496	Green Published			2022-12-24	WOS:A1992HW13200044
J	YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T				YAMAGATA, Y; WATANABE, H; SAITOH, M; NAMBA, T			VOLCANIC PRODUCTION OF POLYPHOSPHATES AND ITS RELEVANCE TO PREBIOTIC EVOLUTION	NATURE			English	Article							AQUEOUS-SOLUTION; PHOSPHORYLATION; PHOSPHORUS; ADENOSINE; AGENTS	PHOSPHATES would probably have been essential compounds for prebiotic evolution on the primitive Earth. In this context, there have been several studies of condensation of water-soluble phosphates to polyphosphates and phosphorylation and condensation or polymerization of biomolecules with polyphosphates 1-20. But most of the phosphorus on the early Earth would have been in the form of water-insoluble apatite, and the origin of the water-soluble polyphosphates required for prebiotic evolution has therefore been a mystery 21-24. Here we show, both from experiments that simulate magmatic conditions and from analysis of volatile condensates in volcanic gas, that volcanic activity can produce water-soluble polyphosphates through partial hydrolysis of P4O10. This mechanism seems to be the only viable route identified so far for the production of these species on the primitive Earth.			YAMAGATA, Y (corresponding author), KANAZAWA UNIV, FAC SCI, DEPT PHYS, 1-1 MARUNOUCHI, KANAZAWA, ISHIKAWA 920, JAPAN.							Best A.G, 1982, IGNEOUS METAMORPHIC; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHUNG NM, 1971, TETRAHEDRON, V27, P1205, DOI 10.1016/S0040-4020(01)90868-3; FERRIS JP, 1968, SCIENCE, V161, P53, DOI 10.1126/science.161.3836.53; GRIFFITH EJ, 1977, ORIGINS LIFE EVOL B, V8, P71, DOI 10.1007/BF00927976; GRIFFITH EJ, 1977, CHEM EVOLUTION EARLY, P61; GULICK A, 1957, ANN NY ACAD SCI, V69, P309, DOI 10.1111/j.1749-6632.1957.tb49666.x; HANDSCHUH GJ, 1973, J MOL EVOL, V2, P251, DOI 10.1007/BF01654094; HULSHOF J, 1976, ORIGINS LIFE EVOL B, V7, P197, DOI 10.1007/BF00926938; LOHRMANN R, 1968, SCIENCE, V161, P64, DOI 10.1126/science.161.3836.64; LOHRMANN R, 1975, J MOL EVOL, V6, P237, DOI 10.1007/BF01794633; LOHRMANN R, 1971, SCIENCE, V171, P490, DOI 10.1126/science.171.3970.490; MAMBO VS, 1991, J VOLCANOL GEOTH RES, V46, P37, DOI 10.1016/0377-0273(91)90074-A; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1964, NATURE, V204, P1248, DOI 10.1038/2041248a0; PONNAMPE.C, 1965, SCIENCE, V148, P1221, DOI 10.1126/science.148.3674.1221; PONNAMPERUMA C, 1963, NATURE, V199, P222, DOI 10.1038/199222a0; RABINOWI.J, 1969, NATURE, V224, P795, DOI 10.1038/224795a0; RABINOWITZ J, 1970, HELV CHIM ACTA, V53, P1350, DOI 10.1002/hlca.19700530614; RABINOWITZ J, 1968, NATURE, V218, P442, DOI 10.1038/218442a0; Ross WH, 1924, IND ENG CHEM, V16, P563; SATO H, 1981, SCI REP KANAZAWA U, V26, P51; SCHOFFSTALL AM, 1976, ORIGINS LIFE EVOL B, V7, P399, DOI 10.1007/BF00927935; SCHWARTZ A, 1968, NATURE, V218, P443, DOI 10.1038/218443a0; SCHWARTZ A, 1964, BIOCHIM BIOPHYS ACTA, V87, P694, DOI 10.1016/0926-6550(64)90290-7; Schwartz A. W., 1972, MOL EVOLUTION PREBIO, P129; SCHWARTZ AW, 1967, BIOCHIM BIOPHYS ACTA, V134, P9, DOI 10.1016/0005-2787(67)90083-4; SCHWARTZ AW, 1971, CHEM EVOLUTION ORIGI, V1, P207; TATSUMI Y, 1983, J GEOPHYS RES, V88, P5815, DOI 10.1029/JB088iB07p05815; Van Wazer J.R., 1958, PHOSPHORUS ITS COMPO, V1; WAENHELDT TV, 1967, BIOCHIM BIOPHYS ACTA, V1234, P1; YAMAGATA Y, 1982, ORIGINS LIFE EVOL B, V12, P333, DOI 10.1007/BF00927064; YAMAGATA Y, 1979, NATURE, V282, P284, DOI 10.1038/282284a0; YAMANAKA J, 1988, ORIGINS LIFE EVOL B, V18, P165, DOI 10.1007/BF01804669	34	241	248	5	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 8	1991	352	6335					516	519		10.1038/352516a0	http://dx.doi.org/10.1038/352516a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA226	11536483				2022-12-24	WOS:A1991GA22600058
J	Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML				Schiemann, B; Gommerman, JL; Vora, K; Cachero, TG; Shulga-Morskaya, S; Dobles, M; Frew, E; Scott, ML			An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway	SCIENCE			English	Article							NECROSIS-FACTOR FAMILY; FACTOR RECEPTOR SUPERFAMILY; MOUSE BONE-MARROW; AUTOIMMUNE-DISEASE; MEMBER; MICE; GROWTH; APRIL; IDENTIFICATION; LYMPHOCYTES	The B cell activating factor BAFF (BtyS/TALL-1/zTNF4) is a tumor necrosis factor (TNF)-related ligand that promotes B cell survival and binds to three receptors (BCMA, TACI, and the recently described BAFF-R). Here we report an absolute requirement for BAFF in normal B cell development. Examination of secondary lymphoid organs from BAFF-deficient mice revealed an almost complete loss of follicular and marginal zone B lymphocytes. In contrast, mice lacking BCMA had normal-appearing B lymphocyte compartments. BAFF therefore plays a crucial role in B cell development and can function through receptors other than BCMA.	Biogen Inc, Cambridge, MA 02142 USA	Biogen	Scott, ML (corresponding author), Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	martin_scott@biogen.com		Gommerman, Jennifer/0000-0003-4576-6168				Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Clarke SH, 1998, J EXP MED, V187, P1325, DOI 10.1084/jem.187.8.1325; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KALLED S, UNPUB; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lentz VM, 1996, J IMMUNOL, V157, P598; Li YS, 1996, IMMUNITY, V5, P527, DOI 10.1016/S1074-7613(00)80268-X; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Madry C, 1998, INT IMMUNOL, V10, P1693, DOI 10.1093/intimm/10.11.1693; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Nemazee D, 2000, Adv Immunol, V74, P89; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	33	863	942	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2111	2114		10.1126/science.1061964	http://dx.doi.org/10.1126/science.1061964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11509691				2022-12-24	WOS:000171028700080
J	Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP				Dhoot, GK; Gustafsson, MK; Ai, XB; Sun, WT; Standiford, DM; Emerson, CP			Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase	SCIENCE			English	Article							SONIC HEDGEHOG; HEPARAN-SULFATE; ARYLSULFATASE-A; ACTIVATION; MYOD; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; DOWNSTREAM; INDUCTION; MUSCLE	The developmental signaling functions of cell surface heparan sulfate proteoglycans (HSPGs) are dependent on their sulfation states. Here, we report the identification of QSulf1, the avian ortholog of an evolutionarily conserved protein family related to heparan-specific N-acetyl glucosamine sulfatases. QSulf1 expression is induced by Sonic hedgehog in myogenic somite progenitors in quail embryos and is required for the activation of MyoD, a Wnt-induced regulator of muscle specification. QSulf1 is localized on the cell surface and regulates heparan-dependent Writ signaling in C2C12 myogenic progenitor cells through a mechanism that requires its catalytic activity, providing evidence that QSulf1 regulates Writ signaling through desulfation of cell surface HSPGs.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of Pennsylvania; University of London; University of London Royal Veterinary College	Emerson, CP (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 1157 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA.							Borycki AG, 1999, DEVELOPMENT, V126, P4053; Borycki AG, 1997, DEV BIOL, V185, P185, DOI 10.1006/dbio.1997.8555; Borycki AG, 1998, DEVELOPMENT, V125, P777; Cumberledge S, 1997, TRENDS GENET, V13, P421, DOI 10.1016/S0168-9525(97)01275-4; DHOOT GK, UNPUB; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBERTSON DA, 1992, BIOCHEM J, V288, P539, DOI 10.1042/bj2880539; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Wei G, 2000, J BIOL CHEM, V275, P27733	25	361	366	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1663	1666		10.1126/science.293.5535.1663	http://dx.doi.org/10.1126/science.293.5535.1663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533491	Green Submitted			2022-12-24	WOS:000170802900064
J	Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE				Yuan, MS; Konstantopoulos, N; Lee, JS; Hansen, L; Li, ZW; Karin, M; Shoelson, SE			Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK beta	SCIENCE			English	Article							KAPPA-B KINASE; NECROSIS-FACTOR-ALPHA; INDUCED TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; ACTIVATION; RECEPTOR; ASPIRIN; IMPAIRS; GLUCOSE; AGENTS	We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the I kappaB kinase beta (IKK beta) attenuated insulin signaling in cultured cells, whereas IKK beta inhibition reversed insulin resistance. Thus, IKK beta, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion (Ikk beta (+/-)) protected against the development of insulin resistance during high-fat feeding and in obese Lep(ob/ob) mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKK beta pathway as a target for insulin sensitization.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Shoelson, SE (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	Steven.Shoelson@joslin.Harvard.edu	Lee, Jongsoon/AAG-1674-2020		NIAID NIH HHS [AI43477] Funding Source: Medline; NIDDK NIH HHS [DK51729, DK45493] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045493, R01DK051729, R37DK051729] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARON SH, 1982, DIABETES CARE, V5, P64, DOI 10.2337/diacare.5.1.64; CARO JF, 1989, DIABETES METAB REV, V5, P665, DOI 10.1002/dmr.5610050804; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; FURST DE, 1994, ARTHRITIS RHEUM-US, V37, P1, DOI 10.1002/art.1780370102; GILGORE SG, 1960, DIABETES, V9, P392, DOI 10.2337/diab.9.5.392; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KONSTANTOPOULOS N, UNPUB; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Lee J.-S., UNPUB; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; ROBINSON KA, 1993, AM J PHYSIOL, V265, pE36, DOI 10.1152/ajpendo.1993.265.1.E36; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	29	1453	1597	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1673	1677		10.1126/science.1061620	http://dx.doi.org/10.1126/science.1061620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533494				2022-12-24	WOS:000170802900067
J	Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R				Moore, A; Herrera, G; Nyamongo, J; Lackritz, E; Granade, T; Nahlen, B; Oloo, A; Opondo, G; Muga, R; Janssen, R			Estimated risk of HIV transmission by blood transfusion in Kenya	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POPULATION; CHILDREN; REGION	Background During the past decade, developing countries have received limited support for blood safety programmes. The Kenya Ministry of Health did a collaborative multicentre assessment to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in this country with a mature HIV epidemic, and to identify methods to reduce the risk of HIV transmission by blood transfusion in Kenya. Methods For 12 weeks, from April to July 1994, we collected information and blood samples from all blood donors, and pretransfusion samples were collected from all recipients in six government hospitals in Kenya. Blood donations were collected and screened for HIV according to standard practice in the hospital laboratories. Test results at a reference laboratory were compared with those of the hospital laboratories and risk of transfusion-associated HIV transmission was calculated. Findings The prevalence of HIV among blood donors was 6.4% (120 of 1877) and varied by hospital (range 2-20%). HIV test results were available for 1290 donor-recipient pairs. Of these, 26 HIV-positive donations were given to HIV-negative patients. We estimate that 2.0% of transfusions transmitted HIV. Problems in the hospitals that contributed to transfusion risk included inconsistent refrigeration, data entry errors, equipment failure, and lack of a quality-assurance programme. Interpretation A high proportion of blood transfusions transmitted HIV in this high-prevalence area of Africa, primarily because of erroneous laboratory practices. On the basis of these results, the Kenya Ministry of Health introduced a number of practical and inexpensive interventions to improve national blood safety.	CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; CDCP, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Kenya Minist Hlth, Nairobi, Kenya; Kenya Minist Hlth, Kisumu, Kenya; Kenya Govt Med Res Ctr, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Janssen, R (corresponding author), CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.		Nahlen, Bernard/AAH-2051-2021; Oloo, James Aggrey/CAF-3948-2022	Oloo, James Aggrey/0000-0001-7495-1827; Lackritz, Eve/0000-0002-5397-7291				ADDOYOBO EOD, 1991, TROP DOCT, V21, P162, DOI 10.1177/004947559102100409; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DORWARD JA, 1989, TROP DOCT, V19, P155, DOI 10.1177/004947558901900404; FOSTER S, 1995, LANCET, V346, P225, DOI 10.1016/S0140-6736(95)91272-X; Fransen L., 1992, SAFE BLOOD DEV COUNT, P11; GREENBERG AE, 1988, JAMA-J AM MED ASSOC, V259, P545, DOI 10.1001/jama.259.4.545; GUMODOKA B, 1993, AIDS, V7, P387, DOI 10.1097/00002030-199303000-00013; JACOBS B, 1994, E AFR MED J, V71, P720; LACKRITZ EM, 1993, AIDS, V7, P995, DOI 10.1097/00002030-199307000-00014; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; McFarland W, 1997, AIDS, V11, pS97; SAVARIT D, 1992, BRIT MED J, V305, P498, DOI 10.1136/bmj.305.6852.498; SCHREIBER GB, 1996, NEW ENGL J MED, V334, P1885; WATSONWILLIAMS EJ, 1994, 10 INT C AIDS AUG	15	80	85	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 25	2001	358	9282					657	660		10.1016/S0140-6736(01)05783-X	http://dx.doi.org/10.1016/S0140-6736(01)05783-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530174				2022-12-24	WOS:000170615500031
J	Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L				Elliott, P; Briggs, D; Morris, S; de Hoogh, C; Hurt, C; Jensen, TK; Maitland, I; Richardson, S; Wakefield, J; Jarup, L			Risk of adverse birth outcomes in populations living near landfill sites	BRITISH MEDICAL JOURNAL			English	Article							HAZARDOUS-WASTE SITES; CONGENITAL-MALFORMATIONS; RETROSPECTIVE ANALYSIS; NEURAL-TUBE; HEALTH; EXPOSURE; ENGLAND; DEFECTS; MORTALITY; PROXIMITY	Objective To investigate the risk of adverse birth outcomes associated with residence near landfill sites in Great Britain. Design Geographical study of risks of adverse birth outcomes in populations living within 2 km of 9565 landfill sites operational at some time between 1982 and 1997 (from a total of 19 196 sites) compared with those living further away. Setting Great Britain. Subjects Over 8.2 million live births, 43 471 stillbirths, and 124 597 congenital anomalies (including terminations). Main outcome measures All congenital anomalies combined, sonic specific anomalies, and prevalence of low and very low birth weight (<2500 g and <1500 g). Results For all anomalies combined, relative risk of residence near landfill sites (all waste types) was 0.92 (99% confidence interval 0.907 to 0.923) unadjusted, and 1.01 (1.005 to 1.023) adjusted for confounders. Adjusted risks were 1.05 (1.01 to 1.10) for neural tube defects, 0.96 (0.93 to 0.99) for cardiovascular defects, 1.07 (1.04 to 1.10) for hypospadias and epispadias (with no excess of surgical correction), 1.08 (1.01 to 1.15) for abdominal wall defects, 1.19 (1.05 to 1.34) for surgical correction of gastroschisis and exomphalos, and 1.05 (1.047 to 1.055) and 1.04 (1.03 to 1.05) for low and very low birth weight respectively. There was no excess risk of stillbirth. Findings for special (hazardous) waste sites did not differ systematically from those for non-special sites. For some specific anomalies, higher risks were found in the period before opening compared with after opening of a landfill site, especially hospital admissions for abdominal wall defects. Conclusions We found small excess risks of congenital anomalies and low and very low birth weight in populations living near landfill sites. No causal mechanisms are available to explain these findings, and alternative explanations include data artefacts and residual confounding. Further studies are needed to help differentiate between the various possibilities.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Small Area Hlth Stat Unit, St Marys Campus, London W2 1PG, England.		Richardson, Sylvia T/G-4691-2015	Richardson, Sylvia T/0000-0003-1998-492X; Hurt, Chris/0000-0003-1206-8355				AFFLICK EF, 1997, AM J EPIDEMIOL, V145, P148; BALARAJAN R, 1989, Archives of Disease in Childhood, V64, P1457, DOI 10.1136/adc.64.10.1457; BRIGGS D, 2001, 20011 SAHSU; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Croen LA, 1997, EPIDEMIOLOGY, V8, P347, DOI 10.1097/00001648-199707000-00001; *DEP ENV, 2001, DIG ENV STAT; Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; ElFadel M, 1997, J ENVIRON MANAGE, V50, P1, DOI 10.1006/jema.1995.0131; ELLIOTT P, 2001, BIRTH OUTCOMES SELEC; Fielder HMP, 2000, BRIT MED J, V320, P19, DOI 10.1136/bmj.320.7226.19; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; Hamar GB, 1996, J EXPO ANAL ENV EPID, V6, P247; Johnson Barry L., 1997, Reviews on Environmental Health, V12, P235; LECK I, 1995, J EPIDEMIOL COMMUN H, V49, P171, DOI 10.1136/jech.49.2.171; LYNBERG MC, 1994, AM J EPIDEMIOL, V140, P244, DOI 10.1093/oxfordjournals.aje.a117243; Marshall EG, 1997, ARCH ENVIRON HEALTH, V52, P416, DOI 10.1080/00039899709602220; NEUTRA R, 1991, ENVIRON HEALTH PERSP, V94, P31, DOI 10.2307/3431289; *OFF POP CENS SURV, 1992, STAT REV NOT CONG MA; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; ROHT LH, 1985, AM J EPIDEMIOL, V122, P418, DOI 10.1093/oxfordjournals.aje.a114123; SCHULMAN J, 1993, ARCH ENVIRON HEALTH, V48, P114, DOI 10.1080/00039896.1993.9938404; SHAW GM, 1992, ARCH ENVIRON HEALTH, V47, P147, DOI 10.1080/00039896.1992.10118769; SOLIMAN MRI, 1993, TOXICOL IND HEALTH, V9, P901, DOI 10.1177/074823379300900511; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107; *US EPA, 1999, REV RISK ASS AIR CHA, V1; VIANNA NJ, 1984, SCIENCE, V226, P1217, DOI 10.1126/science.6505690; Vrijheid M, 2000, ENVIRON HEALTH PERSP, V108, P101, DOI 10.2307/3454635; Ward RS, 1996, WASTE MANAGE RES, V14, P243; Wasserman CR, 1996, TERATOLOGY, V53, P261, DOI 10.1002/(SICI)1096-9926(199604)53:4<261::AID-TERA9>3.3.CO;2-8; *WHO, 2001, METH ASS RISK HLTH E; *WORK GROUP REG GE, 1995, 43 OPCS WORK GROUP R; [No title captured]	33	212	216	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					363	368		10.1136/bmj.323.7309.363	http://dx.doi.org/10.1136/bmj.323.7309.363			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509424	Green Published, Bronze			2022-12-24	WOS:000170581400014
J	Witmer, LM				Witmer, LM			Nostril position in dinosaurs and other vertebrates and its significance for nasal function	SCIENCE			English	Article								Many dinosaurs have enormous and complicated bony nasal apertures. Functional interpretation requires knowledge of the Location of the external opening in the skin. Traditionally, the fleshy nostril of dinosaurs has been placed in the back of the bony opening, but studies of extant dinosaur relatives suggest that it is located far forward. Narial blood supply and cavernous tissue corroborate the rostra[ position in dinosaurs. A rostra[ nostril was, and remains, a virtually invariant rule of construction among Amniota, which has consequences for (I) nasal airstreaming, and hence various physiological parameters, and (ii) the collection of behaviorally relevant circumoral odorants.	Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Witmer, LM (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	witmer@exchange.oucom.ohiou.edu						Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; BANG B G, 1971, Acta Anatomica, V79, P1; BAUMEL JJ, 1983, ZOOMORPHOLOGY, V102, P215, DOI 10.1007/BF00310349; BELLAIRS AD, 1949, J ANAT, V83, P116; BELLAIRS AD, 1953, J ANAT, V87, P367; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Cope ED, 1878, AM NAT, V12, P71, DOI [10.1086/272033., DOI 10.1086/272033]; DAWES J D K, 1952, J Laryngol Otol, V66, P583, DOI 10.1017/S0022215100048143; DAWES JDK, 1953, J ANAT, V87, P311; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; HUNTLEY AC, 1984, J EXP BIOL, V113, P447; LAURENT RS, 1994, J EXP BIOL, V194, P329; MALAN M. E., 1946, ANN UNIV STELLENBOSCH REEKS A, V24A, P69; Marsh O., 1883, AM J SCI, V26, P81; Marsh O. C., 1884, AM J SCI 3, V158, P161, DOI DOI 10.2475/AJS.S3-27.158.161; OSBORN HF, 1898, B AM MUS NAT HIST, V10, P219; OSTROM JH, 1961, AM MUSEUM NATURAL HI, V122, P33; Owen R., 1875, PALAEONTOGRAPHICAL S, V29, P15; PARSONS TS, 1970, BIOLOGY REPTILIA, V2, P99; PRATT CWM, 1948, P ZOOL SOC LOND, V118, P171; REHOREK SJ, 2001, 2001 ANN M AM SOC IC; Ruben JA, 1996, ANIMALS TEMPERATURE, P347; Schmidt-Nielsen K., 1997, ANIMAL PHYSL; Sedlmayr Jayc C., 1999, Journal of Vertebrate Paleontology, V19, p74A; STEBBINS RC, 1948, AM J ANAT, V83, P183, DOI 10.1002/aja.1000830202; Walker WF, 1959, COPEIA, V1959, P257, DOI [10.2307/1440406, DOI 10.2307/1440406]; Ward S, 1999, J EXP BIOL, V202, P1589; Witmer L. M., 1999, Journal of Vertebrate Paleontology, V19, p85A; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1999, J ZOOL, V249, P249, DOI 10.1017/S0952836999009991; Witmer LM, 2001, NAT HIST, V110, P64; WITMER LM, 1997, MEM SOC VERTEBR PALE, V17, P173	35	37	37	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					850	853		10.1126/science.1062681	http://dx.doi.org/10.1126/science.1062681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486085				2022-12-24	WOS:000170241000041
J	Tercero, JA; Diffley, JFX				Tercero, JA; Diffley, JFX			Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint	NATURE			English	Article							CEREVISIAE CHROMOSOME-VI; SACCHAROMYCES-CEREVISIAE; S-PHASE; BUDDING YEAST; ORIGINS; ACTIVATION; INITIATION; SEQUENCES; TELOMERES; PROTEIN	The checkpoint kinase proteins Mec1 and Rad53 are required in the budding yeast, Saccharomyces cerevisiae, to maintain cell viability in the presence of drugs causing damage to DNA or arrest of DNA replication forks(1-3). It is thought that they act by inhibiting cell cycle progression, allowing time for DNA repair to take place. Mec1 and Rad53 also slow S phase progression in response to DNA alkylation(4), although the mechanism for this and its relative importance in protecting cells from DNA damage have not been determined. Here we show that the DNA-alkylating agent methyl methanesulphonate (MMS) profoundly reduces the rate of DNA replication fork progression; however, this moderation does not require Rad53 or Mec1. The accelerated S phase in checkpoint mutants(4), therefore, is primarily a consequence of inappropriate initiation events(5-7). Wild-type cells ultimately complete DNA replication in the presence of MMS. In contrast, replication forks in checkpoint mutants collapse irreversibly at high rates. Moreover, the cytotoxicity of MMS in checkpoint mutants occurs specifically when cells are allowed to enter S phase with DNA damage. Thus, preventing damage-induced DNA replication fork catastrophe seems to be a primary mechanism by which checkpoints preserve viability in the face of DNA alkylation.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		Diffley, JFX (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.		Tercero, José Antonio/D-7489-2016	Tercero, Jose Antonio/0000-0003-4829-3570; Diffley, John/0000-0001-5184-7680				Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Longhese MP, 2000, GENETICS, V155, P1577; Lowndes NF, 2000, CURR OPIN GENET DEV, V10, P17, DOI 10.1016/S0959-437X(99)00050-7; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	22	547	557	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					553	557		10.1038/35087607	http://dx.doi.org/10.1038/35087607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484057				2022-12-24	WOS:000170202900049
J	Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ				Tochio, H; Tsui, MMK; Banfield, DK; Zhang, MJ			An autoinhibitory mechanism for nonsyntaxin SNARE proteins revealed by the structure of Ykt6p	SCIENCE			English	Article							N-TERMINAL DOMAIN; MEMBRANE-FUSION; COMPLEX; NMR; EXOCYTOSIS; PROGRAM; TRANSPORT; SYNTAXIN; YEAST; SSO1P	Ykt6p is a nonsyntaxin SNARE implicated in multiple intracellular membrane trafficking steps. Here we present the structure of the NH2-terminal domain of Ykt6p (Ykt6pN, residues 1 to 140). The structure of Ykt6pN differed entirety from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin. Like some syntaxins, Ykt6p adopted a folded back conformation in which Ykt6pN bound to its COOH-terminal core domain. The NH2-terminal domain plays an important biological rote in the function of Ykt6p, which in vitro studies revealed to include influencing the kinetics and proper assembly of SNARE complexes.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Banfield, DK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.		Tochio, Hidehito/GWV-0429-2022; Tochio, Hidehito/F-6109-2011; Tsui, Man-kin/E-9612-2010	Tochio, Hidehito/0000-0003-3843-3330; Zhang, Mingjie/0000-0001-9404-0190				BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GOLEMIS E, 1996, INTERACTION TRAP 2 H; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson M, 2000, NAT STRUCT BIOL, V7, P894; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOCHIO H, UNPUB; Tsui MMK, 2000, J CELL SCI, V113, P145; Tsui MMK, 2001, MOL BIOL CELL, V12, P521, DOI 10.1091/mbc.12.3.521; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435	33	107	109	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					698	702		10.1126/science.1062950	http://dx.doi.org/10.1126/science.1062950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474112				2022-12-24	WOS:000170204600055
J	Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J				Wadsworth, JDF; Joiner, S; Hill, AF; Campbell, TA; Desbruslais, M; Luthert, PJ; Collinge, J			Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay	LANCET			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRANSMISSIBLE MINK ENCEPHALOPATHY; FATAL FAMILIAL INSOMNIA; BLOOD-TRANSFUSION; STRAIN VARIATION; TRANSGENIC MICE; TONSIL BIOPSY; BSE AGENT; SCRAPIE; INFECTIVITY	Background Variant Creutzfeldt-Jakob disease (vCJD) has a pathogenesis distinct from other forms of human prion disease: disease-related prion protein (PrP(Sc)) is readily detectable in lymphoreticular tissues. Quantitation of risk of secondary transmission, and targeting of risk reduction strategies, is limited by lack of knowledge about relative prion titres in these and other peripheral tissues, the unknown prevalence of preclinical vCJD, and a transmission barrier which limits the sensitivity of bioassay. We aimed to improve immunoblotting methods for high sensitivity detection of PrP(Sc) to investigate the distribution of PrP(Sc) in a range of vCJD tissues. Methods We obtained tissues at necropsy from four patients with neuropathologically confirmed vCJD and from individuals without neurological disease. Tissues were analysed by sodium phosphotungstic acid precipitation of PrP(Sc) and western blotting using high sensitivity enhanced chemiluminescence. Findings We could reliably detect PrP(Sc) in the equivalent of 50 nL 10% vCJD brain homogenate, with a maximum limit of detection equivalent to 5 nl. PrP(Sc) could be detected in tissue homogenates when present at concentrations 10(4)-10(5) fold lower than those reported in brain. Tonsil, spleen, and lymph node were uniformly positive for PrP(Sc) at concentrations in the range of 0.1-15% of those found in brain: the highest concentrations were consistently seen in tonsil. PrP(Sc) was readily detected in the retina and proximal optic nerve of vCJD eye at levels of 2.5 and 25%, respectively of those found in brain. Other peripheral tissues studied were negative for PrP(Sc) with the exception of low concentrations in rectum, adrenal gland, and thymus from a single patient with vCJD. vCJD appendix and blood (Buffy coat fraction) were negative for PrP(Sc) at this level of assay sensitivity. Interpretation We have developed a highly sensitive immunoblot method for detection of PrP(Sc) in vCJD tissues that can be used to provide an upper limit on PrP(Sc) concentrations in peripheral tissues, including blood, to inform risk assessment models. Rectal and other gastrointestinal tissues should be further investigated to assess risk of iatrogenic transmission via biopsy instruments. Ophthalmic surgical instruments used in procedures involving optic nerve and the posterior segment populations; of the eye, in particular the retina, might represent a potential risk for iatrogenic transmission of vCJD. Tonsil is the tissue of choice for diagnostic biopsy and for population screening of surgical tissues to assess prevalence of preclinical vCJD infection within the UK and other populations.	Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England; Imperial Coll Sch Med St Marys, Dept Neurogenet, London W2 1PG, England; UCL, Inst Ophthalmol, Dept Pathol, London EC1V 9EL, England	Imperial College London; Imperial College London; University of London; University College London	Collinge, J (corresponding author), Imperial Coll Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England.	pacollinge@ic.ac.uk	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Luthert, Philip/0000-0001-7276-6898; Wadsworth, Jonathan/0000-0002-4797-2259	Medical Research Council [MC_U123160655] Funding Source: Medline; MRC [MC_U123160655] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		*ADV COMM DANG PAT, 1998, TRANSM SPONG ENC AG; Barbara J, 1998, BRIT MED J, V316, P717, DOI 10.1136/bmj.316.7133.717; BERNOULLI C, 1977, LANCET, V1, P478; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUDKA H, 1995, BRAIN PATHOL, V5, P319, DOI 10.1111/j.1750-3639.1995.tb00609.x; BUELER H, 1993, CELL, V73, P1399; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fraser JR, 1996, J GEN VIROL, V77, P2663, DOI 10.1099/0022-1317-77-10-2663; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill DP, 1997, DEV BRAIN RES, V102, P53, DOI 10.1016/S0165-3806(97)00076-X; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103; Wells GAH, 1999, VET REC, V144, P292, DOI 10.1136/vr.144.11.292; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	47	558	583	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					171	180		10.1016/S0140-6736(01)05403-4	http://dx.doi.org/10.1016/S0140-6736(01)05403-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476832				2022-12-24	WOS:000169967100008
J	Calzada, A; Sacristan, M; Sanchez, E; Bueno, A				Calzada, A; Sacristan, M; Sanchez, E; Bueno, A			Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ANAPHASE-PROMOTING COMPLEX; BUDDING YEAST; DNA-REPLICATION; MCM PROTEINS; S-PHASE; PROTEOLYSIS; GENES; CDK; ORIGINS	Exit from mitosis requires the inactivation of mitotic cyclin-dependent kinases (CDKs). In the budding yeast, Saccharomyces cerevisiae, inactivation of CDKs during late mitosis involves degradation of B-type cyclins as well as direct inhibition of cyclin-CDK complexes by the CDK-inhibitor protein Sic1 (refs 1-3). Several striking similarities exist between Sic1 and Cdc6, a DNA replication factor essential for the formation of pre-replicative complexes at origins of DNA replication(4-9). Transcription of both genes is activated during late mitosis by a process dependent on Swi5 (ref. 10). Like Sic1, Cdc6 binds CDK complexes in vivo(11,12) and downregulates them in vitro(11). Here we show that Cdc6, like Sic1, also contributes to inactivation of CDKs during late mitosis in S. cerevisiae. Deletion of the CDK-interacting domain of Cdc6 does not inhibit the function of origins of DNA replication during S phase, but instead causes a delay in mitotic exit; this delay is accentuated in the absence of Sic1 or of cyclin degradation. By contributing to mitotic exit and inactivation of CDKs, Cdc6 helps to create the conditions that are required for its subsequent role in the formation of pre-replicative complexes at origins of DNA replication.	Univ Salamanca, Inst Microbiol Bioquim, CSIC, Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Dept Genet & Microbiol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bueno, A (corresponding author), Univ Salamanca, Inst Microbiol Bioquim, CSIC, Campus Miguel de Unamuno, Salamanca, Spain.		Bueno, Avelino/A-9505-2016; Sánchez, Elisa/Z-3780-2019; Calzada, Arturo/M-1168-2014; Sacristán, María P/A-9587-2016; Sacristan, Maria/Y-4923-2019	Bueno, Avelino/0000-0002-0362-4391; Calzada, Arturo/0000-0002-3190-688X; Sacristán, María P/0000-0003-2314-8430; Sacristan, Maria/0000-0003-2314-8430				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; Detweiler CS, 1997, J CELL SCI, V110, P753; DONOVAN JD, 1994, GENE DEV, V8, P1640, DOI 10.1101/gad.8.14.1640; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Drury LS, 1997, EMBO J, V16, P5966, DOI 10.1093/emboj/16.19.5966; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; HOGAN E, 1992, P NATL ACAD SCI USA, V89, P3098, DOI 10.1073/pnas.89.7.3098; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Mizushima T, 2000, GENE DEV, V14, P1631; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pichler S, 1997, EMBO J, V16, P5988, DOI 10.1093/emboj/16.19.5988; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yuste-Rojas M, 2000, MOL GEN GENET, V263, P60, DOI 10.1007/PL00008676; ZWERSCHKE W, 1994, J BIOL CHEM, V269, P23352	26	61	63	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					355	358		10.1038/35085610	http://dx.doi.org/10.1038/35085610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460169				2022-12-24	WOS:000169918200052
J	Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA				Gersonde, R; Kyte, FT; Bleil, U; Diekmann, B; Flores, JA; Gohl, K; Grahl, G; Hagen, R; Kuhn, G; Sierro, FJ; Volker, D; Abelmann, A; Bostwick, JA			Geological record and reconstruction of the late Pliocene impact of the Eltanin asteroid in the Southern Ocean	NATURE			English	Article							ANTARCTICA; HISTORY; ICE	In 1995, an expedition on board the research vessel FS Polarstern explored the impact site of the Eltanin asteroid in the Southern Ocean, the only known asteroid impact into a deep ocean basin. Analyses of the geological record of the impact region place the event in the late Pliocene (similar to 2.15 Myr) and constrain the sire of the asteroid to be >1 km, The explosive force inferred for this event places it at the threshold of impacts believed to have global consequences, and its study should therefore provide a baseline for the reconstruction and modelling of similar events, which are common on geological timescales.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90095; UNIV BREMEN,FACHBEREICH GEOWISSENSCH,D-28334 BREMEN,GERMANY; UNIV SALAMANCA,DEPT GEOL,S-37008 SALAMANCA,SPAIN; MACQUARIE UNIV,SCH EARTH SCI,SYDNEY,NSW 2109,AUSTRALIA; USN,RES LAB,WASHINGTON,DC 20375	University of California System; University of California Los Angeles; University of Bremen; University of Salamanca; Macquarie University; United States Department of Defense; United States Navy; Naval Research Laboratory	Gersonde, R (corresponding author), ALFRED WEGENER INST POLAR & MARINE RES,POSTBOX 120161,D-27515 BREMERHAVEN,GERMANY.		Sierro, Francisco/A-4714-2008; Flores, Jose-Abel/D-4218-2009	Sierro, Francisco/0000-0002-8647-456X; Gohl, Karsten/0000-0002-9558-2116; Flores, Jose-Abel/0000-0003-1909-293X; Diekmann, Bernhard/0000-0001-5129-3649; Abelmann, Andrea/0000-0001-9432-0002; Kuhn, Gerhard/0000-0001-6069-7485				BARRETT PJ, 1992, NATURE, V359, P816, DOI 10.1038/359816a0; BARRETT PJ, IN PRESS P TERRA ANT, V3; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; Bruno LA, 1997, EARTH PLANET SC LETT, V147, P37, DOI 10.1016/S0012-821X(97)00003-4; Burckle LH, 1996, GEOLOGY, V24, P235, DOI 10.1130/0091-7613(1996)024<0235:PPDIPA>2.3.CO;2; CANDE SC, 1982, EARTH PLANET SC LETT, V57, P63, DOI 10.1016/0012-821X(82)90173-X; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; DEMUIZON C, 1981, I FRANCAIS ETUDES AN, V6; GERSONDE R, IN PRESS MICROPALEON; GORBUNOVA ZN, 1976, INIT REP DSDP, V35, P479; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; Hall BL, 1997, J GEOL, V105, P285, DOI 10.1086/515922; HARWOOD DM, 1983, ANTARCT J US, V18, P98; HILLS JG, 1994, HAZARDS DUE COMETS A, P779; KELLOGG DE, 1984, ANTARCT J US, V19, P44; KENNETT JP, 1993, GEOGR ANN, V75, P20; KYTE FT, 1988, SCIENCE, V241, P63, DOI 10.1126/science.241.4861.63; KYTE FT, 1986, GEOLOGY, V14, P485, DOI 10.1130/0091-7613(1986)14<485:RVISCA>2.0.CO;2; KYTE FT, 1981, NATURE, V292, P417, DOI 10.1038/292417a0; KYTE FT, 1985, GEOCHIM COSMOCHIM AC, V49, P1095, DOI 10.1016/0016-7037(85)90001-8; MARGOLIS SV, 1990, SCIENCE, V251, P1594; Melosh H.L, 1989, IMPACT CRATERING GEO; OKEEFE JD, 1981, J LUNAR PLANET SCI, V12, P785; Perch-Nielsen K., 1985, PLANKTON STRATIGRAPH, V1, P427; QUILTY PG, 1992, RECENT PROGR ANTARCT, P699; RAFFI I, 1993, PALEOCEANOGRAPHY, V8, P387, DOI 10.1029/93PA00755; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Stroeven AP, 1996, GEOLOGY, V24, P727, DOI 10.1130/0091-7613(1996)024<0727:OMMTAP>2.3.CO;2; SUGDEN DE, 1995, NATURE, V376, P412, DOI 10.1038/376412a0; Toon OB, 1997, REV GEOPHYS, V35, P41, DOI 10.1029/96RG03038; WEBB PN, 1991, QUATERNARY SCI REV, V10, P215, DOI 10.1016/0277-3791(91)90020-U; WEBB PN, 1984, GEOLOGY, V12, P287, DOI 10.1130/0091-7613(1984)12<287:CMSAIV>2.0.CO;2; WEI W, 1992, PALEOCEANOGRAPHY, V8, P85; 1965, MARINE GEOLOGY USNS	34	130	134	0	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 27	1997	390	6658					357	363		10.1038/37044	http://dx.doi.org/10.1038/37044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YH549	11536816	Green Submitted			2022-12-24	WOS:A1997YH54900051
J	RAU, GH; TAKAHASHI, T; MARAIS, DJD				RAU, GH; TAKAHASHI, T; MARAIS, DJD			LATITUDINAL VARIATIONS IN PLANKTON DELTA-C-13 - IMPLICATIONS FOR CO2 AND PRODUCTIVITY IN PAST OCEANS	NATURE			English	Article									NASA,AMES RES CTR,MOFFETT FIELD,CA 94035; COLUMBIA UNIV,LAMONT DOHERTY GEOL OBSERV,PALISADES,NY 10964	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Columbia University	RAU, GH (corresponding author), UNIV CALIF SANTA CRUZ,INST FIS TEORICA,SANTA CRUZ,CA 95064, USA.							ARTHUR MA, 1985, NATURE, V315, P216, DOI 10.1038/315216a0; BARRON EJ, 1985, CARBON CYCLE ATMOSPH, P504; BIGGS DC, 1987, OCEAN DRILLING PROJE, V113, P77; BRALOWER TJ, 1984, GEOLOGY, V12, P614, DOI 10.1130/0091-7613(1984)12<614:LPASDC>2.0.CO;2; CALDER JA, 1973, GEOCHIM COSMOCHIM AC, V37, P133, DOI 10.1016/0016-7037(73)90251-2; CHIPMAN DW, 1985, CARBON CHEM S ATLANT; DEAN WE, 1986, MAR GEOL, V70, P119, DOI 10.1016/0025-3227(86)90092-7; Degens E.T., 1969, ORG GEOCHEM, P304, DOI [10.1007/978-3-642-87734-6_14, DOI 10.1007/978-3-642-87734-6_14]; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; DESCOLASGROS C, 1985, MAR BIOL, V87, P1, DOI 10.1007/BF00396999; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eadie B.J., 1973, MAR CHEM, V1, P199, DOI [10.1016/0304-4203(73)90004-2, DOI 10.1016/0304-4203(73)90004-2]; ELSAYED SZ, 1984, MARINE PHYTOPLANKTON, P19; ESTEP MLF, 1984, GEOCHIM COSMOCHIM AC, V48, P591, DOI 10.1016/0016-7037(84)90287-4; FONTUGNE M, 1978, EARTH PLANET SC LETT, V41, P365, DOI 10.1016/0012-821X(78)90191-7; FONTUGNE MR, 1981, OCEANOL ACTA, V4, P85; Holm-Hansen O., 1977, ADAPTATIONS ANTARCTI, P11; KERBY NW, 1985, ADV BOT RES, V11, P71, DOI 10.1016/S0065-2296(08)60169-X; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KROOPNICK PM, 1985, DEEP-SEA RES, V32, P57, DOI 10.1016/0198-0149(85)90017-2; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; LEWAN MD, 1986, GEOCHIM COSMOCHIM AC, V50, P1583, DOI 10.1016/0016-7037(86)90121-3; MCCABE B, 1985, THESIS U WAIKATO; MIZUTANI H, 1982, ORIGINS LIFE EVOL B, V12, P377, DOI 10.1007/BF00927070; PARDUE JW, 1976, GEOCHIM COSMOCHIM AC, V40, P309, DOI 10.1016/0016-7037(76)90208-8; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; RAU GH, 1987, EARTH PLANET SC LETT, V82, P269, DOI 10.1016/0012-821X(87)90201-9; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Sackett W.M., 1974, ADV ORG GEOCHEM, P661; SACKETT WM, 1986, ORG GEOCHEM, V9, P63, DOI 10.1016/0146-6380(86)90087-2; SACKETT WM, 1965, SCIENCE, V148, P235, DOI 10.1126/science.148.3667.235; Sharkey T. D., 1985, INORGANIC CARBON UPT, P389; SMITH SV, 1981, NATURE, V294, P252, DOI 10.1038/294252a0; WADA E, 1987, DEEP-SEA RES, V34, P829, DOI 10.1016/0198-0149(87)90039-2; Weiss RF., 1974, MAR CHEM, V2, P203, DOI [DOI 10.1016/0304-4203(74)90015-2, 10.1016/0304-4203(74)90015-2]; WONG WW, 1978, GEOCHIM COSMOCHIM AC, V42, P1809, DOI 10.1016/0016-7037(78)90236-3	36	448	465	2	64	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 12	1989	341	6242					516	518		10.1038/341516a0	http://dx.doi.org/10.1038/341516a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU721	11536614				2022-12-24	WOS:A1989AU72100048
J	Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY				Ourednik, V; Ourednik, J; Flax, JD; Zawada, WM; Hutt, C; Yang, CH; Park, KI; Kim, SU; Sidman, RL; Freed, CR; Snyder, EY			Segregation of human neural stem cells in the developing primate forebrain	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING CEREBRAL-CORTEX; ADULT HUMAN HIPPOCAMPUS; MAMMALIAN BRAIN; NEUROGENESIS; NEOCORTEX; MIGRATION; NEURONS; TRANSPLANTATION; PROGENITORS	Many central nervous system regions at all stages of Life contain neural stem cells (NSCs). We explored how these disparate NSC pools might emerge. A traceable clone of human NSCs was implanted intraventricularly to allow its integration into cerebral germinal zones of Old World monkey fetuses. The NSCs distributed into two subpopulations: One contributed to corticogenesis by migrating along radial glia to temporally appropriate layers of the cortical plate and differentiating into lamina-appropriate neurons or glia; the other remained undifferentiated and contributed to a secondary germinal zone (the subventricular zone) with occasional members interspersed throughout brain parenchyma. An early neurogenetic program allocates the progeny of NSCs either immediately for organogenesis or to undifferentiated pools for later use in the "postdevelopmental" brain.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Colorado, Sch Med, Dept Med & Pharmacol, Denver, CO 80220 USA; Univ Colorado, Sch Med, Neurosci Program, Denver, CO 80220 USA; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Univ British Columbia, Dept Neurol, Vancouver, BC V6T 2B5, Canada; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg,LMRC, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Yonsei University; Yonsei University Health System; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ourednik, V (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, 855 Harvard Inst Med,77 Ave Louis Pasteur, Boston, MA 02115 USA.	vouredni@caregroup.harvard.edu; esnyder1@caregroup.harvard.edu						AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BAYER SA, 1994, NEUROIMAGE, V1, P296, DOI 10.1006/nimg.1994.1014; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; Goldman-Rakic P S, 1982, Neurosci Res Program Bull, V20, P520; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRANGER B, 1995, J COMP NEUROL, V360, P363, DOI 10.1002/cne.903600212; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mehler MF, 1999, BRAIN PATHOL, V9, P515, DOI 10.1111/j.1750-3639.1999.tb00539.x; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ourednik J, 1998, J COMP NEUROL, V395, P91, DOI 10.1002/(SICI)1096-9861(19980525)395:1<91::AID-CNE7>3.0.CO;2-C; Ourednik V, 1999, CLIN GENET, V56, P267, DOI 10.1034/j.1399-0004.1999.560403.x; Palmer TD, 1999, J NEUROSCI, V19, P8487; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Park K. I., 1998, Society for Neuroscience Abstracts, V24, P1310; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sidman R. L., 1982, HISTOL HISTOPATHOL, P3; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0	44	164	174	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1820	1824		10.1126/science.1060580	http://dx.doi.org/10.1126/science.1060580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11474066				2022-12-24	WOS:000170894400044
J	Chen, LF; Fischle, W; Verdin, E; Greene, WC				Chen, LF; Fischle, W; Verdin, E; Greene, WC			Duration of nuclear NF-kappa B action regulated by reversible acetylation	SCIENCE			English	Article							HISTONE DEACETYLASES; ALPHA; EXPRESSION; PHOSPHORYLATION; INHIBITOR; PROTEINS; BINDING	The nuclear expression and action of the nuclear factor kappa B (NF-kappaB) transcription factor requires signal-coupled phosphorylation and degradation of the I kappaB inhibitors, which normally bind and sequester this pleiotropically active factor in the cytoplasm. The subsequent molecular events that regulate the termination of nuclear NF-kappaB action remain poorly defined, although the activation of de novo I kappaB alpha gene expression by NF-kappaB likely plays a key rote. Our studies now demonstrate that the RelA subunit of NF-kappaB is subject to inducible acetylation and that acetylated forms of RelA interact weakly, if at all, with I kappaB alpha. Acetytated RelA is subsequently deacetylated through a specific interaction with histone deacetylase 3 (HDAC3). This deacetylation reaction promotes effective binding to I kappaB alpha and leads in turn to I kappaB alpha -dependent nuclear export of the complex through a chromosomal region maintenance-1 (CRM-1)-dependent pathway. Deacetylation of RelA by HDAC3 thus acts as an intranuclear molecular switch that both controls the duration of the NF-kappaB transcriptional response and contributes to the replenishment of the depleted cytoplasmic pool of latent NF-kappaB-I kappaB alpha complexes.	Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA.	wgreene@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER; NIMH NIH HHS [P30MH59037] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOGERD H, 1993, J VIROL, V67, P2496, DOI 10.1128/JVI.67.5.2496-2502.1993; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Denoyelle S., SYNTHESIS SAR STUDY; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	24	994	1029	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1653	1657		10.1126/science.1062374	http://dx.doi.org/10.1126/science.1062374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533489	Green Submitted			2022-12-24	WOS:000170802900062
J	Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR				Griffin, CT; Srinivasan, Y; Zheng, YW; Huang, W; Coughlin, SR			A role of thrombin receptor signaling in endothelial cells during embryonic development	SCIENCE			English	Article							TISSUE FACTOR; TRANSGENIC MICE; GROWTH-FACTOR; PROTHROMBIN DEFICIENCY; BLEEDING EVENTS; GENE-EXPRESSION; LETHALITY; COAGULATION; HEMORRHAGE	The coagulation protease thrombin triggers fibrin formation, platelet activation, and other cellular responses at sites of tissue injury. We report a rote for PAR1, a protease-activated G protein-coupled receptor for thrombin, in em,. bryonic development. Approximately half of Par1(-/-) mouse embryos died at midgestation with bleeding from multiple sites. PAR1 is expressed in endothelial cells, and a PAR1 transgene driven by an endothetial-specific promoter prevented death of Par1(-/-) embryos. our results suggest that the coagulation cascade and PAR1 modulate endothelial cell function in developing blood vessels and that thrombin's actions on endothelial cells-rather than on platelets, mesenchymal cells, or fibrinogen-contribute to vascular development and hemostasis in the mouse embryo.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.				NHLBI NIH HHS [HL44907, HL65590] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL044907] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; Esmon CT, 2000, BLOOD, V95, P1113, DOI 10.1182/blood.V95.4.1113.004k54_1113_1116; GOSPODAROWICZ D, 1978, J CELL BIOL, V77, P774, DOI 10.1083/jcb.77.3.774; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Papadimitriou E, 1997, AM J PHYSIOL-CELL PH, V272, pC1112, DOI 10.1152/ajpcell.1997.272.4.C1112; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Rugh R, 1990, MOUSE ITS REPROD DEV; SAMBRANO GR, IN PRESS NATURE; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SOIFER SJ, 1994, AM J PATHOL, V144, P60; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Toomey JR, 1996, BLOOD, V88, P1583; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603	27	221	236	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1666	1670		10.1126/science.1061259	http://dx.doi.org/10.1126/science.1061259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533492				2022-12-24	WOS:000170802900065
J	Jones, PA; Takai, D				Jones, PA; Takai, D			The role of DNA methylation in mammalian epigenetics	SCIENCE			English	Editorial Material							DE-NOVO METHYLATION; CPG ISLAND; METHYLTRANSFERASE GENE; HISTONE DEACETYLASE; DENOVO METHYLATION; CELL-LINES; BINDING; TRANSCRIPTION; CHROMOSOME; COMPLEX	Genes constitute only a small proportion of the total mammalian genome, and the precise control of their expression in the presence of an overwhelming background of noncoding DNA presents a substantial problem for their regulation. Noncoding DNA, containing introns, repetitive elements, and potentially active transposable elements, requires effective mechanisms for its tong-term silencing. Mammals appear to have taken advantage of the possibilities afforded by cytosine methylation to provide a heritable mechanism for altering DNA-protein interactions to assist in such silencing. Genes can be transcribed from methylation-free promoters even though adjacent transcribed and nontranscribed regions are extensively methylated. Gene promoters can be used and regulated white keeping noncoding DNA, including transposable elements, suppressed. Methylation is also used for Long-term epigenetic silencing of X-linked and imprinted genes and can either increase or decrease the level of transcription, depending on whether the methylation inactivates a positive or negative regulatory element.	Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Jones, PA (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem, USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave,MS 8302L, Los Angeles, CA 90089 USA.	jones_p@ccnt.hsc.usc.edu	jia, xu/A-8386-2016		NATIONAL CANCER INSTITUTE [R01CA082422] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA82422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baylin SB, 1998, ADV CANCER RES, V72, P141; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Carotti D, 1998, BIOCHEMISTRY-US, V37, P1101, DOI 10.1021/bi971031i; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHRISTMAN JK, 1995, P NATL ACAD SCI USA, V92, P7347, DOI 10.1073/pnas.92.16.7347; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gonzalgo ML, 1998, CANCER RES, V58, P1245; GRIGG G, 1994, BIOESSAYS, V16, P431, DOI 10.1002/bies.950160612; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Han L, 2001, MOL CELL BIOL, V21, P3416, DOI 10.1128/MCB.21.10.3416-3424.2001; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; HENDRIKS RW, 1992, GENOMICS, V14, P598, DOI 10.1016/S0888-7543(05)80157-0; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; JAHNER D, 1985, NATURE, V315, P594, DOI 10.1038/315594a0; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; TAKAI D, UNPUB; Turker MS, 1999, SEMIN CANCER BIOL, V9, P329, DOI 10.1006/scbi.1999.0133; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yeivin A, 1993, EXS, V64, P523; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	47	1413	1536	6	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1068	1070		10.1126/science.1063852	http://dx.doi.org/10.1126/science.1063852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498573				2022-12-24	WOS:000170432600041
J	Park, Y; Kuroda, MI				Park, Y; Kuroda, MI			Epigenetic aspects of X-chromosome dosage compensation	SCIENCE			English	Editorial Material							INACTIVATION CENTER; ACETYL TRANSFERASE; MALE DROSOPHILA; MSL COMPLEX; HISTONE H3; RNA PAINTS; CHROMATIN; EVOLUTION; SEX; GENES	The X chromosomes of mammals and fruit flies exhibit unusual properties that have evolved to deal with the different dosages of X-linked genes in mates (XY) and females (XX). The X chromosome dosage-compensation mechanisms discovered in these species are evolutionarily unrelated, but exhibit surprising parallels in their regulatory strategies. These features include the importance of noncoding RNAs, and epigenetic spreading of chromatin-modifying activities.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute	Park, Y (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bone JR, 1996, GENETICS, V144, P705; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Debrand E, 1999, MOL CELL BIOL, V19, P8513; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 2000, CURR OPIN GENET DEV, V10, P555, DOI 10.1016/S0959-437X(00)00127-1; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KRIVSHENKO J, 1959, GENETICS, V44, P1027; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MARIN I, 1996, NATURE, V383; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meyer BJ, 2000, TRENDS GENET, V16, P247, DOI 10.1016/S0168-9525(00)02004-7; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASMUSSEN TP, 2001, CHROMOSOMA      0720; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Sado T, 2001, DEVELOPMENT, V128, P1275; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Solter D, 1997, GENE DEV, V11, P153, DOI 10.1101/gad.11.2.153; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	47	83	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1083	1085		10.1126/science.1063073	http://dx.doi.org/10.1126/science.1063073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498577				2022-12-24	WOS:000170432600045
J	Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM				Harries, AD; Nyangulu, DS; Hargreaves, NJ; Kaluwa, O; Salaniponi, FM			Preventing antiretroviral anarchy in sub-Saharan Africa	LANCET			English	Editorial Material							TUBERCULOSIS; AIDS	Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS In Industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.(1) Treatment of HIV-infection is likely to be lifelong.(2) Unfortunately, many HIV-Infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.	Natl TB Control Programme, Community Hlth Sci Unit, Lilongwe, Malawi; Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; Natl AIDS Control Programme, Lilongwe, Malawi	Liverpool School of Tropical Medicine	Harries, AD (corresponding author), British High Commiss, POB 30042, Lilongwe 3, Malawi.	adharries@malawi.net	Franzeck, Fabian C/B-5055-2011					Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; HARRIES AD, 1996, WHOTB96200; Harrington M, 2000, LANCET, V355, P2147, DOI 10.1016/S0140-6736(00)02388-6; Horton R, 2000, LANCET, V356, P1541, DOI 10.1016/S0140-6736(00)03122-6; Kumar S, 2001, LANCET, V357, P616, DOI 10.1016/S0140-6736(05)71411-2; MAHER D, 1997, WHOTB97220; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; *UNAIDS, 2000, AIDS EP UPD; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; *WHO, 2000, GLOB TUB CONTR WHO R; *WHO, 2001, WHOHIS200004; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; World Health Organization, 1994, WHOTB94179	19	180	186	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2001	358	9279					410	414		10.1016/S0140-6736(01)05551-9	http://dx.doi.org/10.1016/S0140-6736(01)05551-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502341				2022-12-24	WOS:000170235100036
J	Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE				Newman, JH; Wheeler, L; Lane, KB; Loyd, E; Gaddipati, R; Phillips, JA; Loyd, JE			Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GERMLINE MUTATIONS	Background: Most patients with primary pulmonary hypertension are thought to have sporadic, not inherited, disease. Because clinical disease develops in only 10 to 20 percent of persons carrying the gene for familial primary pulmonary hypertension, we hypothesized that many patients with apparently sporadic primary pulmonary hypertension may actually have familial primary pulmonary hypertension. Methods: In a study conducted over 20 years, we developed a registry of 67 families affected by familial primary pulmonary hypertension. Through patient referrals, extensive family histories, and correlation of family pedigrees, we discovered shared ancestry among five subfamilies. We assessed some family members for mutations in the gene encoding bone morphogenetic protein receptor II (BMPR2), which has recently been found to cause familial primary pulmonary hypertension. Results: We linked five separately identified subfamilies that included 394 known members spanning seven generations, which were traced back to a founding couple in the mid-1800s. Familial primary pulmonary hypertension has been diagnosed in 18 family members, 12 of whom were first thought to have sporadic disease. The conditions of 7 of the 18 were initially misdiagnosed as other cardiopulmonary diseases. Six members affected with familial primary pulmonary hypertension and 6 of 10 at risk for carriage have undergone genotype analysis, and they have the same mutation in BMPR2, a transversion of thymine to guanine at position 354 in exon 3. Conclusions: Many cases of apparently sporadic primary pulmonary hypertension may be familial. The recent discovery of mutations in BMPR2 should make it possible to identify those with susceptibility to the disease.	Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med,Ctr Lung Res, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Div Med Genet, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Newman, JH (corresponding author), Vanderbilt Univ, Med Ctr N, Allergy Pulm & Crit Care Div, T-1218, Nashville, TN 37232 USA.			Loyd, James/0000-0002-5042-7390	NCRR NIH HHS [RR 00095] Funding Source: Medline; PHS HHS [R0I 48164-06] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DRESDALE DT, 1954, B NEW YORK ACAD MED, V30, P195; DRESDALE DT, 1951, AM J MED, V11, P686, DOI 10.1016/0002-9343(51)90020-4; ELLIOTT G, 1995, CHEST, V108, P973, DOI 10.1378/chest.108.4.973; KINGDON HS, 1966, ARCH INTERN MED, V118, P422, DOI 10.1001/archinte.118.5.422; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; LOYD JE, 1984, AM REV RESPIR DIS, V129, P194; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nichols WC, 1997, NAT GENET, V15, P277, DOI 10.1038/ng0397-277; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rich S, 1998, WORLD S PRIM PULM HY; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Zhou SB, 1999, NEW ENGL J MED, V341, P1144, DOI 10.1056/NEJM199910073411510	15	246	263	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					319	324		10.1056/NEJM200108023450502	http://dx.doi.org/10.1056/NEJM200108023450502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484688				2022-12-24	WOS:000170193600002
J	DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS				DiAntonio, A; Haghighi, AP; Portman, SL; Lee, JD; Amaranto, AM; Goodman, CS			Ubiquitination-dependent mechanisms regulate synaptic growth and function	NATURE			English	Article							FAT-FACETS GENE; DROSOPHILA; EXPRESSION; SYSTEM; LIGASE	The covalent attachment of ubiquitin to cellular proteins is a powerful mechanism for controlling protein activity and localization(1). Ubiquitination is a reversible modification promoted by ubiquitin ligases and antagonized by deubiquitinating proteases(2). Ubiquitin-dependent mechanisms regulate many important processes including cell-cycle progression, apoptosis and transcriptional regulation(3). Here we show that ubiquitin-dependent mechanisms regulate synaptic development at the Drosophila neuromuscular junction (NMJ). Neuronal overexpression of the deubiquitinating protease fat facets(4) leads to a profound disruption of synaptic growth control; there is a large increase in the number of synaptic boutons, an elaboration of the synaptic branching pattern, and a disruption of synaptic function. Antagonizing the ubiquitination pathway in neurons by expression of the yeast deubiquitinating protease UBP2 (ref. 5) also produces synaptic overgrowth and dysfunction. Genetic interactions between fat facets and highwire(6), a negative regulator of synaptic growth that has structural homology to a family of ubiquitin ligases, suggest that synaptic development may be controlled by the balance between positive and negative regulators of ubiquitination.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Washington University (WUSTL); University of California System; University of California Berkeley	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, 660 S Euclid,Campus Box 8103, St Louis, MO 63110 USA.			DiAntonio, Aaron/0000-0002-7262-0968				[Anonymous], COMPREHENSIVE MENTAL; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; Chen X, 2000, GENETICS, V156, P1829; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Rorth P, 1998, DEVELOPMENT, V125, P1049; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SERDAROGLU P, 1992, NEUROPATH APPL NEURO, V18, P232, DOI 10.1111/j.1365-2990.1992.tb00785.x; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu ZR, 1999, DEV GENET, V25, P312, DOI 10.1002/(SICI)1520-6408(1999)25:4<312::AID-DVG5>3.0.CO;2-Z; YAO KM, 1994, J NEUROCHEM, V63, P41; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	23	315	325	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					449	452		10.1038/35086595	http://dx.doi.org/10.1038/35086595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473321				2022-12-24	WOS:000170068200051
J	Stevens, RC; Wilson, IA				Stevens, RC; Wilson, IA			Industrializing structural biology	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; PROTEIN-PRODUCTION; TECHNOLOGY; AUTOMATION; RIBOSOME; MODEL; CORE; RNA		Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stevens, RC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, Dept Mol Biol, La Jolla, CA 92037 USA.		Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062411] Funding Source: NIH RePORTER; NIGMS NIH HHS [1P50 GM062411] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abola E, 2000, NAT STRUCT BIOL, V7, P973, DOI 10.1038/80754; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bernal JD, 1934, NATURE, V133, P794, DOI 10.1038/133794b0; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Diller DJ, 1999, ACTA CRYSTALLOGR D, V55, P656, DOI 10.1107/S0907444998014589; Ealick SE, 2000, CURR OPIN CHEM BIOL, V4, P495, DOI 10.1016/S1367-5931(00)00122-8; Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751; Georgalis Yannis, 1999, Science Progress, V82, P271; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763; Lorber B, 1999, PRACT APPROACH SER, P17; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McPherson A., 1999, CRYSTALLIZATION BIOL; Muchmore SW, 2000, STRUCTURE, V8, pR243, DOI 10.1016/S0969-2126(00)00535-9; Mueller U, 2001, J BIOTECHNOL, V85, P7, DOI 10.1016/S0168-1656(00)00349-7; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ramakrishnan V, 2001, CURR OPIN STRUC BIOL, V11, P144, DOI 10.1016/S0959-440X(00)00184-6; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROENTGEN WC, 1895, WURZBURG PHYSICAL ME; Service RF, 2001, SCIENCE, V292, P187; Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7; Stevens RC, 2000, STRUCTURE, V8, pR177, DOI 10.1016/S0969-2126(00)00193-3; Sweet RM, 1998, NAT STRUCT BIOL, V5, P654, DOI 10.1038/1344; Thornton JM, 2001, SCIENCE, V292, P2095, DOI 10.1126/science.292.5524.2095; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	31	33	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2001	293	5529					519	520		10.1126/science.293.5529.519	http://dx.doi.org/10.1126/science.293.5529.519			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463918				2022-12-24	WOS:000169966700053
J	Holland, HD				Holland, HD			Geochemistry - Evidence for life on Earth more than 3850 million years ago	SCIENCE			English	Editorial Material											Holland, HD (corresponding author), HARVARD UNIV,DEPT EARTH & PLANETARY SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							Chang S., 1983, EARTHS EARLIEST BIOS, P53; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640	4	39	41	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1997	275	5296					38	39		10.1126/science.275.5296.38	http://dx.doi.org/10.1126/science.275.5296.38			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WA903	11536783				2022-12-24	WOS:A1997WA90300035
J	Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP				Furlong, EEM; Andersen, EC; Null, B; White, KP; Scott, MP			Patterns of gene expression during Drosophila mesoderm Development	SCIENCE			English	Article							DORSAL VENTRAL POLARITY; TWIST GENE; MYOBLAST FUSION; PROTEIN; INDUCTION; EMBRYO; PATHWAY; COMPLEX; CELLS; TOLL	The transcription factor Twist initiates Drosophila mesoderm development, resulting in the formation of heart, somatic muscle, and other cell types. Using a Drosophila embryo sorter, we isolated enough homozygous twist mutant embryos to perform DNA microarray experiments. Transcription profiles of twist loss-of-function embryos, embryos with ubiquitous twist expression, and wild-type embryos were compared at different developmental stages. The results implicate hundreds of genes, many with vertebrate homologs, in stage-specific processes in mesoderm development. One such gene, gleeful, related to the vertebrate Gli genes, is essential for somatic muscle development and sufficient to cause neural cells to express a muscle marker.	Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Scott, MP (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst,Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.			Furlong, Eileen/0000-0002-9544-8339; Andersen, Erik/0000-0003-0229-9651	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG000045] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [K22 HG00045-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARMAND P, 1994, MOL CELL BIOL, V14, P4145, DOI 10.1128/MCB.14.6.4145; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; Campos-Ortega J.A., 1997, EMBRYONIC DEV DROSOP, V2nd, P9; Cann GM, 1999, ANAT EMBRYOL, V200, P239, DOI 10.1007/s004290050276; Casal J, 1996, P NATL ACAD SCI USA, V93, P10327, DOI 10.1073/pnas.93.19.10327; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LAKEY A, 1993, EMBO J, V12, P2863, DOI 10.1002/j.1460-2075.1993.tb05948.x; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; LEVINE M, 1988, CELL, V52, P785, DOI 10.1016/0092-8674(88)90418-7; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; REUTER R, 1993, DEVELOPMENT, V119, P1135; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Spring J, 2000, DEV BIOL, V228, P363, DOI 10.1006/dbio.2000.9956; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yin ZZ, 1997, DEVELOPMENT, V124, P4971	35	207	210	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1629	1633		10.1126/science.1062660	http://dx.doi.org/10.1126/science.1062660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11486054				2022-12-24	WOS:000170802900054
J	Deitsch, KW; Calderwood, MS; Wellems, TE				Deitsch, KW; Calderwood, MS; Wellems, TE			Malaria - Cooperative silencing elements in var genes	NATURE			English	Article							PLASMODIUM-FALCIPARUM; ANTIGENIC VARIATION; ERYTHROCYTES; TRANSCRIPTION; EXPRESSION; SWITCHES		NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deitsch, KW (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000483, Z01AI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Newbold CI, 1999, CURR OPIN MICROBIOL, V2, P420, DOI 10.1016/S1369-5274(99)80074-5; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1	10	172	174	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					875	876		10.1038/35091146	http://dx.doi.org/10.1038/35091146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528468				2022-12-24	WOS:000170689000034
J	Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C				Mollereau, B; Dominguez, M; Webel, R; Colley, NJ; Keung, B; de Celis, JF; Desplan, C			Two-step process for photoreceptor formation in Drosophila	NATURE			English	Article							CELL-FATE; RHODOPSIN; EYE; R7; EXPRESSION; PROTEIN; GENE; IDENTIFICATION; RECEPTOR; COMPLEX	The formation of photoreceptor cells (PRCs) in Drosophila serves as a paradigm for understanding neuronal determination and differentiation. During larval stages, a precise series of sequential inductive processes leads to the recruitment of eight distinct PRCs (R1-R8)(1). But, final photoreceptor differentiation, including rhabdomere morphogenesis and opsin expression, is completed four days later, during pupal development(2,3). It is thought that photoreceptor cell fate is irreversibly established during larval development, when each photoreceptor expresses a particular set of transcriptional regulators and sends its projection to different layers of the optic lobes. Here, we show that the spalt (sal) gene complex(4-7) encodes two transcription factors that are required late in pupation for photoreceptor differentiation. In the absence of the sal complex, rhabdomere morphology and expression of opsin genes in the inner PRCs R7 and R8 are changed to become identical to those of outer R1-R6 PRCs. However, these cells maintain their normal projections to the medulla part of the optic lobe, and not to the lamina where outer PRCs project. These data indicate that photoreceptor differentiation occurs as a two-step process. First, during larval development, the photoreceptor neurons become committed and send their axonal projections to their targets in the brain. Second, terminal differentiation is executed during pupal development and the photoreceptors adopt their final cellular properties.	NYU, Dept Biol, New York, NY 10003 USA; UMH, CSIC, Inst Neurociencias, San Juan Alicante 03550, Spain; Univ Wisconsin, Dept Ophthalmol, Madison, WI 53792 USA; Univ Wisconsin, Dept Visual Sci & Genet, Madison, WI 53792 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Celis, JF (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.		Dominguez, Maria/G-2171-2014; Mollereau, Bertrand/S-4447-2017; de+Celis, Jose/AAE-8142-2019	Dominguez, Maria/0000-0002-3329-7862; Mollereau, Bertrand/0000-0003-4710-8185; de Celis, Jose F./0000-0003-4808-9844; Desplan, Claude/0000-0002-6914-1413	NEI NIH HHS [R01 EY008768] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008768] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; BEGEMANN G, 1995, DEVELOPMENT, V121, P225; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Elstob PR, 2001, DEVELOPMENT, V128, P723; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; Freeman M, 1997, DEVELOPMENT, V124, P261; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kumar JP, 1997, DEV BIOL, V188, P43, DOI 10.1006/dbio.1997.8636; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; PERRY MM, 1968, J MORPHOL, V124, P227, DOI 10.1002/jmor.1051240208; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; Rusten TE, 2001, DEVELOPMENT, V128, P711; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Stowers RS, 1999, GENETICS, V152, P1631; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VENKATESH TR, 1985, TRENDS NEUROSCI, V8, P251, DOI 10.1016/0166-2236(85)90098-0	30	101	101	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2001	412	6850					911	913		10.1038/35091076	http://dx.doi.org/10.1038/35091076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528479				2022-12-24	WOS:000170689000045
J	Chiosis, G; Boneca, IG				Chiosis, G; Boneca, IG			Selective cleavage of D-Ala-D-Lac by small molecules: Re-sensitizing resistant bacteria to vancomycin	SCIENCE			English	Article							BIOSYNTHESIS; MECHANISM; PLASMID	Pathogenic enterococci are becoming resistant to currently available antibiotics, including vancomycin, the drug of last resort for Gram-positive infections. Enterococci pose a significant public health threat, not least because of the risk of transferring vancomycin resistance to the ubiquitous Staphylococcus aureus. Vancomycin resistance is manifested by cell wall peptidoglycan precursors with altered termini that cannot bind the antibiotic. Small molecules with well-oriented nucleophile-electrophile assembly and complementary chirality to the peptidoglycan termini were identified as catalytic and selective cleavers of the peptidoglycan precursor depsipeptide. These molecules were tested in combination with vancomycin and were found to re-sensitize vancomycin-resistant bacteria to the antibiotic.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Columbia University; Rockefeller University	Chiosis, G (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	chiosisg@mskmail.mskcc.org; bonecai@pasteur.fr	Boneca, Ivo G/H-1677-2014	Boneca, Ivo G/0000-0001-8122-509X				Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Arthur M, 1996, MOL MICROBIOL, V21, P33, DOI 10.1046/j.1365-2958.1996.00617.x; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; deJonge BLM, 1996, MICROB DRUG RESIST, V2, P225, DOI 10.1089/mdr.1996.2.225; French GL, 1998, CLIN INFECT DIS, V27, pS75, DOI 10.1086/514910; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; HANDWERGER S, 1990, ANTIMICROB AGENTS CH, V34, P358, DOI 10.1128/AAC.34.2.358; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; NESTLER HP, 1994, J ORG CHEM, V59, P4723, DOI 10.1021/jo00096a008; OHLMEYER MHJ, 1993, P NATL ACAD SCI USA, V90, P10922, DOI 10.1073/pnas.90.23.10922; Perl Trish M., 1999, American Journal of Medicine, V106, p26S, DOI 10.1016/S0002-9343(98)00354-4; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Sundram UN, 1996, J AM CHEM SOC, V118, P13107, DOI 10.1021/ja9621298; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Woodford N, 1998, J MED MICROBIOL, V47, P849, DOI 10.1099/00222615-47-10-849; WRIGHT GD, 1992, ACCOUNTS CHEM RES, V25, P468, DOI 10.1021/ar00022a006; Xu R, 1999, J AM CHEM SOC, V121, P4898, DOI 10.1021/ja990240i	18	52	54	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1484	1487		10.1126/science.1060324	http://dx.doi.org/10.1126/science.1060324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520986				2022-12-24	WOS:000170616000043
J	Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM				Dhanasekaran, SM; Barrette, TR; Ghosh, D; Shah, R; Varambally, S; Kurachi, K; Pienta, KJ; Rubin, MA; Chinnaiyan, AM			Delineation of prognostic biomarkers in prostate cancer	NATURE			English	Article							MOLECULAR CLASSIFICATION; EXPRESSION; PROGRESSION; GENETICS	Prostate cancer is the most frequently diagnosed cancer in American men(1,2). Screening for prostate-specific antigen (PSA) has led to earlier detection of prostate cancer(3), but elevated serum PSA levels may be present in non-malignant conditions such as benign prostatic hyperlasia (BPH). Characterization of gene-expression profiles that molecularly distinguish prostatic neoplasms may identify genes involved in prostate carcinogenesis, elucidate clinical biomarkers, and lead to an improved classification of prostate cancer(4-6). Using microarrays of complementary DNA, we examined gene-expression profiles of more than 50 normal and neoplastic prostate specimens and three common prostate-cancer cell lines. Signature expression profiles of normal adjacent prostate (NAP), BPH, localized prostate cancer, and metastatic, hormone-refractory prostate cancer were determined. Here we establish many associations between genes and prostate cancer. We assessed two of these genes-hepsin, a transmembrane serine protease, and pim-1, a serine/threonine kinase-at the protein level using tissue microarrays consisting of over 700 clinically stratified prostate-cancer specimens. Expression of hepsin and pim-1 proteins was significantly correlated with measures of clinical outcome. Thus, the integration of cDNA microarray, high-density tissue microarray, and linked clinical and pathology data is a powerful approach to molecular profiling of human cancer.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	; Pienta, Kenneth/E-7679-2015	Ghosh, Debashis/0000-0001-6618-1316; Pienta, Kenneth/0000-0002-4138-2186; Rubin, Mark/0000-0002-8321-9950; Varambally, Sooryanarayana/0000-0002-2277-1127; Dhanasekaran, saravana mohan/0000-0002-0489-2224				Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elek J, 2000, IN VIVO, V14, P173; Emmert-Buck MR, 2000, AM J PATHOL, V156, P1109, DOI 10.1016/S0002-9440(10)64979-6; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Tomita K, 2000, CANCER RES, V60, P3650; TSUJI A, 1991, J BIOL CHEM, V266, P16948	20	1328	1471	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2001	412	6849					822	826		10.1038/35090585	http://dx.doi.org/10.1038/35090585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518967	Green Published			2022-12-24	WOS:000170577200038
J	Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB				Peretz, D; Williamson, RA; Kaneko, K; Vergara, J; Leclerc, E; Schmitt-Ulms, G; Mehlhorn, IR; Legname, G; Wormald, MR; Rudd, PM; Dwek, RA; Burton, DR; Prusiner, SB			Antibodies inhibit prion propagation and clear cell cultures of prion infectivity	NATURE			English	Article							DOMINANT-NEGATIVE INHIBITION; MONOCLONAL-ANTIBODIES; HAMSTER PRP; PROTEIN PRP; SCRAPIE; CONVERSION; REPLICATION; PATHOLOGY; MODEL	Prions are the transmissible pathogenic agents responsible for diseases such as scrapie and bovine spongiform encephalopathy. In the favoured model of prion replication, direct interaction between the pathogenic prion protein (PrPSc) template and endogenous cellular prion protein (PrPC) is proposed to drive the formation of nascent infectious prions(1,2). Reagents specifically binding either prion-protein conformer may interrupt prion production by inhibiting this interaction. We examined the ability of several recombinant antibody antigen-binding fragments (Fabs) to inhibit prion propagation in cultured mouse neuroblastoma cells (ScN2a) infected with PrPSc. Here we show that antibodies binding cell-surface PrPC inhibit PrPSc formation in a dose-dependent manner. In cells treated with the most potent antibody, Fab D18, prion replication is abolished and pre-existing PrPSc is rapidly cleared, suggesting that this antibody may cure established infection. The potent activity of Fab D18 is associated with its ability to better recognize the total population of PrPC molecules on the cell surface, and with the location of its epitope on PrPC. Our observations support the use of antibodies in the prevention and treatment of prion diseases and identify a region of PrPC for drug targeting.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oxford	Williamson, RA (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.	anthony@scripps.edu; burton@scripps.edu	Wormald, Mark R/G-2785-2011; Legname, Giuseppe/C-1723-2012	Wormald, Mark R/0000-0002-4853-2773; Legname, Giuseppe/0000-0003-0716-4393				Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chabry J, 1999, J VIROL, V73, P6245, DOI 10.1128/JVI.73.8.6245-6250.1999; CHUONG CM, 1982, P NATL ACAD SCI-BIOL, V79, P4234, DOI 10.1073/pnas.79.13.4234; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Perrier V, 2000, P NATL ACAD SCI USA, V97, P6073, DOI 10.1073/pnas.97.11.6073; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; Priola SA, 2001, J VIROL, V75, P4673, DOI 10.1128/JVI.75.10.4673-4680.2001; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	29	431	467	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2001	412	6848					739	743		10.1038/35089090	http://dx.doi.org/10.1038/35089090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462ZB	11507642				2022-12-24	WOS:000170450200046
J	Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA				Saphire, EO; Parren, PWHI; Pantophlet, R; Zwick, MB; Morris, GM; Rudd, PM; Dwek, RA; Stanfield, RL; Burton, DR; Wilson, IA			Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEIN; GP120; INFECTION; LIBRARIES; EFFICIENT; PROTEINS; RECEPTOR; EPITOPE	We present the crystal structure at 2.7 angstrom resolution of the human antibody lgG1 b12. Antibody b12 recognizes the CD4-binding site of human immunodeficiency virus-1 (HIV-1) gp120 and is one of only two known antibodies against gp120 capable of broad and potent neutralization of primary HIV-1 isolates. A key feature of the antibody-combining site is the protruding, finger-like long CDR H3 that can penetrate the recessed CD4-binding site of gp120. A docking model of b12 and gp120 reveals severe structural constraints that explain the extraordinary challenge in eliciting effective neutralizing antibodies similar to b12. The structure, together with mutagenesis studies, provides a rationale for the extensive cross-reactivity of b12 and a valuable framework for the design of HIV-1 vaccines capable of eliciting b12-like activity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of Oxford	Burton, DR (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Stanfield, Robyn/AAH-3190-2019; Morris, Garrett Matthew/F-2465-2019; Saphire, Erica/A-7055-2009	Morris, Garrett Matthew/0000-0003-1731-8405; Saphire, Erica Ollmann/0000-0002-1206-7451; Parren, Paul/0000-0002-4365-3859	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI033292, R29AI040377] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33292, AI40377] Funding Source: Medline; NIGMS NIH HHS [GM46192] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; Burton DR, 2001, CURR TOP MICROBIOL, V260, P109; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; GELDERBLOM HR, 1987, VIROLOGY, V156, P171, DOI 10.1016/0042-6822(87)90449-1; JONES TA, 1982, COMPUTATIONAL CRYSTA, P303; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MENENDEZ A, UNPUB; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MICHAELSEN TE, 1994, P NATL ACAD SCI USA, V91, P9243, DOI 10.1073/pnas.91.20.9243; Mo HM, 1997, J VIROL, V71, P6869, DOI 10.1128/JVI.71.9.6869-6874.1997; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; SANNA PP, 1995, P NATL ACAD SCI USA, V92, P6439, DOI 10.1073/pnas.92.14.6439; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SANZ I, 1991, J IMMUNOL, V147, P1720; Saphire EO, 2001, ACTA CRYSTALLOGR D, V57, P168, DOI 10.1107/S0907444900017376; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; ZWICK MBV, UNPUB	44	732	802	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2001	293	5532					1155	1159		10.1126/science.1061692	http://dx.doi.org/10.1126/science.1061692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11498595				2022-12-24	WOS:000170432600065
J	Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV				Griffitts, JS; Whitacre, JL; Stevens, DE; Aroian, RV			Bt toxin resistance from loss of a putative carbohydrate-modifying enzyme	SCIENCE			English	Article							PESTICIDAL CRYSTAL PROTEINS; BACILLUS-THURINGIENSIS; CAENORHABDITIS-ELEGANS; AMINOPEPTIDASE-N; IDENTIFICATION; RECEPTOR; LECTIN; FOLD	The development of resistance is the main threat to the long-term use of toxins from Bacillus thuringiensis (Bt) in transgenic plants. Here we report the cloning of a Bt toxin resistance gene, Caenorhabditis elegans bre-5, which encodes a putative beta -1,3-galactosyltransferase. Lack of bre-5 in the intestine led to resistance to the Bt toxin Cry5B. Wild-type but not bre-5 mutant animals were found to uptake toxin into their gut cells, consistent with bre-5 mutants lacking toxin-binding sites on their apical gut. bre-5 mutants displayed resistance to Cry14A, a Bt toxin lethal to both nematodes and insects; this indicates that resistance by loss of carbohydrate modification is relevant to multiple Bt toxins.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aroian, RV (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.							Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GRIFFITTS JS, UNPUB; Jenkins JL, 1999, FEBS LETT, V462, P373, DOI 10.1016/S0014-5793(99)01559-8; Kostich M, 2000, J CELL SCI, V113, P2595; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; MARROQUIN L, UNPUB; Marroquin LD, 2000, GENETICS, V155, P1693; MCGAUGHEY WH, 1998, ISRAEL J ENTOMOL, V2, P1; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; PAYNE J, 1995, Patent No. 5589382; PAYNE JM, 1994, Patent No. 9416079; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; TABASHNIK BE, 1994, P ROY SOC B-BIOL SCI, V255, P7, DOI 10.1098/rspb.1994.0002; WHITACRE JF, UNPUB; Yochem J, 1998, GENETICS, V149, P1323	24	165	197	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					860	864		10.1126/science.1062441	http://dx.doi.org/10.1126/science.1062441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486087				2022-12-24	WOS:000170241000044
J	Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J				Galibert, F; Finan, TM; Long, SR; Puhler, A; Abola, P; Ampe, F; Barloy-Hubler, F; Barnett, MJ; Becker, A; Boistard, P; Bothe, G; Boutry, M; Bowser, L; Buhrmester, J; Cadieu, E; Capela, D; Chain, P; Cowie, A; Davis, RW; Dreano, S; Federspiel, NA; Fisher, RF; Gloux, S; Godrie, T; Goffeau, A; Golding, B; Gouzy, J; Gurjal, M; Hernandez-Lucas, I; Hong, A; Huizar, L; Hyman, RW; Jones, T; Kahn, D; Kahn, ML; Kalman, S; Keating, DH; Kiss, E; Komp, C; Lalaure, V; Masuy, D; Palm, C; Peck, MC; Pohl, TM; Portetelle, D; Purnelle, B; Ramsperger, U; Surzycki, R; Thebault, P; Vandenbol, M; Vorholter, FJ; Weidner, S; Wells, DH; Wong, K; Yeh, KC; Batut, J			The composite genome of the legume symbiont Sinorhizobium meliloti	SCIENCE			English	Article							MOLECULAR-BASIS; RHIZOBIUM; AGROBACTERIUM; GENES	The scarcity of usable nitrogen frequently limits plant growth. A tight metabolic association with rhizobial bacteria allows legumes to obtain nitrogen compounds by bacterial reduction of dinitrogen (N-2) to ammonium (NH4+). We present here the annotated DNA sequence of the alpha -proteobacterium Sinorhizobium meliloti, the symbiont of alfalfa. The tripartite 6.7-megabase (Mb) genome comprises a 3.65-Mb chromosome, and 1.35-Mb pSymA and 1.68-Mb pSymB megaplasmids. Genome sequence analysis indicates that all three elements contribute, in varying degrees, to symbiosis and reveals how this genome may have emerged during evolution. The genome sequence will be useful in understanding the dynamics of interkingdom associations and of life in soil environments.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Fac Med, Lab Genet & Dev, CNRS, UMR 6061, F-35043 Rennes, France; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; Univ Bielefeld, D-33615 Bielefeld, Germany; Stanford Ctr DNA Sequencing & Technol, Stanford, CA 94305 USA; INRA, Lab Biol Mol Relat Plantes Microorganisms, CNRS, UMR 215, F-31326 Castanet Tolosan, France; GATC Biotech AG, D-78467 Constance, Germany; Univ Catholique Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Fac Sci Agron Gembloux, Unite Biol Anim & Microbienne, B-5030 Gembloux, Belgium; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Centre National de la Recherche Scientifique (CNRS); McMaster University; University of Bielefeld; Stanford University; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Catholique Louvain; Washington State University	Long, SR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Yeh, Kuo-Chen/AAG-4485-2021; Kahn, Daniel/B-9393-2013; Albers, Pieter/I-2563-2017; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Thébault, Patricia/AAD-1105-2020; BATUT, Jacques/B-6506-2008; Kiss, Ernö/B-4836-2008; Gouzy, Jerome/AAH-4977-2020	Yeh, Kuo-Chen/0000-0002-3791-3423; Kahn, Daniel/0000-0001-8093-0854; Chain, Patrick/0000-0003-3949-3634; Thébault, Patricia/0000-0003-2276-4573; Gouzy, Jerome/0000-0001-5695-4557; Boutry, Marc/0000-0002-2315-6900; Wong, Kim/0000-0002-0984-1477; Barloy-Hubler, Frederique/0000-0002-8277-6034; Barnett, Melanie/0000-0003-3350-278X; Puhler, Alfred/0000-0003-4723-2960; Kiss, Erno/0000-0002-7344-1750; Kahn, Michael/0000-0002-5204-561X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030962, R37GM030962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARNETT MJ, IN PRESS P NATL ACAD; CAPELA D, IN PRESS P NATL ACAD; FINAN T, IN PRESS P NATL ACAD; FLORES M, 1987, J BACTERIOL, V169, P5782, DOI 10.1128/jb.169.12.5782-5788.1987; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gottfert M, 2001, J BACTERIOL, V183, P1405, DOI 10.1128/JB.183.4.1405-1412.2001; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Matthysse AG, 1996, J BACTERIOL, V178, P5302, DOI 10.1128/jb.178.17.5302-5308.1996; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oresnik IJ, 2000, J BACTERIOL, V182, P3582, DOI 10.1128/JB.182.12.3582-3586.2000; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; RENALIER MH, 1987, J BACTERIOL, V169, P2239; SCHWEDOCK JS, 1992, GENETICS, V132, P899; SCHWEDOCK JS, 1994, MOL PLANT MICROBE IN, V11, P1119; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Viprey V, 2000, Subcell Biochem, V33, P437; Viprey V, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-6-research0014	17	909	1838	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					668	672		10.1126/science.1060966	http://dx.doi.org/10.1126/science.1060966			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474104				2022-12-24	WOS:000170204600047
J	Otterbein, LR; Graceffa, P; Dominguez, R				Otterbein, LR; Graceffa, P; Dominguez, R			The crystal structure of uncomplexed actin in the ADP state	SCIENCE			English	Article							I-BINDING LOOP; F-ACTIN; SUBDOMAIN 2; DIVALENT-CATION; CONFORMATION; MECHANISM; PHOSPHATE; MOVEMENT; GELSOLIN; COMPLEX	The dynamics and polarity of actin filaments are controlled by a conformational change coupled to the hydrolysis of adenosine S'-triphosphate (ATP) by a mechanism that remains to be elucidated. Actin modified to block polymerization was crystallized in the adenosine 5'-diphosphate (ADP) state, and the structure was solved to 1.54 angstrom resolution. Compared with previous ATP-actin structures from complexes with deoxyribonuclease I, profilin, and gelsotin, monomeric ADP-actin is characterized by a marked conformational change in subdomain 2. The successful crystallization of monomeric actin opens the way to future structure determinations of actin complexes with actin-binding proteins such as myosin.	Boston Biomed Res Inst, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Dominguez, R (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.	dominguez@bbri.org	ID, IMCACAT/D-5867-2014		NCRR NIH HHS [RR07707] Funding Source: Medline; NIAMS NIH HHS [R01 AR046524, R01 AR46524, P01 AR41637] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637, R01AR046524] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen PG, 1996, J BIOL CHEM, V271, P4665; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Borovikov YS, 2000, BBA-PROTEIN STRUCT M, V1478, P138, DOI 10.1016/S0167-4838(00)00005-4; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; Graceffa P, 2000, J BIOL CHEM, V275, P17143, DOI 10.1074/jbc.M001979200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; Moraczewska J, 1999, BIOPHYS J, V77, P373, DOI 10.1016/S0006-3495(99)76896-7; MUHLRAD A, 1994, J BIOL CHEM, V269, P11852; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; ORLOVA A, 1992, J MOL BIOL, V227, P1043, DOI 10.1016/0022-2836(92)90520-T; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Robinson RC, 1999, SCIENCE, V286, P1939, DOI 10.1126/science.286.5446.1939; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sheterline P, 1998, ACTIN	28	409	415	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2001	293	5530					708	711		10.1126/science.1059700	http://dx.doi.org/10.1126/science.1059700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474115				2022-12-24	WOS:000170204600058
J	GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N				GRUN, E; ZOOK, HA; BAGUHL, M; FECHTIG, H; HANNER, MS; KISSEL, J; LINDBLAD, BA; LINKERT, D; LINKERT, G; MANN, IB; MCDONNELL, JAM; MORFILL, GE; POLANSKEY, C; RIEMANN, R; SCHWEHM, G; SIDDIQUE, N			ULYSSES DUST MEASUREMENTS NEAR JUPITER	SCIENCE			English	Article							GOSSAMER RING	Submicrometer- to micrometer-sized particles were recorded by the Ulysses dust detector within 40 days of the Jupiter flyby. Nine impacts were recorded within 50 Jupiter radii with most of them recorded after closest approach. Three of these impacts are consistent with particles on prograde orbits around Jupiter and the rest are believed to have resulted from gravitationally focused interplanetary dust. From the ratio of the impact rate before the Jupiter flyby to the impact rate after the Jupiter flyby it is concluded that interplanetary dust particles at the distance of Jupiter move on mostly retrograde orbits. On 10 March 1992, Ulysses passed through an intense dust stream. The dust detector recorded 126 impacts within 26 hours. The stream particles were moving on highly inclined and apparently hyperbolic orbits with perihelion distances of >5 astronomical units. Interplanetary dust is lost rather quickly from the solar system through collisions and other mechanisms and must be almost continuously replenished to maintain observed abundances. Dust flux measurements, therefore, give evidence of the recent rates of production from sources such as comets, asteroids, and moons, as well as the possible presence of interstellar grains.	NASA, LYNDON B JOHNSON SPACE CTR, HOUSTON, TX 77058 USA; JET PROP LAB, PASADENA, CA 91109 USA; MAX PLANCK INST AERON, W-3411 KATLENBURG DUHM, GERMANY; UNIV KENT, CANTERBURY CT2 7NR, ENGLAND; MAX PLANCK INST EXTRATERRESTR PHYS, W-8046 GARCHING, GERMANY; EUROPEAN SPACE AGCY, EUROPEAN SPACE TECHNOL CTR, 2200 AG NOORDWIJK, NETHERLANDS	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; University of Kent; Max Planck Society; European Space Agency	GRUN, E (corresponding author), MAX PLANCK INST NUCL PHYS, W-6900 HEIDELBERG 1, GERMANY.							BAGUHL M, IN PRESS P HYPERVELO; DIVINE N, 1992, 52179214 JET PROP LA; GOLLER JR, 1989, PLANET SPACE SCI, V37, P1197, DOI 10.1016/0032-0633(89)90014-7; GRUN E, 1992, ASTRON ASTROPHYS SUP, V92, P411; GRUN E, 1992, GEOPHYS RES LETT, V19, P1311, DOI 10.1029/92GL00629; Grun E., 1984, PLANETARY RINGS, P275; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; HOLZER TE, 1989, ANNU REV ASTRON ASTR, V27, P199; HUMES DH, 1974, J GEOPHYS RES, V79, P3677, DOI 10.1029/JA079i025p03677; HUMES DH, 1980, J GEOPHYS RES-SPACE, V85, P5841, DOI 10.1029/JA085iA11p05841; KAISER ML, COMMUNICATION; MARSDEN BG, 1989, CATALOGUE COMETARY O; NORTHROP TG, 1989, ICARUS, V79, P101, DOI 10.1016/0019-1035(89)90110-3; SHOWALTER MR, 1985, NATURE, V316, P526, DOI 10.1038/316526a0; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; SMITH EJ, 1992, SCIENCE, V257, P1503, DOI 10.1126/science.257.5076.1503; STONE RG, 1992, ASTRON ASTROPHYS SUP, V92, P291	17	40	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	1992	257	5076					1550	1552		10.1126/science.11538054	http://dx.doi.org/10.1126/science.11538054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JM570	11538054				2022-12-24	WOS:A1992JM57000033
J	DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL				DEBERGH, C; BEZARD, B; OWEN, T; CRISP, D; MAILLARD, JP; LUTZ, BL			DEUTERIUM ON VENUS - OBSERVATIONS FROM EARTH	SCIENCE			English	Article							ATMOSPHERE; HYDROGEN; ABUNDANCE; ESCAPE; MODEL; MARS; WET	Absorption lines of HDO and H2O have been detected in a 0.23-wave number resolution spectrum of the dark side of Venus in the interval 2.34 to 2.43 micrometers, where the atmosphere is sounded in the altitude range from 32 to 42 kilometers (8 to 3 bars). The resulting value of the deuterium-to-hydrogen ratio (D/H) is 120 +/- 40 times the telluric ratio, providing unequivocal confirmation of in situ Pioneer Venus mass spectrometer measurements that were in apparent conflict with an upper limit set from International Ultraviolet Explorer spectra. The 100-fold enrichment of the D/H ratio on Venus compared to Earth is thus a fundamental constraint on models for its atmospheric evolution.	LOWELL OBSERV,FLAGSTAFF,AZ 86001; UNIV HAWAII,INST ASTRON,HONOLULU,HI 96822; CALTECH,JET PROP LAB,PASADENA,CA 91109; INST ASTROPHYS,F-75014 PARIS,FRANCE	University of Hawaii System; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); UDICE-French Research Universities; Sorbonne Universite	DEBERGH, C (corresponding author), OBSERV PARIS,DEPT RECH SPATIALE,SECT MEUDON,F-92195 MEUDON,FRANCE.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998; Bezard, Bruno/0000-0002-5433-5661				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; BERTAUX JL, 1989, NATURE, V338, P567, DOI 10.1038/338567a0; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; desBergh C., 1989, B AM ASTRON SOC, V21, P926; DONAHUE T, 1989, NATURE, V340, P514; DONAHUE TM, 1989, NATURE, V340, P513, DOI 10.1038/340513b0; DONAHUE TM, 1982, SCIENCE, V216, P630, DOI 10.1126/science.216.4546.630; Esposito L. W., 1983, Venus, P484; GRINSPOON DH, 1988, ICARUS, V74, P21, DOI 10.1016/0019-1035(88)90028-0; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; HARTLE RE, 1983, J GEOPHYS RES LETT, V10, P1965; HUNTEN DM, 1989, ORIGIN EVOLUTION PLA, P00386; IP WH, 1988, ICARUS, V74, P47, DOI 10.1016/0019-1035(88)90030-9; KAULA WM, 1990, SCIENCE, V247, P1191, DOI 10.1126/science.247.4947.1191; KUMAR S, 1985, ICARUS, V62, P494, DOI 10.1016/0019-1035(85)90189-7; Lewis J. S., 1970, Earth and Planetary Science Letters, V10, P73, DOI 10.1016/0012-821X(70)90066-X; MCELROY MB, 1982, SCIENCE, V215, P1614, DOI 10.1126/science.215.4540.1614; OWEN T, 1988, SCIENCE, V240, P1767, DOI 10.1126/science.240.4860.1767; REVERCOMB HE, 1985, ICARUS, V61, P521, DOI 10.1016/0019-1035(85)90140-X; RODRIGUEZ JM, 1984, PLANET SPACE SCI, V32, P1235, DOI 10.1016/0032-0633(84)90067-9; Taylor HA, 1980, J GEOPHYS RES-SPACE, V85, P7765, DOI 10.1029/JA085iA13p07765; TUREKIAN KK, 1975, J ATMOS SCI, V32, P1257, DOI 10.1175/1520-0469(1975)032<1257:TNHAMF>2.0.CO;2; von Zahn U., 1983, Venus, P299; WALKER JCG, 1970, J GEOPHYS RES, V75, P3558, DOI 10.1029/JC075i018p03558	30	125	126	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 1	1991	251	4993					547	549		10.1126/science.251.4993.547	http://dx.doi.org/10.1126/science.251.4993.547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV459	11538265	Green Submitted			2022-12-24	WOS:A1991EV45900046
J	Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS				Sale, JE; Calandrini, DM; Takata, M; Takeda, S; Neuberger, MS			Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation	NATURE			English	Article							DOUBLE-STRAND BREAKS; LIGHT-CHAIN GENE; HOMOLOGOUS RECOMBINATION; CHROMOSOME STABILITY; REPAIR GENES; DNA; PROMOTES; CHICKEN; DIVERSIFICATION; MAINTENANCE	After gene rearrangement, immunoglobulin V genes are further diversified by either somatic hypermutation or gene conversion(1). Hypermutation (in man and mouse) occurs by the fixation of individual, non-templated nucleotide substitutions. Gene conversion (in chicken) is templated by a set of upstream V pseudogenes. Here we show that if the RAD51 paralogues(2) XRCC2, XRCC3 or RAD51B are ablated the pattern of diversification of the immunoglobulin V gene in the chicken DT40 B-cell lymphoma line(3) exhibits a marked shift from one of gene conversion to one of somatic hypermutation. Non-templated, single-nucleotide substitutions are incorporated at high frequency specifically into the V domain, largely at G/C and with a marked hotspot preference. These mutant DT40 cell lines provide a tractable model for the genetic dissection of immunoglobulin hypermutation and the results support the idea that gene conversion and somatic hypermutation constitute distinct pathways for processing a common lesion in the immunoglobulin V gene. The marked induction of somatic hypermutation that is achieved by ablating the RAD51 paralogues is probably a consequence of modifying the recombination-mediated repair of such initiating lesions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Kawasaki Med Sch, Okayama 7010192, Japan; Kyoto Univ, Fac Med, CREST Res Project, Sakyo Ku, Kyoto 6068501, Japan	MRC Laboratory Molecular Biology; Kawasaki Medical School; Japan Science & Technology Agency (JST); Kyoto University	Sale, JE (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	msn@mrc-lmb.cam.ac.uk		Takata, Minoru/0000-0002-4926-3675; Takeda, Shunichi/0000-0002-7924-7991; Sale, Julian/0000-0002-5031-3780				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Cui X, 1999, MUTAT RES-DNA REPAIR, V434, P75, DOI 10.1016/S0921-8777(99)00010-5; Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675; Diaz M, 2001, PHILOS T R SOC B, V356, P67, DOI 10.1098/rstb.2000.0750; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; HONJO T, 1995, IMMUNOGLOBULIN GENES; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; MCCORMACK WT, 1993, MOL CELL BIOL, V13, P821, DOI 10.1128/MCB.13.2.821; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sayegh CE, 1999, EMBO J, V18, P6319, DOI 10.1093/emboj/18.22.6319; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; XU B, 1994, SCIENCE, V265, P1590, DOI 10.1126/science.8079173; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430	30	185	196	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					921	926		10.1038/35091100	http://dx.doi.org/10.1038/35091100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528482				2022-12-24	WOS:000170689000048
J	Lovley, DR				Lovley, DR			Bioremediation - Anaerobes to the rescue	SCIENCE			English	Editorial Material							PETROLEUM-CONTAMINATED AQUIFER; IN-SITU; BENZENE		Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA	University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01337 USA.	dlovley@microbio.umass.edu						Alexander M., 1999, BIODEGRADATION BIORE; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 2000, ENVIRON SCI TECHNOL, V34, P2261, DOI 10.1021/es991211a; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Chapelle F, 2001, GROUND WATER MICROBI; Cunningham JA, 2001, ENVIRON SCI TECHNOL, V35, P1663, DOI 10.1021/es001722t; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Lee MD, 1998, ANNU REV MICROBIOL, V52, P423, DOI 10.1146/annurev.micro.52.1.423; Lloyd JR, 2001, CURR OPIN BIOTECH, V12, P248, DOI 10.1016/S0958-1669(00)00207-X; Lovley DR, 2000, BIODEGRADATION, V11, P107, DOI 10.1023/A:1011191220463; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Smith RL, 2001, ENVIRON SCI TECHNOL, V35, P196, DOI 10.1021/es001360p; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Wilson MS, 1999, APPL ENVIRON MICROB, V65, P80	15	151	162	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1444	1446		10.1126/science.1063294	http://dx.doi.org/10.1126/science.1063294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520973				2022-12-24	WOS:000170616000030
J	Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M				Homma, K; Yoshimura, M; Saito, J; Ikebe, R; Ikebe, M			The core of the motor domain determines the direction of myosin movement	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; ACTIN-BASED MOTOR; UNCONVENTIONAL MYOSINS; COMPLEX; KINESIN; VI; CONFORMATION; ELEGANS; FAMILY; CHAIN	Myosins constitute a superfamily of at least 18 known classes of molecular motors that move along actin filaments(1-3). Myosins move towards the plus end of F-actin filaments; however, it was shown recently that a certain class of myosin, class VI myosin, moves towards the opposite end of F-actin, that is, in the minus direction(4). As there is a large, unique insertion in the myosin VI head domain between the motor domain and the light-chain-binding domain (the lever arm), it was thought that this insertion alters the angle of the lever-arm switch movement, thereby changing the direction of motility(4). Here we determine the direction of motility of chimaeric myosins that comprise the motor domain and the lever-arm domain (containing an insert) from myosins that have movement in the opposite direction. The results show that the motor core domain, but neither the large insert nor the converter domain, determines the direction of myosin motility.	Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.							AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hodge T, 2000, J CELL SCI, V113, P3353; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; IKEBE M, 1985, J BIOL CHEM, V260, P3146; Kelleher JF, 2000, CURR BIOL, V10, P1489, DOI 10.1016/S0960-9822(00)00828-9; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sata M, 1996, BIOCHEMISTRY-US, V35, P11113, DOI 10.1021/bi960435s; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	26	60	61	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2001	412	6849					831	834		10.1038/35090597	http://dx.doi.org/10.1038/35090597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465ET	11518969				2022-12-24	WOS:000170577200040
J	Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D				Block, BA; Dewar, H; Blackwell, SB; Williams, TD; Prince, ED; Farwell, CJ; Boustany, A; Teo, SLH; Seitz, A; Walli, A; Fudge, D			Migratory movements, depth preferences, and thermal biology of Atlantic bluefin tuna	SCIENCE			English	Article							GULF-OF-MEXICO; THUNNUS-THYNNUS; SATELLITE; FISH; TEMPERATURE; TRACKING; EAST	The deployment of electronic data storage tags that are surgically implanted or satellite-linked provides marine researchers with new ways to examine the movements, environmental preferences, and physiology of pelagic vertebrates. We report the results obtained from tagging of Atlantic bluefin tuna with implantable archival and pop-up satellite archival tags. The electronic tagging data provide insights into the seasonal movements and environmental preferences of this species. Bluefin tuna dive to depths of >1000 meters and maintain a warm body temperature. Western-tagged bluefin tuna make trans-Atlantic migrations and they frequent spawning grounds in the Gulf of Mexico and eastern Mediterranean. These data are critical for the future management and conservation of bluefin tuna in the Atlantic.	Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Pfleger Inst Environm Res, Oceanside, CA 92054 USA; Monterey Bay Aquarium, Monterey, CA 93940 USA; Natl Marine Fisheries Serv, Miami, FL 33149 USA	Stanford University; Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374				Altringham JD, 1997, J EXP BIOL, V200, P2617; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; BAYLIFF WH, 1991, B IATTC, V20, P1; Block BA, 1998, MAR TECHNOL SOC J, V32, P37; Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; CAREY FG, 1984, J EXP BIOL, V109, P1; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Hill Roger D., 1994, P227; Kitagawa T, 2000, MAR ECOL PROG SER, V206, P251, DOI 10.3354/meps206251; Koudil M, 2000, CR ACAD SCI III-VIE, V323, P377, DOI 10.1016/S0764-4469(00)00144-X; LEBOEUF BJ, 2000, ECOL MONOGR, V353, P70; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MAGGIO T, 2000, MATTANZA; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; MATHER FJ, 1995, 370 NOAA NMFSSFSC; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Nemerson D, 2000, FISH B-NOAA, V98, P118; NISHIDA T, 1998, 107 ICCAT; RODRIGUEZRODA J, 1967, INVEST PESQ, V31, P349; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; SCOTT GP, 1993, B MAR SCI, V53, P912; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	27	485	506	5	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1310	1314		10.1126/science.1061197	http://dx.doi.org/10.1126/science.1061197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509729				2022-12-24	WOS:000170492600038
J	Hippisley-Cox, J; Pringle, M				Hippisley-Cox, J; Pringle, M			General practice workload implications of the national service framework for coronary heart disease: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England	University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283				Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Department of Health, 2000, NAT SERV FRAM COR AR; Hippisley-Cox J, 2001, BMJ-BRIT MED J, V322, P832, DOI 10.1136/bmj.322.7290.832; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367	5	31	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2001	323	7307					269	270		10.1136/bmj.323.7307.269	http://dx.doi.org/10.1136/bmj.323.7307.269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	461ZT	11485958	Bronze, Green Published			2022-12-24	WOS:000170394300022
J	Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA				Alabadi, D; Oyama, T; Yanovsky, MJ; Harmon, FG; Mas, P; Kay, SA			Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock	SCIENCE			English	Article							TRANSCRIPTION FACTOR; MOLECULAR-BASES; EXPRESSION; THALIANA; GENE; RHYTHMS; MUTANT	The interactive regulation between clock genes is central for oscillator function. Here, we show interactions between the Arabidopsis clock genes LATE ELONGATED HYPOCOTYL (LHY), CIRCADIAN CLOCK ASSOCIATED 1 (CCA1), and TIMING OF CAB EXPRESSION 1 (TOC1). The MYB transcription factors LHY and CCA1 negatively regulate TOC1 expression. We show that both proteins bind to a region in the TOC1 promoter that is critical for its clock regulation. Conversely, TOC1 appears to participate in the positive regulation of LHY and CCA1 expression. Our results indicate that these interactions form a loop critical for clock function in Arabidopsis.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.		Rosa, Bruce/F-6393-2010; Kay, Steve A/F-6025-2011; Alabadi, David/AAS-3408-2020; Mas, Paloma/B-8215-2016	Kay, Steve A/0000-0002-0402-2878; Alabadi, David/0000-0001-8492-6713; Mas, Paloma/0000-0002-3780-8041	NIGMS NIH HHS [GM56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALABADI D, UNPUB; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 1998, DEVELOPMENT, V125, P485; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	20	827	891	14	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					880	883		10.1126/science.1061320	http://dx.doi.org/10.1126/science.1061320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486091				2022-12-24	WOS:000170241000049
J	Sonenberg, N; Newgard, CB				Sonenberg, N; Newgard, CB			Protein synthesis - The perks of balancing glucose	SCIENCE			English	Editorial Material							TRANSLATIONAL CONTROL; KINASE; PEK		McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA	McGill University; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; RON D, COMMUNICATION; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shi YG, 1999, J BIOL CHEM, V274, P5723, DOI 10.1074/jbc.274.9.5723; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281	13	18	18	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2001	293	5531					818	819		10.1126/science.1062937	http://dx.doi.org/10.1126/science.1062937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486079				2022-12-24	WOS:000170241000033
J	Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T				Petrie, M; Schwabl, H; Brande-Lavridsen, N; Burke, T			Maternal investment - Sex differences in avian yolk hormone levels	NATURE			English	Article							ATTRACTIVENESS; TESTOSTERONE; RATIOS; EGGS		Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Newcastle University - UK; Washington State University; University of Sheffield	Petrie, M (corresponding author), Univ Newcastle Upon Tyne, Dept Psychol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Burke, Terry/B-3196-2011; Petrie, Marion/AFM-9857-2022	Burke, Terry/0000-0003-3848-1244; Petrie, Marion/0000-0001-5754-6678; Russell, Andy/0000-0002-1299-8555				BOGART MH, 1987, J THEOR BIOL, V128, P349, DOI 10.1016/S0022-5193(87)80077-2; Bowden RM, 2000, P ROY SOC B-BIOL SCI, V267, P1745, DOI 10.1098/rspb.2000.1205; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; Crews D, 1996, GEN COMP ENDOCR, V102, P317, DOI 10.1006/gcen.1996.0075; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; HOYT DF, 1979, AUK, V96, P73; JENNINGS DH, IN PRESS AM ZOOL; KRACKOW S, 1999, JOHANNESBURG BIRD LI; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H., 1997, P3; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sturkie P.D., 1986, AVIAN PHYSIOL, DOI DOI 10.1007/978-1-4612-4862-0_5	13	137	139	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					498	498		10.1038/35087652	http://dx.doi.org/10.1038/35087652			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484039				2022-12-24	WOS:000170202900031
J	Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF				Orphan, VJ; House, CH; Hinrichs, KU; McKeegan, KD; DeLong, EF			Methane-consuming archaea revealed by directly coupled isotopic and phylogenetic analysis	SCIENCE			English	Article							OXIDATION; SEDIMENTS; CONSORTIUM	Microorganisms Living in anoxic marine sediments consume more than 80% of the methane produced in the world's oceans. In addition to single-species aggregates, consortia of metabolically interdependent bacteria and archaea are found in methane-rich sediments. A combination of fluorescence in situ hybridization and secondary ion mass spectrometry shows that cells belonging to one specific archaeal group associated with the Methanosarcinales were all highly depleted in C-13 (to values of -96 parts per thousand). This depletion indicates assimilation of isotopically Light methane into specific archaeal cells. Additional microbial species apparently use other carbon sources, as indicated by significantly higher C-13/C-12 ratios in their cell carbon. Our results demonstrate the feasibility of simultaneous determination of the identity and the metabolic activity of naturally occurring microorganisms.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	Monterey Bay Aquarium Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Woods Hole Oceanographic Institution; University of California System; University of California Los Angeles	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Orphan, Victoria J/K-1002-2014; Orphan, Victoria/AAS-5989-2020; McKeegan, Kevin D/A-4107-2008; Hinrichs, Kai-Uwe/C-7675-2009	Orphan, Victoria J/0000-0002-5374-6178; Orphan, Victoria/0000-0002-5374-6178; McKeegan, Kevin D/0000-0002-1827-729X; Hinrichs, Kai-Uwe/0000-0002-0739-9291				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; BRUCHERT V, 1995, P ODP SCI RES 146 2, P219; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; HINRICHS KU, IN PRESS OCEAN MARGI; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2000, GEOLOGY, V28, P707, DOI 10.1130/0091-7613(2000)28<707:CICOIP>2.0.CO;2; MARTENS CS, 1977, LIMNOL OCEANOGR, V22, P10, DOI 10.4319/lo.1977.22.1.0010; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; PAULL CK, 2001, COMMUNICATION; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Summons RE, 1998, ORG GEOCHEM, V28, P465, DOI 10.1016/S0146-6380(98)00011-4; Valentine DL, 2000, ENVIRON MICROBIOL, V2, P477, DOI 10.1046/j.1462-2920.2000.00135.x	18	732	799	10	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					484	487		10.1126/science.1061338	http://dx.doi.org/10.1126/science.1061338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463914				2022-12-24	WOS:000169966700045
J	Canfield, DE; Teske, A				Canfield, DE; Teske, A			Late Proterozoic rise in atmospheric oxygen concentration inferred from phylogenetic and sulphur-isotope studies	NATURE			English	Article							SULFATE REDUCTION; MARINE-SEDIMENTS; SULFUR CYCLE; EVOLUTION; OXIDATION; IRON; BACTERIA; RATES	The evolution of non-photosynthetic sulphide-oxidizing bacteria was contemporaneous with a large shift in the isotopic composition of biogenic sedimentary sulphides between 0.64 and 1.05 billion years ago. Both events were probably driven by a vise in atmospheric oxygen concentrations to greater than 5-18% of present levels-a change that may also have triggered the evolution of animals.			Canfield, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL, CELSIUSSTR 1, D-28359 BREMEN, GERMANY.		Teske, Andreas/AAQ-9577-2021; Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366				BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BLAND JA, 1978, ARCH MICROBIOL, V117, P79, DOI 10.1007/BF00689355; BOWRING SA, 1993, SCIENCE, V261, P1293, DOI 10.1126/science.11539488; BRETSKY SS, 1976, PALAEONTOGR AM, V8, P217; BUMIE SW, 1972, ECON GEOL, V67, P895; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMPBELL KA, 1993, RES EXPLOR, V9, P326; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CAVANAUGH CM, 1994, AM ZOOL, V34, P79; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; COX DL, 1969, TREATISE INVERTEBRAT, pN225; DISTEL DL, 1994, J MOL EVOL, V38, P533, DOI 10.1007/BF00178852; FEDNKIN MA, 1992, PROTEROZOIC BIOSPHER, P389; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; FOSSING H, 1995, NATURE, V374, P713, DOI 10.1038/374713a0; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; FRY B, 1991, DEEP-SEA RES, V38, pS655; GLAESSNER MF, 1971, GEOL SOC AM BULL, V82, P509, DOI 10.1130/0016-7606(1971)82[509:GDATRO]2.0.CO;2; GOEDERT JL, 1993, VELIGER, V36, P72; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GUNDERSEN JK, 1990, NATURE, V345, P604, DOI 10.1038/345604a0; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1989, AM J SCI, V289, P362, DOI 10.2475/ajs.289.4.362; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1982, PHILOS T R SOC B, V298, P543, DOI 10.1098/rstb.1982.0096; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; KUENEN JG, 1991, PROKARYOTES, P2638; LANE DJ, 1992, J BACTERIOL, V174, P269, DOI 10.1128/jb.174.1.269-278.1992; LINDH TB, 1983, THESIS U MIAMI; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; MAIDAK BL, 1994, NUCLEIC ACIDS RES, V22, P3485, DOI 10.1093/nar/22.17.3485; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; MORAN NA, 1993, P R SOC LONDON B, V253, P157; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; NAKAI N, 1964, GEOCHIM COSMOCHIM AC, V28, P1893, DOI 10.1016/0016-7037(64)90136-X; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Overmann J, 1996, LIMNOL OCEANOGR, V41, P147, DOI 10.4319/lo.1996.41.1.0147; PFENNIG N, 1975, PLANT SOIL, V43, P1, DOI 10.1007/BF01928472; Pierson B.K., 1992, PROTEROZOIC BIOSPHER, P247; Pojeta J., 1988, NEW MEXICO BUREAU MI, V44, P201; Polz MF, 1996, INT J SYST BACTERIOL, V46, P94, DOI 10.1099/00207713-46-1-94; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; REID RGB, 1986, VELIGER, V29, P3; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; RUNNEGAR B, 1986, PALAEONTOLOGY, V29, P1; Runnegar B, 1991, PALAEOGEOGR PALAEOCL, V97, P97, DOI 10.1016/0031-0182(91)90186-U; Schidlowski M, 1993, ORGANIC GEOCHEMISTRY, P639; SERGEEV VN, 1995, J PALEONTOL, V69, P1; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z; Teske A, 1996, SYST APPL MICROBIOL, V18, P517; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; TOWE KM, 1970, P NATL ACAD SCI USA, V65, P781, DOI 10.1073/pnas.65.4.781; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	61	619	669	6	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	1996	382	6587					127	132		10.1038/382127a0	http://dx.doi.org/10.1038/382127a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UW672	11536736				2022-12-24	WOS:A1996UW67200038
J	Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ				Cruzan, JD; Braly, LB; Liu, K; Brown, MG; Loeser, JG; Saykally, RJ			Quantifying hydrogen bond cooperativity in water: VRT spectroscopy of the water tetramer	SCIENCE			English	Article							INFRARED-LASER SPECTROMETERS; (H2O)20 CLUSTERS; MODEL (H2O)8; TRIMER; DYNAMICS; DIMER	Measurement of the far-infrared vibration-rotation tunneling spectrum of the perdeuterated water tetramer is described, Precisely determined rotational constants and relative intensity measurements indicate a cyclic quasi-planar minimum energy structure, which is in agreement with recent ab initio calculations, The O-O separation deduced from the data indicates a rapid exponential convergence to the ordered bulk value with increasing cluster size. Observed quantum tunneling splittings are interpreted in terms of hydrogen bond rearrangements connecting two degenerate structures.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley				SAYKALLY, RICHARD/0000-0001-8942-3656				BELFORD D, 1987, J CHEM PHYS, V86, P7013, DOI 10.1063/1.452350; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1701, DOI 10.1063/1.1142410; BLAKE GA, 1991, REV SCI INSTRUM, V62, P1693, DOI 10.1063/1.1142409; BRINK G, 1984, J PHYS CHEM-US, V88, P3412, DOI 10.1021/j150660a009; Bunker P.R., 2006, MOL SYMMETRY SPECTRO; DYKE TR, 1977, J CHEM PHYS, V66, P492, DOI 10.1063/1.433968; DYKE TR, 1977, J CHEM PHYS, V66, P498, DOI 10.1063/1.433969; DYKSTRA CE, 1989, J CHEM PHYS, V91, P6472, DOI 10.1063/1.457363; ELROD MJ, 1994, CHEM REV, V94, P1975, DOI 10.1021/cr00031a010; GREGORY JK, 1995, J CHEM PHYS, V102, P7817, DOI 10.1063/1.468982; Head-Gordon Martin, COMMUNICATION; KIM KS, 1986, CHEM PHYS LETT, V131, P451, DOI 10.1016/0009-2614(86)80564-4; KLOPPER W, 1995, CHEM PHYS LETT, V237, P536, DOI 10.1016/0009-2614(95)00342-2; LENTZ BR, 1973, J CHEM PHYS, V58, P5926; Liu K, 1996, SCIENCE, V271, P62, DOI 10.1126/science.271.5245.62; LIU K, 1994, FARADAY DISCUSS, V97, P35, DOI 10.1039/fd9949700035; LIU K, 1994, J AM CHEM SOC, V116, P3507, DOI 10.1021/ja00087a042; NARTEN AH, 1982, SCIENCE, V217, P1033, DOI 10.1126/science.217.4564.1033; OWICKI JC, 1975, J PHYS CHEM-US, V79, P1794, DOI 10.1021/j100584a010; PETERSON SW, 1957, ACTA CRYSTALLOGR, V10, P70, DOI 10.1107/S0365110X5700016X; PUGLIANO N, 1993, J CHEM PHYS, V98, P6600, DOI 10.1063/1.464803; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; SCHUTZ M, 1993, J CHEM PHYS, V99, P5228, DOI 10.1063/1.465991; SCHUTZ M, 1995, J CHEM PHYS, V103, P6114, DOI 10.1063/1.470439; SCHUTZ M, 1994, J CHEM PHYS, V100, P1780, DOI 10.1063/1.467292; STILLINGER FH, 1980, J CHEM PHYS, V73, P3384, DOI 10.1063/1.440534; SUZUKI S, 1994, CHEM PHYS LETT, V229, P499, DOI 10.1016/0009-2614(94)01056-0; WALES DJ, 1993, J CHEM PHYS, V98, P7257, DOI 10.1063/1.464717; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; WALES DJ, 1993, J CHEM PHYS, V98, P7245, DOI 10.1063/1.464716; WALES DJ, 1993, J AM CHEM SOC, V115, P11191, DOI 10.1021/ja00077a017; WAWAK RJ, 1992, J PHYS CHEM-US, V96, P5138, DOI 10.1021/j100191a071; XANTHEAS SS, 1994, J CHEM PHYS, V100, P7523, DOI 10.1063/1.466846; XANTHEAS SS, 1993, J CHEM PHYS, V99, P8774, DOI 10.1063/1.465599; XANTHEAS SS, COMMUNICATION	35	385	392	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1996	271	5245					59	62		10.1126/science.271.5245.59	http://dx.doi.org/10.1126/science.271.5245.59			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TP022	11536731				2022-12-24	WOS:A1996TP02200041
J	HICKS, GR; RAYLE, DL; LOMAX, TL				HICKS, GR; RAYLE, DL; LOMAX, TL			THE DIAGEOTROPICA MUTANT OF TOMATO LACKS HIGH SPECIFIC ACTIVITY AUXIN BINDING-SITES	SCIENCE			English	Article									OREGON STATE UNIV, DEPT BOT & PLANT PATHOL, CORVALLIS, OR 97331 USA; OREGON STATE UNIV, CTR GENE RES & BIOTECHNOL, CORVALLIS, OR 97331 USA; SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; SAN DIEGO STATE UNIV, INST MOLEC BIOL, SAN DIEGO, CA 92182 USA	Oregon State University; Oregon State University; California State University System; San Diego State University; California State University System; San Diego State University					NIDCD NIH HHS [DCB-8718731] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRADFORD KJ, 1980, PLANT PHYSIOL, V65, P327, DOI 10.1104/pp.65.2.327; CROSS JW, 1985, PLANT CELL ENVIRON, V8, P351, DOI 10.1111/j.1365-3040.1985.tb01410.x; DANIEL SG, IN PRESS PLANT PHYSL; FUJINO DW, 1988, PLANT PHYSIOL, V88, P780, DOI 10.1104/pp.88.3.780; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HICKS GR, IN PRESS P NATL ACAD; JACKSON MB, 1979, PHYSIOL PLANTARUM, V46, P347, DOI 10.1111/j.1399-3054.1979.tb02631.x; JONES AM, 1984, PLANT PHYSIOL, V74, P295, DOI 10.1104/pp.74.2.295; JONES AM, 1984, PLANT PHYSIOL, V75, P1111, DOI 10.1104/pp.75.4.1111; KELLY MO, 1986, PLANT PHYSIOL, V82, P713, DOI 10.1104/pp.82.3.713; Libbenga K. R., 1987, Plant hormones and their role in plant growth and development., P194; MELHADO LL, 1981, PLANT PHYSIOL, V68, P469, DOI 10.1104/pp.68.2.469; RUBERY PH, 1981, ANNU REV PLANT PHYS, V32, P569, DOI 10.1146/annurev.pp.32.060181.003033; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Venis M., 1985, HORMONE BINDING SITE; WIGHTMAN F, 1980, PHYSIOL PLANTARUM, V49, P304, DOI 10.1111/j.1399-3054.1980.tb02669.x; ZOBEL RW, 1972, J HERED, V63, P94, DOI 10.1093/oxfordjournals.jhered.a108241; ZOBEL RW, 1974, CAN J BOT, V52, P735, DOI 10.1139/b74-095; ZOBEL RW, 1973, PLANT PHYSIOL, V52, P385, DOI 10.1104/pp.52.4.385	19	71	71	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	1989	245	4913					52	54		10.1126/science.245.4913.52	http://dx.doi.org/10.1126/science.245.4913.52			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD786	11537490				2022-12-24	WOS:A1989AD78600029
J	White, A; Hayhoe, S; Hart, A; Ernst, E				White, A; Hayhoe, S; Hart, A; Ernst, E			Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists	BRITISH MEDICAL JOURNAL			English	Article									Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England; Colchester Dist Gen Hosp, Pain Clin, Colchester CO4 5JL, Essex, England; Univ Cent Lancashire, Fac Sci, Preston PR1 2HE, Lancs, England	University of Exeter; University of Central Lancashire	White, A (corresponding author), Univ Exeter, Sch Postgrad Med & Hlth Sci, Dept Complementary Med, Exeter EX2 4NT, Devon, England.							*BRIT MED ASS ETH, 1993, MED ETH TOD ITS PRAC; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ernst E, 1997, PAIN, V71, P123, DOI 10.1016/S0304-3959(97)03368-X; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; White A, 1997, ACUPUNCT MED, V15, P67	5	236	244	2	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2001	323	7311					485	486		10.1136/bmj.323.7311.485	http://dx.doi.org/10.1136/bmj.323.7311.485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532840	Bronze, Green Published			2022-12-24	WOS:000170838500017
J	Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T				Higashiyama, T; Yabe, S; Sasaki, N; Nishimura, Y; Miyagishima, S; Kuroiwa, H; Kuroiwa, T			Pollen tube attraction by the synergid cell	SCIENCE			English	Article							NAKED EMBRYO SAC; TORENIA-FOURNIERI; DOUBLE FERTILIZATION; FEMALE GAMETOPHYTE; NICOTIANA-ALATA; AXON GUIDANCE; IN-VITRO; GROWTH; ARABIDOPSIS; ORGANIZATION	In flowering plants, guidance of the pollen tube to the embryo sac (the haploid female gametophyte) is critical for successful fertilization. The target embryo sac may attract the pollen tube as the final step of guidance in the pistil. We show by laser Ceti ablation that two synergid cells adjacent to the egg cell attract the pollen tube. A single synergid cell was sufficient to generate an attraction signal, and two cells enhanced it. After fertilization, the embryo sac no longer attracts the pollen tube, despite the persistence of one synergid cell. This cessation of attraction might be involved in blocking polyspermy.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Ochanomizu Univ, Dept Biol, Tokyo 1128610, Japan	University of Tokyo; Ochanomizu University	Higashiyama, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	higashi@biol.s.u-tokyo.ac.jp	Higashiyama, Tetsuya/C-2882-2012	Higashiyama, Tetsuya/0000-0002-7346-360X; Miyagishima, Shin-ya/0000-0002-9111-0832; Nishimura, Yoshiki/0000-0001-8686-9206				CASS DD, 1974, PROTOPLASMA, V81, P49, DOI 10.1007/BF02055773; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; DUMAS C, 1984, INT REV CYTOL, V90, P239, DOI 10.1016/S0074-7696(08)61491-6; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; GUILFORD VIVIAN B., 1952, BULL TORREY BOT CLUB, V79, P6, DOI 10.2307/2482102; Higashiyama T, 1997, PLANTA, V203, P101, DOI 10.1007/s004250050170; Higashiyama T, 1998, PLANT CELL, V10, P2019, DOI 10.1105/tpc.10.12.2019; Higashiyama T, 2000, PLANT PHYSIOL, V122, P11, DOI 10.1104/pp.122.1.11; HIGASHIYAMA T, UNPUB; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lush WM, 1999, TRENDS PLANT SCI, V4, P413, DOI 10.1016/S1360-1385(99)01473-9; Lush WM, 1998, PLANT PHYSIOL, V118, P733, DOI 10.1104/pp.118.3.733; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; MOL R, 1986, PLANT CELL REP, V3, P202; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Pruitt RE, 1999, CURR OPIN PLANT BIOL, V2, P419, DOI 10.1016/S1369-5266(99)00015-1; Ray S, 1997, DEVELOPMENT, V124, P2489; Russell SD, 1996, SEX PLANT REPROD, V9, P337, DOI 10.1007/BF02441952; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Wilhelmi LK, 1996, SCIENCE, V274, P1535, DOI 10.1126/science.274.5292.1535; Wilhelmi LK, 1997, PLANT PHYSIOL, V113, P307, DOI 10.1104/pp.113.2.307; Wolters-Arts M, 1998, NATURE, V392, P818, DOI 10.1038/33929; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X	28	303	338	6	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1480	1483		10.1126/science.1062429	http://dx.doi.org/10.1126/science.1062429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520985				2022-12-24	WOS:000170616000042
J	Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G				Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G		Norwegian Childhood Diabet Study	Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL-FACTORS; MELLITUS; DETERMINANTS; YORKSHIRE; UK	Objective To estimate the associations of maternal and paternal age at delivery and of birth order with the risk of childhood onset type I diabetes. Design Cohort study by record linkage of the medical birth registry and the national childhood diabetes registry in Norway. Setting Norway. Subjects All live births in Norway between 1974 and 1998 (1.4 million people) were followed for a maximum of 15 years, contributing 8.2 million person years of observation during 1989-98. 1824 cases of type I diabetes diagnosed between 1989 and 1998 were identified. Main outcome measures Incidence of type I diabetes. Results There was no association between maternal age at delivery and type 1 diabetes among firstborn children, but among fourthborn children there was a 43.2% increase in incidence of diabetes for each five year increase in maternal age (95% confidence interval 6.4% to 92.6%). Each increase in birth order was associated with a 17.9% reduction in incidence (3.2% to 30.4%) when maternal age was 20-24 years, but the association was weaker when maternal age was 30 years or more. Paternal age was not associated with type 1 diabetes after maternal age was adjusted for. Conclusions Intrauterine factors and early life environment may influence the risk of type I diabetes. The relation of maternal age and birth order to risk of type I diabetes is complex.	Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Univ Oslo, Ulleval Hosp, Ctr Diabet Res, Dept Paediat, N-0407 Oslo, Norway; Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, N-0403 Oslo, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway; Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Stene, LC (corresponding author), Aker Hosp, Ctr Diabet Res, N-0407 Oslo, Norway.							Akerblom HK, 1998, DIABETES METAB REV, V14, P31, DOI 10.1002/(SICI)1099-0895(199803)14:1&lt;31::AID-; Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BERENDES HW, 1991, REPROD PERINATAL EPI, P28; Bingley PJ, 2000, BMJ-BRIT MED J, V321, P420, DOI 10.1136/bmj.321.7258.420; BYRNES G, 2000, FLAWED ANAL INVALIDA; DAHLQUIST G, 1992, DIABETOLOGIA, V35, P671, DOI 10.1007/BF00400261; DAHLQUIST G, 1991, DIABETOLOGIA, V34, P757, DOI 10.1007/BF00401524; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; FLOOD TM, 1982, DIABETES CARE, V5, P571, DOI 10.2337/diacare.5.6.571; Green A, 2000, LANCET, V355, P873; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; MORINPAPUNEN L, 1984, MED BIOL, V62, P323; PATTERSON CC, 1994, DIABETES CARE, V17, P376, DOI 10.2337/diacare.17.5.376; PRESTON D. L., 1993, EPICURE USERS GUIDE; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; SOLTESZ G, 1994, ACTA PAEDIATR, V83, P730, DOI 10.1111/j.1651-2227.1994.tb13128.x; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Tai TY, 1998, DIABETES RES CLIN PR, V42, P197, DOI 10.1016/S0168-8227(98)00105-3; Wadsworth EJK, 1997, DIABETIC MED, V14, P390, DOI 10.1002/(SICI)1096-9136(199705)14:5<390::AID-DIA364>3.0.CO;2-E; WAGENER DK, 1983, DIABETOLOGIA, V25, P82	22	69	71	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					369	371		10.1136/bmj.323.7309.369	http://dx.doi.org/10.1136/bmj.323.7309.369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509426	Bronze, Green Published			2022-12-24	WOS:000170581400015
J	Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A				Dhar, SK; Yoshida, K; Machida, Y; Khaira, P; Chaudhuri, B; Wohlschlegel, JA; Leffak, M; Yates, J; Dutta, A			Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin	CELL			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; DROSOPHILA HOMOLOG; CELL-CYCLE; INITIATION; PROTEINS; XENOPUS; YEAST; ASSOCIATION; SEPARATION	A hypomorphic mutation made in the ORC2 gene of a human cancer cell line through homologous recombination decreased Orc2 protein levels by 90%. The G1 phase of the cell cycle was prolonged, but there was no effect on the utilization of either the c-Myc or beta -globin cellular origins of replication. Cells carrying this mutation failed to support the replication of a plasmid bearing the oriP replicator of Epstein Barr virus (EBV), and this defect was rescued by reintroduction of Orc2. Orc2 specifically associates with oriP in cells, most likely through its interaction with EBNA1. Geminin, an inhibitor of the mammalian replication initiation complex, inhibits replication from oriP. Therefore, ORC and the human replication initiation apparatus is required for replication from a viral origin of replication.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton; Roswell Park Cancer Institute	Dutta, A (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	adutta@rics.bwh.harvard.edu	Machida, Yuichi/AAO-3533-2021; Dutta, Anindya/P-3203-2016	Machida, Yuichi/0000-0003-1414-0568; Dutta, Anindya/0000-0002-4319-0073	NCI NIH HHS [CA43122, CA60499] Funding Source: Medline; NIGMS NIH HHS [GM53819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043122, R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053819] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; CHEN CL, 1993, J VIROL, V67, P6303, DOI 10.1128/JVI.67.10.6303-6308.1993; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P391, DOI 10.1128/MCB.13.1.391; Diffley JFX, 1995, J CELL SCI, P67; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FRAPPIER L, 1991, J BIOL CHEM, V266, P7819; GAHN TA, 1989, CELL, V58, P527, DOI 10.1016/0092-8674(89)90433-9; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; HARRISON S, 1994, J VIROL, V68, P1913, DOI 10.1128/JVI.68.3.1913-1925.1994; IP YT, 1988, J BIOL CHEM, V263, P14044; Kamath S, 2001, NUCLEIC ACIDS RES, V29, P809, DOI 10.1093/nar/29.3.809; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; LASKEY R, 1996, DNA REPLICATION EUKA, P119; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Malott M, 1999, MOL CELL BIOL, V19, P5685; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MIDDLETON T, 1992, J VIROL, V66, P489, DOI 10.1128/JVI.66.1.489-495.1992; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Tatsumi Y, 2000, J BIOL CHEM, V275, P5904, DOI 10.1074/jbc.275.8.5904; Thome KC, 2000, J BIOL CHEM, V275, P35233, DOI 10.1074/jbc.M005765200; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; WALDMAN T, 1995, CANCER RES, V55, P5187; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yates JL, 2000, J VIROL, V74, P4512, DOI 10.1128/JVI.74.10.4512-4522.2000; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; YATES JL, 1988, CANC CELLS, P197	44	232	239	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					287	296		10.1016/S0092-8674(01)00458-5	http://dx.doi.org/10.1016/S0092-8674(01)00458-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509178	Bronze			2022-12-24	WOS:000170433300007
J	Menz, RI; Walker, JE; Leslie, AGW				Menz, RI; Walker, JE; Leslie, AGW			Structure of bovine mitochondrial Fl-ATPase with nucleotide bound to all three catalytic sites: Implications for the mechanism of rotary catalysis	CELL			English	Article							F-1-ATPASE; SYNTHASE; HYDROLYSIS; ROTATION; COMPLEXES; BINDING; CONFORMATION; F(1)-ATPASE; REFINEMENT; TRYPTOPHAN	The crystal structure of a novel aluminium fluoride inhibited form of bovine mitochondrial F-1-ATPase has been determined at 2 Angstrom resolution. In contrast to all previously determined structures of the bovine enzyme, all three catalytic sites are occupied by nucleotide. The subunit that did not bind nucleotide in previous structures binds ADP and sulfate (mimicking phosphate), and adopts a "half-closed" conformation. This structure probably represents the posthydrolysis, pre-product release step on the catalytic pathway. A catalytic scheme for hydrolysis (and synthesis) at physiological rates and a mechanism for the ATP-driven rotation of the gamma subunit are proposed based on the crystal structures of the bovine enzyme.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Leslie, AGW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jew@mrc-dunn.cam.ac.uk; andrew@mrc-imb.cam.ac.uk		Walker, John/0000-0001-7929-2162				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Amano T, 1996, J BIOL CHEM, V271, P18128, DOI 10.1074/jbc.271.30.18128; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; CROSS RL, 1982, J BIOL CHEM, V257, P2101; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Dou C, 1997, BIOCHEMISTRY-US, V36, P3719, DOI 10.1021/bi962353+; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; ELSHAWI MK, 1990, J BIOL CHEM, V265, P4402; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELDMAN RI, 1983, J BIOL CHEM, V258, P2178; Fersht A., 1999, STRUCTURE MECH PROTE; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; ISSARTEL JP, 1991, BIOCHEMISTRY-US, V30, P4726, DOI 10.1021/bi00233a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Leslie A., 1992, JOINT CCP4 EACMB NEW; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; Masaike T, 2000, J EXP BIOL, V203, P1; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadanaciva S, 2000, BIOCHEMISTRY-US, V39, P9583, DOI 10.1021/bi000941o; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ren HM, 2000, BBA-BIOENERGETICS, V1458, P221, DOI 10.1016/S0005-2728(00)00075-X; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; ROSING J, 1977, J BIOL CHEM, V252, P2478; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	46	386	392	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2001	106	3					331	341		10.1016/S0092-8674(01)00452-4	http://dx.doi.org/10.1016/S0092-8674(01)00452-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509182	Bronze			2022-12-24	WOS:000170433300011
J	Breiling, A; Turner, BM; Bianchi, ME; Orlando, V				Breiling, A; Turner, BM; Bianchi, ME; Orlando, V			General transcription factors bind promoters repressed by Polycomb group proteins	NATURE			English	Article							DROSOPHILA-MELANOGASTER; IN-VIVO; CHROMATIN; COMPLEX; INTERACTS; TRITHORAX	To maintain cell identity during development and differentiation, mechanisms of cellular memory have evolved that preserve transcription patterns in an epigenetic manner. The proteins of the Polycomb group (PcG) are part of such a mechanism, maintaining gene silencing. They act as repressive multiprotein complexes that may render target genes inaccessible to the transcriptional machinery(1,2), inhibit chromatin remodelling(3,4), influence chromosome domain topology(5) and recruit histone deacetylases (HDACs)(6). PcG proteins have also been found to bind to core promoter regions(7), but the mechanism by which they regulate transcription remains unknown. To address this, we used formaldehyde-crosslinked chromatin immunoprecipitation (X-ChIP) to map TATA-binding protein (TBP), transcription initiation factor IIB (TFIIB) and IIF (TFIIF), and dHDAC1 (RPD3) across several Drosophila promoter regions. Here we show that binding of PcG proteins to repressed promoters does not exclude general transcription factors (GTFs) and that depletion of PcG proteins by double-stranded RNA interference leads to de-repression of developmentally regulated genes. We further show that PcG proteins interact in vitro with GTFs. We suggest that PcG complexes maintain silencing by inhibiting GTF-mediated activation of transcription.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Birmingham, Sch Med, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Orlando, V (corresponding author), San Raffaele Sci Inst, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.		Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445; Breiling, Achim/0000-0002-7928-299X				Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CHINWALLA V, 1995, EMBO J, V14, P2056, DOI 10.1002/j.1460-2075.1995.tb07197.x; GREGORY RI, IN PRESS MOL CELL BI; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Johnson CA, 2001, J BIOL CHEM, V276, P4539, DOI 10.1074/jbc.C000824200; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; PARO R, 1992, MECH DEVELOP, V40, P37; Paro R., 1996, EPIGENETIC MECH GENE, P507; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Wei Q, 2000, DEV BIOL, V228, P239, DOI 10.1006/dbio.2000.9938; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878	28	201	203	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					651	655		10.1038/35088090	http://dx.doi.org/10.1038/35088090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493924				2022-12-24	WOS:000170318000044
J	Tod, AM; Read, C; Lacey, A; Abbott, J				Tod, AM; Read, C; Lacey, A; Abbott, J			Barriers to uptake of services for coronary heart disease: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; ANGINA	Objectives To identify factors within the South Yorkshire coalfields that influence use of health services by people with angina. Design Qualitative study using semistructured individual and group interviews. Setting General practice and community settings in Barnsley and Rotherham health authorities. Participants 14 patients with stable angina and nine primary care staff had individual interviews plus five community groups and one group of general practitioners. Main outcome measures Barriers to accessing health services. Results A complex web of factors was identified that prevented, delayed, or facilitated referral to secondary care. Delay, denial, and self management by patients meant that the Rill extent of symptoms often remained hidden from general practitioners, resulting in a delayed or missed referral. Barriers identified fell into six categories: structural personal, social and cultural, past experience and expectations, diagnostic confusion, and knowledge and awareness. Conclusions Many of the factors influencing referral operate before general practitioners become involved. Community development could be one way of tackling inequalities and promoting sustainable change. Structural changes are needed to improve access and increase the acceptability of general practice services. Primary care staff should be educated to detect under-reporting of symptoms and promote appropriate referral.	Rotherham Hlth Author, Rotherham S60 3AQ, S Yorkshire, England; Sheffield Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Tod, AM (corresponding author), Rotherham Hlth Author, Bevan House, Rotherham S60 3AQ, S Yorkshire, England.		Tod, Angela M/P-2330-2015	Tod, Angela M/0000-0001-6336-3747				Blaxter M., 1990, HLTH LIFESTYLES; Bowling A., 1997, RES METHODS HLTH; *BRIT HEART FDN, 1999, COR HEART DIS STAT; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DAVISON C, 1992, SOC SCI MED, V34, P675, DOI 10.1016/0277-9536(92)90195-V; Fisher B, 1999, BRIT MED J, V318, P749, DOI 10.1136/bmj.318.7186.749; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Glaser B. G., 1978, AWARENESS DYING; Goddard M, 1998, EQUITY ACCESS HLTH C; GORDON D, 2000, INEQUALITIES HLTH EV; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Lincon YS., 1985, NATURALISTIC INQUIRY; Maggs-Rapport F, 2000, J ADV NURS, V31, P219, DOI 10.1046/j.1365-2648.2000.01243.x; Mays N, 1996, QUALITATIVE RES HLTH; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; *ROTH HLTH AUTH, 1998, HLTH ROTH PEOPL 1998; Ruston A, 1998, BRIT MED J, V316, P1060; SORRELL JM, 1995, J ADV NURS, V21, P117; Strauss A., 1990, BASICS QUALITATIVE R; Wiles R, 1998, SOC SCI MED, V46, P1477, DOI 10.1016/S0277-9536(97)10140-X	22	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2001	323	7306					214	217		10.1136/bmj.323.7306.214	http://dx.doi.org/10.1136/bmj.323.7306.214			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	459UQ	11473916	Green Published, Bronze			2022-12-24	WOS:000170270200022
J	Wilson, PA; Norris, RD				Wilson, PA; Norris, RD			Warm tropical ocean surface and global anoxia during the mid-Cretaceous period	NATURE			English	Article							PLANKTONIC-FORAMINIFERA; NORTH-ATLANTIC; TEMPERATURES; EVOLUTION; CLIMATE; EVENTS; ORIGIN; OXYGEN; MODEL; ROCKS	The middle of the Cretaceous period (about 120 to 80 Myr ago) was a time of unusually warm polar temperatures(1), repeated reef-drowning in the tropics(2) and a series of oceanic anoxic events (OAEs) that promoted both the widespread deposition of organic carbon-rich marine sediments and high biological turnover(3-8). The cause of the warm temperatures is unproven but widely attributed to high levels of atmospheric greenhouse gases such as carbon dioxide(7-12). In contrast, there is no consensus on the climatic causes and effects of the OAEs, with both high biological productivity and ocean `stagnation' being invoked as the cause of ocean anoxia(3-8). Here we show, using stable isotope records from multiple species of well-preserved foraminifera, that the thermal structure of surface waters in the western tropical Atlantic Ocean underwent pronounced variability about 100 Myr ago, with maximum sea surface temperatures 3-5 degreesC warmer than today. This variability culminated in a collapse of upper-ocean stratification during OAE-1d (the `Breistroffer' event), a globally significant period of organic-carbon burial that we show to have fundamental, stratigraphically valuable, geochemical similarities to the main OAEs of the Mesozoic era. Our records are consistent with greenhouse forcing being responsible for the warm temperatures, but are inconsistent both with explanations for OAEs based on ocean stagnation, and with the traditional view (reviewed in ref. 12) that past warm periods were more stable than today's climate.	Southampton Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	NERC National Oceanography Centre; University of Southampton; Woods Hole Oceanographic Institution	Wilson, PA (corresponding author), Southampton Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	paw1@soc.soton.ac.uk		Wilson, Paul/0000-0001-6425-8906				Arthur M.A., 1985, CARBON CYCLE ATMOSPH, P504, DOI [10.1159/000020165, DOI 10.1029/GM032P0504]; ARTHUR MA, 1990, NATO ADV SCI I C-MAT, V304, P75; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Barron E. J, 1985, CARBON CYCLE ATMOSPH, P546, DOI [10.1029/GM032p0546, DOI 10.1029/GM032P0546]; Barron EJ, 1995, STUDIES GEOPHYSICS, P108; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Crowley TJ, 1991, PALEOCEANOGRAPHY, V6, P387, DOI 10.1029/91PA00432; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; Erba E, 1999, J FORAMIN RES, V29, P371; Erbacher J, 1997, MAR MICROPALEONTOL, V30, P139, DOI 10.1016/S0377-8398(96)00023-0; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; Fischer A.G., 1982, CLIMATE EARTH HIST, P97, DOI DOI 10.17226/11798; Gale AS, 1996, CRETACEOUS RES, V17, P515, DOI 10.1006/cres.1996.0032; HERBERT TD, 1986, NATURE, V321, P739, DOI 10.1038/321739a0; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hofmann P, 2000, PALAEOGEOGR PALAEOCL, V163, P97, DOI 10.1016/S0031-0182(00)00147-4; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; MANABE S, 1985, J GEOPHYS RES-OCEANS, V90, P1689, DOI 10.1029/JC090iC06p11689; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; OPDYKE BN, 1999, EOS, V80, pF486; Poulsen CJ, 1999, PALEOCEANOGRAPHY, V14, P679, DOI 10.1029/1999PA900034; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; SCHLANGER SO, 1981, EARTH PLANET SC LETT, V52, P435, DOI 10.1016/0012-821X(81)90196-5; *SHIPB SCI PART, 1995, P ODP INIT REP, V144, P20; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Stoll HM, 2000, GEOL SOC AM BULL, V112, P308, DOI 10.1130/0016-7606(2000)112<308:HSIRFT>2.0.CO;2; Wilson PA, 1998, NATURE, V392, P889, DOI 10.1038/31865; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; Wolff T, 1999, PALEOCEANOGRAPHY, V14, P374, DOI 10.1029/1999PA900011	30	315	327	4	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2001	412	6845					425	429		10.1038/35086553	http://dx.doi.org/10.1038/35086553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473314				2022-12-24	WOS:000170068200044
J	Fisk, HA; Winey, M				Fisk, HA; Winey, M			The mouse Mps1p-like kinase regulates centrosome duplication	CELL			English	Article							POLE BODY DUPLICATION; CYCLIN-DEPENDENT KINASES; HAMSTER OVARY CELLS; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; MITOTIC CHECKPOINT; BUDDING YEAST; DNA-SYNTHESIS; GENE MPS1; REPRODUCTION	The yeast Mps1p protein kinase acts in centrosome duplication and the spindle assembly checkpoint. We demonstrate here that a mouse Mps1p ortholog (esk, which we designate mMps1p) regulates centrosome duplication. Endogenous mMps1p and overexpressed GFP-mMps1p localize to centrosomes and kinetochores in mouse cells. Overexpression of GFP-mMps1p causes reduplication of centrosomes during S phase arrest. In contrast, a kinase-deficient mutant blocks centrosome duplication altogether. Control of centrosome duplication by mMps1p requires a known regulator of the process, Cdk2. Inhibition of Cdk2 prevents centrosome reduplication and destabilizes mMps1p, causing its subsequent loss from centrosomes, suggesting that Cdk2 promotes mMps1p's centrosome duplication function by regulating its stability during S phase. Thus, mMps1p, an in vitro Cdk2 substrate, regulates centrosome duplication jointly with Cdk2.	Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Winey, M (corresponding author), Univ Colorado, UCB 347, Boulder, CO 80309 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51312] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hartley RS, 1997, DEV BIOL, V188, P312, DOI 10.1006/dbio.1997.8647; HE X, 1997, J CELL SCI, V111, P1635; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOGG D, 1994, ONCOGENE, V9, P89; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KURIYAMA R, 1986, CELL MOTIL CYTOSKEL, V6, P355, DOI 10.1002/cm.970060402; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LINDBERG RA, 1993, ONCOGENE, V8, P351; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 1997, METHOD ENZYMOL, V283, P113; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schnackenberg BJ, 1999, BIOL CELL, V91, P429, DOI 10.1016/S0248-4900(99)80084-7; Schutz AR, 1998, MOL BIOL CELL, V9, P759, DOI 10.1091/mbc.9.4.759; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; STEIN GS, 1994, CELL BIOL LAB HDB, P282; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1	44	180	187	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					95	104		10.1016/S0092-8674(01)00411-1	http://dx.doi.org/10.1016/S0092-8674(01)00411-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461705	Green Published, Bronze			2022-12-24	WOS:000169870300012
J	Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN				Allison, TJ; Winter, CC; Fournie, JJ; Bonneville, M; Garboczi, DN			Structure of a human gamma delta T-cell antigen receptor	NATURE			English	Article							NONPEPTIDIC MYCOBACTERIAL LIGANDS; RECOGNITION; STIMULATION; CRYSTALLOGRAPHY; PYROPHOSPHATE; SUBSET; SUITE	T-cell antigen receptors composed of gamma and delta polypeptide chains (gamma delta TCRs) can directly recognize antigens in the form of intact proteins or non-peptide compounds, unlike alpha beta TCRs, which recognize antigens bound to major histocompatibility complex molecules (MHC). About 5% of peripheral blood T cells bear gamma delta TCRs, most of which recognize non-peptide phosphorylated antigens(1,2). Here we describe the 3.1 Angstrom resolution structure of a human gamma delta TCR from a T-cell clone(3) that is phosphoantigen-reactive. The orientation of the variable (V) and constant (C) regions of the gamma delta TCR is unique when compared with alpha beta TCRs or antibodies, and results from an unusually small angle between the V gamma and C gamma domains. The complementarity-determining regions (CDRs) of the V domains exhibit a chemically reasonable binding site for phosphorylated antigens, providing a possible explanation for the canonical usage of the V gamma9 and V delta2 gene segments by phosphoantigen-reactive receptors. Although the gamma delta TCR V domains are similar in overall structure to those of alpha beta TCRs, gamma delta TCR C domains are markedly different. Structural differences in C gamma and C delta, and in the location of the disulphide bond between them, may enable gamma delta TCRs to form different recognition/signalling complexes than alpha beta TCRs.	NIAID, Struct Biol Sect, Immunogenet Lab, Rockville, MD 20852 USA; CHU Purpan, INSERM, U395, F-31024 Toulouse, France; Inst Biol, INSERM, U463, F-44035 Nantes, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Allison, TJ (corresponding author), NIAID, Struct Biol Sect, Immunogenet Lab, 12441 Parklawn Dr, Rockville, MD 20852 USA.		Fournie, Jean-Jacques/J-7805-2013	Fournie, Jean-Jacques/0000-0001-6542-6908	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000835] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belman C, 1999, J BIOL CHEM, V274, P32079, DOI 10.1074/jbc.274.45.32079; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; BENTLEY GA, 1995, SCIENCE, V267, P1984, DOI 10.1126/science.7701320; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DAVODEAU F, 1993, J IMMUNOL, V151, P1214; DAVODEAU F, 1993, EUR J IMMUNOL, V23, P804, DOI 10.1002/eji.1830230405; DAVODEAU F, 1993, J BIOL CHEM, V268, P15455; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fournie JJ, 1996, RES IMMUNOL, V147, P338, DOI 10.1016/0923-2494(96)89648-9; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; Kunzmann V, 2000, BLOOD, V96, P384; LANG F, 1995, J IMMUNOL, V154, P5986; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li HM, 1998, NATURE, V391, P502, DOI 10.1038/35172; LOH EY, 1994, J IMMUNOL, V152, P3324; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Morita CT, 2001, IMMUNITY, V14, P331, DOI 10.1016/S1074-7613(01)00113-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANCHAMOORTHY G, 1991, J IMMUNOL, V147, P3360; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; SCIAMMAS R, 1994, J IMMUNOL, V152, P5392; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10	30	196	206	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					820	824		10.1038/35081115	http://dx.doi.org/10.1038/35081115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459064	Green Published			2022-12-24	WOS:000169246400055
J	Wohlgemuth, S; Ronacher, B; Wehner, R				Wohlgemuth, S; Ronacher, B; Wehner, R			Ant odometry in the third dimension	NATURE			English	Article							PATH-INTEGRATION; CATAGLYPHIS-FORTIS; DESERT ANTS; HONEYBEE NAVIGATION; DISTANCE ESTIMATION; OPTIC FLOW; ORIENTATION; GOAL	Desert ants (Cataglyphis) are renowned for their ability to perform large-scale foraging excursions and then return to the nest by path integration. They do so by integrating courses steered and the distances travelled into a continually updated home vector(1). Whereas the angular orientation is based on skylight cues(2), how the ants gauge the distances travelled has remained largely unclear(3,4). Furthermore, almost all studies on path integration in Cataglyphis(5,6), as well as in spiders(7,8), rodents(9), and humans(10,11), have aimed at understanding how the animals compute home-bound courses in the horizontal plane. Here, we investigate for the first time how an animal's odometer operates when a path integration task has to be accomplished that includes a vertical component. We trained Cataglyphis ants within arrays of uphill and downhill channels, and later tested them on flat terrain, or vice versa. In all these cases, the ants indicated homing distances that corresponded not to the distances actually travelled but to the ground distances; that is, to the sum of the horizontal projections of the uphill and downhill segments of the ants' paths.	Univ Zurich, Dept Zool, CH-8057 Zurich, Switzerland; Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	University of Zurich; Humboldt University of Berlin	Ronacher, B (corresponding author), Univ Zurich, Dept Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernhard.ronacher@rz.hu-berlin.de						Bardunias PM, 2000, NATURWISSENSCHAFTEN, V87, P532, DOI 10.1007/s001140050772; Esch HE, 1996, J EXP BIOL, V199, P155; Etienne AS, 1996, J EXP BIOL, V199, P201; Gorner P., 1985, P275; HERAN H, 1956, Z VERGL PHYSIOL, V38, P168, DOI 10.1007/BF00338625; HILL DE, 1979, BEHAV ECOL SOCIOBIOL, V5, P301, DOI 10.1007/BF00293678; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; MARKL H, 1962, Z VERGL PHYSIOL, V45, P475, DOI 10.1007/BF00342998; Mittelstaedt H., 1973, FORTSCHR ZOOL, V21, P46; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Ronacher B, 2000, J EXP BIOL, V203, P1113; RONACHER B, 1995, J COMP PHYSIOL A, V177, P21; SAUVE JP, 1989, THESIS U AIX MARSEIL; Schafer M, 1993, VERH DTSCH ZOOL GES, V86, P270; SEYFARTH EA, 1982, BEHAV ECOL SOCIOBIOL, V11, P139, DOI 10.1007/BF00300103; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Srinivasan MV, 1997, J EXP BIOL, V200, P2513; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WEHNER R, 1994, FORTS ZOOL, V39, P103; WEHNER R, 1990, ETHOL ECOL EVOL, V2, P27, DOI 10.1080/08927014.1990.9525492; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; WEHNER R, 1997, ORIENTATION COMMUNIC, P145	25	99	99	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					795	798		10.1038/35081069	http://dx.doi.org/10.1038/35081069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459057				2022-12-24	WOS:000169246400048
J	MILLER, SL; BADA, JL				MILLER, SL; BADA, JL			SUBMARINE HOT SPRINGS AND THE ORIGIN OF LIFE	NATURE			English	Article									UNIV CALIF SAN DIEGO,SCRIPPS INST OCEANOG,AMINO ACID DATING LAB A-012B,LA JOLLA,CA 92093	University of California System; University of California San Diego; Scripps Institution of Oceanography	MILLER, SL (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM B-017,LA JOLLA,CA 92093, USA.							BADA JL, 1987, BIOSYSTEMS, V20, P21, DOI 10.1016/0303-2647(87)90016-5; BADA JL, 1978, EARTH PLANET SC LETT, V41, P67, DOI 10.1016/0012-821X(78)90042-0; BAROSS JA, 1983, NATURE, V303, P423, DOI 10.1038/303423a0; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; BERNHARDT G, 1984, NATURWISSENSCHAFTEN, V71, P583, DOI 10.1007/BF01189186; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.bi.55.070186.003123; Corliss J. B., 1981, Oceanologica Acta, V4, P59; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; Feather M.S., 1973, ADV CARBOHYDR CHEM B, V28, P161, DOI 10.1016/S0065-2318(08)60383-2; Fox SW, 1972, MOL EVOLUTION ORIGIN; FULLER WD, 1972, J MOL EVOL, V1, P249, DOI 10.1007/BF01660244; GINOZA W, 1964, NATURE, V203, P606, DOI 10.1038/203606a0; HARADA K, 1964, NATURE, V201, P335, DOI 10.1038/201335a0; HAYATSU R, 1981, TOP CURR CHEM, V99, P1; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; KNOLL AH, 1988, SCIENCE, V239, P199, DOI 10.1126/science.239.4836.199; LAWLESS JG, 1973, NATURE, V243, P405, DOI 10.1038/243405a0; MACDONALD KC, 1980, EARTH PLANET SC LETT, V48, P1, DOI 10.1016/0012-821X(80)90163-6; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MEGGY AB, 1956, J CHEM SOC, P1444, DOI 10.1039/jr9560001444; MILLER SL, 1976, J MOL EVOL, V9, P59, DOI 10.1007/BF01796123; MILLER SL, 1974, ORIGINS LIFE EARTH, P118; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NISBET EG, 1987, YOUNG EARTH; SIMONEIT BRT, 1985, CAN J EARTH SCI, V22, P1919, DOI 10.1139/e85-208; SLEEP NH, 1986, ORIGINS LIFE EVOL B, V16, P179, DOI 10.1007/BF02421968; Storch H.H., 1951, FISCHER TROPSCH RELA; STRIBLING R, 1988, ORIGINS LIFE, V17, P261; TRENT JD, 1984, NATURE, V307, P737, DOI 10.1038/307737a0; TUREKIAN KK, 1986, P NATL ACAD SCI USA, V83, P6241, DOI 10.1073/pnas.83.17.6241; VALLENTYNE JR, 1968, GEOCHIM COSMOCHIM AC, V32, P1853; WESTHEIMER FH, 1986, NATURE, V319, P534, DOI 10.1038/319534a0; WHITE RH, 1984, NATURE, V310, P430, DOI 10.1038/310430a0; YAYANOS AA, 1983, APPL ENVIRON MICROB, V46, P1357, DOI 10.1128/AEM.46.6.1357-1363.1983	35	254	258	3	105	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 18	1988	334	6183					609	611		10.1038/334609a0	http://dx.doi.org/10.1038/334609a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P7090	11536607				2022-12-24	WOS:A1988P709000061
J	Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G				Litt, MD; Simpson, M; Gaszner, M; Allis, CD; Felsenfeld, G			Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus	SCIENCE			English	Article							ENHANCER-BLOCKING ACTIVITY; INSULATOR; EXPRESSION; GENE	Methylation of histories at specific residues plays an important role in transcriptional regulation. Chromatin immunoprecipitation of dimethytated lysine 9 on histone H3 across 53 kilobases of the chicken beta -globin locus during erythropoiesis shows an almost complete anticorrelation between regions of elevated lysine 9 methylation and acetylation. Lysine 9 is methylated most over constitutive condensed chromatin and developmentally inactive globin genes. In contrast, lysine 4 methylation of histone H3 correlates with H3 acetylation. These results lead us to propose a mechanism by which the insulator in the beta -globin locus can protect the globin genes from being silenced by adjacent condensed chromatin.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Virginia	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	gxf@vger.niddk.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLIS CD, COMMUNICATION; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Davie JR, 1999, J CELL BIOCHEM, P141; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; FELSENFELD G, 1993, GENE, V135, P119, DOI 10.1016/0378-1119(93)90056-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; RECILLASTARGA F, COMMUNICATION; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X	21	497	516	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2453	2455		10.1126/science.1064413	http://dx.doi.org/10.1126/science.1064413			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11498546	Green Submitted			2022-12-24	WOS:000171237200047
J	Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S				Chalder, T; Hotopf, M; Unwin, C; Hull, L; Ismail, K; David, A; Wessely, S			Prevalence of Gulf war veterans who believe they have Gulf war syndrome: questionnaire study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH	Objectives To determine how many veterans in a random sample of British veterans who served in the Gulf war believe they have "Gulf war syndrome," to examine factors associated with the presence of this belief, and to compare the health status of those who believe they have Gulf war syndrome with those who do not. Design Questionnaire study asking British Gulf war veterans whether they believe they have Gulf war syndrome and about symptoms, fatigue, psychological distress, post-traumatic stress, physical functioning, and their perception of health, Participants 2961 respondents to questionnaires sent out to a random sample of 4250 Gulf war veterans (69.7%). Main outcome measure The proportion of veterans who believe they have Gulf war syndrome. Results Overall, 17.3% (95% confidence interval 15.9 to 18.7) of the respondents believed they had Gulf war syndrome. The belief was associated with the veteran having poor health, not serving in the army when responding to the questionnaire, and having received a high number of vaccinations before deployment to the Gulf. The strongest association was knowing another person who also thought they had Gulf war syndrome. Conclusions Substantial numbers of British Gulf war veterans believe they have Gulf war syndrome, which is associated with psychological distress, a high number of symptoms, and some reduction in activity levels. A combination of biological, psychological, and sociological factors are associated with the belief, and these factors should be addressed in clinical practice.	Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England; Kings Coll London, St Thomass Sch Med, London SE5 8AZ, England	University of London; King's College London; University of London; King's College London	Chalder, T (corresponding author), Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England.	sphatrc@iop.kcl.ac.uk	Wessely, Simon C/A-8713-2008; David, Anthony S/C-1315-2011; Hotopf, Matthew/E-4971-2010; David, Anthony/O-1750-2019; Chalder, Trudie/A-5717-2011	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Wessely, Simon Charles/0000-0002-6743-9929; Ismail, Khalida/0000-0001-6084-449X; Chalder, Trudie/0000-0003-0775-1045; Hotopf, Matthew/0000-0002-3980-4466				CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Coker WJ, 1999, BMJ-BRIT MED J, V318, P290, DOI 10.1136/bmj.318.7179.290; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; Hotopf M, 2000, BRIT MED J, V320, P1363, DOI 10.1136/bmj.320.7246.1363; Ismail K, 1999, LANCET, V353, P179, DOI 10.1016/S0140-6736(98)11339-9; O'Brien LS, 1998, TRAUMATIC EVENTS MEN; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	13	29	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					473	476		10.1136/bmj.323.7311.473	http://dx.doi.org/10.1136/bmj.323.7311.473			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532836	Bronze, Green Published			2022-12-24	WOS:000170838500013
J	Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP				Salghetti, SE; Caudy, AA; Chenoweth, JG; Tansey, WP			Regulation of transcriptional activation domain function by ubiquitin	SCIENCE			English	Article							MEDIATED PROTEOLYSIS; DNA-REPLICATION; DEGRADATION; PROTEASOME; PROTEINS; COMPLEX; SIGNAL; CHAIN; MET4	The ability of transcriptional activation domains (TADs) to signal ubiquitin-mediated proteolysis suggests an involvement of the ubiquitin-proteasome pathway in transcription. To probe this involvement, we asked how ubiquitylation regulates the activity of a transcription factor containing the VP16 TAD. We show that the VP16 TAD signals ubiquitylation through the Met30 ubiquitin-ligase and that Met30 is also required for the VP16 TAD to activate transcription. The requirement for Met30 in transcription is circumvented by fusion of ubiquitin to the VP16 activator, demonstrating that activator ubiquitylation is essential for transcriptional activation. We propose that ubiquitylation regulates TAD function by serving as a dual signal for activation and activator destruction.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tansey, WP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd,POB 100, Cold Spring Harbor, NY 11724 USA.			Caudy, Amy/0000-0001-6307-8137	NCI NIH HHS [CA-13106, CA45508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106, P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015	18	311	318	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1651	1653		10.1126/science.1062079	http://dx.doi.org/10.1126/science.1062079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11463878				2022-12-24	WOS:000170802900061
J	Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ				Davies, MK; Hobbs, FDR; Davis, RC; Kenkre, JE; Roalfe, AK; Hare, R; Wosornu, D; Lancashire, RJ			Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study	LANCET			English	Article							DIAGNOSIS; MORBIDITY; CAPTOPRIL; MORTALITY; TIME	Background Accurate data for prevalence rates for heart failure due to various causes, and for left-ventricular systolic dysfunction in all adults are unavailable. Our aim was to assess prevalence of left-ventricular systolic dysfunction and heart failure in a large representative adult population in England. Methods Of 6286 randomly selected patients aged 45 years and older, 3960 (63%) participated in the study. They came from 16 randomly selected general practices. We assessed patients by history and examination, electrocardiography, and echocardiography. Prevalence of left-ventricular systolic dysfunction (defined as ejection fraction <40%) and heart failure was calculated for the overall population on the basis of strict criteria and, when necessary, adjudication by a panel. Findings Left-ventricular systolic dysfunction was diagnosed in 72 (1.8% [95% CI 1.4-2.3]) participants, half of whom had no symptoms. Borderline left-ventricular function (ejection fraction 40-50%) was seen in 139 patients (3.5% [3.0-4.1]). Definite heart failure was seen in 92 (2.3%, [1.9-2.8]) and was associated with an ejection fraction of less than 40% in 38 (41%) patients, atrial fibrillation in 30 (33%), and valve disease in 24 (26%). Probable heart failure was seen in a further 32 (0.8% [0.6-1.1]) patients. In total, 124 (3.1% [2.6-3.7]) patients aged 45 years or older had definite or probable heart failure. Interpretation Heart failure is often misdiagnosed or underdiagnosed in primary care. Our results suggest that assessment of left-ventricular function in patients with suspected heart failure could lead to more effective diagnosis and treatment of this disorder.	Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Sch Med, Dept Publ Hlth & Epidemiol, Birmingham B15 2TT, W Midlands, England; Selly Oak Hosp, Dept Cardiol, Selly Oak, W Midlands, England	University of Birmingham; University of Birmingham	Hobbs, FDR (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk		hobbs, richard/0000-0001-7976-7172				Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; CLELAND JG, 1995, EUR HEART J, V16, P741; Davie AP, 1997, EUR HEART J, V18, P981; *DEP HLTH, 2000, NAT SERV FRAM COR HE; ERIKSSON H, 1995, J INTERN MED, V237, P135, DOI 10.1111/j.1365-2796.1995.tb01153.x; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GILLUM RF, 1993, AM HEART J, V126, P1042, DOI 10.1016/0002-8703(93)90738-U; Hjalmarson A, 1999, LANCET, V353, P2001; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Lechat P, 1999, LANCET, V353, P9; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; NORRIS RM, 1984, AM J CARDIOL, V53, P408, DOI 10.1016/0002-9149(84)90003-1; PARAMESHWAR J, 1992, BRIT J GEN PRACT, V42, P287; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Remme WJ, 1997, EUR HEART J, V18, P736; Schunkert H, 1998, LANCET, V351, P372, DOI 10.1016/S0140-6736(05)78298-2; SUTTON GC, 1990, AM HEART J, V120, P1538, DOI 10.1016/0002-8703(90)90055-3; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Townsend PP., 1988, HLTH DEPRIVATION INE; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; WHEELDON NM, 1993, Q J MED, V86, P17	30	365	373	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2001	358	9280					439	444		10.1016/S0140-6736(01)05620-3	http://dx.doi.org/10.1016/S0140-6736(01)05620-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463TB	11513906				2022-12-24	WOS:000170492400008
J	Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN				Fiorillo, L; Zucker, M; Sawyer, D; Lin, AN			The pseudomonas hot-foot syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	6th Congress of the European-Society-for-Pediatric-Dermatology	SEP 13-18, 1999	CATHOLIC UNIV OF THE SACRED HEART, ROME, ITALY	European Soc Pediat Dermatol	CATHOLIC UNIV OF THE SACRED HEART		IDIOPATHIC PALMOPLANTAR HIDRADENITIS; PLANTAR HIDRADENITIS; ECCRINE HIDRADENITIS; CHILDREN; AERUGINOSA; EXPOSURE; WET	Background: Between March and May 1998, there was an outbreak of a clinically distinct skin eruption on the soles of the feet of children who used a community wading pool. Methods: We reviewed the medical records of 40 children in whom this syndrome developed during this time. We treated 17 children and advised the attending physicians on the care of the other 23. Follow-up data were obtained for up to one year. Results: Exquisitely painful erythematous plantar nodules developed in 40 children (age, 2 to 15 years) within 40 hours after they had used a wading pool whose floor was coated with abrasive grit. Culture of the plantar pustules from one child yielded Pseudomonas aeruginosa with a pattern on pulsed-field gel electrophoresis that was identical to that of a strain of P. aeruginosa cultured from the pool water. A skin-biopsy specimen from this patient showed a perivascular and perieccrine neutrophilic infiltrate, and a specimen from another patient showed a dermal microabscess. Thirty-seven patients were treated symptomatically; three others were treated with cephalexin. All patients recovered within 14 days, but three children had recurrences of the painful plantar nodules within 24 hours after using the pool again. Folliculitis developed in one patient. Conclusions: The "pseudomonas hot-foot syndrome'' is characterized by the acute onset in children of exquisitely tender plantar nodules and a benign, self-limited course. This community outbreak developed after exposure to pool water containing high concentrations of P. aeruginosa.	Univ Alberta, Div Dermatol & Cutaneous Sci, Edmonton, AB T6G 2G3, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Pathol, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Calgary; University of Calgary	Lin, AN (corresponding author), Univ Alberta, Div Dermatol & Cutaneous Sci, 2-104 Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.							Aleman CT, 1999, CUTIS, V63, P161; Bartolo E, 1998, J EUR ACAD DERMATOL, V10, P257; BLAUVELT A, 1992, J AM ACAD DERMATOL, V27, P111, DOI 10.1016/S0190-9622(08)80819-5; Buezo GF, 1996, AM J DERMATOPATH, V18, P413, DOI 10.1097/00000372-199608000-00015; HAY RJ, 1998, ROOK WILKINSON EBLIN, V2, P1097; HERN AE, 1992, J AM ACAD DERMATOL, V26, P259, DOI 10.1016/S0190-9622(08)80304-0; KOSATSKY T, 1985, AM J MED, V79, P10, DOI 10.1016/0002-9343(85)90539-X; Landau M, 1998, PEDIATR DERMATOL, V15, P97, DOI 10.1046/j.1525-1470.1998.1998015097.x; METZKER A, 1988, J AM ACAD DERMATOL, V18, P144, DOI 10.1016/S0190-9622(88)80055-0; Naimer SA, 2000, PEDIATR EMERG CARE, V16, P182, DOI 10.1097/00006565-200006000-00013; Pique E, 1997, DERMATOLOGY, V195, P379, DOI 10.1159/000245992; RABINOWITZ LG, 1995, ARCH DERMATOL, V131, P817, DOI 10.1001/archderm.131.7.817; RASMUSSEN JE, 1982, AM J DIS CHILD, V136, P553, DOI 10.1001/archpedi.1982.03970420077018; REED RK, 1976, J PEDIATR-US, V88, P977, DOI 10.1016/S0022-3476(76)81054-2; Simon M, 1998, ARCH DERMATOL, V134, P76, DOI 10.1001/archderm.134.1.76; STAHR BJ, 1994, J CUTAN PATHOL, V21, P289, DOI 10.1111/j.1600-0560.1994.tb00702.x; Weigl L, 2000, BRIT J DERMATOL, V142, P1048, DOI 10.1046/j.1365-2133.2000.03497.x	17	49	52	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					335	338		10.1056/NEJM200108023450504	http://dx.doi.org/10.1056/NEJM200108023450504			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484690				2022-12-24	WOS:000170193600004
J	Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX				Marie, Y; Sanson, M; Mokhtari, K; Leuraud, P; Kujas, M; Delattre, JY; Poirier, J; Zalc, B; Khe, HX			OLIG2 as a specific marker of oligodendroglial tumour cells	LANCET			English	Article								OLIG2 is a recently Identified transcription factor involved In the specification of cells In the oligodendroglial lineage. We Investigated the expression of OLIG2 by In-situ hybridisation In 21 brain tumours: nine grade II and III oligodendrogliomas, three grade II oligoastrocytomas, and nine non-oligodendroglial tumours (four grade IV astrocytomas, two meningiomas, a dysembryoplastic neuroepithelial tumour, and two metastases). OLIG2-positive cells corresponding to neoplastic oligodendrocytes were present in all oligodendrogliomas and oligoastrocytomas. By contrast, OLIG2 expression was not detected in the non-oligodendroglial tumours. Thus, oligodendroglioma probably arise from oligodendrocyte precursor cells. OLIG2 should prove a useful marker for the diagnosis of oligodendroglial tumours.	Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France; INSERM, U495, Lab Biol Interact Neurone Glie, Paris, France; UPMC, Paris, France; Grp Hosp Pitie Salpetriere, Lab Histoembryol Cytogenet, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khe, HX (corresponding author), Grp Hosp Pitie Salpetriere, Federat Neurol Mazarin, F-75651 Paris 13, France.		Messier, Claude/A-2322-2008; Hoang-Xuan, Khe/O-7527-2017	Messier, Claude/0000-0002-4791-1763; 				Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; REIFENBERGER J, 1994, AM J PATHOL, V145, P1175; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	5	122	129	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 28	2001	358	9278					298	300		10.1016/S0140-6736(01)05499-X	http://dx.doi.org/10.1016/S0140-6736(01)05499-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	457AF	11498220				2022-12-24	WOS:000170114400017
J	Reddy, A; Caler, EV; Andrews, NW				Reddy, A; Caler, EV; Andrews, NW			Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes	CELL			English	Article							REGULATES CA2+-DEPENDENT EXOCYTOSIS; EPITHELIAL-CELLS; PC12 CELLS; FIBROBLASTS; SYNAPTOTAGMINS; RELEASE; MACROMOLECULES; CONTRACTION; DISRUPTIONS; MECHANISM	Plasma membrane wounds are repaired by a mechanism involving Ca2+-regulated exocytosis. Elevation in intracellular [Ca2+] triggers fusion of lysosomes with the plasma membrane, a process regulated by the lysosomal synaptotagmin isoform Syt VII. Here, we show that Ca2+-regulated exocytosis of lysosomes is required for the repair of plasma membrane disruptions. Lysosomal exocytosis and membrane resealing are inhibited by the recombinant Syt VII C(2)A domain or anti-Syt VII C(2)A antibodies, or by antibodies against the cytosolic domain of Lamp-1, which specifically aggregate lysosomes. We further demonstrate that lysosomal exocytosis mediates the resealing of primary skin fibroblasts wounded during the contraction of collagen matrices. These findings reveal a fundamental, novel role for lysosomes: as Ca2+-regulated exocytic compartments responsible for plasma membrane repair.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Andrews, NW (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06520 USA.			Andrews, Norma/0000-0002-0611-2412	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034867, R01AI034867] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34867] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Bakker AC, 1997, J CELL SCI, V110, P2227; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; BODEMANN H, 1972, J MEMBRANE BIOL, V8, P1, DOI 10.1007/BF01868092; BUSSONMABILLOT S, 1984, BIOL CELL, V51, P53, DOI 10.1111/j.1768-322X.1984.tb00283.x; Butcher BA, 2000, MOL BIOCHEM PARASIT, V107, P207, DOI 10.1016/S0166-6851(00)00189-4; Caler EV, 2001, J EXP MED, V193, P1097, DOI 10.1084/jem.193.9.1097; CHANG DC, 1990, BIOPHYS J, V58, P1, DOI 10.1016/S0006-3495(90)82348-1; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; CHEN WT, 1981, J CELL SCI, V49, P1; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Detrait ER, 2000, J NEUROSCI RES, V62, P566, DOI 10.1002/1097-4547(20001115)62:4<566::AID-JNR11>3.3.CO;2-W; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HART NH, 1987, J EXP ZOOL, V244, P17, DOI 10.1002/jez.1402440104; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Kasai H, 1999, P NATL ACAD SCI USA, V96, P945, DOI 10.1073/pnas.96.3.945; LEE B, 1985, BIOCHIM BIOPHYS ACTA, V815, P128, DOI 10.1016/0005-2736(85)90482-1; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIEBER MR, 1982, J BIOL CHEM, V257, P1660; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MCNEIL PL, 1987, J CELL SCI, V88, P669; McNeil PL, 2000, J CELL SCI, V113, P1891; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Rodriguez A, 1999, J BIOL CHEM, V274, P16754, DOI 10.1074/jbc.274.24.16754; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; Togo T, 1999, J CELL SCI, V112, P719; Togo T, 2000, MOL BIOL CELL, V11, P4339, DOI 10.1091/mbc.11.12.4339; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; WALL DA, 1985, J CELL BIOL, V101, P1651, DOI 10.1083/jcb.101.5.1651	52	722	738	3	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					157	169		10.1016/S0092-8674(01)00421-4	http://dx.doi.org/10.1016/S0092-8674(01)00421-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511344	Bronze			2022-12-24	WOS:000170193100006
J	Chinsamy, A; Elzanowski, A				Chinsamy, A; Elzanowski, A			Bone histology - Evolution of growth pattern in birds	NATURE			English	Article									Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, South Africa; S African Museum, ZA-8000 Cape Town, South Africa; Univ Wroclaw, Inst Zool, PL-50335 Wroclaw, Poland	University of Cape Town; University of Wroclaw	Chinsamy, A (corresponding author), Univ Cape Town, Dept Zool, Private Bag, ZA-7700 Rondebosch, South Africa.		Elzanowski, Andrzej/ABD-5511-2020	Chinsamy-Turan, Anusuya/0000-0002-9786-5080				CHINSAMY A, 1994, NATURE, V368, P196, DOI 10.1038/368196a0; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; ELZANOWSKI A, 1981, PALAEONTOL POLON, V42, P147; HOUDE P, 1987, AUK, V104, P125, DOI 10.2307/4087243; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Reid R.E.H., 1993, Modern Geology, V18, P391; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P247; STARCK JM, 1994, J MORPHOL, V222, P113, DOI 10.1002/jmor.1052220202; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; [No title captured]	13	66	69	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					402	403		10.1038/35086650	http://dx.doi.org/10.1038/35086650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473304				2022-12-24	WOS:000170068200034
J	Lockey, D; Davies, G; Coats, T				Lockey, D; Davies, G; Coats, T			Survival of trauma patients who have prehospital tracheal intubation without anaesthesia or muscle relaxants: observational study	BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL		Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Lockey, D (corresponding author), Royal London Hosp, Dept Accid & Emergency, London E1 1BB, England.		Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784				Blostein PA, 1998, J TRAUMA, V44, P534, DOI 10.1097/00005373-199803000-00021; Cooke MW, 1999, BRIT MED J, V319, P1150, DOI 10.1136/bmj.319.7218.1150; GULY UM, 1995, BRIT MED J, V310, P1091, DOI 10.1136/bmj.310.6987.1091; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Pelucio M, 1997, ACAD EMERG MED, V4, P563, DOI 10.1111/j.1553-2712.1997.tb03579.x	5	52	54	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					141	141		10.1136/bmj.323.7305.141	http://dx.doi.org/10.1136/bmj.323.7305.141			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463683	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000170106200017
J	YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP				YUNG, YL; ALLEN, M; CRISP, D; ZUREK, RW; SANDER, SP			SPATIAL VARIATION OF OZONE DEPLETION RATES IN THE SPRINGTIME ANTARCTIC POLAR VORTEX	SCIENCE			English	Article									CALTECH,JET PROP LAB,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	YUNG, YL (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Crisp, David/F-6642-2017; Yung, Yuk/AAM-4850-2021	Crisp, David/0000-0002-4573-9998; Yung, Yuk/0000-0002-4263-2562				ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11480, DOI 10.1029/JD094iD09p11480; BARRETT JW, 1988, NATURE, V336, P455, DOI 10.1038/336455a0; BRUNE WH, 1989, EOS, V70, P1040; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; DEZAFRA RL, 1989, J GEOPHYS RES-ATMOS, V94, P11423, DOI 10.1029/JD094iD09p11423; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; FARMER CB, 1987, NATURE, V329, P126, DOI 10.1038/329126a0; KRUEGER A, 1988, NASA REF PUBL, V1201; MAHLMAN JD, 1986, GEOPHYS RES LETT, V13, P1316, DOI 10.1029/GL013i012p01316; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MCINTYRE ME, 1984, J ATMOS TERR PHYS, V46, P825, DOI 10.1016/0021-9169(84)90063-1; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; SANDER SP, 1989, SCIENCE, V245, P1095, DOI 10.1126/science.245.4922.1095; SANDERS RW, 1989, J GEOPHYS RES-ATMOS, V94, P11381, DOI 10.1029/JD094iD09p11381; SCHOEBERL MR, 1986, GEOPHYS RES LETT, V13, P1217, DOI 10.1029/GL013i012p01217; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; SOLOMON S, 1989, J GEOPHYS RES-ATMOS, V94, P11393, DOI 10.1029/JD094iD09p11393; STOLARSKI RS, 1986, GEOPHYS RES LETT, V13, P1210, DOI 10.1029/GL013i012p01210; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; TUNG KK, 1986, NATURE, V333, P811; WATSON B, 1989, J GEOPHYS RES-ATMOS, V94, P11179, DOI 10.1029/JD094iD09p11179; WATSON R, 1989, J GEOPHYS RES, V94, P16437	23	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					721	724		10.1126/science.11538181	http://dx.doi.org/10.1126/science.11538181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	11538181				2022-12-24	WOS:A1990DC92600030
J	BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S				BLAKE, DF; FREUND, F; KRISHNAN, KFM; ECHER, CJ; SHIPP, R; BUNCH, TE; TIELENS, AG; LIPARI, RJ; HETHERINGTON, CJD; CHANG, S			THE NATURE AND ORIGIN OF INTERSTELLAR DIAMOND	NATURE			English	Article									UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,NATL CTR ELECTRON MICROSCOPY,BERKELEY,CA 94720; SURFACE SCI LABS,MT VIEW,CA 94043	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	BLAKE, DF (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							ASH RD, IN PRESS METEORITICS, V22; CAREY W, IN PRESS METEORITICS, V22; DECARLI PS, 1961, SCIENCE, V133, P1821, DOI 10.1126/science.133.3467.1821; HECHT JH, 1987, NATURE, V328, P765, DOI 10.1038/328765a0; KERRIDGE JF, 1987, GEOCHIM COSMOCHIM AC, V51, P2527, DOI 10.1016/0016-7037(87)90303-6; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; LEWIS RS, 1983, NATURE, V305, P767, DOI 10.1038/305767a0; LEWIS RS, 1983, SCI AM, V249, P66, DOI 10.1038/scientificamerican0883-66; MORAR JF, 1986, PHYS REV B, V33, P1346, DOI 10.1103/PhysRevB.33.1346; NUTH JA, 1987, NATURE, V329, P589, DOI 10.1038/329589b0; OTT U, 1981, GEOCHIM COSMOCHIM AC, V45, P1751, DOI 10.1016/0016-7037(81)90009-0; ROY R, 1987, NATURE, V325, P17, DOI 10.1038/325017a0; SWART PK, 1983, SCIENCE, V220, P406, DOI 10.1126/science.220.4595.406; TIELENS AGG, 1987, APJ, V319, pL103; VANDERBILT D, 1984, PHYS REV B, V30, P6118, DOI 10.1103/PhysRevB.30.6118	15	61	60	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 14	1988	332	6165					611	613		10.1038/332611a0	http://dx.doi.org/10.1038/332611a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M9218	11536600				2022-12-24	WOS:A1988M921800051
J	Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS				Gill, TM; Desai, MM; Gahbauer, EA; Holford, TR; Williams, CS			Restricted activity among community-living older persons: Incidence, precipitants, and health care utilization	ANNALS OF INTERNAL MEDICINE			English	Article							BASE-LINE VULNERABILITY; RANDOMIZED-TRIAL; PREVENTING DISABILITY; FUNCTIONAL DEPENDENCE; ADULTS; SYMPTOMS; PEOPLE; DISEASE; EVENTS; FALLS	Background: Restricted activity is a potentially important indicator of health and functional status. Yet, relatively little is known about the incidence, precipitants, or health care utilization associated with restricted activity among older persons. Objective: To more accurately estimate the rate of restricted activity among community-living older persons, to identify the health-related and non-health-related problems that lead to restricted activity, and to determine whether restricted activity is associated with increased health care utilization. Design: Prospective cohort study. Setting: New Haven, Connecticut. Participants: 754 nondisabled members of a large health plan, 70 years of age or older, who were categorized according to their risk for disability (low, intermediate, or high). Measurements: Occurrence of restricted activity (defined as having stayed in bed for at least half a day or having cut down on one's usual activities because of an illness, injury, or another problem), problems leading to restricted activity, and health care utilization were ascertained during monthly telephone interviews for up to 2 years. Results: In median follow-up of 15 months, 76.6% of participants reported restricted activity during at least 1 month and 39.3% reported restricted activity during 2 consecutive months. The rates of restricted activity per 100 person-months were 19.0 episodes for all participants and 16.9, 27.3, and 22.7 episodes for participants at low, intermediate, and high risk for disability, respectively. Of the 24 prespecified health-related and non-health-related problems, the rates per 100 person-months of restricted activity ranged from 0.1 episode for "problem with alcohol" to 65.5 episodes for "been fatigued." On average, participants identified 4.5 different problems as a cause for their restricted activity, Health care utilization was substantially greater during months with restricted activity than months without restricted activity. The corresponding rates per 100 person-months were 63.8 and 45.1 for physician office visits, 12.5 and 1.0 for emergency department visits, 14.1 and 0.3 for hospital admissions, and 67.6 and 45.1 for any health care utilization (P<0.001 for each pairwise comparison). Conclusions: Restricted activity is common among community-living older persons, regardless of risk for disability, and it is usually attributable to several concurrent health-related problems. Although restricted activity is associated with a. substantial increase in health care utilization, older persons with restricted activity often do not seek medical attention.	Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, New Haven, CT 06504 USA; Dept Vet Affairs, Connecticut Healthcare Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriat Assessment Ctr, 20 York St, New Haven, CT 06504 USA.		Gill, Thomas M./H-7043-2019; Fazli, Ghazal/AAE-8320-2022	Gill, Thomas M./0000-0002-6450-0368; Desai, Mayur/0000-0001-6616-0945	NIA NIH HHS [K23AG00759, 1RO1AG17560-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017560, K23AG000759] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DW, 1998, SOC SCI MED, V47, P1601, DOI 10.1016/S0277-9536(98)00215-9; BRODY EM, 1983, GERONTOLOGIST, V23, P75, DOI 10.1093/geront/23.1.75; BRODY EM, 1983, J AM GERIATR SOC, V31, P489, DOI 10.1111/j.1532-5415.1983.tb05124.x; Feinstein AR, 1987, CLINIMETRICS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haas J, 1998, NEW ENGL J MED, V338, P1694, DOI 10.1056/NEJM199806043382312; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Institute of Medicine, 1996, HLTH OUTC OLD PEOPL; Jones R, 2000, BMJ-BRIT MED J, V320, P596, DOI 10.1136/bmj.320.7235.596; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; *NAT CTR HLTH STAT, 1986, DHHS PUBL; Nevitt MC, 2000, ARCH INTERN MED, V160, P77, DOI 10.1001/archinte.160.1.77; RAKOWSKI W, 1988, MED CARE, V26, P278, DOI 10.1097/00005650-198803000-00005; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; *SAS I, 1996, SAS SOFTW SYST VERS; SCHOLES D, 1991, AM J PUBLIC HEALTH, V81, P485, DOI 10.2105/AJPH.81.4.485; STUKEL TA, 1994, STAT MED, V13, P1781, DOI 10.1002/sim.4780131709; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; *US DHEW, 1979, DHEW PUBL; VERBRUGGE LM, 1985, SOC SCI MED, V20, P855, DOI 10.1016/0277-9536(85)90343-0; VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; WAGNER EH, 1993, J AM GERIATR SOC, V41, P241, DOI 10.1111/j.1532-5415.1993.tb06700.x	34	247	248	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2001	135	5					313	321		10.7326/0003-4819-135-5-200109040-00007	http://dx.doi.org/10.7326/0003-4819-135-5-200109040-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	468WF	11529694				2022-12-24	WOS:000170780600001
J	Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ				Isshiki, T; Pearson, B; Holbrook, S; Doe, CQ			Drosophila neuroblasts sequentially express transcription factors which specify the temporal identity of their neuronal progeny	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; IKAROS GENE FAMILY; EMBRYONIC NEUROBLASTS; SEGMENTATION GENE; DOMAIN GENE; GLIAL-CELLS; CNS; HUNCHBACK; SPECIFICATION; KRUPPEL	Neural precursors often generate distinct cell types in a specific order, but the intrinsic or extrinsic cues regulating the timing of cell fate specification are poorly understood. Here we show that Drosophila neural precursors (neuroblasts) sequentially express the transcription factors Hunchback --> Kruppel --> Pdm --> Castor, with differentiated progeny maintaining the transcription factor profile present at their birth. Hunchback is necessary and sufficient for first-born cell fates, whereas Kruppel is necessary and sufficient for second-born cell fates; this is observed in multiple lineages and is independent of the cell type involved. We propose that Hunchback and Kruppel control early-born temporal identity in neuroblast cell lineages.	Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon 1254, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA.		Isshiki, Takako/L-5255-2013	Pearson, Bret/0000-0002-3473-901X	NICHD NIH HHS [HD27056] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brody T, 2000, DEV BIOL, V226, P34, DOI 10.1006/dbio.2000.9829; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; CUI X, 1995, DEVELOPMENT, V121, P3233; CUI X, 1992, DEVELOPMENT, V116, P943; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Durand B, 2000, BIOESSAYS, V22, P64; Farkas G, 2000, GENE, V253, P117, DOI 10.1016/S0378-1119(00)00240-7; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; FRANTZ GD, 1994, J NEUROSCI, V14, P472; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; FURST A, 1985, DEV BIOL, V109, P184, DOI 10.1016/0012-1606(85)90359-8; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Honma Y, 1999, FEBS LETT, V447, P76, DOI 10.1016/S0014-5793(99)00265-3; HULSKAMP M, 1994, GENETICS, V138, P125; Iwasa JH, 2000, DEV GENES EVOL, V210, P277, DOI 10.1007/s004270050315; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lundell MJ, 1998, DEVELOPMENT, V125, P463; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Muller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; PROKOP A, 1994, DEVELOPMENT, V120, P2567; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Romani S, 1996, MECH DEVELOP, V60, P95, DOI 10.1016/S0925-4773(96)00603-X; Schmid A, 1999, DEVELOPMENT, V126, P4653; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SOMMER RJ, 1992, P NATL ACAD SCI USA, V89, P10782, DOI 10.1073/pnas.89.22.10782; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; YANG XH, 1993, GENE DEV, V7, P504, DOI 10.1101/gad.7.3.504	39	463	466	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					511	521		10.1016/S0092-8674(01)00465-2	http://dx.doi.org/10.1016/S0092-8674(01)00465-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525736	Bronze			2022-12-24	WOS:000170665200014
J	Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ				Mohle-Boetani, JC; Farrar, JA; Werner, SB; Minassian, D; Bryant, R; Abbott, S; Slutsker, L; Vugia, DJ		Investigation Team	Escherichia coli O157 and Salmonella infections associated with sprouts in California, 1996-1998	ANNALS OF INTERNAL MEDICINE			English	Article							OUTBREAK	Background: In California, from 1996 through 1998, more than 50% of multicounty outbreaks with confirmed food vehicles were related to alfalfa or clover sprouts. Objective: To summarize investigations of sprout-associated outbreaks. Design: Matched case-control studies. Setting: California. Patients: Outbreak-associated patients and matched population controls. Measurements: Matched odds ratios and 95% Cis; traceback and environmental investigations of sprout and seed growers; and pulsed-field gel electrophoresis of isolates from patients, sprouts, and seeds. Results: Five sprout-associated outbreaks of salmonellosis and one outbreak of infection with nonmotile Shiga toxin-producing Escherichia coli O157 occurred. Six hundred patients had culture-confirmed disease, and two died. It is estimated that these outbreaks caused 22 800 cases of gastrointestinal illness or urinary tract infection. In the case-control studies, odds ratios for the association between illness and alfalfa sprout consumption ranged from 5.0 to proportional to (all were statistically significant). Three sprout growers were implicated, and each was associated with two outbreaks. Outbreak strains of Salmonella were isolated from sprouts supplied by two sprout growers and from seeds used by the third sprout grower. Conclusions: As currently produced, sprouts can be a hazardous food. Seeds can be contaminated before sprouting, and no method can eliminate all pathogens from seeds. Seed and sprout growers should implement measures to decrease contamination. The general public should recognize the risks of eating sprouts, and populations at high risk for complications from salmonellosis or E coli O157 infection should avoid sprout consumption.	Calif Dept Hlth Serv, Berkeley, CA 94704 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Ctr Dis Control & Prevent, Atlanta, GA USA	California Department of Health Care Services; Centers for Disease Control & Prevention - USA	Mohle-Boetani, JC (corresponding author), Dis Invest & Surveillance Branch, Div Communicable Dis Control, 2151 Berkeley Way,Room 708, Berkeley, CA 94704 USA.	jmohlebo@dhs.ca.gov	Mohle-Boetani, Janet/AAH-4221-2019					Abbott SL, 1999, J CLIN MICROBIOL, V37, P4177, DOI 10.1128/JCM.37.12.4177-4178.1999; Andre AD, 1995, INT J AVIAT PSYCHOL, V5, P1, DOI 10.1207/s15327108ijap0501_1; Backer HD, 2000, PUBLIC HEALTH REP, V115, P339, DOI 10.1093/phr/115.4.339; Buck P., 1998, 47 ANN EP INT SERV C; *CDCP, 1999, FOODB DIS ACT SURV N, P6; *CDCP, 1995, EPI INFO VERS 6 04B; GLYNN MK, 1998, 36 ANN M INF DIS SOC; Inami GB, 1999, J FOOD PROTECT, V62, P662, DOI 10.4315/0362-028X-62.6.662; Kurtzweil P, 1999, FDA Consum, V33, P18; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; MARTIN D, 1991, EPIDEMIOLOGY, V2, P359, DOI 10.1097/00001648-199109000-00008; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; OMAHONEY M, 1990, J PUBLIC HEALTH MED, V12, P91; PONKA A, 1995, LANCET, V345, P462, DOI 10.1016/S0140-6736(95)90451-4; Puohiniemi R, 1997, J CLIN MICROBIOL, V35, P2487, DOI 10.1128/JCM.35.10.2487-2491.1997; SWAMINATHAN B, 1993, DIAGNOSTIC MOL MICRO; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Beneden CA, 1999, JAMA-J AM MED ASSOC, V281, P158, DOI 10.1001/jama.281.2.158; 1997, MMWR MORB MORTAL WKL, V46, P741	21	88	90	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					239	247		10.7326/0003-4819-135-4-200108210-00008	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511138				2022-12-24	WOS:000170587500002
J	Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN				Hall, NF; Gale, CR; Syddall, H; Phillips, DIW; Martyn, CN			Risk of macular degeneration in users of statins: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	University of Southampton	Martyn, CN (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.		Gale, Catharine R/B-1653-2012	Gale, Catharine/0000-0002-3361-8638	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bressler NM, 2000, BRIT MED J, V321, P1425, DOI 10.1136/bmj.321.7274.1425; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983	5	98	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					375	376		10.1136/bmj.323.7309.375	http://dx.doi.org/10.1136/bmj.323.7309.375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11509429	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000170581400020
J	Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K				Sano, Y; Inamura, K; Miyake, A; Mochizuki, S; Yokoi, H; Matsushime, H; Furuichi, K			Immunocyte Ca2+ influx system mediated by LTRPC2	SCIENCE			English	Article							TRP; DROSOPHILA; CHANNELS; PROTEIN; GENE; FAMILY; CD38	We characterized an activation mechanism of the human LTRPC2 protein, a member of the transient receptor potential family of ion channels, and demonstrated that LTRPC2 mediates Call influx into immunocytes. Intracellular pyrimidine nucleotides, adenosine 5'-diphosphoribose (ADPR), and nicotinamide adenine dinucleotide (NAD), directly activated LTRPC2, which functioned as a Ca2+-permeable nonselective cation channel and enabled Ca2+ influx into cells. This activation was suppressed by intracellular adenosine triphosphate. These results reveal that ADPR and NAD act as intracellular messengers and may have an important role in Ca2+ influx by activating LTRPC2 in immunocytes.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan	Astellas Pharmaceuticals	Sano, Y (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	sano.yorikata@yamanouchi.co.jp						Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Duncan LM, 1998, CANCER RES, V58, P1515; FINKEL TH, 1991, IMMUNOL TODAY, V12, P79, DOI 10.1016/0167-5699(91)90162-M; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Guse AH, 1998, CRIT REV IMMUNOL, V18, P419, DOI 10.1615/CritRevImmunol.v18.i5.20; Han MK, 2000, J BIOL CHEM, V275, P20799, DOI 10.1074/jbc.M001189200; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SANO Y, UNPUB; Sestini S, 2000, ARCH BIOCHEM BIOPHYS, V379, P277, DOI 10.1006/abbi.2000.1888; WEISS A, 1991, ANNU REV GENET, V25, P487, DOI 10.1146/annurev.ge.25.120191.002415; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	25	359	380	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1327	1330		10.1126/science.1062473	http://dx.doi.org/10.1126/science.1062473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509734				2022-12-24	WOS:000170492600043
J	Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC				Gupta, R; Kim, JY; Espinal, MA; Caudron, JM; Pecoul, B; Farmer, PE; Raviglione, MC			Public health - Responding to market failures in tuberculosis control	SCIENCE			English	Editorial Material							RESISTANT TUBERCULOSIS; COUNTRIES		WHO, Stop TB Dept, Geneva, Switzerland; Harvard Univ, Sch Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Med Sans Frontieres, B-1090 Brussels, Belgium; MSF, Access Essential Med, CH-1211 Geneva 6, Switzerland	World Health Organization; Harvard University; Harvard Medical School; Doctors Without Borders; Doctors Without Borders	Gupta, R (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, Geneva, Switzerland.	guptara@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067; Gupta, Rajesh/0000-0002-3307-6541				Baleta A, 2001, LANCET, V357, P775, DOI 10.1016/S0140-6736(00)04158-1; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; CROFTON J, 1960, BRIT MED J, V17, P679; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DYE C, UNPUB; ENARSON DA, 2000, MANGEMENT TUBERCULOS; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Farmer P., 2000, INFECT INEQUALITIES; GUPTA R, 2001, GUIDELINES ESTABLISH; GUPTA R, 2000, P PROC 2 LIN ANT DRU; Harvard Medical School and Open Society Institute, 1999, GLOB IMP DRUG RES TU; ISEMAN MD, 1993, NEW ENGL J MED, V328, P576, DOI 10.1056/NEJM199302253280811; Kim J., 2000, DYING GROWTH; *MED SANS FRONT, 1999, CAMP ACC ESSMED PRIC; MIGLIORI GB, 1999, B WORLD HEALTH ORGAN, V76, P475; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; SUAREZ PG, IN PRESS J INFECT DI; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; WHO, 1997, GUID MAN DRUG RES TU; World Health Organization (WHO), 2001, HUM RIGHTS APPR TUB	23	114	114	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2001	293	5532					1049	1051		10.1126/science.1061861	http://dx.doi.org/10.1126/science.1061861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	462RB	11463877				2022-12-24	WOS:000170432600028
J	Digicaylioglu, M; Lipton, SA				Digicaylioglu, M; Lipton, SA			Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades	NATURE			English	Article							NITRIC-OXIDE; TRANSCRIPTION FACTOR; CYTOKINE RECEPTORS; INDUCED APOPTOSIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; ACTIVATION; INHIBITION; HIPPOCAMPAL	Erythropoietin, a kidney cytokine regulating haematopoiesis (the production of blood cells), is also produced in the brain after oxidative or nitrosative stress(1,2). The transcription factor hypoxia-inducible factor-1 (HIF-1) upregulates EPO following hypoxic stimuli(3,4). Here we show that preconditioning with EPO protects neurons in models of ischaemic and degenerative damage due to excitotoxins(4,5) and consequent generation of free radicals, including nitric oxide (NO). Activation of neuronal EPO receptors (EPORs) prevents apoptosis induced by NMDA (N-methyl-D-aspartate) or NO by triggering cross-talk between the signalling pathways of Janus kinase-2 (Jak2) and nuclear factor-kappaB (NF-kappaB). We show that EPOR-mediated activation of Jak2 leads to phosphorylation of the inhibitor of NF-kappaB (I kappaB), subsequent nuclear translocation of the transcription factor NF-kappaB, and NF-kappaB-dependent transcription of neuroprotective genes. Transfection of cerebrocortical neurons with a dominant interfering form of Jak2 or an I kappaB alpha super-repressor blocks EPO-mediated prevention of neuronal apoptosis. Thus neuronal EPORs activate a neuroprotective pathway that is distinct from previously well characterized Jak and NF-kappaB functions. Moreover, this EPO effect may underlie neuroprotection mediated by hypoxic-schaemic preconditioning.	Burnham Inst, Ctr Neurosci & Aging Res, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp,Program Neurosci, Cerebrovasc & NeuroSci Res Inst, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Digicaylioglu, Murat H/D-3302-2009	Lipton, Stuart/0000-0002-3490-1259				ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bonfoco E, 1996, NEUROREPORT, V8, P273, DOI 10.1097/00001756-199612200-00054; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Gage AT, 1996, BRAIN RES, V719, P172, DOI 10.1016/0006-8993(96)00092-3; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; VAN AD, 1996, SCIENCE, V274, P787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; ZHUANG HM, 1994, J BIOL CHEM, V269, P21411	30	778	859	0	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					641	647		10.1038/35088074	http://dx.doi.org/10.1038/35088074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493922				2022-12-24	WOS:000170318000042
J	Donaldson, M				Donaldson, M			What is the role of growth-hormone therapy in short children who were small for gestational age?	LANCET			English	Editorial Material							SHORT STATURE; FINAL HEIGHT; RETARDATION; BIRTH; TERM		Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland	University of Glasgow	Donaldson, M (corresponding author), Royal Hosp Sick Children, Dept Child Hlth, Glasgow GS3 8SJ, Lanark, Scotland.							Coutant R, 1998, J CLIN ENDOCR METAB, V83, P1070, DOI 10.1210/jc.83.4.1070; de Zegher F, 2000, J CLIN ENDOCR METAB, V85, P2816, DOI 10.1210/jc.85.8.2816; DEWAAL WJ, 1994, CLIN ENDOCRINOL, V41, P621; DEZEGHER F, 1990, BIOL NEONATE, V58, P188; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Zucchini S, 2001, ARCH DIS CHILD, V84, P340, DOI 10.1136/adc.84.4.340	6	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2001	358	9279					347	348		10.1016/S0140-6736(01)05585-4	http://dx.doi.org/10.1016/S0140-6736(01)05585-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459DE	11502309				2022-12-24	WOS:000170235100004
J	Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR				Devireddy, LR; Teodoro, JG; Richard, FA; Green, MR			Induction of apoptosis by a secreted lipocatin that is transcriptionally regulated by IL-3 deprivation	SCIENCE			English	Article							ACUTE-PHASE PROTEIN; CELL-DEATH; HEMATOPOIETIC-CELLS; INDUCED EXPRESSION; GENE; SURVIVAL; ENDONUCLEASE; ACTIVATION; WITHDRAWAL; LINES	Many hematopoietic cells undergo apoptosis when deprived of specific cytokines, and this process requires de novo RNA/protein synthesis. Using DNA microarrays to analyze interleukin-3 (IL-3)- dependent murine FL5.12 pro-B cells, we found that the gene undergoing maximal transcriptional induction after cytokine withdrawal is 24p3, which encodes a secreted lipocalin. Conditioned medium from IL-3-deprived FL5.12 cells contained 24p3 and induced apoptosis in naive FL5.12 cells even when IL-3 was present. 24p3 also induced apoptosis in a wide variety of leukocytes but not other cell types. Apoptotic sensitivity correlated with the presence of a putative 24p3 cell surface receptor. We conclude that IL-3 deprivation activates 24p3 transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an autocrine pathway.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Gene Funct & Express, 373 Plantat St, Worcester, MA 01605 USA.		Teodoro, Joe/AFT-2440-2022	Teodoro, Joe/0000-0002-3713-6839				Blalock WL, 1999, LEUKEMIA, V13, P1109, DOI 10.1038/sj.leu.2401493; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chu ST, 1996, BIOCHEM J, V316, P545, DOI 10.1042/bj3160545; COHEN JJ, 1984, J IMMUNOL, V132, P38; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Endres R, 1997, IMMUNITY, V7, P419, DOI 10.1016/S1074-7613(00)80363-5; Flower DR, 1996, BIOCHEM J, V318, P1; GALILI U, 1982, CANCER RES, V42, P1433; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; JOHNSON DE, 1998, FRONT BIOSCI, V3, P313; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Liu QS, 1997, MOL REPROD DEV, V46, P507, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;507::AID-MRD9&gt;3.0.CO;2-S; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; MISHIZAWA M, 1992, FEBS LETT, V299, P36; NIELSEN BS, 1996, GUT, V38, P41; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; RODRIGUEZTARDUCHY G, 1990, EMBO J, V9, P2997, DOI 10.1002/j.1460-2075.1990.tb07492.x; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	31	312	333	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					829	834		10.1126/science.1061075	http://dx.doi.org/10.1126/science.1061075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11486081				2022-12-24	WOS:000170241000036
J	He, XW; Rines, DR; Espelin, CW; Sorger, PK				He, XW; Rines, DR; Espelin, CW; Sorger, PK			Molecular analysis of kinetochore-microtubule attachment in budding yeast	CELL			English	Article							SPINDLE POLE BODY; CELL-CYCLE ARREST; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC SPINDLE; PRECOCIOUS SEPARATION; CENTROMERE PROTEIN; FISSION YEAST; XENOPUS EGGS; PLUS-END	The complex series of movements that mediates chromosome segregation during mitosis is dependent on the attachment of microtubules to kinetochores, DNA-protein complexes that assemble on centromeric DNA. We describe the use of live-cell imaging and chromatin immunoprecipitation in S. cerevisiae to identify ten kinetochore subunits, among which are yeast homologs of microtubule binding proteins in animal cells. By analyzing conditional mutations in several of these proteins, we show that they are required for the imposition of tension on paired sister kinetochores and for correct chromosome movement. The proteins include both molecular motors and microtubule associated proteins (MAPs), implying that motors and MAPs function together in binding chromosomes to spindle microtubules.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Rines, Daniel/0000-0002-1830-2926; Sorger, Peter/0000-0002-3364-1838	NIGMS NIH HHS [GM19483, GM51464] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051464] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloom K, 2000, NAT CELL BIOL, V2, pE96, DOI 10.1038/35014089; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gardner RD, 2001, GENETICS, V157, P1493; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hofmann C, 1998, J CELL BIOL, V143, P1029, DOI 10.1083/jcb.143.4.1029; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Hunter AW, 2000, J CELL SCI, V113, P4379; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cb.11.110195.002351; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Jones MH, 1999, MOL BIOL CELL, V10, P2377, DOI 10.1091/mbc.10.7.2377; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; OSBORNE MA, 1994, J CELL BIOL, V125, P853, DOI 10.1083/jcb.125.4.853; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; STRUNNIKOV AV, 1995, J CELL BIOL, V128, P749, DOI 10.1083/jcb.128.5.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tavormina PA, 1998, GENETICS, V148, P1701; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zheng L, 2000, MOL CELL BIOL, V20, P3529, DOI 10.1128/MCB.20.10.3529-3537.2000	54	213	216	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					195	206		10.1016/S0092-8674(01)00438-X	http://dx.doi.org/10.1016/S0092-8674(01)00438-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511347	Bronze			2022-12-24	WOS:000170193100009
J	Bae, SH; Bae, KH; Kim, JA; Seo, YS				Bae, SH; Bae, KH; Kim, JA; Seo, YS			RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes	NATURE			English	Article							REPLICATION PROTEIN-A; DNA-BINDING-PROTEIN; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; STRANDED-DNA; POLYMERASE-DELTA; SV40 ORIGIN; YEAST; GENE; METABOLISM	Extensive work on the maturation of lagging strands during the replication of simian virus 40 DNA suggests that the initiator RNA primers of Okazaki fragments are removed by the combined action of two nucleases, RNase HI and Fen1, before the Okazaki fragments join(1-5). Despite the well established in vitro roles of these two enzymes(6), genetic analyses in yeast revealed that null mutants of RNase HI and/or Fen1 are not lethal(7-9), suggesting that an additional enzymatic activity may be required for the removal of RNA. One such enzyme is the Saccharomyces cerevisiae Dna2 helicase(10-12)/endonuclease(12), which is essential for cell viability(13,14) and is well suited to removing RNA primers of Okazaki fragments(15). In addition, Dna2 interacts genetically and physically with several proteins involved in the elongation or maturation of Okazaki fragments(10,16). Here we show that the endonucleases Dna2 and Fen1 act sequentially to facilitate the complete removal of the primer RNA. The sequential action of these enzymes is governed by a single-stranded DNA-binding protein, replication protein-A (RPA). Our results demonstrate that the processing of Okazaki fragments in eukaryotes differs significantly from, and is more complicated than, that occurring in prokaryotes. We propose a novel biochemical mechanism for the maturation of eukaryotic Okazaki fragments.	Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, Suwon 440746, South Korea	Sungkyunkwan University (SKKU)	Seo, YS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Natl Creat Res Initiat Ctr Cell Cycle Control, 300 Chunchun Dong, Suwon 440746, South Korea.	ysseo@med.skku.ac.kr	Seo, Yeonsoo/C-1605-2011	Bae, Kwang-Hee/0000-0002-5868-2556				Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2000, J BIOCHEM MOL BIOL, V33, P155; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; CHALLBERG MD, 1989, ANNU REV BIOCHEM, V58, P671; Frank P, 1998, FEBS LETT, V421, P23, DOI 10.1016/S0014-5793(97)01528-7; Gary R, 1999, MOL CELL BIOL, V19, P5373; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Iftode C, 1997, MOL CELL BIOL, V17, P3876, DOI 10.1128/MCB.17.7.3876; Kang HY, 2000, GENETICS, V155, P1055; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Mass G, 1998, MOL CELL BIOL, V18, P6399, DOI 10.1128/MCB.18.11.6399; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	30	274	278	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					456	461		10.1038/35086609	http://dx.doi.org/10.1038/35086609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473323				2022-12-24	WOS:000170068200053
J	Shortle, D; Ackerman, MS				Shortle, D; Ackerman, MS			Persistence of native-like topology in a denatured protein in 8 M urea	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; STAPHYLOCOCCAL NUCLEASE; 131-RESIDUE FRAGMENT; BACKBONE DYNAMICS; NMR; RESTRAINTS; ALIGNMENT; STATE; COMPACT; GELS	Experimental methods have demonstrated that when a protein unfolds, not all of its structure is Lost. Here we report measurement of residual dipolar couplings in denatured forms of the small protein staphylococcal nuclease oriented in strained polyacrylamide gels. A highly significant correlation among the dipolar couplings for individual residues suggests that a native-like spatial positioning and orientation of chain segments (topology) persists to concentrations of at least 8 molar urea. These data demonstrate that long-range ordering can occur well before a folding protein attains a compact conformation, a conclusion not anticipated by any of the standard models of protein folding.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Shortle, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM34171] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034171] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; GILLESPIE JH, UNPUB; Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953; Meiler J, 2000, J BIOMOL NMR, V16, P245, DOI 10.1023/A:1008378624590; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Sinclair JF, 1999, PROTEIN SCI, V8, P991, DOI 10.1110/ps.8.5.991; Skrynnikov NR, 2000, J BIOMOL NMR, V18, P239, DOI 10.1023/A:1026501101716; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; TJANDRA N, 1999, STRUCT FOLD DES, V9, pR205; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q	20	525	532	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					487	489		10.1126/science.1060438	http://dx.doi.org/10.1126/science.1060438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463915				2022-12-24	WOS:000169966700046
J	Parnell, RJ; Buchanan-Smith, HM				Parnell, RJ; Buchanan-Smith, HM			Animal behaviour - An unusual social display by gorillas	NATURE			English	Article									Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland; New York Zool Soc, Wildlife Conservat Soc, Bronx, NY 10460 USA	University of Stirling; Wildlife Conservation Society	Parnell, RJ (corresponding author), Univ Stirling, Dept Psychol, Scottish Primate Res Grp, Stirling FK9 4LA, Scotland.		Buchanan-Smith, Hannah M/A-5350-2009	Buchanan-Smith, Hannah M/0000-0002-2516-7734				Beck B. B., 1980, ANIMAL TOOL BEHAV US; Byrne Richard W., 1996, P111; WILLIAMSON EA, 1990, AM J PRIMATOL, V21, P265, DOI 10.1002/ajp.1350210403	3	21	23	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2001	412	6844					294	294		10.1038/35085631	http://dx.doi.org/10.1038/35085631			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	453LW	11460152				2022-12-24	WOS:000169918200035
J	RYE, R; KUO, PH; HOLLAND, HD				RYE, R; KUO, PH; HOLLAND, HD			ATMOSPHERIC CARBON-DIOXIDE CONCENTRATIONS BEFORE 2.2-BILLION YEARS AGO	NATURE			English	Article							SURFACE TEMPERATURES; EARLY EARTH; DISSOLUTION; EVOLUTION; SEDIMENT; FEEDBACK	THE composition of the Earth's early atmosphere is a subject of continuing debate(1-4). In particular, it has been suggested that elevated concentrations of atmospheric carbon dioxide would have been necessary to maintain normal surface temperatures in the face of lower solar luminosity in early Earth history(5,6). Fossil weathering profiles, known as palaeosols, have provided semiquantitative constraints on atmospheric oxygen partial pressure (pO(2)) before 2.2 Gyr ago(36,37). Here we use the same well studied palaeosols to constrain atmospheric p(CO2) between 2.75 and 2.2 Gyr ago, The observation that iron lost from the tops of these profiles was reprecipitated lower down as iron silicate minerals(7-9), rather than as iron carbonate, indicates that atmospheric p(CO2) must have been less than 10(-1.4) atm-about 100 times today's level of 360 p.p.m., and at least five times lower than that required in one-dimensional climate models to compensate for lower solar luminosity at 2.75 Gyr. Our results suggest that either the Earth's early climate was much more sensitive to increases in p(CO2) than has been thought, or that one or more greenhouse gases other than CO2 contributed significantly to the atmosphere's radiative balance during the late Archaean and early Proterozoic eons.			RYE, R (corresponding author), HARVARD UNIV,DEPT EARTH & SPACE SCI,20 OXFORD ST,CAMBRIDGE,MA 02138, USA.							ARNDT NT, 1991, AUST J EARTH SCI, V38, P261, DOI 10.1080/08120099108727971; BAKER JA, 1955, USGS1257 WAT SUPPL P; BRUNO J, 1992, GEOCHIM COSMOCHIM AC, V56, P1149, DOI 10.1016/0016-7037(92)90052-K; BUICK R, 1995, NATURE, V375, P674; BUTTON A, 1981, EC GEOLOGY ANNIVERSA, V0075, P00686; BUTTON A, 1979, 133 U WITW EC GEOL R; CESS RD, 1990, J GEOPHYS RES-ATMOS, V95, P16601, DOI 10.1029/JD095iD10p16601; COTTER RD, 1965, USGS1759BE WAT PAP; EUGSTER HP, 1973, ECON GEOL, V68, P1144, DOI 10.2113/gsecongeo.68.7.1144; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GREENBERG J, 1992, APPL GEOCHEM, V7, P185, DOI 10.1016/0883-2927(92)90036-3; Hayes JM, 1994, NOBEL S, P220; HOFFMAN PF, 1995, NATURE, V375, P537, DOI 10.1038/375537a0; HOLLAND HD, 1990, AM J SCI, V290A, P1; HOLLAND HD, 1994, CHEM EVOLUTION ATMOS; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; KLEIN C, 1983, IRON FORMATION FACTS, V6, P417; MACFARLANE AW, 1994, PRECAMBRIAN RES, V65, P297, DOI 10.1016/0301-9268(94)90110-4; MAY F, 1994, MINERAL MAG A, V58, P577; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Pinto J.P., 1988, GEOL SOC AM SPEC PAP, P21, DOI DOI 10.1130/SPE216-P21; POSTMA D, 1981, CHEM GEOL, V31, P225; POSTMA D, 1977, J SEDIMENT PETROL, V47, P1089; POTH CW, 1963, B PENNS GEOL SURVEY, V16; POTH CW, 1973, B WATER RESOURCES RE, V36; POWELL JD, 1985, USGS2274 WAT SUPP PA; PRASAD N, 1991, 91IC GEOL SURV CAN P, P43; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1994, 1ST INT C CIRC HAB Z, P2; SUTTON SJ, 1993, CAN J EARTH SCI, V30, P60, DOI 10.1139/e93-006; TOWE KM, 1994, NOBEL S, V84, P36; WALKER JCG, 1990, GLOBAL PLANET CHANGE, V82, P261; WILLIAMS DR, 1991, USGS90384 OP FIL REP; WUNSCH DR, 1993, THESIS 5	38	267	272	2	50	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 7	1995	378	6557					603	605		10.1038/378603a0	http://dx.doi.org/10.1038/378603a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TJ221	11536713				2022-12-24	WOS:A1995TJ22100072
J	JABLONSKI, D; RAUP, DM				JABLONSKI, D; RAUP, DM			SELECTIVITY OF END-CRETACEOUS MARINE BIVALVE EXTINCTIONS	SCIENCE			English	Article							TERTIARY BOUNDARY; DEEP-SEA; MASS EXTINCTIONS; OCEAN; EVOLUTION; PATTERNS; SIZE	Analyses of the end-Cretaceous or Cretaceous-Tertiary mass extinction show no selectivity of marine bivalve genera by life position (burrowing versus exposed), body size, bathymetric position on the continental shelf, or relative breadth of bathymetric range. Deposit-feeders as a group have significantly lower extinction intensities than suspension-feeders, but this pattern is due entirely to low extinction in two groups (Nuculoida and Lucinoidea), which suggests that survivorship was not simply linked to feeding mode. Geographically widespread genera have significantly lower extinction intensities than narrowly distributed genera. These results corroborate earlier work suggesting that some biotic factors that enhance survivorship during times of lesser extinction intensities are ineffectual during mass extinctions.			JABLONSKI, D (corresponding author), UNIV CHICAGO, DEPT GEOPHYS SCI, 5734 S ELLIS AVE, CHICAGO, IL 60637 USA.							BOTTJER D J, 1988, Palaios, V3, P540, DOI 10.2307/3514444; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Calder WA., 1984, SIZE FUNCTION LIFE H; CAMPOSCREASEY LS, 1994, DEEP-SEA RES PT I, V41, P369, DOI 10.1016/0967-0637(94)90009-4; DANDO PR, 1994, MAR ECOL PROG SER, V107, P169, DOI 10.3354/meps107169; ERWIN D H, 1989, Palaios, V4, P424, DOI 10.2307/3514587; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; HICKMAN CS, 1994, VELIGER, V37, P43; HUBER BT, 1994, MAR MICROPALEONTOL, V24, P91, DOI 10.1016/0377-8398(94)90017-5; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1986, B MAR SCI, V39, P565; Jablonski D., 1986, P183; JABLONSKI D, 1991, SCIENCE, V253, P754, DOI 10.1126/science.253.5021.754; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; JABLONSKI D, IN PRESS GEOL SOC AM; Jablonski David, 1995, P25; JOHNSON CC, 1990, EXTINCTION EVENTS EA, P305; JUMARS PA, 1990, PHILOS T R SOC A, V331, P85, DOI 10.1098/rsta.1990.0058; KAMERMANS P, 1994, MAR ECOL PROG SER, V104, P63, DOI 10.3354/meps104063; Kauffman E.G., 1973, P353; KAUFFMAN EG, 1978, PHILOS T ROY SOC B, V284, P277, DOI 10.1098/rstb.1978.0068; KAUFFMAN EG, 1986, GLOBAL BIOEVENTS, P279; KELLER G, 1993, MAR MICROPALEONTOL, V21, P1, DOI 10.1016/0377-8398(93)90010-U; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; LAMBSHEAD PJD, 1990, DEEP-SEA RES, V37, P1263, DOI 10.1016/0198-0149(90)90042-T; LEVINTON JS, 1991, MAR BIOL, V110, P375, DOI 10.1007/BF01344356; LIN JD, 1994, OIKOS, V69, P28, DOI 10.2307/3545280; MACLEOD KG, 1994, GEOLOGY, V22, P139, DOI 10.1130/0091-7613(1994)022<0139:BIEAMM>2.3.CO;2; MACLEOD KG, 1994, J PALEONTOL, V68, P1048, DOI 10.1017/S0022336000026652; MACLEOD KG, 1990, GEOLOGICAL SOC AM SP, V247, P509; MARINCOVICH L, 1993, J PALEONTOL, V67, P1; Martin R.A., 1992, Historical Biology, V6, P73; McGhee G.R. Jr, 1989, P133; McKinney M.L., 1990, P75; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; PAUL CRC, 1994, GEOLOGY, V22, P679, DOI 10.1130/0091-7613(1994)022<0679:IFACFI>2.3.CO;2; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POHLO R, 1969, Proceedings of the Malacological Society of London, V38, P361; RAUP D., 1991, ANAL PALEOBIOLOGY, V4, P207; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; REID RGB, 1986, VELIGER, V29, P3; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; RHODES MC, 1991, GEOLOGY, V19, P877, DOI 10.1130/0091-7613(1991)019<0877:MEESAP>2.3.CO;2; ROY K, 1994, PALEOBIOLOGY, V20, P274, DOI 10.1017/S0094837300012781; SEPKOSKI JJ, 1987, SCIENCE, V235, P64, DOI 10.1126/science.11539724; SHEEHAN PM, 1992, GEOLOGY, V20, P556, DOI 10.1130/0091-7613(1992)020<0556:MEOLDV>2.3.CO;2; SHEEHAN PM, 1986, GEOLOGY, V14, P868, DOI 10.1130/0091-7613(1986)14<868:DFAABT>2.0.CO;2; SORAUF JE, 1986, CAN J EARTH SCI, V23, P1265, DOI 10.1139/e86-123; STANLEY SM, 1986, PALEOBIOLOGY, V12, P89, DOI 10.1017/S0094837300003006; STANLEY SM, 1988, MOLLUSCA, V11, P105; TYLER PA, 1988, OCEANOGR MAR BIOL, V26, P227; VANVALEN LM, 1994, MASS-EXTINCTION DEBATES: HOW SCIENCE WORKS IN A CRISIS, P200; WARD PD, 1991, GEOLOGY, V19, P1181, DOI 10.1130/0091-7613(1991)019<1181:AAIBEP>2.3.CO;2; WESTROP SR, 1989, PALEOBIOLOGY, V15, P46, DOI 10.1017/S0094837300009179; WINGARD GL, 1990, US GEOL SURV B, V1881, pD1; WINGARD GL, 1994, US GEOL SURV PROF PA, V1535, P1	58	161	164	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	1995	268	5209					389	391		10.1126/science.11536722	http://dx.doi.org/10.1126/science.11536722			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU572	11536722				2022-12-24	WOS:A1995QU57200030
J	BUICK, R				BUICK, R			THE ANTIQUITY OF OXYGENIC PHOTOSYNTHESIS - EVIDENCE FROM STROMATOLITES IN SULFATE-DEFICIENT ARCHEAN LAKES	SCIENCE			English	Article							WESTERN-AUSTRALIA; LACUSTRINE STROMATOLITES; WARRAWOONA GROUP; NORTH-POLE; BIOSTRATIGRAPHY; MICROFOSSILS; ROCKS	The Tumbiana Formation, about 2700 million years old, was largely deposited in ephemeral saline lakes, as judged by the unusual evaporite paragenesis of carbonate and halite with no sulfate. Stromatolites of diverse morphology occur in the lacustrine sediments, some with palimpsest fabrics after erect filaments. These stromatolites were probably accreted by phototropic microbes that, from their habitat in shallow isolated basins with negligible sulfate concentrations, almost certainly metabolized by oxygenic photosynthesis.	HARVARD UNIV,MUSEUM BOT,CAMBRIDGE,MA 02138	Harvard University				Buick, Roger/0000-0003-0139-1659				ABELL PI, 1982, SEDIMENT GEOL, V32, P1, DOI 10.1016/0037-0738(82)90011-2; [Anonymous], EARTHS EARLIEST BIOS; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; BLAKE TS, 1987, GEOLOGY, V15, P229, DOI 10.1130/0091-7613(1987)15<229:CRATAT>2.0.CO;2; BLAKE TS, 1984, NATURE, V307, P721, DOI 10.1038/307721a0; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; GREY K, 1982, PRECAMBRIAN RES, V18, P347, DOI 10.1016/0301-9268(82)90008-0; Grotzinger J.P., 1989, SOC EC PALEONTOLOGIS, V44, P79, DOI DOI 10.2110/PEC; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HOLLAND HD, 1990, AM J SCI, V290A, P1; KRYLOV IN, 1982, SEDIMENT GEOL, V32, P27, DOI 10.1016/0037-0738(82)90012-4; KUMAR S, 1984, PRECAMBRIAN RES, V14, P96; LIANG YZ, 1985, PRECAMBRIAN RES, V29, P15, DOI 10.1016/0301-9268(85)90056-7; Schidlowski M., 1983, P149; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Schopf J.W., 1983, P361; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SMITH RE, 1982, J PETROL, V23, P75, DOI 10.1093/petrology/23.1.75; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; Thorne A.M., 1990, U W AUST PUBL, P14; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; TRENDALL AF, 1990, 3RD INT ARCH S PERTH, P81; VEIZER J, 1990, GEOCHIM COSMOCHIM AC, V54, P2717, DOI 10.1016/0016-7037(90)90007-8; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; [No title captured]	27	264	275	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 3	1992	255	5040					74	77		10.1126/science.11536492	http://dx.doi.org/10.1126/science.11536492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX791	11536492				2022-12-24	WOS:A1992GX79100039
J	MacPherson, H; Thomas, K; Walters, S; Fitter, M				MacPherson, H; Thomas, K; Walters, S; Fitter, M			The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England; Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Sheffield Hlth Econ Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	MacPherson, H (corresponding author), Fdn Tradit Chinese Med, York YO24 4EY, N Yorkshire, England.	hugh@ftcm.org.uk		Walters, Stephen/0000-0001-9000-8126; MacPherson, Hugh/0000-0003-4255-4768				*BRIT MED ASS BOAR, 2000, AC EFF SAF PRACT; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; *HOUS LORDS, 2000, COMPL ALT MED; MacPherson H, 1999, J ALTERN COMPLEM MED, V5, P223, DOI 10.1089/acm.1999.5.223; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5	5	246	255	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2001	323	7311					486	487		10.1136/bmj.323.7311.486	http://dx.doi.org/10.1136/bmj.323.7311.486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469WF	11532841	Bronze, Green Published			2022-12-24	WOS:000170838500018
J	Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH				Huang, Y; Street-Perrott, FA; Metcalfe, SE; Brenner, M; Moreland, M; Freeman, KH			Climate change as the dominant control on glacial-interglacial variations in C-3 and C-4 plant abundance	SCIENCE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; LATE MIOCENE; EXPANSION; BOUNDARY; GRASSES; NEOGENE; RECORD; KENYA	Although C-4 plant expansions have been recognized in the late Miocene, identification of the underlying causes is complicated by the uncertainties associated with estimates of ancient precipitation, temperature, and partial pressure of atmospheric carbon dioxide (PCO2). Here we report the carbon isotopic compositions of leaf wax n-alkanes in take sediment cores from two sites in Mesoamerica that have experienced contrasting moisture variations since the last glacial maximum. Opposite isotopic trends obtained from these two sites indicate that regional climate exerts a strong control on the relative abundance of C-3 and C-4 plants and that in the absence of favorable moisture and temperature conditions, low PCO2 atone is insufficient to drive an expansion of C-4 plants.	Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Univ Coll Swansea, Dept Geog, Swansea SA2 8PP, W Glam, Wales; Univ Edinburgh, Dept Geog, Edinburgh EH8 9XP, Midlothian, Scotland; Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Brown University; Swansea University; University of Edinburgh; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Huang, Y (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.		Metcalfe, Sarah/H-9484-2013; Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				Bernor R.L., 1996, P449; BOUTTON TW, 1994, NATURE, V372, P625, DOI 10.1038/372625a0; Bradbury JP, 1997, QUATERN INT, V43-4, P97, DOI 10.1016/S1040-6182(97)00025-6; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Connin SL, 1998, QUATERNARY RES, V50, P179, DOI 10.1006/qres.1998.1986; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fischer H.G., COMMUNICATION; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; HUANG CT, 1971, INSECT BIOCHEM, V1, P27; Huang YS, 1999, GEOCHIM COSMOCHIM AC, V63, P1383, DOI 10.1016/S0016-7037(99)00074-5; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Latorre C, 1997, EARTH PLANET SC LETT, V146, P83, DOI 10.1016/S0012-821X(96)00231-2; LEYDEN BW, 1994, PALAEOGEOGR PALAEOCL, V109, P193, DOI 10.1016/0031-0182(94)90176-7; Metcalfe SE, 1997, J PALEOLIMNOL, V17, P155, DOI 10.1023/A:1007905824147; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; Muhs DR, 1999, GEOL SOC AM BULL, V111, P1861, DOI 10.1130/0016-7606(1999)111<1861:LQLINC>2.3.CO;2; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; RAMIREZ JO, 1995, GEOFISICA INT, V34, P107; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; RIELEY G, 1993, RAPID COMMUN MASS SP, V7, P488, DOI 10.1002/rcm.1290070617; Sage R.F., 1999, C4 PLANT BIOL, P3; Schulze ED, 1996, OECOLOGIA, V106, P352, DOI 10.1007/BF00334563; StreetPerrott FA, 1997, SCIENCE, V278, P1422, DOI 10.1126/science.278.5342.1422; SUKUMAR R, 1993, NATURE, V364, P703, DOI 10.1038/364703a0; TALBOT MR, 1992, EARTH PLANET SC LETT, V110, P23, DOI 10.1016/0012-821X(92)90036-U; Williams DG, 1996, OECOLOGIA, V106, P455, DOI 10.1007/BF00329701	28	290	351	9	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1647	1651		10.1126/science.1060143	http://dx.doi.org/10.1126/science.1060143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533488				2022-12-24	WOS:000170802900060
J	O'Boyle, CP; Cole, RP				O'Boyle, CP; Cole, RP			Rationing in the NHS: audit of outcome and acceptance of restriction criteria for minor operations	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England	Salisbury District Hospital	O'Boyle, CP (corresponding author), Salisbury Dist Hosp, Odstock Ctr Burns Plast & Maxillofacial Surg, Salisbury SP2 8BJ, Wilts, England.	ciaranoboyle@saintly.com	O'Boyle, Ciaran P/J-5853-2019	O'Boyle, Ciaran/0000-0001-9650-2133				Asch DA, 1997, NEW ENGL J MED, V336, P1668, DOI 10.1056/NEJM199706053362309; Charatan FB, 1996, BRIT MED J, V313, P1506, DOI 10.1136/bmj.313.7071.1506a; Latham SR, 1999, CLIN PLAST SURG, V26, P115; MCWILLIAM LJ, 1991, BRIT MED J, V303, P1177, DOI 10.1136/bmj.303.6811.1177; Timmons MJ, 2000, ANN ROY COLL SURG, V82, P332	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2001	323	7310					428	429		10.1136/bmj.323.7310.428	http://dx.doi.org/10.1136/bmj.323.7310.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	469BX	11520840	Green Published, Bronze			2022-12-24	WOS:000170793600021
J	Casares, F; Mann, RS				Casares, F; Mann, RS			The ground state of the ventral appendage in Drosophila	SCIENCE			English	Article							DISTAL-LESS; HOX GENE; PROXIMODISTAL AXIS; ANTENNAL IDENTITY; LEG DEVELOPMENT; NOTCH; EVOLUTION; SEGMENTATION; HOMOTHORAX; DOMAINS	In Drosophila melanogaster, the antennae, legs, genitalia, and analia make up a serially homologous set of ventral appendages that depend on different selector genes for their unique identities. The diversity among these structures implies that there is a common ground state that selector genes modify to generate these different appendage morphologies. Here we show that the ventral appendage that forms in the absence of selector gene activity is leglike but consists of only two segments along its proximo-distal axis: a proximal segment and a distal tarsus. These results raise the possibility that, during evolution, leglike appendages could have developed without selector gene activity.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 701 W 168 St, New York, NY 10032 USA.	rsm10@columbia.edu	Casares, Fernando/M-5451-2019	Casares, Fernando/0000-0002-2181-3858	NIGMS NIH HHS [R01 GM058575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Bishop SA, 1999, DEVELOPMENT, V126, P2993; BOUDREAUX BH, 1987, ARTHROPOD PHYLOGENY; Brown S, 2000, P NATL ACAD SCI USA, V97, P4510, DOI 10.1073/pnas.97.9.4510; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Dong PDS, 2000, DEVELOPMENT, V127, P209; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Estrada B, 2001, DEVELOPMENT, V128, P331; Gehring W., 1966, ARCH JULIUS KALAUSST, V41, P44; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; HANNAH-ALAVA ALOHA, 1958, J MORPH, V103, P281, DOI 10.1002/jmor.1051030205; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Snodgrass R, 1935, PRINCIPLES INSECT MO, P83; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0; Wu J, 1999, DEVELOPMENT, V126, P109	27	76	79	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1477	1480		10.1126/science.1062542	http://dx.doi.org/10.1126/science.1062542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520984				2022-12-24	WOS:000170616000041
J	Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL				Drazner, MH; Rame, JE; Stevenson, LW; Dries, DL			Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DILATED CARDIOMYOPATHY; CRITICALLY ILL; HEMODYNAMIC CORRELATIONS; INTEROBSERVER AGREEMENT; CARDIAC TRANSPLANTATION; MYOCARDIAL-INFARCTION; PHYSICAL-EXAMINATION; DOPPLER EVALUATION; CATHETERIZATION; SURVIVAL	Background: The independent prognostic value of elevated jugular venous pressure or a third heart sound in patients with heart failure is not well established. Methods: We performed a retrospective analysis of the Studies of Left Ventricular Dysfunction treatment trial, in which 2569 patients with symptomatic heart failure or a history of it were randomly assigned to receive enalapril or placebo. The mean (+/-SD) follow-up was 32+/-15 months. The presence of elevated jugular venous pressure or a third heart sound was ascertained by physical examination on entry into the trial. The risks of hospitalization for heart failure and progression of heart failure as defined by death from pump failure and the composite end point of death or hospitalization for heart failure were compared in patients with these findings on physical examination and patients without these findings. Results: In multivariate analyses that were adjusted for other markers of the severity of heart failure, elevated jugular venous pressure was associated with an increased risk of hospitalization for heart failure (relative risk, 1.32; 95 percent confidence interval, 1.08 to 1.62; P<0.01), death or hospitalization for heart failure (relative risk, 1.30; 95 percent confidence interval, 1.11 to 1.53; P<0.005), and death from pump failure (relative risk, 1.37; 95 percent confidence interval, 1.07 to 1.75; P<0.05). The presence of a third heart sound was associated with similarly increased risks of these outcomes. Conclusions: In patients with heart failure, elevated jugular venous pressure and a third heart sound are each independently associated with adverse outcomes, including progression of heart failure. Assessment for these findings is clinically meaningful.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital	Drazner, MH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Heart Failure Res Unit, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Rame, J. Eduardo/ABF-2208-2021	Rame, J. Eduardo/0000-0002-2936-1702				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Adolph RJ, 1998, CHEST, V114, P1235, DOI 10.1378/chest.114.5.1235; Azevedo ER, 2000, CIRCULATION, V101, P2053, DOI 10.1161/01.CIR.101.17.2053; Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; BRAUNWALD E, 1997, HEART DIS TXB CARDIO, V1, P445; BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; CHAKKO S, 1991, AM J MED, V90, P353, DOI 10.1016/0002-9343(91)90576-J; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; COOK DJ, 1990, AM J MED SCI, V299, P175, DOI 10.1097/00000441-199003000-00006; CRAIGE E, 1988, NEW ENGL J MED, V318, P1611, DOI 10.1056/NEJM198806163182409; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; DAVISON R, 1974, AM HEART J, V87, P279, DOI 10.1016/0002-8703(74)90064-7; Drazner MH, 1999, J HEART LUNG TRANSPL, V18, P1126, DOI 10.1016/S1053-2498(99)00070-4; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Dries DL, 1999, NEW ENGL J MED, V341, P298; EISENBERG PR, 1984, CRIT CARE MED, V12, P549, DOI 10.1097/00003246-198407000-00001; FLETCHER RH, 1992, ANN INTERN MED, V117, P786, DOI 10.7326/0003-4819-117-9-786; FOLLAND ED, 1992, NEW ENGL J MED, V327, P458, DOI 10.1056/NEJM199208133270703; GADSBOLL N, 1989, EUR HEART J, V10, P1017, DOI 10.1093/oxfordjournals.eurheartj.a059414; GLOVER DR, 1987, BRIT HEART J, V57, P125; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; ISHIMITSU T, 1985, J AM COLL CARDIOL, V5, P268, DOI 10.1016/S0735-1097(85)80046-2; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; Joshi N, 1999, SOUTH MED J, V92, P756, DOI 10.1097/00007611-199908000-00002; KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2; KEOGH AM, 1990, AM J CARDIOL, V65, P903, DOI 10.1016/0002-9149(90)91434-8; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Levin A, 1998, ANN INTERN MED, V128, P334, DOI 10.7326/0003-4819-128-4-199802150-00057; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; Lok CE, 1998, CHEST, V114, P1283, DOI 10.1378/chest.114.5.1283; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; Mangione S, 1998, JAMA-J AM MED ASSOC, V279, P1444; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; MORLEY D, 1994, AM J CARDIOL, V73, P379, DOI 10.1016/0002-9149(94)90012-4; PATEL R, 1993, WESTERN J MED, V158, P606; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808, DOI 10.1016/0735-1097(93)90195-7; Pozzoli M, 1997, CIRCULATION, V95, P1222; POZZOLI M, 1990, EUR HEART J, V11, P500, DOI 10.1093/oxfordjournals.eurheartj.a059742; RIHAL CS, 1994, CIRCULATION, V90, P2772, DOI 10.1161/01.CIR.90.6.2772; SHAH PM, 1969, AM HEART J, V78, P823, DOI 10.1016/0002-8703(69)90450-5; STCLAIR EW, 1992, ANN INTERN MED, V117, P751, DOI 10.7326/0003-4819-117-9-751; Stein JH, 1997, AM J CARDIOL, V80, P1615, DOI 10.1016/S0002-9149(97)00776-5; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; *STUD LEFT VENTR D, 1990, AM J CARDIOL, V66, P1026; UNVERFERTH DV, 1984, AM J CARDIOL, V54, P147, DOI 10.1016/0002-9149(84)90320-5; VANDEWERF F, 1984, CIRCULATION, V69, P1070, DOI 10.1161/01.CIR.69.6.1070; Weitz HH, 2000, AM J MED, V108, P669, DOI 10.1016/S0002-9343(00)00385-5; WESTMAN EC, 1995, J GEN INTERN MED, V10, P455, DOI 10.1007/BF02599919; XIE GY, 1994, J AM COLL CARDIOL, V24, P132, DOI 10.1016/0735-1097(94)90553-3; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1990, AM J CARDIOL, V66, P315	54	414	435	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2001	345	8					574	581		10.1056/NEJMoa010641	http://dx.doi.org/10.1056/NEJMoa010641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464ZH	11529211				2022-12-24	WOS:000170562900004
J	Snell, B				Snell, B			Inappropriate drug donations: the need for reforms	LANCET			English	Editorial Material									Macfarlane Burnet Ctr Med Res, Int Hlth Unit, Fairfield, Vic 3078, Australia		Snell, B (corresponding author), Macfarlane Burnet Ctr Med Res, Int Hlth Unit, POB 254, Fairfield, Vic 3078, Australia.							Forte GB, 1998, NEW ENGL J MED, V338, P1473; WHO, 1999, GUID SAF DISP UNW PH; World Health Organization, 1999, GUID DRUG DON	3	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 18	2001	358	9281					578	580		10.1016/S0140-6736(01)05712-9	http://dx.doi.org/10.1016/S0140-6736(01)05712-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	464NB	11520548				2022-12-24	WOS:000170537700036
J	Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL				Cifuentes, L; Borja-Aburto, VH; Gouveia, N; Thurston, G; Davis, DL			Climate change: Hidden health benefits of greenhouse gas mitigation	SCIENCE			English	Editorial Material							AIR-POLLUTION; INFANT-MORTALITY		Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA; NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil; Direcc Gen Salud Ambiental, Mexico City, DF, Mexico; Pontificia Univ Catolica Chile, Santiago, Chile	Carnegie Mellon University; New York University; Universidade de Sao Paulo; Pontificia Universidad Catolica de Chile	Davis, DL (corresponding author), Carnegie Mellon Univ, H John Heinz III Sch Publ Policy & Management, Pittsburgh, PA 15213 USA.	ddavis@andrew.cmu.edu	Cifuentes, Luis Abdon/C-7081-2009; Gouveia, Nelson C/C-4580-2013	Cifuentes, Luis Abdon/0000-0001-7416-5607; Gouveia, Nelson C/0000-0003-0625-0265	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		*ABT ASS INC, 2000, PART REL HLTH BEN RE; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; Bobak M, 1999, EPIDEMIOLOGY, V10, P666, DOI 10.1097/00001648-199911000-00004; Cifuentes L, 2001, ENVIRON HEALTH PERSP, V109, P419, DOI 10.2307/3434790; Davis DL, 1997, LANCET, V350, P1341, DOI 10.1016/S0140-6736(97)10209-4; *EPA NCEA, 1996, EPA600P93004AC NCEA; Farrow RS, 2001, IMPROVING REGULATION: CASES IN ENVIRONMENT HEALTH AND SAFETY, P429; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Krewski D, 2000, REANALYSIS HARVARD 1; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; LEVY J, 2001, RISK PERSPECT, V9, P2; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; Maisonet M, 2001, ENVIRON HEALTH PERSP, V109, P351, DOI 10.2307/3434782; National Research Council, 2001, CLIM CHANG SCI AN SO; *ONT MED ASS, 2000, ILLN COSTS AIR POLL; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; U.S. Environmental Protection Agency (EPA), 1996, EPA600P95001CF NCEA; [WHO] World Health Organization, 1997, HLTH ENV SUST DEV 5	20	110	112	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1257	1259		10.1126/science.1063357	http://dx.doi.org/10.1126/science.1063357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509711				2022-12-24	WOS:000170492600018
J	Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM				Fuchs, M; Gerber, J; Drapkin, R; Sif, S; Ikura, T; Ogryzko, V; Lane, WS; Nakatani, Y; Livingston, DM			The p400 complex is an essential E1A transformation target	CELL			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE ACETYLASE COMPLEX; ESSENTIAL COFACTOR; C-MYC; ACETYLTRANSFERASE COMPLEX; SWI/SNF COMPLEX; PROTEIN; TRANSCRIPTION; BINDING; ONCOPROTEINS	Here, we report the identification of a new E1A binding protein complex that is essential for E1A-mediated transformation. Its core component is a SWI2/SNF2-related, 400 kDa protein (p400). Other components include the myc- and p/CAF-associated cofactor, TRRAP/PAF400, the DNA helicases TAP54 alpha/beta, actin-like proteins, and the human homolog of the Drosophila Enhancer of Polycomb protein. An E1A mutant, defective in p400 binding, is also defective in transformation. Certain p400 fragments partially rescued this phenotype, underscoring the role of E1A-p400 complex formation in the E1A transforming process. Furthermore, E1A and c-myc each alter the subunit composition of p400 complexes, implying that physiological p400 complex formation contributes to transformation suppression.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Ohio State Univ, Sch Med, Columbus, OH 43210 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA; Inst Andre Lwoff, Villejuif, France	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University System of Ohio; Ohio State University; Harvard University	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Drapkin, Ronny/E-9944-2016; Ogryzko, Vasily/M-6665-2015; Sif, Said/AAE-5554-2019	Drapkin, Ronny/0000-0002-6912-6977; Ogryzko, Vasily/0000-0002-8548-1389; Sif, Said/0000-0001-6268-1145	NHLBI NIH HHS [T32-HL07627-16] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; BARBEAU D, 1994, ONCOGENE, V9, P359; BAYLEY ST, 1994, INT J ONCOL, V5, P425; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Goodman RH, 2000, GENE DEV, V14, P1553; Grand F, 1999, CANCER RES, V59, P3870; HOWE JA, 1992, VIROLOGY, V186, P15, DOI 10.1016/0042-6822(92)90057-V; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LAND H, 1995, METHOD ENZYMOL, V254, P37; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; NEVINS JR, 1992, SCIENCE, V258, P424; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Saleh A, 1998, J BIOL CHEM, V273, P26559, DOI 10.1074/jbc.273.41.26559; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; SHIMONO Y, 1939, J BIOL CHEM, P275; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sinclair DAR, 1998, GENETICS, V148, P211; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	36	245	251	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					297	307		10.1016/S0092-8674(01)00450-0	http://dx.doi.org/10.1016/S0092-8674(01)00450-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509179	Bronze			2022-12-24	WOS:000170433300008
J	Walker, JR; Corpina, RA; Goldberg, J				Walker, JR; Corpina, RA; Goldberg, J			Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; KU80-DEFICIENT CELLS; END; COMPLEX; BINDING; SUBUNIT; RECOMBINATION; ASSOCIATION; STABILITY; PATHWAY	The Ku heterodimer (Ku70 and Ku80 subunits) contributes to genomic integrity through its ability to bind DNA double-strand breaks and facilitate repair by the non-homologous end-joining pathway. The crystal structure of the human Ku heterodimer was determined both alone and bound to a 55-nucleotide DNA element at 2.7 and 2.5 Angstrom resolution, respectively. Ku70 and Ku80 share a common topology and form a dyad-symmetrical molecule with a preformed ring that encircles duplex DNA. The binding site can cradle two full turns of DNA while encircling only the central 3-4 base pairs (bp). Ku makes no contacts with DNA bases and few with the sugar-phosphate backbone, but it fits sterically to major and minor groove contours so as to position the DNA helix in a defined path through the protein ring. These features seem well designed to structurally support broken DNA ends and to bring the DNA helix into phase across the junction during end processing and ligation.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org		/0000-0002-5255-895X				Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calsou P, 1999, J BIOL CHEM, V274, P7848, DOI 10.1074/jbc.274.12.7848; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; CHOU CH, 1992, J EXP MED, V175, P1677, DOI 10.1084/jem.175.6.1677; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Liang F, 1996, J BIOL CHEM, V271, P14405, DOI 10.1074/jbc.271.24.14405; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAILLARD S, 1993, PROTEINS, V15, P330, DOI 10.1002/prot.340150310; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THODE S, 1990, CELL, V60, P921, DOI 10.1016/0092-8674(90)90340-K; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034; Zhao JK, 1999, BIOCHEMISTRY-US, V38, P2152, DOI 10.1021/bi9825246; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	44	834	874	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					607	614		10.1038/35088000	http://dx.doi.org/10.1038/35088000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493912				2022-12-24	WOS:000170318000032
J	Annas, GJ				Annas, GJ			The limits of state laws to protect genetic information	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ABELSON R, 2001, NY TIMES        0610, P1; Andrews L. B., 2001, FUTURE PERFECT CONFR; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; CUMMINGS J, 2001, WALL STREET J   0625, pB2; Fedder RS, 2000, J LEGAL MED, V21, P557, DOI 10.1080/019476400455807; Greely H T, 2000, Jurimetrics, V40, P153; JAGUTIS MA, 1999, MARQ L REV, V82, P429; LASALANDRA M, 2001, BOSTON HERALD   0225, P3; Laurie GT, 2001, J LEGAL MED, V22, P1, DOI 10.1080/019476401750171115; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; MURRAY TH, 1997, GENETIC SECRETS PROT, P60; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; Nelkin D, 2001, NAT REV GENET, V2, P555, DOI 10.1038/35080583; Roche PA, 2001, NAT REV GENET, V2, P392, DOI 10.1038/35072029; ROCHE PA, 1996, JURIMETICS, V31, P1; SIXEL LM, 2001, HOUSTON CHRONIC 0216, pB1; SWAZEY JP, 1992, GENE MAPPING USING L, P45; 2000, FDCH POLITICAL  0602, P20; 2000, NY TIMES        0627, pF8	19	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2001	345	5					385	388		10.1056/NEJM200108023450523	http://dx.doi.org/10.1056/NEJM200108023450523			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	458KM	11484711	Green Published			2022-12-24	WOS:000170193600030
J	Krause, DW				Krause, DW			Fossil molar from a Madagascan marsupial - The discovery of a tiny tooth from the Late Cretaceous period has sizeable implications.	NATURE			English	Article									SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krause, DW (corresponding author), SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA.							Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; CIFELLI RL, 1987, NATURE, V325, P520, DOI 10.1038/325520a0; CIFELLI RL, 1993, P NATL ACAD SCI USA, V90, P9413, DOI 10.1073/pnas.90.20.9413; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; FOX RC, 1975, CAN J EARTH SCI, V12, P412, DOI 10.1139/e75-037; Fox Richard C., 1995, P247; Krause D.W., 1999, GSA TODAY, V9, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Masters JC, 1995, CREATURES OF THE DARK, P31; PRASAD GVR, 1988, NATURE, V332, P638, DOI 10.1038/332638a0; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; SLAUGHTER BH, 1968, SCIENCE, V162, P254, DOI 10.1126/science.162.3850.254; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359; [No title captured]	15	55	58	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					497	498		10.1038/35087649	http://dx.doi.org/10.1038/35087649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484038				2022-12-24	WOS:000170202900030
J	Foster, JE; Holmes, SF; Erie, DA				Foster, JE; Holmes, SF; Erie, DA			Allosteric binding of nucleoside triphosphates to RNA polymerase regulates transcription elongation	CELL			English	Article							RIBONUCLEIC-ACID POLYMERASE; TERMINATION; ENZYME; DNA; MECHANISM; SITES; CONFORMATIONS; FIDELITY; MODEL	The regulation of transcription elongation and termination appears to be governed by the ability of RNA polymerase elongation complexes to adopt multiple conformational states; however, the factors controlling the distribution between these states remain elusive. We used transient-state kinetics to investigate the incorporation of single nucleotides. We demonstrate that E. coli RNA polymerase contains an allosteric binding site in addition to the catalytic site. Binding of the templated nucleoside triphosphate (NTP), but not nontemplated NTPs, to this site increases the rate of nucleotide incorporation. The data suggest that RNA polymerase can exist in a state that catalyzes synthesis slowly (unactivated) and one that catalyzes synthesis rapidly (activated), with the transition from the slow to the fast state being induced by binding of the templated NTP to the allosteric site.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Erie, DA (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [GM-54316] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; ARMSTRONG VW, 1979, BIOCHEMISTRY-US, V18, P4120, DOI 10.1021/bi00586a010; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Buc H, 2000, SCIENCE, V287, P2437, DOI 10.1126/science.287.5462.2437; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEMERCOYROL L, 1990, BIOCHEM J, V269, P651, DOI 10.1042/bj2690651; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Guthold M, 2001, CHEMBIOCHEM, V2, P167; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Landick R, 1999, SCIENCE, V284, P598, DOI 10.1126/science.284.5414.598; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MOORE DS, 1995, BASIC PRACTICE STAT, P630; NEFF NF, 1980, BIOCHEMISTRY-US, V19, P3005, DOI 10.1021/bi00554a027; NIERMAN WC, 1980, J BIOL CHEM, V255, P4495; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; SCHULZ AR, 1994, ENZYME KINETICS DIST, P133; Segel IH., 1975, ENZYME KINETICS, P227; SHOEMAKER DP, 1981, EXPT PHYSICAL CHEM, P727; TELESNITSKY APW, 1989, J MOL BIOL, V205, P315, DOI 10.1016/0022-2836(89)90343-4; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Uptain SM, 1997, P NATL ACAD SCI USA, V94, P13548, DOI 10.1073/pnas.94.25.13548; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	39	93	95	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2001	106	2					243	252		10.1016/S0092-8674(01)00420-2	http://dx.doi.org/10.1016/S0092-8674(01)00420-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	458KG	11511351	Bronze, Green Published			2022-12-24	WOS:000170193100013
J	Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR				Wainger, BJ; DeGennaro, M; Santoro, B; Siegelbaum, SA; Tibbs, GR			Molecular mechanism of cAMP modulation of HCN pacemaker channels	NATURE			English	Article							K+ CHANNEL; T1 DOMAIN; C-LINKER; LIGAND; IDENTIFICATION; ACTIVATION; SUBUNIT; BINDING; FAMILY	Hyperpolarization-activated cation channels of the HCN gene family(1-6) contribute to spontaneous rhythmic activity in both heart(7) and brain(5,6,8). All four family members contain both a core transmembrane segment domain, homologous to the S1-S6 regions of voltage-gated K+ channels, and a carboxy-terminal 120 amino-acid cyclic nucleotide-binding domain (CNBD) motif. Homologous CNBDs are responsible for the direct activation of cyclic nucleotide-gated channels and for modulation of the HERG voltage-gated K+ channel-important for visual and olfactory signalling(9) and for cardiac repolarization(10), respectively. The direct binding of cyclic AMP to the cytoplasmic site on HCN channels permits the channels to open more rapidly and completely after repolarization of the action potential(1,2,11), thereby accelerating rhythmogenesis(6-8). However, the mechanism by which cAMP binding modulates HCN channel gating and the basis for functional differences between HCN isoforms remain unknown. Here we demonstrate by constructing truncation mutants that the CNBD inhibits activation of the core transmembrane domain. cAMP binding relieves this inhibition. Differences in activation gating and extent of cAMP modulation between the HCN1 and HCN2 isoforms result largely from differences in the efficacy of CNBD inhibition.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Tibbs, GR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	grt1@columbia.edu	Wainger, Brian/L-7553-2017; DeGennaro, Matthew/H-4975-2015	DeGennaro, Matthew/0000-0003-3837-4430; Santoro, Bina/0000-0002-4277-1992				Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; CHEN S, 2000, SOC NEUR ABSTR, V26, P2139; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	28	365	380	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					805	810		10.1038/35081088	http://dx.doi.org/10.1038/35081088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459060				2022-12-24	WOS:000169246400051
J	Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B				Smith, HJ; Fischer, H; Wahlen, M; Mastroianni, D; Deck, B			Dual modes of the carbon cycle since the Last Glacial Maximum	NATURE			English	Article							ICE-CORE; ATMOSPHERIC CO2; GREENLAND ICE; RECORD	The most conspicuous feature of the record of past climate contained in polar ice is the rapid warming which occurs after long intervals of gradual cooling. During the last four transitions from glacial to interglacial conditions, over which such abrupt warmings occur, ice records indicate that the CO2 concentration of the atmosphere increased by roughly 80 to 100 parts per million by volume (refs 1-4). But the causes of the atmospheric CO2 concentration increases are unclear. Here we present the stable-carbon-isotope composition (delta(13)CO(2)) Of CO2 extracted from air trapped in ice at Taylor Dome, Antarctica, rom the Last Glacial Maximum to the onset of Holocene times. The global carbon cycle is shown to have operated in two distinct primary modes on the timescale of thousands of years, one when climate was changing relatively slowly and another when warming was rapid, each with a characteristic average stable-carbon-isotope composition of the net CO2 exchanged by the atmosphere with the land and oceans. delta(13)CO(2) increased betiveen 16.5 and 9 thousand years ago by slightly more than would be estimated to be caused by the physical effects of a 5 degrees C rise in global average sea surface temperature driving a CO2 efflux from the ocean, but our data do not allow specific causes to be constrained.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Smith, HJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	hjsmith@aaas.org	Fischer, Hubertus/A-1211-2014	Fischer, Hubertus/0000-0002-2787-4221				ANKLIN M, 1995, TELLUS B, V47, P461, DOI 10.1034/j.1600-0889.47.issue4.6.x; BARNOLA JM, 1995, TELLUS B, V47, P264, DOI 10.1034/j.1600-0889.47.issue1.22.x; BARNOLA JM, 1987, NATURE, V329, P408, DOI 10.1038/329408a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; *CLIMAP PROJ MEMB, 1981, MAP CHART SER; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; CRAIG H, 1988, SCIENCE, V242, P1675, DOI 10.1126/science.242.4886.1675; DELMAS RJ, 1993, TELLUS B, V45, P391, DOI 10.1034/j.1600-0889.1993.t01-3-00006.x; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fairbanks RG, 1990, PALEOCEANOGRAPHY, V5, P937, DOI 10.1029/PA005i006p00937; Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; LEUENBERGER M, 1992, NATURE, V360, P449, DOI 10.1038/360449a0; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; MARINO BD, 1992, NATURE, V357, P461, DOI 10.1038/357461a0; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; NEFTEL A, 1988, NATURE, V331, P609, DOI 10.1038/331609a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SCHWANDER J, 1989, PHYS CH EAR, V8, P53; Smith HJ, 1997, GEOPHYS RES LETT, V24, P1, DOI 10.1029/96GL03700; SOWERS T, 1989, J GEOPHYS RES, V94, P3137; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; SUCHER C, 1997, TRAPPED GASES TAYLOR; TAKAHASHI T, 1993, GLOBAL BIOGEOCHEM CY, V7, P843, DOI 10.1029/93GB02263; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; WAHLEN M, 1991, GEOPHYS RES LETT, V18, P1457, DOI 10.1029/91GL01724; Weiss RF., 1974, MAR CHEM, V2, P203, DOI [DOI 10.1016/0304-4203(74)90015-2, 10.1016/0304-4203(74)90015-2]	30	147	153	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	1999	400	6741					248	250		10.1038/22291	http://dx.doi.org/10.1038/22291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217MP	11536907	Green Published			2022-12-24	WOS:000081503800039
J	Sagan, C; Chyba, C				Sagan, C; Chyba, C			The early faint sun paradox: Organic shielding of ultraviolet-labile greenhouse gases	SCIENCE			English	Review							EARTHS EARLY ATMOSPHERE; CHARGED-PARTICLE IRRADIATION; OUTER SOLAR-SYSTEM; OPTICAL-PROPERTIES; AMORPHOUS-CARBON; EARLY MARS; VERTICAL-DISTRIBUTION; NORTHERN PLAINS; EARLY EVOLUTION; ENERGY YIELDS	Atmospheric mixing ratios of similar to 10(-5 +/- 1) for ammonia on the early Earth would have been sufficient, through the resulting greenhouse warming, to counteract the temperature effects of the faint early sun. One argument against such model atmospheres has been the short time scale for ammonia photodissociation by solar ultraviolet light. Here it is shown that ultraviotet absorption by steady-state amounts of high-attitude organic solids produced from methane photolysis may have shielded ammonia sufficiently that ammonia resupply rates were able to maintain surface temperatures above freezing.	CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853; UNIV ARIZONA,DEPT PLANETARY SCI,TUCSON,AZ 85721	Cornell University; University of Arizona								ABELSON PH, 1966, P NATL ACAD SCI USA, V55, P1365, DOI 10.1073/pnas.55.6.1365; ACKERMAN M, 1971, MESOSPHERIC MODELS R, P00149; ANDERSON DA, 1977, PHILOS MAG, V35, P17, DOI 10.1080/14786437708235968; ANDERSON DL, 1993, SCIENCE, V261, P170, DOI 10.1126/science.261.5118.170; ARAKAWA ET, 1985, PHYS REV B, V31, P8097, DOI 10.1103/PhysRevB.31.8097; ARCULUS RJ, 1985, ANNU REV EARTH PL SC, V13, P75, DOI 10.1146/annurev.ea.13.050185.000451; BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; BAULCH DL, 1982, J PHYS CHEM REF DATA, V11, P327, DOI 10.1063/1.555664; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; Burns R.C., 2012, MOL BIOL BIOCH BIOPH, DOI DOI 10.1007/978-3-642-80926-2; BUSSOLETTI E, 1987, ASTRON ASTROPHYS SUP, V70, P257; Carr M.H, 1996, WATER MARS; CHLEWICKI G, 1990, ASTROPHYS J, V365, P230, DOI 10.1086/169474; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Chyba C.F., 1994, HAZARDS DUE COMETS A, P9; DAWSON GA, 1977, J GEOPHYS RES-OC ATM, V82, P3125, DOI 10.1029/JC082i021p03125; DULEY WW, 1984, ASTROPHYS J, V287, P694, DOI 10.1086/162727; Eiler JM, 1997, NATURE, V386, P665, DOI 10.1038/386665a0; ERIKSSON KA, 1982, TECTONOPHYSICS, V81, P179, DOI 10.1016/0040-1951(82)90128-7; FARQUHAR GD, 1980, PLANT PHYSIOL, V66, P710, DOI 10.1104/pp.66.4.710; GOGARTENBOEKELS M, 1995, ORIGINS LIFE EVOL B, V25, P251, DOI 10.1007/BF01581588; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1994, THESIS CORNELL U; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GREENBERG JM, 1990, ASTROPHYS J, V361, P260, DOI 10.1086/169191; GUZIK JA, 1987, ASTROPHYS J, V319, P957, DOI 10.1086/165512; HAGEMANN HJ, 1975, J OPT SOC AM, V65, P742, DOI 10.1364/JOSA.65.000742; HENDERSON-SELLERS A, 1980, NATURE, V287, P526, DOI 10.1038/287526a0; HENDERSONSELLER.A, 1973, NATURE, V279, P786; Holland H.D., 1984, CHEM EVOLUTION ATMOS; HOLMAN MJ, 1993, ASTRON J, V105, P1987, DOI 10.1086/116574; HONG KY, 1974, SCIENCE, V184, P984, DOI 10.1126/science.184.4140.984; HUNTEN DM, 1976, ANNU REV EARTH PL SC, V4, P265, DOI 10.1146/annurev.ea.04.050176.001405; JENKINS GS, 1993, J GEOPHYS RES-ATMOS, V98, P8785, DOI 10.1029/93JD00033; JENNISKENS P, 1993, ASTRON ASTROPHYS, V272, P465; KARHU J, 1986, GEOCHIM COSMOCHIM AC, V50, P1745, DOI 10.1016/0016-7037(86)90136-5; Kasting J.F., 1991, SUN TIME, P447; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KASTING JF, 1992, PROTEROZOIC BIOSPHER, P165; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; KHARE BN, 1978, SCIENCE, V199, P1199, DOI 10.1126/science.199.4334.1199; KHARE BN, 1981, ICARUS, V48, P290, DOI 10.1016/0019-1035(81)90110-X; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; LANGFORD AO, 1992, SCIENCE, V255, P581, DOI 10.1126/science.255.5044.581; LASAGA AC, 1971, SCIENCE, V174, P53, DOI 10.1126/science.174.4004.53; LEE SC, 1981, 18TH S INT COMB PITT, P1159; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEVINE JS, 1980, GEOPHYS RES LETT, V7, P317, DOI 10.1029/GL007i005p00317; LOVELOCK J, 1988, AGES GAIA, pCH4; MCDONALD GD, 1994, ICARUS, V107, P137; MCGOVERN WE, 1969, J ATMOS SCI, V26, P623, DOI 10.1175/1520-0469(1969)26<623:TPETMO>2.0.CO;2; Miller S. L., 1981, ORIGINS LIFE, P135; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; MILLER SL, 1984, ORIGINS LIFE EVOL B, V14, P83, DOI 10.1007/BF00933643; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NORTH GR, 1975, J ATMOS SCI, V32, P2033, DOI 10.1175/1520-0469(1975)032<2033:TOEBCM>2.0.CO;2; Noyes W.A., 1941, PHOTOCHEMISTRY GASES; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OBERBECK VR, 1993, J GEOL, V101, P1, DOI 10.1086/648193; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POLLACK JB, 1993, NEAR EARTH RESOURCES; QUINN PK, 1988, NATURE, V335, P336, DOI 10.1038/335336a0; RAGES K, 1980, ICARUS, V41, P119, DOI 10.1016/0019-1035(80)90164-5; RAVEN JA, 1992, NEW PHYTOL, V121, P5, DOI 10.1111/j.1469-8137.1992.tb01087.x; ROBINSON E, 1970, Journal of the Air Pollution Control Association, V20, P303; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; ROULEAU F, 1991, ASTROPHYS J, V377, P526, DOI 10.1086/170382; RYE R, 1995, NATURE, V378, P603, DOI 10.1038/378603a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAGAN C, 1977, NATURE, V269, P224, DOI 10.1038/269224a0; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1973, J THEOR BIOL, V39, P195, DOI 10.1016/0022-5193(73)90216-6; SAGAN C, 1973, J GEOPHYS RES, V78, P1250; SAGAN C, 1984, SATURN, P788; SCHAEFER MW, 1990, J GEOPHYS RES-SOLID, V95, P14291, DOI 10.1029/JB095iB09p14291; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SUMMERS DP, 1993, NATURE, V365, P630, DOI 10.1038/365630a0; THOMAS PJ, 1997, COMETS ORIGIN EVOLUT, P147; THOMPSON WR, 1994, ICARUS, V112, P376, DOI 10.1006/icar.1994.1191; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TJEPKEMA JD, 1981, NATURE, V294, P445, DOI 10.1038/294445a0; TOUPANCE G, 1977, ORIGINS LIFE EVOL B, V8, P259, DOI 10.1007/BF00930687; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1983, NATURE, V302, P518, DOI 10.1038/302518a0; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WANG WC, 1980, J ATMOS SCI, V37, P545, DOI 10.1175/1520-0469(1980)037<0545:EOIAFO>2.0.CO;2; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOFSY SC, 1973, J GEOPHYS RES, V78, P2619, DOI 10.1029/JC078i015p02619; YUNG YL, 1978, NATURE, V273, P730, DOI 10.1038/273730a0; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZAHNLE KJ, 1982, REV GEOPHYS, V20, P280, DOI 10.1029/RG020i002p00280; [No title captured]	112	257	260	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 23	1997	276	5316					1217	1221		10.1126/science.276.5316.1217	http://dx.doi.org/10.1126/science.276.5316.1217			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XA497	11536805				2022-12-24	WOS:A1997XA49700032
J	THOMPSON, WR; SAGAN, C				THOMPSON, WR; SAGAN, C			COLOR AND CHEMISTRY ON TRITON	SCIENCE			English	Article											THOMPSON, WR (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Billmeyer F.W., 1981, PRINCIPLES COLOR TEC; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CONRATH B, 1989, SCIENCE, V246, P1454, DOI 10.1126/science.246.4936.1454; CRUIKSHANK DP, 1984, ICARUS, V58, P306, DOI 10.1016/0019-1035(84)90047-2; CRUIKSHANK DP, 1988, ICARUS, V74, P413, DOI 10.1016/0019-1035(88)90112-1; CRUIKSHANK DP, 1984, ICARUS, V58, P293, DOI 10.1016/0019-1035(84)90046-0; DELITSKY ML, 1987, ICARUS, V70, P354, DOI 10.1016/0019-1035(87)90141-2; LARK NL, 1989, ICARUS, V79, P15, DOI 10.1016/0019-1035(89)90104-8; MCEWEN AS, GEOPHYS RES LETT, V17, P1733; MCKAY CP, 1989, GEOPHYS RES LETT, V16, P973, DOI 10.1029/GL016i008p00973; PISCITELLI JR, 1988, ICARUS, V76, P118, DOI 10.1016/0019-1035(88)90144-3; SAGAN C, 1990, NATURE, V346, P546, DOI 10.1038/346546a0; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SMITH BA, 1989, SCIENCE, V246, P1422, DOI 10.1126/science.246.4936.1422; SODERBLOM LA, 1990, SCIENCE, V250, P410, DOI 10.1126/science.250.4979.410; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; SPENCER JR, IN PRESS ICARUS; STANSBERRY JA, 1990, GEOPHYS RES LETT, V17, P1773, DOI 10.1029/GL017i010p01773; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P969, DOI 10.1029/GL016i008p00969; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THOMPSON WR, 1989, GEOPHYS RES LETT, V16, P981, DOI 10.1029/GL016i008p00981; THOMPSON WR, 1990, INT J SUPERCOMPUT AP, V4, P48, DOI 10.1177/109434209000400205; THOMPSON WR, IN PRESS ICARUS; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466	26	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 19	1990	250	4979					415	418		10.1126/science.11538073	http://dx.doi.org/10.1126/science.11538073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED616	11538073				2022-12-24	WOS:A1990ED61600032
J	CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C				CHYBA, CF; THOMAS, PJ; BROOKSHAW, L; SAGAN, C			COMETARY DELIVERY OF ORGANIC-MOLECULES TO THE EARLY EARTH	SCIENCE			English	Article									YALE UNIV,APPL PHYS SECT,NEW HAVEN,CT 06520	Yale University	CHYBA, CF (corresponding author), CORNELL UNIV,PLANETARY STUDIES LAB,ITHACA,NY 14853, USA.							Abelson P.H., 1959, RES GEOCHEMISTRY, P79; ALLEN HJ, 1963, NASA TR R185 TECHN R; ALLEN M, 1987, ASTRON ASTROPHYS, V187, P502; ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARAKAWA ET, 1989, BAAS, V21, P940; ARNOSTI C, 1987, ORG GEOCHEM, V11, P505, DOI 10.1016/0146-6380(87)90006-4; ATKINS PW, 1986, PHYSICAL CHEM; BALDWIN B, 1971, J GEOPHYS RES, V76, P4653, DOI 10.1029/JA076i019p04653; BARAK I, 1975, ORIGINS LIFE EVOL B, V6, P483, DOI 10.1007/BF00928897; BARNUN A, 1970, SCIENCE, V168, P470, DOI 10.1126/science.168.3930.470; BENSON SW, 1970, NSRDSDNBS21 PUBL; BENZ W, 1989, ICARUS, V81, P113, DOI 10.1016/0019-1035(89)90129-2; BENZ W, 1987, ICARUS, V71, P30, DOI 10.1016/0019-1035(87)90160-6; BENZ W, 1988, ICARUS, V74, P516, DOI 10.1016/0019-1035(88)90118-2; BRONSHTEN VA, 1983, PHYSICS METEORIC PHE; BROWN WT, 1981, AIP C, V78, P529; BURNHAM AK, 1987, ENERG FUEL, V1, P452, DOI 10.1021/ef00006a001; CEPLECHA Z, 1977, COMETS ASTEROIDS MET, pCH5; Chamberlin T C, 1908, Science, V28, P897, DOI 10.1126/science.28.730.897; CHANG S, 1978, NASA C PUBLICATION, V2089, P59; Chang S., 1983, EARTHS EARLIEST BIOS, P53; CHYBA C, 1988, NATURE, V332, P592, DOI 10.1038/332592a0; CHYBA C, 1989, NASA CONF P, V3036, P433; CHYBA C, 1987, NATURE, V330, P350, DOI 10.1038/330350a0; CHYBA C, 1987, NATURE, V329, P208, DOI 10.1038/329208a0; CHYBA CF, 1987, NATURE, V330, P632, DOI 10.1038/330632a0; CHYBA CF, 1990, NATURE, V343, P129, DOI 10.1038/343129a0; CLARK BC, 1988, ORIGINS LIFE EVOL B, V18, P209, DOI 10.1007/BF01804671; Cronin J.R., 1988, METEORITES EARLY SOL, P819; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; DELSEMME AH, 1988, PHILOS T R SOC A, V325, P509, DOI 10.1098/rsta.1988.0064; DELSEMME AH, 1989, ADV SPACE RES, V9, P25; DURHAM R, 1989, ICARUS, V77, P59, DOI 10.1016/0019-1035(89)90006-7; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; FERNANDEZ JA, 1983, ICARUS, V54, P377, DOI 10.1016/0019-1035(83)90235-X; Folinsbee R.E., 1967, GEOCHIM COSMOCHIM AC, V31, P1625; GOBEL JH, 1980, ASTROPHYS J, V235, P104; GRADIE J, 1980, NATURE, V283, P840, DOI 10.1038/283840a0; Greenberg J., 1982, COMETS, P131; GREENBERG JM, 1986, GALAXY SOLAR SYSTEM, P103; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HOYLE F, 1988, NATURE, V331, P123, DOI 10.1038/331123c0; HOYLE F, 1987, NATURE, V328, P117, DOI 10.1038/328117a0; HOYLE F, 1988, NATURE, V331, P666, DOI 10.1038/331666c0; HUGHES DW, 1988, ICARUS, V73, P149, DOI 10.1016/0019-1035(88)90089-9; HUGHES DW, 1987, S DIVERSITY SIMILAAR, P43; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; KASTING J F, 1989, Origins of Life and Evolution of the Biosphere, V19, P225, DOI 10.1007/BF02388821; KASTING JF, 1988, SCI AM, V258, P90, DOI 10.1038/scientificamerican0288-90; KASTING JF, UNPUB; Kasting JF, 1989, ORIGIN EVOLUTION PLA, P423; KASTING JF, 1989, PALAEOGEOGR PALAEOCL, V75, P83; Khandelwal S., 1981, SHOCK WAVES CHEM, P1; KHARE BN, 1989, ICARUS, V79, P350, DOI 10.1016/0019-1035(89)90082-1; KRUEGER FR, 1987, NATURWISSENSCHAFTEN, V74, P312, DOI 10.1007/BF00367925; KSTING JF, 1986, SCIENCE, V234, P1383; KUHN WR, 1979, ICARUS, V37, P207, DOI 10.1016/0019-1035(79)90126-X; LARSON HP, 1989, ASTROPHYS J, V338, P1106, DOI 10.1086/167260; LEVIN BY, 1986, METEORITICS, V21, P199, DOI 10.1111/j.1945-5100.1986.tb01242.x; LEVINE JS, 1985, ORIGINS LIFE EVOL B, V15, P299, DOI 10.1007/BF01808175; LEWIS JS, 1984, SATUM, P788; LIU VC, 1978, GEOPHYS RES LETT, V5, P309, DOI 10.1029/GL005i004p00309; MCKAY CP, 1989, LUNAR PLANET SCI C, V20, P671; Melosh H.L, 1989, IMPACT CRATERING GEO; MONAGHAN JJ, 1985, COMPUT PHYS REP, V3, P71, DOI 10.1016/0167-7977(85)90010-3; MONAHAN JJ, 1988, COMMUNICATION; MUKHIN LM, 1989, NATURE, V340, P46, DOI 10.1038/340046a0; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; MUMMA MJ, 1989, ICARUS, V79, P362; NOH WF, 1987, J COMPUT PHYS, V72, P78, DOI 10.1016/0021-9991(87)90074-X; OBERBECK VR, 1989, ORIGINS LIFE EVOL B, V19, P39, DOI 10.1007/BF01808286; OKEEFE JD, 1982, SPECIAL PAPER GEOLOG, V190, P103, DOI DOI 10.1130/SPE190-P103; OPIK EJ, 1958, PHYSICS METEOR FLIGH; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; PINTO JP, 1980, SCIENCE, V210, P183, DOI 10.1126/science.210.4466.183; PONGRACIC H, 1988, THESIS MONASH U CLAY; PONNAMPERUMA C, 1981, COMETS ORIGIN LIFE; RATCLIFF MA, 1974, J ORG CHEM, V39, P1481, DOI 10.1021/jo00924a007; REUTER DC, 1989, B AM ASTRON SOC, V21, P937; ROTH P, 1976, BER BUNSEN PHYS CHEM, V80, P171, DOI 10.1002/bbpc.19760800216; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SAGDEEV RZ, 1988, NATURE, V331, P240, DOI 10.1038/331240a0; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; SCHLESINGER G, 1983, J MOL EVOL, V19, P383, DOI 10.1007/BF02101643; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; SEKANINA Z, 1982, COMETS, P251; Shoemaker E. M., 1979, ASTEROIDS, P253; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, 1984, LUNAR PLANET SCI, V15, P780; SHURSHALOV IV, 1967, IZV AKAD NAUK SSSR M, V2, P184; SHURSHALOV IV, 1967, FLUID DYN, V2, P133; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; SMITH GG, 1964, J PHYS CHEM-US, V68, P1231, DOI 10.1021/j100787a506; SNYDER LE, 1983, ASTROPHYS J, V268, P123, DOI 10.1086/160937; STEVENSON DJ, 1983, EARTHS EARLIEST BIOS, P32; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; SZEKELY A, 1984, J PHYS CHEM-US, V88, P666, DOI 10.1021/j150648a009; THOMAS P, UNPUB; THOMAS PJ, 1989, LUNAR PLANET SCI C, V20, P117; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; TILLOTSON JH, 1962, GA3216 GEN AT CORP R; TSANG W, 1978, INT J CHEM KINET, V10, P41; TURCOTTE DL, 1986, J GEOPHYS RES-SOLID, V91, P1921, DOI 10.1029/JB091iB02p01921; VALLENTYNE JR, 1964, GEOCHIM COSMOCHIM AC, V28, P157, DOI 10.1016/0016-7037(64)90147-4; Walker, 1977, EVOLUTION ATMOSPHERE, V32, P71; WALKER JCG, 1986, ORIGINS LIFE, V16, P117; Warnatz J., 1984, COMBUSTION CHEM; WEISSMAN PR, 1985, NATURE, V314, P517, DOI 10.1038/314517a0; WILKENING LL, 1978, NATURWISSENSCHAFTEN, V65, P73, DOI 10.1007/BF00440544; WOLFE RF, 1986, GALAXY SOLAR SYSTEM, P338; ZAHNLE K, UNPUB; ZAHNLE KJ, 1986, J GEOPHYS RES-ATMOS, V91, P2819, DOI 10.1029/JD091iD02p02819; ZHAO MX, 1989, NATURE, V339, P463, DOI 10.1038/339463a0; 1983, LALP834 LOS AL NAT L	118	437	439	6	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					366	373		10.1126/science.11538074	http://dx.doi.org/10.1126/science.11538074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	11538074				2022-12-24	WOS:A1990DQ70200030
J	REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW				REPETA, DJ; SIMPSON, DJ; JORGENSEN, BB; JANNASCH, HW			EVIDENCE FOR ANOXYGENIC PHOTOSYNTHESIS FROM THE DISTRIBUTION OF BACTERIOCHLOROPHYLLS IN THE BLACK-SEA	NATURE			English	Article									WOODS HOLE OCEANOG INST,DEPT BIOL,WOODS HOLE,MA 02543; AARHUS UNIV,DEPT ECOL & GENET,DK-8000 AARHUS C,DENMARK	Woods Hole Oceanographic Institution; Aarhus University	REPETA, DJ (corresponding author), WOODS HOLE OCEANOG INST,DEPT CHEM,WOODS HOLE,MA 02543, USA.		Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027				BERGSTEIN T, 1979, CAN J MICROBIOL, V25, P999, DOI 10.1139/m79-154; BROCKMANN H, 1976, PHILOS T ROY SOC B, V273, P277, DOI 10.1098/rstb.1976.0013; CAPLE MB, 1978, J BIOL CHEM, V253, P6730; DEUSER WG, 1971, DEEP-SEA RES, V18, P995, DOI 10.1016/0011-7471(71)90004-0; DICKMAN M, 1978, NATURE, V275, P191, DOI 10.1038/275191a0; HASHWA FA, 1978, HELGOLAND WISS MEER, V31, P249, DOI 10.1007/BF02297000; JANNASCH HW, 1974, AAPG BULL, V20, P419; KARL DM, 1988, EOS, V69, P1241; KRISS AE, 1953, DOKL AKAD NAUK SSSR+, V93, P1107; LIAAENJENSEN S, 1985, PURE APPL CHEM, V57, P649, DOI 10.1351/pac198557050649; LIAAENJENSEN S, 1978, MARINE NATURAL PRODU, V2, P2; LIAAENJENSEN S, 1965, ACTA CHEM SCAND, V19, P1025; MURRAY JW, 1989, NATURE, V338, P411, DOI 10.1038/338411a0; Pfenning N., 1978, PHOTOSYNTHETIC BACTE, P3; SIMPSON DJ, 1988, J AM CHEM SOC, V110, P1753, DOI 10.1021/ja00214a016; SMITH KM, 1983, J CHROMATOGR, V281, P209, DOI 10.1016/S0021-9673(01)87879-1; Sorokin Y. I., 1964, J CONS PERM INT EXPL, V29, P41, DOI [10.1093/icesjms/29.1.41, DOI 10.1093/ICESJMS/29.1.41]; TRUPER HG, 1968, LIMNOL OCEANOGR, V13, P225, DOI 10.4319/lo.1968.13.2.0225; WIRSEN CO, 1988, EOS, V69, P1241; WRIGHT SW, 1987, MAR ECOL PROG SER, V38, P259, DOI 10.3354/meps038259	20	179	185	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	NOV 2	1989	342	6245					69	72		10.1038/342069a0	http://dx.doi.org/10.1038/342069a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX868	11536615				2022-12-24	WOS:A1989AX86800056
J	MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT				MCKAY, CP; SCATTERGOOD, TW; POLLACK, JB; BORUCKI, WJ; VANGHYSEGHEM, HT			HIGH-TEMPERATURE SHOCK FORMATION OF N-2 AND ORGANICS ON PRIMORDIAL TITAN	NATURE			English	Article									SUNY STONY BROOK,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	MCKAY, CP (corresponding author), NASA,AMES RES CTR,SOLAR SYST EXPLORAT BRANCH,MOFFETT FIELD,CA 94035, USA.							ATREYA SK, 1978, SCIENCE, V201, P611, DOI 10.1126/science.201.4356.611; BORUCKI WJ, 1987, APPL OPTICS, V26, P4319, DOI 10.1364/AO.26.004319; BORUCKI WJ, 1984, REV GEOPHYS, V22, P363, DOI 10.1029/RG022i004p00363; BORUCKI WJ, 1985, ICARUS, V64, P221, DOI 10.1016/0019-1035(85)90087-9; BORUCKI WJ, 1987, NATURE, V328, P509, DOI 10.1038/328509a0; BORUCKI WJ, 1984, ICARUS, V60, P260, DOI 10.1016/0019-1035(84)90188-X; BORUCKI WJ, IN PRESS ICARUS; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHAMEIDES WL, 1979, NATURE, V277, P123, DOI 10.1038/277123a0; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; JONES TD, 1987, ICARUS, V72, P381, DOI 10.1016/0019-1035(87)90181-3; LEWIS JS, 1982, SP190 GEOL SOC AM, P215; LUNINE JI, IN PRESS ORIGIN EVOL; PARK C, 1978, J GEOPHYS RES-OCEANS, V83, P4029, DOI 10.1029/JC083iC08p04029; POLLACK JB, 1986, ICARUS, V67, P409, DOI 10.1016/0019-1035(86)90123-5; POLLACK JB, IN PRESS ORIGIN EVOL; PRINN RG, 1981, ASTROPHYS J, V249, P308, DOI 10.1086/159289; PRINN RG, 1987, EARTH PLANET SC LETT, V83, P1, DOI 10.1016/0012-821X(87)90046-X; Stevenson DJ, 1986, SATELLITES, P687	19	67	67	1	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 7	1988	332	6164					520	522		10.1038/332520a0	http://dx.doi.org/10.1038/332520a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	M8230	11536599				2022-12-24	WOS:A1988M823000051
J	LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N				LeCouter, J; Kowalski, J; Foster, J; Hass, P; Zhang, ZM; Dillard-Telm, L; Frantz, G; Rangell, L; DeGuzman, L; Keller, GA; Peale, F; Gurney, A; Hillan, KJ; Ferrara, N			Identification of an angiogenic mitogen selective for endocrine gland endothelium	NATURE			English	Article							GROWTH-FACTOR; VASCULAR-PERMEABILITY; CORPUS-LUTEUM; EXPRESSION; CELLS; GENE; VEGF; MICROENVIRONMENT; DIFFERENTIATION; PROLIFERATION	The known endothelial mitogens stimulate growth of vascular endothelial cells without regard to their tissue of origin. Here we report a growth factor that is expressed largely in one type of tissue and acts selectively on one type of endothelium. This molecule, called endocrine-gland-derived vascular endothelial growth factor (EG-VEGF), induced proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. However, EG-VEGF had little or no effect on a variety of other endothelial and non-endothelial cell types tested. Similar to VEGF, EG-VEGF possesses a HIF-1 binding site, and its expression is induced by hypoxia. Both EG-VEGF and VEGF resulted in extensive angiogenesis and cyst formation when delivered in the ovary. However, unlike VEGF, EG-VEGF failed to promote angiogenesis in the cornea or skeletal muscle. Expression of human EG-VEGF messenger RNA is restricted to the steroidogenic glands, ovary, testis, adrenal and placenta and is often complementary to the expression of VEGF, suggesting that these molecules function in a coordinated manner. EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Toxicol Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA.	nf@gene.com						AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Basset DL, 1943, AM J ANAT, V73, P251, DOI 10.1002/aja.1000730206; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Collin O, 1996, INT J ANDROL, V19, P221, DOI 10.1111/j.1365-2605.1996.tb00466.x; Dellian M, 1996, AM J PATHOL, V149, P59; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GOLDZIEHER JW, 1962, J CLIN ENDOCR METAB, V22, P325, DOI 10.1210/jcem-22-3-325; GOSPODAROWICZ D, 1984, J CELL BIOL, V99, P947, DOI 10.1083/jcb.99.3.947; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P1787, DOI 10.1515/bchm2.1980.361.2.1787; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; MONACCI WT, 1993, AM J PHYSIOL, V264, pC995, DOI 10.1152/ajpcell.1993.264.4.C995; PALADE GE, 1979, ACTA PHYSIOL SCAND, P11; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; RAVINDRANATH N, 1992, ENDOCRINOLOGY, V131, P254, DOI 10.1210/en.131.1.254; Roberts WG, 1997, CANCER RES, V57, P765; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; Schweitz H, 1999, FEBS LETT, V461, P183, DOI 10.1016/S0014-5793(99)01459-3; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Simionescu N., 1988, CELL TISSUE BIOL, P355; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; VANTILBEURGH H, 1992, NATURE, V359, P159, DOI 10.1038/359159a0; Wechselberger C, 1999, FEBS LETT, V462, P177, DOI 10.1016/S0014-5793(99)01473-8; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; ZETTER BR, 1980, NATURE, V285, P41, DOI 10.1038/285041a0	46	426	486	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2001	412	6850					877	884		10.1038/35091000	http://dx.doi.org/10.1038/35091000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	467EG	11528470				2022-12-24	WOS:000170689000036
J	Beaglehole, R				Beaglehole, R			Global cardiovascular disease prevention: time to get serious	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; RISK-FACTORS; MORTALITY; TRENDS		Univ Auckland, Auckland 1, New Zealand	University of Auckland	Beaglehole, R (corresponding author), 206 Rue Chateau, F-01170 Vesancy, France.	beaglehole@compuserve.com						*ADV BOARD, 2001, 4 INT HEART HLTH C O; Beaglehole R, 1999, J CARDIOVASC RISK, V6, P63; BONITA R, IN PRESS GLOBAL BEHA; Bonita R, 2001, STROKE PREVENTION; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Holtzman NA, 2001, INT J HEALTH SERV, V31, P445, DOI 10.2190/JPFC-A4NW-KWT6-Y2H7; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; MacGregor G., 1998, SALT DIET HLTH NEPTU; MAGNUS P, IN PRESS ARCH INTERN; McKinlay JB, 1999, AM J PUBLIC HEALTH, V89, P295, DOI 10.2105/AJPH.89.3.295; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; STARNLER J, 1999, JAMA-J AM MED ASSOC, V282, P2012; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 2000, WORLD HLTH REP 2000; *WORLD HEART FED, 2001, BROCH WORLD HEART; Zhang X, 2000, J HYPERTENS, V18, pS25	27	67	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2001	358	9282					661	663		10.1016/S0140-6736(01)05784-1	http://dx.doi.org/10.1016/S0140-6736(01)05784-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465XP	11530175				2022-12-24	WOS:000170615500032
J	Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH				Mukhopadhyay, J; Kapanidis, AN; Mekler, V; Kortkhonjia, E; Ebright, YW; Ebright, RH			Translocation of sigma(70) with RNA polymerase during transcription: Fluorescence resonance energy transfer assay for movement relative to DNA	CELL			English	Article							LAC UV5 PROMOTER; ESCHERICHIA-COLI; TERNARY COMPLEXES; NUCLEIC-ACIDS; INITIATION; SUBUNIT; PROTEIN; ELONGATION; ORGANIZATION; PURIFICATION	Using fluorescence resonance energy transfer, we show that, in the majority of transcription complexes, sigma (70) is not released from RNA polymerase upon transition from initiation to elongation, but, instead, remains associated with RNA polymerase and translocates with RNA polymerase. The results argue against the presumption that there are necessary subunit-composition differences, and corresponding necessary mechanistic differences, in initiation and elongation. The methods of this report should be generalizable to monitor movement of any molecule relative to any nucleic acid.	Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Dept Chem, Waksman Inst, Howard Hughes Med Inst, POB 939, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CHUI MM, 1995, J COLLOID INTERF SCI, V174, P336, DOI 10.1006/jcis.1995.1399; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HSU TP, 1984, POLYMER, V25, P1419, DOI 10.1016/0032-3861(84)90103-4; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OSUMIDAVIS PA, 1987, BIOCHIM BIOPHYS ACTA, V910, P130, DOI 10.1016/0167-4781(87)90065-0; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Pluen A, 1998, ELECTROPHORESIS, V19, P1548, DOI 10.1002/elps.1150191005; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9	41	144	153	2	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2001	106	4					453	463		10.1016/S0092-8674(01)00464-0	http://dx.doi.org/10.1016/S0092-8674(01)00464-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525731	Bronze			2022-12-24	WOS:000170665200009
J	Wu, YT; Marsh, JW				Wu, YT; Marsh, JW			Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; QUIESCENT CD4 LYMPHOCYTES; NEF GENE; MESSENGER-RNA; IN-VITRO; REPLICATION; ACTIVATION; INFECTION; EXPRESSION; PROTEIN	The quiescent nature of most peripheral T cells poses an effective limitation to human immunodeficiency virus (HIV) replication and, in particular, to viral integration into the host chromatin. Two HIV proteins, Nef and Tat, increase T cell activity, but a requirement of integration for viral gene expression would preclude a rote for these proteins in resting cells. Here, we report that HIV infection leads to selective transcription of the nef and tat genes before integration. This preintegration transcription in quiescent cells leads to increased T cell activation and viral replication.	NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Mol Biol Lab, Bethesda, MD 20892 USA.	jon@codon.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002629, ZIAMH002629] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; [Anonymous], UNPUB; CARA A, 1995, VIROLOGY, V208, P242, DOI 10.1006/viro.1995.1148; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGLUND G, 1995, J VIROL, V69, P3216, DOI 10.1128/JVI.69.5.3216-3219.1995; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MILLER MD, 1995, J VIROL, V69, P579, DOI 10.1128/JVI.69.1.579-584.1995; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; RHEE SS, 1994, J IMMUNOL, V152, P5128; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	31	284	294	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2001	293	5534					1503	1506		10.1126/science.1061548	http://dx.doi.org/10.1126/science.1061548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	465XV	11520990				2022-12-24	WOS:000170616000048
J	Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL				Scuteri, A; Bos, AJG; Brant, LJ; Talbot, L; Lakatta, EG; Fleg, JL			Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ESTROGEN REPLACEMENT; NITRIC-OXIDE; HYPERTENSION; MENOPAUSE; ESTRADIOL; AGE; PREVENTION; HEALTH; GENDER	Background: The incidence of hypertension in postmenopausal women exceeds that in age-matched men. Longitudinal studies relating hormone replacement therapy (HRT) to blood pressure changes are sparse. Objective: To investigate the association between HRT and longitudinal changes In blood pressure In postmenopausal women. Design: Longitudinal observational study. Setting: Community-dwelling volunteers. Patients: 226 healthy, normotensive postmenopausal women from the Baltimore Longitudinal Study of Aging with a mean (+/- SD) age of 64 +/- 10 years were followed for 5.7 +/- 5.3 years. Seventy-seven women used both estrogen and progestin, and 149 used neither. Measurements: Lifestyle variables, blood pressure, and traditional cardiovascular risk factors were measured at baseline and approximately every 2 years thereafter. Results: Systolic blood pressure at baseline was similar in HRT users and nonusers (133.9 +/- 16.0 mm Hg vs. 132.4 +/- 14.8 mm Hg). Over time, average systolic blood pressure increased less in HRT users than nonusers, independent of other cardiovascular risk factors, physical activity, and alcohol use. For example, HRT users who were 55 years of age at their first Baltimore Longitudinal Study of Aging visit experienced a 7.6-mm Hg average increase in systolic blood pressure over 10 years; in contrast, the average increase in nonusers was 18.7 mm Hg. The lesser increase in systolic blood pressure in HRT users was more evident at older age. Diastolic blood pressure, which did not change statistically over time in either group, was not associated with HRT. Conclusion: Postmenopausal women taking HRT have a smaller increase in systolic blood pressure over time than those not taking HRT. This difference is intensified at older ages.	NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fleg, JL (corresponding author), NIA, Gerontol Res Ctr, Cardiovasc Sci Lab, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.		Lakatta, Edward G/AAL-1447-2020; Bos, Angelo Jose/A-5227-2017	Lakatta, Edward/0000-0002-4772-0035; Bos, Angelo Jose/0000-0003-4901-3155; SCUTERI, ANGELO/0000-0003-4784-5441; Talbot, Laura/0000-0002-0381-4486	NATIONAL INSTITUTE ON AGING [Z01AG000270] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ANASTOS K, 1991, ANN INTERN MED, V115, P287, DOI 10.7326/0003-4819-115-4-287; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Best PJM, 1998, ANN INTERN MED, V128, P285, DOI 10.7326/0003-4819-128-4-199802150-00006; Brant Larry J., 1994, P373; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cagnacci A, 1999, AM J PHYSIOL-HEART C, V276, pH1355, DOI 10.1152/ajpheart.1999.276.4.H1355; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; CRANE MG, 1971, ANN INTERN MED, V74, P13, DOI 10.7326/0003-4819-74-1-13; FISCHER GM, 1977, AM J PHYSIOL, V232, pH617, DOI 10.1152/ajpheart.1977.232.6.H617; GANGAR KF, 1991, LANCET, V338, P839; GORDON T, 1979, NATL HEART I FRAMING, P74; Grady D, 2000, ANN INTERN MED, V133, P999, DOI 10.7326/0003-4819-133-12-200012190-00016; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; HIMMELMANN A, 1994, J HUM HYPERTENS, V8, P485; HJORTLAND MC, 1976, AM J EPIDEMIOL, V103, P304, DOI 10.1093/oxfordjournals.aje.a112228; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kawano H, 1997, J AM COLL CARDIOL, V30, P914, DOI 10.1016/S0735-1097(97)00234-9; Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x; Lesaffre E, 1998, BIOMETRICS, V54, P570, DOI 10.2307/3109764; Lind T, 1979, Br J Obstet Gynaecol, V86 Suppl 3, P1, DOI 10.1111/j.1471-0528.1979.tb16232.x; LIP GYH, 1994, J HUM HYPERTENS, V8, P491; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; Majmudar NG, 2000, J CLIN ENDOCR METAB, V85, P1577, DOI 10.1210/jc.85.4.1577; MARIGLIANO V, 1997, SENILEHYPERTENSION 9, P1; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Miyagawa K, 1997, NAT MED, V3, P324, DOI 10.1038/nm0397-324; Morrell CH, 1997, AM STAT, V51, P338, DOI 10.2307/2685902; Pearson JD, 1997, J GERONTOL A-BIOL, V52, pM177, DOI 10.1093/gerona/52A.3.M177; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Scuteri A, 1999, CIRCULATION, V100, P105; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; SHOCK NW, 1984, NORMAL HUMAN AGING B, V84, P2450; STAESSEN J, 1989, J HUM HYPERTENS, V3, P427; STAMLER J, 1976, JAMA-J AM MED ASSOC, V235, P2299, DOI 10.1001/jama.235.21.2299; UTIAN WH, 1978, MATURITAS, V1, P3, DOI 10.1016/0378-5122(78)90003-8; VANBERESTEYN ECH, 1989, AM J EPIDEMIOL, V129, P947, DOI 10.1093/oxfordjournals.aje.a115227; VARGAS R, 1993, BRIT J PHARMACOL, V109, P612, DOI 10.1111/j.1476-5381.1993.tb13616.x; VERBEKE G, 1998, LINEAR MIXED MODELS, P63; Verbrugge LM, 1996, J GERONTOL B-PSYCHOL, V51, pS30, DOI 10.1093/geronb/51B.1.S30; WEISS NS, 1972, AM J EPIDEMIOL, V96, P237, DOI 10.1093/oxfordjournals.aje.a121454; YONG LC, 1993, AM J EPIDEMIOL, V138, P973, DOI 10.1093/oxfordjournals.aje.a116817	47	72	77	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2001	135	4					229	238		10.7326/0003-4819-135-4-200108210-00007	http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465KE	11511137				2022-12-24	WOS:000170587500001
J	Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ				Liu, R; Liu, H; Chen, X; Kirby, M; Brown, PO; Zhao, KJ			Regulation of CSF1 promoter by the SWI/SNF-like BAF complex	CELL			English	Article							RNA ADENOSINE-DEAMINASE; HANDED Z-DNA; FORMING SEQUENCES; NUCLEAR FACTOR-1; HUMAN GENOME; ZAB DOMAIN; CHROMATIN; TRANSCRIPTION; NUCLEOSOME; BINDING	The mammalian BAF complex regulates gene expression by modifying chromatin structure. In this report, we identify 80 genes activated and 2 genes repressed by the BAF complex in SW-13 cells. We find that prior binding of NFI/CTF to the NFI/CTF binding site in CSF1 promoter is required for the recruitment of the BAF complex and the BAF-dependent activation of the promoter. Furthermore, the activation of the CSF1 promoter requires Z-DNA-forming sequences that are converted to Z-DNA structure upon activation by the BAF complex. The BAF complex facilitates Z-DNA formation in a nucleosomal template in vitro. We propose a model in which the BAF complex promotes Z-DNA formation which, in turn, stabilizes the open chromatin structure at the CSF1 promoter.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.							Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gao B, 1996, MOL CELL BIOL, V16, P5997; GARNER MM, 1987, J MOL BIOL, V196, P581, DOI 10.1016/0022-2836(87)90034-9; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; HERBERT A, 1995, P NATL ACAD SCI USA, V92, P7550, DOI 10.1073/pnas.92.16.7550; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kim YG, 1999, J BIOL CHEM, V274, P19081, DOI 10.1074/jbc.274.27.19081; Kim YG, 2000, J BIOL CHEM, V275, P26828; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; RAHMOUNI AR, 1989, SCIENCE, V246, P358, DOI 10.1126/science.2678475; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; RUNKEL L, 1986, J MOL BIOL, V189, P487, DOI 10.1016/0022-2836(86)90319-0; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SCHROTH GP, 1992, J BIOL CHEM, V267, P11846; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	45	279	288	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2001	106	3					309	318		10.1016/S0092-8674(01)00446-9	http://dx.doi.org/10.1016/S0092-8674(01)00446-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	462RJ	11509180	Bronze			2022-12-24	WOS:000170433300009
J	Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE				Saurin, AJ; Shao, ZH; Erdjument-Bromage, H; Tempst, P; Kingston, RE			A Drosophila Polycomb group complex includes Zeste and dTAFII proteins	NATURE			English	Article							HISTONE; CHROMATIN; BINDING; IDENTIFICATION; EXPRESSION; TRITHORAX; SITES; TAFS	A goal of modern biology is to identify the physical interactions that define 'functional modules'(1) of proteins that govern biological processes. One essential regulatory process is the maintenance of master regulatory genes, such as homeotic genes, in an appropriate 'on' or 'off' state for the lifetime of an organism. The Polycomb group (PcG) of genes maintain a repressed transcriptional state, and PcG proteins form large multiprotein complexes(2,3), but these complexes have not been described owing to inherent difficulties in purification. We previously fractionated a major PcG complex, PRC1, to 20-50% homogeneity from Drosophila embryos. Here, we identify 30 proteins in these preparations, then further fractionate the preparation and use western analyses to validate unanticipated connections. We show that the known PcG proteins Polycomb, Posterior sex combs, Polyhomeotic and dRING1 exist in robust association with the sequence-specific DNA-binding factor Zeste and with numerous TBP (TATA-binding-protein)-associated factors that are components of general transcription factor TFIID (dTAFIIs). Thus, in fly embryos, there is a direct physical connection between proteins that bind to specific regulatory sequences, PcG proteins, and proteins of the general transcription machinery.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@frodo.mgh.harvard.edu		Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Saurin, Andrew/0000-0001-5162-003X				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; DeRubertis F, 1996, NATURE, V384, P589; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Kal AJ, 2000, GENE DEV, V14, P1058; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lessard J, 1998, BLOOD, V91, P1216, DOI 10.1182/blood.V91.4.1216; LOCKE J, 1988, GENETICS, V120, P181; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Nakatani Y, 1996, J BIOL CHEM, V271, P6575, DOI 10.1074/jbc.271.12.6575; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Tie F, 2001, DEVELOPMENT, V128, P275; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tyler JK, 1996, MOL CELL BIOL, V16, P6149; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	29	311	328	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2001	412	6847					655	660		10.1038/35088096	http://dx.doi.org/10.1038/35088096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493925				2022-12-24	WOS:000170318000045
J	Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM				Zehr, JP; Waterbury, JB; Turner, PJ; Montoya, JP; Omoregie, E; Steward, GF; Hansen, A; Karl, DM			Unicellular cyanobacteria fix N-2 in the subtropical North Pacific Ocean	NATURE			English	Article							NITROGEN-FIXATION; ATLANTIC OCEAN; NIFH GENES; TRICHODESMIUM; SEA; MICROORGANISMS; PHYTOPLANKTON; VARIABILITY; EXPRESSION; STRAIN	Fixed nitrogen (N) often limits the growth of organisms in terrestrial and aquatic biomes(1,2), and N availability has been important in controlling the CO2 balance of modern and ancient oceans(3,4). The fixation of atmospheric dinitrogen gas (N-2) to ammonia is catalysed by nitrogenase and provides a fixed N for N-limited environments(2,5). The filamentous cyanobacterium Trichodesmium has been assumed to be the predominant oceanic N-2-fixing microorganism since the discovery of N-2 fixation in Trichodesmium in 1961 (ref. 6). Attention has recently focused on oceanic N-2 fixation because nitrogen availability is generally limiting in many oceans, and attempts to constrain the global atmosphere-ocean fluxes of CO2 are based on basin-scale N balances(7-9). Biogeochemical studies and models have suggested that total N-2-fixation rates may be substantially greater than previously believed(7,8) but cannot be reconciled with observed Trichodesmium abundances(8,9). It is curious that there are so few known N-2-fixing microorganisms in oligotrophic oceans when it is clearly ecologically advantageous. Here we show that there are unicellular cyanobacteria in the open ocean that are expressing nitrogenase, and are abundant enough to potentially have a significant role in N dynamics.	Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Woods Hole Oceanographic Institution; University System of Georgia; Georgia Institute of Technology; University of Hawaii System	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.		Zehr, Jonathan P/B-3513-2014; Karl, David/AFP-3837-2022; Montoya, Joseph/C-3115-2013; Steward, Grieg F./D-9768-2011	Zehr, Jonathan P/0000-0002-5691-5408; Montoya, Joseph/0000-0001-7197-4660; Steward, Grieg F./0000-0001-5988-0522; Karl, David/0000-0002-6660-6721; Omoregie, Enoma/0000-0002-7701-4182				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BRASS S, 1994, APPL ENVIRON MICROB, V60, P2575, DOI 10.1128/AEM.60.7.2575-2583.1994; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; DUGDALE RC, 1961, DEEP-SEA RES, V7, P298; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Haug GH, 1998, PALEOCEANOGRAPHY, V13, P427, DOI 10.1029/98PA01976; HAWSER SP, 1992, J APPL PHYCOL, V4, P79, DOI 10.1007/BF00003963; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2000, TRENDS MICROBIOL, V8, P301, DOI 10.1016/S0966-842X(00)01774-1; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Krieg NR, 1989, BERGEYS MANUAL SYSTE, V3, P1728; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Neveux J, 1999, J GEOPHYS RES-OCEANS, V104, P3311, DOI 10.1029/98JC02000; PAERL HW, 1990, ADV MICROB ECOL, V11, P305; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wasmund N, 2001, MAR ECOL PROG SER, V214, P1, DOI 10.3354/meps214001; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4	28	551	575	4	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2001	412	6847					635	638		10.1038/35088063	http://dx.doi.org/10.1038/35088063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	460PP	11493920				2022-12-24	WOS:000170318000040
J	Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED				Lee, PY; Alexander, KP; Hammill, BG; Pasquali, SK; Peterson, ED			Representation of elderly persons and women in published randomized trials of acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; THROMBOLYTIC THERAPY; CLINICAL-TRIALS; AGE; MORTALITY; OLDER	Context Elderly persons and women were underrepresented in randomized controlled trials (RCTs) prior to 1990. Since then, efforts have been made to correct these biases, but their effect is unclear. Objective To determine whether the percentage of elderly persons and women in published clinical trials of acute coronary syndromes has increased and how this enrollment compared with disease prevalence. Data Sources The MEDLINE and Cochrane databases were searched for English-language articles from January 1966 to March 2000 regarding myocardial infarction, unstable angina, or acute coronary syndromes. Additional data sources included meta-analyses, review articles, and cardiology textbooks. Estimates of community-based myocardial infarction rates came from the National Registry of Myocardial Infarction and the Worcester Heart Study. Study Selection Published RCTs of acute coronary syndrome patients were included and trials enrolling 50 patients or fewer, those without clinical end points, papers published in a language other than English, and unpublished manuscripts were excluded. Of 7645 studies identified, 593 RCTs were selected for review. Data Extraction The RCTs were abstracted by 2 of the authors for year of publication, source of support (ie, funding), pharmacotherapy, study phase, number of study sites, trial location, number of patients, mean age of the study population, and any age exclusion criteria for enrollment. Data Synthesis The number of published RCTs with explicit age exclusions has declined from 58% during 1966-1990 to 40% during 1991-2000. Trial enrollment of patients aged 75 years or older increased from 2% for studies published during 1966-1990 to 9% during 1991-2000, but remains well below their representation among all patients with myocardial infarction (37%) in the United States. Enrollment of women has risen from 20% for studies published between 1966-1990 to 25% during 1991-2000, but remains well below their proportion of all patients with myocardial infarction (43%) in the United States. Conclusions Attempts at making cardiovascular RCTs more inclusive appear to have had limited success; thus, women and elderly persons remain underrepresented in published trial literature relative to their disease prevalence. Because safety and efficacy can vary as a function of sex and age, these enrollment biases undermine efforts to provide evidence-based care to all cardiac patients.	Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Dept Med, Outcomes Res & Assessment Grp, Box 3236, Durham, NC 27710 USA.		Peterson, Eric David/ABF-5033-2021		NIGMS NIH HHS [T35-GM-08679] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T35GM008679] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; JECKER NS, 1991, JAMA-J AM MED ASSOC, V266, P3012, DOI 10.1001/jama.266.21.3012; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; MACDONALD ET, 1982, DRUG TREATMENT ELDER, P217; National Institutes of Health, 1994, FED REGISTER, V59, P11146; *NIH, 1990, PUBL NIH; RICH MW, 1992, AM J MED, V92, P7, DOI 10.1016/0002-9343(92)90008-Y; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; *US FDA, 1989, GUID STUD DRUGS LIK; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; VOGT TM, 1986, CONTROL CLIN TRIALS, V7, P118, DOI 10.1016/0197-2456(86)90028-0; [No title captured]	21	625	642	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2001	286	6					708	713		10.1001/jama.286.6.708	http://dx.doi.org/10.1001/jama.286.6.708			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	459VE	11495621	Bronze			2022-12-24	WOS:000170271500027
J	Wilkinson, DM				Wilkinson, DM			At cross purposes - How do we cope with scientific terms that have two different definitions?	NATURE			English	Editorial Material									Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England	Liverpool John Moores University	Wilkinson, DM (corresponding author), Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England.							Douglas AE, 1994, SYMBIOTIC INTERACTIO; Margulis L., 1998, SYMBIOTIC PLANET	2	30	33	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2001	412	6846					485	485		10.1038/35087676	http://dx.doi.org/10.1038/35087676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PC	11484028				2022-12-24	WOS:000170202900022
J	Tewksbury, JJ; Nabhan, GP				Tewksbury, JJ; Nabhan, GP			Seed dispersal - Directed deterrence by capsaicin in chillies	NATURE			English	Article							FRUIT; PAIN		Univ Montana, Dept Biol Sci, Missoula, MT 59812 USA; No Arizona Univ, Ctr Sustainable Environm, Flagstaff, AZ 86011 USA	University of Montana System; University of Montana; Northern Arizona University	Tewksbury, JJ (corresponding author), Univ Florida, Dept Zool, Box 118525, Gainesville, FL 32611 USA.			Tewksbury, Joshua/0000-0002-9786-1477				Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cipollini ML, 1997, AM NAT, V150, P346, DOI 10.1086/286069; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; JANSEN DH, 1969, EVOLUTION, V23, P1; MASON JR, 1991, J CHEM ECOL, V17, P2539, DOI 10.1007/BF00994601; McKey D., 1975, COEVOLUTION ANIMALS, P158; NORMAN DM, 1992, WILSON BULL, V104, P549; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x	11	200	211	3	94	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					403	404		10.1038/35086653	http://dx.doi.org/10.1038/35086653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473305				2022-12-24	WOS:000170068200035
J	Drummond, PD				Drummond, PD			Mechanism of complex regional pain syndrome: no longer excessive sympathetic outflow?	LANCET			English	Editorial Material							PERIAQUEDUCTAL GRAY; LOCUS-COERULEUS; DYSTROPHY; RESPONSES; RATS		Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia	Murdoch University	Drummond, PD (corresponding author), Murdoch Univ, Sch Psychol, Murdoch, WA 6150, Australia.							Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; ARNOLD JMO, 1993, ANN INTERN MED, V118, P619, DOI 10.7326/0003-4819-118-8-199304150-00008; Bajic D, 1999, J COMP NEUROL, V405, P359; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Butler SH, 2000, PROG PAIN RES MANAG, V16, P657; HODGE CJ, 1983, BRAIN RES, V288, P325, DOI 10.1016/0006-8993(83)90111-7; JONES SL, 1991, PROG BRAIN RES, V88, P381; Ochoa JL, 1999, J NEUROL, V246, P875, DOI 10.1007/s004150050476; Perl ER, 1999, P NATL ACAD SCI USA, V96, P7664, DOI 10.1073/pnas.96.14.7664; Rommel O, 1999, PAIN, V80, P95, DOI 10.1016/S0304-3959(98)00202-4; SATO J, 1993, NEUROSCI LETT, V164, P225, DOI 10.1016/0304-3940(93)90897-T; TRACEY DJ, 1995, INFLAMM RES, V44, P407, DOI 10.1007/BF01757696; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Zhang C, 1998, BRAIN RES, V784, P116, DOI 10.1016/S0006-8993(97)01197-9; Zhang YH, 1997, J PHYSIOL-LONDON, V503, P177, DOI 10.1111/j.1469-7793.1997.177bi.x	15	31	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 21	2001	358	9277					168	170		10.1016/S0140-6736(01)05400-9	http://dx.doi.org/10.1016/S0140-6736(01)05400-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	454HL	11476829				2022-12-24	WOS:000169967100005
J	Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM				Tettelin, H; Nelson, KE; Paulsen, IT; Eisen, JA; Read, TD; Peterson, S; Heidelberg, J; DeBoy, RT; Haft, DH; Dodson, RJ; Durkin, AS; Gwinn, M; Kolonay, JF; Nelson, WC; Peterson, JD; Umayam, LA; White, O; Salzberg, SL; Lewis, MR; Radune, D; Holtzapple, E; Khouri, H; Wolf, AM; Utterback, TR; Hansen, CL; McDonald, LA; Feldblyum, TV; Angiuoli, S; Dickinson, T; Hickey, EK; Holt, IE; Loftus, BJ; Yang, F; Smith, HO; Venter, JC; Dougherty, BA; Morrison, DA; Hollingshead, SK; Fraser, CM			Complete genome sequence of a virulent isolate of Streptococcus pneumoniae	SCIENCE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; MICROBIAL GENE IDENTIFICATION; HAEMOPHILUS-INFLUENZAE; MARKOV-MODELS; TRANSFORMATION; ELEMENT; LIPOPROTEINS; COMPETENCE; CHROMOSOME; EXPRESSION	The 2,160,837-base pair genome sequence of an isolate of Streptococcus pneumoniae, a Cram-positive pathogen that causes pneumonia, bacteremia, meningitis, and otitis media, contains 2236 predicted coding regions; of these, 1440 (64%) were assigned a biological role. Approximately 5% of the genome is composed of insertion sequences that may contribute to genome rearrangements through uptake of foreign DNA. Extracellular enzyme systems for the metabolism of polysaccharides and hexosamines provide a substantial source of carbon and nitrogen for S. pneumoniae and also damage host tissues and facilitate colonization. A motif identified within the signal peptide of proteins is potentially involved in targeting these proteins to the cell surface of low-guanine/cytosine (GC) Gram-positive species. Several surface-exposed proteins that may serve as potential vaccine candidates were identified. Comparative genome hybridization with DNA arrays revealed strain differences in S. pneumoniae that could contribute to differences in virulence and antigenicity.	Inst Genome Res TIGR, Rockville, MD 20850 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Alabama, Birmingham, AL 35294 USA	J. Craig Venter Institute; Johns Hopkins University; George Washington University; Bristol-Myers Squibb; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alabama System; University of Alabama Birmingham	Fraser, CM (corresponding author), Inst Genome Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Eisen, Jonathan A./H-2706-2019; Read, Timothy/E-6240-2011; Nelson, William C/E-9263-2016; Paulsen, Ian T/K-3832-2012; Salzberg, Steven/Q-6514-2019; Angiuoli, Samuel V/H-7340-2014	Salzberg, Steven L/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Paulsen, Ian T/0000-0001-9015-9418; Salzberg, Steven/0000-0002-8859-7432; loftus, brendan/0000-0001-8871-8356; Read, Timothy/0000-0001-8966-9680; Heidelberg, John/0000-0003-0673-3224; Fraser, Claire/0000-0003-1462-2428; Angiuoli, Samuel/0000-0001-9525-4350	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040645] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI40645-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BANERJEI L, COMMUNICATION; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENSON G, 1994, NUCLEIC ACIDS RES, V22, P4828, DOI 10.1093/nar/22.22.4828; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; CHANDLER M, 1993, MOL MICROBIOL, V7, P497, DOI 10.1111/j.1365-2958.1993.tb01140.x; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DAVIES J, 1995, INFECT IMMUN, V63, P2485, DOI 10.1128/IAI.63.7.2485-2492.1995; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Garcia E, 2000, RES MICROBIOL, V151, P429, DOI 10.1016/S0923-2508(00)00173-X; Garcia JL, 2000, STREPTOCOCCUS PNEUMO, P231; GASC AM, 1991, J BACTERIOL, V173, P7361, DOI 10.1128/jb.173.22.7361-7367.1991; Gill SI, COMMUNICATION; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; HUMBERT O, 1995, P NATL ACAD SCI USA, V92, P9052, DOI 10.1073/pnas.92.20.9052; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; PACE NR, 1995, J BACTERIOL, V177, P1919, DOI 10.1128/jb.177.8.1919-1928.1995; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; PEARCE BJ, 1994, MOL MICROBIOL, V12, P881, DOI 10.1111/j.1365-2958.1994.tb01076.x; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Santagati M, 2000, ANTIMICROB AGENTS CH, V44, P2585, DOI 10.1128/AAC.44.9.2585-2587.2000; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; SMITH MD, 1979, J BACTERIOL, V137, P735, DOI 10.1128/JB.137.2.735-739.1979; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; TOMASZ A, 1995, NEW ENGL J MED, V333, P514, DOI 10.1056/NEJM199508243330810; VIDGREN G, 1992, J BACTERIOL, V174, P7419, DOI 10.1128/jb.174.22.7419-7427.1992; WEISER JN, 2000, STREPTOCOCCUS PNEUMO, P245; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; WOOD WB, 1949, J EXP MED, V90	60	1059	1661	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					498	506		10.1126/science.1061217	http://dx.doi.org/10.1126/science.1061217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463916				2022-12-24	WOS:000169966700049
J	He, XL; Chow, DC; Martick, MM; Garcia, KC				He, XL; Chow, DC; Martick, MM; Garcia, KC			Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone	SCIENCE			English	Article							STABLE ENTEROTOXIN RECEPTOR; A GUANYLYL CYCLASE; GLYCOSYLATION SITES; BINDING DOMAIN; ATRIAL; PROTEIN; LIGAND; HEAT; IDENTIFICATION; PHARMACOLOGY	Natriuretic peptides (NPs) are vasoactive cyclic-peptide hormones important in blood pressure regulation through interaction with natriuretic cell-surface receptors. We report the hormone-binding thermodynamics and crystal structures at 2.9 and 2.0 angstroms, respectively, of the extracellular domain of the unliganded human NP receptor (NPR-C) and its complex with CNP, a 22-amino acid NP. A single CNP molecule is bound in the interface of an NPR-C dimer, resulting in asymmetric interactions between the hormone and the symmetrically related receptors. Hormone binding induces a 20 angstrom closure between the membrane-proximal domains of the dimer. In each monomer, the opening of an interdomain cleft, which is tethered together by a linker peptide acting as a molecular spring, is likely a conserved allosteric trigger for intracellular signaling by the natriuretic receptor family.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 93405 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 93405 USA	Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild D319,299 Campus Dr, Stanford, CA 93405 USA.	kcgarcia@stanford.edu						Anand-Srivastava MB, 2000, BIOCHEMISTRY-US, V39, P6503, DOI 10.1021/bi992660q; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BENNETT BD, 1991, J BIOL CHEM, V266, P23060; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; DUDA T, 1995, BIOCHEM BIOPH RES CO, V212, P1046, DOI 10.1006/bbrc.1995.2075; ENGEL AM, 1994, J BIOL CHEM, V269, P17005; ENGEL AM, 1995, FEBS LETT, V360, P169, DOI 10.1016/0014-5793(95)00096-R; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FAIRBROTHER WJ, 1994, BIOCHEMISTRY-US, V33, P8897, DOI 10.1021/bi00196a006; Fenrick R, 1996, MOL CELL BIOCHEM, V165, P103, DOI 10.1007/BF00229471; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; Hasegawa M, 1999, EUR J BIOCHEM, V263, P338, DOI 10.1046/j.1432-1327.1999.00488.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itakura M, 1997, BIOCHEM J, V322, P585, DOI 10.1042/bj3220585; Janin J, 1997, STRUCTURE, V5, P473, DOI 10.1016/S0969-2126(97)00204-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1992, J BIOL CHEM, V267, P21691; Lucas KA, 2000, PHARMACOL REV, V52, P375; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Misono KS, 2000, CIRC RES, V86, P1135; Misono KS, 1999, BIOCHEMISTRY-US, V38, P516, DOI 10.1021/bi982127v; Miyagi M, 2000, EUR J BIOCHEM, V267, P5758, DOI 10.1046/j.1432-1327.2000.01647.x; Mowbray SL, 1999, J MOL BIOL, V294, P487, DOI 10.1006/jmbi.1999.3271; Pedro L, 1998, MOL CELL BIOCHEM, V178, P95, DOI 10.1023/A:1006808604321; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RONDEAU JJ, 1995, BIOCHEMISTRY-US, V34, P2130, DOI 10.1021/bi00007a005; RUDNER XL, 1995, P NATL ACAD SCI USA, V92, P5169, DOI 10.1073/pnas.92.11.5169; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; STULTS JT, 1994, BIOCHEMISTRY-US, V33, P11372, DOI 10.1021/bi00203a036; Takida S, 1999, HYPERTENSION, V33, P124, DOI 10.1161/01.HYP.33.1.124; Trachte GJ, 2000, J PHARMACOL EXP THER, V294, P210; TRACHTE GJ, 1995, AM J PHYSIOL-CELL PH, V268, pC978, DOI 10.1152/ajpcell.1995.268.4.C978; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Wada A, 1996, INFECT IMMUN, V64, P5144, DOI 10.1128/IAI.64.12.5144-5150.1996	46	139	150	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2001	293	5535					1657	1662		10.1126/science.1062246	http://dx.doi.org/10.1126/science.1062246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533490				2022-12-24	WOS:000170802900063
J	Passera, L; Aron, S; Vargo, EL; Keller, L				Passera, L; Aron, S; Vargo, EL; Keller, L			Queen control of sex ratio in fire ants	SCIENCE			English	Article							SOLENOPSIS-INVICTA; EUSOCIAL HYMENOPTERA; KIN SELECTION; INVESTMENT RATIOS; WORKER CONFLICT; SOCIAL INSECTS; POPULATIONS; ALLOCATION; COLONIES; FORMICIDAE	The haptodiploid sex-determination system of ants gives rise to conflict between queens and workers over colony sex ratios, and the female-biased allocation ratios seen in many species suggest that workers often prevail in this conflict. We exchanged queens between male- and female-specialist colonies of the fire ant Solenopsis invicta. These exchanges quickly reversed the sex-ratio biases of adopting colonies. The sex ratio of queen-laid eggs differed strongly between male- and female-specialist colonies. These findings suggest that queens can force workers to raise mate sexuals by limiting the number of female brood and help to explain why sex investment ratios lie between the queen and worker equilibria in this and many other ant species.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland; Univ Toulouse 3, Lab Ethol & Anim Cognit, CNRS, FRE 2382, F-31062 Toulouse, France; Free Univ Brussels, Unit Anim Communities, B-1050 Brussels, Belgium; N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of North Carolina; North Carolina State University	Keller, L (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.	Laurent.keller@ie-zea.unit.ch	keller, laurent/AAI-7175-2020; Vargo, Edward/D-1097-2010	Vargo, Edward/0000-0002-8712-1248; keller, laurent/0000-0002-5046-9953				ARON S, 1995, ANIM BEHAV, V49, P749, DOI 10.1016/0003-3472(95)80207-X; ARON S, 1994, J EVOLUTION BIOL, V7, P403, DOI 10.1046/j.1420-9101.1994.7040403.x; BOOMSMA JJ, 1989, AM NAT, V133, P517, DOI 10.1086/284933; Bourke A, 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; Bourke Andrew F.G., 1997, P203; BULMER MG, 1981, HEREDITY, V47, P197, DOI 10.1038/hdy.1981.76; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Crozier R.H., 1996, EVOLUTION SOCIAL INS; FLETCHER DJC, 1983, SCIENCE, V219, P312, DOI 10.1126/science.219.4582.312; FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; Helms KR, 1999, EVOLUTION, V53, P1470, DOI 10.2307/2640893; Keller L, 1999, MG BEH ECOL, P153; Keller L, 1996, BEHAV ECOL, V7, P292, DOI 10.1093/beheco/7.3.292; Keller L, 1999, BIOSCIENCE, V49, P899, DOI 10.2307/1313649; Krieger MJB, 1997, MOL ECOL, V6, P997, DOI 10.1046/j.1365-294X.1997.00264.x; MARKIN GP, 1971, ANN ENTOMOL SOC AM, V64, P562, DOI 10.1093/aesa/64.3.562; NONACS P, 1986, Q REV BIOL, V61, P1, DOI 10.1086/414723; PAMILO P, 1982, AM NAT, V119, P638, DOI 10.1086/283940; PAMILO P, 1990, BEHAV ECOL SOCIOBIOL, V27, P31; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Reuter M, 2001, AM NAT, V158, P166, DOI 10.1086/321311; ROSS KG, 1985, BEHAV ECOL SOCIOBIOL, V17, P349, DOI 10.1007/BF00293212; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Seger J, 1996, SCIENCE, V274, P941, DOI 10.1126/science.274.5289.941; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Vargo EL, 1996, J EVOLUTION BIOL, V9, P783, DOI 10.1046/j.1420-9101.1996.9060783.x; VARGO EL, 1987, PHYSIOL ENTOMOL, V12, P109, DOI 10.1111/j.1365-3032.1987.tb00729.x	31	83	85	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2001	293	5533					1308	1310		10.1126/science.1062076	http://dx.doi.org/10.1126/science.1062076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	463TD	11509728	Green Published			2022-12-24	WOS:000170492600037
J	Packer, C; Pusey, AE; Eberly, LE				Packer, C; Pusey, AE; Eberly, LE			Egalitarianism in female African lions	SCIENCE			English	Article							REPRODUCTIVE SKEW; PANTHERA-LEO; COOPERATION; EVOLUTION; TERRITORIALITY; DOMINANCE; SOCIETIES; CONTESTS	Because most cooperative societies are despotic, it has been difficult to test models of egalitarianism. Female African lions demonstrate a unique form of plural breeding in which companions consistently produce similar numbers of surviving offspring. Consistent with theoretical predictions from models of reproductive skew, female lions are unable to control each other's reproduction because of high costs of fighting and low access to each other's newborn cubs. A female also tacks incentives to reduce her companions' reproduction, because her own survival and reproduction depend on group territoriality and synchronous breeding. Consequently, female relationships are highly symmetrical, and female lions are "free agents" who only contribute to communal care when they have cubs of their own.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.			Eberly, Lynn/0000-0003-4763-330X; Pusey, Anne/0000-0002-2280-8954				BERTRAM BCR, 1975, J ZOOL, V177, P463; Boehm Christopher, 1997, American Naturalist, V150, P100; Brown J.L., 1987, HELPING COMMUNAL BRE; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; COX DR, 1972, J R STAT SOC B, V34, P187; Creel SR, 1991, BEHAV ECOL, V2, P7, DOI 10.1093/beheco/2.1.7; De Luca DW, 2001, ANIM BEHAV, V61, P17, DOI 10.1006/anbe.2000.1559; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hammerstein P, 1988, EVOL ECOL, V2, P115, DOI 10.1007/BF02067272; Hanby J. P., 1995, SERENGETI, P315; Heinsohn R, 1996, P ROY SOC B-BIOL SCI, V263, P475, DOI 10.1098/rspb.1996.0071; Heinsohn R, 1997, ANIM BEHAV, V53, P1143, DOI 10.1006/anbe.1996.0316; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Johnstone RA, 1999, AM NAT, V153, P315, DOI 10.1086/303169; LIMA SL, 1989, AM NAT, V134, P828, DOI 10.1086/285015; Macdonald D. W., 1982, PERSPECTIVES ETHOLOG, P433; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Packer C., 1988, P363; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Packer C., 1985, P173; PACKER C, 1983, ANIM BEHAV, V31, P334, DOI 10.1016/S0003-3472(83)80051-7; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; Packer C., 1986, P429; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; PUSEY AE, 1994, BEHAV ECOL, V5, P362, DOI 10.1093/beheco/5.4.362; PUSEY AE, 1994, PROTECTION ABUSE YOU, P277; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Reeve Hudson K., 1993, P45; Schaller G. B., 1972, SERENGETI LION; Silk J.B., 1987, P318; Sober E., 1999, OTHERS EVOLUTION PSY; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; VEHRENCAMP SL, 1983, ANIM BEHAV, V31, P667, DOI 10.1016/S0003-3472(83)80222-X; Walters J.R., 1987, P306	45	146	147	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					690	693		10.1126/science.1062320	http://dx.doi.org/10.1126/science.1062320			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474110				2022-12-24	WOS:000170204600053
J	von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR				von Dohlen, CD; Kohler, S; Alsop, ST; McManus, WR			Mealybug beta-proteobacterial endosymbionts contain gamma-proteobacterial symbionts	NATURE			English	Article							BACTERIAL ENDOSYMBIONTS; RIBOSOMAL-RNA; EVOLUTION; BUCHNERA; APHIDS; HOMOPTERA; HEMIPTERA; SEQUENCE; INSECTS	Some insects have cultivated intimate relationships with mutualistic bacteria since their early evolutionary history. Most ancient `primary' endosymbionts live within the cytoplasm of large, polyploid host cells of a specialized organ (bacteriome)(1). Within their large, ovoid bacteriomes, mealybugs (Pseudococcidae) package the intracellular endosymbionts into `mucus-filled' spheres, which surround the host cell nucleus and occupy most of the cytoplasm(2). The genesis of symbiotic spheres has not been determined, and they are structurally unlike eukaryotic cell vesicles. Recent molecular phylogenetic and fluorescent in situ hybridization (FISH) studies suggested that two unrelated bacterial species may share individual host cells(3,4), and that bacteria within spheres comprise these two species(5). Here we show that mealybug host cells do indeed harbour both beta- and gamma -subdivision Proteobacteria, but they are not co-inhabitants of the spheres. Rather, we show that the symbiotic spheres themselves are beta -proteobacterial cells. Thus, gamma -Proteobacteria live symbiotically inside beta -Proteobacteria. This is the first report, to our knowledge, of an intracellular symbiosis involving two species of bacteria.	Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	von Dohlen, CD (corresponding author), Utah State Univ, Dept Biol, 5305 Old Main Hill, Logan, UT 84322 USA.			von Dohlen, Carol/0000-0002-3961-251X				Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Baumann P, 2000, PROKARYOTES HDB BIOL; Buchner P, 1965, ENDOSYMBIOSIS ANIMAL; Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; COSTA HS, 1993, PROTOPLASMA, V176, P106, DOI 10.1007/BF01378946; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; DU YB, 1994, P NATL ACAD SCI USA, V91, P8437, DOI 10.1073/pnas.91.18.8437; FINK R, 1962, Z MORPHOL OKOL TIERE, V41, P78; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P643, DOI 10.1128/AEM.66.2.643-650.2000; GRUNEWALDJANHO S, 1996, NONRADIOACTIVE IN SI; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Kantheti P, 1996, INSECT BIOCHEM MOLEC, V26, P997, DOI 10.1016/S0965-1748(96)00009-4; KOHLER M, 1962, Z ALLG MIKROBIOL, V2, P190; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Lambert JD, 1998, P NATL ACAD SCI USA, V95, P4458, DOI 10.1073/pnas.95.8.4458; LOUIS C, 1972, CR ACAD SCI D NAT, V274, P715; LOUIS C, 1974, B OBSERVATOIRE MER, P43; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Munson MA, 1992, MOL PHYLOGENET EVOL, V1, P26, DOI 10.1016/1055-7903(92)90032-C; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Smith D.C., 1987, BIOL SYMBIOSIS; Spaulding AW, 1998, MOL BIOL EVOL, V15, P1506, DOI 10.1093/oxfordjournals.molbev.a025878; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tremblay E., 1989, P145; Van Ham RCHJ, 2000, P NATL ACAD SCI USA, V97, P10855, DOI 10.1073/pnas.180310197; Wernegreen JJ, 1999, MOL BIOL EVOL, V16, P83, DOI 10.1093/oxfordjournals.molbev.a026040	30	241	250	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2001	412	6845					433	436		10.1038/35086563	http://dx.doi.org/10.1038/35086563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	456DQ	11473316				2022-12-24	WOS:000170068200046
J	Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E				Nuesch, R; Schroeder, K; Dieterle, T; Martina, B; Battegay, E			Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study	BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE CONTROL; PATIENT COMPLIANCE; MEDICATION COMPLIANCE; MONITORING COMPLIANCE; REGIMEN; HYPERTENSION; THERAPY	Objectives To prospectively compare compliance with treatment in patients with hypertension responsive to treatment versus patients with treatment resistant hypertension. Design Prospective case control study. Setting Outpatient department in large city hospital in Switzerland, providing primary, secondary, and tertiary care. Participants 110 consecutive medial outpatients with hypertension and taking stable treatment with at least two antihypertensive drugs for at least four weeks. Main outcome measures Treatment compliance assess with MEM devices; blood pressure determined by 12 hour daytime ambulatory monitoring (pressure <135/85 mm Hg in patients age <less than or equal to>60 years and <155/90 mm Hg in patients aged >60 indicated hypertension responsive to treatment). Results Complete data were available for 103 patients, of whom 86 took greater than or equal to 80% of their prescribed doses ("compliant") and 17 took <80% ("non-compliant"). Of the 49 patients with treatment resistant hypertension, 40 (82%) were compliant, while 46 (85%) of the patients responsive to treatment were compliant. Conclusion Non-compliance with treatment was not more prevalent in patients with treatment resistant hypertension than in treatment responsive patients.	Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland	University of Basel	Battegay, E (corresponding author), Univ Basel Hosp, Outpatient Dept Internal Med, CH-4031 Basel, Switzerland.		Dieterle, Thomas/AAG-3619-2019; Dieterle, Thomas/CAA-2532-2022	Dieterle, Thomas/0000-0002-3740-1903				Altman DG., 1982, STATISTICS PRACTICE, P6; Andrejak M, 2000, AM J HYPERTENS, V13, P184, DOI 10.1016/S0895-7061(99)00175-2; BATTEGAY E, 1996, MED HYG, V54, P541; Black HR, 1997, ARCH INTERN MED, V157, P2413; Boissel JP, 1996, EUR J CLIN PHARMACOL, V50, P63, DOI 10.1007/s002280050070; CALDERBANK PH, 1976, FLUIDIZATION TECHNOL, V1, P115; CONRAD P, 1985, SOC SCI MED, V20, P29, DOI 10.1016/0277-9536(85)90308-9; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; Graves John W., 2000, Mayo Clinic Proceedings, V75, P278; GUERRERO D, 1993, AM J HYPERTENS, V6, P586, DOI 10.1093/ajh/6.7.586; KJELLGREN KI, 1995, INT J CARDIOL, V47, P257, DOI 10.1016/0167-5273(94)02203-U; Krall RL, 1991, PATIENT COMPLIANCE M, P19; KRUSE W, 1990, EUR J CLIN PHARMACOL, V38, P561, DOI 10.1007/BF00278582; Leenen FHH, 1997, CAN J CARDIOL, V13, P914; Mallion JM, 1998, J HYPERTENS, V16, pS75; Mallion JM, 1996, J HYPERTENS, V14, P137; MALLION JM, 1992, J CARDIOVASC PHARM, V19, pS41, DOI 10.1097/00005344-199219002-00011; MCKENNEY JM, 1992, J CLIN PHARMACOL, V32, P277, DOI 10.1002/j.1552-4604.1992.tb03837.x; MELNIKOW J, 1994, J GEN INTERN MED, V9, P96, DOI 10.1007/BF02600211; OBRIEN E, 1993, J HYPERTENS, V11, P673, DOI 10.1097/00004872-199306000-00012; Sackett D L, 1978, Patient Couns Health Educ, V1, P18; SETARO J, 1992, NEW ENGL J MED, V327, P534; URQUHART J, 1994, CLIN PHARMACOKINET, V27, P202, DOI 10.2165/00003088-199427030-00004; Waeber B, 1999, INT J CLIN PRACT, V53, P37; Waeber B, 1999, J HYPERTENS, V17, P1041, DOI 10.1097/00004872-199917070-00022; WRIGHT EC, 1993, LANCET, V342, P909, DOI 10.1016/0140-6736(93)91951-H	28	77	84	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2001	323	7305					142	146		10.1136/bmj.323.7305.142	http://dx.doi.org/10.1136/bmj.323.7305.142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	456WR	11463685	Green Published, Bronze			2022-12-24	WOS:000170106200018
J	Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM				Jeppesen, C; Wong, JY; Kuhl, TL; Israelachvili, JN; Mullah, N; Zalipsky, S; Marques, CM			Impact of polymer tether length on multiple ligand-receptor bond formation	SCIENCE			English	Article								The promoters of cell adhesion are ligands, which are often attached to flexible tethers that bind to surface receptors on adjacent cells. Using a combination of Monte Carte simulations, diffusion reaction theory, and direct experiments (surface force measurements) of the biotin-streptavidin system, we have quantified polymer chain dynamics and the kinetics and spatial range of tethered ligand-receptor binding. The results show that the efficiency of strong binding does not depend solely on the molecular architecture or binding energy of the receptor-ligand pair, nor on the equilibrium configuration of the polymer tether, but rather on its "rare" extended conformations.	LDFC Inst Phys, F-67084 Strasbourg, France; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; ALZA Corp, Mt View, CA 94043 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Boston University; University of California System; University of California Davis; Johnson & Johnson; Johnson & Johnson USA	Marques, CM (corresponding author), LDFC Inst Phys, 3 Rue Univ, F-67084 Strasbourg, France.		Wong, Joyce Y./AAF-5759-2019; Marques, Carlos M/B-2322-2010; Wong, Joyce Y/F-3732-2011	Wong, Joyce Y./0000-0002-3526-6381; Marques, Carlos M/0000-0002-3952-0498; Wong, Joyce Y/0000-0002-3526-6381; Marques, Carlos/0000-0002-6526-1258	NIGMS NIH HHS [GM-47334, GM-17876] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM017876, R01GM047334] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, INTERMOLECULAR SURFA; de Gennes P. G., 1979, SCALING CONCEPTS POL, P128; DEGENNES PG, 1982, J CHEM PHYS, V76, P3316, DOI 10.1063/1.443328; DOI M, 1975, CHEM PHYS, V9, P455, DOI 10.1016/0301-0104(75)80083-8; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; Kolb A, 1997, MACROMOL THEOR SIMUL, V6, P169, DOI 10.1002/mats.1997.040060112; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LECKBAND DE, 1994, BIOCHEMISTRY-US, V33, P4611, DOI 10.1021/bi00181a023; WILEMSKI G, 1973, J CHEM PHYS, V58, P4009, DOI 10.1063/1.1679757; Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820	14	191	205	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2001	293	5529					465	468		10.1126/science.293.5529.465	http://dx.doi.org/10.1126/science.293.5529.465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	454HG	11463908				2022-12-24	WOS:000169966700039
J	Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB				Bach, PB; Cramer, LD; Schrag, D; Downey, RJ; Gelfand, SE; Begg, CB			The influence of hospital volume on survival after resection for lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-STATE; ADMINISTRATIVE DATA; OUTCOMES RESEARCH; PATIENT OUTCOMES; RANDOMIZED TRIAL; SURGICAL VOLUME; MORTALITY; SURGERY; QUALITY; CARE	Background: Among patients who have undergone high-risk operations for cancer, postoperative mortality rates are often lower at hospitals where more of these procedures are performed. We undertook a population-based study to estimate the extent to which the number of procedures performed at a hospital (hospital volume) is associated with survival after resection for lung cancer. Methods: We studied patients 65 years old or older who received a diagnosis of stage I, II, or IIIA non-small-cell lung cancer between 1985 and 1996, resided in 1 of the 10 study areas covered by the Surveillance, Epidemiology, and End Results Program, and underwent surgery at a hospital that participates in the Nationwide Inpatient Sample (2118 patients and 76 hospitals). Results: The volume of procedures at the hospital was positively associated with the survival of patients (P<0.001). Five years after surgery, 44 percent of patients who underwent operations at the hospitals with the highest volume were alive, as compared with 33 percent of those who underwent operations at the hospitals with the lowest volume. Patients at the highest-volume hospitals also had lower rates of postoperative complications (20 percent vs. 44 percent) and lower 30-day mortality (3 percent vs. 6 percent) than those at the lowest-volume hospitals. Conclusions: Patients who undergo resection for lung cancer at hospitals that perform large numbers of such procedures are likely to survive longer than patients who have such surgery at hospitals with a low volume of lung-resection procedures. (N Engl J Med 2001;345:181-8.) Copyright (C) 2001 Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 221, New York, NY 10021 USA.			Schrag, Deborah/0000-0002-4334-5717	NATIONAL CANCER INSTITUTE [R01CA090226] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA-090226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison PD, 1999, LOGISTIC REGRESSION, P179; Asamura H, 1996, J THORAC CARDIOV SUR, V111, P1125, DOI 10.1016/S0022-5223(96)70213-1; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg MD, 1999, BIOMETRICS, V55, P302, DOI 10.1111/j.0006-341X.1999.00302.x; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Ellison LM, 2000, J UROLOGY, V163, P867, DOI 10.1016/S0022-5347(05)67821-4; Ettinger D S, 1996, Oncology (Williston Park), V10, P81; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hewitt M, 2000, INTERPRETING VOLUME; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hillner BE, 1998, JAMA-J AM MED ASSOC, V280, P1783, DOI 10.1001/jama.280.20.1783; Holm T, 1997, BRIT J SURG, V84, P657, DOI 10.1046/j.1365-2168.1997.02745.x; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; ISHIDA T, 1990, ANN THORAC SURG, V50, P708, DOI 10.1016/0003-4975(90)90666-T; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Keller SM, 2000, NEW ENGL J MED, V343, P1217, DOI 10.1056/NEJM200010263431703; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Liang K-Y., 1995, J AM STAT ASSOC, V90, P1123; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; Percy C., 1990, INT CLASSIFICATION D; Phillips KA, 1997, INT J QUAL HEALTH C, V9, P341, DOI 10.1093/intqhc/9.5.341; POTOSKY AL, 1993, MED CARE, V31, P732; ROMANO PS, 1992, CHEST, V101, P1332, DOI 10.1378/chest.101.5.1332; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950; 1999, HOSP PAYOR ICD9CM IN	42	545	552	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2001	345	3					181	188		10.1056/NEJM200107193450306	http://dx.doi.org/10.1056/NEJM200107193450306			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453JM	11463014				2022-12-24	WOS:000169912800006
J	Hunter, N; Kleckner, N				Hunter, N; Kleckner, N			The single-end invasion: An asymmetric intermediate at the double-strand break to double-holliday junction transition of meiotic recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHROMOSOME SYNAPSIS; ALLOHEXAPLOID WHEAT; SORDARIA-MACROSPORA; INITIATION SITE; GENE CONVERSION; CROSSING-OVER; MEIOSIS	We identify a novel meiotic recombination intermediate, the single-end invasion (SEI), which occurs during the transition from double-strand breaks (DSBs) to double-Holliday junction (dHJs). SEIs are products of strand exchange between one DSB end and its homolog. The structural asymmetry of SEIs indicates that the two ends of a DSB interact with the homolog in temporal succession, via structurally (and thus biochemically) distinct processes. SEIs arise surprisingly late in prophase, concomitant with synaptonemal complex (SC) formation. These and other data imply that SEIs are preceded by nascent DSB-partner intermediates, which then undergo selective differentiation into crossover and noncrossover types, with SC formation and strand exchange as downstream consequences. Late occurrence of strand exchange provides opportunity to reverse recombinational fate even after homologs are coaligned and/or synapsed. This feature can explain crossover suppression between homeologous and structurally heterozygous chromosomes.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu			NIGMS NIH HHS [GM44794] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2000, Nucleic Acids Res, V28, pe6, DOI 10.1093/nar/28.2.e6; Arbel A, 1999, EMBO J, V18, P2648, DOI 10.1093/emboj/18.9.2648; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BELMAAZA A, 1994, MUTAT RES, V314, P199, DOI 10.1016/0921-8777(94)90065-5; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; CARPENTER ATC, 1994, CELL, V77, P959, DOI 10.1016/0092-8674(94)90434-0; Cha RS, 2000, GENE DEV, V14, P493; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; FOSS E, 1993, GENETICS, V133, P681; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Grushcow JM, 1999, GENETICS, V153, P607; Havekes FWJ, 1994, CHROMOSOME RES, V2, P315, DOI 10.1007/BF01552725; HOBOLTH P, 1981, CARLSBERG RES COMMUN, V46, P129, DOI 10.1007/BF02910465; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; Hunter N, 2001, NAT GENET, V27, P236, DOI 10.1038/85781; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KLECKNER N, 1993, COLD SPRING HARB SYM, V58, P553, DOI 10.1101/SQB.1993.058.01.062; MAGUIRE MP, 1994, GENETICS, V137, P281; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; MOSES MJ, 1984, CONTROLLING EVENTS M, P245; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; STACK SM, 1993, CHROMOSOMES TODAY, V11, P301; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Villemure JF, 1997, MOL GEN GENET, V256, P533, DOI 10.1007/s004380050598; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Worth L, 1998, J BIOL CHEM, V273, P23176, DOI 10.1074/jbc.273.36.23176; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; YAMAMOTO K, 1992, MOL GEN GENET, V234, P1; ZICKLER D, 1977, CHROMOSOMA, V61, P289, DOI 10.1007/BF00288615; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619; ZICKLER D, 1992, GENETICS, V132, P135	55	507	518	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2001	106	1					59	70		10.1016/S0092-8674(01)00430-5	http://dx.doi.org/10.1016/S0092-8674(01)00430-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461702	Bronze			2022-12-24	WOS:000169870300009
J	Pearce, G; Moura, DS; Stratmann, J; Ryan, CA				Pearce, G; Moura, DS; Stratmann, J; Ryan, CA			Production of multiple plant hormones from a single polyprotein precursor	NATURE			English	Article							SELF-INCOMPATIBILITY; TOMATO LEAVES; SYSTEMIN; RECEPTOR; PROTEIN; PHYTOSULFOKINE; CLAVATA3; BRASSICA; PEPTIDE; CELLS	Some animal and yeast hormone genes produce prohormone polypeptides that are proteolytically processed to produce multiple copies of hormones with the same or different functions(1). In plants, four polypeptides have been identified that can be classed as hormones(2-5) (intercellular chemical messengers(6)) but none are known to be produced as multiple copies from a single precursor. Here we describe a polyprotein hormone precursor, present in tobacco plants, that gives rise to two polypeptide hormones, as often found in animals and yeast. The tobacco polypeptides activate the synthesis of defensive proteinase-inhibitor proteins in a manner similar to that of systemin, an 18-amino-acid polypeptide found in tomato plants(2). The two tobacco polypeptides are derived from each end of a 165-amino-acid precursor that bears no homology to tomato prosystemin. The data show that structurally diverse polypeptide hormones in different plant species can serve similar signalling roles, a condition not found in animals or yeast.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Ryan, CA (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.		Moura, Daniel S/D-6673-2012; Moura, Daniel/F-3011-2010	Moura, Daniel S/0000-0003-2042-1403; 				BRYANT J, 1976, BIOCHEMISTRY-US, V15, P3418, DOI 10.1021/bi00661a004; Constabel CP, 1998, PLANT MOL BIOL, V36, P55, DOI 10.1023/A:1005986004615; DOMBROWSKI JE, 1994, PLANT MOL BIOL MANUA, V3, P1; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Karban R, 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; MCGURL B, 1992, SCIENCE, V255, P1570, DOI 10.1126/science.1549783; Meindl T, 1998, PLANT CELL, V10, P1561, DOI 10.1105/tpc.10.9.1561; NIALL HD, 1982, ANNU REV PHYSIOL, V44, P615, DOI 10.1146/annurev.ph.44.030182.003151; PATTERSON DH, 1995, ANAL CHEM, V67, P3971, DOI 10.1021/ac00117a024; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; PEARCE G, 1993, PLANT PHYSIOL, V102, P639, DOI 10.1104/pp.102.2.639; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stratmann JW, 1997, P NATL ACAD SCI USA, V94, P11085, DOI 10.1073/pnas.94.20.11085; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; VOET D, 1995, BIOCHEMISTRY-US, P1261	23	180	209	1	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					817	820		10.1038/35081107	http://dx.doi.org/10.1038/35081107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459063				2022-12-24	WOS:000169246400054
J	Shimojo, S; Kamitani, Y; Nishida, S				Shimojo, S; Kamitani, Y; Nishida, S			Afterimage of perceptually filled-in surface	SCIENCE			English	Article							SUBJECTIVE CONTOURS; FILLING-IN; ILLUSION; DEPTH	An afterimage induced by prior adaptation to a visual stimulus is believed to be due to bleaching of photochemical pigments or neural adaptation in the retina. We report a type of afterimage that appears to require cortical adaptation. Fixating a neon-color spreading configuration led not only to negative afterimages corresponding to the inducers (local afterimages), but also to one corresponding to the perceptually fitted-in surface during adaptation (global afterimage). These afterimages were mutually exclusive, undergoing monocular rivalry. The strength of the global afterimage correlated to a greater extent with perceptual filling-in during adaptation than with the strength of the local afterimages. Thus, global afterimages are not merely by-products of local afterimages, but involve adaptation at a cortical representation of surface.	CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; NTT Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shimojo, S (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.							ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; ATKINSON J, 1972, J EXP PSYCHOL, V98, P55; ATKINSON J, 1973, PERCEPT PSYCHOPHYS, V12, P257; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; CRASSINI B, 1982, VISION RES, V22, P203, DOI 10.1016/0042-6989(82)90184-5; DAVIES P, 1973, BRIT J PSYCHOL, V64, P325, DOI 10.1111/j.2044-8295.1973.tb01358.x; De Weerd P, 1998, VISION RES, V38, P2721, DOI 10.1016/S0042-6989(97)00432-X; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; MEYER GE, 1987, J EXP PSYCHOL HUMAN, V13, P353; MOTHER G, 1998, MOTION AFTEREFFECT; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; NAKAYAMA K, 1990, PERCEPTION, V19, P497, DOI 10.1068/p190497; NAKAYAMA K, 1998, VIS COGN, V2, P1; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Pessoa L, 1998, TRENDS COGN SCI, V2, P422, DOI 10.1016/S1364-6613(98)01237-6; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; REDIES C, 1981, PERCEPTION, V10, P667, DOI 10.1068/p100667; REDIES C, 1984, VISION RES, V24, P1301, DOI 10.1016/0042-6989(84)90185-8; SHIRNOJO S, 1999, NEUR ABSTR, P1053; SHIVELY F, 1973, PERCEPT PSYCHOPHYS, V13, P525, DOI 10.3758/BF03205814; SINDERMANN F, 1972, VISION RES, V12, P763, DOI 10.1016/0042-6989(72)90002-8; TAKEICHI H, 1992, PERCEPTION, V21, P313, DOI 10.1068/p210313; VANTUIJL HFJM, 1975, ACTA PSYCHOL, V39, P441, DOI 10.1016/0001-6918(75)90042-6; Varin D., 1971, RIV PSICOL, V65, P101; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; VIRSU V, 1962, MED BIOL, V56, P84; WARE C, 1980, PERCEPTION, V9, P103, DOI 10.1068/p090103	33	93	94	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1677	1680		10.1126/science.1060161	http://dx.doi.org/10.1126/science.1060161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	469FA	11533495				2022-12-24	WOS:000170802900068
J	Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J				Jeruzalmi, D; Yurieva, O; Zhao, YX; Young, M; Stewart, J; Hingorani, M; O'Donnell, M; Kuriyan, J			Mechanism of processivity clamp opening by the delta subunit wrench of the clamp loader complex of E-coli DNA polymerase III	CELL			English	Article							CELL NUCLEAR ANTIGEN; C-TERMINAL REGION; CRYSTAL-STRUCTURE; SLIDING CLAMP; ACCESSORY PROTEINS; BETA-CLAMP; HOLOENZYME; PEPTIDE; BINDING; DOMAIN	The dimeric ring-shaped sliding clamp of E. coli DNA polymerase III (beta subunit, homolog of eukaryotic PCNA) is loaded onto DNA by the clamp loader gamma complex (homolog of eukaryotic Replication Factor C, RFC). The delta subunit of the gamma complex binds to the beta ring and opens it. The crystal structure of a beta:delta complex shows that delta, which is structurally related to the delta' and gamma subunits of the gamma complex, is a molecular wrench that induces or traps a conformational change in beta such that one of its dimer interfaces is destabilized. Structural comparisons and molecular dynamics simulations suggest a spring-loaded mechanism in which the beta ring opens spontaneously once a dimer interface is perturbed by the delta wrench.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Kuriyan, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	kuriyan@rockefeller.edu	Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020	Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Zhao, Yanxiang/0000-0002-9408-9979; O'Donnell, Michael/0000-0001-9002-4214	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R01GM045547] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-45547, R01 GM-38839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DONG ZM, 1993, J BIOL CHEM, V268, P11758; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hingorani MM, 2000, CURR BIOL, V10, pR25, DOI 10.1016/S0960-9822(99)00252-3; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUANG CC, 1981, J BIOL CHEM, V256, P4087; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kelman Z, 2000, J BIOL CHEM, V275, P7327, DOI 10.1074/jbc.275.10.7327; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1991, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; ONRUST R, 1991, J BIOL CHEM, V266, P21681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARLMAN DA, 1995, AMBER 4 1; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Stewart J, 2001, J BIOL CHEM, V276, P19182, DOI 10.1074/jbc.M100592200; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	49	203	211	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2001	106	4					417	428		10.1016/S0092-8674(01)00462-7	http://dx.doi.org/10.1016/S0092-8674(01)00462-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	466UU	11525728	Bronze			2022-12-24	WOS:000170665200006
J	Betran, AP; de Onis, M; Lauer, JA; Villar, J				Betran, AP; de Onis, M; Lauer, JA; Villar, J			Ecological study of effect of breast feeding on infant mortality in Latin America	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POTENTIAL INTERVENTIONS; DEVELOPING-COUNTRIES; CHILDHOOD PNEUMONIA; PROMOTION PROGRAM; DIARRHEAL; DISEASES; CHILDREN; RISK; PREVENTION	Objective To estimate the effect of exclusive breast feeding and partial breast feeding on infant mortality from diarrhoeal disease and acute respiratory infections in Latin America. Design Attributable fraction analysis of national data on infant mortality arid breast feeding. Setting Latin America and the Caribbean. Main outcome measures Mortality from diarrhoeal disease and acute respiratory infections and nationally representative breastfeeding rates. Results 55% of infant deaths from diarrhoeal disease and acute respiratory infections in Latin America are preventable by exclusive breast feeding among infants aged 0-3 months and partial breast feeding throughout the remainder of infancy. Among infants aged 0-3 months, 66% of deaths from these causes are preventable by exclusive breast feeding; among infants aged 4-11 months, 32% of such deaths are preventable by partial breast feeding. 13.9% of infant deaths from all causes are preventable by these breastfeeding patterns. The annual number of preventable deaths is about 52 000 for the region. Conclusions Exclusive breastfeeding of infants aged 0-3 months and partial breastfeeding throughout the remainder of infancy could substantially reduce infant mortality in Latin America. Interventions to promote breast feeding should target younger infants.	WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland; WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva, Switzerland; WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva, Switzerland; Univ Zaragoza, Fac Med, Dept Prevent Med & Publ Hlth, Zaragoza, Spain	World Health Organization; World Health Organization; World Health Organization; University of Zaragoza	Betran, AP (corresponding author), WHO, Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	betrana@who.int	Betrán, Ana Pilar/G-2023-2010	Lauer, Jeremy A/0000-0003-0652-0691				Albernaz E, 1998, J Hum Lact, V14, P283, DOI 10.1177/089033449801400402; Amador Manuel, 1992, Food and Nutrition Bulletin, V14, P101; BARROS FC, 1986, PEDIATRICS, V78, P656; BROWN KH, 1989, PEDIATRICS, V83, P31; Carnes BA, 1996, POPUL DEV REV, V22, P231, DOI 10.2307/2137434; Castillo C, 1996, Bull Pan Am Health Organ, V30, P125; COLE P, 1971, BRIT J PREV SOC MED, V25, P242; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P271; Garenne Michel, 1992, World Health Statistics Quarterly, V45, P180; Golding J, 1997, EARLY HUM DEV, V49, pS143, DOI 10.1016/S0378-3782(97)00060-1; Heligman L., 1980, J I ACTUARIES, V107, P49, DOI DOI 10.1017/S0020268100040257; HUFFMAN S, 1991, BREASTFEEDING SAVES; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Lopez A., 2000, 9 WHO GPE; MARTINES JC, 1994, J NUTR, V124, P1189, DOI 10.1093/jn/124.8.1189; Monteiro C., 1990, Health Policy and Planning, V5, P23, DOI 10.1093/heapol/5.1.23; Murray C., 1996, GLOBAL BURDEN DIS IN, V2; OUELLET BL, 1979, AM J EPIDEMIOL, V109, P451, DOI 10.1093/oxfordjournals.aje.a112703; *POP COUNC, 1990, STUD FAMILY PLANN, V21, P181; POPKIN BM, 1991, J BIOSOC SCI, V23, P5, DOI 10.1017/S0021932000019027; PUFFER RR, 1973, PATTERNS MORTALITY C; SACHDEV HPS, 1991, J PEDIATR GASTR NUTR, V12, P76, DOI 10.1097/00005176-199101000-00016; United Nations, 1995, WORLD POP PROSP; VALDES V, 1993, J TROP PEDIATRICS, V39, P142, DOI 10.1093/tropej/39.3.142; Victora Cesar G., 1996, Food and Nutrition Bulletin, V17, P390; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; VICTORA CG, 1992, ACTA PAEDIATR, V81, P7, DOI 10.1111/j.1651-2227.1992.tb12364.x; VICTORA CG, 1987, LANCET, V2, P319; Victora CG, 1999, AM J CLIN NUTR, V70, P309; VILLAR J, 1981, LANCET, V2, P621; WHO, 1996, WHONUT961; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	33	69	80	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2001	323	7308					303	306		10.1136/bmj.323.7308.303	http://dx.doi.org/10.1136/bmj.323.7308.303			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	463HK	11498485	Green Published, Bronze			2022-12-24	WOS:000170470900016
J	Cohen, JE; Gurtler, RE				Cohen, JE; Gurtler, RE			Modeling household transmission of American trypanosomiasis	SCIENCE			English	Article							NORTH-WEST ARGENTINA; TRIATOMA-INFESTANS HEMIPTERA; CHAGAS-DISEASE TRANSMISSION; CRUZI; PREVALENCE; INFECTION; VECTOR; SEROPOSITIVITY; POPULATIONS; REDUVIIDAE	American trypanosomiasis, or Chagas disease, caused by the protozoan parasite Trypanosoma cruzi and transmitted by blood-feeding triatomine bugs, is a chronic, frequently fatal infection that is common in Latin America. Neither adequate drugs nor a vaccine is available. A mathematical model calibrated to detailed household data from three villages in northwest Argentina shows that householders could greatly reduce the risk of human infection by excluding domestic animals, especially infected dogs, from bedrooms; removing potential refuges for bugs from waits and ceilings; and using domestically applied insecticides. Low-cost, locally practicable environmental management combined with intermittent use of insecticides can sustainably control transmission of T. cruzi to humans in rural Argentina and probably elsewhere.	Rockefeller Univ, Lab Populat, New York, NY 10021 USA; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Ecol Gen, Buenos Aires, DF, Argentina	Rockefeller University; University of Buenos Aires	Cohen, JE (corresponding author), Rockefeller Univ, Lab Populat, 1230 York Ave,Box 20, New York, NY 10021 USA.	cohen@rockefeller.edu						AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35; BUSENBERG SN, 1991, LECT NOTES PURE APPL, V131, P283; CANALS M, 1992, REV MED CHILE, V120, P1359; Castanera M. B., 1999, THESIS U BUENOS AIRE; CATALA S, 1991, MED VET ENTOMOL, V5, P325, DOI 10.1111/j.1365-2915.1991.tb00558.x; Cecere MC, 1997, MED VET ENTOMOL, V11, P383, DOI 10.1111/j.1365-2915.1997.tb00426.x; Cecere MC, 1998, B WORLD HEALTH ORGAN, V76, P373; da Silva G R, 1969, Rev Saude Publica, V3, P23, DOI 10.1590/S0034-89101969000100004; GIOJALAS LC, 1990, T ROY SOC TROP MED H, V84, P439, DOI 10.1016/0035-9203(90)90355-I; Gurtler RE, 1996, J MED ENTOMOL, V33, P15, DOI 10.1093/jmedent/33.1.15; GURTLER RE, 1993, T ROY SOC TROP MED H, V87, P12, DOI 10.1016/0035-9203(93)90400-K; Gurtler RE, 1998, AM J TROP MED HYG, V59, P741; Gurtler RE, 1997, J APPL ECOL, V34, P699, DOI 10.2307/2404917; GURTLER RE, 1991, T ROY SOC TROP MED H, V85, P741, DOI 10.1016/0035-9203(91)90440-A; Gurtler RE, 1998, AM J TROP MED HYG, V58, P748, DOI 10.4269/ajtmh.1998.58.748; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Himschoot P. H, 1993, THESIS U BUENOS AIRE; KITRON U, 1989, REV INFECT DIS, V11, P391; LEHANE MJ, 1992, ACTA TROP, V52, P27, DOI 10.1016/0001-706X(92)90004-H; MINTER DM, 1976, PAN AM HLTH ORG SCI, V318, P330; Moncayo Alvaro, 1997, World Health Statistics Quarterly, V50, P195; RABINOVICH JE, 1990, B WORLD HEALTH ORGAN, V68, P737; RABINOVICH JE, 1990, ECOL MODEL, V52, P249, DOI 10.1016/0304-3800(90)90019-D; RABINOVICH JE, 1987, CHAGAS DIS VECTORS, V1, P119; Schmunis GA, 1996, LANCET, V348, P1171, DOI 10.1016/S0140-6736(05)65305-6; Schofield C. J., 1990, Appropriate technology in vector control., P187; Segura EL, 2000, AM J TROP MED HYG, V62, P353, DOI 10.4269/ajtmh.2000.62.353; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; VELASCOHERNANDEZ JX, 1994, THEOR POPUL BIOL, V46, P1, DOI 10.1006/tpbi.1994.1017; *WHO, 1999, SPEC PROGR RES TRAIN	30	188	195	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2001	293	5530					694	698		10.1126/science.1060638	http://dx.doi.org/10.1126/science.1060638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	458PW	11474111	Green Submitted			2022-12-24	WOS:000170204600054
J	Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M				Reizes, O; Lincecum, J; Wang, ZH; Goldberger, O; Huang, L; Kaksonen, M; Ahima, R; Hinkes, MT; Barsh, GS; Rauvala, H; Bernfield, M			Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; CELL-SURFACE; MELANOCORTIN RECEPTORS; FIBROBLAST GROWTH; FOOD-INTAKE; N-SYNDECAN; IN-VIVO; OBESITY	Transgenic expression in the hypothalamus of syndecan-1, a cell surface heparan sulfate proteoglycan (HSPG) and modulator of ligand-receptor encounters, produces mice with hyperphagia and maturity-onset obesity resembling mice with reduced action of alpha melanocyte stimulating hormone (alpha MSH). Via their HS chains, syndecans potentiate the action of agouti-related protein and agouti signaling protein, endogenous inhibitors of alpha MSH. In wild-type mice, syndecan-3, the predominantly neural syndecan, is expressed in hypothalamic regions that control energy balance. Food deprivation increases hypothalamic syndecan-3 levels several-fold. Syndecan-3 null mice, otherwise apparently normal, respond to food deprivation with markedly reduced reflex hyperphagia. We propose that oscillation of hypothalamic syndecan-3 levels physiologically modulates feeding behavior.	Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Hosp, Div Endocrinol, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, Helsinki 00014, Finland; Univ Helsinki, Dept Biosci, Helsinki 00014, Finland	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of Helsinki; University of Helsinki	Bernfield, M (corresponding author), Harvard Univ, Sch Med, Dept Pediat & Cell Biol, Div Newborn Med, 300 Longwood Ave, Boston, MA 02115 USA.		Reizes, Ofer/ABA-4179-2021; Ahima, Rexford/W-1394-2019	Reizes, Ofer/0000-0003-0075-6871; Rauvala, Heikki/0000-0001-7809-9811; Kaksonen, Marko/0000-0003-3645-7689	NICHD NIH HHS [HD18655, HD06763] Funding Source: Medline; NIDDK NIH HHS [DK28506] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD006763, R37HD006763] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bagnol D, 1999, J NEUROSCI, V19; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Conrad H. E., 1998, HEPARIN BINDING PROT; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47, DOI 10.1152/ajpregu.2000.279.1.R47; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kiefer LL, 1998, BIOCHEMISTRY-US, V37, P991, DOI 10.1021/bi971913h; Lauri SE, 1999, J NEUROSCI, V19, P1226; Loeb JA, 1999, DEVELOPMENT, V126, P781; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAULO E, 1994, J BIOL CHEM, V269, P12999; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; Yang YK, 1999, MOL ENDOCRINOL, V13, P148, DOI 10.1210/me.13.1.148; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666	45	171	177	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2001	106	1					105	116		10.1016/S0092-8674(01)00415-9	http://dx.doi.org/10.1016/S0092-8674(01)00415-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	452QM	11461706	Bronze			2022-12-24	WOS:000169870300013
J	Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF				Beja, O; Spudich, EN; Spudich, JL; Leclerc, M; DeLong, EF			Proteorhodopsin phototrophy in the ocean	NATURE			English	Article							SENSORY RHODOPSIN-II; HALOBACTERIUM-HALOBIUM; PURPLE MEMBRANE; PROCHLOROCOCCUS; PHOBORHODOPSIN; CYANOBACTERIA; COMMUNITY; BACTERIA; ATLANTIC; PROTEIN	Proteorhodopsin(1), a retinal-containing integral membrane protein that functions as a light-driven proton pump, was discovered in the genome of an uncultivated marine bacterium; however, the prevalence, expression and genetic variability of this protein in native marine microbial populations remain unknown. Here we report that photoactive proteorhodopsin is present in oceanic surface waters. We also provide evidence of an extensive family of globally distributed proteorhodopsin variants. The protein pigments comprising this rhodopsin family seem to be spectrally tuned to different habitats-absorbing light at different wavelengths in accordance with light available in the environment. Together, our data suggest that proteorhodopsin-based phototrophy is a globally significant oceanic microbial process.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Monterey Bay Aquarium Research Institute; University of Texas System	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Leclerc, Marion/AAZ-3950-2021	Leclerc, Marion/0000-0001-8684-2847				Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Bowmaker James K., 1999, Novartis Foundation Symposium, V224, P21, DOI 10.1002/9780470515693.ch3; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; DeLong EF, 1999, APPL ENVIRON MICROB, V65, P5554; DeLong EF, 1998, APPL ENVIRON MICROB, V64, P1133; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; KIRK JTO, 1983, LIGHT PHOTOSYNTHESIS, P104; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4607, DOI 10.1021/bi00561a011; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; NEUGEBAUER DC, 1983, METHOD ENZYMOL, V97, P218; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294	25	578	613	9	128	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2001	411	6839					786	789		10.1038/35081051	http://dx.doi.org/10.1038/35081051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459054				2022-12-24	WOS:000169246400045
J	Gilbert, IR; Jarvis, PG; Smith, H				Gilbert, IR; Jarvis, PG; Smith, H			Proximity signal and shade avoidance differences between early and late successional trees	NATURE			English	Article							NATURAL-ENVIRONMENT; LIGHT QUALITY; PHYTOCHROME; PLANTS; PERCEPTION; CANOPIES; GROWTH	Competitive interactions between plants determine the success of individuals and species. In developing forests, competition for light is the predominant factor. Shade tolerators acclimate photo-synthetically to low light(1-3) and are capable of long-term survival under the shade cast by others, whereas shade avoiders rapidly dominate gaps but are overtaken in due course by shade-tolerant, later successional species. Shade avoidance(4-6) results from the phytochrome-mediated perception of far-red radiation (700- 800 nm) scattered from the leaves of neighbours, provides early warning of shading(7), and induces developmental responses that, when successful, result in the overgrowth of those neighbours(8). Shade tolerators cast a deep shade, whereas less-tolerant species cast light shade(9), and saplings tend to have high survivorship in shade cast by conspecific adults, but high rates of mortality when shaded by more-tolerant species(9). Here we report a parallel relationship in which the shade-avoidance responses of three tree species are inversely proportional to proximity signals generated by those species. On this basis, early successional species generate small proximity signals but react strongly to them, whereas late successional species react weakly but generate strong signals.	Univ Nottingham, Div Plant Sci, Loughborough LE12 5RD, Leics, England; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland	University of Nottingham; University of Edinburgh; University of Edinburgh	Smith, H (corresponding author), Univ Nottingham, Div Plant Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Harry.Smith@Nottingham.ac.uk						BALLARE CL, 1990, SCIENCE, V247, P329, DOI 10.1126/science.247.4940.329; Bj÷rkman O., 1981, ENCY PLANT PHYSL A, P57; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; CANHAM CD, 1994, CAN J FOREST RES, V24, P337, DOI 10.1139/x94-046; CASAL JJ, 1989, PLANT CELL ENVIRON, V12, P855, DOI 10.1111/j.1365-3040.1989.tb01966.x; CHILD R, 1981, NEW PHYTOL, V89, P545, DOI 10.1111/j.1469-8137.1981.tb02334.x; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; HAYWARD PM, 1984, TECHNIQUES PHOTOMORP, P159; Kull O, 1998, FUNCT ECOL, V12, P472, DOI 10.1046/j.1365-2435.1998.00214.x; Lei TT, 1998, ANN BOT-LONDON, V82, P9, DOI 10.1006/anbo.1998.0644; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MORGAN DC, 1976, NATURE, V262, P210, DOI 10.1038/262210a0; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; SMITH H, 1977, PHOTOCHEM PHOTOBIOL, V25, P547; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445	16	91	98	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2001	411	6839					792	795		10.1038/35081062	http://dx.doi.org/10.1038/35081062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	441TV	11459056	Green Published			2022-12-24	WOS:000169246400047
J	SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ				SCHMUTTENMAER, CA; COHEN, RC; PUGLIANO, N; HEATH, JR; COOKSY, AL; BUSAROW, KL; SAYKALLY, RJ			TUNABLE FAR-IR LASER SPECTROSCOPY OF JET-COOLED CARBON CLUSTERS - THE NU-2 BENDING VIBRATION OF C-3	SCIENCE			English	Article									UNIV CALIF BERKELEY,DIV CHEM SCI,BERKELEY,CA 94720; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	SCHMUTTENMAER, CA (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.		Cohen, Ronald C/A-8842-2011	Cohen, Ronald C/0000-0001-6617-7691; Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; COHEN RC, 1989, CHEM PHYS LETT, V164, P321, DOI 10.1016/0009-2614(89)85212-1; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; GAUSSET L, 1965, ASTROPHYS J, V142, P45, DOI 10.1086/148262; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; KAUR D, 1990, APPL OPTICS, V29, P119, DOI 10.1364/AO.29.000119; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RHEATH JR, 1989, SCIENCE, V244, P564; ROHLFING EA, 1988, J CHEM PHYS, V89, P6103, DOI 10.1063/1.455426; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZMUIDZINAS J, 1988, ASTROPHYS J, V335, P774, DOI 10.1086/166966	15	102	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 24	1990	249	4971					897	900		10.1126/science.11538082	http://dx.doi.org/10.1126/science.11538082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV751	11538082				2022-12-24	WOS:A1990DV75100038
J	Long, MY; Thornton, K				Long, MY; Thornton, K			Gene duplication and evolution	SCIENCE			English	Editorial Material							PRESERVATION; DROSOPHILA		Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Vision, Todd J/B-4867-2010	Vision, Todd J/0000-0002-6133-2581; Thornton, Kevin/0000-0003-0743-4445				Force A, 1999, GENETICS, V151, P1531; Li W-H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985; Zeng LW, 1998, GENETICA, V102-3, P369, DOI 10.1023/A:1017035109224	9	62	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1551	1551						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533445				2022-12-24	WOS:000170802900001
